1 WORDTAG Third 
511 WORDTAG , 
4 WORDTAG consistent 
115 WORDTAG with 
19 WORDTAG these 
12 WORDTAG data 
10 WORDTAG N 
520 WORDTAG - 
1 WORDTAG acetylcysteine 
4 WORDTAG reduced 
581 WORDTAG the 
1 WORDTAG stimulatory 
12 WORDTAG effect 
539 WORDTAG of 
1 WORDTAG HGF 
37 WORDTAG on 
6 WORDTAG stress 
26 WORDTAG kinase 
3 WORDTAG activities 
3 WORDTAG while 
1 WORDTAG p42 
82 WORDTAG / 
1 WORDTAG 44 
4 WORDTAG mitogen 
7 WORDTAG activated 
252 WORDTAG ( 
7 WORDTAG MAPK 
169 WORDTAG ) 
81 WORDTAG was 
1 WORDTAG unmodified 
4 WORDTAG suggesting 
40 WORDTAG an 
1 WORDTAG involvement 
6 WORDTAG c 
2 WORDTAG Jun 
16 WORDTAG terminal 
3 WORDTAG JNK 
373 WORDTAG and 
1 WORDTAG p38 
305 WORDTAG in 
4 WORDTAG HIF 
65 WORDTAG 1 
18 WORDTAG activation 
587 WORDTAG . 
85 WORDTAG The 
1 WORDTAG Sox 
64 WORDTAG gene 
9 WORDTAG family 
1 WORDTAG Sry 
7 WORDTAG like 
1 WORDTAG HMG 
4 WORDTAG box 
88 WORDTAG is 
1 WORDTAG characterised 
103 WORDTAG by 
194 WORDTAG a 
5 WORDTAG conserved 
19 WORDTAG DNA 
18 WORDTAG sequence 
9 WORDTAG encoding 
22 WORDTAG domain 
3 WORDTAG approximately 
3 WORDTAG 80 
13 WORDTAG amino 
8 WORDTAG acids 
29 WORDTAG which 
3 WORDTAG responsible 
106 WORDTAG for 
15 WORDTAG specific 
32 WORDTAG binding 
1 WORDTAG Respiratory 
4 WORDTAG parameters 
3 WORDTAG suggested 
95 WORDTAG that 
1 WORDTAG M6G 
4 WORDTAG produced 
4 WORDTAG less 
2 WORDTAG respiratory 
1 WORDTAG depression 
23 WORDTAG than 
1 WORDTAG morphine 
14 WORDTAG This 
2 WORDTAG slow 
3 WORDTAG progression 
12 WORDTAG through 
6 WORDTAG early 
5 WORDTAG G1 
4 WORDTAG phase 
4 WORDTAG resulted 
7 WORDTAG decreased 
14 WORDTAG phosphorylation 
1 WORDTAG RB 
61 WORDTAG protein 
3 WORDTAG subsequent 
1 WORDTAG delay 
9 WORDTAG into 
8 WORDTAG S 
3 WORDTAG transition 
2 WORDTAG Responses 
1 WORDTAG TLD 
2 WORDTAG Mg2SiO4 
57 WORDTAG : 
2 WORDTAG Tb 
1 WORDTAG radiophotoluminescent 
1 WORDTAG glass 
219 WORDTAG to 
2 WORDTAG heavy 
1 WORDTAG charged 
1 WORDTAG particles 
4 WORDTAG space 
4 WORDTAG radiation 
37 WORDTAG In 
1 WORDTAG meantime 
8 WORDTAG one 
17 WORDTAG has 
1 WORDTAG succeeded 
4 WORDTAG establish 
1 WORDTAG deammonification 
2 WORDTAG processes 
1 WORDTAG continuous 
5 WORDTAG flow 
1 WORDTAG moving 
1 WORDTAG bed 
1 WORDTAG pilot 
3 WORDTAG plant 
3 WORDTAG An 
4 WORDTAG 18 
5 WORDTAG kb 
9 WORDTAG genomic 
2 WORDTAG clone 
3 WORDTAG including 
8 WORDTAG sequences 
27 WORDTAG two 
1 WORDTAG GHS 
5 WORDTAG R 
2 WORDTAG variants 
5 WORDTAG isolated 
10 WORDTAG further 
6 WORDTAG development 
1 WORDTAG bladder 
1 WORDTAG neck 
1 WORDTAG suspension 
2 WORDTAG according 
1 WORDTAG Stamey 
1 WORDTAG Pereyra 
9 WORDTAG use 
1 WORDTAG miniature 
7 WORDTAG bone 
1 WORDTAG anchors 
6 WORDTAG received 
2 WORDTAG considerable 
4 WORDTAG support 
1 WORDTAG CHAP 
2 WORDTAG Department 
1 WORDTAG Veterans 
1 WORDTAG Affairs 
3 WORDTAG Finally 
1 WORDTAG chromogenic 
7 WORDTAG method 
12 WORDTAG used 
9 WORDTAG based 
1 WORDTAG thrombin 
6 WORDTAG inhibition 
1 WORDTAG substrate 
1 WORDTAG 2238 
3 WORDTAG As 
3 WORDTAG oral 
1 WORDTAG nontoxic 
2 WORDTAG compound 
4 WORDTAG mechanism 
1 WORDTAG action 
2 WORDTAG distinct 
37 WORDTAG from 
2 WORDTAG ABL 
10 WORDTAG tyrosine 
1 WORDTAG FTI 
1 WORDTAG SCH66336 
3 WORDTAG shows 
1 WORDTAG promise 
13 WORDTAG treatment 
2 WORDTAG BCR 
15 WORDTAG induced 
4 WORDTAG leukemia 
1 WORDTAG Recruitment 
7 WORDTAG RNA 
4 WORDTAG polymerase 
12 WORDTAG II 
11 WORDTAG complex 
9 WORDTAG mediated 
2 WORDTAG constitutive 
7 WORDTAG CREB 
2 WORDTAG independently 
7 WORDTAG Our 
21 WORDTAG results 
34 WORDTAG are 
1 WORDTAG reassuring 
24 WORDTAG we 
2 WORDTAG therefore 
1 WORDTAG advise 
28 WORDTAG patients 
3 WORDTAG undergoing 
3 WORDTAG free 
1 WORDTAG jejunum 
4 WORDTAG flap 
1 WORDTAG reconstruction 
1 WORDTAG hypopharyngo 
2 WORDTAG esophageal 
1 WORDTAG tract 
2 WORDTAG voice 
1 WORDTAG restoration 
4 WORDTAG should 
35 WORDTAG be 
1 WORDTAG attempted 
1 WORDTAG placing 
1 WORDTAG prosthesis 
5 WORDTAG secondary 
1 WORDTAG tracheo 
1 WORDTAG puncture 
1 WORDTAG providing 
1 WORDTAG intensive 
1 WORDTAG speech 
1 WORDTAG training 
1 WORDTAG Regarding 
2 WORDTAG gestational 
9 WORDTAG risk 
40 WORDTAG 3 
1 WORDTAG 243 
2 WORDTAG drugs 
2 WORDTAG 34 
6 WORDTAG %) 
1 WORDTAG belonged 
7 WORDTAG category 
30 WORDTAG A 
1 WORDTAG 923 
1 WORDTAG 22 
19 WORDTAG 6 
21 WORDTAG B 
1 WORDTAG 798 
1 WORDTAG 39 
14 WORDTAG 7 
31 WORDTAG C 
1 WORDTAG 289 
52 WORDTAG 0 
6 WORDTAG D 
4 WORDTAG 55 
7 WORDTAG X 
25 WORDTAG human 
1 WORDTAG ABCG1 
3 WORDTAG encodes 
5 WORDTAG member 
3 WORDTAG ATP 
4 WORDTAG cassette 
2 WORDTAG ABC 
2 WORDTAG superfamily 
3 WORDTAG transporter 
13 WORDTAG proteins 
4 WORDTAG highly 
9 WORDTAG when 
1 WORDTAG macrophages 
1 WORDTAG incubated 
1 WORDTAG oxysterols 
5 WORDTAG At 
6 WORDTAG end 
5 WORDTAG each 
4 WORDTAG day 
1 WORDTAG migration 
2 WORDTAG pulmonary 
1 WORDTAG hemolymph 
1 WORDTAG PO2 
64 WORDTAG 2 
30 WORDTAG 5 
1 WORDTAG kPa 
22 WORDTAG but 
1 WORDTAG hemocyanin 
1 WORDTAG remained 
1 WORDTAG saturated 
2 WORDTAG O2 
2 WORDTAG venous 
1 WORDTAG reserve 
2 WORDTAG largely 
1 WORDTAG unchanged 
9 WORDTAG > 
18 WORDTAG 4 
4 WORDTAG mmol 
3 WORDTAG x 
4 WORDTAG l 
4 WORDTAG (- 
1 WORDTAG )). 
19 WORDTAG We 
21 WORDTAG have 
3 WORDTAG investigated 
12 WORDTAG role 
5 WORDTAG NGF 
5 WORDTAG regulating 
22 WORDTAG transcription 
2 WORDTAG PC12 
1 WORDTAG INS 
34 WORDTAG cells 
3 WORDTAG order 
3 WORDTAG define 
2 WORDTAG if 
4 WORDTAG there 
5 WORDTAG regulated 
21 WORDTAG genes 
5 WORDTAG per 
1 WORDTAG se 
8 WORDTAG Thus 
6 WORDTAG change 
1 WORDTAG conformation 
4 WORDTAG upon 
2 WORDTAG repair 
1 WORDTAG 6RG 
4 WORDTAG lesion 
2 WORDTAG MGMT 
1 WORDTAG switches 
21 WORDTAG factor 
4 WORDTAG regulator 
32 WORDTAG ), 
1 WORDTAG enabling 
36 WORDTAG cell 
2 WORDTAG sense 
46 WORDTAG as 
4 WORDTAG well 
2 WORDTAG respond 
1 WORDTAG mutagens 
1 WORDTAG TaqMan 
20 WORDTAG analysis 
36 WORDTAG expression 
5 WORDTAG following 
5 WORDTAG chronic 
1 WORDTAG FA 
13 WORDTAG showed 
2 WORDTAG neither 
5 WORDTAG decrease 
3 WORDTAG amount 
1 WORDTAG leptin 
27 WORDTAG receptor 
1 WORDTAG Ob 
10 WORDTAG mRNA 
2 WORDTAG nor 
10 WORDTAG increase 
14 WORDTAG negative 
3 WORDTAG regulators 
2 WORDTAG STAT 
2 WORDTAG signalling 
1 WORDTAG SOCS3 
1 WORDTAG suppressors 
2 WORDTAG cytokine 
51 WORDTAG or 
5 WORDTAG inducible 
1 WORDTAG CIS 
31 WORDTAG ). 
2 WORDTAG Nine 
3 WORDTAG animals 
1 WORDTAG served 
14 WORDTAG control 
3 WORDTAG whereas 
8 WORDTAG 20 
3 WORDTAG focal 
1 WORDTAG arachnoid 
1 WORDTAG scar 
47 WORDTAG at 
2 WORDTAG C1 
1 WORDTAG C2 
1 WORDTAG placement 
1 WORDTAG kaolin 
1 WORDTAG soaked 
1 WORDTAG fibrin 
1 WORDTAG sponge 
1 WORDTAG posterior 
3 WORDTAG surface 
2 WORDTAG spinal 
1 WORDTAG cord 
2 WORDTAG comparison 
3 WORDTAG duplicated 
1 WORDTAG Vkappa 
5 WORDTAG suggests 
11 WORDTAG positive 
1 WORDTAG selection 
1 WORDTAG complementarity 
2 WORDTAG determining 
11 WORDTAG regions 
11 WORDTAG point 
2 WORDTAG mutations 
1 WORDTAG They 
39 WORDTAG not 
14 WORDTAG been 
7 WORDTAG previously 
5 WORDTAG reported 
4 WORDTAG reaction 
3 WORDTAG i 
3 WORDTAG v 
7 WORDTAG contrast 
1 WORDTAG material 
3 WORDTAG presence 
1 WORDTAG AS 
1 WORDTAG oligo 
14 WORDTAG had 
8 WORDTAG no 
1 WORDTAG FSH 
1 WORDTAG EB 
1 WORDTAG *- 
1 WORDTAG mTf 
2 WORDTAG CAT 
4 WORDTAG construct 
2 WORDTAG cAMP 
2 WORDTAG homologous 
5 WORDTAG active 
13 WORDTAG site 
1 WORDTAG framework 
3 WORDTAG enzymes 
2 WORDTAG structures 
1 WORDTAG convergent 
3 WORDTAG evolution 
4 WORDTAG common 
2 WORDTAG catalytic 
2 WORDTAG Additional 
2 WORDTAG education 
1 WORDTAG research 
1 WORDTAG needed 
2 WORDTAG provide 
1 WORDTAG direction 
2 WORDTAG intervention 
1 WORDTAG incorporation 
1 WORDTAG practice 
2 WORDTAG Many 
10 WORDTAG important 
12 WORDTAG associated 
18 WORDTAG regulation 
8 WORDTAG shown 
4 WORDTAG play 
2 WORDTAG key 
4 WORDTAG proliferation 
4 WORDTAG differentiation 
1 WORDTAG oncogenic 
5 WORDTAG transformation 
2 WORDTAG programmed 
2 WORDTAG death 
3 WORDTAG apoptosis 
1 WORDTAG Drug 
5 WORDTAG interactions 
12 WORDTAG found 
1 WORDTAG compete 
3 WORDTAG same 
1 WORDTAG CYP450 
1 WORDTAG isoenzymes 
1 WORDTAG statins 
1 WORDTAG Regulation 
1 WORDTAG laminin 
1 WORDTAG beta2 
6 WORDTAG chain 
14 WORDTAG cancer 
6 WORDTAG lines 
2 WORDTAG Mutation 
4 WORDTAG NF 
4 WORDTAG kappaB 
1 WORDTAG Mdr1b 
28 WORDTAG promoter 
1 WORDTAG prevents 
16 WORDTAG its 
10 WORDTAG induction 
6 WORDTAG TNF 
9 WORDTAG alpha 
1 WORDTAG Effect 
1 WORDTAG heat 
2 WORDTAG treatments 
1 WORDTAG meltability 
2 WORDTAG cheeses 
9 WORDTAG vitro 
5 WORDTAG studies 
4 WORDTAG demonstrate 
2 WORDTAG eIF 
2 WORDTAG 5A 
8 WORDTAG required 
2 WORDTAG efficient 
12 WORDTAG interaction 
2 WORDTAG Rev 
1 WORDTAG NES 
1 WORDTAG CRM1 
1 WORDTAG exportin1 
4 WORDTAG interacts 
1 WORDTAG nucleoporins 
1 WORDTAG CAN 
1 WORDTAG nup214 
1 WORDTAG nup153 
1 WORDTAG nup98 
1 WORDTAG nup62 
1 WORDTAG Forced 
1 WORDTAG BZAP45 
4 WORDTAG strongly 
1 WORDTAG stimulates 
1 WORDTAG H4 
1 WORDTAG nt 
1 WORDTAG 215 
4 WORDTAG )/ 
4 WORDTAG reporter 
27 WORDTAG activity 
4 WORDTAG Copyright 
5 WORDTAG 2001 
3 WORDTAG Academic 
3 WORDTAG Press 
2 WORDTAG diagnosis 
1 WORDTAG HCV 
1 WORDTAG arthritis 
1 WORDTAG rheumatoid 
3 WORDTAG inflammatory 
1 WORDTAG polyarthritis 
17 WORDTAG may 
1 WORDTAG difficult 
1 WORDTAG UBA 
5 WORDTAG domains 
1 WORDTAG RAD23 
1 WORDTAG DDI1 
2 WORDTAG E47 
25 WORDTAG levels 
1 WORDTAG remain 
6 WORDTAG high 
1 WORDTAG until 
2 WORDTAG double 
2 WORDTAG developmental 
3 WORDTAG stage 
3 WORDTAG they 
1 WORDTAG drop 
2 WORDTAG relatively 
1 WORDTAG moderate 
1 WORDTAG downregulated 
12 WORDTAG single 
1 WORDTAG By 
1 WORDTAG Caveman 
12 WORDTAG These 
4 WORDTAG findings 
8 WORDTAG suggest 
1 WORDTAG adapter 
1 WORDTAG Gab1 
1 WORDTAG redirect 
1 WORDTAG Met 
7 WORDTAG signaling 
2 WORDTAG PI3K 
1 WORDTAG away 
1 WORDTAG Akt 
1 WORDTAG Pak1 
3 WORDTAG survival 
7 WORDTAG pathway 
1 WORDTAG Another 
10 WORDTAG mutant 
1 WORDTAG T255A 
2 WORDTAG lost 
6 WORDTAG ability 
5 WORDTAG bind 
1 WORDTAG E4orf6 
2 WORDTAG unexpectedly 
1 WORDTAG viral 
1 WORDTAG late 
3 WORDTAG affected 
8 WORDTAG However 
1 WORDTAG N63S 
10 WORDTAG mutation 
5 WORDTAG wild 
12 WORDTAG type 
1 WORDTAG VP5 
2 WORDTAG background 
13 WORDTAG increased 
1 WORDTAG judged 
11 WORDTAG beta 
1 WORDTAG galactosidase 
9 WORDTAG 9 
4 WORDTAG relative 
1 WORDTAG PR7 
6 WORDTAG present 
4 WORDTAG Here 
1 WORDTAG report 
2 WORDTAG isolation 
5 WORDTAG characterization 
2 WORDTAG forkhead 
2 WORDTAG homologue 
1 WORDTAG rhabdomyosarcoma 
1 WORDTAG FKHR 
2 WORDTAG recently 
5 WORDTAG described 
1 WORDTAG hepatocyte 
9 WORDTAG nuclear 
1 WORDTAG homeotic 
2 WORDTAG hormone 
1 WORDTAG NR 
1 WORDTAG intermediary 
1 WORDTAG Unlike 
12 WORDTAG other 
2 WORDTAG progenitor 
6 WORDTAG brain 
1 WORDTAG SVZa 
5 WORDTAG capacity 
1 WORDTAG divide 
6 WORDTAG even 
3 WORDTAG though 
4 WORDTAG express 
3 WORDTAG neuronal 
2 WORDTAG phenotype 
4 WORDTAG Tax 
3 WORDTAG cycle 
1 WORDTAG G0 
1 WORDTAG G2 
6 WORDTAG M 
1 WORDTAG phases 
10 WORDTAG T 
6 WORDTAG line 
1 WORDTAG Kit 
1 WORDTAG 225 
1 WORDTAG Phosphotyrosyl 
3 WORDTAG peptides 
2 WORDTAG block 
1 WORDTAG Stat3 
1 WORDTAG Exp 
2 WORDTAG Human 
6 WORDTAG cDNA 
1 WORDTAG library 
3 WORDTAG screening 
20 WORDTAG ' 
5 WORDTAG rapid 
1 WORDTAG amplification 
2 WORDTAG ends 
1 WORDTAG yielded 
5 WORDTAG full 
4 WORDTAG length 
1 WORDTAG DENTT 
12 WORDTAG containing 
1 WORDTAG 1899 
9 WORDTAG bp 
3 WORDTAG open 
2 WORDTAG reading 
2 WORDTAG frame 
1 WORDTAG predicted 
1 WORDTAG 633 
13 WORDTAG acid 
7 WORDTAG four 
5 WORDTAG potential 
3 WORDTAG localization 
2 WORDTAG signals 
1 WORDTAG NLSs 
1 WORDTAG coiled 
1 WORDTAG coil 
1 WORDTAG NaeI 
9 WORDTAG novel 
1 WORDTAG endonuclease 
2 WORDTAG topoisomerase 
2 WORDTAG recombinase 
1 WORDTAG Lys 
2 WORDTAG residue 
1 WORDTAG substituted 
1 WORDTAG Leu 
3 WORDTAG 43 
1 WORDTAG rev 
1 WORDTAG RRE 
1 WORDTAG defective 
6 WORDTAG HIV 
3 WORDTAG molecular 
2 WORDTAG complementation 
3 WORDTAG experiments 
1 WORDTAG posttranscriptional 
9 WORDTAG regulatory 
4 WORDTAG elements 
4 WORDTAG mammalian 
4 WORDTAG genome 
1 WORDTAG selecting 
1 WORDTAG rescue 
8 WORDTAG virus 
4 WORDTAG replication 
1 WORDTAG OBJECTIVES 
1 WORDTAG objective 
24 WORDTAG this 
3 WORDTAG review 
1 WORDTAG compare 
1 WORDTAG effectiveness 
1 WORDTAG safety 
1 WORDTAG acceptability 
1 WORDTAG diaphragm 
10 WORDTAG without 
1 WORDTAG spermicide 
2 WORDTAG DESIGN 
1 WORDTAG Retrospective 
12 WORDTAG study 
1 WORDTAG Considering 
2 WORDTAG reactor 
1 WORDTAG thoroughly 
2 WORDTAG mixed 
18 WORDTAG during 
1 WORDTAG discharge 
1 WORDTAG LD50 
27 WORDTAG = 
2 WORDTAG values 
2 WORDTAG nearly 
8 WORDTAG independent 
6 WORDTAG E 
4 WORDTAG coli 
7 WORDTAG concentrations 
9 WORDTAG range 
8 WORDTAG 10 
7 WORDTAG < 
1 WORDTAG cfu 
1 WORDTAG mL 
1 WORDTAG ascribe 
1 WORDTAG nonexponential 
1 WORDTAG Pn 
1 WORDTAG decay 
3 WORDTAG strain 
1 WORDTAG colonies 
1 WORDTAG shielding 
2 WORDTAG phenomenon 
2 WORDTAG where 
3 WORDTAG inactive 
1 WORDTAG protect 
1 WORDTAG successively 
2 WORDTAG smaller 
2 WORDTAG numbers 
1 WORDTAG viable 
1 WORDTAG EHD 
4 WORDTAG encode 
1 WORDTAG tryptophanyl 
2 WORDTAG tRNA 
1 WORDTAG translocase 
4 WORDTAG component 
1 WORDTAG SecE 
1 WORDTAG antiterminator 
1 WORDTAG NusG 
1 WORDTAG ribosomal 
1 WORDTAG L11 
2 WORDTAG L1 
6 WORDTAG addition 
1 WORDTAG PkwR 
1 WORDTAG putative 
1 WORDTAG LacI 
1 WORDTAG GalR 
1 WORDTAG Body 
1 WORDTAG fat 
2 WORDTAG distribution 
6 WORDTAG determined 
2 WORDTAG abdominal 
1 WORDTAG computed 
1 WORDTAG tomography 
1 WORDTAG telomerase 
2 WORDTAG maintenance 
1 WORDTAG telomeric 
6 WORDTAG chromosome 
1 WORDTAG usually 
8 WORDTAG most 
9 WORDTAG primary 
2 WORDTAG somatic 
4 WORDTAG specifically 
1 WORDTAG immortalization 
2 WORDTAG tumorigenesis 
1 WORDTAG challenging 
1 WORDTAG task 
1 WORDTAG insofar 
3 WORDTAG direct 
1 WORDTAG measures 
1 WORDTAG ISF 
3 WORDTAG glucose 
1 WORDTAG readily 
2 WORDTAG available 
1 WORDTAG SELECTION 
1 WORDTAG CRITERIA 
1 WORDTAG All 
2 WORDTAG randomised 
3 WORDTAG controlled 
2 WORDTAG trials 
1 WORDTAG comparing 
1 WORDTAG IUSs 
6 WORDTAG forms 
1 WORDTAG reversible 
1 WORDTAG contraceptives 
1 WORDTAG reporting 
2 WORDTAG pre 
1 WORDTAG outcomes 
3 WORDTAG women 
2 WORDTAG reproductive 
4 WORDTAG years 
6 WORDTAG There 
3 WORDTAG statistically 
10 WORDTAG significant 
3 WORDTAG correlation 
17 WORDTAG between 
1 WORDTAG simultaneous 
2 WORDTAG weekly 
1 WORDTAG average 
3 WORDTAG pollen 
1 WORDTAG Philadelphia 
1 WORDTAG Cherry 
1 WORDTAG Hill 
1 WORDTAG Acer 
10 WORDTAG r 
11 WORDTAG p 
1 WORDTAG 987 
1 WORDTAG Quercus 
1 WORDTAG 645 
1 WORDTAG Betula 
1 WORDTAG 896 
1 WORDTAG Pinus 
1 WORDTAG 732 
1 WORDTAG Cupressaceae 
1 WORDTAG 695 
1 WORDTAG Poaceae 
1 WORDTAG 950 
1 WORDTAG Ambrosia 
1 WORDTAG 903 
1 WORDTAG Rumex 
1 WORDTAG 572 
16 WORDTAG P 
2 WORDTAG 001 
2 WORDTAG Through 
5 WORDTAG mechanisms 
1 WORDTAG Arf 
5 WORDTAG inhibits 
2 WORDTAG oncoprotein 
1 WORDTAG Hdm2 
8 WORDTAG p53 
1 WORDTAG dynamic 
1 WORDTAG moduli 
1 WORDTAG microcrystalline 
2 WORDTAG cellulose 
1 WORDTAG Such 
2 WORDTAG knowledge 
5 WORDTAG could 
1 WORDTAG advance 
7 WORDTAG patient 
1 WORDTAG counseling 
8 WORDTAG show 
1 WORDTAG uncertainties 
1 WORDTAG models 
1 WORDTAG terrestrial 
1 WORDTAG planets 
2 WORDTAG dense 
1 WORDTAG atmosphere 
1 WORDTAG Venus 
11 WORDTAG can 
1 WORDTAG evolve 
11 WORDTAG only 
2 WORDTAG possible 
1 WORDTAG rotation 
1 WORDTAG states 
1 WORDTAG WASP 
3 WORDTAG activates 
1 WORDTAG TCR 
3 WORDTAG stimulation 
4 WORDTAG manner 
1 WORDTAG Arp2 
2 WORDTAG directed 
1 WORDTAG actin 
1 WORDTAG polymerization 
1 WORDTAG ubiquitous 
1 WORDTAG p19 
1 WORDTAG INK4d 
2 WORDTAG murine 
1 WORDTAG lineage 
1 WORDTAG animal 
4 WORDTAG model 
1 WORDTAG dystonia 
1 WORDTAG appears 
1 WORDTAG NAD 
1 WORDTAG man 
1 WORDTAG viewpoint 
12 WORDTAG response 
4 WORDTAG indicate 
3 WORDTAG evaluation 
2 WORDTAG exposure 
1 WORDTAG neurona 
1 WORDTAG WB 
9 WORDTAG serum 
1 WORDTAG misleading 
1 WORDTAG young 
1 WORDTAG horses 
1 WORDTAG Delta6CCI 
1 WORDTAG extremely 
2 WORDTAG attenuated 
1 WORDTAG yet 
1 WORDTAG retained 
1 WORDTAG infectiousness 
1 WORDTAG CEMx174 
1 WORDTAG MT4 
2 WORDTAG OBJECTIVE 
10 WORDTAG To 
2 WORDTAG determine 
5 WORDTAG association 
1 WORDTAG depressive 
2 WORDTAG symptoms 
9 WORDTAG related 
3 WORDTAG mortality 
2 WORDTAG decline 
1 WORDTAG CD4 
1 WORDTAG lymphocyte 
1 WORDTAG counts 
3 WORDTAG among 
1 WORDTAG Phase 
3 WORDTAG paclitaxel 
1 WORDTAG etoposide 
1 WORDTAG locally 
3 WORDTAG advanced 
2 WORDTAG metastatic 
4 WORDTAG non 
4 WORDTAG small 
9 WORDTAG lung 
1 WORDTAG Analyses 
3 WORDTAG revealed 
2 WORDTAG scale 
1 WORDTAG matters 
2 WORDTAG above 
1 WORDTAG beyond 
1 WORDTAG quadrat 
4 WORDTAG area 
1 WORDTAG Rind 
1 WORDTAG et 
1 WORDTAG al 
1 WORDTAG .' 
10 WORDTAG s 
3 WORDTAG main 
1 WORDTAG conclusions 
55 WORDTAG were 
2 WORDTAG supported 
1 WORDTAG original 
1 WORDTAG Not 
1 WORDTAG Available 
1 WORDTAG Lactate 
2 WORDTAG accumulation 
4 WORDTAG peak 
1 WORDTAG unaffected 
2 WORDTAG supplementation 
1 WORDTAG HMB 
16 WORDTAG 8 
13 WORDTAG +/- 
3 WORDTAG mM 
19 WORDTAG ; 
1 WORDTAG LEU 
1 WORDTAG CON 
1 WORDTAG abi1 
2 WORDTAG product 
1 WORDTAG ABA 
2 WORDTAG suppression 
2 WORDTAG GA 
4 WORDTAG responsive 
2 WORDTAG amylase 
1 WORDTAG Polyclonal 
5 WORDTAG antibodies 
4 WORDTAG against 
4 WORDTAG part 
4 WORDTAG 12 
2 WORDTAG 363 
1 WORDTAG 330 
1 WORDTAG 730 
2 WORDTAG rainbow 
2 WORDTAG trout 
3 WORDTAG 1alpha 
2 WORDTAG recognized 
1 WORDTAG chinook 
1 WORDTAG salmon 
3 WORDTAG Western 
5 WORDTAG blot 
2 WORDTAG Southern 
1 WORDTAG hybrids 
2 WORDTAG endothelial 
1 WORDTAG TACC 
2 WORDTAG maps 
1 WORDTAG PABP 
1 WORDTAG modular 
1 WORDTAG extensive 
5 WORDTAG terminus 
1 WORDTAG 95 
18 WORDTAG % 
2 WORDTAG CI 
2 WORDTAG micromol 
7 WORDTAG L 
1 WORDTAG 003 
5 WORDTAG mean 
1 WORDTAG waiting 
10 WORDTAG time 
2 WORDTAG receive 
1 WORDTAG pancreas 
1 WORDTAG transplant 
1 WORDTAG 244 
6 WORDTAG days 
1 WORDTAG SPK 
1 WORDTAG 167 
1 WORDTAG PAK 
2 WORDTAG recipients 
1 WORDTAG Zarix 
1 WORDTAG expected 
1 WORDTAG enrollment 
1 WORDTAG Canadian 
11 WORDTAG clinical 
12 WORDTAG sites 
1 WORDTAG begin 
1 WORDTAG Spring 
8 WORDTAG [ 
1 WORDTAG 397955 
1 WORDTAG ], 
1 WORDTAG 405928 
1 WORDTAG ]. 
1 WORDTAG isoform 
2 WORDTAG designated 
1 WORDTAG HDAC9a 
1 WORDTAG 132 
1 WORDTAG aa 
1 WORDTAG shorter 
1 WORDTAG HDAC9 
1 WORDTAG Long 
10 WORDTAG mouse 
1 WORDTAG SCL 
3 WORDTAG loci 
3 WORDTAG localized 
3 WORDTAG sensitivity 
2 WORDTAG restriction 
2 WORDTAG endonucleases 
1 WORDTAG correspond 
1 WORDTAG precisely 
4 WORDTAG peaks 
1 WORDTAG noncoding 
3 WORDTAG Saccharomyces 
3 WORDTAG cerevisiae 
1 WORDTAG eIF6 
3 WORDTAG encoded 
5 WORDTAG copy 
5 WORDTAG essential 
2 WORDTAG Three 
2 WORDTAG additional 
1 WORDTAG cycles 
2 WORDTAG fluorouracil 
1 WORDTAG leucovorin 
3 WORDTAG chemotherapy 
9 WORDTAG RESULTS 
1 WORDTAG Thirty 
1 WORDTAG males 
4 WORDTAG 21 
2 WORDTAG females 
3 WORDTAG median 
4 WORDTAG age 
2 WORDTAG 31 
4 WORDTAG -- 
2 WORDTAG 73 
1 WORDTAG treated 
1 WORDTAG Within 
8 WORDTAG all 
8 WORDTAG groups 
2 WORDTAG re 
2 WORDTAG acquired 
1 WORDTAG responding 
1 WORDTAG heroin 
5 WORDTAG under 
1 WORDTAG CRF 
4 WORDTAG rates 
4 WORDTAG similar 
5 WORDTAG their 
3 WORDTAG performance 
2 WORDTAG application 
1 WORDTAG biotechnology 
2 WORDTAG plants 
1 WORDTAG storm 
1 WORDTAG waters 
1 WORDTAG industrial 
2 WORDTAG zone 
1 WORDTAG Telychka 
1 WORDTAG city 
1 WORDTAG Kyiv 
1 WORDTAG allowed 
1 WORDTAG content 
1 WORDTAG petroleum 
2 WORDTAG water 
1 WORDTAG dropped 
1 WORDTAG Dnieper 
1 WORDTAG constantly 
9 WORDTAG 50 
2 WORDTAG 100 
2 WORDTAG times 
3 WORDTAG Using 
1 WORDTAG immunochemical 
2 WORDTAG co 
1 WORDTAG precipitation 
2 WORDTAG methods 
15 WORDTAG also 
6 WORDTAG bound 
4 WORDTAG vivo 
1 WORDTAG Utility 
2 WORDTAG OAE 
2 WORDTAG screener 
2 WORDTAG GSI 
2 WORDTAG 70 
1 WORDTAG distortion 
1 WORDTAG otoacoustic 
1 WORDTAG emissions 
5 WORDTAG ] 
4 WORDTAG purpose 
4 WORDTAG investigate 
2 WORDTAG evaluate 
1 WORDTAG cochlea 
8 WORDTAG function 
2 WORDTAG neonates 
2 WORDTAG infants 
3 WORDTAG adults 
6 WORDTAG demonstrated 
4 WORDTAG hepatic 
4 WORDTAG artery 
6 WORDTAG alone 
1 WORDTAG ALT 
1 WORDTAG graft 
1 WORDTAG almost 
6 WORDTAG normal 
3 WORDTAG structure 
1 WORDTAG histologically 
2 WORDTAG month 
11 WORDTAG after 
1 WORDTAG grafting 
3 WORDTAG bile 
3 WORDTAG secretion 
2 WORDTAG preserved 
1 WORDTAG Mean 
2 WORDTAG Hg 
1 WORDTAG livers 
3 WORDTAG mice 
3 WORDTAG some 
1 WORDTAG Isle 
1 WORDTAG Royale 
11 WORDTAG significantly 
6 WORDTAG lower 
2 WORDTAG 62 
4 WORDTAG considered 
1 WORDTAG government 
1 WORDTAG agencies 
1 WORDTAG unhealthy 
2 WORDTAG consumption 
3 WORDTAG here 
1 WORDTAG extract 
6 WORDTAG contains 
2 WORDTAG initiator 
9 WORDTAG element 
2 WORDTAG thus 
1 WORDTAG participate 
1 WORDTAG recruiting 
1 WORDTAG SL 
1 WORDTAG desirability 
2 WORDTAG search 
2 WORDTAG global 
1 WORDTAG optimum 
1 WORDTAG f 
1 WORDTAG Y1 
1 WORDTAG Y2 
1 WORDTAG ..., 
1 WORDTAG Yn 
2 WORDTAG )] 
5 WORDTAG measured 
1 WORDTAG property 
1 WORDTAG dimensionless 
1 WORDTAG criterion 
1 WORDTAG Naltrexone 
1 WORDTAG hydrochloride 
2 WORDTAG synthetic 
3 WORDTAG opioid 
3 WORDTAG antagonist 
2 WORDTAG efforts 
1 WORDTAG detoxification 
1 WORDTAG mapped 
1 WORDTAG DGCR6 
1 WORDTAG 22q11 
9 WORDTAG within 
9 WORDTAG low 
2 WORDTAG repeat 
2 WORDTAG termed 
2 WORDTAG sc11 
1 WORDTAG 1a 
9 WORDTAG identified 
2 WORDTAG second 
1 WORDTAG DGCR6L 
1 WORDTAG duplicate 
3 WORDTAG locus 
1 WORDTAG 1b 
1 WORDTAG Proliferative 
1 WORDTAG vasculopathy 
1 WORDTAG cutaneous 
1 WORDTAG hemorrhages 
2 WORDTAG porcine 
2 WORDTAG infected 
5 WORDTAG syndrome 
1 WORDTAG child 
1 WORDTAG left 
1 WORDTAG behind 
4 WORDTAG hybrid 
5 WORDTAG system 
1 WORDTAG nonprenylated 
2 WORDTAG Rac1 
4 WORDTAG very 
2 WORDTAG weakly 
1 WORDTAG Rho 
1 WORDTAG GDI 
1 WORDTAG pointing 
1 WORDTAG predominant 
1 WORDTAG isoprene 
4 WORDTAG formation 
9 WORDTAG I 
1 WORDTAG argentina 
1 WORDTAG theezans 
1 WORDTAG exerted 
3 WORDTAG any 
1 WORDTAG BF 
1 WORDTAG intestinal 
1 WORDTAG propulsion 
24 WORDTAG region 
18 WORDTAG both 
1 WORDTAG serines 
1 WORDTAG destruction 
1 WORDTAG IkappaBalpha 
1 WORDTAG epsilon 
2 WORDTAG No 
4 WORDTAG dominant 
4 WORDTAG multiple 
3 WORDTAG regression 
2 WORDTAG body 
1 WORDTAG valve 
4 WORDTAG size 
1 WORDTAG shop 
1 WORDTAG fracture 
3 WORDTAG rate 
1 WORDTAG manufacturing 
3 WORDTAG period 
9 WORDTAG factors 
1 WORDTAG OSF 
8 WORDTAG growth 
3 WORDTAG binds 
7 WORDTAG rat 
1 WORDTAG aldolase 
3 WORDTAG Northern 
4 WORDTAG mlt 
3 WORDTAG normally 
7 WORDTAG expressed 
1 WORDTAG spleen 
1 WORDTAG stom 
1 WORDTAG ach 
10 WORDTAG liver 
2 WORDTAG NO 
1 WORDTAG metabolites 
3 WORDTAG measurement 
1 WORDTAG nitrate 
1 WORDTAG nitrite 
1 WORDTAG NOx 
3 WORDTAG creatinine 
2 WORDTAG cyclic 
1 WORDTAG guanosine 
1 WORDTAG monophosphate 
1 WORDTAG cGMP 
1 WORDTAG nmol 
6 WORDTAG plasma 
4 WORDTAG urine 
2 WORDTAG complement 
2 WORDTAG wide 
1 WORDTAG mapping 
1 WORDTAG sequencing 
4 WORDTAG it 
2 WORDTAG often 
4 WORDTAG generate 
1 WORDTAG detailed 
3 WORDTAG interest 
6 WORDTAG observed 
1 WORDTAG phenotypes 
2 WORDTAG explained 
3 WORDTAG selective 
3 WORDTAG disruption 
2 WORDTAG density 
2 WORDTAG lipoprotein 
3 WORDTAG due 
1 WORDTAG apolipoprotein 
1 WORDTAG microsomal 
1 WORDTAG triglyceride 
5 WORDTAG transfer 
1 WORDTAG ii 
1 WORDTAG cholesterol 
6 WORDTAG uptake 
7 WORDTAG major 
1 WORDTAG scavenger 
1 WORDTAG BI 
1 WORDTAG iii 
4 WORDTAG down 
1 WORDTAG basolateral 
2 WORDTAG transporters 
2 WORDTAG sodium 
1 WORDTAG taurocholate 
1 WORDTAG cotransporter 
1 WORDTAG organic 
1 WORDTAG anion 
2 WORDTAG Effects 
1 WORDTAG aerosol 
1 WORDTAG vapor 
1 WORDTAG JP 
1 WORDTAG jet 
1 WORDTAG fuel 
2 WORDTAG functional 
1 WORDTAG observational 
1 WORDTAG battery 
1 WORDTAG learning 
1 WORDTAG memory 
1 WORDTAG Mmip1 
1 WORDTAG Mad 
2 WORDTAG interacting 
1 WORDTAG Smc3 
1 WORDTAG share 
4 WORDTAG 99 
2 WORDTAG identity 
5 WORDTAG products 
4 WORDTAG identify 
2 WORDTAG cis 
3 WORDTAG involved 
4 WORDTAG tissue 
3 WORDTAG -, 
1 WORDTAG mE 
1 WORDTAG RABP 
4 WORDTAG fragment 
1 WORDTAG sequenced 
1 WORDTAG Regional 
8 WORDTAG blood 
1 WORDTAG blow 
2 WORDTAG means 
1 WORDTAG microspheres 
1 WORDTAG predefined 
1 WORDTAG C6 
1 WORDTAG T11 
1 WORDTAG L6 
1 WORDTAG vertebrae 
1 WORDTAG Breast 
2 WORDTAG assessment 
1 WORDTAG Who 
1 WORDTAG holds 
1 WORDTAG magic 
1 WORDTAG crystal 
1 WORDTAG ball 
3 WORDTAG ? 
1 WORDTAG frameshift 
3 WORDTAG initiated 
1 WORDTAG ADEx2 
1 WORDTAG believed 
2 WORDTAG alter 
1 WORDTAG regular 
2 WORDTAG coding 
1 WORDTAG acting 
5 WORDTAG loss 
1 WORDTAG ASIP 
7 WORDTAG CONCLUSIONS 
2 WORDTAG Adding 
3 WORDTAG MMF 
4 WORDTAG potent 
1 WORDTAG topical 
2 WORDTAG corticosteroid 
2 WORDTAG emollient 
2 WORDTAG cream 
10 WORDTAG more 
1 WORDTAG effective 
1 WORDTAG reducing 
3 WORDTAG acute 
1 WORDTAG dermatitis 
3 WORDTAG Although 
2 WORDTAG oxLDL 
2 WORDTAG might 
2 WORDTAG modified 
3 WORDTAG hypertension 
2 WORDTAG once 
3 WORDTAG coronary 
11 WORDTAG disease 
2 WORDTAG developed 
4 WORDTAG does 
5 WORDTAG affect 
5 WORDTAG anti 
1 WORDTAG reverse 
1 WORDTAG genetics 
1 WORDTAG introduced 
2 WORDTAG nucleotide 
1 WORDTAG UCU 
1 WORDTAG ACU 
2 WORDTAG immediate 
1 WORDTAG downstream 
1 WORDTAG editing 
12 WORDTAG V 
1 WORDTAG hPIV2 
1 WORDTAG able 
1 WORDTAG obtain 
2 WORDTAG infectious 
1 WORDTAG viruses 
1 WORDTAG rPIV2V 
1 WORDTAG (-)] 
1 WORDTAG companies 
2 WORDTAG Salmonella 
1 WORDTAG enteritidis 
1 WORDTAG typhimurium 
1 WORDTAG Tr104 
1 WORDTAG occasionally 
4 WORDTAG various 
2 WORDTAG locations 
2 WORDTAG Most 
10 WORDTAG yeast 
2 WORDTAG peroxisomal 
2 WORDTAG matrix 
2 WORDTAG contain 
1 WORDTAG 1C 
1 WORDTAG targeting 
6 WORDTAG signal 
1 WORDTAG PTS1 
3 WORDTAG consisting 
1 WORDTAG tripeptide 
1 WORDTAG SKL 
1 WORDTAG conservative 
2 WORDTAG variant 
1 WORDTAG thereof 
2 WORDTAG Tumor 
1 WORDTAG Tl 
1 WORDTAG 201 
1 WORDTAG SPECT 
1 WORDTAG subacute 
1 WORDTAG hemorrhagic 
1 WORDTAG cerebral 
1 WORDTAG infarction 
1 WORDTAG WRN 
2 WORDTAG helicase 
1 WORDTAG resolves 
2 WORDTAG alternate 
1 WORDTAG tetraplex 
1 WORDTAG triplex 
1 WORDTAG Holliday 
1 WORDTAG junctions 
2 WORDTAG number 
2 WORDTAG hairs 
4 WORDTAG defined 
2 WORDTAG 60 
2 WORDTAG microm 
1 WORDTAG diameter 
1 WORDTAG cm 
1 WORDTAG square 
6 WORDTAG 25 
3 WORDTAG cm2 
2 WORDTAG procyanidin 
19 WORDTAG group 
8 WORDTAG subjects 
2 WORDTAG trial 
2 WORDTAG greater 
3 WORDTAG placebo 
2 WORDTAG 58 
2 WORDTAG SD 
1 WORDTAG 82 
6 WORDTAG 40 
1 WORDTAG 02 
3 WORDTAG sample 
3 WORDTAG t 
9 WORDTAG test 
1 WORDTAG SKP1 
1 WORDTAG SnRK 
3 WORDTAG mediate 
1 WORDTAG proteasomal 
1 WORDTAG SCF 
2 WORDTAG ubiquitin 
1 WORDTAG ligase 
1 WORDTAG Based 
3 WORDTAG hypothesis 
1 WORDTAG evolutionarily 
1 WORDTAG functionally 
1 WORDTAG likely 
2 WORDTAG interact 
1 WORDTAG coactivators 
12 WORDTAG compared 
1 WORDTAG EBPalpha 
13 WORDTAG different 
3 WORDTAG species 
1 WORDTAG frog 
1 WORDTAG CR1 
1 WORDTAG CR4 
2 WORDTAG transactivation 
1 WORDTAG Colorectal 
1 WORDTAG disproportionately 
1 WORDTAG overburden 
1 WORDTAG Ashkenazi 
1 WORDTAG Jews 
3 WORDTAG who 
1 WORDTAG ovarian 
1 WORDTAG pancreatic 
1 WORDTAG stomach 
1 WORDTAG Hodgkin 
1 WORDTAG lymphoma 
1 WORDTAG Percentages 
2 WORDTAG recovery 
1 WORDTAG overload 
1 WORDTAG dilution 
3 WORDTAG tests 
1 WORDTAG 87 
2 WORDTAG 120 
2 WORDTAG %. 
2 WORDTAG situations 
2 WORDTAG separated 
1 WORDTAG breaks 
1 WORDTAG NHEJ 
1 WORDTAG deficiency 
3 WORDTAG leads 
1 WORDTAG rearrangements 
1 WORDTAG agreement 
3 WORDTAG chromosomal 
1 WORDTAG After 
1 WORDTAG nerve 
3 WORDTAG injury 
1 WORDTAG nociceptive 
2 WORDTAG responses 
1 WORDTAG neurons 
2 WORDTAG polymodal 
3 WORDTAG fibers 
4 WORDTAG drive 
1 WORDTAG NK1 
3 WORDTAG pain 
1 WORDTAG transmission 
4 WORDTAG completely 
10 WORDTAG changes 
3 WORDTAG ones 
2 WORDTAG NMDA 
3 WORDTAG III 
1 WORDTAG capsaicin 
1 WORDTAG insensitive 
2 WORDTAG possibly 
3 WORDTAG markedly 
4 WORDTAG enhanced 
1 WORDTAG SV1 
1 WORDTAG 33 
1 WORDTAG insert 
3 WORDTAG S1 
3 WORDTAG transmembrane 
2 WORDTAG overall 
1 WORDTAG hydrophobicity 
1 WORDTAG makes 
1 WORDTAG S0 
3 WORDTAG linker 
3 WORDTAG longer 
2 WORDTAG variety 
6 WORDTAG pathways 
4 WORDTAG extracellular 
4 WORDTAG base 
3 WORDTAG pair 
1 WORDTAG oligonucleotide 
1 WORDTAG nonamer 
1 WORDTAG confers 
3 WORDTAG up 
1 WORDTAG hypoxia 
1 WORDTAG unsaturated 
3 WORDTAG fatty 
2 WORDTAG placed 
5 WORDTAG upstream 
3 WORDTAG heterologous 
2 WORDTAG lacZ 
1 WORDTAG 2L 
6 WORDTAG receptors 
2 WORDTAG activate 
7 WORDTAG ERK 
2 WORDTAG cascade 
10 WORDTAG first 
1 WORDTAG mobilizing 
1 WORDTAG PDGF 
2 WORDTAG followed 
1 WORDTAG ERK1 
1 WORDTAG Raes 
3 WORDTAG differential 
2 WORDTAG techniques 
1 WORDTAG terms 
5 WORDTAG efficiency 
1 WORDTAG occurrence 
1 WORDTAG false 
1 WORDTAG positives 
1 WORDTAG EBPbeta 
1 WORDTAG LIP 
1 WORDTAG overexpressing 
1 WORDTAG HC11 
13 WORDTAG did 
1 WORDTAG casein 
2 WORDTAG mammary 
1 WORDTAG epithelial 
2 WORDTAG marker 
1 WORDTAG lactogenic 
1 WORDTAG hormones 
1 WORDTAG CD154 
1 WORDTAG CD40 
3 WORDTAG ligand 
1 WORDTAG Subacute 
1 WORDTAG diencephalic 
1 WORDTAG angioencephalopathy 
1 WORDTAG SDAE 
2 WORDTAG rare 
1 WORDTAG fatal 
2 WORDTAG unknown 
1 WORDTAG etiology 
3 WORDTAG involves 
1 WORDTAG thalami 
1 WORDTAG bilaterally 
1 WORDTAG elicits 
1 WORDTAG delayed 
3 WORDTAG sustained 
3 WORDTAG EGF 
3 WORDTAG previous 
1 WORDTAG reports 
1 WORDTAG TBARS 
3 WORDTAG oxygen 
2 WORDTAG radical 
1 WORDTAG absorbing 
3 WORDTAG assay 
1 WORDTAG AFR 
1 WORDTAG release 
3 WORDTAG assessed 
1 WORDTAG electron 
1 WORDTAG paramagnetic 
3 WORDTAG resonance 
1 WORDTAG EPR 
2 WORDTAG explore 
1 WORDTAG existence 
1 WORDTAG oxidative 
2 WORDTAG diabetes 
1 WORDTAG Pulmonary 
2 WORDTAG vein 
1 WORDTAG varix 
1 WORDTAG bilateral 
1 WORDTAG stenosis 
1 WORDTAG Derivation 
9 WORDTAG initial 
7 WORDTAG tumor 
2 WORDTAG carrying 
1 WORDTAG polyomavirus 
1 WORDTAG middle 
4 WORDTAG antigen 
1 WORDTAG utility 
1 WORDTAG therapeutics 
2 WORDTAG images 
2 WORDTAG predominantly 
1 WORDTAG urinary 
2 WORDTAG excretion 
1 WORDTAG 99mTc 
1 WORDTAG ciprofloxacin 
1 WORDTAG absent 
1 WORDTAG marrow 
1 WORDTAG interferon 
2 WORDTAG functions 
1 WORDTAG vIRF 
1 WORDTAG contribute 
1 WORDTAG establishment 
1 WORDTAG latent 
5 WORDTAG infection 
1 WORDTAG Topological 
1 WORDTAG mutational 
1 WORDTAG Ste14p 
1 WORDTAG founding 
1 WORDTAG isoprenylcysteine 
1 WORDTAG carboxyl 
1 WORDTAG methyltransferase 
4 WORDTAG Two 
1 WORDTAG remotely 
1 WORDTAG situated 
3 WORDTAG exons 
1 WORDTAG C3 
5 WORDTAG proximal 
1 WORDTAG ORF 
1 WORDTAG bidirectional 
2 WORDTAG sap 
3 WORDTAG flux 
3 WORDTAG densities 
1 WORDTAG registered 
1 WORDTAG old 
4 WORDTAG new 
2 WORDTAG sensors 
7 WORDTAG differences 
3 WORDTAG detected 
1 WORDTAG Their 
1 WORDTAG regularly 
2 WORDTAG since 
1 WORDTAG mid 
1 WORDTAG 1970s 
1 WORDTAG hcKrox 
4 WORDTAG regulates 
1 WORDTAG NB 
1 WORDTAG 506 
1 WORDTAG phosphorylate 
4 WORDTAG splicing 
8 WORDTAG alternative 
4 WORDTAG SF2 
3 WORDTAG ASF 
2 WORDTAG Recent 
10 WORDTAG using 
1 WORDTAG adipocytes 
1 WORDTAG chemically 
1 WORDTAG synthesized 
2 WORDTAG PIG 
3 WORDTAG compounds 
1 WORDTAG IRS1 
1 WORDTAG p59Lyn 
3 WORDTAG cross 
1 WORDTAG talk 
1 WORDTAG caveolin 
2 WORDTAG apparently 
1 WORDTAG abrogated 
8 WORDTAG effects 
3 WORDTAG exogenous 
1 WORDTAG hyaluronic 
1 WORDTAG port 
1 WORDTAG metastasis 
5 WORDTAG examined 
1 WORDTAG adenocarcinoma 
1 WORDTAG colon 
2 WORDTAG 26 
9 WORDTAG METHODS 
1 WORDTAG Thyroid 
4 WORDTAG status 
4 WORDTAG baseline 
1 WORDTAG 1990 
2 WORDTAG 93 
3 WORDTAG thyroid 
1 WORDTAG peroxidase 
2 WORDTAG TPO 
1 WORDTAG Abs 
1 WORDTAG IU 
5 WORDTAG ml 
3 WORDTAG TSH 
3 WORDTAG abnormal 
1 WORDTAG (< 
1 WORDTAG mU 
1 WORDTAG thyroxin 
1 WORDTAG T4 
1 WORDTAG Mechanical 
1 WORDTAG ventilation 
1 WORDTAG lungs 
1 WORDTAG 47 
1 WORDTAG chord 
1 WORDTAG compliance 
1 WORDTAG lavage 
2 WORDTAG necrosis 
9 WORDTAG )- 
1 WORDTAG 722 
1 WORDTAG 306 
4 WORDTAG pg 
4 WORDTAG interleukin 
5 WORDTAG IL 
1 WORDTAG 1beta 
1 WORDTAG 902 
2 WORDTAG 322 
2 WORDTAG macrophage 
1 WORDTAG MIP 
1 WORDTAG 104 
2 WORDTAG cytokines 
1 WORDTAG preventilation 
3 WORDTAG percentage 
1 WORDTAG surfactant 
3 WORDTAG large 
1 WORDTAG aggregates 
2 WORDTAG LA 
1 WORDTAG Autoregulation 
1 WORDTAG enables 
1 WORDTAG CCAAT 
5 WORDTAG enhancer 
5 WORDTAG EBP 
1 WORDTAG past 
1 WORDTAG decade 
1 WORDTAG enormous 
2 WORDTAG advances 
2 WORDTAG Bayesian 
1 WORDTAG methodology 
1 WORDTAG epidemiologic 
1 WORDTAG now 
3 WORDTAG many 
1 WORDTAG practical 
1 WORDTAG advantages 
1 WORDTAG approach 
3 WORDTAG strains 
2 WORDTAG lacking 
1 WORDTAG tup11 
1 WORDTAG tup12 
2 WORDTAG atf1 
1 WORDTAG pcr1 
7 WORDTAG transcriptional 
2 WORDTAG activator 
1 WORDTAG continues 
3 WORDTAG central 
1 WORDTAG fbp1 
4 WORDTAG however 
1 WORDTAG spc1 
1 WORDTAG Single 
2 WORDTAG substitutions 
2 WORDTAG acyl 
5 WORDTAG CoA 
1 WORDTAG interrupt 
4 WORDTAG 14 
1 WORDTAG palmitoyl 
1 WORDTAG ACBP2 
1 WORDTAG Arabidopsis 
2 WORDTAG ankyrin 
1 WORDTAG repeats 
1 WORDTAG Sixty 
1 WORDTAG cent 
1 WORDTAG African 
1 WORDTAG Americans 
1 WORDTAG exposed 
1 WORDTAG community 
1 WORDTAG outbreaks 
1 WORDTAG TST 
1 WORDTAG whites 
3 WORDTAG comparable 
1 WORDTAG exposures 
4 WORDTAG For 
1 WORDTAG immunological 
5 WORDTAG identification 
9 WORDTAG such 
1 WORDTAG antigens 
1 WORDTAG intermolecular 
1 WORDTAG variability 
1 WORDTAG e 
1 WORDTAG g 
1 WORDTAG ., 
3 WORDTAG structural 
1 WORDTAG aescin 
1 WORDTAG analogs 
1 WORDTAG validity 
3 WORDTAG It 
2 WORDTAG intrathecal 
3 WORDTAG administration 
1 WORDTAG .) 
3 WORDTAG D2 
2 WORDTAG agonist 
1 WORDTAG LY171555 
3 WORDTAG D1 
1 WORDTAG apomorphine 
2 WORDTAG threshold 
1 WORDTAG potentiating 
1 WORDTAG AA 
1 WORDTAG Interactions 
3 WORDTAG checkpoint 
1 WORDTAG abrogator 
1 WORDTAG UCN 
1 WORDTAG 01 
5 WORDTAG several 
1 WORDTAG pharmacological 
3 WORDTAG inhibitors 
2 WORDTAG MEK 
3 WORDTAG Analysis 
1 WORDTAG ctr4 
2 WORDTAG (+) 
2 WORDTAG copper 
1 WORDTAG fission 
1 WORDTAG Schizosaccharomyces 
1 WORDTAG pombe 
5 WORDTAG reveals 
1 WORDTAG CuSE 
1 WORDTAG Cuf1 
3 WORDTAG our 
2 WORDTAG work 
3 WORDTAG deficient 
4 WORDTAG expressing 
1 WORDTAG progesterone 
2 WORDTAG discovered 
6 WORDTAG level 
1 WORDTAG 293 
1 WORDTAG producer 
4 WORDTAG absence 
1 WORDTAG inducer 
1 WORDTAG PSP 
3 WORDTAG commonly 
1 WORDTAG misdiagnosed 
1 WORDTAG majority 
5 WORDTAG cases 
1 WORDTAG initially 
1 WORDTAG referred 
1 WORDTAG neurologists 
2 WORDTAG Between 
1 WORDTAG 1967 
1 WORDTAG 1994 
1 WORDTAG 495 
2 WORDTAG underwent 
4 WORDTAG surgery 
1 WORDTAG PTC 
1 WORDTAG Surgery 
1 WORDTAG Helsinki 
1 WORDTAG University 
1 WORDTAG Central 
1 WORDTAG Hospital 
1 WORDTAG DTD 
1 WORDTAG fast 
1 WORDTAG simple 
1 WORDTAG easy 
1 WORDTAG automate 
4 WORDTAG requires 
9 WORDTAG mg 
2 WORDTAG ); 
1 WORDTAG affords 
3 WORDTAG quantitative 
1 WORDTAG information 
1 WORDTAG about 
1 WORDTAG Srb10 
3 WORDTAG physiological 
2 WORDTAG Gcn4 
2 WORDTAG stability 
1 WORDTAG because 
1 WORDTAG turnover 
2 WORDTAG diminished 
1 WORDTAG srb10 
6 WORDTAG mutants 
1 WORDTAG restricted 
1 WORDTAG subset 
1 WORDTAG prestalk 
1 WORDTAG medicine 
1 WORDTAG physicians 
1 WORDTAG blinded 
2 WORDTAG surgical 
3 WORDTAG interpreted 
1 WORDTAG Tc 
1 WORDTAG 99m 
1 WORDTAG MIBI 
2 WORDTAG image 
1 WORDTAG combinations 
11 WORDTAG 15 
5 WORDTAG minutes 
4 WORDTAG hours 
1 WORDTAG correlative 
1 WORDTAG pertechnetate 
3 WORDTAG imaging 
2 WORDTAG starved 
4 WORDTAG conditions 
1 WORDTAG KMS 
4 WORDTAG 11 
1 WORDTAG OPM 
1 WORDTAG appreciable 
3 WORDTAG phosphorylated 
1 WORDTAG FGFR3 
3 WORDTAG indicating 
1 WORDTAG Y373C 
1 WORDTAG K650E 
1 WORDTAG aFGF 
1 WORDTAG Identical 
3 WORDTAG obtained 
1 WORDTAG tested 
1 WORDTAG 29 
16 WORDTAG + 
1 WORDTAG 139 
3 WORDTAG cyclin 
2 WORDTAG paper 
1 WORDTAG dephosphorylating 
2 WORDTAG phosphatases 
3 WORDTAG PTPs 
4 WORDTAG studied 
1 WORDTAG grouped 
1 WORDTAG subfamilies 
2 WORDTAG soluble 
1 WORDTAG RPTPs 
1 WORDTAG Coexposure 
1 WORDTAG FP 
1 WORDTAG pronounced 
4 WORDTAG PMA 
4 WORDTAG although 
5 WORDTAG inhibitor 
1 WORDTAG U0126 
2 WORDTAG prevent 
1 WORDTAG potentiation 
1 WORDTAG 50s 
2 WORDTAG derived 
4 WORDTAG combined 
1 WORDTAG earlier 
1 WORDTAG series 
1 WORDTAG 1965 
1 WORDTAG 1970 
1 WORDTAG harboring 
1 WORDTAG metronidazole 
1 WORDTAG clarithromycin 
2 WORDTAG resistant 
1 WORDTAG eradicated 
1 WORDTAG equal 
11 WORDTAG three 
1 WORDTAG regimens 
1 WORDTAG unit 
1 WORDTAG carotid 
1 WORDTAG chemoreceptors 
3 WORDTAG adult 
2 WORDTAG rats 
3 WORDTAG MKK7 
2 WORDTAG SAPK 
2 WORDTAG mast 
3 WORDTAG negatively 
2 WORDTAG driven 
1 WORDTAG hematopoietic 
3 WORDTAG portion 
1 WORDTAG Notch 
1 WORDTAG IC 
5 WORDTAG inhibited 
2 WORDTAG p50 
1 WORDTAG interacted 
3 WORDTAG subunit 
2 WORDTAG p65 
1 WORDTAG account 
1 WORDTAG observation 
1 WORDTAG causes 
1 WORDTAG include 
4 WORDTAG CSF 
1 WORDTAG pulsation 
6 WORDTAG children 
1 WORDTAG creating 
1 WORDTAG motion 
1 WORDTAG artifact 
3 WORDTAG arterial 
3 WORDTAG concentration 
1 WORDTAG intrinsic 
2 WORDTAG propofol 
1 WORDTAG supplemental 
3 WORDTAG administered 
3 WORDTAG Molecular 
1 WORDTAG cloning 
1 WORDTAG OsPSK 
1 WORDTAG precursor 
1 WORDTAG phytosulfokine 
3 WORDTAG rice 
2 WORDTAG biological 
1 WORDTAG combining 
1 WORDTAG trickling 
1 WORDTAG filter 
1 WORDTAG TF 
1 WORDTAG sludge 
2 WORDTAG process 
1 WORDTAG ASP 
1 WORDTAG treat 
2 WORDTAG wastewater 
1 WORDTAG trichloroethylene 
1 WORDTAG TCE 
1 WORDTAG ambient 
2 WORDTAG temperature 
1 WORDTAG hydraulic 
1 WORDTAG retention 
2 WORDTAG HRT 
1 WORDTAG If 
1 WORDTAG you 
1 WORDTAG think 
1 WORDTAG expensive 
1 WORDTAG try 
1 WORDTAG ignorance 
1 WORDTAG Bok 
1 WORDTAG Law 
1 WORDTAG COD 
1 WORDTAG color 
1 WORDTAG removals 
3 WORDTAG 90 
1 WORDTAG FeCl3 
2 WORDTAG coagulation 
1 WORDTAG dosages 
1 WORDTAG step 
1 WORDTAG 031 
1 WORDTAG 012 
2 WORDTAG mol 
2 WORDTAG respectively 
1 WORDTAG ferrous 
1 WORDTAG hydrogen 
1 WORDTAG peroxide 
2 WORDTAG oxidation 
1 WORDTAG pretreatment 
1 WORDTAG H2O2 
1 WORDTAG dosage 
2 WORDTAG 06 
3 WORDTAG untranslated 
1 WORDTAG Hsp70 
4 WORDTAG acts 
3 WORDTAG general 
3 WORDTAG translation 
1 WORDTAG alteration 
1 WORDTAG Cre 
5 WORDTAG target 
1 WORDTAG rearrangement 
3 WORDTAG flanked 
2 WORDTAG LOX 
3 WORDTAG recognition 
2 WORDTAG separate 
2 WORDTAG genetic 
2 WORDTAG constructs 
1 WORDTAG trans 
1 WORDTAG cre 
3 WORDTAG members 
2 WORDTAG exhibit 
1 WORDTAG prolyl 
1 WORDTAG isomerase 
1 WORDTAG chaperone 
1 WORDTAG Newcastle 
8 WORDTAG antibody 
1 WORDTAG titre 
10 WORDTAG dependent 
3 WORDTAG calcium 
1 WORDTAG %), 
5 WORDTAG MR 
1 WORDTAG microscopic 
1 WORDTAG around 
1 WORDTAG seroma 
1 WORDTAG reexcision 
1 WORDTAG nonviable 
1 WORDTAG Vp1s 
1 WORDTAG failed 
2 WORDTAG localize 
2 WORDTAG nucleus 
1 WORDTAG Vp2 
1 WORDTAG Vp3 
1 WORDTAG mutated 
1 WORDTAG NLS1 
1 WORDTAG acted 
6 WORDTAG cytoplasmic 
2 WORDTAG Vp1 
1 WORDTAG Compared 
2 WORDTAG 74 
1 WORDTAG TOF 
1 WORDTAG systolic 
1 WORDTAG diastolic 
1 WORDTAG myocardial 
1 WORDTAG velocities 
1 WORDTAG isovolumic 
1 WORDTAG relaxation 
4 WORDTAG corresponding 
1 WORDTAG orifice 
1 WORDTAG voltages 
1 WORDTAG instruments 
3 WORDTAG API 
1 WORDTAG 365 
2 WORDTAG 30 
1 WORDTAG 130 
1 WORDTAG 2000 
1 WORDTAG 3000 
3 WORDTAG methylation 
5 WORDTAG tumors 
2 WORDTAG SV40 
1 WORDTAG transgenic 
1 WORDTAG MT 
1 WORDTAG Restriction 
1 WORDTAG Landmark 
1 WORDTAG Genomic 
1 WORDTAG Scanning 
1 WORDTAG Methylation 
1 WORDTAG RLGS 
1 WORDTAG spots 
1 WORDTAG appeared 
1 WORDTAG methylated 
1 WORDTAG frequently 
3 WORDTAG cloned 
1 WORDTAG TAF 
1 WORDTAG 140 
1 WORDTAG HFD 
1 WORDTAG homeodomain 
1 WORDTAG PHD 
3 WORDTAG finger 
2 WORDTAG immunoprecipitation 
1 WORDTAG TFIID 
2 WORDTAG 3D 
2 WORDTAG processing 
1 WORDTAG permits 
1 WORDTAG analyse 
1 WORDTAG ultrasound 
1 WORDTAG interactively 
1 WORDTAG orthogonal 
1 WORDTAG planes 
1 WORDTAG section 
3 WORDTAG mode 
1 WORDTAG realistic 
1 WORDTAG views 
1 WORDTAG rendering 
1 WORDTAG proposal 
6 WORDTAG indicators 
1 WORDTAG divided 
1 WORDTAG five 
3 WORDTAG presented 
1 WORDTAG namely 
1 WORDTAG operational 
1 WORDTAG service 
1 WORDTAG quality 
1 WORDTAG personnel 
1 WORDTAG economic 
3 WORDTAG analyses 
1 WORDTAG question 
2 WORDTAG whether 
1 WORDTAG CesA 
2 WORDTAG synthases 
1 WORDTAG sub 
3 WORDTAG class 
1 WORDTAG cellulosic 
6 WORDTAG --> 
1 WORDTAG glycan 
2 WORDTAG relationship 
1 WORDTAG Leiden 
4 WORDTAG deletion 
2 WORDTAG polymorphism 
1 WORDTAG angiotensin 
1 WORDTAG converting 
1 WORDTAG enzyme 
2 WORDTAG postoperative 
1 WORDTAG thromboembolic 
2 WORDTAG events 
2 WORDTAG total 
1 WORDTAG joint 
1 WORDTAG arthroplasty 
1 WORDTAG PTHrP1 
2 WORDTAG 86 
7 WORDTAG production 
1 WORDTAG moreover 
2 WORDTAG PTHrP 
1 WORDTAG neutralizing 
3 WORDTAG inhibit 
3 WORDTAG transfected 
3 WORDTAG Furthermore 
1 WORDTAG MeSADP 
1 WORDTAG caspase 
1 WORDTAG Against 
1 WORDTAG gram 
1 WORDTAG organisms 
1 WORDTAG 4767 
1 WORDTAG 5065 
2 WORDTAG eight 
1 WORDTAG fourfold 
1 WORDTAG tosufloxacin 
1 WORDTAG reference 
1 WORDTAG AR1 
1 WORDTAG CAP 
1 WORDTAG papBA 
2 WORDTAG histone 
3 WORDTAG H 
1 WORDTAG NS 
1 WORDTAG Under 
1 WORDTAG current 
1 WORDTAG immunization 
1 WORDTAG practices 
2 WORDTAG authors 
2 WORDTAG estimate 
5 WORDTAG 13 
3 WORDTAG 000 
1 WORDTAG Asian 
1 WORDTAG Pacific 
1 WORDTAG Islander 
1 WORDTAG living 
2 WORDTAG United 
2 WORDTAG States 
1 WORDTAG today 
1 WORDTAG will 
2 WORDTAG become 
1 WORDTAG HBV 
1 WORDTAG future 
5 WORDTAG resulting 
2 WORDTAG 600 
2 WORDTAG carcinoma 
1 WORDTAG deaths 
1 WORDTAG structured 
1 WORDTAG interview 
1 WORDTAG undertaken 
1 WORDTAG consultation 
2 WORDTAG year 
1 WORDTAG intervals 
1 WORDTAG regarding 
1 WORDTAG BHS 
4 WORDTAG frequency 
2 WORDTAG spells 
1 WORDTAG sequelae 
2 WORDTAG history 
2 WORDTAG termination 
1 WORDTAG Cell 
1 WORDTAG Rapid 
1 WORDTAG LAGLIDADG 
1 WORDTAG homing 
1 WORDTAG fliF 
2 WORDTAG Inhibition 
2 WORDTAG JNK1 
7 WORDTAG either 
1 WORDTAG chemical 
1 WORDTAG PD098059 
1 WORDTAG substantially 
1 WORDTAG abrogates 
1 WORDTAG UV 
1 WORDTAG GADD45 
1 WORDTAG gd 
4 WORDTAG confirmed 
1 WORDTAG pregnant 
1 WORDTAG evaluated 
3 WORDTAG outcome 
1 WORDTAG live 
1 WORDTAG fetuses 
1 WORDTAG external 
2 WORDTAG visceral 
2 WORDTAG skeletal 
1 WORDTAG malformations 
1 WORDTAG mammals 
1 WORDTAG repressors 
1 WORDTAG Wnt 
1 WORDTAG Intravenous 
2 WORDTAG carnitine 
1 WORDTAG improved 
1 WORDTAG fatigue 
1 WORDTAG exercise 
1 WORDTAG hemodialysis 
1 WORDTAG Van 
1 WORDTAG der 
1 WORDTAG Hoeve 
1 WORDTAG lesions 
1 WORDTAG poorly 
1 WORDTAG mineralized 
1 WORDTAG salt 
1 WORDTAG apparent 
1 WORDTAG phosphates 
1 WORDTAG computerized 
1 WORDTAG electrical 
1 WORDTAG pallidum 
1 WORDTAG parkinsonian 
1 WORDTAG stimulus 
1 WORDTAG behaviour 
1 WORDTAG successful 
1 WORDTAG attentive 
1 WORDTAG participants 
1 WORDTAG interpret 
3 WORDTAG evidence 
1 WORDTAG GTPase 
2 WORDTAG de 
2 WORDTAG novo 
5 WORDTAG synthesis 
1 WORDTAG deacetylase 
1 WORDTAG cobalt 
1 WORDTAG StREs 
1 WORDTAG quantify 
1 WORDTAG conducted 
2 WORDTAG NASA 
1 WORDTAG MSFC 
1 WORDTAG Neutral 
1 WORDTAG Buoyancy 
1 WORDTAG Simulator 
1 WORDTAG KC 
2 WORDTAG 135 
1 WORDTAG parabolic 
1 WORDTAG flight 
1 WORDTAG EASE 
1 WORDTAG program 
1 WORDTAG Shuttle 
1 WORDTAG Atlantis 
1 WORDTAG mission 
2 WORDTAG 61 
2 WORDTAG complete 
2 WORDTAG congenital 
2 WORDTAG heart 
1 WORDTAG CCHB 
1 WORDTAG fetus 
1 WORDTAG AE 
1 WORDTAG benzimidazole 
1 WORDTAG carbamate 
1 WORDTAG derivatives 
1 WORDTAG mebendazole 
1 WORDTAG albendazole 
1 WORDTAG fluorine 
1 WORDTAG fluorodeoxyglucose 
3 WORDTAG F 
1 WORDTAG FDG 
2 WORDTAG malignant 
1 WORDTAG depends 
1 WORDTAG Deterministic 
2 WORDTAG retrospective 
1 WORDTAG chart 
1 WORDTAG procedures 
1 WORDTAG January 
1 WORDTAG 1993 
2 WORDTAG December 
1 WORDTAG 1998 
1 WORDTAG Peripheral 
1 WORDTAG preemptive 
1 WORDTAG antinociception 
1 WORDTAG benefit 
1 WORDTAG depth 
1 WORDTAG RR 
1 WORDTAG nonuniform 
1 WORDTAG AC 
1 WORDTAG scanning 
1 WORDTAG source 
1 WORDTAG scatter 
1 WORDTAG correction 
1 WORDTAG photon 
2 WORDTAG energy 
1 WORDTAG PER 
1 WORDTAG ]) 
2 WORDTAG filtered 
1 WORDTAG backprojection 
1 WORDTAG Cloning 
1 WORDTAG integrin 
3 WORDTAG assays 
1 WORDTAG interference 
1 WORDTAG p30 
1 WORDTAG assembly 
3 WORDTAG p300 
2 WORDTAG CBP 
1 WORDTAG multiprotein 
2 WORDTAG complexes 
1 WORDTAG oligonucleotides 
1 WORDTAG Transient 
1 WORDTAG transfections 
1 WORDTAG 556M 
1 WORDTAG TBLV 
4 WORDTAG least 
4 WORDTAG fold 
4 WORDTAG conclusion 
3 WORDTAG tube 
1 WORDTAG estimated 
1 WORDTAG Cole 
2 WORDTAG formula 
1 WORDTAG tends 
1 WORDTAG practically 
1 WORDTAG appropriate 
1 WORDTAG pediatric 
1 WORDTAG cardiac 
2 WORDTAG anesthesia 
1 WORDTAG T47D 
3 WORDTAG breast 
1 WORDTAG synergy 
1 WORDTAG autocrine 
1 WORDTAG Nerve 
1 WORDTAG retinoic 
2 WORDTAG RA 
1 WORDTAG exert 
1 WORDTAG actions 
1 WORDTAG HexA71 
1 WORDTAG affects 
1 WORDTAG RpoS 
1 WORDTAG sigma 
10 WORDTAG higher 
2 WORDTAG HexA 
1 WORDTAG Moreover 
2 WORDTAG elderly 
2 WORDTAG men 
2 WORDTAG bioavailable 
2 WORDTAG estradiol 
1 WORDTAG below 
2 WORDTAG pmol 
2 WORDTAG liter 
1 WORDTAG resorption 
2 WORDTAG markers 
1 WORDTAG histamine 
1 WORDTAG H1 
2 WORDTAG antagonists 
1 WORDTAG antihistamines 
2 WORDTAG medications 
1 WORDTAG relief 
1 WORDTAG hyperhistaminic 
1 WORDTAG occurring 
1 WORDTAG ceramide 
1 WORDTAG emerging 
1 WORDTAG fixture 
1 WORDTAG toluidine 
1 WORDTAG pH 
2 WORDTAG value 
1 WORDTAG donor 
1 WORDTAG solution 
2 WORDTAG Managing 
3 WORDTAG BACKGROUND 
1 WORDTAG increasing 
1 WORDTAG investigators 
1 WORDTAG public 
2 WORDTAG finding 
1 WORDTAG ways 
2 WORDTAG improve 
1 WORDTAG seriously 
1 WORDTAG mentally 
1 WORDTAG ill 
1 WORDTAG exposing 
5 WORDTAG individuals 
1 WORDTAG unnecessary 
1 WORDTAG risks 
1 WORDTAG Multidrug 
1 WORDTAG resistance 
1 WORDTAG mainly 
3 WORDTAG overexpression 
2 WORDTAG membrane 
1 WORDTAG efflux 
1 WORDTAG pumps 
1 WORDTAG facilitators 
1 WORDTAG PDR1 
1 WORDTAG PDR3 
1 WORDTAG Serum 
1 WORDTAG PTH 
1 WORDTAG tended 
1 WORDTAG WL 
1 WORDTAG WM 
1 WORDTAG Bandshift 
2 WORDTAG BmHR3A 
1 WORDTAG RORE 
1 WORDTAG Retinoic 
1 WORDTAG Orphan 
1 WORDTAG Response 
1 WORDTAG Element 
3 WORDTAG promoters 
1 WORDTAG BmGATAbeta 
1 WORDTAG ESP 
1 WORDTAG vitellogenesis 
1 WORDTAG Efficacy 
2 WORDTAG generation 
1 WORDTAG Cavermap 
1 WORDTAG verify 
1 WORDTAG location 
1 WORDTAG cavernous 
1 WORDTAG nerves 
1 WORDTAG prostatectomy 
1 WORDTAG multi 
1 WORDTAG institutional 
1 WORDTAG experienced 
1 WORDTAG surgeons 
1 WORDTAG During 
1 WORDTAG separase 
1 WORDTAG kept 
4 WORDTAG inhibitory 
1 WORDTAG called 
1 WORDTAG securin 
1 WORDTAG obesity 
1 WORDTAG alcohol 
1 WORDTAG intake 
1 WORDTAG multimetabolic 
1 WORDTAG disorders 
1 WORDTAG predictors 
1 WORDTAG hyperuricemia 
2 WORDTAG cholesteryl 
3 WORDTAG ester 
1 WORDTAG CET 
1 WORDTAG CETP 
1 WORDTAG phospholipid 
1 WORDTAG PLTP 
1 WORDTAG prevalence 
1 WORDTAG calcification 
2 WORDTAG CAC 
1 WORDTAG diabetic 
1 WORDTAG nondiabetic 
1 WORDTAG sex 
3 WORDTAG difference 
1 WORDTAG reside 
1 WORDTAG syntenic 
1 WORDTAG 8E1 
1 WORDTAG NP 
1 WORDTAG NMP4 
1 WORDTAG CIZ 
1 WORDTAG osteocytes 
1 WORDTAG osteoblasts 
1 WORDTAG chondrocytes 
1 WORDTAG Following 
3 WORDTAG examination 
1 WORDTAG periodontal 
4 WORDTAG therapy 
1 WORDTAG 32 
1 WORDTAG mucogingival 
1 WORDTAG gingival 
2 WORDTAG grafts 
1 WORDTAG insufficient 
1 WORDTAG attached 
1 WORDTAG gingiva 
2 WORDTAG failure 
1 WORDTAG QKTT 
2 WORDTAG motif 
1 WORDTAG TGN46 
1 WORDTAG tail 
2 WORDTAG induce 
2 WORDTAG steady 
1 WORDTAG state 
2 WORDTAG ER 
1 WORDTAG vesicular 
1 WORDTAG stomatitis 
1 WORDTAG glycoprotein 
1 WORDTAG VSVG 
1 WORDTAG chimeras 
2 WORDTAG HeLa 
1 WORDTAG NRK 
1 WORDTAG indicates 
1 WORDTAG secretory 
1 WORDTAG trafficking 
1 WORDTAG exist 
1 WORDTAG proteolysis 
1 WORDTAG acutely 
1 WORDTAG promoted 
3 WORDTAG phorbol 
2 WORDTAG myristate 
3 WORDTAG acetate 
1 WORDTAG metalloprotease 
1 WORDTAG generates 
1 WORDTAG shed 
1 WORDTAG GHBP 
4 WORDTAG GHR 
1 WORDTAG remnant 
3 WORDTAG abundance 
1 WORDTAG GH 
1 WORDTAG SIP1 
1 WORDTAG confine 
1 WORDTAG XBra 
1 WORDTAG mesoderm 
1 WORDTAG Changes 
1 WORDTAG DB 
1 WORDTAG affecting 
1 WORDTAG postulated 
1 WORDTAG stem 
3 WORDTAG led 
1 WORDTAG drastic 
1 WORDTAG losses 
1 WORDTAG subfamily 
1 WORDTAG set 
1 WORDTAG segments 
1 WORDTAG Subsequently 
1 WORDTAG coordinates 
1 WORDTAG must 
1 WORDTAG particular 
4 WORDTAG tissues 
1 WORDTAG organs 
1 WORDTAG cyclins 
1 WORDTAG CDK 
2 WORDTAG then 
2 WORDTAG suppressor 
2 WORDTAG pRb 
4 WORDTAG controls 
1 WORDTAG commitment 
1 WORDTAG progress 
1 WORDTAG repressing 
1 WORDTAG E2F 
3 WORDTAG known 
1 WORDTAG promote 
8 WORDTAG months 
1 WORDTAG withdrawal 
2 WORDTAG severity 
1 WORDTAG pathologic 
1 WORDTAG magnitude 
1 WORDTAG percussion 
2 WORDTAG Patients 
1 WORDTAG fivefold 
4 WORDTAG titer 
1 WORDTAG lowest 
4 WORDTAG over 
2 WORDTAG course 
2 WORDTAG GBS 
1 WORDTAG disability 
2 WORDTAG scores 
4 WORDTAG weeks 
1 WORDTAG worse 
1 WORDTAG GM1 
2 WORDTAG IgG 
2 WORDTAG GD1a 
2 WORDTAG IgM 
1 WORDTAG axonal 
1 WORDTAG damage 
1 WORDTAG titers 
7 WORDTAG post 
3 WORDTAG TBI 
1 WORDTAG irradiated 
2 WORDTAG avoidance 
3 WORDTAG statistical 
1 WORDTAG b 
1 WORDTAG way 
2 WORDTAG performed 
1 WORDTAG TE 
1 WORDTAG 671 
3 WORDTAG basal 
1 WORDTAG GnRH 
1 WORDTAG SOFA 
3 WORDTAG score 
1 WORDTAG APACHE 
2 WORDTAG 16 
2 WORDTAG effector 
5 WORDTAG Ras 
4 WORDTAG p21 
1 WORDTAG Promoter 
1 WORDTAG annexin 
1 WORDTAG A5 
1 WORDTAG 1275 
1 WORDTAG 79 
1 WORDTAG discrete 
2 WORDTAG start 
1 WORDTAG points 
1 WORDTAG Structure 
1 WORDTAG EMAPII 
1 WORDTAG aminoacyl 
2 WORDTAG synthetase 
1 WORDTAG evolutionary 
2 WORDTAG dimer 
1 WORDTAG mimicry 
1 WORDTAG SDS 
2 WORDTAG transient 
1 WORDTAG acidification 
2 WORDTAG metal 
1 WORDTAG solubilization 
2 WORDTAG sulfur 
1 WORDTAG Competition 
1 WORDTAG electrophoretic 
1 WORDTAG mobility 
1 WORDTAG shift 
1 WORDTAG immunoshift 
1 WORDTAG NF1 
2 WORDTAG extracts 
1 WORDTAG CV 
1 WORDTAG BKV 
1 WORDTAG MLP 
1 WORDTAG Graf2 
3 WORDTAG highest 
6 WORDTAG muscle 
2 WORDTAG minimal 
1 WORDTAG ER3 
2 WORDTAG FXR 
1 WORDTAG HRE 
1 WORDTAG Ka13 
1 WORDTAG CoCl 
2 WORDTAG stimulated 
1 WORDTAG luciferase 
1 WORDTAG kilobase 
2 WORDTAG ho 
1 WORDTAG pHO15luc 
1 WORDTAG subtyped 
1 WORDTAG Camp 
2 WORDTAG jejuni 
1 WORDTAG subsp 
2 WORDTAG biotype 
2 WORDTAG remaining 
3 WORDTAG Ig 
1 WORDTAG typical 
1 WORDTAG metazoan 
2 WORDTAG module 
1 WORDTAG classified 
1 WORDTAG disulphide 
1 WORDTAG represents 
1 WORDTAG phylogenetic 
1 WORDTAG earliest 
1 WORDTAG budding 
1 WORDTAG latter 
1 WORDTAG Mad1 
1 WORDTAG Bub1 
1 WORDTAG Bub3 
1 WORDTAG whose 
1 WORDTAG vertebrate 
1 WORDTAG counterparts 
1 WORDTAG unattached 
1 WORDTAG kinetochores 
1 WORDTAG hyaluronan 
2 WORDTAG HA 
1 WORDTAG motility 
2 WORDTAG src 
1 WORDTAG Oral 
2 WORDTAG arginine 
1 WORDTAG citrulline 
4 WORDTAG indicated 
1 WORDTAG enhancement 
1 WORDTAG classify 
2 WORDTAG antibiotics 
1 WORDTAG bactericidal 
1 WORDTAG aeruginosa 
1 WORDTAG having 
2 WORDTAG killing 
1 WORDTAG AMK 
1 WORDTAG IPM 
1 WORDTAG PAPM 
1 WORDTAG CAZ 
1 WORDTAG MEPM 
2 WORDTAG showing 
1 WORDTAG truncated 
2 WORDTAG isoforms 
2 WORDTAG diverse 
1 WORDTAG roles 
1 WORDTAG EGFR 
4 WORDTAG Of 
2 WORDTAG E6 
1 WORDTAG inactivates 
1 WORDTAG proteasome 
1 WORDTAG degradation 
2 WORDTAG Low 
1 WORDTAG affinity 
1 WORDTAG Rab6A 
3 WORDTAG GTP 
1 WORDTAG K 
1 WORDTAG d 
1 WORDTAG Rab1B 
1 WORDTAG 11A 
1 WORDTAG 1997 
1 WORDTAG Nature 
1 WORDTAG 387 
1 WORDTAG 370 
1 WORDTAG 376 
1 WORDTAG )], 
1 WORDTAG fluoride 
1 WORDTAG ions 
1 WORDTAG replaced 
2 WORDTAG phosphate 
2 WORDTAG iron 
1 WORDTAG Kp2 
1 WORDTAG mismatch 
1 WORDTAG CYP3A4 
2 WORDTAG sufficient 
2 WORDTAG AIMS 
2 WORDTAG intraindividual 
2 WORDTAG fluctuations 
1 WORDTAG tumour 
1 WORDTAG CEA 
2 WORDTAG CA 
1 WORDTAG 242 
1 WORDTAG cured 
1 WORDTAG colorectal 
3 WORDTAG do 
1 WORDTAG differ 
1 WORDTAG Substitution 
1 WORDTAG serine 
4 WORDTAG residues 
1 WORDTAG appear 
1 WORDTAG pRA2 
1 WORDTAG partitioning 
1 WORDTAG ParB 
1 WORDTAG autoregulates 
1 WORDTAG parAB 
1 WORDTAG nucleoprotein 
3 WORDTAG plasmid 
1 WORDTAG partition 
1 WORDTAG parS 
1 WORDTAG transduced 
1 WORDTAG MOI 
1 WORDTAG ISREs 
1 WORDTAG GABA 
1 WORDTAG R1g 
3 WORDTAG peripheral 
1 WORDTAG Granulocyte 
1 WORDTAG colony 
1 WORDTAG stimulating 
2 WORDTAG G 
1 WORDTAG defence 
1 WORDTAG microbes 
1 WORDTAG Use 
1 WORDTAG dual 
1 WORDTAG pulse 
1 WORDTAG lithotripter 
1 WORDTAG intensified 
1 WORDTAG cavitation 
1 WORDTAG field 
3 WORDTAG best 
1 WORDTAG predicting 
1 WORDTAG WCXR 
3 WORDTAG included 
3 WORDTAG culture 
1 WORDTAG Pa 
1 WORDTAG elastase 
1 WORDTAG plating 
1 WORDTAG stable 
2 WORDTAG throughout 
1 WORDTAG applied 
1 WORDTAG river 
1 WORDTAG reclamation 
1 WORDTAG Yangpu 
1 WORDTAG District 
1 WORDTAG Shanghai 
1 WORDTAG City 
1 WORDTAG China 
2 WORDTAG Multiple 
2 WORDTAG long 
2 WORDTAG term 
1 WORDTAG abiotic 
1 WORDTAG nymphal 
2 WORDTAG R2 
1 WORDTAG coefficients 
1 WORDTAG every 
1 WORDTAG habitat 
2 WORDTAG variation 
1 WORDTAG tick 
3 WORDTAG Src 
5 WORDTAG SH3 
1 WORDTAG facilitates 
3 WORDTAG adhesion 
4 WORDTAG six 
1 WORDTAG polyposis 
1 WORDTAG none 
1 WORDTAG CT 
1 WORDTAG diagnosed 
1 WORDTAG bowel 
2 WORDTAG follow 
1 WORDTAG Right 
2 WORDTAG LHR 
2 WORDTAG provided 
1 WORDTAG interobserver 
1 WORDTAG intraobserver 
1 WORDTAG reproducibility 
2 WORDTAG intronic 
1 WORDTAG PDE5A 
1 WORDTAG concern 
5 WORDTAG food 
1 WORDTAG processors 
1 WORDTAG inadvertent 
1 WORDTAG contact 
1 WORDTAG allergenic 
2 WORDTAG result 
1 WORDTAG potentially 
1 WORDTAG life 
1 WORDTAG threatening 
2 WORDTAG reactions 
8 WORDTAG those 
2 WORDTAG allergy 
1 WORDTAG Diffuse 
1 WORDTAG myalgias 
1 WORDTAG frequent 
1 WORDTAG deltoid 
1 WORDTAG biopsy 
1 WORDTAG 0001 
1 WORDTAG Functional 
1 WORDTAG PTP 
1 WORDTAG DT40 
2 WORDTAG stably 
1 WORDTAG chimeric 
1 WORDTAG Fc 
2 WORDTAG gamma 
1 WORDTAG RIIB1 
1 WORDTAG PECAM 
3 WORDTAG homology 
2 WORDTAG SHP 
2 WORDTAG necessary 
1 WORDTAG deliver 
1 WORDTAG coligation 
1 WORDTAG Subtraction 
3 WORDTAG hybridization 
2 WORDTAG melanoma 
1 WORDTAG mda 
4 WORDTAG case 
1 WORDTAG streptococcal 
1 WORDTAG peritonitis 
1 WORDTAG Among 
2 WORDTAG correlated 
1 WORDTAG ACR 
1 WORDTAG augmented 
2 WORDTAG feedback 
1 WORDTAG vertical 
1 WORDTAG ground 
1 WORDTAG force 
1 WORDTAG minute 
3 WORDTAG reduction 
2 WORDTAG 85 
3 WORDTAG week 
1 WORDTAG sensory 
1 WORDTAG lactate 
1 WORDTAG pyruvate 
2 WORDTAG elevated 
1 WORDTAG Histological 
1 WORDTAG lichenoid 
1 WORDTAG acantholytic 
1 WORDTAG blister 
1 WORDTAG apoptotic 
2 WORDTAG keratinocytes 
1 WORDTAG Enantiomer 
2 WORDTAG separation 
2 WORDTAG venlafaxine 
3 WORDTAG O 
1 WORDTAG desmethylvenlafaxine 
1 WORDTAG Paul 
1 WORDTAG Monagle 
1 WORDTAG addresses 
1 WORDTAG epidemiology 
1 WORDTAG neonatal 
1 WORDTAG thrombosis 
1 WORDTAG outside 
1 WORDTAG nervous 
2 WORDTAG occur 
2 WORDTAG utero 
1 WORDTAG MSL 
2 WORDTAG male 
1 WORDTAG booster 
6 WORDTAG dose 
1 WORDTAG tetanus 
1 WORDTAG toxoid 
1 WORDTAG courses 
1 WORDTAG vaccination 
1 WORDTAG implications 
2 WORDTAG immune 
1 WORDTAG globulin 
1 WORDTAG Crk 
1 WORDTAG Abl 
1 WORDTAG FAK 
1 WORDTAG offers 
1 WORDTAG paradigm 
1 WORDTAG autoinhibitory 
1 WORDTAG red 
1 WORDTAG cultivation 
1 WORDTAG Sri 
1 WORDTAG Lanka 
1 WORDTAG coincident 
1 WORDTAG HIDD 
1 WORDTAG villages 
1 WORDTAG Prophylactic 
1 WORDTAG lymph 
1 WORDTAG node 
1 WORDTAG dissection 
1 WORDTAG nodal 
1 WORDTAG local 
1 WORDTAG recurrence 
1 WORDTAG consistently 
1 WORDTAG Secretion 
1 WORDTAG RANTES 
1 WORDTAG kappaDa 
1 WORDTAG IFN 
1 WORDTAG differentiating 
1 WORDTAG ChromaFlo 
1 WORDTAG IVUS 
2 WORDTAG demonstrates 
1 WORDTAG colorized 
1 WORDTAG inside 
1 WORDTAG vessel 
1 WORDTAG lumen 
2 WORDTAG helpful 
1 WORDTAG distinguishing 
1 WORDTAG echolucent 
1 WORDTAG luminal 
1 WORDTAG perform 
1 WORDTAG interventions 
2 WORDTAG renal 
1 WORDTAG avoiding 
1 WORDTAG media 
1 WORDTAG concomitant 
2 WORDTAG corticosteroids 
1 WORDTAG anticoagulants 
2 WORDTAG prior 
1 WORDTAG ulcer 
2 WORDTAG complications 
1 WORDTAG morbid 
1 WORDTAG diseases 
1 WORDTAG bleeding 
1 WORDTAG icodextrin 
1 WORDTAG instead 
1 WORDTAG PD 
1 WORDTAG fluids 
1 WORDTAG reduce 
1 WORDTAG Amadori 
1 WORDTAG albumin 
1 WORDTAG AGEs 
1 WORDTAG GC 
2 WORDTAG rich 
1 WORDTAG /- 
3 WORDTAG 91 
1 WORDTAG Cp 
2 WORDTAG oriPI 
2 WORDTAG EBNA1 
1 WORDTAG SB203580 
1 WORDTAG LPS 
4 WORDTAG Sp1 
3 WORDTAG consensus 
1 WORDTAG echocardiographic 
1 WORDTAG technique 
2 WORDTAG conventional 
1 WORDTAG digitalised 
1 WORDTAG 2D 
1 WORDTAG tissular 
1 WORDTAG Doppler 
1 WORDTAG anomalous 
1 WORDTAG electric 
1 WORDTAG conduction 
1 WORDTAG invasive 
1 WORDTAG Is 
2 WORDTAG clopidogrel 
2 WORDTAG superior 
2 WORDTAG aspirin 
2 WORDTAG prevention 
3 WORDTAG vascular 
1 WORDTAG cornerstone 
1 WORDTAG efficacy 
1 WORDTAG thienopyridines 
1 WORDTAG ticlopidine 
2 WORDTAG versus 
1 WORDTAG Clopidogrel 
1 WORDTAG Aspirin 
1 WORDTAG Risk 
1 WORDTAG Ischaemic 
1 WORDTAG Events 
1 WORDTAG DBD 
1 WORDTAG taking 
2 WORDTAG advantage 
1 WORDTAG NLS 
1 WORDTAG phenotypic 
1 WORDTAG probability 
1 WORDTAG lamotrigine 
1 WORDTAG being 
2 WORDTAG maintained 
1 WORDTAG %, 
1 WORDTAG twelve 
1 WORDTAG volatile 
1 WORDTAG ecological 
1 WORDTAG planktonic 
1 WORDTAG webs 
1 WORDTAG OsBBPI 
1 WORDTAG rapidly 
1 WORDTAG seedling 
1 WORDTAG leaf 
1 WORDTAG cut 
1 WORDTAG jasmonic 
1 WORDTAG JA 
4 WORDTAG phosphatase 
2 WORDTAG 2A 
2 WORDTAG PP2A 
1 WORDTAG cantharidin 
4 WORDTAG CN 
1 WORDTAG endothall 
1 WORDTAG EN 
1 WORDTAG light 
1 WORDTAG dark 
1 WORDTAG cycloheximide 
1 WORDTAG CHX 
1 WORDTAG requirement 
1 WORDTAG ace2Delta 
1 WORDTAG Ace2p 
1 WORDTAG polarized 
1 WORDTAG investigation 
1 WORDTAG morphological 
2 WORDTAG characteristics 
1 WORDTAG fibrous 
1 WORDTAG capsule 
1 WORDTAG implantation 
1 WORDTAG aluminum 
1 WORDTAG ALCAP 
1 WORDTAG hydroxyapetite 
1 WORDTAG bioceramics 
1 WORDTAG event 
1 WORDTAG Irr 
2 WORDTAG rMFP 
1 WORDTAG Un 
2 WORDTAG nrMFP 
1 WORDTAG Sta 
1 WORDTAG summary 
1 WORDTAG conclude 
1 WORDTAG adenoviral 
2 WORDTAG E1A 
2 WORDTAG endogenous 
5 WORDTAG AP 
2 WORDTAG 2alpha 
1 WORDTAG derepression 
1 WORDTAG 2rep 
1 WORDTAG corepressor 
1 WORDTAG CtBP1 
1 WORDTAG Unusual 
2 WORDTAG kinases 
2 WORDTAG AKs 
1 WORDTAG arose 
1 WORDTAG phosphagen 
1 WORDTAG primitive 
1 WORDTAG sea 
1 WORDTAG anemone 
1 WORDTAG Anthopleurura 
1 WORDTAG japonicus 
1 WORDTAG clam 
1 WORDTAG Pseudocardium 
1 WORDTAG sachalinensis 
1 WORDTAG Mutagenesis 
1 WORDTAG SNT1 
1 WORDTAG IRS 
1 WORDTAG CX 
2 WORDTAG classes 
4 WORDTAG motifs 
1 WORDTAG SNT 
2 WORDTAG critical 
2 WORDTAG phosphotyrosine 
3 WORDTAG recruitment 
1 WORDTAG Grb2 
1 WORDTAG Shp2 
1 WORDTAG helping 
1 WORDTAG recruit 
1 WORDTAG Sos 
2 WORDTAG meta 
1 WORDTAG randomized 
1 WORDTAG noted 
1 WORDTAG nonvertebral 
1 WORDTAG fractures 
2 WORDTAG C4B 
1 WORDTAG monomodular 
1 WORDTAG short 
2 WORDTAG C4A 
1 WORDTAG CSR 
1 WORDTAG isotypes 
1 WORDTAG activators 
1 WORDTAG unrearranged 
1 WORDTAG germline 
1 WORDTAG GL 
1 WORDTAG patterns 
3 WORDTAG seven 
1 WORDTAG '( 
1 WORDTAG acceptor 
1 WORDTAG utilization 
1 WORDTAG cryptic 
1 WORDTAG splice 
1 WORDTAG Mutational 
1 WORDTAG U 
1 WORDTAG RING 
3 WORDTAG physical 
1 WORDTAG basis 
1 WORDTAG E2 
1 WORDTAG GafChromic 
1 WORDTAG MD 
1 WORDTAG radiochromic 
1 WORDTAG film 
1 WORDTAG increasingly 
1 WORDTAG popular 
1 WORDTAG medical 
1 WORDTAG applications 
1 WORDTAG proven 
3 WORDTAG useful 
1 WORDTAG brachytherapy 
2 WORDTAG dosimetry 
1 WORDTAG 438 
1 WORDTAG EcoRI 
2 WORDTAG 103 
2 WORDTAG hormonal 
1 WORDTAG Mek 
1 WORDTAG Erk1 
2 WORDTAG estrogen 
1 WORDTAG deltex 
1 WORDTAG homologs 
1 WORDTAG suppressed 
2 WORDTAG basic 
2 WORDTAG helix 
2 WORDTAG loop 
2 WORDTAG bHLH 
2 WORDTAG form 
1 WORDTAG Notch1 
1 WORDTAG DTX1 
1 WORDTAG undertook 
1 WORDTAG pathology 
1 WORDTAG quantification 
1 WORDTAG papillary 
1 WORDTAG serous 
1 WORDTAG (% 
1 WORDTAG PSC 
1 WORDTAG Csk 
2 WORDTAG SH2 
1 WORDTAG Nucleotide 
2 WORDTAG map 
1 WORDTAG 13q14 
2 WORDTAG deleted 
1 WORDTAG lymphocytic 
1 WORDTAG MTX 
1 WORDTAG ara 
1 WORDTAG PCNSL 
2 WORDTAG enhances 
1 WORDTAG upper 
1 WORDTAG bands 
2 WORDTAG Fra 
2 WORDTAG AND 
1 WORDTAG Palmaz 
1 WORDTAG Schatz 
1 WORDTAG stents 
1 WORDTAG dip 
1 WORDTAG coated 
1 WORDTAG 187 
1 WORDTAG microgram 
1 WORDTAG stent 
1 WORDTAG immersion 
1 WORDTAG ethanolic 
1 WORDTAG evaporation 
1 WORDTAG solvent 
1 WORDTAG Currently 
1 WORDTAG aminolaevulinic 
2 WORDTAG ALA 
1 WORDTAG protoporphyrin 
1 WORDTAG IX 
1 WORDTAG PPIX 
1 WORDTAG photodynamic 
1 WORDTAG PDT 
1 WORDTAG limited 
1 WORDTAG maximum 
1 WORDTAG tolerated 
1 WORDTAG kg 
1 WORDTAG twelfth 
1 WORDTAG insertion 
1 WORDTAG disrupts 
1 WORDTAG Nrk 
9 WORDTAG " 
1 WORDTAG neurospecific 
1 WORDTAG Tpp 
1 WORDTAG neuropeptidase 
1 WORDTAG ATF4 
1 WORDTAG CdCl 
1 WORDTAG Nrf2 
1 WORDTAG Adjuvant 
1 WORDTAG neoadjuvant 
1 WORDTAG SVend 
2 WORDTAG HCM 
2 WORDTAG respective 
1 WORDTAG Control 
2 WORDTAG Raf 
2 WORDTAG abolished 
1 WORDTAG Rp 
1 WORDTAG cAMPS 
2 WORDTAG PKI 
1 WORDTAG caldesmon 
1 WORDTAG fiber 
1 WORDTAG TVD 
2 WORDTAG decreases 
1 WORDTAG skin 
3 WORDTAG healthy 
2 WORDTAG mCTR 
1 WORDTAG mRNAs 
1 WORDTAG give 
2 WORDTAG rise 
3 WORDTAG '- 
1 WORDTAG lengths 
1 WORDTAG PGHS 
1 WORDTAG cultures 
1 WORDTAG bovine 
1 WORDTAG uterine 
1 WORDTAG stromal 
1 WORDTAG nM 
1 WORDTAG linkage 
1 WORDTAG disequilibrium 
1 WORDTAG polymorphic 
1 WORDTAG UTR 
1 WORDTAG Several 
1 WORDTAG dozen 
1 WORDTAG targets 
1 WORDTAG VEGF 
1 WORDTAG Klinefelter 
1 WORDTAG 47XXY 
1 WORDTAG testosterone 
1 WORDTAG dihydrotestosterone 
1 WORDTAG composed 
1 WORDTAG hydrophobic 
1 WORDTAG When 
2 WORDTAG aqueous 
2 WORDTAG solutions 
4 WORDTAG TMT 
1 WORDTAG reagent 
1 WORDTAG grade 
2 WORDTAG zinc 
1 WORDTAG cadmium 
1 WORDTAG lead 
1 WORDTAG salts 
1 WORDTAG precipitate 
2 WORDTAG crystalline 
1 WORDTAG Zn 
1 WORDTAG ", 
2 WORDTAG amorphous 
1 WORDTAG Cd 
1 WORDTAG Pb 
1 WORDTAG M3 
1 WORDTAG S3C3N3 
1 WORDTAG nH2O 
1 WORDTAG Cd2 
2 WORDTAG +, 
1 WORDTAG Pb2 
1 WORDTAG Zn2 
3 WORDTAG n 
1 WORDTAG eventually 
1 WORDTAG crystallize 
1 WORDTAG stored 
1 WORDTAG air 
1 WORDTAG Online 
1 WORDTAG teaching 
1 WORDTAG design 
1 WORDTAG reciprocal 
1 WORDTAG strong 
1 WORDTAG ATF 
1 WORDTAG absorbed 
2 WORDTAG combination 
1 WORDTAG integrating 
1 WORDTAG detectors 
1 WORDTAG thermo 
1 WORDTAG luminescent 
1 WORDTAG dosemeter 
1 WORDTAG TDMS 
1 WORDTAG plastic 
1 WORDTAG track 
1 WORDTAG detector 
1 WORDTAG PNTD 
1 WORDTAG complexity 
1 WORDTAG shared 
1 WORDTAG assembled 
1 WORDTAG Mbp 
1 WORDTAG SRO 
1 WORDTAG bacteriophage 
1 WORDTAG P1 
1 WORDTAG artificial 
1 WORDTAG PAC 
1 WORDTAG clones 
2 WORDTAG Xlim 
2 WORDTAG unique 
1 WORDTAG CT239 
1 WORDTAG 403 
2 WORDTAG underlying 
1 WORDTAG organizer 
1 WORDTAG selenium 
4 WORDTAG diet 
1 WORDTAG unfavourable 
1 WORDTAG impact 
1 WORDTAG next 
1 WORDTAG adrenergic 
1 WORDTAG atenolol 
1 WORDTAG added 
1 WORDTAG titrated 
1 WORDTAG assess 
1 WORDTAG PKA 
1 WORDTAG mediation 
1 WORDTAG LH 
1 WORDTAG contribution 
1 WORDTAG LDL 
1 WORDTAG 1076 
1 WORDTAG cotransfected 
1 WORDTAG rabbit 
1 WORDTAG minigene 
2 WORDTAG constitutively 
1 WORDTAG Rous 
1 WORDTAG sarcoma 
1 WORDTAG SN 
2 WORDTAG 48 
1 WORDTAG GR 
2 WORDTAG HT1A 
1 WORDTAG inactivation 
1 WORDTAG nGRE 
1 WORDTAG GRE 
1 WORDTAG eliminated 
1 WORDTAG inclusion 
1 WORDTAG conferred 
1 WORDTAG Transition 
1 WORDTAG BPPV 
1 WORDTAG HNF 
3 WORDTAG HFH 
1 WORDTAG profiles 
1 WORDTAG 24 
2 WORDTAG Grade 
3 WORDTAG pneumonitis 
1 WORDTAG passive 
3 WORDTAG transport 
1 WORDTAG fluorescein 
1 WORDTAG BRB 
1 WORDTAG quantitated 
1 WORDTAG vitreous 
1 WORDTAG fluorometry 
2 WORDTAG Sixteen 
1 WORDTAG out 
1 WORDTAG 52 
2 WORDTAG seropositive 
1 WORDTAG MS 
1 WORDTAG pneumoniae 
2 WORDTAG %). 
1 WORDTAG Consistent 
1 WORDTAG specificity 
1 WORDTAG DmCKIIalpha 
1 WORDTAG alignment 
1 WORDTAG m5 
1 WORDTAG m7 
1 WORDTAG m8 
1 WORDTAG CKII 
1 WORDTAG subdomain 
1 WORDTAG Deletion 
3 WORDTAG repression 
1 WORDTAG Myc 
1 WORDTAG PATIENTS 
1 WORDTAG June 
1 WORDTAG 1991 
1 WORDTAG 1996 
2 WORDTAG nucleoside 
1 WORDTAG analog 
1 WORDTAG chlorodeoxyadenosine 
1 WORDTAG CDA 
2 WORDTAG AML 
1 WORDTAG myelodysplastic 
1 WORDTAG MDS 
1 WORDTAG Drosophila 
1 WORDTAG Menin1 
3 WORDTAG transcripts 
1 WORDTAG polyadenylation 
1 WORDTAG messages 
1 WORDTAG Mice 
1 WORDTAG homozygous 
1 WORDTAG dlg 
1 WORDTAG retardation 
1 WORDTAG hypoplasia 
1 WORDTAG premaxilla 
1 WORDTAG mandible 
2 WORDTAG cleft 
1 WORDTAG palate 
1 WORDTAG die 
1 WORDTAG perinatally 
2 WORDTAG detect 
1 WORDTAG TNFalpha 
1 WORDTAG Its 
1 WORDTAG pol 
1 WORDTAG U6 
1 WORDTAG exception 
3 WORDTAG TATA 
3 WORDTAG TBP 
1 WORDTAG DR2 
1 WORDTAG TBPwt 
1 WORDTAG Expression 
1 WORDTAG tumorigenic 
1 WORDTAG astrocytes 
1 WORDTAG SETA 
1 WORDTAG astrocyte 
1 WORDTAG kinetic 
13 WORDTAG N2 
3 WORDTAG ') 
1 WORDTAG pure 
2 WORDTAG discharges 
2 WORDTAG CH4 
2 WORDTAG M2 
1 WORDTAG '), 
1 WORDTAG Hepatitis 
1 WORDTAG nonalcoholic 
1 WORDTAG NAFL 
1 WORDTAG 1229 
1 WORDTAG endocytosis 
2 WORDTAG androgen 
2 WORDTAG AR 
1 WORDTAG imposes 
2 WORDTAG via 
1 WORDTAG exonic 
1 WORDTAG Can 
1 WORDTAG prolonged 
1 WORDTAG prostate 
1 WORDTAG Y 
1 WORDTAG decisive 
1 WORDTAG mrp2 
1 WORDTAG MRP2 
1 WORDTAG differently 
1 WORDTAG Intact 
1 WORDTAG Flag 
1 WORDTAG tagged 
1 WORDTAG vectors 
1 WORDTAG ORF40 
2 WORDTAG 41 
2 WORDTAG transcript 
1 WORDTAG primase 
1 WORDTAG proved 
2 WORDTAG spliced 
1 WORDTAG 127 
1 WORDTAG intron 
1 WORDTAG Hypomorphic 
1 WORDTAG dSLBP 
2 WORDTAG alleles 
1 WORDTAG zygotic 
1 WORDTAG cause 
2 WORDTAG female 
1 WORDTAG sterility 
1 WORDTAG hypertensive 
1 WORDTAG nephrosclerosis 
1 WORDTAG ACEI 
2 WORDTAG reduces 
1 WORDTAG incidence 
1 WORDTAG TLS 
1 WORDTAG pull 
1 WORDTAG coimmunoprecipitation 
1 WORDTAG experiment 
1 WORDTAG cultured 
1 WORDTAG CDR3 
1 WORDTAG lambdaL 
1 WORDTAG kappaL 
1 WORDTAG lymphocytes 
1 WORDTAG NBS 
1 WORDTAG migrants 
1 WORDTAG macronutrients 
1 WORDTAG micronutrients 
1 WORDTAG Dutch 
1 WORDTAG Experimental 
2 WORDTAG ta 
2 WORDTAG chengchi 
2 WORDTAG tang 
1 WORDTAG decoction 
2 WORDTAG relieving 
2 WORDTAG necrotizing 
2 WORDTAG pancreatitis 
1 WORDTAG objectives 
2 WORDTAG leukocyte 
1 WORDTAG adhesiveness 
2 WORDTAG ANP 
1 WORDTAG go 
1 WORDTAG relation 
1 WORDTAG prohibitive 
1 WORDTAG Decoction 
1 WORDTAG ventriculopleural 
1 WORDTAG shunting 
1 WORDTAG preferred 
2 WORDTAG peritoneal 
1 WORDTAG drainage 
2 WORDTAG intra 
1 WORDTAG adhesions 
1 WORDTAG recent 
1 WORDTAG Positive 
1 WORDTAG correlations 
1 WORDTAG pregnancy 
1 WORDTAG Se 
1 WORDTAG kidney 
1 WORDTAG 433 
1 WORDTAG 023 
1 WORDTAG 313 
1 WORDTAG 030 
1 WORDTAG Doxorubicin 
1 WORDTAG DOX 
1 WORDTAG hematological 
1 WORDTAG solid 
1 WORDTAG PDF 
1 WORDTAG Bayley 
1 WORDTAG motor 
1 WORDTAG scales 
1 WORDTAG Immunofixation 
1 WORDTAG allotypes 
2 WORDTAG seen 
1 WORDTAG SHIP2 
1 WORDTAG possessing 
1 WORDTAG R47G 
1 WORDTAG Myasthenia 
1 WORDTAG gravis 
1 WORDTAG autoimmune 
1 WORDTAG ACh 
1 WORDTAG neuromuscular 
1 WORDTAG synapse 
1 WORDTAG Rad23 
1 WORDTAG AMP 
2 WORDTAG regulate 
1 WORDTAG pigs 
1 WORDTAG assigned 
1 WORDTAG randomly 
1 WORDTAG shock 
1 WORDTAG TRA1 
1 WORDTAG TRA2 
1 WORDTAG TRA 
2 WORDTAG door 
1 WORDTAG survey 
1 WORDTAG Rac 
2 WORDTAG Cdc42 
1 WORDTAG Pak 
1 WORDTAG microtubule 
1 WORDTAG Zhu 
1 WORDTAG plasmids 
2 WORDTAG TyrRS 
1 WORDTAG supports 
1 WORDTAG arguments 
1 WORDTAG improbability 
1 WORDTAG UHF 
1 WORDTAG frequencies 
1 WORDTAG unless 
1 WORDTAG accumulating 
1 WORDTAG focussing 
2 WORDTAG students 
1 WORDTAG later 
1 WORDTAG confirm 
1 WORDTAG Cells 
1 WORDTAG subunits 
1 WORDTAG lacked 
3 WORDTAG distal 
1 WORDTAG alternatively 
1 WORDTAG Jak 
1 WORDTAG substrates 
1 WORDTAG CD86 
1 WORDTAG Despite 
1 WORDTAG abundant 
1 WORDTAG NtmybAS 
1 WORDTAG mature 
1 WORDTAG gPAL1 
2 WORDTAG detectable 
1 WORDTAG profiling 
1 WORDTAG gcn4Delta 
1 WORDTAG uncovered 
1 WORDTAG operating 
1 WORDTAG Gcn4p 
1 WORDTAG histidine 
1 WORDTAG MFI 
1 WORDTAG fresh 
1 WORDTAG frozen 
1 WORDTAG 94 
1 WORDTAG 92 
1 WORDTAG lamb 
1 WORDTAG pork 
1 WORDTAG longissimus 
1 WORDTAG green 
2 WORDTAG fluorescent 
1 WORDTAG GFP 
1 WORDTAG EAV 
1 WORDTAG constructed 
1 WORDTAG Significantly 
1 WORDTAG extubated 
1 WORDTAG LPD 
1 WORDTAG TX 
1 WORDTAG Lack 
1 WORDTAG Kawasaki 
2 WORDTAG Rickettsia 
1 WORDTAG conorii 
1 WORDTAG typhi 
1 WORDTAG Coxiella 
1 WORDTAG burnetii 
1 WORDTAG Ehrlichia 
1 WORDTAG phagocytophila 
1 WORDTAG utilisation 
2 WORDTAG imply 
1 WORDTAG annual 
1 WORDTAG drug 
2 WORDTAG costs 
4 WORDTAG $ 
2 WORDTAG US 
1 WORDTAG 480 
1 WORDTAG million 
1 WORDTAG population 
1 WORDTAG Alignment 
1 WORDTAG cDNAs 
1 WORDTAG NR5A2 
1 WORDTAG hB1F 
1 WORDTAG facilitated 
1 WORDTAG delineation 
1 WORDTAG organization 
1 WORDTAG spans 
1 WORDTAG 150 
1 WORDTAG consists 
1 WORDTAG interrupted 
1 WORDTAG introns 
1 WORDTAG Ketamine 
1 WORDTAG dissociative 
1 WORDTAG produces 
1 WORDTAG persistently 
1 WORDTAG BIS 
1 WORDTAG index 
1 WORDTAG thiamylal 
1 WORDTAG anesthetic 
2 WORDTAG agents 
1 WORDTAG aneurysm 
1 WORDTAG originated 
1 WORDTAG A1 
1 WORDTAG fenestration 
1 WORDTAG canonical 
2 WORDTAG anticodon 
4 WORDTAG anchor 
1 WORDTAG leading 
1 WORDTAG better 
1 WORDTAG tyrosylation 
1 WORDTAG Temperature 
1 WORDTAG microfluidic 
1 WORDTAG systems 
1 WORDTAG dye 
3 WORDTAG exon 
2 WORDTAG 1A 
1 WORDTAG corresponded 
2 WORDTAG 250 
1 WORDTAG NAUSICAA 
1 WORDTAG gives 
1 WORDTAG good 
1 WORDTAG LET 
1 WORDTAG spectra 
1 WORDTAG MABP 
1 WORDTAG MCBFV 
1 WORDTAG bandpass 
1 WORDTAG VLF 
1 WORDTAG 015 
2 WORDTAG 07 
3 WORDTAG Hz 
1 WORDTAG LF 
1 WORDTAG HF 
1 WORDTAG before 
1 WORDTAG applying 
1 WORDTAG CCF 
1 WORDTAG studying 
1 WORDTAG bandwidths 
1 WORDTAG CCFs 
1 WORDTAG purposes 
1 WORDTAG introduction 
1 WORDTAG extended 
1 WORDTAG oligoarthritis 
1 WORDTAG onset 
1 WORDTAG susceptibility 
1 WORDTAG Aspergillus 
1 WORDTAG fumigatus 
1 WORDTAG mulundocandin 
1 WORDTAG echinocandin 
1 WORDTAG antifungal 
1 WORDTAG National 
1 WORDTAG Committee 
1 WORDTAG Clinical 
1 WORDTAG Laboratory 
1 WORDTAG Standards 
1 WORDTAG NCCLS 
1 WORDTAG M38 
1 WORDTAG bis 
1 WORDTAG methoxy 
1 WORDTAG nitro 
1 WORDTAG sulfophenyl 
1 WORDTAG -[( 
1 WORDTAG phenyl 
1 WORDTAG carbonyl 
1 WORDTAG ]- 
1 WORDTAG 2H 
1 WORDTAG tetrazolium 
1 WORDTAG hydroxide 
1 WORDTAG XTT 
1 WORDTAG colorimetric 
1 WORDTAG determination 
1 WORDTAG morphologic 
1 WORDTAG alterations 
1 WORDTAG microscopy 
1 WORDTAG Epstein 
1 WORDTAG Barr 
1 WORDTAG mononucleosis 
1 WORDTAG immunodeficiency 
1 WORDTAG occupational 
1 WORDTAG wood 
1 WORDTAG industry 
1 WORDTAG Members 
1 WORDTAG leucine 
1 WORDTAG zipper 
1 WORDTAG StRE 
1 WORDTAG TraI36 
1 WORDTAG stranded 
1 WORDTAG Overexpression 
1 WORDTAG RORgamma 
1 WORDTAG hybridomas 
1 WORDTAG repress 
1 WORDTAG Fas 
1 WORDTAG metabolized 
1 WORDTAG cytochrome 
1 WORDTAG 450 
2 WORDTAG CYP 
1 WORDTAG 2D6 
1 WORDTAG 3A4 
1 WORDTAG far 
1 WORDTAG lesser 
1 WORDTAG extent 
1 WORDTAG SSRIs 
2 WORDTAG MKK4 
1 WORDTAG upregulated 
1 WORDTAG mkk7 
1 WORDTAG (-/-) 
1 WORDTAG occurred 
1 WORDTAG stimuli 
1 WORDTAG engines 
1 WORDTAG cumbersome 
1 WORDTAG experts 
1 WORDTAG tolerate 
1 WORDTAG immunoglobulin 
1 WORDTAG TBII 
1 WORDTAG presentation 
1 WORDTAG rose 
1 WORDTAG extraordinary 
3 WORDTAG peptide 
1 WORDTAG gp96 
1 WORDTAG plasticity 
1 WORDTAG pocket 
1 WORDTAG proposed 
1 WORDTAG relay 
1 WORDTAG MHC 
1 WORDTAG molecules 
1 WORDTAG Elevated 
2 WORDTAG UhpB 
2 WORDTAG GST 
1 WORDTAG Bc 
1 WORDTAG glutathione 
1 WORDTAG transferase 
1 WORDTAG fused 
1 WORDTAG blockage 
1 WORDTAG uhpT 
1 WORDTAG uhp 
1 WORDTAG Physical 
1 WORDTAG principles 
1 WORDTAG therapeutic 
1 WORDTAG apheresis 
1 WORDTAG Evidence 
1 WORDTAG jadM 
1 WORDTAG jadomycin 
1 WORDTAG copies 
1 WORDTAG rsmB 
2 WORDTAG hand 
1 WORDTAG stimulate 
1 WORDTAG exoenzyme 
1 WORDTAG hexA 
1 WORDTAG +. 
1 WORDTAG Systematic 
1 WORDTAG diagnostic 
1 WORDTAG vaginal 
1 WORDTAG trichomoniasis 
1 WORDTAG Anecdotal 
1 WORDTAG observations 
1 WORDTAG scattered 
1 WORDTAG literature 
1 WORDTAG clues 
2 WORDTAG variations 
1 WORDTAG humans 
1 WORDTAG handle 
1 WORDTAG dietary 
1 WORDTAG chemicals 
1 WORDTAG PK 
1 WORDTAG restored 
1 WORDTAG purified 
1 WORDTAG reactivation 
1 WORDTAG blocked 
1 WORDTAG microcystin 
1 WORDTAG Herein 
1 WORDTAG PPARgamma 
1 WORDTAG liganded 
1 WORDTAG natural 
1 WORDTAG 15d 
1 WORDTAG PGJ 
1 WORDTAG PGD 
2 WORDTAG )) 
1 WORDTAG ligands 
1 WORDTAG BRL49653 
1 WORDTAG troglitazone 
1 WORDTAG selectively 
1 WORDTAG integrated 
1 WORDTAG RTC 
1 WORDTAG algorithm 
1 WORDTAG urban 
1 WORDTAG formulated 
1 WORDTAG optimized 
1 WORDTAG optimization 
1 WORDTAG routines 
1 WORDTAG Recently 
1 WORDTAG alanine 
1 WORDTAG center 
1 WORDTAG impair 
1 WORDTAG depurinating 
1 WORDTAG ribosome 
1 WORDTAG PAP 
1 WORDTAG partial 
1 WORDTAG transection 
1 WORDTAG permit 
1 WORDTAG vasopressin 
1 WORDTAG secreted 
1 WORDTAG larger 
1 WORDTAG Reciprocally 
1 WORDTAG HMGI 
1 WORDTAG coordinately 
1 WORDTAG PIAS3 
1 WORDTAG STAT3 
1 WORDTAG SPEC1 
2 WORDTAG close 
1 WORDTAG proximity 
1 WORDTAG AF1q 
1 WORDTAG translocation 
1 WORDTAG PEX5 
2 WORDTAG TPR 
1 WORDTAG tobacco 
1 WORDTAG nematode 
1 WORDTAG inserted 
2 WORDTAG Pex5p 
1 WORDTAG chimaeras 
1 WORDTAG Ets 
1 WORDTAG GPIX 
1 WORDTAG smg 
1 WORDTAG surveillance 
1 WORDTAG elegans 
1 WORDTAG Cytosolic 
2 WORDTAG acetyl 
1 WORDTAG AceCS1 
1 WORDTAG supply 
1 WORDTAG lipid 
1 WORDTAG onto 
1 WORDTAG While 
1 WORDTAG proton 
1 WORDTAG intracellular 
1 WORDTAG WT 
1 WORDTAG HSAL2 
1 WORDTAG hematopoiesis 
1 WORDTAG radial 
2 WORDTAG forearm 
1 WORDTAG lateral 
1 WORDTAG arm 
1 WORDTAG choice 
1 WORDTAG certain 
1 WORDTAG procedure 
1 WORDTAG aggressive 
1 WORDTAG painful 
1 WORDTAG sternotomy 
1 WORDTAG GGT 
1 WORDTAG HepG2 
1 WORDTAG Further 
1 WORDTAG osteo 
1 WORDTAG retentive 
1 WORDTAG hydroxyapatite 
1 WORDTAG sockets 
2 WORDTAG significance 
1 WORDTAG width 
1 WORDTAG canine 
1 WORDTAG 059 
1 WORDTAG LHS 
1 WORDTAG 065 
1 WORDTAG RHS 
1 WORDTAG LAD 
1 WORDTAG FGFR 
2 WORDTAG vertigo 
1 WORDTAG syndromes 
1 WORDTAG A8G 
1 WORDTAG hnRNP 
2 WORDTAG A2 
1 WORDTAG A2RE 
1 WORDTAG station 
1 WORDTAG dimensional 
2 WORDTAG magnetic 
1 WORDTAG angiography 
1 WORDTAG extremities 
1 WORDTAG segmented 
2 WORDTAG volume 
1 WORDTAG acquisition 
1 WORDTAG Treatment 
1 WORDTAG N18TG 
1 WORDTAG demethylating 
1 WORDTAG agent 
1 WORDTAG aza 
1 WORDTAG deoxycytidine 
1 WORDTAG attributable 
1 WORDTAG silenced 
1 WORDTAG rCBF 
1 WORDTAG increases 
2 WORDTAG meso 
1 WORDTAG striatal 
1 WORDTAG corticolimbic 
1 WORDTAG circuits 
1 WORDTAG monetary 
1 WORDTAG reward 
1 WORDTAG nonmonetary 
1 WORDTAG reinforcement 
1 WORDTAG Reverse 
1 WORDTAG transcriptase 
1 WORDTAG PKRDeltaE7 
1 WORDTAG broad 
1 WORDTAG variable 
1 WORDTAG final 
1 WORDTAG swelling 
1 WORDTAG fixation 
1 WORDTAG strengths 
1 WORDTAG swellable 
1 WORDTAG designs 
1 WORDTAG smooth 
1 WORDTAG screw 
1 WORDTAG foams 
1 WORDTAG simulate 
1 WORDTAG CYP2C19 
1 WORDTAG genotype 
1 WORDTAG adjunct 
1 WORDTAG mammography 
1 WORDTAG radiographically 
1 WORDTAG breasts 
1 WORDTAG palpable 
1 WORDTAG masses 
1 WORDTAG Activation 
1 WORDTAG Jurkat 
1 WORDTAG JunD 
1 WORDTAG weak 
1 WORDTAG JunB 
1 WORDTAG Fos 
1 WORDTAG still 
1 WORDTAG screen 
1 WORDTAG toxic 
1 WORDTAG dissecting 
1 WORDTAG cellular 
1 WORDTAG developing 
1 WORDTAG therapies 
1 WORDTAG Local 
1 WORDTAG 89 
1 WORDTAG T1 
1 WORDTAG 2N0M0 
1 WORDTAG cognitive 
1 WORDTAG Boston 
1 WORDTAG Naming 
1 WORDTAG Test 
1 WORDTAG Word 
1 WORDTAG List 
1 WORDTAG Recognition 
1 WORDTAG Task 
1 WORDTAG reach 
1 WORDTAG Gimpl 
1 WORDTAG actA 
1 WORDTAG chrysogenum 
1 WORDTAG opposite 
1 WORDTAG pcbC 
1 WORDTAG cefEF 
2 WORDTAG cephalosporin 
1 WORDTAG biosynthetic 
1 WORDTAG fermentation 
1 WORDTAG Maternal 
1 WORDTAG DDE 
1 WORDTAG HCH 
1 WORDTAG newborn 
1 WORDTAG PCBs 
2 WORDTAG families 
1 WORDTAG closely 
1 WORDTAG questioned 
1 WORDTAG orthostasia 
1 WORDTAG transactivated 
1 WORDTAG GAMyb 
1 WORDTAG itself 
1 WORDTAG Cardiac 
1 WORDTAG output 
1 WORDTAG anaerobic 
1 WORDTAG COAT 
1 WORDTAG min 
1 WORDTAG cutoff 
1 WORDTAG identifying 
1 WORDTAG multivessel 
1 WORDTAG Tolerance 
2 WORDTAG ADAL 
1 WORDTAG Vicryl 
1 WORDTAG suture 
1 WORDTAG tolerance 
1 WORDTAG Tisuacryl 
1 WORDTAG 728 
1 WORDTAG zoledronic 
1 WORDTAG 776 
1 WORDTAG pamidronate 
1 WORDTAG retrospectively 
1 WORDTAG selected 
1 WORDTAG TFCD 
1 WORDTAG intractable 
1 WORDTAG epilepsy 
1 WORDTAG aim 
1 WORDTAG removing 
1 WORDTAG epileptogenic 
1 WORDTAG stereoelectroencephalographic 
1 WORDTAG recordings 
1 WORDTAG gain 
1 WORDTAG understanding 
1 WORDTAG mGSTM2 
1 WORDTAG analyzed 
1 WORDTAG Cyclins 
1 WORDTAG pivotal 
1 WORDTAG determinants 
1 WORDTAG Architecture 
1 WORDTAG anatomy 
1 WORDTAG RUNX1 
1 WORDTAG AML1 
1 WORDTAG Rad1 
1 WORDTAG Hus1 
1 WORDTAG Rad9 
1 WORDTAG Together 
2 WORDTAG HFV 
1 WORDTAG modify 
1 WORDTAG fate 
1 WORDTAG office 
1 WORDTAG fewer 
1 WORDTAG cardiovascular 
1 WORDTAG mutagenesis 
1 WORDTAG 2003 
1 WORDTAG 2212 
1 WORDTAG call 
1 WORDTAG carboxy 
1 WORDTAG CR2 
1 WORDTAG Fetal 
1 WORDTAG estimation 
1 WORDTAG Plane 
1 WORDTAG wave 
2 WORDTAG geometry 
1 WORDTAG impractical 
1 WORDTAG encouraged 
1 WORDTAG us 
1 WORDTAG develop 
1 WORDTAG P3 
1 WORDTAG approximation 
1 WORDTAG spherical 
1 WORDTAG systematic 
1 WORDTAG reviews 
1 WORDTAG drawn 
1 WORDTAG ACP 
1 WORDTAG Journal 
1 WORDTAG Club 
1 WORDTAG PubMed 
1 WORDTAG strategy 
1 WORDTAG achieved 
1 WORDTAG 97 
1 WORDTAG she 
1 WORDTAG infusion 
1 WORDTAG levoforinate 
1 WORDTAG LV 
1 WORDTAG FU 
1 WORDTAG 500 
1 WORDTAG metastases 
1 WORDTAG starting 
1 WORDTAG infuser 
1 WORDTAG pump 
1 WORDTAG Because 
1 WORDTAG measurements 
1 WORDTAG concordant 
1 WORDTAG inheritance 
1 WORDTAG DNAH9 
1 WORDTAG NIRS 
1 WORDTAG mV 
1 WORDTAG FBF 
1 WORDTAG 78 
1 WORDTAG influence 
1 WORDTAG educational 
1 WORDTAG power 
1 WORDTAG eliminate 
1 WORDTAG sources 
1 WORDTAG error 
1 WORDTAG myb 
1 WORDTAG cdk2 
1 WORDTAG Like 
1 WORDTAG LHbeta 
1 WORDTAG flanking 
1 WORDTAG gpLH 
1 WORDTAG CGbeta 
1 WORDTAG 37 
1 WORDTAG codon 
1 WORDTAG HTLV 
1 WORDTAG Th2 
1 WORDTAG strongyloidiasis 
1 WORDTAG Indeed 
1 WORDTAG sid1 
1 WORDTAG altered 
1 WORDTAG sid2 
1 WORDTAG Nutritional 
1 WORDTAG traditional 
1 WORDTAG Plant 
1 WORDTAG lacks 
2 WORDTAG vitamin 
1 WORDTAG B12 
1 WORDTAG polyunsaturated 
1 WORDTAG On 
1 WORDTAG forced 
1 WORDTAG inactivated 
2 WORDTAG nm23H1 
1 WORDTAG converted 
1 WORDTAG GDP 
1 WORDTAG RhoA 
1 WORDTAG diphosphate 
1 WORDTAG produce 
1 WORDTAG GTPases 
1 WORDTAG Novel 
1 WORDTAG Coronary 
1 WORDTAG 17 
2 WORDTAG tertile 
1 WORDTAG CRP 
1 WORDTAG fibrinogen 
1 WORDTAG tertiles 
1 WORDTAG hepatitis 
1 WORDTAG infections 
1 WORDTAG adolescents 
1 WORDTAG lodged 
1 WORDTAG security 
1 WORDTAG institutes 
1 WORDTAG Buenos 
1 WORDTAG Aires 
1 WORDTAG MyoD 
1 WORDTAG myeloid 
1 WORDTAG caudal 
1 WORDTAG homeobox 
2 WORDTAG Cdx 
1 WORDTAG RPM 
1 WORDTAG RGL3 
1 WORDTAG resembled 
1 WORDTAG AF 
1 WORDTAG Nore1 
1 WORDTAG stratified 
1 WORDTAG gender 
1 WORDTAG blind 
1 WORDTAG antiemetic 
1 WORDTAG regimes 
2 WORDTAG dolasetron 
3 WORDTAG given 
1 WORDTAG orally 
1 WORDTAG 45 
3 WORDTAG anaesthesia 
2 WORDTAG intravenously 
1 WORDTAG DHB 
1 WORDTAG IV 
1 WORDTAG Transcriptional 
1 WORDTAG pS2 
1 WORDTAG ERR 
1 WORDTAG orphan 
1 1-GRAM Third
511 1-GRAM ,
4 1-GRAM consistent
115 1-GRAM with
19 1-GRAM these
12 1-GRAM data
10 1-GRAM N
520 1-GRAM -
1 1-GRAM acetylcysteine
4 1-GRAM reduced
581 1-GRAM the
1 1-GRAM stimulatory
12 1-GRAM effect
539 1-GRAM of
1 1-GRAM HGF
37 1-GRAM on
6 1-GRAM stress
26 1-GRAM kinase
3 1-GRAM activities
3 1-GRAM while
1 1-GRAM p42
82 1-GRAM /
1 1-GRAM 44
4 1-GRAM mitogen
7 1-GRAM activated
252 1-GRAM (
7 1-GRAM MAPK
169 1-GRAM )
81 1-GRAM was
1 1-GRAM unmodified
4 1-GRAM suggesting
40 1-GRAM an
1 1-GRAM involvement
6 1-GRAM c
2 1-GRAM Jun
16 1-GRAM terminal
3 1-GRAM JNK
373 1-GRAM and
1 1-GRAM p38
305 1-GRAM in
4 1-GRAM HIF
65 1-GRAM 1
18 1-GRAM activation
587 1-GRAM .
85 1-GRAM The
1 1-GRAM Sox
64 1-GRAM gene
9 1-GRAM family
1 1-GRAM Sry
7 1-GRAM like
1 1-GRAM HMG
4 1-GRAM box
88 1-GRAM is
1 1-GRAM characterised
103 1-GRAM by
194 1-GRAM a
5 1-GRAM conserved
19 1-GRAM DNA
18 1-GRAM sequence
9 1-GRAM encoding
22 1-GRAM domain
3 1-GRAM approximately
3 1-GRAM 80
13 1-GRAM amino
8 1-GRAM acids
29 1-GRAM which
3 1-GRAM responsible
106 1-GRAM for
15 1-GRAM specific
32 1-GRAM binding
1 1-GRAM Respiratory
4 1-GRAM parameters
3 1-GRAM suggested
95 1-GRAM that
1 1-GRAM M6G
4 1-GRAM produced
4 1-GRAM less
2 1-GRAM respiratory
1 1-GRAM depression
23 1-GRAM than
1 1-GRAM morphine
14 1-GRAM This
2 1-GRAM slow
3 1-GRAM progression
12 1-GRAM through
6 1-GRAM early
5 1-GRAM G1
4 1-GRAM phase
4 1-GRAM resulted
7 1-GRAM decreased
14 1-GRAM phosphorylation
1 1-GRAM RB
61 1-GRAM protein
3 1-GRAM subsequent
1 1-GRAM delay
9 1-GRAM into
8 1-GRAM S
3 1-GRAM transition
2 1-GRAM Responses
1 1-GRAM TLD
2 1-GRAM Mg2SiO4
57 1-GRAM :
2 1-GRAM Tb
1 1-GRAM radiophotoluminescent
1 1-GRAM glass
219 1-GRAM to
2 1-GRAM heavy
1 1-GRAM charged
1 1-GRAM particles
4 1-GRAM space
4 1-GRAM radiation
37 1-GRAM In
1 1-GRAM meantime
8 1-GRAM one
17 1-GRAM has
1 1-GRAM succeeded
4 1-GRAM establish
1 1-GRAM deammonification
2 1-GRAM processes
1 1-GRAM continuous
5 1-GRAM flow
1 1-GRAM moving
1 1-GRAM bed
1 1-GRAM pilot
3 1-GRAM plant
3 1-GRAM An
4 1-GRAM 18
5 1-GRAM kb
9 1-GRAM genomic
2 1-GRAM clone
3 1-GRAM including
8 1-GRAM sequences
27 1-GRAM two
1 1-GRAM GHS
5 1-GRAM R
2 1-GRAM variants
5 1-GRAM isolated
10 1-GRAM further
6 1-GRAM development
1 1-GRAM bladder
1 1-GRAM neck
1 1-GRAM suspension
2 1-GRAM according
1 1-GRAM Stamey
1 1-GRAM Pereyra
9 1-GRAM use
1 1-GRAM miniature
7 1-GRAM bone
1 1-GRAM anchors
6 1-GRAM received
2 1-GRAM considerable
4 1-GRAM support
1 1-GRAM CHAP
2 1-GRAM Department
1 1-GRAM Veterans
1 1-GRAM Affairs
3 1-GRAM Finally
1 1-GRAM chromogenic
7 1-GRAM method
12 1-GRAM used
9 1-GRAM based
1 1-GRAM thrombin
6 1-GRAM inhibition
1 1-GRAM substrate
1 1-GRAM 2238
3 1-GRAM As
3 1-GRAM oral
1 1-GRAM nontoxic
2 1-GRAM compound
4 1-GRAM mechanism
1 1-GRAM action
2 1-GRAM distinct
37 1-GRAM from
2 1-GRAM ABL
10 1-GRAM tyrosine
1 1-GRAM FTI
1 1-GRAM SCH66336
3 1-GRAM shows
1 1-GRAM promise
13 1-GRAM treatment
2 1-GRAM BCR
15 1-GRAM induced
4 1-GRAM leukemia
1 1-GRAM Recruitment
7 1-GRAM RNA
4 1-GRAM polymerase
12 1-GRAM II
11 1-GRAM complex
9 1-GRAM mediated
2 1-GRAM constitutive
7 1-GRAM CREB
2 1-GRAM independently
7 1-GRAM Our
21 1-GRAM results
34 1-GRAM are
1 1-GRAM reassuring
24 1-GRAM we
2 1-GRAM therefore
1 1-GRAM advise
28 1-GRAM patients
3 1-GRAM undergoing
3 1-GRAM free
1 1-GRAM jejunum
4 1-GRAM flap
1 1-GRAM reconstruction
1 1-GRAM hypopharyngo
2 1-GRAM esophageal
1 1-GRAM tract
2 1-GRAM voice
1 1-GRAM restoration
4 1-GRAM should
35 1-GRAM be
1 1-GRAM attempted
1 1-GRAM placing
1 1-GRAM prosthesis
5 1-GRAM secondary
1 1-GRAM tracheo
1 1-GRAM puncture
1 1-GRAM providing
1 1-GRAM intensive
1 1-GRAM speech
1 1-GRAM training
1 1-GRAM Regarding
2 1-GRAM gestational
9 1-GRAM risk
40 1-GRAM 3
1 1-GRAM 243
2 1-GRAM drugs
2 1-GRAM 34
6 1-GRAM %)
1 1-GRAM belonged
7 1-GRAM category
30 1-GRAM A
1 1-GRAM 923
1 1-GRAM 22
19 1-GRAM 6
21 1-GRAM B
1 1-GRAM 798
1 1-GRAM 39
14 1-GRAM 7
31 1-GRAM C
1 1-GRAM 289
52 1-GRAM 0
6 1-GRAM D
4 1-GRAM 55
7 1-GRAM X
25 1-GRAM human
1 1-GRAM ABCG1
3 1-GRAM encodes
5 1-GRAM member
3 1-GRAM ATP
4 1-GRAM cassette
2 1-GRAM ABC
2 1-GRAM superfamily
3 1-GRAM transporter
13 1-GRAM proteins
4 1-GRAM highly
9 1-GRAM when
1 1-GRAM macrophages
1 1-GRAM incubated
1 1-GRAM oxysterols
5 1-GRAM At
6 1-GRAM end
5 1-GRAM each
4 1-GRAM day
1 1-GRAM migration
2 1-GRAM pulmonary
1 1-GRAM hemolymph
1 1-GRAM PO2
64 1-GRAM 2
30 1-GRAM 5
1 1-GRAM kPa
22 1-GRAM but
1 1-GRAM hemocyanin
1 1-GRAM remained
1 1-GRAM saturated
2 1-GRAM O2
2 1-GRAM venous
1 1-GRAM reserve
2 1-GRAM largely
1 1-GRAM unchanged
9 1-GRAM >
18 1-GRAM 4
4 1-GRAM mmol
3 1-GRAM x
4 1-GRAM l
4 1-GRAM (-
1 1-GRAM )).
19 1-GRAM We
21 1-GRAM have
3 1-GRAM investigated
12 1-GRAM role
5 1-GRAM NGF
5 1-GRAM regulating
22 1-GRAM transcription
2 1-GRAM PC12
1 1-GRAM INS
34 1-GRAM cells
3 1-GRAM order
3 1-GRAM define
2 1-GRAM if
4 1-GRAM there
5 1-GRAM regulated
21 1-GRAM genes
5 1-GRAM per
1 1-GRAM se
8 1-GRAM Thus
6 1-GRAM change
1 1-GRAM conformation
4 1-GRAM upon
2 1-GRAM repair
1 1-GRAM 6RG
4 1-GRAM lesion
2 1-GRAM MGMT
1 1-GRAM switches
21 1-GRAM factor
4 1-GRAM regulator
32 1-GRAM ),
1 1-GRAM enabling
36 1-GRAM cell
2 1-GRAM sense
46 1-GRAM as
4 1-GRAM well
2 1-GRAM respond
1 1-GRAM mutagens
1 1-GRAM TaqMan
20 1-GRAM analysis
36 1-GRAM expression
5 1-GRAM following
5 1-GRAM chronic
1 1-GRAM FA
13 1-GRAM showed
2 1-GRAM neither
5 1-GRAM decrease
3 1-GRAM amount
1 1-GRAM leptin
27 1-GRAM receptor
1 1-GRAM Ob
10 1-GRAM mRNA
2 1-GRAM nor
10 1-GRAM increase
14 1-GRAM negative
3 1-GRAM regulators
2 1-GRAM STAT
2 1-GRAM signalling
1 1-GRAM SOCS3
1 1-GRAM suppressors
2 1-GRAM cytokine
51 1-GRAM or
5 1-GRAM inducible
1 1-GRAM CIS
31 1-GRAM ).
2 1-GRAM Nine
3 1-GRAM animals
1 1-GRAM served
14 1-GRAM control
3 1-GRAM whereas
8 1-GRAM 20
3 1-GRAM focal
1 1-GRAM arachnoid
1 1-GRAM scar
47 1-GRAM at
2 1-GRAM C1
1 1-GRAM C2
1 1-GRAM placement
1 1-GRAM kaolin
1 1-GRAM soaked
1 1-GRAM fibrin
1 1-GRAM sponge
1 1-GRAM posterior
3 1-GRAM surface
2 1-GRAM spinal
1 1-GRAM cord
2 1-GRAM comparison
3 1-GRAM duplicated
1 1-GRAM Vkappa
5 1-GRAM suggests
11 1-GRAM positive
1 1-GRAM selection
1 1-GRAM complementarity
2 1-GRAM determining
11 1-GRAM regions
11 1-GRAM point
2 1-GRAM mutations
1 1-GRAM They
39 1-GRAM not
14 1-GRAM been
7 1-GRAM previously
5 1-GRAM reported
4 1-GRAM reaction
3 1-GRAM i
3 1-GRAM v
7 1-GRAM contrast
1 1-GRAM material
3 1-GRAM presence
1 1-GRAM AS
1 1-GRAM oligo
14 1-GRAM had
8 1-GRAM no
1 1-GRAM FSH
1 1-GRAM EB
1 1-GRAM *-
1 1-GRAM mTf
2 1-GRAM CAT
4 1-GRAM construct
2 1-GRAM cAMP
2 1-GRAM homologous
5 1-GRAM active
13 1-GRAM site
1 1-GRAM framework
3 1-GRAM enzymes
2 1-GRAM structures
1 1-GRAM convergent
3 1-GRAM evolution
4 1-GRAM common
2 1-GRAM catalytic
2 1-GRAM Additional
2 1-GRAM education
1 1-GRAM research
1 1-GRAM needed
2 1-GRAM provide
1 1-GRAM direction
2 1-GRAM intervention
1 1-GRAM incorporation
1 1-GRAM practice
2 1-GRAM Many
10 1-GRAM important
12 1-GRAM associated
18 1-GRAM regulation
8 1-GRAM shown
4 1-GRAM play
2 1-GRAM key
4 1-GRAM proliferation
4 1-GRAM differentiation
1 1-GRAM oncogenic
5 1-GRAM transformation
2 1-GRAM programmed
2 1-GRAM death
3 1-GRAM apoptosis
1 1-GRAM Drug
5 1-GRAM interactions
12 1-GRAM found
1 1-GRAM compete
3 1-GRAM same
1 1-GRAM CYP450
1 1-GRAM isoenzymes
1 1-GRAM statins
1 1-GRAM Regulation
1 1-GRAM laminin
1 1-GRAM beta2
6 1-GRAM chain
14 1-GRAM cancer
6 1-GRAM lines
2 1-GRAM Mutation
4 1-GRAM NF
4 1-GRAM kappaB
1 1-GRAM Mdr1b
28 1-GRAM promoter
1 1-GRAM prevents
16 1-GRAM its
10 1-GRAM induction
6 1-GRAM TNF
9 1-GRAM alpha
1 1-GRAM Effect
1 1-GRAM heat
2 1-GRAM treatments
1 1-GRAM meltability
2 1-GRAM cheeses
9 1-GRAM vitro
5 1-GRAM studies
4 1-GRAM demonstrate
2 1-GRAM eIF
2 1-GRAM 5A
8 1-GRAM required
2 1-GRAM efficient
12 1-GRAM interaction
2 1-GRAM Rev
1 1-GRAM NES
1 1-GRAM CRM1
1 1-GRAM exportin1
4 1-GRAM interacts
1 1-GRAM nucleoporins
1 1-GRAM CAN
1 1-GRAM nup214
1 1-GRAM nup153
1 1-GRAM nup98
1 1-GRAM nup62
1 1-GRAM Forced
1 1-GRAM BZAP45
4 1-GRAM strongly
1 1-GRAM stimulates
1 1-GRAM H4
1 1-GRAM nt
1 1-GRAM 215
4 1-GRAM )/
4 1-GRAM reporter
27 1-GRAM activity
4 1-GRAM Copyright
5 1-GRAM 2001
3 1-GRAM Academic
3 1-GRAM Press
2 1-GRAM diagnosis
1 1-GRAM HCV
1 1-GRAM arthritis
1 1-GRAM rheumatoid
3 1-GRAM inflammatory
1 1-GRAM polyarthritis
17 1-GRAM may
1 1-GRAM difficult
1 1-GRAM UBA
5 1-GRAM domains
1 1-GRAM RAD23
1 1-GRAM DDI1
2 1-GRAM E47
25 1-GRAM levels
1 1-GRAM remain
6 1-GRAM high
1 1-GRAM until
2 1-GRAM double
2 1-GRAM developmental
3 1-GRAM stage
3 1-GRAM they
1 1-GRAM drop
2 1-GRAM relatively
1 1-GRAM moderate
1 1-GRAM downregulated
12 1-GRAM single
1 1-GRAM By
1 1-GRAM Caveman
12 1-GRAM These
4 1-GRAM findings
8 1-GRAM suggest
1 1-GRAM adapter
1 1-GRAM Gab1
1 1-GRAM redirect
1 1-GRAM Met
7 1-GRAM signaling
2 1-GRAM PI3K
1 1-GRAM away
1 1-GRAM Akt
1 1-GRAM Pak1
3 1-GRAM survival
7 1-GRAM pathway
1 1-GRAM Another
10 1-GRAM mutant
1 1-GRAM T255A
2 1-GRAM lost
6 1-GRAM ability
5 1-GRAM bind
1 1-GRAM E4orf6
2 1-GRAM unexpectedly
1 1-GRAM viral
1 1-GRAM late
3 1-GRAM affected
8 1-GRAM However
1 1-GRAM N63S
10 1-GRAM mutation
5 1-GRAM wild
12 1-GRAM type
1 1-GRAM VP5
2 1-GRAM background
13 1-GRAM increased
1 1-GRAM judged
11 1-GRAM beta
1 1-GRAM galactosidase
9 1-GRAM 9
4 1-GRAM relative
1 1-GRAM PR7
6 1-GRAM present
4 1-GRAM Here
1 1-GRAM report
2 1-GRAM isolation
5 1-GRAM characterization
2 1-GRAM forkhead
2 1-GRAM homologue
1 1-GRAM rhabdomyosarcoma
1 1-GRAM FKHR
2 1-GRAM recently
5 1-GRAM described
1 1-GRAM hepatocyte
9 1-GRAM nuclear
1 1-GRAM homeotic
2 1-GRAM hormone
1 1-GRAM NR
1 1-GRAM intermediary
1 1-GRAM Unlike
12 1-GRAM other
2 1-GRAM progenitor
6 1-GRAM brain
1 1-GRAM SVZa
5 1-GRAM capacity
1 1-GRAM divide
6 1-GRAM even
3 1-GRAM though
4 1-GRAM express
3 1-GRAM neuronal
2 1-GRAM phenotype
4 1-GRAM Tax
3 1-GRAM cycle
1 1-GRAM G0
1 1-GRAM G2
6 1-GRAM M
1 1-GRAM phases
10 1-GRAM T
6 1-GRAM line
1 1-GRAM Kit
1 1-GRAM 225
1 1-GRAM Phosphotyrosyl
3 1-GRAM peptides
2 1-GRAM block
1 1-GRAM Stat3
1 1-GRAM Exp
2 1-GRAM Human
6 1-GRAM cDNA
1 1-GRAM library
3 1-GRAM screening
20 1-GRAM '
5 1-GRAM rapid
1 1-GRAM amplification
2 1-GRAM ends
1 1-GRAM yielded
5 1-GRAM full
4 1-GRAM length
1 1-GRAM DENTT
12 1-GRAM containing
1 1-GRAM 1899
9 1-GRAM bp
3 1-GRAM open
2 1-GRAM reading
2 1-GRAM frame
1 1-GRAM predicted
1 1-GRAM 633
13 1-GRAM acid
7 1-GRAM four
5 1-GRAM potential
3 1-GRAM localization
2 1-GRAM signals
1 1-GRAM NLSs
1 1-GRAM coiled
1 1-GRAM coil
1 1-GRAM NaeI
9 1-GRAM novel
1 1-GRAM endonuclease
2 1-GRAM topoisomerase
2 1-GRAM recombinase
1 1-GRAM Lys
2 1-GRAM residue
1 1-GRAM substituted
1 1-GRAM Leu
3 1-GRAM 43
1 1-GRAM rev
1 1-GRAM RRE
1 1-GRAM defective
6 1-GRAM HIV
3 1-GRAM molecular
2 1-GRAM complementation
3 1-GRAM experiments
1 1-GRAM posttranscriptional
9 1-GRAM regulatory
4 1-GRAM elements
4 1-GRAM mammalian
4 1-GRAM genome
1 1-GRAM selecting
1 1-GRAM rescue
8 1-GRAM virus
4 1-GRAM replication
1 1-GRAM OBJECTIVES
1 1-GRAM objective
24 1-GRAM this
3 1-GRAM review
1 1-GRAM compare
1 1-GRAM effectiveness
1 1-GRAM safety
1 1-GRAM acceptability
1 1-GRAM diaphragm
10 1-GRAM without
1 1-GRAM spermicide
2 1-GRAM DESIGN
1 1-GRAM Retrospective
12 1-GRAM study
1 1-GRAM Considering
2 1-GRAM reactor
1 1-GRAM thoroughly
2 1-GRAM mixed
18 1-GRAM during
1 1-GRAM discharge
1 1-GRAM LD50
27 1-GRAM =
2 1-GRAM values
2 1-GRAM nearly
8 1-GRAM independent
6 1-GRAM E
4 1-GRAM coli
7 1-GRAM concentrations
9 1-GRAM range
8 1-GRAM 10
7 1-GRAM <
1 1-GRAM cfu
1 1-GRAM mL
1 1-GRAM ascribe
1 1-GRAM nonexponential
1 1-GRAM Pn
1 1-GRAM decay
3 1-GRAM strain
1 1-GRAM colonies
1 1-GRAM shielding
2 1-GRAM phenomenon
2 1-GRAM where
3 1-GRAM inactive
1 1-GRAM protect
1 1-GRAM successively
2 1-GRAM smaller
2 1-GRAM numbers
1 1-GRAM viable
1 1-GRAM EHD
4 1-GRAM encode
1 1-GRAM tryptophanyl
2 1-GRAM tRNA
1 1-GRAM translocase
4 1-GRAM component
1 1-GRAM SecE
1 1-GRAM antiterminator
1 1-GRAM NusG
1 1-GRAM ribosomal
1 1-GRAM L11
2 1-GRAM L1
6 1-GRAM addition
1 1-GRAM PkwR
1 1-GRAM putative
1 1-GRAM LacI
1 1-GRAM GalR
1 1-GRAM Body
1 1-GRAM fat
2 1-GRAM distribution
6 1-GRAM determined
2 1-GRAM abdominal
1 1-GRAM computed
1 1-GRAM tomography
1 1-GRAM telomerase
2 1-GRAM maintenance
1 1-GRAM telomeric
6 1-GRAM chromosome
1 1-GRAM usually
8 1-GRAM most
9 1-GRAM primary
2 1-GRAM somatic
4 1-GRAM specifically
1 1-GRAM immortalization
2 1-GRAM tumorigenesis
1 1-GRAM challenging
1 1-GRAM task
1 1-GRAM insofar
3 1-GRAM direct
1 1-GRAM measures
1 1-GRAM ISF
3 1-GRAM glucose
1 1-GRAM readily
2 1-GRAM available
1 1-GRAM SELECTION
1 1-GRAM CRITERIA
1 1-GRAM All
2 1-GRAM randomised
3 1-GRAM controlled
2 1-GRAM trials
1 1-GRAM comparing
1 1-GRAM IUSs
6 1-GRAM forms
1 1-GRAM reversible
1 1-GRAM contraceptives
1 1-GRAM reporting
2 1-GRAM pre
1 1-GRAM outcomes
3 1-GRAM women
2 1-GRAM reproductive
4 1-GRAM years
6 1-GRAM There
3 1-GRAM statistically
10 1-GRAM significant
3 1-GRAM correlation
17 1-GRAM between
1 1-GRAM simultaneous
2 1-GRAM weekly
1 1-GRAM average
3 1-GRAM pollen
1 1-GRAM Philadelphia
1 1-GRAM Cherry
1 1-GRAM Hill
1 1-GRAM Acer
10 1-GRAM r
11 1-GRAM p
1 1-GRAM 987
1 1-GRAM Quercus
1 1-GRAM 645
1 1-GRAM Betula
1 1-GRAM 896
1 1-GRAM Pinus
1 1-GRAM 732
1 1-GRAM Cupressaceae
1 1-GRAM 695
1 1-GRAM Poaceae
1 1-GRAM 950
1 1-GRAM Ambrosia
1 1-GRAM 903
1 1-GRAM Rumex
1 1-GRAM 572
16 1-GRAM P
2 1-GRAM 001
2 1-GRAM Through
5 1-GRAM mechanisms
1 1-GRAM Arf
5 1-GRAM inhibits
2 1-GRAM oncoprotein
1 1-GRAM Hdm2
8 1-GRAM p53
1 1-GRAM dynamic
1 1-GRAM moduli
1 1-GRAM microcrystalline
2 1-GRAM cellulose
1 1-GRAM Such
2 1-GRAM knowledge
5 1-GRAM could
1 1-GRAM advance
7 1-GRAM patient
1 1-GRAM counseling
8 1-GRAM show
1 1-GRAM uncertainties
1 1-GRAM models
1 1-GRAM terrestrial
1 1-GRAM planets
2 1-GRAM dense
1 1-GRAM atmosphere
1 1-GRAM Venus
11 1-GRAM can
1 1-GRAM evolve
11 1-GRAM only
2 1-GRAM possible
1 1-GRAM rotation
1 1-GRAM states
1 1-GRAM WASP
3 1-GRAM activates
1 1-GRAM TCR
3 1-GRAM stimulation
4 1-GRAM manner
1 1-GRAM Arp2
2 1-GRAM directed
1 1-GRAM actin
1 1-GRAM polymerization
1 1-GRAM ubiquitous
1 1-GRAM p19
1 1-GRAM INK4d
2 1-GRAM murine
1 1-GRAM lineage
1 1-GRAM animal
4 1-GRAM model
1 1-GRAM dystonia
1 1-GRAM appears
1 1-GRAM NAD
1 1-GRAM man
1 1-GRAM viewpoint
12 1-GRAM response
4 1-GRAM indicate
3 1-GRAM evaluation
2 1-GRAM exposure
1 1-GRAM neurona
1 1-GRAM WB
9 1-GRAM serum
1 1-GRAM misleading
1 1-GRAM young
1 1-GRAM horses
1 1-GRAM Delta6CCI
1 1-GRAM extremely
2 1-GRAM attenuated
1 1-GRAM yet
1 1-GRAM retained
1 1-GRAM infectiousness
1 1-GRAM CEMx174
1 1-GRAM MT4
2 1-GRAM OBJECTIVE
10 1-GRAM To
2 1-GRAM determine
5 1-GRAM association
1 1-GRAM depressive
2 1-GRAM symptoms
9 1-GRAM related
3 1-GRAM mortality
2 1-GRAM decline
1 1-GRAM CD4
1 1-GRAM lymphocyte
1 1-GRAM counts
3 1-GRAM among
1 1-GRAM Phase
3 1-GRAM paclitaxel
1 1-GRAM etoposide
1 1-GRAM locally
3 1-GRAM advanced
2 1-GRAM metastatic
4 1-GRAM non
4 1-GRAM small
9 1-GRAM lung
1 1-GRAM Analyses
3 1-GRAM revealed
2 1-GRAM scale
1 1-GRAM matters
2 1-GRAM above
1 1-GRAM beyond
1 1-GRAM quadrat
4 1-GRAM area
1 1-GRAM Rind
1 1-GRAM et
1 1-GRAM al
1 1-GRAM .'
10 1-GRAM s
3 1-GRAM main
1 1-GRAM conclusions
55 1-GRAM were
2 1-GRAM supported
1 1-GRAM original
1 1-GRAM Not
1 1-GRAM Available
1 1-GRAM Lactate
2 1-GRAM accumulation
4 1-GRAM peak
1 1-GRAM unaffected
2 1-GRAM supplementation
1 1-GRAM HMB
16 1-GRAM 8
13 1-GRAM +/-
3 1-GRAM mM
19 1-GRAM ;
1 1-GRAM LEU
1 1-GRAM CON
1 1-GRAM abi1
2 1-GRAM product
1 1-GRAM ABA
2 1-GRAM suppression
2 1-GRAM GA
4 1-GRAM responsive
2 1-GRAM amylase
1 1-GRAM Polyclonal
5 1-GRAM antibodies
4 1-GRAM against
4 1-GRAM part
4 1-GRAM 12
2 1-GRAM 363
1 1-GRAM 330
1 1-GRAM 730
2 1-GRAM rainbow
2 1-GRAM trout
3 1-GRAM 1alpha
2 1-GRAM recognized
1 1-GRAM chinook
1 1-GRAM salmon
3 1-GRAM Western
5 1-GRAM blot
2 1-GRAM Southern
1 1-GRAM hybrids
2 1-GRAM endothelial
1 1-GRAM TACC
2 1-GRAM maps
1 1-GRAM PABP
1 1-GRAM modular
1 1-GRAM extensive
5 1-GRAM terminus
1 1-GRAM 95
18 1-GRAM %
2 1-GRAM CI
2 1-GRAM micromol
7 1-GRAM L
1 1-GRAM 003
5 1-GRAM mean
1 1-GRAM waiting
10 1-GRAM time
2 1-GRAM receive
1 1-GRAM pancreas
1 1-GRAM transplant
1 1-GRAM 244
6 1-GRAM days
1 1-GRAM SPK
1 1-GRAM 167
1 1-GRAM PAK
2 1-GRAM recipients
1 1-GRAM Zarix
1 1-GRAM expected
1 1-GRAM enrollment
1 1-GRAM Canadian
11 1-GRAM clinical
12 1-GRAM sites
1 1-GRAM begin
1 1-GRAM Spring
8 1-GRAM [
1 1-GRAM 397955
1 1-GRAM ],
1 1-GRAM 405928
1 1-GRAM ].
1 1-GRAM isoform
2 1-GRAM designated
1 1-GRAM HDAC9a
1 1-GRAM 132
1 1-GRAM aa
1 1-GRAM shorter
1 1-GRAM HDAC9
1 1-GRAM Long
10 1-GRAM mouse
1 1-GRAM SCL
3 1-GRAM loci
3 1-GRAM localized
3 1-GRAM sensitivity
2 1-GRAM restriction
2 1-GRAM endonucleases
1 1-GRAM correspond
1 1-GRAM precisely
4 1-GRAM peaks
1 1-GRAM noncoding
3 1-GRAM Saccharomyces
3 1-GRAM cerevisiae
1 1-GRAM eIF6
3 1-GRAM encoded
5 1-GRAM copy
5 1-GRAM essential
2 1-GRAM Three
2 1-GRAM additional
1 1-GRAM cycles
2 1-GRAM fluorouracil
1 1-GRAM leucovorin
3 1-GRAM chemotherapy
9 1-GRAM RESULTS
1 1-GRAM Thirty
1 1-GRAM males
4 1-GRAM 21
2 1-GRAM females
3 1-GRAM median
4 1-GRAM age
2 1-GRAM 31
4 1-GRAM --
2 1-GRAM 73
1 1-GRAM treated
1 1-GRAM Within
8 1-GRAM all
8 1-GRAM groups
2 1-GRAM re
2 1-GRAM acquired
1 1-GRAM responding
1 1-GRAM heroin
5 1-GRAM under
1 1-GRAM CRF
4 1-GRAM rates
4 1-GRAM similar
5 1-GRAM their
3 1-GRAM performance
2 1-GRAM application
1 1-GRAM biotechnology
2 1-GRAM plants
1 1-GRAM storm
1 1-GRAM waters
1 1-GRAM industrial
2 1-GRAM zone
1 1-GRAM Telychka
1 1-GRAM city
1 1-GRAM Kyiv
1 1-GRAM allowed
1 1-GRAM content
1 1-GRAM petroleum
2 1-GRAM water
1 1-GRAM dropped
1 1-GRAM Dnieper
1 1-GRAM constantly
9 1-GRAM 50
2 1-GRAM 100
2 1-GRAM times
3 1-GRAM Using
1 1-GRAM immunochemical
2 1-GRAM co
1 1-GRAM precipitation
2 1-GRAM methods
15 1-GRAM also
6 1-GRAM bound
4 1-GRAM vivo
1 1-GRAM Utility
2 1-GRAM OAE
2 1-GRAM screener
2 1-GRAM GSI
2 1-GRAM 70
1 1-GRAM distortion
1 1-GRAM otoacoustic
1 1-GRAM emissions
5 1-GRAM ]
4 1-GRAM purpose
4 1-GRAM investigate
2 1-GRAM evaluate
1 1-GRAM cochlea
8 1-GRAM function
2 1-GRAM neonates
2 1-GRAM infants
3 1-GRAM adults
6 1-GRAM demonstrated
4 1-GRAM hepatic
4 1-GRAM artery
6 1-GRAM alone
1 1-GRAM ALT
1 1-GRAM graft
1 1-GRAM almost
6 1-GRAM normal
3 1-GRAM structure
1 1-GRAM histologically
2 1-GRAM month
11 1-GRAM after
1 1-GRAM grafting
3 1-GRAM bile
3 1-GRAM secretion
2 1-GRAM preserved
1 1-GRAM Mean
2 1-GRAM Hg
1 1-GRAM livers
3 1-GRAM mice
3 1-GRAM some
1 1-GRAM Isle
1 1-GRAM Royale
11 1-GRAM significantly
6 1-GRAM lower
2 1-GRAM 62
4 1-GRAM considered
1 1-GRAM government
1 1-GRAM agencies
1 1-GRAM unhealthy
2 1-GRAM consumption
3 1-GRAM here
1 1-GRAM extract
6 1-GRAM contains
2 1-GRAM initiator
9 1-GRAM element
2 1-GRAM thus
1 1-GRAM participate
1 1-GRAM recruiting
1 1-GRAM SL
1 1-GRAM desirability
2 1-GRAM search
2 1-GRAM global
1 1-GRAM optimum
1 1-GRAM f
1 1-GRAM Y1
1 1-GRAM Y2
1 1-GRAM ...,
1 1-GRAM Yn
2 1-GRAM )]
5 1-GRAM measured
1 1-GRAM property
1 1-GRAM dimensionless
1 1-GRAM criterion
1 1-GRAM Naltrexone
1 1-GRAM hydrochloride
2 1-GRAM synthetic
3 1-GRAM opioid
3 1-GRAM antagonist
2 1-GRAM efforts
1 1-GRAM detoxification
1 1-GRAM mapped
1 1-GRAM DGCR6
1 1-GRAM 22q11
9 1-GRAM within
9 1-GRAM low
2 1-GRAM repeat
2 1-GRAM termed
2 1-GRAM sc11
1 1-GRAM 1a
9 1-GRAM identified
2 1-GRAM second
1 1-GRAM DGCR6L
1 1-GRAM duplicate
3 1-GRAM locus
1 1-GRAM 1b
1 1-GRAM Proliferative
1 1-GRAM vasculopathy
1 1-GRAM cutaneous
1 1-GRAM hemorrhages
2 1-GRAM porcine
2 1-GRAM infected
5 1-GRAM syndrome
1 1-GRAM child
1 1-GRAM left
1 1-GRAM behind
4 1-GRAM hybrid
5 1-GRAM system
1 1-GRAM nonprenylated
2 1-GRAM Rac1
4 1-GRAM very
2 1-GRAM weakly
1 1-GRAM Rho
1 1-GRAM GDI
1 1-GRAM pointing
1 1-GRAM predominant
1 1-GRAM isoprene
4 1-GRAM formation
9 1-GRAM I
1 1-GRAM argentina
1 1-GRAM theezans
1 1-GRAM exerted
3 1-GRAM any
1 1-GRAM BF
1 1-GRAM intestinal
1 1-GRAM propulsion
24 1-GRAM region
18 1-GRAM both
1 1-GRAM serines
1 1-GRAM destruction
1 1-GRAM IkappaBalpha
1 1-GRAM epsilon
2 1-GRAM No
4 1-GRAM dominant
4 1-GRAM multiple
3 1-GRAM regression
2 1-GRAM body
1 1-GRAM valve
4 1-GRAM size
1 1-GRAM shop
1 1-GRAM fracture
3 1-GRAM rate
1 1-GRAM manufacturing
3 1-GRAM period
9 1-GRAM factors
1 1-GRAM OSF
8 1-GRAM growth
3 1-GRAM binds
7 1-GRAM rat
1 1-GRAM aldolase
3 1-GRAM Northern
4 1-GRAM mlt
3 1-GRAM normally
7 1-GRAM expressed
1 1-GRAM spleen
1 1-GRAM stom
1 1-GRAM ach
10 1-GRAM liver
2 1-GRAM NO
1 1-GRAM metabolites
3 1-GRAM measurement
1 1-GRAM nitrate
1 1-GRAM nitrite
1 1-GRAM NOx
3 1-GRAM creatinine
2 1-GRAM cyclic
1 1-GRAM guanosine
1 1-GRAM monophosphate
1 1-GRAM cGMP
1 1-GRAM nmol
6 1-GRAM plasma
4 1-GRAM urine
2 1-GRAM complement
2 1-GRAM wide
1 1-GRAM mapping
1 1-GRAM sequencing
4 1-GRAM it
2 1-GRAM often
4 1-GRAM generate
1 1-GRAM detailed
3 1-GRAM interest
6 1-GRAM observed
1 1-GRAM phenotypes
2 1-GRAM explained
3 1-GRAM selective
3 1-GRAM disruption
2 1-GRAM density
2 1-GRAM lipoprotein
3 1-GRAM due
1 1-GRAM apolipoprotein
1 1-GRAM microsomal
1 1-GRAM triglyceride
5 1-GRAM transfer
1 1-GRAM ii
1 1-GRAM cholesterol
6 1-GRAM uptake
7 1-GRAM major
1 1-GRAM scavenger
1 1-GRAM BI
1 1-GRAM iii
4 1-GRAM down
1 1-GRAM basolateral
2 1-GRAM transporters
2 1-GRAM sodium
1 1-GRAM taurocholate
1 1-GRAM cotransporter
1 1-GRAM organic
1 1-GRAM anion
2 1-GRAM Effects
1 1-GRAM aerosol
1 1-GRAM vapor
1 1-GRAM JP
1 1-GRAM jet
1 1-GRAM fuel
2 1-GRAM functional
1 1-GRAM observational
1 1-GRAM battery
1 1-GRAM learning
1 1-GRAM memory
1 1-GRAM Mmip1
1 1-GRAM Mad
2 1-GRAM interacting
1 1-GRAM Smc3
1 1-GRAM share
4 1-GRAM 99
2 1-GRAM identity
5 1-GRAM products
4 1-GRAM identify
2 1-GRAM cis
3 1-GRAM involved
4 1-GRAM tissue
3 1-GRAM -,
1 1-GRAM mE
1 1-GRAM RABP
4 1-GRAM fragment
1 1-GRAM sequenced
1 1-GRAM Regional
8 1-GRAM blood
1 1-GRAM blow
2 1-GRAM means
1 1-GRAM microspheres
1 1-GRAM predefined
1 1-GRAM C6
1 1-GRAM T11
1 1-GRAM L6
1 1-GRAM vertebrae
1 1-GRAM Breast
2 1-GRAM assessment
1 1-GRAM Who
1 1-GRAM holds
1 1-GRAM magic
1 1-GRAM crystal
1 1-GRAM ball
3 1-GRAM ?
1 1-GRAM frameshift
3 1-GRAM initiated
1 1-GRAM ADEx2
1 1-GRAM believed
2 1-GRAM alter
1 1-GRAM regular
2 1-GRAM coding
1 1-GRAM acting
5 1-GRAM loss
1 1-GRAM ASIP
7 1-GRAM CONCLUSIONS
2 1-GRAM Adding
3 1-GRAM MMF
4 1-GRAM potent
1 1-GRAM topical
2 1-GRAM corticosteroid
2 1-GRAM emollient
2 1-GRAM cream
10 1-GRAM more
1 1-GRAM effective
1 1-GRAM reducing
3 1-GRAM acute
1 1-GRAM dermatitis
3 1-GRAM Although
2 1-GRAM oxLDL
2 1-GRAM might
2 1-GRAM modified
3 1-GRAM hypertension
2 1-GRAM once
3 1-GRAM coronary
11 1-GRAM disease
2 1-GRAM developed
4 1-GRAM does
5 1-GRAM affect
5 1-GRAM anti
1 1-GRAM reverse
1 1-GRAM genetics
1 1-GRAM introduced
2 1-GRAM nucleotide
1 1-GRAM UCU
1 1-GRAM ACU
2 1-GRAM immediate
1 1-GRAM downstream
1 1-GRAM editing
12 1-GRAM V
1 1-GRAM hPIV2
1 1-GRAM able
1 1-GRAM obtain
2 1-GRAM infectious
1 1-GRAM viruses
1 1-GRAM rPIV2V
1 1-GRAM (-)]
1 1-GRAM companies
2 1-GRAM Salmonella
1 1-GRAM enteritidis
1 1-GRAM typhimurium
1 1-GRAM Tr104
1 1-GRAM occasionally
4 1-GRAM various
2 1-GRAM locations
2 1-GRAM Most
10 1-GRAM yeast
2 1-GRAM peroxisomal
2 1-GRAM matrix
2 1-GRAM contain
1 1-GRAM 1C
1 1-GRAM targeting
6 1-GRAM signal
1 1-GRAM PTS1
3 1-GRAM consisting
1 1-GRAM tripeptide
1 1-GRAM SKL
1 1-GRAM conservative
2 1-GRAM variant
1 1-GRAM thereof
2 1-GRAM Tumor
1 1-GRAM Tl
1 1-GRAM 201
1 1-GRAM SPECT
1 1-GRAM subacute
1 1-GRAM hemorrhagic
1 1-GRAM cerebral
1 1-GRAM infarction
1 1-GRAM WRN
2 1-GRAM helicase
1 1-GRAM resolves
2 1-GRAM alternate
1 1-GRAM tetraplex
1 1-GRAM triplex
1 1-GRAM Holliday
1 1-GRAM junctions
2 1-GRAM number
2 1-GRAM hairs
4 1-GRAM defined
2 1-GRAM 60
2 1-GRAM microm
1 1-GRAM diameter
1 1-GRAM cm
1 1-GRAM square
6 1-GRAM 25
3 1-GRAM cm2
2 1-GRAM procyanidin
19 1-GRAM group
8 1-GRAM subjects
2 1-GRAM trial
2 1-GRAM greater
3 1-GRAM placebo
2 1-GRAM 58
2 1-GRAM SD
1 1-GRAM 82
6 1-GRAM 40
1 1-GRAM 02
3 1-GRAM sample
3 1-GRAM t
9 1-GRAM test
1 1-GRAM SKP1
1 1-GRAM SnRK
3 1-GRAM mediate
1 1-GRAM proteasomal
1 1-GRAM SCF
2 1-GRAM ubiquitin
1 1-GRAM ligase
1 1-GRAM Based
3 1-GRAM hypothesis
1 1-GRAM evolutionarily
1 1-GRAM functionally
1 1-GRAM likely
2 1-GRAM interact
1 1-GRAM coactivators
12 1-GRAM compared
1 1-GRAM EBPalpha
13 1-GRAM different
3 1-GRAM species
1 1-GRAM frog
1 1-GRAM CR1
1 1-GRAM CR4
2 1-GRAM transactivation
1 1-GRAM Colorectal
1 1-GRAM disproportionately
1 1-GRAM overburden
1 1-GRAM Ashkenazi
1 1-GRAM Jews
3 1-GRAM who
1 1-GRAM ovarian
1 1-GRAM pancreatic
1 1-GRAM stomach
1 1-GRAM Hodgkin
1 1-GRAM lymphoma
1 1-GRAM Percentages
2 1-GRAM recovery
1 1-GRAM overload
1 1-GRAM dilution
3 1-GRAM tests
1 1-GRAM 87
2 1-GRAM 120
2 1-GRAM %.
2 1-GRAM situations
2 1-GRAM separated
1 1-GRAM breaks
1 1-GRAM NHEJ
1 1-GRAM deficiency
3 1-GRAM leads
1 1-GRAM rearrangements
1 1-GRAM agreement
3 1-GRAM chromosomal
1 1-GRAM After
1 1-GRAM nerve
3 1-GRAM injury
1 1-GRAM nociceptive
2 1-GRAM responses
1 1-GRAM neurons
2 1-GRAM polymodal
3 1-GRAM fibers
4 1-GRAM drive
1 1-GRAM NK1
3 1-GRAM pain
1 1-GRAM transmission
4 1-GRAM completely
10 1-GRAM changes
3 1-GRAM ones
2 1-GRAM NMDA
3 1-GRAM III
1 1-GRAM capsaicin
1 1-GRAM insensitive
2 1-GRAM possibly
3 1-GRAM markedly
4 1-GRAM enhanced
1 1-GRAM SV1
1 1-GRAM 33
1 1-GRAM insert
3 1-GRAM S1
3 1-GRAM transmembrane
2 1-GRAM overall
1 1-GRAM hydrophobicity
1 1-GRAM makes
1 1-GRAM S0
3 1-GRAM linker
3 1-GRAM longer
2 1-GRAM variety
6 1-GRAM pathways
4 1-GRAM extracellular
4 1-GRAM base
3 1-GRAM pair
1 1-GRAM oligonucleotide
1 1-GRAM nonamer
1 1-GRAM confers
3 1-GRAM up
1 1-GRAM hypoxia
1 1-GRAM unsaturated
3 1-GRAM fatty
2 1-GRAM placed
5 1-GRAM upstream
3 1-GRAM heterologous
2 1-GRAM lacZ
1 1-GRAM 2L
6 1-GRAM receptors
2 1-GRAM activate
7 1-GRAM ERK
2 1-GRAM cascade
10 1-GRAM first
1 1-GRAM mobilizing
1 1-GRAM PDGF
2 1-GRAM followed
1 1-GRAM ERK1
1 1-GRAM Raes
3 1-GRAM differential
2 1-GRAM techniques
1 1-GRAM terms
5 1-GRAM efficiency
1 1-GRAM occurrence
1 1-GRAM false
1 1-GRAM positives
1 1-GRAM EBPbeta
1 1-GRAM LIP
1 1-GRAM overexpressing
1 1-GRAM HC11
13 1-GRAM did
1 1-GRAM casein
2 1-GRAM mammary
1 1-GRAM epithelial
2 1-GRAM marker
1 1-GRAM lactogenic
1 1-GRAM hormones
1 1-GRAM CD154
1 1-GRAM CD40
3 1-GRAM ligand
1 1-GRAM Subacute
1 1-GRAM diencephalic
1 1-GRAM angioencephalopathy
1 1-GRAM SDAE
2 1-GRAM rare
1 1-GRAM fatal
2 1-GRAM unknown
1 1-GRAM etiology
3 1-GRAM involves
1 1-GRAM thalami
1 1-GRAM bilaterally
1 1-GRAM elicits
1 1-GRAM delayed
3 1-GRAM sustained
3 1-GRAM EGF
3 1-GRAM previous
1 1-GRAM reports
1 1-GRAM TBARS
3 1-GRAM oxygen
2 1-GRAM radical
1 1-GRAM absorbing
3 1-GRAM assay
1 1-GRAM AFR
1 1-GRAM release
3 1-GRAM assessed
1 1-GRAM electron
1 1-GRAM paramagnetic
3 1-GRAM resonance
1 1-GRAM EPR
2 1-GRAM explore
1 1-GRAM existence
1 1-GRAM oxidative
2 1-GRAM diabetes
1 1-GRAM Pulmonary
2 1-GRAM vein
1 1-GRAM varix
1 1-GRAM bilateral
1 1-GRAM stenosis
1 1-GRAM Derivation
9 1-GRAM initial
7 1-GRAM tumor
2 1-GRAM carrying
1 1-GRAM polyomavirus
1 1-GRAM middle
4 1-GRAM antigen
1 1-GRAM utility
1 1-GRAM therapeutics
2 1-GRAM images
2 1-GRAM predominantly
1 1-GRAM urinary
2 1-GRAM excretion
1 1-GRAM 99mTc
1 1-GRAM ciprofloxacin
1 1-GRAM absent
1 1-GRAM marrow
1 1-GRAM interferon
2 1-GRAM functions
1 1-GRAM vIRF
1 1-GRAM contribute
1 1-GRAM establishment
1 1-GRAM latent
5 1-GRAM infection
1 1-GRAM Topological
1 1-GRAM mutational
1 1-GRAM Ste14p
1 1-GRAM founding
1 1-GRAM isoprenylcysteine
1 1-GRAM carboxyl
1 1-GRAM methyltransferase
4 1-GRAM Two
1 1-GRAM remotely
1 1-GRAM situated
3 1-GRAM exons
1 1-GRAM C3
5 1-GRAM proximal
1 1-GRAM ORF
1 1-GRAM bidirectional
2 1-GRAM sap
3 1-GRAM flux
3 1-GRAM densities
1 1-GRAM registered
1 1-GRAM old
4 1-GRAM new
2 1-GRAM sensors
7 1-GRAM differences
3 1-GRAM detected
1 1-GRAM Their
1 1-GRAM regularly
2 1-GRAM since
1 1-GRAM mid
1 1-GRAM 1970s
1 1-GRAM hcKrox
4 1-GRAM regulates
1 1-GRAM NB
1 1-GRAM 506
1 1-GRAM phosphorylate
4 1-GRAM splicing
8 1-GRAM alternative
4 1-GRAM SF2
3 1-GRAM ASF
2 1-GRAM Recent
10 1-GRAM using
1 1-GRAM adipocytes
1 1-GRAM chemically
1 1-GRAM synthesized
2 1-GRAM PIG
3 1-GRAM compounds
1 1-GRAM IRS1
1 1-GRAM p59Lyn
3 1-GRAM cross
1 1-GRAM talk
1 1-GRAM caveolin
2 1-GRAM apparently
1 1-GRAM abrogated
8 1-GRAM effects
3 1-GRAM exogenous
1 1-GRAM hyaluronic
1 1-GRAM port
1 1-GRAM metastasis
5 1-GRAM examined
1 1-GRAM adenocarcinoma
1 1-GRAM colon
2 1-GRAM 26
9 1-GRAM METHODS
1 1-GRAM Thyroid
4 1-GRAM status
4 1-GRAM baseline
1 1-GRAM 1990
2 1-GRAM 93
3 1-GRAM thyroid
1 1-GRAM peroxidase
2 1-GRAM TPO
1 1-GRAM Abs
1 1-GRAM IU
5 1-GRAM ml
3 1-GRAM TSH
3 1-GRAM abnormal
1 1-GRAM (<
1 1-GRAM mU
1 1-GRAM thyroxin
1 1-GRAM T4
1 1-GRAM Mechanical
1 1-GRAM ventilation
1 1-GRAM lungs
1 1-GRAM 47
1 1-GRAM chord
1 1-GRAM compliance
1 1-GRAM lavage
2 1-GRAM necrosis
9 1-GRAM )-
1 1-GRAM 722
1 1-GRAM 306
4 1-GRAM pg
4 1-GRAM interleukin
5 1-GRAM IL
1 1-GRAM 1beta
1 1-GRAM 902
2 1-GRAM 322
2 1-GRAM macrophage
1 1-GRAM MIP
1 1-GRAM 104
2 1-GRAM cytokines
1 1-GRAM preventilation
3 1-GRAM percentage
1 1-GRAM surfactant
3 1-GRAM large
1 1-GRAM aggregates
2 1-GRAM LA
1 1-GRAM Autoregulation
1 1-GRAM enables
1 1-GRAM CCAAT
5 1-GRAM enhancer
5 1-GRAM EBP
1 1-GRAM past
1 1-GRAM decade
1 1-GRAM enormous
2 1-GRAM advances
2 1-GRAM Bayesian
1 1-GRAM methodology
1 1-GRAM epidemiologic
1 1-GRAM now
3 1-GRAM many
1 1-GRAM practical
1 1-GRAM advantages
1 1-GRAM approach
3 1-GRAM strains
2 1-GRAM lacking
1 1-GRAM tup11
1 1-GRAM tup12
2 1-GRAM atf1
1 1-GRAM pcr1
7 1-GRAM transcriptional
2 1-GRAM activator
1 1-GRAM continues
3 1-GRAM central
1 1-GRAM fbp1
4 1-GRAM however
1 1-GRAM spc1
1 1-GRAM Single
2 1-GRAM substitutions
2 1-GRAM acyl
5 1-GRAM CoA
1 1-GRAM interrupt
4 1-GRAM 14
1 1-GRAM palmitoyl
1 1-GRAM ACBP2
1 1-GRAM Arabidopsis
2 1-GRAM ankyrin
1 1-GRAM repeats
1 1-GRAM Sixty
1 1-GRAM cent
1 1-GRAM African
1 1-GRAM Americans
1 1-GRAM exposed
1 1-GRAM community
1 1-GRAM outbreaks
1 1-GRAM TST
1 1-GRAM whites
3 1-GRAM comparable
1 1-GRAM exposures
4 1-GRAM For
1 1-GRAM immunological
5 1-GRAM identification
9 1-GRAM such
1 1-GRAM antigens
1 1-GRAM intermolecular
1 1-GRAM variability
1 1-GRAM e
1 1-GRAM g
1 1-GRAM .,
3 1-GRAM structural
1 1-GRAM aescin
1 1-GRAM analogs
1 1-GRAM validity
3 1-GRAM It
2 1-GRAM intrathecal
3 1-GRAM administration
1 1-GRAM .)
3 1-GRAM D2
2 1-GRAM agonist
1 1-GRAM LY171555
3 1-GRAM D1
1 1-GRAM apomorphine
2 1-GRAM threshold
1 1-GRAM potentiating
1 1-GRAM AA
1 1-GRAM Interactions
3 1-GRAM checkpoint
1 1-GRAM abrogator
1 1-GRAM UCN
1 1-GRAM 01
5 1-GRAM several
1 1-GRAM pharmacological
3 1-GRAM inhibitors
2 1-GRAM MEK
3 1-GRAM Analysis
1 1-GRAM ctr4
2 1-GRAM (+)
2 1-GRAM copper
1 1-GRAM fission
1 1-GRAM Schizosaccharomyces
1 1-GRAM pombe
5 1-GRAM reveals
1 1-GRAM CuSE
1 1-GRAM Cuf1
3 1-GRAM our
2 1-GRAM work
3 1-GRAM deficient
4 1-GRAM expressing
1 1-GRAM progesterone
2 1-GRAM discovered
6 1-GRAM level
1 1-GRAM 293
1 1-GRAM producer
4 1-GRAM absence
1 1-GRAM inducer
1 1-GRAM PSP
3 1-GRAM commonly
1 1-GRAM misdiagnosed
1 1-GRAM majority
5 1-GRAM cases
1 1-GRAM initially
1 1-GRAM referred
1 1-GRAM neurologists
2 1-GRAM Between
1 1-GRAM 1967
1 1-GRAM 1994
1 1-GRAM 495
2 1-GRAM underwent
4 1-GRAM surgery
1 1-GRAM PTC
1 1-GRAM Surgery
1 1-GRAM Helsinki
1 1-GRAM University
1 1-GRAM Central
1 1-GRAM Hospital
1 1-GRAM DTD
1 1-GRAM fast
1 1-GRAM simple
1 1-GRAM easy
1 1-GRAM automate
4 1-GRAM requires
9 1-GRAM mg
2 1-GRAM );
1 1-GRAM affords
3 1-GRAM quantitative
1 1-GRAM information
1 1-GRAM about
1 1-GRAM Srb10
3 1-GRAM physiological
2 1-GRAM Gcn4
2 1-GRAM stability
1 1-GRAM because
1 1-GRAM turnover
2 1-GRAM diminished
1 1-GRAM srb10
6 1-GRAM mutants
1 1-GRAM restricted
1 1-GRAM subset
1 1-GRAM prestalk
1 1-GRAM medicine
1 1-GRAM physicians
1 1-GRAM blinded
2 1-GRAM surgical
3 1-GRAM interpreted
1 1-GRAM Tc
1 1-GRAM 99m
1 1-GRAM MIBI
2 1-GRAM image
1 1-GRAM combinations
11 1-GRAM 15
5 1-GRAM minutes
4 1-GRAM hours
1 1-GRAM correlative
1 1-GRAM pertechnetate
3 1-GRAM imaging
2 1-GRAM starved
4 1-GRAM conditions
1 1-GRAM KMS
4 1-GRAM 11
1 1-GRAM OPM
1 1-GRAM appreciable
3 1-GRAM phosphorylated
1 1-GRAM FGFR3
3 1-GRAM indicating
1 1-GRAM Y373C
1 1-GRAM K650E
1 1-GRAM aFGF
1 1-GRAM Identical
3 1-GRAM obtained
1 1-GRAM tested
1 1-GRAM 29
16 1-GRAM +
1 1-GRAM 139
3 1-GRAM cyclin
2 1-GRAM paper
1 1-GRAM dephosphorylating
2 1-GRAM phosphatases
3 1-GRAM PTPs
4 1-GRAM studied
1 1-GRAM grouped
1 1-GRAM subfamilies
2 1-GRAM soluble
1 1-GRAM RPTPs
1 1-GRAM Coexposure
1 1-GRAM FP
1 1-GRAM pronounced
4 1-GRAM PMA
4 1-GRAM although
5 1-GRAM inhibitor
1 1-GRAM U0126
2 1-GRAM prevent
1 1-GRAM potentiation
1 1-GRAM 50s
2 1-GRAM derived
4 1-GRAM combined
1 1-GRAM earlier
1 1-GRAM series
1 1-GRAM 1965
1 1-GRAM 1970
1 1-GRAM harboring
1 1-GRAM metronidazole
1 1-GRAM clarithromycin
2 1-GRAM resistant
1 1-GRAM eradicated
1 1-GRAM equal
11 1-GRAM three
1 1-GRAM regimens
1 1-GRAM unit
1 1-GRAM carotid
1 1-GRAM chemoreceptors
3 1-GRAM adult
2 1-GRAM rats
3 1-GRAM MKK7
2 1-GRAM SAPK
2 1-GRAM mast
3 1-GRAM negatively
2 1-GRAM driven
1 1-GRAM hematopoietic
3 1-GRAM portion
1 1-GRAM Notch
1 1-GRAM IC
5 1-GRAM inhibited
2 1-GRAM p50
1 1-GRAM interacted
3 1-GRAM subunit
2 1-GRAM p65
1 1-GRAM account
1 1-GRAM observation
1 1-GRAM causes
1 1-GRAM include
4 1-GRAM CSF
1 1-GRAM pulsation
6 1-GRAM children
1 1-GRAM creating
1 1-GRAM motion
1 1-GRAM artifact
3 1-GRAM arterial
3 1-GRAM concentration
1 1-GRAM intrinsic
2 1-GRAM propofol
1 1-GRAM supplemental
3 1-GRAM administered
3 1-GRAM Molecular
1 1-GRAM cloning
1 1-GRAM OsPSK
1 1-GRAM precursor
1 1-GRAM phytosulfokine
3 1-GRAM rice
2 1-GRAM biological
1 1-GRAM combining
1 1-GRAM trickling
1 1-GRAM filter
1 1-GRAM TF
1 1-GRAM sludge
2 1-GRAM process
1 1-GRAM ASP
1 1-GRAM treat
2 1-GRAM wastewater
1 1-GRAM trichloroethylene
1 1-GRAM TCE
1 1-GRAM ambient
2 1-GRAM temperature
1 1-GRAM hydraulic
1 1-GRAM retention
2 1-GRAM HRT
1 1-GRAM If
1 1-GRAM you
1 1-GRAM think
1 1-GRAM expensive
1 1-GRAM try
1 1-GRAM ignorance
1 1-GRAM Bok
1 1-GRAM Law
1 1-GRAM COD
1 1-GRAM color
1 1-GRAM removals
3 1-GRAM 90
1 1-GRAM FeCl3
2 1-GRAM coagulation
1 1-GRAM dosages
1 1-GRAM step
1 1-GRAM 031
1 1-GRAM 012
2 1-GRAM mol
2 1-GRAM respectively
1 1-GRAM ferrous
1 1-GRAM hydrogen
1 1-GRAM peroxide
2 1-GRAM oxidation
1 1-GRAM pretreatment
1 1-GRAM H2O2
1 1-GRAM dosage
2 1-GRAM 06
3 1-GRAM untranslated
1 1-GRAM Hsp70
4 1-GRAM acts
3 1-GRAM general
3 1-GRAM translation
1 1-GRAM alteration
1 1-GRAM Cre
5 1-GRAM target
1 1-GRAM rearrangement
3 1-GRAM flanked
2 1-GRAM LOX
3 1-GRAM recognition
2 1-GRAM separate
2 1-GRAM genetic
2 1-GRAM constructs
1 1-GRAM trans
1 1-GRAM cre
3 1-GRAM members
2 1-GRAM exhibit
1 1-GRAM prolyl
1 1-GRAM isomerase
1 1-GRAM chaperone
1 1-GRAM Newcastle
8 1-GRAM antibody
1 1-GRAM titre
10 1-GRAM dependent
3 1-GRAM calcium
1 1-GRAM %),
5 1-GRAM MR
1 1-GRAM microscopic
1 1-GRAM around
1 1-GRAM seroma
1 1-GRAM reexcision
1 1-GRAM nonviable
1 1-GRAM Vp1s
1 1-GRAM failed
2 1-GRAM localize
2 1-GRAM nucleus
1 1-GRAM Vp2
1 1-GRAM Vp3
1 1-GRAM mutated
1 1-GRAM NLS1
1 1-GRAM acted
6 1-GRAM cytoplasmic
2 1-GRAM Vp1
1 1-GRAM Compared
2 1-GRAM 74
1 1-GRAM TOF
1 1-GRAM systolic
1 1-GRAM diastolic
1 1-GRAM myocardial
1 1-GRAM velocities
1 1-GRAM isovolumic
1 1-GRAM relaxation
4 1-GRAM corresponding
1 1-GRAM orifice
1 1-GRAM voltages
1 1-GRAM instruments
3 1-GRAM API
1 1-GRAM 365
2 1-GRAM 30
1 1-GRAM 130
1 1-GRAM 2000
1 1-GRAM 3000
3 1-GRAM methylation
5 1-GRAM tumors
2 1-GRAM SV40
1 1-GRAM transgenic
1 1-GRAM MT
1 1-GRAM Restriction
1 1-GRAM Landmark
1 1-GRAM Genomic
1 1-GRAM Scanning
1 1-GRAM Methylation
1 1-GRAM RLGS
1 1-GRAM spots
1 1-GRAM appeared
1 1-GRAM methylated
1 1-GRAM frequently
3 1-GRAM cloned
1 1-GRAM TAF
1 1-GRAM 140
1 1-GRAM HFD
1 1-GRAM homeodomain
1 1-GRAM PHD
3 1-GRAM finger
2 1-GRAM immunoprecipitation
1 1-GRAM TFIID
2 1-GRAM 3D
2 1-GRAM processing
1 1-GRAM permits
1 1-GRAM analyse
1 1-GRAM ultrasound
1 1-GRAM interactively
1 1-GRAM orthogonal
1 1-GRAM planes
1 1-GRAM section
3 1-GRAM mode
1 1-GRAM realistic
1 1-GRAM views
1 1-GRAM rendering
1 1-GRAM proposal
6 1-GRAM indicators
1 1-GRAM divided
1 1-GRAM five
3 1-GRAM presented
1 1-GRAM namely
1 1-GRAM operational
1 1-GRAM service
1 1-GRAM quality
1 1-GRAM personnel
1 1-GRAM economic
3 1-GRAM analyses
1 1-GRAM question
2 1-GRAM whether
1 1-GRAM CesA
2 1-GRAM synthases
1 1-GRAM sub
3 1-GRAM class
1 1-GRAM cellulosic
6 1-GRAM -->
1 1-GRAM glycan
2 1-GRAM relationship
1 1-GRAM Leiden
4 1-GRAM deletion
2 1-GRAM polymorphism
1 1-GRAM angiotensin
1 1-GRAM converting
1 1-GRAM enzyme
2 1-GRAM postoperative
1 1-GRAM thromboembolic
2 1-GRAM events
2 1-GRAM total
1 1-GRAM joint
1 1-GRAM arthroplasty
1 1-GRAM PTHrP1
2 1-GRAM 86
7 1-GRAM production
1 1-GRAM moreover
2 1-GRAM PTHrP
1 1-GRAM neutralizing
3 1-GRAM inhibit
3 1-GRAM transfected
3 1-GRAM Furthermore
1 1-GRAM MeSADP
1 1-GRAM caspase
1 1-GRAM Against
1 1-GRAM gram
1 1-GRAM organisms
1 1-GRAM 4767
1 1-GRAM 5065
2 1-GRAM eight
1 1-GRAM fourfold
1 1-GRAM tosufloxacin
1 1-GRAM reference
1 1-GRAM AR1
1 1-GRAM CAP
1 1-GRAM papBA
2 1-GRAM histone
3 1-GRAM H
1 1-GRAM NS
1 1-GRAM Under
1 1-GRAM current
1 1-GRAM immunization
1 1-GRAM practices
2 1-GRAM authors
2 1-GRAM estimate
5 1-GRAM 13
3 1-GRAM 000
1 1-GRAM Asian
1 1-GRAM Pacific
1 1-GRAM Islander
1 1-GRAM living
2 1-GRAM United
2 1-GRAM States
1 1-GRAM today
1 1-GRAM will
2 1-GRAM become
1 1-GRAM HBV
1 1-GRAM future
5 1-GRAM resulting
2 1-GRAM 600
2 1-GRAM carcinoma
1 1-GRAM deaths
1 1-GRAM structured
1 1-GRAM interview
1 1-GRAM undertaken
1 1-GRAM consultation
2 1-GRAM year
1 1-GRAM intervals
1 1-GRAM regarding
1 1-GRAM BHS
4 1-GRAM frequency
2 1-GRAM spells
1 1-GRAM sequelae
2 1-GRAM history
2 1-GRAM termination
1 1-GRAM Cell
1 1-GRAM Rapid
1 1-GRAM LAGLIDADG
1 1-GRAM homing
1 1-GRAM fliF
2 1-GRAM Inhibition
2 1-GRAM JNK1
7 1-GRAM either
1 1-GRAM chemical
1 1-GRAM PD098059
1 1-GRAM substantially
1 1-GRAM abrogates
1 1-GRAM UV
1 1-GRAM GADD45
1 1-GRAM gd
4 1-GRAM confirmed
1 1-GRAM pregnant
1 1-GRAM evaluated
3 1-GRAM outcome
1 1-GRAM live
1 1-GRAM fetuses
1 1-GRAM external
2 1-GRAM visceral
2 1-GRAM skeletal
1 1-GRAM malformations
1 1-GRAM mammals
1 1-GRAM repressors
1 1-GRAM Wnt
1 1-GRAM Intravenous
2 1-GRAM carnitine
1 1-GRAM improved
1 1-GRAM fatigue
1 1-GRAM exercise
1 1-GRAM hemodialysis
1 1-GRAM Van
1 1-GRAM der
1 1-GRAM Hoeve
1 1-GRAM lesions
1 1-GRAM poorly
1 1-GRAM mineralized
1 1-GRAM salt
1 1-GRAM apparent
1 1-GRAM phosphates
1 1-GRAM computerized
1 1-GRAM electrical
1 1-GRAM pallidum
1 1-GRAM parkinsonian
1 1-GRAM stimulus
1 1-GRAM behaviour
1 1-GRAM successful
1 1-GRAM attentive
1 1-GRAM participants
1 1-GRAM interpret
3 1-GRAM evidence
1 1-GRAM GTPase
2 1-GRAM de
2 1-GRAM novo
5 1-GRAM synthesis
1 1-GRAM deacetylase
1 1-GRAM cobalt
1 1-GRAM StREs
1 1-GRAM quantify
1 1-GRAM conducted
2 1-GRAM NASA
1 1-GRAM MSFC
1 1-GRAM Neutral
1 1-GRAM Buoyancy
1 1-GRAM Simulator
1 1-GRAM KC
2 1-GRAM 135
1 1-GRAM parabolic
1 1-GRAM flight
1 1-GRAM EASE
1 1-GRAM program
1 1-GRAM Shuttle
1 1-GRAM Atlantis
1 1-GRAM mission
2 1-GRAM 61
2 1-GRAM complete
2 1-GRAM congenital
2 1-GRAM heart
1 1-GRAM CCHB
1 1-GRAM fetus
1 1-GRAM AE
1 1-GRAM benzimidazole
1 1-GRAM carbamate
1 1-GRAM derivatives
1 1-GRAM mebendazole
1 1-GRAM albendazole
1 1-GRAM fluorine
1 1-GRAM fluorodeoxyglucose
3 1-GRAM F
1 1-GRAM FDG
2 1-GRAM malignant
1 1-GRAM depends
1 1-GRAM Deterministic
2 1-GRAM retrospective
1 1-GRAM chart
1 1-GRAM procedures
1 1-GRAM January
1 1-GRAM 1993
2 1-GRAM December
1 1-GRAM 1998
1 1-GRAM Peripheral
1 1-GRAM preemptive
1 1-GRAM antinociception
1 1-GRAM benefit
1 1-GRAM depth
1 1-GRAM RR
1 1-GRAM nonuniform
1 1-GRAM AC
1 1-GRAM scanning
1 1-GRAM source
1 1-GRAM scatter
1 1-GRAM correction
1 1-GRAM photon
2 1-GRAM energy
1 1-GRAM PER
1 1-GRAM ])
2 1-GRAM filtered
1 1-GRAM backprojection
1 1-GRAM Cloning
1 1-GRAM integrin
3 1-GRAM assays
1 1-GRAM interference
1 1-GRAM p30
1 1-GRAM assembly
3 1-GRAM p300
2 1-GRAM CBP
1 1-GRAM multiprotein
2 1-GRAM complexes
1 1-GRAM oligonucleotides
1 1-GRAM Transient
1 1-GRAM transfections
1 1-GRAM 556M
1 1-GRAM TBLV
4 1-GRAM least
4 1-GRAM fold
4 1-GRAM conclusion
3 1-GRAM tube
1 1-GRAM estimated
1 1-GRAM Cole
2 1-GRAM formula
1 1-GRAM tends
1 1-GRAM practically
1 1-GRAM appropriate
1 1-GRAM pediatric
1 1-GRAM cardiac
2 1-GRAM anesthesia
1 1-GRAM T47D
3 1-GRAM breast
1 1-GRAM synergy
1 1-GRAM autocrine
1 1-GRAM Nerve
1 1-GRAM retinoic
2 1-GRAM RA
1 1-GRAM exert
1 1-GRAM actions
1 1-GRAM HexA71
1 1-GRAM affects
1 1-GRAM RpoS
1 1-GRAM sigma
10 1-GRAM higher
2 1-GRAM HexA
1 1-GRAM Moreover
2 1-GRAM elderly
2 1-GRAM men
2 1-GRAM bioavailable
2 1-GRAM estradiol
1 1-GRAM below
2 1-GRAM pmol
2 1-GRAM liter
1 1-GRAM resorption
2 1-GRAM markers
1 1-GRAM histamine
1 1-GRAM H1
2 1-GRAM antagonists
1 1-GRAM antihistamines
2 1-GRAM medications
1 1-GRAM relief
1 1-GRAM hyperhistaminic
1 1-GRAM occurring
1 1-GRAM ceramide
1 1-GRAM emerging
1 1-GRAM fixture
1 1-GRAM toluidine
1 1-GRAM pH
2 1-GRAM value
1 1-GRAM donor
1 1-GRAM solution
2 1-GRAM Managing
3 1-GRAM BACKGROUND
1 1-GRAM increasing
1 1-GRAM investigators
1 1-GRAM public
2 1-GRAM finding
1 1-GRAM ways
2 1-GRAM improve
1 1-GRAM seriously
1 1-GRAM mentally
1 1-GRAM ill
1 1-GRAM exposing
5 1-GRAM individuals
1 1-GRAM unnecessary
1 1-GRAM risks
1 1-GRAM Multidrug
1 1-GRAM resistance
1 1-GRAM mainly
3 1-GRAM overexpression
2 1-GRAM membrane
1 1-GRAM efflux
1 1-GRAM pumps
1 1-GRAM facilitators
1 1-GRAM PDR1
1 1-GRAM PDR3
1 1-GRAM Serum
1 1-GRAM PTH
1 1-GRAM tended
1 1-GRAM WL
1 1-GRAM WM
1 1-GRAM Bandshift
2 1-GRAM BmHR3A
1 1-GRAM RORE
1 1-GRAM Retinoic
1 1-GRAM Orphan
1 1-GRAM Response
1 1-GRAM Element
3 1-GRAM promoters
1 1-GRAM BmGATAbeta
1 1-GRAM ESP
1 1-GRAM vitellogenesis
1 1-GRAM Efficacy
2 1-GRAM generation
1 1-GRAM Cavermap
1 1-GRAM verify
1 1-GRAM location
1 1-GRAM cavernous
1 1-GRAM nerves
1 1-GRAM prostatectomy
1 1-GRAM multi
1 1-GRAM institutional
1 1-GRAM experienced
1 1-GRAM surgeons
1 1-GRAM During
1 1-GRAM separase
1 1-GRAM kept
4 1-GRAM inhibitory
1 1-GRAM called
1 1-GRAM securin
1 1-GRAM obesity
1 1-GRAM alcohol
1 1-GRAM intake
1 1-GRAM multimetabolic
1 1-GRAM disorders
1 1-GRAM predictors
1 1-GRAM hyperuricemia
2 1-GRAM cholesteryl
3 1-GRAM ester
1 1-GRAM CET
1 1-GRAM CETP
1 1-GRAM phospholipid
1 1-GRAM PLTP
1 1-GRAM prevalence
1 1-GRAM calcification
2 1-GRAM CAC
1 1-GRAM diabetic
1 1-GRAM nondiabetic
1 1-GRAM sex
3 1-GRAM difference
1 1-GRAM reside
1 1-GRAM syntenic
1 1-GRAM 8E1
1 1-GRAM NP
1 1-GRAM NMP4
1 1-GRAM CIZ
1 1-GRAM osteocytes
1 1-GRAM osteoblasts
1 1-GRAM chondrocytes
1 1-GRAM Following
3 1-GRAM examination
1 1-GRAM periodontal
4 1-GRAM therapy
1 1-GRAM 32
1 1-GRAM mucogingival
1 1-GRAM gingival
2 1-GRAM grafts
1 1-GRAM insufficient
1 1-GRAM attached
1 1-GRAM gingiva
2 1-GRAM failure
1 1-GRAM QKTT
2 1-GRAM motif
1 1-GRAM TGN46
1 1-GRAM tail
2 1-GRAM induce
2 1-GRAM steady
1 1-GRAM state
2 1-GRAM ER
1 1-GRAM vesicular
1 1-GRAM stomatitis
1 1-GRAM glycoprotein
1 1-GRAM VSVG
1 1-GRAM chimeras
2 1-GRAM HeLa
1 1-GRAM NRK
1 1-GRAM indicates
1 1-GRAM secretory
1 1-GRAM trafficking
1 1-GRAM exist
1 1-GRAM proteolysis
1 1-GRAM acutely
1 1-GRAM promoted
3 1-GRAM phorbol
2 1-GRAM myristate
3 1-GRAM acetate
1 1-GRAM metalloprotease
1 1-GRAM generates
1 1-GRAM shed
1 1-GRAM GHBP
4 1-GRAM GHR
1 1-GRAM remnant
3 1-GRAM abundance
1 1-GRAM GH
1 1-GRAM SIP1
1 1-GRAM confine
1 1-GRAM XBra
1 1-GRAM mesoderm
1 1-GRAM Changes
1 1-GRAM DB
1 1-GRAM affecting
1 1-GRAM postulated
1 1-GRAM stem
3 1-GRAM led
1 1-GRAM drastic
1 1-GRAM losses
1 1-GRAM subfamily
1 1-GRAM set
1 1-GRAM segments
1 1-GRAM Subsequently
1 1-GRAM coordinates
1 1-GRAM must
1 1-GRAM particular
4 1-GRAM tissues
1 1-GRAM organs
1 1-GRAM cyclins
1 1-GRAM CDK
2 1-GRAM then
2 1-GRAM suppressor
2 1-GRAM pRb
4 1-GRAM controls
1 1-GRAM commitment
1 1-GRAM progress
1 1-GRAM repressing
1 1-GRAM E2F
3 1-GRAM known
1 1-GRAM promote
8 1-GRAM months
1 1-GRAM withdrawal
2 1-GRAM severity
1 1-GRAM pathologic
1 1-GRAM magnitude
1 1-GRAM percussion
2 1-GRAM Patients
1 1-GRAM fivefold
4 1-GRAM titer
1 1-GRAM lowest
4 1-GRAM over
2 1-GRAM course
2 1-GRAM GBS
1 1-GRAM disability
2 1-GRAM scores
4 1-GRAM weeks
1 1-GRAM worse
1 1-GRAM GM1
2 1-GRAM IgG
2 1-GRAM GD1a
2 1-GRAM IgM
1 1-GRAM axonal
1 1-GRAM damage
1 1-GRAM titers
7 1-GRAM post
3 1-GRAM TBI
1 1-GRAM irradiated
2 1-GRAM avoidance
3 1-GRAM statistical
1 1-GRAM b
1 1-GRAM way
2 1-GRAM performed
1 1-GRAM TE
1 1-GRAM 671
3 1-GRAM basal
1 1-GRAM GnRH
1 1-GRAM SOFA
3 1-GRAM score
1 1-GRAM APACHE
2 1-GRAM 16
2 1-GRAM effector
5 1-GRAM Ras
4 1-GRAM p21
1 1-GRAM Promoter
1 1-GRAM annexin
1 1-GRAM A5
1 1-GRAM 1275
1 1-GRAM 79
1 1-GRAM discrete
2 1-GRAM start
1 1-GRAM points
1 1-GRAM Structure
1 1-GRAM EMAPII
1 1-GRAM aminoacyl
2 1-GRAM synthetase
1 1-GRAM evolutionary
2 1-GRAM dimer
1 1-GRAM mimicry
1 1-GRAM SDS
2 1-GRAM transient
1 1-GRAM acidification
2 1-GRAM metal
1 1-GRAM solubilization
2 1-GRAM sulfur
1 1-GRAM Competition
1 1-GRAM electrophoretic
1 1-GRAM mobility
1 1-GRAM shift
1 1-GRAM immunoshift
1 1-GRAM NF1
2 1-GRAM extracts
1 1-GRAM CV
1 1-GRAM BKV
1 1-GRAM MLP
1 1-GRAM Graf2
3 1-GRAM highest
6 1-GRAM muscle
2 1-GRAM minimal
1 1-GRAM ER3
2 1-GRAM FXR
1 1-GRAM HRE
1 1-GRAM Ka13
1 1-GRAM CoCl
2 1-GRAM stimulated
1 1-GRAM luciferase
1 1-GRAM kilobase
2 1-GRAM ho
1 1-GRAM pHO15luc
1 1-GRAM subtyped
1 1-GRAM Camp
2 1-GRAM jejuni
1 1-GRAM subsp
2 1-GRAM biotype
2 1-GRAM remaining
3 1-GRAM Ig
1 1-GRAM typical
1 1-GRAM metazoan
2 1-GRAM module
1 1-GRAM classified
1 1-GRAM disulphide
1 1-GRAM represents
1 1-GRAM phylogenetic
1 1-GRAM earliest
1 1-GRAM budding
1 1-GRAM latter
1 1-GRAM Mad1
1 1-GRAM Bub1
1 1-GRAM Bub3
1 1-GRAM whose
1 1-GRAM vertebrate
1 1-GRAM counterparts
1 1-GRAM unattached
1 1-GRAM kinetochores
1 1-GRAM hyaluronan
2 1-GRAM HA
1 1-GRAM motility
2 1-GRAM src
1 1-GRAM Oral
2 1-GRAM arginine
1 1-GRAM citrulline
4 1-GRAM indicated
1 1-GRAM enhancement
1 1-GRAM classify
2 1-GRAM antibiotics
1 1-GRAM bactericidal
1 1-GRAM aeruginosa
1 1-GRAM having
2 1-GRAM killing
1 1-GRAM AMK
1 1-GRAM IPM
1 1-GRAM PAPM
1 1-GRAM CAZ
1 1-GRAM MEPM
2 1-GRAM showing
1 1-GRAM truncated
2 1-GRAM isoforms
2 1-GRAM diverse
1 1-GRAM roles
1 1-GRAM EGFR
4 1-GRAM Of
2 1-GRAM E6
1 1-GRAM inactivates
1 1-GRAM proteasome
1 1-GRAM degradation
2 1-GRAM Low
1 1-GRAM affinity
1 1-GRAM Rab6A
3 1-GRAM GTP
1 1-GRAM K
1 1-GRAM d
1 1-GRAM Rab1B
1 1-GRAM 11A
1 1-GRAM 1997
1 1-GRAM Nature
1 1-GRAM 387
1 1-GRAM 370
1 1-GRAM 376
1 1-GRAM )],
1 1-GRAM fluoride
1 1-GRAM ions
1 1-GRAM replaced
2 1-GRAM phosphate
2 1-GRAM iron
1 1-GRAM Kp2
1 1-GRAM mismatch
1 1-GRAM CYP3A4
2 1-GRAM sufficient
2 1-GRAM AIMS
2 1-GRAM intraindividual
2 1-GRAM fluctuations
1 1-GRAM tumour
1 1-GRAM CEA
2 1-GRAM CA
1 1-GRAM 242
1 1-GRAM cured
1 1-GRAM colorectal
3 1-GRAM do
1 1-GRAM differ
1 1-GRAM Substitution
1 1-GRAM serine
4 1-GRAM residues
1 1-GRAM appear
1 1-GRAM pRA2
1 1-GRAM partitioning
1 1-GRAM ParB
1 1-GRAM autoregulates
1 1-GRAM parAB
1 1-GRAM nucleoprotein
3 1-GRAM plasmid
1 1-GRAM partition
1 1-GRAM parS
1 1-GRAM transduced
1 1-GRAM MOI
1 1-GRAM ISREs
1 1-GRAM GABA
1 1-GRAM R1g
3 1-GRAM peripheral
1 1-GRAM Granulocyte
1 1-GRAM colony
1 1-GRAM stimulating
2 1-GRAM G
1 1-GRAM defence
1 1-GRAM microbes
1 1-GRAM Use
1 1-GRAM dual
1 1-GRAM pulse
1 1-GRAM lithotripter
1 1-GRAM intensified
1 1-GRAM cavitation
1 1-GRAM field
3 1-GRAM best
1 1-GRAM predicting
1 1-GRAM WCXR
3 1-GRAM included
3 1-GRAM culture
1 1-GRAM Pa
1 1-GRAM elastase
1 1-GRAM plating
1 1-GRAM stable
2 1-GRAM throughout
1 1-GRAM applied
1 1-GRAM river
1 1-GRAM reclamation
1 1-GRAM Yangpu
1 1-GRAM District
1 1-GRAM Shanghai
1 1-GRAM City
1 1-GRAM China
2 1-GRAM Multiple
2 1-GRAM long
2 1-GRAM term
1 1-GRAM abiotic
1 1-GRAM nymphal
2 1-GRAM R2
1 1-GRAM coefficients
1 1-GRAM every
1 1-GRAM habitat
2 1-GRAM variation
1 1-GRAM tick
3 1-GRAM Src
5 1-GRAM SH3
1 1-GRAM facilitates
3 1-GRAM adhesion
4 1-GRAM six
1 1-GRAM polyposis
1 1-GRAM none
1 1-GRAM CT
1 1-GRAM diagnosed
1 1-GRAM bowel
2 1-GRAM follow
1 1-GRAM Right
2 1-GRAM LHR
2 1-GRAM provided
1 1-GRAM interobserver
1 1-GRAM intraobserver
1 1-GRAM reproducibility
2 1-GRAM intronic
1 1-GRAM PDE5A
1 1-GRAM concern
5 1-GRAM food
1 1-GRAM processors
1 1-GRAM inadvertent
1 1-GRAM contact
1 1-GRAM allergenic
2 1-GRAM result
1 1-GRAM potentially
1 1-GRAM life
1 1-GRAM threatening
2 1-GRAM reactions
8 1-GRAM those
2 1-GRAM allergy
1 1-GRAM Diffuse
1 1-GRAM myalgias
1 1-GRAM frequent
1 1-GRAM deltoid
1 1-GRAM biopsy
1 1-GRAM 0001
1 1-GRAM Functional
1 1-GRAM PTP
1 1-GRAM DT40
2 1-GRAM stably
1 1-GRAM chimeric
1 1-GRAM Fc
2 1-GRAM gamma
1 1-GRAM RIIB1
1 1-GRAM PECAM
3 1-GRAM homology
2 1-GRAM SHP
2 1-GRAM necessary
1 1-GRAM deliver
1 1-GRAM coligation
1 1-GRAM Subtraction
3 1-GRAM hybridization
2 1-GRAM melanoma
1 1-GRAM mda
4 1-GRAM case
1 1-GRAM streptococcal
1 1-GRAM peritonitis
1 1-GRAM Among
2 1-GRAM correlated
1 1-GRAM ACR
1 1-GRAM augmented
2 1-GRAM feedback
1 1-GRAM vertical
1 1-GRAM ground
1 1-GRAM force
1 1-GRAM minute
3 1-GRAM reduction
2 1-GRAM 85
3 1-GRAM week
1 1-GRAM sensory
1 1-GRAM lactate
1 1-GRAM pyruvate
2 1-GRAM elevated
1 1-GRAM Histological
1 1-GRAM lichenoid
1 1-GRAM acantholytic
1 1-GRAM blister
1 1-GRAM apoptotic
2 1-GRAM keratinocytes
1 1-GRAM Enantiomer
2 1-GRAM separation
2 1-GRAM venlafaxine
3 1-GRAM O
1 1-GRAM desmethylvenlafaxine
1 1-GRAM Paul
1 1-GRAM Monagle
1 1-GRAM addresses
1 1-GRAM epidemiology
1 1-GRAM neonatal
1 1-GRAM thrombosis
1 1-GRAM outside
1 1-GRAM nervous
2 1-GRAM occur
2 1-GRAM utero
1 1-GRAM MSL
2 1-GRAM male
1 1-GRAM booster
6 1-GRAM dose
1 1-GRAM tetanus
1 1-GRAM toxoid
1 1-GRAM courses
1 1-GRAM vaccination
1 1-GRAM implications
2 1-GRAM immune
1 1-GRAM globulin
1 1-GRAM Crk
1 1-GRAM Abl
1 1-GRAM FAK
1 1-GRAM offers
1 1-GRAM paradigm
1 1-GRAM autoinhibitory
1 1-GRAM red
1 1-GRAM cultivation
1 1-GRAM Sri
1 1-GRAM Lanka
1 1-GRAM coincident
1 1-GRAM HIDD
1 1-GRAM villages
1 1-GRAM Prophylactic
1 1-GRAM lymph
1 1-GRAM node
1 1-GRAM dissection
1 1-GRAM nodal
1 1-GRAM local
1 1-GRAM recurrence
1 1-GRAM consistently
1 1-GRAM Secretion
1 1-GRAM RANTES
1 1-GRAM kappaDa
1 1-GRAM IFN
1 1-GRAM differentiating
1 1-GRAM ChromaFlo
1 1-GRAM IVUS
2 1-GRAM demonstrates
1 1-GRAM colorized
1 1-GRAM inside
1 1-GRAM vessel
1 1-GRAM lumen
2 1-GRAM helpful
1 1-GRAM distinguishing
1 1-GRAM echolucent
1 1-GRAM luminal
1 1-GRAM perform
1 1-GRAM interventions
2 1-GRAM renal
1 1-GRAM avoiding
1 1-GRAM media
1 1-GRAM concomitant
2 1-GRAM corticosteroids
1 1-GRAM anticoagulants
2 1-GRAM prior
1 1-GRAM ulcer
2 1-GRAM complications
1 1-GRAM morbid
1 1-GRAM diseases
1 1-GRAM bleeding
1 1-GRAM icodextrin
1 1-GRAM instead
1 1-GRAM PD
1 1-GRAM fluids
1 1-GRAM reduce
1 1-GRAM Amadori
1 1-GRAM albumin
1 1-GRAM AGEs
1 1-GRAM GC
2 1-GRAM rich
1 1-GRAM /-
3 1-GRAM 91
1 1-GRAM Cp
2 1-GRAM oriPI
2 1-GRAM EBNA1
1 1-GRAM SB203580
1 1-GRAM LPS
4 1-GRAM Sp1
3 1-GRAM consensus
1 1-GRAM echocardiographic
1 1-GRAM technique
2 1-GRAM conventional
1 1-GRAM digitalised
1 1-GRAM 2D
1 1-GRAM tissular
1 1-GRAM Doppler
1 1-GRAM anomalous
1 1-GRAM electric
1 1-GRAM conduction
1 1-GRAM invasive
1 1-GRAM Is
2 1-GRAM clopidogrel
2 1-GRAM superior
2 1-GRAM aspirin
2 1-GRAM prevention
3 1-GRAM vascular
1 1-GRAM cornerstone
1 1-GRAM efficacy
1 1-GRAM thienopyridines
1 1-GRAM ticlopidine
2 1-GRAM versus
1 1-GRAM Clopidogrel
1 1-GRAM Aspirin
1 1-GRAM Risk
1 1-GRAM Ischaemic
1 1-GRAM Events
1 1-GRAM DBD
1 1-GRAM taking
2 1-GRAM advantage
1 1-GRAM NLS
1 1-GRAM phenotypic
1 1-GRAM probability
1 1-GRAM lamotrigine
1 1-GRAM being
2 1-GRAM maintained
1 1-GRAM %,
1 1-GRAM twelve
1 1-GRAM volatile
1 1-GRAM ecological
1 1-GRAM planktonic
1 1-GRAM webs
1 1-GRAM OsBBPI
1 1-GRAM rapidly
1 1-GRAM seedling
1 1-GRAM leaf
1 1-GRAM cut
1 1-GRAM jasmonic
1 1-GRAM JA
4 1-GRAM phosphatase
2 1-GRAM 2A
2 1-GRAM PP2A
1 1-GRAM cantharidin
4 1-GRAM CN
1 1-GRAM endothall
1 1-GRAM EN
1 1-GRAM light
1 1-GRAM dark
1 1-GRAM cycloheximide
1 1-GRAM CHX
1 1-GRAM requirement
1 1-GRAM ace2Delta
1 1-GRAM Ace2p
1 1-GRAM polarized
1 1-GRAM investigation
1 1-GRAM morphological
2 1-GRAM characteristics
1 1-GRAM fibrous
1 1-GRAM capsule
1 1-GRAM implantation
1 1-GRAM aluminum
1 1-GRAM ALCAP
1 1-GRAM hydroxyapetite
1 1-GRAM bioceramics
1 1-GRAM event
1 1-GRAM Irr
2 1-GRAM rMFP
1 1-GRAM Un
2 1-GRAM nrMFP
1 1-GRAM Sta
1 1-GRAM summary
1 1-GRAM conclude
1 1-GRAM adenoviral
2 1-GRAM E1A
2 1-GRAM endogenous
5 1-GRAM AP
2 1-GRAM 2alpha
1 1-GRAM derepression
1 1-GRAM 2rep
1 1-GRAM corepressor
1 1-GRAM CtBP1
1 1-GRAM Unusual
2 1-GRAM kinases
2 1-GRAM AKs
1 1-GRAM arose
1 1-GRAM phosphagen
1 1-GRAM primitive
1 1-GRAM sea
1 1-GRAM anemone
1 1-GRAM Anthopleurura
1 1-GRAM japonicus
1 1-GRAM clam
1 1-GRAM Pseudocardium
1 1-GRAM sachalinensis
1 1-GRAM Mutagenesis
1 1-GRAM SNT1
1 1-GRAM IRS
1 1-GRAM CX
2 1-GRAM classes
4 1-GRAM motifs
1 1-GRAM SNT
2 1-GRAM critical
2 1-GRAM phosphotyrosine
3 1-GRAM recruitment
1 1-GRAM Grb2
1 1-GRAM Shp2
1 1-GRAM helping
1 1-GRAM recruit
1 1-GRAM Sos
2 1-GRAM meta
1 1-GRAM randomized
1 1-GRAM noted
1 1-GRAM nonvertebral
1 1-GRAM fractures
2 1-GRAM C4B
1 1-GRAM monomodular
1 1-GRAM short
2 1-GRAM C4A
1 1-GRAM CSR
1 1-GRAM isotypes
1 1-GRAM activators
1 1-GRAM unrearranged
1 1-GRAM germline
1 1-GRAM GL
1 1-GRAM patterns
3 1-GRAM seven
1 1-GRAM '(
1 1-GRAM acceptor
1 1-GRAM utilization
1 1-GRAM cryptic
1 1-GRAM splice
1 1-GRAM Mutational
1 1-GRAM U
1 1-GRAM RING
3 1-GRAM physical
1 1-GRAM basis
1 1-GRAM E2
1 1-GRAM GafChromic
1 1-GRAM MD
1 1-GRAM radiochromic
1 1-GRAM film
1 1-GRAM increasingly
1 1-GRAM popular
1 1-GRAM medical
1 1-GRAM applications
1 1-GRAM proven
3 1-GRAM useful
1 1-GRAM brachytherapy
2 1-GRAM dosimetry
1 1-GRAM 438
1 1-GRAM EcoRI
2 1-GRAM 103
2 1-GRAM hormonal
1 1-GRAM Mek
1 1-GRAM Erk1
2 1-GRAM estrogen
1 1-GRAM deltex
1 1-GRAM homologs
1 1-GRAM suppressed
2 1-GRAM basic
2 1-GRAM helix
2 1-GRAM loop
2 1-GRAM bHLH
2 1-GRAM form
1 1-GRAM Notch1
1 1-GRAM DTX1
1 1-GRAM undertook
1 1-GRAM pathology
1 1-GRAM quantification
1 1-GRAM papillary
1 1-GRAM serous
1 1-GRAM (%
1 1-GRAM PSC
1 1-GRAM Csk
2 1-GRAM SH2
1 1-GRAM Nucleotide
2 1-GRAM map
1 1-GRAM 13q14
2 1-GRAM deleted
1 1-GRAM lymphocytic
1 1-GRAM MTX
1 1-GRAM ara
1 1-GRAM PCNSL
2 1-GRAM enhances
1 1-GRAM upper
1 1-GRAM bands
2 1-GRAM Fra
2 1-GRAM AND
1 1-GRAM Palmaz
1 1-GRAM Schatz
1 1-GRAM stents
1 1-GRAM dip
1 1-GRAM coated
1 1-GRAM 187
1 1-GRAM microgram
1 1-GRAM stent
1 1-GRAM immersion
1 1-GRAM ethanolic
1 1-GRAM evaporation
1 1-GRAM solvent
1 1-GRAM Currently
1 1-GRAM aminolaevulinic
2 1-GRAM ALA
1 1-GRAM protoporphyrin
1 1-GRAM IX
1 1-GRAM PPIX
1 1-GRAM photodynamic
1 1-GRAM PDT
1 1-GRAM limited
1 1-GRAM maximum
1 1-GRAM tolerated
1 1-GRAM kg
1 1-GRAM twelfth
1 1-GRAM insertion
1 1-GRAM disrupts
1 1-GRAM Nrk
9 1-GRAM "
1 1-GRAM neurospecific
1 1-GRAM Tpp
1 1-GRAM neuropeptidase
1 1-GRAM ATF4
1 1-GRAM CdCl
1 1-GRAM Nrf2
1 1-GRAM Adjuvant
1 1-GRAM neoadjuvant
1 1-GRAM SVend
2 1-GRAM HCM
2 1-GRAM respective
1 1-GRAM Control
2 1-GRAM Raf
2 1-GRAM abolished
1 1-GRAM Rp
1 1-GRAM cAMPS
2 1-GRAM PKI
1 1-GRAM caldesmon
1 1-GRAM fiber
1 1-GRAM TVD
2 1-GRAM decreases
1 1-GRAM skin
3 1-GRAM healthy
2 1-GRAM mCTR
1 1-GRAM mRNAs
1 1-GRAM give
2 1-GRAM rise
3 1-GRAM '-
1 1-GRAM lengths
1 1-GRAM PGHS
1 1-GRAM cultures
1 1-GRAM bovine
1 1-GRAM uterine
1 1-GRAM stromal
1 1-GRAM nM
1 1-GRAM linkage
1 1-GRAM disequilibrium
1 1-GRAM polymorphic
1 1-GRAM UTR
1 1-GRAM Several
1 1-GRAM dozen
1 1-GRAM targets
1 1-GRAM VEGF
1 1-GRAM Klinefelter
1 1-GRAM 47XXY
1 1-GRAM testosterone
1 1-GRAM dihydrotestosterone
1 1-GRAM composed
1 1-GRAM hydrophobic
1 1-GRAM When
2 1-GRAM aqueous
2 1-GRAM solutions
4 1-GRAM TMT
1 1-GRAM reagent
1 1-GRAM grade
2 1-GRAM zinc
1 1-GRAM cadmium
1 1-GRAM lead
1 1-GRAM salts
1 1-GRAM precipitate
2 1-GRAM crystalline
1 1-GRAM Zn
1 1-GRAM ",
2 1-GRAM amorphous
1 1-GRAM Cd
1 1-GRAM Pb
1 1-GRAM M3
1 1-GRAM S3C3N3
1 1-GRAM nH2O
1 1-GRAM Cd2
2 1-GRAM +,
1 1-GRAM Pb2
1 1-GRAM Zn2
3 1-GRAM n
1 1-GRAM eventually
1 1-GRAM crystallize
1 1-GRAM stored
1 1-GRAM air
1 1-GRAM Online
1 1-GRAM teaching
1 1-GRAM design
1 1-GRAM reciprocal
1 1-GRAM strong
1 1-GRAM ATF
1 1-GRAM absorbed
2 1-GRAM combination
1 1-GRAM integrating
1 1-GRAM detectors
1 1-GRAM thermo
1 1-GRAM luminescent
1 1-GRAM dosemeter
1 1-GRAM TDMS
1 1-GRAM plastic
1 1-GRAM track
1 1-GRAM detector
1 1-GRAM PNTD
1 1-GRAM complexity
1 1-GRAM shared
1 1-GRAM assembled
1 1-GRAM Mbp
1 1-GRAM SRO
1 1-GRAM bacteriophage
1 1-GRAM P1
1 1-GRAM artificial
1 1-GRAM PAC
1 1-GRAM clones
2 1-GRAM Xlim
2 1-GRAM unique
1 1-GRAM CT239
1 1-GRAM 403
2 1-GRAM underlying
1 1-GRAM organizer
1 1-GRAM selenium
4 1-GRAM diet
1 1-GRAM unfavourable
1 1-GRAM impact
1 1-GRAM next
1 1-GRAM adrenergic
1 1-GRAM atenolol
1 1-GRAM added
1 1-GRAM titrated
1 1-GRAM assess
1 1-GRAM PKA
1 1-GRAM mediation
1 1-GRAM LH
1 1-GRAM contribution
1 1-GRAM LDL
1 1-GRAM 1076
1 1-GRAM cotransfected
1 1-GRAM rabbit
1 1-GRAM minigene
2 1-GRAM constitutively
1 1-GRAM Rous
1 1-GRAM sarcoma
1 1-GRAM SN
2 1-GRAM 48
1 1-GRAM GR
2 1-GRAM HT1A
1 1-GRAM inactivation
1 1-GRAM nGRE
1 1-GRAM GRE
1 1-GRAM eliminated
1 1-GRAM inclusion
1 1-GRAM conferred
1 1-GRAM Transition
1 1-GRAM BPPV
1 1-GRAM HNF
3 1-GRAM HFH
1 1-GRAM profiles
1 1-GRAM 24
2 1-GRAM Grade
3 1-GRAM pneumonitis
1 1-GRAM passive
3 1-GRAM transport
1 1-GRAM fluorescein
1 1-GRAM BRB
1 1-GRAM quantitated
1 1-GRAM vitreous
1 1-GRAM fluorometry
2 1-GRAM Sixteen
1 1-GRAM out
1 1-GRAM 52
2 1-GRAM seropositive
1 1-GRAM MS
1 1-GRAM pneumoniae
2 1-GRAM %).
1 1-GRAM Consistent
1 1-GRAM specificity
1 1-GRAM DmCKIIalpha
1 1-GRAM alignment
1 1-GRAM m5
1 1-GRAM m7
1 1-GRAM m8
1 1-GRAM CKII
1 1-GRAM subdomain
1 1-GRAM Deletion
3 1-GRAM repression
1 1-GRAM Myc
1 1-GRAM PATIENTS
1 1-GRAM June
1 1-GRAM 1991
1 1-GRAM 1996
2 1-GRAM nucleoside
1 1-GRAM analog
1 1-GRAM chlorodeoxyadenosine
1 1-GRAM CDA
2 1-GRAM AML
1 1-GRAM myelodysplastic
1 1-GRAM MDS
1 1-GRAM Drosophila
1 1-GRAM Menin1
3 1-GRAM transcripts
1 1-GRAM polyadenylation
1 1-GRAM messages
1 1-GRAM Mice
1 1-GRAM homozygous
1 1-GRAM dlg
1 1-GRAM retardation
1 1-GRAM hypoplasia
1 1-GRAM premaxilla
1 1-GRAM mandible
2 1-GRAM cleft
1 1-GRAM palate
1 1-GRAM die
1 1-GRAM perinatally
2 1-GRAM detect
1 1-GRAM TNFalpha
1 1-GRAM Its
1 1-GRAM pol
1 1-GRAM U6
1 1-GRAM exception
3 1-GRAM TATA
3 1-GRAM TBP
1 1-GRAM DR2
1 1-GRAM TBPwt
1 1-GRAM Expression
1 1-GRAM tumorigenic
1 1-GRAM astrocytes
1 1-GRAM SETA
1 1-GRAM astrocyte
1 1-GRAM kinetic
13 1-GRAM N2
3 1-GRAM ')
1 1-GRAM pure
2 1-GRAM discharges
2 1-GRAM CH4
2 1-GRAM M2
1 1-GRAM '),
1 1-GRAM Hepatitis
1 1-GRAM nonalcoholic
1 1-GRAM NAFL
1 1-GRAM 1229
1 1-GRAM endocytosis
2 1-GRAM androgen
2 1-GRAM AR
1 1-GRAM imposes
2 1-GRAM via
1 1-GRAM exonic
1 1-GRAM Can
1 1-GRAM prolonged
1 1-GRAM prostate
1 1-GRAM Y
1 1-GRAM decisive
1 1-GRAM mrp2
1 1-GRAM MRP2
1 1-GRAM differently
1 1-GRAM Intact
1 1-GRAM Flag
1 1-GRAM tagged
1 1-GRAM vectors
1 1-GRAM ORF40
2 1-GRAM 41
2 1-GRAM transcript
1 1-GRAM primase
1 1-GRAM proved
2 1-GRAM spliced
1 1-GRAM 127
1 1-GRAM intron
1 1-GRAM Hypomorphic
1 1-GRAM dSLBP
2 1-GRAM alleles
1 1-GRAM zygotic
1 1-GRAM cause
2 1-GRAM female
1 1-GRAM sterility
1 1-GRAM hypertensive
1 1-GRAM nephrosclerosis
1 1-GRAM ACEI
2 1-GRAM reduces
1 1-GRAM incidence
1 1-GRAM TLS
1 1-GRAM pull
1 1-GRAM coimmunoprecipitation
1 1-GRAM experiment
1 1-GRAM cultured
1 1-GRAM CDR3
1 1-GRAM lambdaL
1 1-GRAM kappaL
1 1-GRAM lymphocytes
1 1-GRAM NBS
1 1-GRAM migrants
1 1-GRAM macronutrients
1 1-GRAM micronutrients
1 1-GRAM Dutch
1 1-GRAM Experimental
2 1-GRAM ta
2 1-GRAM chengchi
2 1-GRAM tang
1 1-GRAM decoction
2 1-GRAM relieving
2 1-GRAM necrotizing
2 1-GRAM pancreatitis
1 1-GRAM objectives
2 1-GRAM leukocyte
1 1-GRAM adhesiveness
2 1-GRAM ANP
1 1-GRAM go
1 1-GRAM relation
1 1-GRAM prohibitive
1 1-GRAM Decoction
1 1-GRAM ventriculopleural
1 1-GRAM shunting
1 1-GRAM preferred
2 1-GRAM peritoneal
1 1-GRAM drainage
2 1-GRAM intra
1 1-GRAM adhesions
1 1-GRAM recent
1 1-GRAM Positive
1 1-GRAM correlations
1 1-GRAM pregnancy
1 1-GRAM Se
1 1-GRAM kidney
1 1-GRAM 433
1 1-GRAM 023
1 1-GRAM 313
1 1-GRAM 030
1 1-GRAM Doxorubicin
1 1-GRAM DOX
1 1-GRAM hematological
1 1-GRAM solid
1 1-GRAM PDF
1 1-GRAM Bayley
1 1-GRAM motor
1 1-GRAM scales
1 1-GRAM Immunofixation
1 1-GRAM allotypes
2 1-GRAM seen
1 1-GRAM SHIP2
1 1-GRAM possessing
1 1-GRAM R47G
1 1-GRAM Myasthenia
1 1-GRAM gravis
1 1-GRAM autoimmune
1 1-GRAM ACh
1 1-GRAM neuromuscular
1 1-GRAM synapse
1 1-GRAM Rad23
1 1-GRAM AMP
2 1-GRAM regulate
1 1-GRAM pigs
1 1-GRAM assigned
1 1-GRAM randomly
1 1-GRAM shock
1 1-GRAM TRA1
1 1-GRAM TRA2
1 1-GRAM TRA
2 1-GRAM door
1 1-GRAM survey
1 1-GRAM Rac
2 1-GRAM Cdc42
1 1-GRAM Pak
1 1-GRAM microtubule
1 1-GRAM Zhu
1 1-GRAM plasmids
2 1-GRAM TyrRS
1 1-GRAM supports
1 1-GRAM arguments
1 1-GRAM improbability
1 1-GRAM UHF
1 1-GRAM frequencies
1 1-GRAM unless
1 1-GRAM accumulating
1 1-GRAM focussing
2 1-GRAM students
1 1-GRAM later
1 1-GRAM confirm
1 1-GRAM Cells
1 1-GRAM subunits
1 1-GRAM lacked
3 1-GRAM distal
1 1-GRAM alternatively
1 1-GRAM Jak
1 1-GRAM substrates
1 1-GRAM CD86
1 1-GRAM Despite
1 1-GRAM abundant
1 1-GRAM NtmybAS
1 1-GRAM mature
1 1-GRAM gPAL1
2 1-GRAM detectable
1 1-GRAM profiling
1 1-GRAM gcn4Delta
1 1-GRAM uncovered
1 1-GRAM operating
1 1-GRAM Gcn4p
1 1-GRAM histidine
1 1-GRAM MFI
1 1-GRAM fresh
1 1-GRAM frozen
1 1-GRAM 94
1 1-GRAM 92
1 1-GRAM lamb
1 1-GRAM pork
1 1-GRAM longissimus
1 1-GRAM green
2 1-GRAM fluorescent
1 1-GRAM GFP
1 1-GRAM EAV
1 1-GRAM constructed
1 1-GRAM Significantly
1 1-GRAM extubated
1 1-GRAM LPD
1 1-GRAM TX
1 1-GRAM Lack
1 1-GRAM Kawasaki
2 1-GRAM Rickettsia
1 1-GRAM conorii
1 1-GRAM typhi
1 1-GRAM Coxiella
1 1-GRAM burnetii
1 1-GRAM Ehrlichia
1 1-GRAM phagocytophila
1 1-GRAM utilisation
2 1-GRAM imply
1 1-GRAM annual
1 1-GRAM drug
2 1-GRAM costs
4 1-GRAM $
2 1-GRAM US
1 1-GRAM 480
1 1-GRAM million
1 1-GRAM population
1 1-GRAM Alignment
1 1-GRAM cDNAs
1 1-GRAM NR5A2
1 1-GRAM hB1F
1 1-GRAM facilitated
1 1-GRAM delineation
1 1-GRAM organization
1 1-GRAM spans
1 1-GRAM 150
1 1-GRAM consists
1 1-GRAM interrupted
1 1-GRAM introns
1 1-GRAM Ketamine
1 1-GRAM dissociative
1 1-GRAM produces
1 1-GRAM persistently
1 1-GRAM BIS
1 1-GRAM index
1 1-GRAM thiamylal
1 1-GRAM anesthetic
2 1-GRAM agents
1 1-GRAM aneurysm
1 1-GRAM originated
1 1-GRAM A1
1 1-GRAM fenestration
1 1-GRAM canonical
2 1-GRAM anticodon
4 1-GRAM anchor
1 1-GRAM leading
1 1-GRAM better
1 1-GRAM tyrosylation
1 1-GRAM Temperature
1 1-GRAM microfluidic
1 1-GRAM systems
1 1-GRAM dye
3 1-GRAM exon
2 1-GRAM 1A
1 1-GRAM corresponded
2 1-GRAM 250
1 1-GRAM NAUSICAA
1 1-GRAM gives
1 1-GRAM good
1 1-GRAM LET
1 1-GRAM spectra
1 1-GRAM MABP
1 1-GRAM MCBFV
1 1-GRAM bandpass
1 1-GRAM VLF
1 1-GRAM 015
2 1-GRAM 07
3 1-GRAM Hz
1 1-GRAM LF
1 1-GRAM HF
1 1-GRAM before
1 1-GRAM applying
1 1-GRAM CCF
1 1-GRAM studying
1 1-GRAM bandwidths
1 1-GRAM CCFs
1 1-GRAM purposes
1 1-GRAM introduction
1 1-GRAM extended
1 1-GRAM oligoarthritis
1 1-GRAM onset
1 1-GRAM susceptibility
1 1-GRAM Aspergillus
1 1-GRAM fumigatus
1 1-GRAM mulundocandin
1 1-GRAM echinocandin
1 1-GRAM antifungal
1 1-GRAM National
1 1-GRAM Committee
1 1-GRAM Clinical
1 1-GRAM Laboratory
1 1-GRAM Standards
1 1-GRAM NCCLS
1 1-GRAM M38
1 1-GRAM bis
1 1-GRAM methoxy
1 1-GRAM nitro
1 1-GRAM sulfophenyl
1 1-GRAM -[(
1 1-GRAM phenyl
1 1-GRAM carbonyl
1 1-GRAM ]-
1 1-GRAM 2H
1 1-GRAM tetrazolium
1 1-GRAM hydroxide
1 1-GRAM XTT
1 1-GRAM colorimetric
1 1-GRAM determination
1 1-GRAM morphologic
1 1-GRAM alterations
1 1-GRAM microscopy
1 1-GRAM Epstein
1 1-GRAM Barr
1 1-GRAM mononucleosis
1 1-GRAM immunodeficiency
1 1-GRAM occupational
1 1-GRAM wood
1 1-GRAM industry
1 1-GRAM Members
1 1-GRAM leucine
1 1-GRAM zipper
1 1-GRAM StRE
1 1-GRAM TraI36
1 1-GRAM stranded
1 1-GRAM Overexpression
1 1-GRAM RORgamma
1 1-GRAM hybridomas
1 1-GRAM repress
1 1-GRAM Fas
1 1-GRAM metabolized
1 1-GRAM cytochrome
1 1-GRAM 450
2 1-GRAM CYP
1 1-GRAM 2D6
1 1-GRAM 3A4
1 1-GRAM far
1 1-GRAM lesser
1 1-GRAM extent
1 1-GRAM SSRIs
2 1-GRAM MKK4
1 1-GRAM upregulated
1 1-GRAM mkk7
1 1-GRAM (-/-)
1 1-GRAM occurred
1 1-GRAM stimuli
1 1-GRAM engines
1 1-GRAM cumbersome
1 1-GRAM experts
1 1-GRAM tolerate
1 1-GRAM immunoglobulin
1 1-GRAM TBII
1 1-GRAM presentation
1 1-GRAM rose
1 1-GRAM extraordinary
3 1-GRAM peptide
1 1-GRAM gp96
1 1-GRAM plasticity
1 1-GRAM pocket
1 1-GRAM proposed
1 1-GRAM relay
1 1-GRAM MHC
1 1-GRAM molecules
1 1-GRAM Elevated
2 1-GRAM UhpB
2 1-GRAM GST
1 1-GRAM Bc
1 1-GRAM glutathione
1 1-GRAM transferase
1 1-GRAM fused
1 1-GRAM blockage
1 1-GRAM uhpT
1 1-GRAM uhp
1 1-GRAM Physical
1 1-GRAM principles
1 1-GRAM therapeutic
1 1-GRAM apheresis
1 1-GRAM Evidence
1 1-GRAM jadM
1 1-GRAM jadomycin
1 1-GRAM copies
1 1-GRAM rsmB
2 1-GRAM hand
1 1-GRAM stimulate
1 1-GRAM exoenzyme
1 1-GRAM hexA
1 1-GRAM +.
1 1-GRAM Systematic
1 1-GRAM diagnostic
1 1-GRAM vaginal
1 1-GRAM trichomoniasis
1 1-GRAM Anecdotal
1 1-GRAM observations
1 1-GRAM scattered
1 1-GRAM literature
1 1-GRAM clues
2 1-GRAM variations
1 1-GRAM humans
1 1-GRAM handle
1 1-GRAM dietary
1 1-GRAM chemicals
1 1-GRAM PK
1 1-GRAM restored
1 1-GRAM purified
1 1-GRAM reactivation
1 1-GRAM blocked
1 1-GRAM microcystin
1 1-GRAM Herein
1 1-GRAM PPARgamma
1 1-GRAM liganded
1 1-GRAM natural
1 1-GRAM 15d
1 1-GRAM PGJ
1 1-GRAM PGD
2 1-GRAM ))
1 1-GRAM ligands
1 1-GRAM BRL49653
1 1-GRAM troglitazone
1 1-GRAM selectively
1 1-GRAM integrated
1 1-GRAM RTC
1 1-GRAM algorithm
1 1-GRAM urban
1 1-GRAM formulated
1 1-GRAM optimized
1 1-GRAM optimization
1 1-GRAM routines
1 1-GRAM Recently
1 1-GRAM alanine
1 1-GRAM center
1 1-GRAM impair
1 1-GRAM depurinating
1 1-GRAM ribosome
1 1-GRAM PAP
1 1-GRAM partial
1 1-GRAM transection
1 1-GRAM permit
1 1-GRAM vasopressin
1 1-GRAM secreted
1 1-GRAM larger
1 1-GRAM Reciprocally
1 1-GRAM HMGI
1 1-GRAM coordinately
1 1-GRAM PIAS3
1 1-GRAM STAT3
1 1-GRAM SPEC1
2 1-GRAM close
1 1-GRAM proximity
1 1-GRAM AF1q
1 1-GRAM translocation
1 1-GRAM PEX5
2 1-GRAM TPR
1 1-GRAM tobacco
1 1-GRAM nematode
1 1-GRAM inserted
2 1-GRAM Pex5p
1 1-GRAM chimaeras
1 1-GRAM Ets
1 1-GRAM GPIX
1 1-GRAM smg
1 1-GRAM surveillance
1 1-GRAM elegans
1 1-GRAM Cytosolic
2 1-GRAM acetyl
1 1-GRAM AceCS1
1 1-GRAM supply
1 1-GRAM lipid
1 1-GRAM onto
1 1-GRAM While
1 1-GRAM proton
1 1-GRAM intracellular
1 1-GRAM WT
1 1-GRAM HSAL2
1 1-GRAM hematopoiesis
1 1-GRAM radial
2 1-GRAM forearm
1 1-GRAM lateral
1 1-GRAM arm
1 1-GRAM choice
1 1-GRAM certain
1 1-GRAM procedure
1 1-GRAM aggressive
1 1-GRAM painful
1 1-GRAM sternotomy
1 1-GRAM GGT
1 1-GRAM HepG2
1 1-GRAM Further
1 1-GRAM osteo
1 1-GRAM retentive
1 1-GRAM hydroxyapatite
1 1-GRAM sockets
2 1-GRAM significance
1 1-GRAM width
1 1-GRAM canine
1 1-GRAM 059
1 1-GRAM LHS
1 1-GRAM 065
1 1-GRAM RHS
1 1-GRAM LAD
1 1-GRAM FGFR
2 1-GRAM vertigo
1 1-GRAM syndromes
1 1-GRAM A8G
1 1-GRAM hnRNP
2 1-GRAM A2
1 1-GRAM A2RE
1 1-GRAM station
1 1-GRAM dimensional
2 1-GRAM magnetic
1 1-GRAM angiography
1 1-GRAM extremities
1 1-GRAM segmented
2 1-GRAM volume
1 1-GRAM acquisition
1 1-GRAM Treatment
1 1-GRAM N18TG
1 1-GRAM demethylating
1 1-GRAM agent
1 1-GRAM aza
1 1-GRAM deoxycytidine
1 1-GRAM attributable
1 1-GRAM silenced
1 1-GRAM rCBF
1 1-GRAM increases
2 1-GRAM meso
1 1-GRAM striatal
1 1-GRAM corticolimbic
1 1-GRAM circuits
1 1-GRAM monetary
1 1-GRAM reward
1 1-GRAM nonmonetary
1 1-GRAM reinforcement
1 1-GRAM Reverse
1 1-GRAM transcriptase
1 1-GRAM PKRDeltaE7
1 1-GRAM broad
1 1-GRAM variable
1 1-GRAM final
1 1-GRAM swelling
1 1-GRAM fixation
1 1-GRAM strengths
1 1-GRAM swellable
1 1-GRAM designs
1 1-GRAM smooth
1 1-GRAM screw
1 1-GRAM foams
1 1-GRAM simulate
1 1-GRAM CYP2C19
1 1-GRAM genotype
1 1-GRAM adjunct
1 1-GRAM mammography
1 1-GRAM radiographically
1 1-GRAM breasts
1 1-GRAM palpable
1 1-GRAM masses
1 1-GRAM Activation
1 1-GRAM Jurkat
1 1-GRAM JunD
1 1-GRAM weak
1 1-GRAM JunB
1 1-GRAM Fos
1 1-GRAM still
1 1-GRAM screen
1 1-GRAM toxic
1 1-GRAM dissecting
1 1-GRAM cellular
1 1-GRAM developing
1 1-GRAM therapies
1 1-GRAM Local
1 1-GRAM 89
1 1-GRAM T1
1 1-GRAM 2N0M0
1 1-GRAM cognitive
1 1-GRAM Boston
1 1-GRAM Naming
1 1-GRAM Test
1 1-GRAM Word
1 1-GRAM List
1 1-GRAM Recognition
1 1-GRAM Task
1 1-GRAM reach
1 1-GRAM Gimpl
1 1-GRAM actA
1 1-GRAM chrysogenum
1 1-GRAM opposite
1 1-GRAM pcbC
1 1-GRAM cefEF
2 1-GRAM cephalosporin
1 1-GRAM biosynthetic
1 1-GRAM fermentation
1 1-GRAM Maternal
1 1-GRAM DDE
1 1-GRAM HCH
1 1-GRAM newborn
1 1-GRAM PCBs
2 1-GRAM families
1 1-GRAM closely
1 1-GRAM questioned
1 1-GRAM orthostasia
1 1-GRAM transactivated
1 1-GRAM GAMyb
1 1-GRAM itself
1 1-GRAM Cardiac
1 1-GRAM output
1 1-GRAM anaerobic
1 1-GRAM COAT
1 1-GRAM min
1 1-GRAM cutoff
1 1-GRAM identifying
1 1-GRAM multivessel
1 1-GRAM Tolerance
2 1-GRAM ADAL
1 1-GRAM Vicryl
1 1-GRAM suture
1 1-GRAM tolerance
1 1-GRAM Tisuacryl
1 1-GRAM 728
1 1-GRAM zoledronic
1 1-GRAM 776
1 1-GRAM pamidronate
1 1-GRAM retrospectively
1 1-GRAM selected
1 1-GRAM TFCD
1 1-GRAM intractable
1 1-GRAM epilepsy
1 1-GRAM aim
1 1-GRAM removing
1 1-GRAM epileptogenic
1 1-GRAM stereoelectroencephalographic
1 1-GRAM recordings
1 1-GRAM gain
1 1-GRAM understanding
1 1-GRAM mGSTM2
1 1-GRAM analyzed
1 1-GRAM Cyclins
1 1-GRAM pivotal
1 1-GRAM determinants
1 1-GRAM Architecture
1 1-GRAM anatomy
1 1-GRAM RUNX1
1 1-GRAM AML1
1 1-GRAM Rad1
1 1-GRAM Hus1
1 1-GRAM Rad9
1 1-GRAM Together
2 1-GRAM HFV
1 1-GRAM modify
1 1-GRAM fate
1 1-GRAM office
1 1-GRAM fewer
1 1-GRAM cardiovascular
1 1-GRAM mutagenesis
1 1-GRAM 2003
1 1-GRAM 2212
1 1-GRAM call
1 1-GRAM carboxy
1 1-GRAM CR2
1 1-GRAM Fetal
1 1-GRAM estimation
1 1-GRAM Plane
1 1-GRAM wave
2 1-GRAM geometry
1 1-GRAM impractical
1 1-GRAM encouraged
1 1-GRAM us
1 1-GRAM develop
1 1-GRAM P3
1 1-GRAM approximation
1 1-GRAM spherical
1 1-GRAM systematic
1 1-GRAM reviews
1 1-GRAM drawn
1 1-GRAM ACP
1 1-GRAM Journal
1 1-GRAM Club
1 1-GRAM PubMed
1 1-GRAM strategy
1 1-GRAM achieved
1 1-GRAM 97
1 1-GRAM she
1 1-GRAM infusion
1 1-GRAM levoforinate
1 1-GRAM LV
1 1-GRAM FU
1 1-GRAM 500
1 1-GRAM metastases
1 1-GRAM starting
1 1-GRAM infuser
1 1-GRAM pump
1 1-GRAM Because
1 1-GRAM measurements
1 1-GRAM concordant
1 1-GRAM inheritance
1 1-GRAM DNAH9
1 1-GRAM NIRS
1 1-GRAM mV
1 1-GRAM FBF
1 1-GRAM 78
1 1-GRAM influence
1 1-GRAM educational
1 1-GRAM power
1 1-GRAM eliminate
1 1-GRAM sources
1 1-GRAM error
1 1-GRAM myb
1 1-GRAM cdk2
1 1-GRAM Like
1 1-GRAM LHbeta
1 1-GRAM flanking
1 1-GRAM gpLH
1 1-GRAM CGbeta
1 1-GRAM 37
1 1-GRAM codon
1 1-GRAM HTLV
1 1-GRAM Th2
1 1-GRAM strongyloidiasis
1 1-GRAM Indeed
1 1-GRAM sid1
1 1-GRAM altered
1 1-GRAM sid2
1 1-GRAM Nutritional
1 1-GRAM traditional
1 1-GRAM Plant
1 1-GRAM lacks
2 1-GRAM vitamin
1 1-GRAM B12
1 1-GRAM polyunsaturated
1 1-GRAM On
1 1-GRAM forced
1 1-GRAM inactivated
2 1-GRAM nm23H1
1 1-GRAM converted
1 1-GRAM GDP
1 1-GRAM RhoA
1 1-GRAM diphosphate
1 1-GRAM produce
1 1-GRAM GTPases
1 1-GRAM Novel
1 1-GRAM Coronary
1 1-GRAM 17
2 1-GRAM tertile
1 1-GRAM CRP
1 1-GRAM fibrinogen
1 1-GRAM tertiles
1 1-GRAM hepatitis
1 1-GRAM infections
1 1-GRAM adolescents
1 1-GRAM lodged
1 1-GRAM security
1 1-GRAM institutes
1 1-GRAM Buenos
1 1-GRAM Aires
1 1-GRAM MyoD
1 1-GRAM myeloid
1 1-GRAM caudal
1 1-GRAM homeobox
2 1-GRAM Cdx
1 1-GRAM RPM
1 1-GRAM RGL3
1 1-GRAM resembled
1 1-GRAM AF
1 1-GRAM Nore1
1 1-GRAM stratified
1 1-GRAM gender
1 1-GRAM blind
1 1-GRAM antiemetic
1 1-GRAM regimes
2 1-GRAM dolasetron
3 1-GRAM given
1 1-GRAM orally
1 1-GRAM 45
3 1-GRAM anaesthesia
2 1-GRAM intravenously
1 1-GRAM DHB
1 1-GRAM IV
1 1-GRAM Transcriptional
1 1-GRAM pS2
1 1-GRAM ERR
1 1-GRAM orphan
1 2-GRAM * Third
510 2-GRAM * *
1 2-GRAM Third ,
2 2-GRAM , consistent
4 2-GRAM consistent with
2 2-GRAM with these
3 2-GRAM these data
3 2-GRAM data ,
1 2-GRAM , N
8 2-GRAM N -
1 2-GRAM - acetylcysteine
1 2-GRAM acetylcysteine reduced
1 2-GRAM reduced the
1 2-GRAM the stimulatory
1 2-GRAM stimulatory effect
4 2-GRAM effect of
1 2-GRAM of HGF
1 2-GRAM HGF on
1 2-GRAM on stress
1 2-GRAM stress kinase
2 2-GRAM kinase activities
1 2-GRAM activities ,
3 2-GRAM , while
1 2-GRAM while p42
1 2-GRAM p42 /
1 2-GRAM / 44
1 2-GRAM 44 mitogen
1 2-GRAM mitogen activated
1 2-GRAM activated kinase
5 2-GRAM kinase (
2 2-GRAM ( MAPK
2 2-GRAM MAPK )
1 2-GRAM ) was
1 2-GRAM was unmodified
1 2-GRAM unmodified ,
3 2-GRAM , suggesting
1 2-GRAM suggesting an
1 2-GRAM an involvement
1 2-GRAM involvement of
1 2-GRAM of c
6 2-GRAM c -
2 2-GRAM - Jun
1 2-GRAM Jun -
1 2-GRAM - N
15 2-GRAM - terminal
1 2-GRAM terminal kinase
1 2-GRAM ( JNK
1 2-GRAM JNK )
26 2-GRAM ) and
1 2-GRAM and p38
1 2-GRAM p38 MAPK
1 2-GRAM MAPK in
1 2-GRAM in HIF
4 2-GRAM HIF -
28 2-GRAM - 1
1 2-GRAM 1 activation
3 2-GRAM activation .
468 2-GRAM . STOP
77 2-GRAM * The
1 2-GRAM The Sox
1 2-GRAM Sox gene
3 2-GRAM gene family
1 2-GRAM family (
1 2-GRAM ( Sry
1 2-GRAM Sry like
1 2-GRAM like HMG
1 2-GRAM HMG box
1 2-GRAM box gene
1 2-GRAM gene )
4 2-GRAM ) is
1 2-GRAM is characterised
1 2-GRAM characterised by
7 2-GRAM by a
2 2-GRAM a conserved
1 2-GRAM conserved DNA
1 2-GRAM DNA sequence
1 2-GRAM sequence encoding
4 2-GRAM encoding a
1 2-GRAM a domain
3 2-GRAM domain of
1 2-GRAM of approximately
1 2-GRAM approximately 80
1 2-GRAM 80 amino
6 2-GRAM amino acids
1 2-GRAM acids which
7 2-GRAM which is
1 2-GRAM is responsible
3 2-GRAM responsible for
1 2-GRAM for sequence
1 2-GRAM sequence specific
1 2-GRAM specific DNA
4 2-GRAM DNA binding
1 2-GRAM binding .
1 2-GRAM * Respiratory
1 2-GRAM Respiratory parameters
1 2-GRAM parameters suggested
2 2-GRAM suggested that
1 2-GRAM that M6G
1 2-GRAM M6G produced
1 2-GRAM produced less
1 2-GRAM less respiratory
1 2-GRAM respiratory depression
1 2-GRAM depression than
1 2-GRAM than morphine
1 2-GRAM morphine .
14 2-GRAM * This
1 2-GRAM This slow
1 2-GRAM slow progression
1 2-GRAM progression through
5 2-GRAM through the
2 2-GRAM the early
1 2-GRAM early G1
1 2-GRAM G1 -
1 2-GRAM - phase
1 2-GRAM phase resulted
4 2-GRAM resulted in
1 2-GRAM in decreased
1 2-GRAM decreased phosphorylation
4 2-GRAM phosphorylation of
123 2-GRAM of the
1 2-GRAM the RB
1 2-GRAM RB protein
2 2-GRAM protein and
1 2-GRAM and subsequent
1 2-GRAM subsequent delay
1 2-GRAM delay into
2 2-GRAM into the
1 2-GRAM the S
2 2-GRAM S phase
1 2-GRAM phase transition
1 2-GRAM transition .
2 2-GRAM * Responses
2 2-GRAM Responses of
1 2-GRAM of TLD
1 2-GRAM TLD Mg2SiO4
2 2-GRAM Mg2SiO4 :
2 2-GRAM : Tb
1 2-GRAM Tb and
1 2-GRAM and radiophotoluminescent
1 2-GRAM radiophotoluminescent glass
1 2-GRAM glass to
1 2-GRAM to heavy
1 2-GRAM heavy charged
1 2-GRAM charged particles
1 2-GRAM particles and
2 2-GRAM and space
1 2-GRAM space radiation
1 2-GRAM radiation .
37 2-GRAM * In
8 2-GRAM In the
1 2-GRAM the meantime
1 2-GRAM meantime ,
2 2-GRAM , one
1 2-GRAM one has
1 2-GRAM has succeeded
1 2-GRAM succeeded to
3 2-GRAM to establish
1 2-GRAM establish the
1 2-GRAM the deammonification
1 2-GRAM deammonification processes
1 2-GRAM processes in
13 2-GRAM in a
1 2-GRAM a continuous
1 2-GRAM continuous flow
1 2-GRAM flow moving
1 2-GRAM moving -
1 2-GRAM - bed
1 2-GRAM bed pilot
1 2-GRAM pilot plant
1 2-GRAM plant .
3 2-GRAM * An
1 2-GRAM An 18
1 2-GRAM 18 -
4 2-GRAM - kb
1 2-GRAM kb genomic
1 2-GRAM genomic clone
1 2-GRAM clone including
1 2-GRAM including sequences
1 2-GRAM sequences encoding
1 2-GRAM encoding for
23 2-GRAM for the
6 2-GRAM the two
1 2-GRAM two GHS
1 2-GRAM GHS -
2 2-GRAM - R
1 2-GRAM R variants
1 2-GRAM variants was
1 2-GRAM was isolated
1 2-GRAM isolated .
1 2-GRAM the further
1 2-GRAM further development
4 2-GRAM development of
1 2-GRAM of bladder
1 2-GRAM bladder neck
1 2-GRAM neck suspension
1 2-GRAM suspension according
2 2-GRAM according to
1 2-GRAM to Stamey
1 2-GRAM Stamey -
1 2-GRAM - Pereyra
1 2-GRAM Pereyra ,
32 2-GRAM , the
5 2-GRAM the use
7 2-GRAM use of
1 2-GRAM of miniature
1 2-GRAM miniature bone
1 2-GRAM bone anchors
1 2-GRAM anchors received
1 2-GRAM received considerable
1 2-GRAM considerable support
1 2-GRAM support .
1 2-GRAM * CHAP
1 2-GRAM CHAP and
16 2-GRAM and the
2 2-GRAM the Department
2 2-GRAM Department of
1 2-GRAM of Veterans
1 2-GRAM Veterans Affairs
1 2-GRAM Affairs .
3 2-GRAM * Finally
3 2-GRAM Finally ,
9 2-GRAM , a
1 2-GRAM a chromogenic
1 2-GRAM chromogenic method
1 2-GRAM method was
3 2-GRAM was used
1 2-GRAM used ,
1 2-GRAM , based
5 2-GRAM based on
1 2-GRAM on thrombin
1 2-GRAM thrombin inhibition
1 2-GRAM inhibition and
1 2-GRAM the substrate
1 2-GRAM substrate S
2 2-GRAM S -
1 2-GRAM - 2238
1 2-GRAM 2238 .
3 2-GRAM * As
2 2-GRAM As an
1 2-GRAM an oral
1 2-GRAM oral ,
1 2-GRAM , nontoxic
1 2-GRAM nontoxic compound
1 2-GRAM compound with
13 2-GRAM with a
2 2-GRAM a mechanism
1 2-GRAM mechanism of
1 2-GRAM of action
1 2-GRAM action distinct
1 2-GRAM distinct from
1 2-GRAM from that
3 2-GRAM that of
1 2-GRAM of ABL
1 2-GRAM ABL tyrosine
3 2-GRAM tyrosine kinase
1 2-GRAM kinase inhibition
1 2-GRAM inhibition ,
1 2-GRAM , FTI
1 2-GRAM FTI SCH66336
1 2-GRAM SCH66336 shows
1 2-GRAM shows promise
1 2-GRAM promise for
2 2-GRAM the treatment
6 2-GRAM treatment of
2 2-GRAM of BCR
1 2-GRAM BCR /
1 2-GRAM / ABL
1 2-GRAM ABL -
8 2-GRAM - induced
1 2-GRAM induced leukemia
2 2-GRAM leukemia .
1 2-GRAM * Recruitment
1 2-GRAM Recruitment of
3 2-GRAM of an
1 2-GRAM an RNA
2 2-GRAM RNA polymerase
2 2-GRAM polymerase II
1 2-GRAM II complex
2 2-GRAM complex is
2 2-GRAM is mediated
1 2-GRAM mediated by
22 2-GRAM by the
1 2-GRAM the constitutive
2 2-GRAM constitutive activation
2 2-GRAM activation domain
3 2-GRAM domain in
1 2-GRAM in CREB
1 2-GRAM CREB ,
1 2-GRAM , independently
1 2-GRAM independently of
2 2-GRAM of CREB
1 2-GRAM CREB phosphorylation
2 2-GRAM phosphorylation .
6 2-GRAM * Our
5 2-GRAM Our results
2 2-GRAM results are
1 2-GRAM are reassuring
1 2-GRAM reassuring and
1 2-GRAM and we
1 2-GRAM we therefore
1 2-GRAM therefore advise
1 2-GRAM advise that
2 2-GRAM that in
8 2-GRAM in patients
3 2-GRAM patients undergoing
1 2-GRAM undergoing free
1 2-GRAM free jejunum
1 2-GRAM jejunum flap
1 2-GRAM flap reconstruction
1 2-GRAM reconstruction of
1 2-GRAM the hypopharyngo
1 2-GRAM hypopharyngo -
2 2-GRAM - esophageal
1 2-GRAM esophageal tract
1 2-GRAM tract voice
1 2-GRAM voice restoration
1 2-GRAM restoration should
4 2-GRAM should be
1 2-GRAM be attempted
1 2-GRAM attempted by
1 2-GRAM by placing
1 2-GRAM placing a
1 2-GRAM a voice
1 2-GRAM voice prosthesis
1 2-GRAM prosthesis through
2 2-GRAM through a
1 2-GRAM a secondary
1 2-GRAM secondary tracheo
1 2-GRAM tracheo -
1 2-GRAM esophageal puncture
1 2-GRAM puncture and
1 2-GRAM and providing
1 2-GRAM providing intensive
1 2-GRAM intensive speech
1 2-GRAM speech training
1 2-GRAM training .
1 2-GRAM * Regarding
1 2-GRAM Regarding gestational
1 2-GRAM gestational risk
3 2-GRAM risk ,
6 2-GRAM , 3
5 2-GRAM 3 ,
1 2-GRAM , 243
1 2-GRAM 243 drugs
1 2-GRAM drugs used
1 2-GRAM used (
1 2-GRAM ( 34
1 2-GRAM 34 %)
1 2-GRAM %) belonged
1 2-GRAM belonged to
5 2-GRAM to category
1 2-GRAM category A
1 2-GRAM A risk
2 2-GRAM , 1
5 2-GRAM 1 ,
1 2-GRAM , 923
1 2-GRAM 923 (
1 2-GRAM ( 22
1 2-GRAM 22 .
7 2-GRAM . 6
2 2-GRAM 6 %)
4 2-GRAM %) to
1 2-GRAM category B
5 2-GRAM B ,
1 2-GRAM , 798
1 2-GRAM 798 (
1 2-GRAM ( 39
1 2-GRAM 39 .
5 2-GRAM . 7
1 2-GRAM 7 %)
1 2-GRAM category C
2 2-GRAM C ,
1 2-GRAM , 289
1 2-GRAM 289 (
3 2-GRAM ( 3
5 2-GRAM 3 .
2 2-GRAM . 0
1 2-GRAM 0 %)
1 2-GRAM category D
1 2-GRAM D ,
58 2-GRAM , and
1 2-GRAM and 55
1 2-GRAM 55 (
3 2-GRAM ( 0
48 2-GRAM 0 .
1 2-GRAM category X
1 2-GRAM X .
1 2-GRAM The human
1 2-GRAM human ABCG1
1 2-GRAM ABCG1 gene
1 2-GRAM gene encodes
3 2-GRAM encodes a
1 2-GRAM a member
4 2-GRAM member of
1 2-GRAM the ATP
3 2-GRAM ATP -
9 2-GRAM - binding
2 2-GRAM binding cassette
1 2-GRAM cassette (
1 2-GRAM ( ABC
1 2-GRAM ABC )
1 2-GRAM ) superfamily
2 2-GRAM superfamily of
1 2-GRAM of transporter
1 2-GRAM transporter proteins
1 2-GRAM proteins and
2 2-GRAM and is
2 2-GRAM is highly
1 2-GRAM highly induced
1 2-GRAM induced when
1 2-GRAM when macrophages
1 2-GRAM macrophages are
1 2-GRAM are incubated
1 2-GRAM incubated with
1 2-GRAM with oxysterols
1 2-GRAM oxysterols .
5 2-GRAM * At
1 2-GRAM At the
1 2-GRAM the end
3 2-GRAM end of
1 2-GRAM of each
1 2-GRAM each day
1 2-GRAM day of
1 2-GRAM of migration
1 2-GRAM migration the
1 2-GRAM the pulmonary
1 2-GRAM pulmonary hemolymph
1 2-GRAM hemolymph PO2
1 2-GRAM PO2 decreased
1 2-GRAM decreased by
1 2-GRAM by 1
7 2-GRAM 1 -
23 2-GRAM - 2
10 2-GRAM 2 .
6 2-GRAM . 5
1 2-GRAM 5 kPa
1 2-GRAM kPa ,
12 2-GRAM , but
2 2-GRAM but the
1 2-GRAM the hemocyanin
1 2-GRAM hemocyanin remained
1 2-GRAM remained saturated
1 2-GRAM saturated with
1 2-GRAM with O2
1 2-GRAM O2 and
1 2-GRAM the venous
1 2-GRAM venous reserve
1 2-GRAM reserve was
1 2-GRAM was largely
1 2-GRAM largely unchanged
1 2-GRAM unchanged (
1 2-GRAM ( O2
1 2-GRAM O2 >
1 2-GRAM > 0
5 2-GRAM . 4
1 2-GRAM 4 mmol
1 2-GRAM mmol x
1 2-GRAM x l
1 2-GRAM l (-
3 2-GRAM (- 1
1 2-GRAM 1 )).
1 2-GRAM )). STOP
17 2-GRAM * We
2 2-GRAM We have
1 2-GRAM have investigated
2 2-GRAM investigated the
2 2-GRAM the role
4 2-GRAM role of
1 2-GRAM of NGF
1 2-GRAM NGF in
3 2-GRAM in regulating
1 2-GRAM regulating gene
2 2-GRAM gene transcription
2 2-GRAM transcription in
1 2-GRAM in PC12
1 2-GRAM PC12 and
1 2-GRAM and INS
1 2-GRAM INS -
2 2-GRAM 1 cells
5 2-GRAM cells ,
10 2-GRAM , in
1 2-GRAM in order
2 2-GRAM order to
2 2-GRAM to define
1 2-GRAM define if
1 2-GRAM if there
2 2-GRAM there are
1 2-GRAM are NGF
1 2-GRAM NGF -
3 2-GRAM - regulated
1 2-GRAM regulated genes
1 2-GRAM genes per
1 2-GRAM per se
1 2-GRAM se .
7 2-GRAM * Thus
8 2-GRAM Thus ,
1 2-GRAM , through
1 2-GRAM a change
3 2-GRAM change in
1 2-GRAM in conformation
1 2-GRAM conformation upon
1 2-GRAM upon repair
1 2-GRAM repair of
1 2-GRAM the 6RG
1 2-GRAM 6RG lesion
1 2-GRAM lesion ,
1 2-GRAM , MGMT
1 2-GRAM MGMT switches
1 2-GRAM switches from
4 2-GRAM from a
1 2-GRAM a DNA
1 2-GRAM DNA repair
1 2-GRAM repair factor
1 2-GRAM factor to
9 2-GRAM to a
1 2-GRAM a transcription
1 2-GRAM transcription regulator
1 2-GRAM regulator (
2 2-GRAM ( R
2 2-GRAM R -
1 2-GRAM - MGMT
1 2-GRAM MGMT ),
1 2-GRAM ), enabling
1 2-GRAM enabling the
2 2-GRAM the cell
1 2-GRAM cell to
1 2-GRAM to sense
1 2-GRAM sense as
3 2-GRAM as well
3 2-GRAM well as
1 2-GRAM as respond
1 2-GRAM respond to
1 2-GRAM to mutagens
1 2-GRAM mutagens .
1 2-GRAM * TaqMan
1 2-GRAM TaqMan analysis
10 2-GRAM analysis of
1 2-GRAM of gene
5 2-GRAM gene expression
1 2-GRAM expression following
1 2-GRAM following chronic
1 2-GRAM chronic FA
1 2-GRAM FA treatment
1 2-GRAM treatment showed
1 2-GRAM showed neither
1 2-GRAM neither a
2 2-GRAM a decrease
4 2-GRAM decrease in
74 2-GRAM in the
1 2-GRAM the amount
3 2-GRAM amount of
1 2-GRAM of leptin
1 2-GRAM leptin receptor
3 2-GRAM receptor (
1 2-GRAM ( Ob
1 2-GRAM Ob -
1 2-GRAM R )
1 2-GRAM ) mRNA
1 2-GRAM mRNA ,
1 2-GRAM , nor
1 2-GRAM nor an
4 2-GRAM an increase
7 2-GRAM increase in
3 2-GRAM the negative
1 2-GRAM negative regulators
1 2-GRAM regulators of
1 2-GRAM of STAT
1 2-GRAM STAT signalling
1 2-GRAM signalling ,
1 2-GRAM , SOCS3
1 2-GRAM SOCS3 (
1 2-GRAM ( suppressors
1 2-GRAM suppressors of
1 2-GRAM of cytokine
1 2-GRAM cytokine signalling
1 2-GRAM signalling )
4 2-GRAM ) or
1 2-GRAM or cytokine
1 2-GRAM cytokine inducible
1 2-GRAM inducible sequence
1 2-GRAM sequence (
1 2-GRAM ( CIS
1 2-GRAM CIS ).
31 2-GRAM ). STOP
2 2-GRAM * Nine
1 2-GRAM Nine animals
1 2-GRAM animals served
1 2-GRAM served as
1 2-GRAM as control
1 2-GRAM control animals
1 2-GRAM animals ,
2 2-GRAM , whereas
1 2-GRAM whereas 20
1 2-GRAM 20 animals
1 2-GRAM animals received
2 2-GRAM received a
1 2-GRAM a focal
1 2-GRAM focal arachnoid
1 2-GRAM arachnoid scar
1 2-GRAM scar at
1 2-GRAM at C1
1 2-GRAM C1 -
1 2-GRAM - C2
1 2-GRAM C2 ,
17 2-GRAM , which
2 2-GRAM which was
1 2-GRAM was produced
1 2-GRAM produced by
1 2-GRAM by placement
1 2-GRAM placement of
20 2-GRAM of a
1 2-GRAM a kaolin
1 2-GRAM kaolin -
1 2-GRAM - soaked
1 2-GRAM soaked fibrin
1 2-GRAM fibrin sponge
1 2-GRAM sponge on
17 2-GRAM on the
1 2-GRAM the posterior
1 2-GRAM posterior surface
1 2-GRAM surface of
1 2-GRAM the spinal
1 2-GRAM spinal cord
1 2-GRAM cord .
15 2-GRAM * A
1 2-GRAM A comparison
2 2-GRAM comparison of
3 2-GRAM the duplicated
1 2-GRAM duplicated Vkappa
1 2-GRAM Vkappa genes
1 2-GRAM genes suggests
1 2-GRAM suggests positive
1 2-GRAM positive selection
1 2-GRAM selection on
1 2-GRAM the complementarity
1 2-GRAM complementarity -
1 2-GRAM - determining
1 2-GRAM determining regions
5 2-GRAM regions of
1 2-GRAM duplicated genes
1 2-GRAM genes by
1 2-GRAM by point
1 2-GRAM point mutations
1 2-GRAM mutations .
1 2-GRAM * They
1 2-GRAM They have
1 2-GRAM have not
2 2-GRAM not been
2 2-GRAM been previously
3 2-GRAM previously reported
1 2-GRAM reported as
10 2-GRAM as a
1 2-GRAM a reaction
1 2-GRAM reaction to
1 2-GRAM to i
2 2-GRAM i .
1 2-GRAM . v
1 2-GRAM v .
1 2-GRAM . contrast
1 2-GRAM contrast material
1 2-GRAM material .
2 2-GRAM The presence
3 2-GRAM presence of
1 2-GRAM of AS
1 2-GRAM AS -
1 2-GRAM - oligo
1 2-GRAM oligo had
2 2-GRAM had no
1 2-GRAM no further
1 2-GRAM further effect
6 2-GRAM effect on
1 2-GRAM the FSH
1 2-GRAM FSH -
7 2-GRAM - mediated
2 2-GRAM mediated activation
7 2-GRAM activation of
1 2-GRAM the EB
1 2-GRAM EB *-
1 2-GRAM *- mTf
1 2-GRAM mTf -
1 2-GRAM - CAT
1 2-GRAM CAT construct
1 2-GRAM construct but
1 2-GRAM but reduced
1 2-GRAM reduced cAMP
1 2-GRAM cAMP -
1 2-GRAM The homologous
1 2-GRAM homologous active
1 2-GRAM active -
2 2-GRAM - site
1 2-GRAM site framework
1 2-GRAM framework of
3 2-GRAM of these
1 2-GRAM these enzymes
1 2-GRAM enzymes with
1 2-GRAM with distinct
1 2-GRAM distinct structures
1 2-GRAM structures suggests
1 2-GRAM suggests convergent
1 2-GRAM convergent evolution
3 2-GRAM evolution of
1 2-GRAM a common
1 2-GRAM common catalytic
1 2-GRAM catalytic mechanism
1 2-GRAM mechanism .
2 2-GRAM * Additional
1 2-GRAM Additional education
1 2-GRAM education and
1 2-GRAM and research
1 2-GRAM research is
1 2-GRAM is needed
1 2-GRAM needed to
2 2-GRAM to provide
1 2-GRAM provide further
1 2-GRAM further direction
1 2-GRAM direction for
1 2-GRAM for intervention
1 2-GRAM intervention and
1 2-GRAM and incorporation
1 2-GRAM incorporation into
1 2-GRAM into practice
1 2-GRAM practice .
2 2-GRAM * Many
1 2-GRAM Many of
2 2-GRAM the important
1 2-GRAM important genes
1 2-GRAM genes associated
6 2-GRAM associated with
1 2-GRAM with G1
1 2-GRAM G1 regulation
1 2-GRAM regulation have
6 2-GRAM have been
5 2-GRAM been shown
6 2-GRAM shown to
2 2-GRAM to play
4 2-GRAM play a
1 2-GRAM a key
1 2-GRAM key role
5 2-GRAM role in
1 2-GRAM in proliferation
1 2-GRAM proliferation ,
1 2-GRAM , differentiation
1 2-GRAM differentiation and
1 2-GRAM and oncogenic
1 2-GRAM oncogenic transformation
1 2-GRAM transformation and
1 2-GRAM and programmed
2 2-GRAM programmed cell
2 2-GRAM cell death
1 2-GRAM death (
1 2-GRAM ( apoptosis
1 2-GRAM apoptosis ).
1 2-GRAM * Drug
1 2-GRAM Drug interactions
1 2-GRAM interactions have
1 2-GRAM been found
1 2-GRAM found with
1 2-GRAM with drugs
1 2-GRAM drugs that
1 2-GRAM that compete
1 2-GRAM compete for
3 2-GRAM the same
1 2-GRAM same CYP450
1 2-GRAM CYP450 isoenzymes
1 2-GRAM isoenzymes as
1 2-GRAM as statins
1 2-GRAM statins .
1 2-GRAM * Regulation
1 2-GRAM Regulation of
1 2-GRAM of laminin
1 2-GRAM laminin beta2
1 2-GRAM beta2 chain
2 2-GRAM chain gene
7 2-GRAM expression in
5 2-GRAM in human
1 2-GRAM human cancer
1 2-GRAM cancer cell
6 2-GRAM cell lines
3 2-GRAM lines .
2 2-GRAM * Mutation
1 2-GRAM Mutation of
1 2-GRAM the NF
4 2-GRAM NF -
4 2-GRAM - kappaB
1 2-GRAM kappaB site
5 2-GRAM site in
1 2-GRAM the Mdr1b
1 2-GRAM Mdr1b promoter
1 2-GRAM promoter prevents
1 2-GRAM prevents its
2 2-GRAM its induction
1 2-GRAM induction by
1 2-GRAM by TNF
2 2-GRAM TNF -
3 2-GRAM - alpha
1 2-GRAM alpha .
1 2-GRAM * Effect
1 2-GRAM Effect of
1 2-GRAM of heat
1 2-GRAM heat treatments
1 2-GRAM treatments on
1 2-GRAM the meltability
1 2-GRAM meltability of
1 2-GRAM of cheeses
2 2-GRAM cheeses .
1 2-GRAM In vitro
1 2-GRAM vitro binding
1 2-GRAM binding studies
1 2-GRAM studies demonstrate
3 2-GRAM demonstrate that
2 2-GRAM that eIF
2 2-GRAM eIF -
2 2-GRAM - 5A
1 2-GRAM 5A is
3 2-GRAM is required
6 2-GRAM required for
1 2-GRAM for efficient
1 2-GRAM efficient interaction
3 2-GRAM interaction of
1 2-GRAM of Rev
2 2-GRAM Rev -
1 2-GRAM - NES
1 2-GRAM NES with
1 2-GRAM with CRM1
1 2-GRAM CRM1 /
1 2-GRAM / exportin1
1 2-GRAM exportin1 and
4 2-GRAM and that
1 2-GRAM 5A interacts
3 2-GRAM interacts with
18 2-GRAM with the
1 2-GRAM the nucleoporins
1 2-GRAM nucleoporins CAN
1 2-GRAM CAN /
1 2-GRAM / nup214
1 2-GRAM nup214 ,
1 2-GRAM , nup153
1 2-GRAM nup153 ,
1 2-GRAM , nup98
1 2-GRAM nup98 ,
1 2-GRAM and nup62
1 2-GRAM nup62 .
1 2-GRAM * Forced
1 2-GRAM Forced expression
16 2-GRAM expression of
1 2-GRAM of BZAP45
1 2-GRAM BZAP45 strongly
1 2-GRAM strongly stimulates
1 2-GRAM stimulates H4
1 2-GRAM H4 promoter
2 2-GRAM promoter (
1 2-GRAM ( nt
1 2-GRAM nt -
1 2-GRAM - 215
1 2-GRAM 215 to
2 2-GRAM to -
1 2-GRAM 1 )/
1 2-GRAM )/ CAT
1 2-GRAM CAT reporter
2 2-GRAM reporter gene
1 2-GRAM gene activity
5 2-GRAM activity .
4 2-GRAM * Copyright
4 2-GRAM Copyright 2001
3 2-GRAM 2001 Academic
3 2-GRAM Academic Press
3 2-GRAM Press .
1 2-GRAM The diagnosis
1 2-GRAM diagnosis of
1 2-GRAM of HCV
1 2-GRAM HCV arthritis
1 2-GRAM arthritis in
9 2-GRAM patients with
1 2-GRAM with positive
1 2-GRAM positive rheumatoid
1 2-GRAM rheumatoid factor
2 2-GRAM factor and
1 2-GRAM and chronic
1 2-GRAM chronic inflammatory
1 2-GRAM inflammatory polyarthritis
1 2-GRAM polyarthritis may
5 2-GRAM may be
1 2-GRAM be difficult
1 2-GRAM difficult .
1 2-GRAM The UBA
1 2-GRAM UBA domains
1 2-GRAM domains of
1 2-GRAM of RAD23
1 2-GRAM RAD23 and
1 2-GRAM and DDI1
1 2-GRAM DDI1 are
1 2-GRAM are required
1 2-GRAM for these
1 2-GRAM these interactions
1 2-GRAM interactions .
1 2-GRAM * E47
1 2-GRAM E47 protein
2 2-GRAM protein levels
1 2-GRAM levels remain
1 2-GRAM remain high
1 2-GRAM high until
1 2-GRAM until the
1 2-GRAM the double
1 2-GRAM double positive
1 2-GRAM positive developmental
1 2-GRAM developmental stage
1 2-GRAM stage ,
2 2-GRAM , at
1 2-GRAM at which
1 2-GRAM which point
1 2-GRAM point they
1 2-GRAM they drop
1 2-GRAM drop to
1 2-GRAM to relatively
1 2-GRAM relatively moderate
1 2-GRAM moderate levels
4 2-GRAM levels ,
2 2-GRAM and are
1 2-GRAM are further
1 2-GRAM further downregulated
1 2-GRAM downregulated upon
1 2-GRAM upon transition
1 2-GRAM transition to
23 2-GRAM to the
1 2-GRAM the single
1 2-GRAM single positive
1 2-GRAM positive stage
1 2-GRAM stage .
1 2-GRAM * By
1 2-GRAM By Caveman
1 2-GRAM Caveman .
12 2-GRAM * These
3 2-GRAM These findings
3 2-GRAM findings suggest
6 2-GRAM suggest that
14 2-GRAM that the
1 2-GRAM the adapter
1 2-GRAM adapter Gab1
1 2-GRAM Gab1 may
1 2-GRAM may redirect
1 2-GRAM redirect c
1 2-GRAM - Met
1 2-GRAM Met signaling
1 2-GRAM signaling through
1 2-GRAM through PI3K
1 2-GRAM PI3K away
1 2-GRAM away from
1 2-GRAM a c
1 2-GRAM - Akt
1 2-GRAM Akt /
1 2-GRAM / Pak1
1 2-GRAM Pak1 cell
1 2-GRAM cell survival
1 2-GRAM survival pathway
1 2-GRAM pathway .
1 2-GRAM * Another
1 2-GRAM Another mutant
1 2-GRAM mutant ,
1 2-GRAM , T255A
1 2-GRAM T255A ,
1 2-GRAM , lost
1 2-GRAM lost the
2 2-GRAM the ability
4 2-GRAM ability to
1 2-GRAM to bind
1 2-GRAM bind E4orf6
1 2-GRAM E4orf6 ,
1 2-GRAM but unexpectedly
1 2-GRAM unexpectedly ,
1 2-GRAM , viral
1 2-GRAM viral late
1 2-GRAM late -
1 2-GRAM - gene
1 2-GRAM expression was
1 2-GRAM was not
1 2-GRAM not affected
1 2-GRAM affected .
8 2-GRAM * However
7 2-GRAM However ,
1 2-GRAM the N63S
1 2-GRAM N63S mutation
2 2-GRAM mutation in
2 2-GRAM the wild
4 2-GRAM wild -
4 2-GRAM - type
1 2-GRAM type VP5
1 2-GRAM VP5 background
1 2-GRAM background increased
2 2-GRAM increased the
4 2-GRAM the interaction
1 2-GRAM interaction ,
4 2-GRAM , as
1 2-GRAM as judged
1 2-GRAM judged by
2 2-GRAM the beta
5 2-GRAM beta -
1 2-GRAM - galactosidase
1 2-GRAM galactosidase activity
5 2-GRAM activity ,
1 2-GRAM , by
1 2-GRAM a factor
2 2-GRAM factor of
2 2-GRAM of 9
1 2-GRAM 9 relative
2 2-GRAM relative to
1 2-GRAM to when
1 2-GRAM when the
1 2-GRAM the PR7
1 2-GRAM PR7 mutation
1 2-GRAM mutation was
1 2-GRAM was present
1 2-GRAM present .
4 2-GRAM * Here
3 2-GRAM Here we
1 2-GRAM we report
1 2-GRAM report the
1 2-GRAM the isolation
1 2-GRAM isolation and
3 2-GRAM and characterization
5 2-GRAM characterization of
1 2-GRAM the forkhead
1 2-GRAM forkhead homologue
1 2-GRAM homologue in
1 2-GRAM in rhabdomyosarcoma
1 2-GRAM rhabdomyosarcoma (
1 2-GRAM ( FKHR
1 2-GRAM FKHR ),
1 2-GRAM ), a
1 2-GRAM a recently
1 2-GRAM recently described
1 2-GRAM described member
1 2-GRAM the hepatocyte
1 2-GRAM hepatocyte nuclear
2 2-GRAM nuclear factor
1 2-GRAM factor 3
1 2-GRAM 3 /
1 2-GRAM / forkhead
1 2-GRAM forkhead homeotic
1 2-GRAM homeotic gene
1 2-GRAM family ,
1 2-GRAM a nuclear
1 2-GRAM nuclear hormone
1 2-GRAM hormone receptor
1 2-GRAM ( NR
1 2-GRAM NR )
1 2-GRAM ) intermediary
1 2-GRAM intermediary protein
1 2-GRAM protein .
1 2-GRAM * Unlike
1 2-GRAM Unlike other
1 2-GRAM other progenitor
2 2-GRAM progenitor cells
1 2-GRAM cells of
1 2-GRAM the brain
3 2-GRAM brain ,
1 2-GRAM , SVZa
1 2-GRAM SVZa progenitor
1 2-GRAM cells have
1 2-GRAM have the
2 2-GRAM the capacity
1 2-GRAM capacity to
1 2-GRAM to divide
1 2-GRAM divide even
2 2-GRAM even though
1 2-GRAM though they
1 2-GRAM they express
1 2-GRAM express a
1 2-GRAM a neuronal
1 2-GRAM neuronal phenotype
2 2-GRAM phenotype .
2 2-GRAM We previously
1 2-GRAM reported that
1 2-GRAM that Tax
1 2-GRAM Tax induced
1 2-GRAM induced cell
3 2-GRAM cell cycle
2 2-GRAM cycle progression
1 2-GRAM progression from
1 2-GRAM from G0
1 2-GRAM G0 /
1 2-GRAM / G1
1 2-GRAM G1 phase
1 2-GRAM phase to
3 2-GRAM to S
1 2-GRAM S and
1 2-GRAM and G2
1 2-GRAM G2 /
1 2-GRAM / M
1 2-GRAM M phases
1 2-GRAM phases in
2 2-GRAM human T
2 2-GRAM T -
3 2-GRAM - cell
3 2-GRAM cell line
1 2-GRAM line Kit
1 2-GRAM Kit 225
1 2-GRAM 225 cells
11 2-GRAM cells .
1 2-GRAM * Phosphotyrosyl
1 2-GRAM Phosphotyrosyl peptides
1 2-GRAM peptides block
1 2-GRAM block Stat3
1 2-GRAM Stat3 -
1 2-GRAM mediated DNA
2 2-GRAM binding activity
1 2-GRAM , gene
1 2-GRAM gene regulation
2 2-GRAM regulation ,
3 2-GRAM and cell
1 2-GRAM cell transformation
1 2-GRAM transformation .
1 2-GRAM In Exp
1 2-GRAM Exp .
2 2-GRAM * Human
1 2-GRAM Human brain
1 2-GRAM brain cDNA
1 2-GRAM cDNA library
1 2-GRAM library screening
1 2-GRAM screening and
4 2-GRAM and 5
7 2-GRAM 5 '
1 2-GRAM ' rapid
1 2-GRAM rapid amplification
1 2-GRAM amplification of
1 2-GRAM of cDNA
1 2-GRAM cDNA ends
1 2-GRAM ends yielded
1 2-GRAM yielded full
4 2-GRAM full -
3 2-GRAM - length
1 2-GRAM length DENTT
1 2-GRAM DENTT cDNA
1 2-GRAM cDNA containing
3 2-GRAM containing an
1 2-GRAM an 1899
1 2-GRAM 1899 -
3 2-GRAM - bp
1 2-GRAM bp open
2 2-GRAM open reading
2 2-GRAM reading frame
1 2-GRAM frame encoding
1 2-GRAM a predicted
1 2-GRAM predicted 633
1 2-GRAM 633 -
3 2-GRAM - amino
2 2-GRAM amino -
1 2-GRAM - acid
1 2-GRAM acid protein
2 2-GRAM protein with
2 2-GRAM with four
1 2-GRAM four potential
1 2-GRAM potential nuclear
1 2-GRAM nuclear localization
1 2-GRAM localization signals
1 2-GRAM signals (
1 2-GRAM ( NLSs
1 2-GRAM NLSs )
2 2-GRAM and two
1 2-GRAM two coiled
1 2-GRAM coiled -
1 2-GRAM - coil
1 2-GRAM coil regions
2 2-GRAM regions .
1 2-GRAM * NaeI
1 2-GRAM NaeI ,
4 2-GRAM a novel
1 2-GRAM novel DNA
1 2-GRAM DNA endonuclease
1 2-GRAM endonuclease ,
1 2-GRAM , shows
1 2-GRAM shows topoisomerase
1 2-GRAM topoisomerase and
1 2-GRAM and recombinase
1 2-GRAM recombinase activities
1 2-GRAM activities when
1 2-GRAM when a
1 2-GRAM a Lys
1 2-GRAM Lys residue
1 2-GRAM residue is
1 2-GRAM is substituted
1 2-GRAM substituted for
1 2-GRAM for Leu
1 2-GRAM Leu 43
1 2-GRAM 43 .
1 2-GRAM We used
1 2-GRAM used a
1 2-GRAM a rev
1 2-GRAM rev -
6 2-GRAM - and
1 2-GRAM and RRE
1 2-GRAM RRE -
1 2-GRAM - defective
1 2-GRAM defective HIV
1 2-GRAM HIV type
1 2-GRAM type 1
1 2-GRAM 1 (
1 2-GRAM ( HIV
3 2-GRAM HIV -
7 2-GRAM 1 )
1 2-GRAM ) molecular
1 2-GRAM molecular clone
1 2-GRAM clone in
1 2-GRAM in complementation
1 2-GRAM complementation experiments
1 2-GRAM experiments to
2 2-GRAM establish a
1 2-GRAM a method
1 2-GRAM method for
1 2-GRAM the rapid
1 2-GRAM rapid isolation
1 2-GRAM isolation of
1 2-GRAM of posttranscriptional
1 2-GRAM posttranscriptional regulatory
3 2-GRAM regulatory elements
1 2-GRAM elements from
14 2-GRAM from the
1 2-GRAM the mammalian
1 2-GRAM mammalian genome
1 2-GRAM genome by
1 2-GRAM by selecting
1 2-GRAM selecting for
1 2-GRAM for rescue
1 2-GRAM rescue of
1 2-GRAM of virus
1 2-GRAM virus replication
2 2-GRAM replication .
1 2-GRAM * OBJECTIVES
1 2-GRAM OBJECTIVES :
5 2-GRAM : The
1 2-GRAM The objective
1 2-GRAM objective of
9 2-GRAM of this
1 2-GRAM this review
1 2-GRAM review was
3 2-GRAM was to
1 2-GRAM to compare
1 2-GRAM compare the
1 2-GRAM the effectiveness
1 2-GRAM effectiveness ,
1 2-GRAM , safety
1 2-GRAM safety and
1 2-GRAM and acceptability
1 2-GRAM acceptability of
1 2-GRAM the diaphragm
1 2-GRAM diaphragm with
2 2-GRAM with and
2 2-GRAM and without
1 2-GRAM without spermicide
1 2-GRAM spermicide .
2 2-GRAM * DESIGN
2 2-GRAM DESIGN :
1 2-GRAM : Retrospective
1 2-GRAM Retrospective study
1 2-GRAM study .
1 2-GRAM * Considering
1 2-GRAM Considering that
1 2-GRAM the reactor
1 2-GRAM reactor is
1 2-GRAM is thoroughly
1 2-GRAM thoroughly mixed
1 2-GRAM mixed during
1 2-GRAM during each
1 2-GRAM each discharge
1 2-GRAM discharge and
1 2-GRAM that LD50
1 2-GRAM LD50 =
20 2-GRAM = 0
3 2-GRAM . 9
1 2-GRAM 9 values
1 2-GRAM values are
1 2-GRAM are nearly
1 2-GRAM nearly independent
4 2-GRAM independent of
1 2-GRAM of E
3 2-GRAM E .
3 2-GRAM . coli
1 2-GRAM coli concentrations
3 2-GRAM concentrations in
2 2-GRAM the range
3 2-GRAM range of
1 2-GRAM of 2
1 2-GRAM 2 x
2 2-GRAM x 10
2 2-GRAM 10 (
6 2-GRAM 3 )
3 2-GRAM ) <
3 2-GRAM < or
4 2-GRAM or =
1 2-GRAM = E
1 2-GRAM E coli
1 2-GRAM coli /
1 2-GRAM / cfu
1 2-GRAM cfu mL
1 2-GRAM mL (-
1 2-GRAM = 3
1 2-GRAM 3 x
1 2-GRAM ( 6
1 2-GRAM 6 ),
1 2-GRAM ), we
1 2-GRAM we ascribe
1 2-GRAM ascribe the
1 2-GRAM the nonexponential
1 2-GRAM nonexponential Pn
1 2-GRAM Pn decay
1 2-GRAM decay of
3 2-GRAM of single
4 2-GRAM single -
1 2-GRAM - strain
1 2-GRAM strain E
1 2-GRAM coli colonies
1 2-GRAM colonies to
1 2-GRAM a shielding
1 2-GRAM shielding phenomenon
1 2-GRAM phenomenon where
1 2-GRAM where inactive
1 2-GRAM inactive cells
1 2-GRAM cells protect
1 2-GRAM protect the
1 2-GRAM the successively
1 2-GRAM successively smaller
1 2-GRAM smaller numbers
1 2-GRAM numbers of
1 2-GRAM of viable
1 2-GRAM viable cells
1 2-GRAM cells in
1 2-GRAM the EHD
1 2-GRAM EHD .
1 2-GRAM These genes
2 2-GRAM genes encode
1 2-GRAM encode a
1 2-GRAM a tryptophanyl
1 2-GRAM tryptophanyl tRNA
1 2-GRAM tRNA ,
3 2-GRAM the protein
1 2-GRAM protein translocase
1 2-GRAM translocase component
1 2-GRAM component SecE
1 2-GRAM SecE ,
1 2-GRAM the antiterminator
1 2-GRAM antiterminator protein
1 2-GRAM protein NusG
1 2-GRAM NusG ,
1 2-GRAM the ribosomal
1 2-GRAM ribosomal proteins
1 2-GRAM proteins L11
1 2-GRAM L11 and
1 2-GRAM and L1
1 2-GRAM L1 in
1 2-GRAM in addition
2 2-GRAM addition to
1 2-GRAM to PkwR
1 2-GRAM PkwR ,
1 2-GRAM a putative
1 2-GRAM putative regulatory
1 2-GRAM regulatory protein
2 2-GRAM protein of
1 2-GRAM the LacI
1 2-GRAM LacI -
1 2-GRAM - GalR
1 2-GRAM GalR family
3 2-GRAM family .
1 2-GRAM * Body
1 2-GRAM Body fat
1 2-GRAM fat distribution
1 2-GRAM distribution was
3 2-GRAM was determined
3 2-GRAM determined by
1 2-GRAM by abdominal
1 2-GRAM abdominal computed
1 2-GRAM computed tomography
1 2-GRAM tomography .
1 2-GRAM The telomerase
1 2-GRAM telomerase RNA
3 2-GRAM RNA -
1 2-GRAM - protein
1 2-GRAM protein complex
1 2-GRAM complex responsible
1 2-GRAM for maintenance
1 2-GRAM maintenance of
1 2-GRAM of telomeric
1 2-GRAM telomeric DNA
1 2-GRAM DNA at
1 2-GRAM at chromosome
1 2-GRAM chromosome ends
1 2-GRAM ends ,
4 2-GRAM , is
1 2-GRAM is usually
1 2-GRAM usually inactive
1 2-GRAM inactive in
1 2-GRAM in most
1 2-GRAM most primary
1 2-GRAM primary somatic
1 2-GRAM somatic human
1 2-GRAM human cells
1 2-GRAM but is
2 2-GRAM is specifically
1 2-GRAM specifically activated
1 2-GRAM activated with
1 2-GRAM with in
8 2-GRAM in vitro
1 2-GRAM vitro immortalization
1 2-GRAM immortalization and
1 2-GRAM and during
1 2-GRAM during tumorigenesis
1 2-GRAM tumorigenesis .
1 2-GRAM This is
8 2-GRAM is a
1 2-GRAM a challenging
1 2-GRAM challenging task
1 2-GRAM task insofar
1 2-GRAM insofar as
1 2-GRAM as direct
1 2-GRAM direct measures
1 2-GRAM measures of
1 2-GRAM of ISF
1 2-GRAM ISF glucose
1 2-GRAM glucose are
4 2-GRAM are not
1 2-GRAM not readily
1 2-GRAM readily available
1 2-GRAM available .
1 2-GRAM * SELECTION
1 2-GRAM SELECTION CRITERIA
1 2-GRAM CRITERIA :
1 2-GRAM : All
1 2-GRAM All randomised
1 2-GRAM randomised controlled
2 2-GRAM controlled trials
1 2-GRAM trials comparing
1 2-GRAM comparing IUSs
1 2-GRAM IUSs with
2 2-GRAM with other
1 2-GRAM other forms
3 2-GRAM forms of
1 2-GRAM of reversible
1 2-GRAM reversible contraceptives
1 2-GRAM contraceptives and
1 2-GRAM and reporting
1 2-GRAM reporting on
1 2-GRAM on pre
2 2-GRAM pre -
1 2-GRAM - determined
1 2-GRAM determined outcomes
1 2-GRAM outcomes in
1 2-GRAM in women
1 2-GRAM women of
1 2-GRAM of reproductive
1 2-GRAM reproductive years
1 2-GRAM years .
4 2-GRAM * There
4 2-GRAM There was
2 2-GRAM was a
2 2-GRAM a statistically
2 2-GRAM statistically significant
2 2-GRAM significant correlation
3 2-GRAM correlation between
1 2-GRAM between simultaneous
1 2-GRAM simultaneous weekly
1 2-GRAM weekly average
1 2-GRAM average pollen
1 2-GRAM pollen levels
2 2-GRAM levels in
1 2-GRAM in Philadelphia
1 2-GRAM Philadelphia and
4 2-GRAM and in
1 2-GRAM in Cherry
1 2-GRAM Cherry Hill
1 2-GRAM Hill (
1 2-GRAM ( Acer
1 2-GRAM Acer ,
8 2-GRAM , r
8 2-GRAM r (
8 2-GRAM ( p
8 2-GRAM p )
9 2-GRAM ) =
1 2-GRAM . 987
1 2-GRAM 987 ,
1 2-GRAM , Quercus
1 2-GRAM Quercus ,
1 2-GRAM . 645
1 2-GRAM 645 ,
1 2-GRAM , Betula
1 2-GRAM Betula ,
1 2-GRAM . 896
1 2-GRAM 896 ,
1 2-GRAM , Pinus
1 2-GRAM Pinus ,
1 2-GRAM . 732
1 2-GRAM 732 ,
1 2-GRAM , Cupressaceae
1 2-GRAM Cupressaceae ,
1 2-GRAM . 695
1 2-GRAM 695 ,
1 2-GRAM , Poaceae
1 2-GRAM Poaceae ,
1 2-GRAM . 950
1 2-GRAM 950 ,
1 2-GRAM , Ambrosia
1 2-GRAM Ambrosia ,
1 2-GRAM . 903
1 2-GRAM 903 ,
1 2-GRAM and Rumex
1 2-GRAM Rumex ,
1 2-GRAM . 572
1 2-GRAM 572 ,
4 2-GRAM , P
4 2-GRAM P <
4 2-GRAM < 0
2 2-GRAM . 001
2 2-GRAM 001 ).
2 2-GRAM * Through
1 2-GRAM Through two
1 2-GRAM two novel
1 2-GRAM novel mechanisms
3 2-GRAM mechanisms ,
1 2-GRAM , Arf
1 2-GRAM Arf inhibits
2 2-GRAM inhibits the
1 2-GRAM the oncoprotein
1 2-GRAM oncoprotein Hdm2
1 2-GRAM Hdm2 ,
2 2-GRAM a negative
1 2-GRAM negative regulator
3 2-GRAM regulator of
2 2-GRAM of p53
2 2-GRAM p53 .
2 2-GRAM * 2
1 2-GRAM 2 :
1 2-GRAM The dynamic
1 2-GRAM dynamic moduli
1 2-GRAM moduli of
1 2-GRAM of microcrystalline
1 2-GRAM microcrystalline cellulose
1 2-GRAM cellulose .
1 2-GRAM * Such
1 2-GRAM Such knowledge
1 2-GRAM knowledge could
1 2-GRAM could advance
1 2-GRAM advance diagnosis
1 2-GRAM diagnosis and
1 2-GRAM and treatment
1 2-GRAM the patient
2 2-GRAM patient and
1 2-GRAM and counseling
1 2-GRAM counseling of
1 2-GRAM the affected
1 2-GRAM affected family
3 2-GRAM we show
6 2-GRAM show that
1 2-GRAM that independent
1 2-GRAM of uncertainties
1 2-GRAM uncertainties in
1 2-GRAM the models
1 2-GRAM models ,
1 2-GRAM , terrestrial
1 2-GRAM terrestrial planets
1 2-GRAM planets with
1 2-GRAM with dense
1 2-GRAM dense atmosphere
1 2-GRAM atmosphere like
1 2-GRAM like Venus
1 2-GRAM Venus can
1 2-GRAM can evolve
1 2-GRAM evolve into
1 2-GRAM into one
4 2-GRAM one of
1 2-GRAM of only
1 2-GRAM only four
1 2-GRAM four possible
1 2-GRAM possible rotation
1 2-GRAM rotation states
1 2-GRAM states .
2 2-GRAM results suggest
1 2-GRAM that WASP
1 2-GRAM WASP activates
2 2-GRAM activates transcription
1 2-GRAM transcription following
1 2-GRAM following TCR
1 2-GRAM TCR stimulation
1 2-GRAM stimulation in
2 2-GRAM a manner
1 2-GRAM manner that
4 2-GRAM that is
1 2-GRAM is independent
2 2-GRAM of its
1 2-GRAM its role
1 2-GRAM in Arp2
1 2-GRAM Arp2 /
2 2-GRAM / 3
6 2-GRAM 3 -
1 2-GRAM - directed
1 2-GRAM directed actin
1 2-GRAM actin polymerization
1 2-GRAM polymerization .
5 2-GRAM In contrast
5 2-GRAM contrast ,
1 2-GRAM the ubiquitous
1 2-GRAM ubiquitous expression
1 2-GRAM of p19
1 2-GRAM p19 (
1 2-GRAM ( INK4d
1 2-GRAM INK4d )
1 2-GRAM ) has
1 2-GRAM has not
1 2-GRAM previously described
2 2-GRAM described in
1 2-GRAM human or
1 2-GRAM or murine
1 2-GRAM murine B
5 2-GRAM B -
1 2-GRAM - lineage
1 2-GRAM lineage cells
1 2-GRAM This animal
1 2-GRAM animal model
2 2-GRAM model of
1 2-GRAM of dystonia
1 2-GRAM dystonia appears
1 2-GRAM appears to
15 2-GRAM to be
2 2-GRAM be a
1 2-GRAM a model
1 2-GRAM of NAD
1 2-GRAM NAD in
1 2-GRAM in man
1 2-GRAM man from
1 2-GRAM the viewpoint
1 2-GRAM viewpoint of
2 2-GRAM of treatment
1 2-GRAM treatment -
2 2-GRAM - response
1 2-GRAM response .
3 2-GRAM These results
3 2-GRAM results indicate
4 2-GRAM indicate that
1 2-GRAM that evaluation
2 2-GRAM evaluation of
1 2-GRAM of exposure
1 2-GRAM exposure to
2 2-GRAM S .
1 2-GRAM . neurona
1 2-GRAM neurona by
1 2-GRAM by WB
1 2-GRAM WB analysis
2 2-GRAM of serum
1 2-GRAM serum may
1 2-GRAM be misleading
1 2-GRAM misleading in
1 2-GRAM in young
1 2-GRAM young horses
1 2-GRAM horses .
1 2-GRAM The Delta6CCI
1 2-GRAM Delta6CCI virus
1 2-GRAM virus was
1 2-GRAM was extremely
1 2-GRAM extremely attenuated
1 2-GRAM attenuated in
1 2-GRAM in replication
1 2-GRAM replication capacity
1 2-GRAM capacity yet
1 2-GRAM yet retained
1 2-GRAM retained infectiousness
1 2-GRAM infectiousness for
1 2-GRAM for CEMx174
1 2-GRAM CEMx174 and
1 2-GRAM and MT4
1 2-GRAM MT4 cells
2 2-GRAM * OBJECTIVE
2 2-GRAM OBJECTIVE :
3 2-GRAM : To
2 2-GRAM To determine
2 2-GRAM determine the
2 2-GRAM the association
1 2-GRAM association of
1 2-GRAM of depressive
1 2-GRAM depressive symptoms
1 2-GRAM symptoms with
2 2-GRAM with HIV
6 2-GRAM - related
1 2-GRAM related mortality
1 2-GRAM mortality and
1 2-GRAM and decline
2 2-GRAM decline in
1 2-GRAM in CD4
1 2-GRAM CD4 lymphocyte
1 2-GRAM lymphocyte counts
1 2-GRAM counts among
2 2-GRAM among women
1 2-GRAM women with
2 2-GRAM HIV .
1 2-GRAM * Phase
1 2-GRAM Phase II
1 2-GRAM II study
2 2-GRAM study of
1 2-GRAM of paclitaxel
2 2-GRAM paclitaxel and
1 2-GRAM and oral
1 2-GRAM oral etoposide
1 2-GRAM etoposide in
1 2-GRAM with locally
1 2-GRAM locally advanced
1 2-GRAM advanced or
1 2-GRAM or metastatic
1 2-GRAM metastatic non
4 2-GRAM non -
1 2-GRAM - small
1 2-GRAM small cell
1 2-GRAM cell lung
3 2-GRAM lung cancer
2 2-GRAM cancer .
1 2-GRAM * Analyses
1 2-GRAM Analyses revealed
3 2-GRAM revealed that
1 2-GRAM that scale
1 2-GRAM scale matters
1 2-GRAM matters above
1 2-GRAM above and
1 2-GRAM and beyond
1 2-GRAM beyond the
2 2-GRAM the effect
1 2-GRAM of quadrat
1 2-GRAM quadrat area
1 2-GRAM area .
1 2-GRAM * Rind
1 2-GRAM Rind et
1 2-GRAM et al
1 2-GRAM al .'
1 2-GRAM .' s
1 2-GRAM s study
1 2-GRAM study '
8 2-GRAM ' s
1 2-GRAM s main
1 2-GRAM main conclusions
1 2-GRAM conclusions were
5 2-GRAM were not
1 2-GRAM not supported
1 2-GRAM supported by
1 2-GRAM the original
1 2-GRAM original data
1 2-GRAM data .
1 2-GRAM * Not
1 2-GRAM Not Available
1 2-GRAM Available STOP
1 2-GRAM * Lactate
1 2-GRAM Lactate accumulation
1 2-GRAM accumulation peak
1 2-GRAM peak was
1 2-GRAM was unaffected
1 2-GRAM unaffected by
1 2-GRAM by supplementation
1 2-GRAM supplementation (
1 2-GRAM ( HMB
1 2-GRAM HMB ,
1 2-GRAM , 8
6 2-GRAM 8 .
5 2-GRAM . 1
1 2-GRAM 1 +/-
2 2-GRAM +/- 1
8 2-GRAM 1 .
1 2-GRAM 1 mM
2 2-GRAM mM ;
1 2-GRAM ; LEU
1 2-GRAM LEU ,
2 2-GRAM , 6
3 2-GRAM 6 .
4 2-GRAM . 2
1 2-GRAM 2 +/-
3 2-GRAM +/- 0
4 2-GRAM . 8
1 2-GRAM 8 mM
1 2-GRAM ; CON
1 2-GRAM CON ,
1 2-GRAM , 7
5 2-GRAM 7 .
1 2-GRAM 5 +/-
10 2-GRAM . 3
1 2-GRAM 3 mM
1 2-GRAM mM ).
1 2-GRAM the abi1
1 2-GRAM abi1 -
2 2-GRAM 1 gene
1 2-GRAM gene product
1 2-GRAM product has
1 2-GRAM has no
1 2-GRAM no effect
1 2-GRAM the ABA
1 2-GRAM ABA suppression
1 2-GRAM suppression of
1 2-GRAM a GA
1 2-GRAM GA -
3 2-GRAM - responsive
1 2-GRAM responsive alpha
3 2-GRAM alpha -
2 2-GRAM - amylase
1 2-GRAM amylase gene
8 2-GRAM gene .
1 2-GRAM * Polyclonal
1 2-GRAM Polyclonal antibodies
2 2-GRAM antibodies against
2 2-GRAM against the
4 2-GRAM the N
2 2-GRAM terminal part
2 2-GRAM part (
2 2-GRAM ( amino
1 2-GRAM acids 12
3 2-GRAM 12 -
1 2-GRAM - 363
1 2-GRAM 363 )
5 2-GRAM the C
10 2-GRAM C -
1 2-GRAM acids 330
1 2-GRAM 330 -
1 2-GRAM - 730
1 2-GRAM 730 )
3 2-GRAM ) of
1 2-GRAM of rainbow
2 2-GRAM rainbow trout
1 2-GRAM trout HIF
2 2-GRAM - 1alpha
2 2-GRAM 1alpha protein
1 2-GRAM protein recognized
1 2-GRAM recognized rainbow
1 2-GRAM trout and
1 2-GRAM and chinook
1 2-GRAM chinook salmon
1 2-GRAM salmon HIF
1 2-GRAM protein in
1 2-GRAM in Western
3 2-GRAM Western blot
3 2-GRAM blot analysis
3 2-GRAM analysis .
1 2-GRAM * Southern
1 2-GRAM Southern blot
1 2-GRAM of genomic
1 2-GRAM genomic DNA
1 2-GRAM DNA from
1 2-GRAM from somatic
1 2-GRAM somatic cell
1 2-GRAM cell hybrids
1 2-GRAM hybrids showed
5 2-GRAM showed that
1 2-GRAM that endothelial
1 2-GRAM endothelial -
1 2-GRAM - TACC
1 2-GRAM TACC -
1 2-GRAM related cDNA
1 2-GRAM cDNA maps
1 2-GRAM maps to
2 2-GRAM to chromosome
1 2-GRAM chromosome 10
2 2-GRAM 10 .
1 2-GRAM * PABP
1 2-GRAM PABP is
1 2-GRAM a modular
1 2-GRAM modular protein
7 2-GRAM protein ,
5 2-GRAM , with
1 2-GRAM four N
1 2-GRAM terminal RNA
1 2-GRAM binding domains
1 2-GRAM domains and
2 2-GRAM and an
1 2-GRAM an extensive
1 2-GRAM extensive C
2 2-GRAM C terminus
1 2-GRAM terminus .
1 2-GRAM * 9
3 2-GRAM 9 .
2 2-GRAM 7 (
1 2-GRAM ( 95
1 2-GRAM 95 %
1 2-GRAM % CI
1 2-GRAM CI :
1 2-GRAM : 9
5 2-GRAM 6 -
1 2-GRAM - 9
1 2-GRAM 7 )
1 2-GRAM ) micromol
2 2-GRAM micromol /
3 2-GRAM / L
1 2-GRAM L among
1 2-GRAM women (
5 2-GRAM ( P
7 2-GRAM P =
1 2-GRAM . 003
1 2-GRAM 003 ).
2 2-GRAM The mean
1 2-GRAM mean waiting
1 2-GRAM waiting time
2 2-GRAM time to
2 2-GRAM to receive
1 2-GRAM receive the
1 2-GRAM the pancreas
1 2-GRAM pancreas transplant
1 2-GRAM transplant was
1 2-GRAM was 244
1 2-GRAM 244 days
2 2-GRAM days for
1 2-GRAM for SPK
1 2-GRAM SPK and
1 2-GRAM and 167
1 2-GRAM 167 days
1 2-GRAM for PAK
1 2-GRAM PAK recipients
1 2-GRAM recipients (
1 2-GRAM * Zarix
1 2-GRAM Zarix expected
1 2-GRAM expected patient
1 2-GRAM patient enrollment
1 2-GRAM enrollment in
1 2-GRAM in Canadian
1 2-GRAM Canadian clinical
1 2-GRAM clinical sites
1 2-GRAM sites to
1 2-GRAM to begin
1 2-GRAM begin in
1 2-GRAM in Spring
1 2-GRAM Spring 2001
1 2-GRAM 2001 [
1 2-GRAM [ 397955
1 2-GRAM 397955 ],
1 2-GRAM ], [
1 2-GRAM [ 405928
1 2-GRAM 405928 ].
1 2-GRAM ]. STOP
1 2-GRAM The isoform
1 2-GRAM isoform ,
1 2-GRAM , designated
1 2-GRAM designated HDAC9a
1 2-GRAM HDAC9a ,
1 2-GRAM is 132
1 2-GRAM 132 aa
1 2-GRAM aa shorter
1 2-GRAM shorter at
10 2-GRAM at the
1 2-GRAM terminus than
1 2-GRAM than HDAC9
1 2-GRAM HDAC9 .
1 2-GRAM * Long
1 2-GRAM Long -
1 2-GRAM - range
1 2-GRAM range comparison
6 2-GRAM of human
1 2-GRAM human and
1 2-GRAM and mouse
1 2-GRAM mouse SCL
1 2-GRAM SCL loci
1 2-GRAM loci :
1 2-GRAM : localized
1 2-GRAM localized regions
2 2-GRAM of sensitivity
1 2-GRAM sensitivity to
1 2-GRAM to restriction
1 2-GRAM restriction endonucleases
1 2-GRAM endonucleases correspond
1 2-GRAM correspond precisely
1 2-GRAM precisely with
1 2-GRAM with peaks
1 2-GRAM peaks of
1 2-GRAM of conserved
1 2-GRAM conserved noncoding
1 2-GRAM noncoding sequences
1 2-GRAM sequences .
1 2-GRAM In Saccharomyces
3 2-GRAM Saccharomyces cerevisiae
1 2-GRAM cerevisiae ,
1 2-GRAM , eIF6
1 2-GRAM eIF6 is
1 2-GRAM is encoded
3 2-GRAM encoded by
7 2-GRAM a single
1 2-GRAM - copy
1 2-GRAM copy essential
1 2-GRAM essential gene
2 2-GRAM * Three
1 2-GRAM Three patients
2 2-GRAM patients received
1 2-GRAM received additional
1 2-GRAM additional cycles
1 2-GRAM cycles of
2 2-GRAM of 5
11 2-GRAM 5 -
2 2-GRAM - fluorouracil
1 2-GRAM fluorouracil +/-
1 2-GRAM +/- leucovorin
1 2-GRAM leucovorin as
1 2-GRAM as maintenance
1 2-GRAM maintenance chemotherapy
1 2-GRAM chemotherapy .
1 2-GRAM . RESULTS
9 2-GRAM RESULTS :
1 2-GRAM : Thirty
1 2-GRAM Thirty males
1 2-GRAM males and
1 2-GRAM and 21
1 2-GRAM 21 females
1 2-GRAM females with
1 2-GRAM a median
1 2-GRAM median age
1 2-GRAM age of
1 2-GRAM of 55
1 2-GRAM 55 years
1 2-GRAM years (
1 2-GRAM ( range
1 2-GRAM range 31
1 2-GRAM 31 --
1 2-GRAM -- 73
1 2-GRAM 73 years
1 2-GRAM years )
4 2-GRAM ) were
1 2-GRAM were treated
1 2-GRAM treated .
7 2-GRAM * RESULTS
1 2-GRAM : Within
1 2-GRAM Within 7
1 2-GRAM 7 days
1 2-GRAM days ,
3 2-GRAM , all
1 2-GRAM all groups
1 2-GRAM groups re
2 2-GRAM re -
1 2-GRAM - acquired
1 2-GRAM acquired responding
1 2-GRAM responding for
1 2-GRAM for heroin
1 2-GRAM heroin under
1 2-GRAM under CRF
1 2-GRAM CRF at
1 2-GRAM at rates
1 2-GRAM rates similar
3 2-GRAM similar to
2 2-GRAM to their
1 2-GRAM their pre
1 2-GRAM - lesion
1 2-GRAM lesion performance
1 2-GRAM performance .
1 2-GRAM The application
2 2-GRAM application of
1 2-GRAM the biotechnology
1 2-GRAM biotechnology at
1 2-GRAM the plants
1 2-GRAM plants for
2 2-GRAM for treatment
1 2-GRAM the surface
1 2-GRAM surface storm
1 2-GRAM storm waters
1 2-GRAM waters from
1 2-GRAM the industrial
1 2-GRAM industrial zone
1 2-GRAM zone Telychka
1 2-GRAM Telychka of
1 2-GRAM the city
1 2-GRAM city of
1 2-GRAM of Kyiv
1 2-GRAM Kyiv has
1 2-GRAM has allowed
1 2-GRAM allowed the
1 2-GRAM the content
1 2-GRAM content of
1 2-GRAM of petroleum
1 2-GRAM petroleum in
1 2-GRAM in water
1 2-GRAM water dropped
1 2-GRAM dropped to
1 2-GRAM the Dnieper
1 2-GRAM Dnieper to
1 2-GRAM be constantly
1 2-GRAM constantly reduced
1 2-GRAM reduced 50
1 2-GRAM 50 -
1 2-GRAM - 100
1 2-GRAM 100 times
1 2-GRAM times .
2 2-GRAM * Using
1 2-GRAM Using immunochemical
1 2-GRAM immunochemical co
2 2-GRAM co -
1 2-GRAM - precipitation
1 2-GRAM precipitation methods
2 2-GRAM methods ,
15 2-GRAM , we
1 2-GRAM we also
1 2-GRAM also found
3 2-GRAM found that
1 2-GRAM two proteins
1 2-GRAM proteins are
1 2-GRAM are bound
2 2-GRAM bound in
4 2-GRAM in vivo
3 2-GRAM vivo .
1 2-GRAM * Utility
1 2-GRAM Utility of
1 2-GRAM of OAE
2 2-GRAM OAE screener
1 2-GRAM screener (
1 2-GRAM ( GSI
2 2-GRAM GSI 70
1 2-GRAM 70 )
3 2-GRAM ) for
1 2-GRAM the evaluation
1 2-GRAM of distortion
1 2-GRAM distortion product
1 2-GRAM product otoacoustic
1 2-GRAM otoacoustic emissions
1 2-GRAM emissions ]
2 2-GRAM ] The
2 2-GRAM The purpose
3 2-GRAM purpose of
1 2-GRAM this study
2 2-GRAM study was
2 2-GRAM to investigate
4 2-GRAM investigate the
2 2-GRAM ability of
1 2-GRAM the OAE
1 2-GRAM screener GSI
1 2-GRAM 70 to
2 2-GRAM to evaluate
1 2-GRAM evaluate of
1 2-GRAM of cochlea
1 2-GRAM cochlea function
1 2-GRAM function in
1 2-GRAM in neonates
1 2-GRAM neonates ,
1 2-GRAM , infants
1 2-GRAM infants and
2 2-GRAM and adults
2 2-GRAM adults .
1 2-GRAM results demonstrated
3 2-GRAM demonstrated that
1 2-GRAM that 50
2 2-GRAM 50 %
3 2-GRAM % of
1 2-GRAM the hepatic
1 2-GRAM hepatic artery
1 2-GRAM artery -
1 2-GRAM - alone
1 2-GRAM alone ALT
1 2-GRAM ALT graft
1 2-GRAM graft showed
1 2-GRAM showed almost
1 2-GRAM almost normal
1 2-GRAM normal structure
1 2-GRAM structure histologically
1 2-GRAM histologically at
1 2-GRAM at 1
1 2-GRAM 1 month
1 2-GRAM month after
1 2-GRAM after grafting
1 2-GRAM grafting ,
1 2-GRAM with bile
1 2-GRAM bile secretion
1 2-GRAM secretion preserved
1 2-GRAM preserved .
1 2-GRAM * Mean
1 2-GRAM Mean Hg
2 2-GRAM Hg concentrations
1 2-GRAM the livers
1 2-GRAM livers of
1 2-GRAM of mice
1 2-GRAM mice at
1 2-GRAM at some
1 2-GRAM some sites
1 2-GRAM sites in
1 2-GRAM in Isle
1 2-GRAM Isle Royale
1 2-GRAM Royale are
2 2-GRAM not significantly
3 2-GRAM significantly lower
1 2-GRAM lower (
2 2-GRAM . 62
1 2-GRAM 62 )
1 2-GRAM ) than
1 2-GRAM than Hg
1 2-GRAM concentrations considered
1 2-GRAM considered by
1 2-GRAM by some
1 2-GRAM some government
1 2-GRAM government agencies
1 2-GRAM agencies to
1 2-GRAM be unhealthy
1 2-GRAM unhealthy for
1 2-GRAM for human
1 2-GRAM human consumption
1 2-GRAM consumption .
1 2-GRAM We show
1 2-GRAM show here
1 2-GRAM here that
1 2-GRAM the in
1 2-GRAM vitro transcription
1 2-GRAM transcription extract
1 2-GRAM extract contains
4 2-GRAM contains a
1 2-GRAM a binding
1 2-GRAM activity that
1 2-GRAM is specific
1 2-GRAM specific for
1 2-GRAM the initiator
2 2-GRAM initiator element
2 2-GRAM element and
1 2-GRAM and thus
1 2-GRAM thus may
1 2-GRAM may participate
1 2-GRAM participate in
1 2-GRAM in recruiting
1 2-GRAM recruiting RNA
1 2-GRAM II to
1 2-GRAM the SL
1 2-GRAM SL RNA
1 2-GRAM RNA gene
3 2-GRAM gene promoter
10 2-GRAM promoter .
1 2-GRAM The desirability
1 2-GRAM desirability function
1 2-GRAM function is
2 2-GRAM is based
1 2-GRAM the search
1 2-GRAM search for
5 2-GRAM for a
1 2-GRAM a global
1 2-GRAM global optimum
1 2-GRAM optimum [
1 2-GRAM [ D
1 2-GRAM D =
1 2-GRAM = f
1 2-GRAM f (
1 2-GRAM ( Y1
1 2-GRAM Y1 ,
1 2-GRAM , Y2
1 2-GRAM Y2 ,
1 2-GRAM , ...,
1 2-GRAM ..., Yn
1 2-GRAM Yn )]
1 2-GRAM )] by
1 2-GRAM the transformation
1 2-GRAM transformation of
1 2-GRAM the measured
1 2-GRAM measured property
1 2-GRAM property to
1 2-GRAM a dimensionless
1 2-GRAM dimensionless scale
1 2-GRAM scale for
1 2-GRAM for each
1 2-GRAM each criterion
1 2-GRAM criterion .
1 2-GRAM * Naltrexone
1 2-GRAM Naltrexone hydrochloride
1 2-GRAM hydrochloride is
1 2-GRAM a synthetic
1 2-GRAM synthetic opioid
1 2-GRAM opioid receptor
1 2-GRAM receptor antagonist
1 2-GRAM antagonist recently
1 2-GRAM recently used
1 2-GRAM used in
1 2-GRAM in efforts
1 2-GRAM efforts to
1 2-GRAM provide rapid
1 2-GRAM rapid opioid
1 2-GRAM opioid detoxification
1 2-GRAM detoxification .
1 2-GRAM We mapped
1 2-GRAM mapped the
1 2-GRAM the DGCR6
1 2-GRAM DGCR6 gene
1 2-GRAM gene to
1 2-GRAM chromosome 22q11
1 2-GRAM 22q11 within
2 2-GRAM within a
1 2-GRAM a low
1 2-GRAM low copy
1 2-GRAM copy repeat
1 2-GRAM repeat ,
2 2-GRAM , termed
2 2-GRAM termed sc11
2 2-GRAM sc11 .
1 2-GRAM . 1a
1 2-GRAM 1a ,
3 2-GRAM and identified
1 2-GRAM identified a
2 2-GRAM a second
1 2-GRAM second copy
2 2-GRAM copy of
6 2-GRAM the gene
6 2-GRAM gene ,
1 2-GRAM , DGCR6L
1 2-GRAM DGCR6L ,
1 2-GRAM , within
5 2-GRAM within the
1 2-GRAM the duplicate
1 2-GRAM duplicate locus
1 2-GRAM locus ,
1 2-GRAM . 1b
1 2-GRAM 1b .
1 2-GRAM * Proliferative
1 2-GRAM Proliferative vasculopathy
1 2-GRAM vasculopathy and
1 2-GRAM and cutaneous
1 2-GRAM cutaneous hemorrhages
1 2-GRAM hemorrhages in
1 2-GRAM in porcine
1 2-GRAM porcine neonates
1 2-GRAM neonates infected
2 2-GRAM infected with
1 2-GRAM the porcine
1 2-GRAM porcine reproductive
1 2-GRAM reproductive and
1 2-GRAM and respiratory
1 2-GRAM respiratory syndrome
1 2-GRAM syndrome virus
1 2-GRAM virus .
1 2-GRAM The child
1 2-GRAM child left
1 2-GRAM left behind
1 2-GRAM behind .
1 2-GRAM Using the
5 2-GRAM two -
2 2-GRAM - hybrid
1 2-GRAM hybrid system
2 2-GRAM system ,
1 2-GRAM that nonprenylated
1 2-GRAM nonprenylated Rac1
1 2-GRAM Rac1 interacts
1 2-GRAM interacts very
1 2-GRAM very weakly
1 2-GRAM weakly with
1 2-GRAM with Rho
1 2-GRAM Rho -
1 2-GRAM - GDI
1 2-GRAM GDI ,
1 2-GRAM , pointing
1 2-GRAM pointing to
1 2-GRAM the predominant
1 2-GRAM predominant role
1 2-GRAM of protein
6 2-GRAM protein -
1 2-GRAM - isoprene
1 2-GRAM isoprene interaction
1 2-GRAM interaction in
1 2-GRAM in complex
1 2-GRAM complex formation
2 2-GRAM formation .
1 2-GRAM , neither
1 2-GRAM neither I
3 2-GRAM I .
1 2-GRAM . argentina
1 2-GRAM argentina nor
1 2-GRAM nor I
1 2-GRAM . theezans
1 2-GRAM theezans exerted
1 2-GRAM exerted any
2 2-GRAM any effect
1 2-GRAM on BF
1 2-GRAM BF or
1 2-GRAM or intestinal
1 2-GRAM intestinal propulsion
1 2-GRAM propulsion .
1 2-GRAM The region
1 2-GRAM region containing
1 2-GRAM containing both
1 2-GRAM both serines
1 2-GRAM serines is
1 2-GRAM is homologous
1 2-GRAM homologous to
1 2-GRAM terminal destruction
1 2-GRAM destruction box
2 2-GRAM box of
1 2-GRAM of IkappaBalpha
1 2-GRAM IkappaBalpha ,
5 2-GRAM , -
1 2-GRAM - beta
3 2-GRAM beta ,
1 2-GRAM and -
1 2-GRAM - epsilon
1 2-GRAM epsilon .
2 2-GRAM * No
1 2-GRAM No dominant
1 2-GRAM dominant clinical
1 2-GRAM clinical factor
1 2-GRAM of risk
1 2-GRAM risk was
7 2-GRAM was found
1 2-GRAM found ,
1 2-GRAM but multiple
1 2-GRAM multiple regression
2 2-GRAM regression analysis
1 2-GRAM analysis identified
1 2-GRAM identified age
2 2-GRAM age ,
1 2-GRAM , body
1 2-GRAM body surface
1 2-GRAM surface area
1 2-GRAM area ,
1 2-GRAM , valve
1 2-GRAM valve size
1 2-GRAM size ,
1 2-GRAM , shop
1 2-GRAM shop order
1 2-GRAM order fracture
1 2-GRAM fracture rate
1 2-GRAM rate ,
1 2-GRAM and manufacturing
1 2-GRAM manufacturing period
1 2-GRAM period as
1 2-GRAM as risk
2 2-GRAM risk factors
1 2-GRAM factors for
1 2-GRAM for OSF
1 2-GRAM OSF .
2 2-GRAM A novel
1 2-GRAM novel growth
1 2-GRAM growth -
1 2-GRAM related nuclear
1 2-GRAM nuclear protein
1 2-GRAM protein binds
1 2-GRAM binds and
1 2-GRAM and inhibits
1 2-GRAM inhibits rat
1 2-GRAM rat aldolase
1 2-GRAM aldolase B
1 2-GRAM B gene
2 2-GRAM * Northern
1 2-GRAM Northern blot
1 2-GRAM analysis revealed
1 2-GRAM that mlt
4 2-GRAM mlt 1
3 2-GRAM 1 is
1 2-GRAM is normally
1 2-GRAM normally expressed
5 2-GRAM expressed in
1 2-GRAM in brain
1 2-GRAM , spleen
1 2-GRAM spleen ,
1 2-GRAM , stom
1 2-GRAM stom ach
1 2-GRAM ach ,
2 2-GRAM and liver
1 2-GRAM liver .
1 2-GRAM * NO
1 2-GRAM NO metabolites
1 2-GRAM metabolites were
2 2-GRAM were determined
1 2-GRAM the measurement
2 2-GRAM measurement of
1 2-GRAM of nitrate
1 2-GRAM nitrate /
1 2-GRAM / nitrite
1 2-GRAM nitrite (
1 2-GRAM ( NOx
1 2-GRAM NOx ,
1 2-GRAM , micromol
2 2-GRAM / mmol
2 2-GRAM mmol creatinine
2 2-GRAM creatinine )
1 2-GRAM and cyclic
1 2-GRAM cyclic guanosine
1 2-GRAM guanosine monophosphate
1 2-GRAM monophosphate (
1 2-GRAM ( cGMP
1 2-GRAM cGMP ,
1 2-GRAM , nmol
1 2-GRAM nmol /
7 2-GRAM ) in
2 2-GRAM in plasma
1 2-GRAM plasma and
1 2-GRAM and urine
1 2-GRAM urine .
1 2-GRAM As a
1 2-GRAM a complement
1 2-GRAM complement to
1 2-GRAM to genome
1 2-GRAM genome -
1 2-GRAM - wide
1 2-GRAM wide mapping
1 2-GRAM mapping and
1 2-GRAM and sequencing
1 2-GRAM sequencing efforts
1 2-GRAM efforts ,
1 2-GRAM , it
1 2-GRAM it is
1 2-GRAM is often
1 2-GRAM often important
2 2-GRAM important to
3 2-GRAM to generate
1 2-GRAM generate detailed
1 2-GRAM detailed maps
1 2-GRAM maps and
1 2-GRAM and sequence
1 2-GRAM sequence data
1 2-GRAM data for
1 2-GRAM for specific
1 2-GRAM specific regions
2 2-GRAM of interest
1 2-GRAM interest .
1 2-GRAM The observed
1 2-GRAM observed phenotypes
1 2-GRAM phenotypes may
1 2-GRAM be explained
1 2-GRAM explained by
1 2-GRAM by (
2 2-GRAM ( i
1 2-GRAM i )
3 2-GRAM ) a
2 2-GRAM a selective
1 2-GRAM selective disruption
2 2-GRAM disruption of
2 2-GRAM of very
1 2-GRAM very -
1 2-GRAM - low
3 2-GRAM low -
2 2-GRAM - density
2 2-GRAM density lipoprotein
1 2-GRAM lipoprotein secretion
1 2-GRAM secretion due
3 2-GRAM due to
1 2-GRAM to decreased
1 2-GRAM decreased expression
4 2-GRAM of genes
1 2-GRAM genes encoding
1 2-GRAM encoding apolipoprotein
1 2-GRAM apolipoprotein B
1 2-GRAM B and
1 2-GRAM and microsomal
1 2-GRAM microsomal triglyceride
1 2-GRAM triglyceride transfer
3 2-GRAM transfer protein
1 2-GRAM , (
1 2-GRAM ( ii
1 2-GRAM ii )
1 2-GRAM ) an
1 2-GRAM in hepatic
1 2-GRAM hepatic cholesterol
1 2-GRAM cholesterol uptake
1 2-GRAM uptake due
1 2-GRAM to increased
1 2-GRAM increased expression
5 2-GRAM the major
1 2-GRAM major high
2 2-GRAM high -
1 2-GRAM lipoprotein receptor
2 2-GRAM receptor ,
1 2-GRAM , scavenger
1 2-GRAM scavenger receptor
1 2-GRAM receptor BI
1 2-GRAM BI ,
1 2-GRAM and (
1 2-GRAM ( iii
1 2-GRAM iii )
1 2-GRAM in bile
2 2-GRAM bile acid
1 2-GRAM acid uptake
1 2-GRAM uptake to
1 2-GRAM the liver
1 2-GRAM liver due
2 2-GRAM to down
3 2-GRAM down -
3 2-GRAM - regulation
12 2-GRAM regulation of
1 2-GRAM major basolateral
1 2-GRAM basolateral bile
1 2-GRAM acid transporters
1 2-GRAM transporters sodium
1 2-GRAM sodium taurocholate
1 2-GRAM taurocholate cotransporter
1 2-GRAM cotransporter protein
1 2-GRAM and organic
1 2-GRAM organic anion
1 2-GRAM anion transporter
1 2-GRAM transporter protein
2 2-GRAM protein 1
2 2-GRAM * Effects
2 2-GRAM Effects of
1 2-GRAM of aerosol
1 2-GRAM aerosol -
1 2-GRAM - vapor
1 2-GRAM vapor JP
1 2-GRAM JP -
7 2-GRAM - 8
1 2-GRAM 8 jet
1 2-GRAM jet fuel
1 2-GRAM fuel on
1 2-GRAM the functional
1 2-GRAM functional observational
1 2-GRAM observational battery
1 2-GRAM battery ,
1 2-GRAM and learning
1 2-GRAM learning and
1 2-GRAM and memory
1 2-GRAM memory in
4 2-GRAM the rat
1 2-GRAM rat .
1 2-GRAM In mouse
2 2-GRAM mouse ,
1 2-GRAM , Mmip1
1 2-GRAM Mmip1 (
1 2-GRAM ( Mad
1 2-GRAM Mad member
1 2-GRAM member interacting
1 2-GRAM interacting protein
1 2-GRAM and Smc3
1 2-GRAM Smc3 share
1 2-GRAM share 99
1 2-GRAM 99 %
1 2-GRAM % sequence
1 2-GRAM sequence identity
1 2-GRAM identity and
1 2-GRAM are products
1 2-GRAM products of
1 2-GRAM same gene
7 2-GRAM * To
1 2-GRAM To identify
2 2-GRAM identify the
1 2-GRAM important cis
2 2-GRAM cis -
1 2-GRAM - DNA
1 2-GRAM DNA regulatory
1 2-GRAM regulatory element
2 2-GRAM element (
1 2-GRAM ( s
1 2-GRAM s )
1 2-GRAM ) involved
3 2-GRAM involved in
2 2-GRAM the tissue
1 2-GRAM tissue -,
1 2-GRAM -, region
1 2-GRAM region -,
1 2-GRAM -, and
3 2-GRAM cell -
7 2-GRAM - specific
2 2-GRAM specific expression
1 2-GRAM the mE
1 2-GRAM mE -
1 2-GRAM - RABP
1 2-GRAM RABP gene
5 2-GRAM the 5
1 2-GRAM kb DNA
1 2-GRAM DNA fragment
1 2-GRAM fragment was
1 2-GRAM was sequenced
1 2-GRAM sequenced .
1 2-GRAM * Regional
1 2-GRAM Regional blood
1 2-GRAM blood blow
1 2-GRAM blow was
3 2-GRAM was measured
2 2-GRAM measured by
2 2-GRAM by means
2 2-GRAM means of
1 2-GRAM of microspheres
1 2-GRAM microspheres in
1 2-GRAM in predefined
1 2-GRAM predefined regions
1 2-GRAM the C6
1 2-GRAM C6 ,
1 2-GRAM , T11
1 2-GRAM T11 ,
1 2-GRAM and L6
1 2-GRAM L6 vertebrae
1 2-GRAM vertebrae .
1 2-GRAM * Breast
1 2-GRAM Breast cancer
1 2-GRAM cancer risk
1 2-GRAM risk assessment
1 2-GRAM assessment :
1 2-GRAM : Who
1 2-GRAM Who holds
1 2-GRAM holds the
1 2-GRAM the magic
1 2-GRAM magic crystal
1 2-GRAM crystal ball
1 2-GRAM ball ?
2 2-GRAM ? STOP
1 2-GRAM The frameshift
1 2-GRAM frameshift initiated
2 2-GRAM initiated by
1 2-GRAM by ADEx2
1 2-GRAM ADEx2 is
1 2-GRAM is believed
1 2-GRAM believed to
1 2-GRAM to alter
1 2-GRAM alter the
1 2-GRAM the regular
1 2-GRAM regular coding
1 2-GRAM coding sequence
2 2-GRAM sequence ,
1 2-GRAM , acting
1 2-GRAM acting as
1 2-GRAM a loss
1 2-GRAM loss -
1 2-GRAM - of
1 2-GRAM of -
1 2-GRAM - function
1 2-GRAM function ASIP
1 2-GRAM ASIP mutation
1 2-GRAM mutation .
7 2-GRAM * CONCLUSIONS
7 2-GRAM CONCLUSIONS :
1 2-GRAM : Adding
1 2-GRAM Adding MMF
1 2-GRAM MMF ,
1 2-GRAM a potent
1 2-GRAM potent topical
1 2-GRAM topical corticosteroid
1 2-GRAM corticosteroid ,
1 2-GRAM , to
2 2-GRAM to an
1 2-GRAM an emollient
2 2-GRAM emollient cream
1 2-GRAM cream is
1 2-GRAM is statistically
1 2-GRAM statistically significantly
1 2-GRAM significantly more
1 2-GRAM more effective
1 2-GRAM effective than
1 2-GRAM than emollient
1 2-GRAM cream alone
1 2-GRAM alone in
1 2-GRAM in reducing
1 2-GRAM reducing acute
1 2-GRAM acute radiation
1 2-GRAM radiation dermatitis
1 2-GRAM dermatitis .
1 2-GRAM : Although
1 2-GRAM Although the
2 2-GRAM the levels
8 2-GRAM levels of
1 2-GRAM of oxLDL
1 2-GRAM oxLDL antibodies
1 2-GRAM antibodies might
1 2-GRAM might be
1 2-GRAM be modified
1 2-GRAM modified in
2 2-GRAM in early
1 2-GRAM early hypertension
1 2-GRAM hypertension ,
1 2-GRAM , once
1 2-GRAM once advanced
1 2-GRAM advanced coronary
3 2-GRAM coronary artery
2 2-GRAM artery disease
1 2-GRAM disease has
1 2-GRAM has developed
1 2-GRAM developed the
1 2-GRAM the presence
1 2-GRAM of hypertension
1 2-GRAM hypertension does
4 2-GRAM does not
2 2-GRAM not affect
1 2-GRAM affect anti
5 2-GRAM anti -
1 2-GRAM - oxLDL
1 2-GRAM oxLDL levels
2 2-GRAM levels .
1 2-GRAM an application
1 2-GRAM of reverse
1 2-GRAM reverse genetics
1 2-GRAM genetics ,
1 2-GRAM we introduced
1 2-GRAM introduced one
1 2-GRAM one nucleotide
1 2-GRAM nucleotide change
2 2-GRAM change (
1 2-GRAM ( UCU
1 2-GRAM UCU to
1 2-GRAM to ACU
1 2-GRAM ACU )
2 2-GRAM ) to
1 2-GRAM to immediate
1 2-GRAM immediate downstream
1 2-GRAM downstream of
1 2-GRAM the RNA
1 2-GRAM - editing
1 2-GRAM editing site
2 2-GRAM site of
1 2-GRAM the V
1 2-GRAM V gene
3 2-GRAM gene in
1 2-GRAM the full
1 2-GRAM length hPIV2
1 2-GRAM hPIV2 cDNA
1 2-GRAM cDNA and
1 2-GRAM and were
1 2-GRAM were able
1 2-GRAM able to
1 2-GRAM to obtain
1 2-GRAM obtain infectious
1 2-GRAM infectious viruses
1 2-GRAM viruses [
1 2-GRAM [ rPIV2V
1 2-GRAM rPIV2V (-)]
1 2-GRAM (-)] from
1 2-GRAM the cDNA
1 2-GRAM cDNA .
1 2-GRAM At both
1 2-GRAM both companies
1 2-GRAM companies sites
1 2-GRAM sites Salmonella
1 2-GRAM Salmonella enteritidis
1 2-GRAM enteritidis and
1 2-GRAM and Salmonella
1 2-GRAM Salmonella typhimurium
1 2-GRAM typhimurium Tr104
1 2-GRAM Tr104 were
2 2-GRAM were also
1 2-GRAM also isolated
1 2-GRAM isolated occasionally
1 2-GRAM occasionally from
1 2-GRAM from various
1 2-GRAM various locations
1 2-GRAM locations .
2 2-GRAM * Most
1 2-GRAM Most yeast
1 2-GRAM yeast peroxisomal
1 2-GRAM peroxisomal matrix
1 2-GRAM matrix proteins
1 2-GRAM proteins contain
2 2-GRAM contain a
1 2-GRAM a type
1 2-GRAM type 1C
1 2-GRAM 1C -
1 2-GRAM terminal peroxisomal
1 2-GRAM peroxisomal targeting
1 2-GRAM targeting signal
1 2-GRAM signal (
1 2-GRAM ( PTS1
1 2-GRAM PTS1 )
1 2-GRAM ) consisting
2 2-GRAM consisting of
1 2-GRAM the tripeptide
1 2-GRAM tripeptide SKL
1 2-GRAM SKL or
1 2-GRAM or a
1 2-GRAM a conservative
1 2-GRAM conservative variant
1 2-GRAM variant thereof
1 2-GRAM thereof .
2 2-GRAM * Tumor
1 2-GRAM Tumor -
3 2-GRAM - like
1 2-GRAM like accumulation
1 2-GRAM accumulation on
1 2-GRAM on Tl
1 2-GRAM Tl -
1 2-GRAM - 201
1 2-GRAM 201 SPECT
1 2-GRAM SPECT in
1 2-GRAM in subacute
1 2-GRAM subacute hemorrhagic
1 2-GRAM hemorrhagic cerebral
1 2-GRAM cerebral infarction
1 2-GRAM infarction .
1 2-GRAM * WRN
1 2-GRAM WRN helicase
1 2-GRAM helicase resolves
1 2-GRAM resolves alternate
1 2-GRAM alternate DNA
1 2-GRAM DNA structures
1 2-GRAM structures including
1 2-GRAM including tetraplex
1 2-GRAM tetraplex and
1 2-GRAM and triplex
1 2-GRAM triplex DNA
2 2-GRAM DNA ,
1 2-GRAM and Holliday
1 2-GRAM Holliday junctions
1 2-GRAM junctions .
1 2-GRAM The increase
1 2-GRAM in number
1 2-GRAM number of
1 2-GRAM of terminal
1 2-GRAM terminal hairs
1 2-GRAM hairs ,
6 2-GRAM which are
1 2-GRAM are defined
2 2-GRAM defined as
1 2-GRAM as hairs
1 2-GRAM hairs more
3 2-GRAM more than
1 2-GRAM than 60
1 2-GRAM 60 microm
1 2-GRAM microm in
1 2-GRAM in diameter
1 2-GRAM diameter ,
1 2-GRAM the designated
1 2-GRAM designated area
1 2-GRAM area (
1 2-GRAM 5 cm
1 2-GRAM cm square
1 2-GRAM square =
4 2-GRAM . 25
3 2-GRAM 25 cm2
1 2-GRAM cm2 area
1 2-GRAM area )
1 2-GRAM the procyanidin
2 2-GRAM procyanidin B
1 2-GRAM 2 group
2 2-GRAM group subjects
1 2-GRAM subjects after
1 2-GRAM after the
1 2-GRAM the 6
1 2-GRAM - month
1 2-GRAM month trial
1 2-GRAM trial was
2 2-GRAM was significantly
1 2-GRAM significantly greater
1 2-GRAM greater than
2 2-GRAM than that
1 2-GRAM the placebo
1 2-GRAM placebo control
1 2-GRAM control group
1 2-GRAM subjects (
1 2-GRAM ( procyanidin
8 2-GRAM 2 ,
1 2-GRAM . 99
1 2-GRAM 99 +/-
1 2-GRAM +/- 2
2 2-GRAM . 58
1 2-GRAM 58 (
2 2-GRAM ( mean
2 2-GRAM mean +/-
2 2-GRAM +/- SD
2 2-GRAM SD )/
2 2-GRAM )/ 0
2 2-GRAM cm2 ;
1 2-GRAM ; placebo
1 2-GRAM placebo ,
4 2-GRAM - 0
1 2-GRAM . 82
1 2-GRAM 82 +/-
1 2-GRAM +/- 3
2 2-GRAM . 40
1 2-GRAM 40 (
1 2-GRAM ; P
1 2-GRAM . 02
1 2-GRAM 02 ,
1 2-GRAM , two
1 2-GRAM - sample
1 2-GRAM sample t
1 2-GRAM t test
1 2-GRAM test ).
1 2-GRAM * SKP1
1 2-GRAM SKP1 -
1 2-GRAM - SnRK
1 2-GRAM SnRK protein
7 2-GRAM protein kinase
1 2-GRAM kinase interactions
1 2-GRAM interactions mediate
1 2-GRAM mediate proteasomal
1 2-GRAM proteasomal binding
4 2-GRAM binding of
2 2-GRAM a plant
1 2-GRAM plant SCF
1 2-GRAM SCF ubiquitin
1 2-GRAM ubiquitin ligase
1 2-GRAM ligase .
1 2-GRAM * Based
1 2-GRAM Based on
2 2-GRAM the hypothesis
2 2-GRAM hypothesis that
1 2-GRAM that evolutionarily
1 2-GRAM evolutionarily conserved
2 2-GRAM conserved regions
1 2-GRAM regions are
1 2-GRAM are functionally
1 2-GRAM functionally important
1 2-GRAM important and
1 2-GRAM and likely
1 2-GRAM likely to
2 2-GRAM to interact
1 2-GRAM interact with
1 2-GRAM with coactivators
1 2-GRAM coactivators ,
2 2-GRAM we compared
2 2-GRAM compared the
1 2-GRAM the amino
4 2-GRAM amino acid
1 2-GRAM acid sequence
2 2-GRAM sequence of
2 2-GRAM of C
7 2-GRAM C /
1 2-GRAM / EBPalpha
1 2-GRAM EBPalpha from
1 2-GRAM from different
1 2-GRAM different species
1 2-GRAM species (
1 2-GRAM ( frog
1 2-GRAM frog to
1 2-GRAM to human
1 2-GRAM human )
1 2-GRAM identified four
1 2-GRAM four highly
1 2-GRAM highly conserved
1 2-GRAM regions (
1 2-GRAM ( CR1
1 2-GRAM CR1 -
1 2-GRAM - CR4
1 2-GRAM CR4 )
1 2-GRAM ) within
1 2-GRAM the transactivation
1 2-GRAM transactivation domain
2 2-GRAM domain .
1 2-GRAM * Colorectal
1 2-GRAM Colorectal cancer
1 2-GRAM cancer was
2 2-GRAM was shown
1 2-GRAM to disproportionately
1 2-GRAM disproportionately overburden
1 2-GRAM overburden Ashkenazi
1 2-GRAM Ashkenazi Jews
1 2-GRAM Jews ,
1 2-GRAM , who
1 2-GRAM who may
1 2-GRAM may also
2 2-GRAM also be
1 2-GRAM be at
1 2-GRAM at increased
1 2-GRAM increased risk
1 2-GRAM risk for
1 2-GRAM for ovarian
1 2-GRAM ovarian ,
1 2-GRAM , pancreatic
1 2-GRAM pancreatic and
1 2-GRAM and stomach
1 2-GRAM stomach cancer
3 2-GRAM cancer ,
1 2-GRAM and non
1 2-GRAM - Hodgkin
1 2-GRAM Hodgkin '
1 2-GRAM s lymphoma
1 2-GRAM lymphoma .
1 2-GRAM * Percentages
1 2-GRAM Percentages of
1 2-GRAM of recovery
1 2-GRAM recovery for
1 2-GRAM for overload
1 2-GRAM overload and
1 2-GRAM and dilution
1 2-GRAM dilution tests
2 2-GRAM tests were
1 2-GRAM were between
1 2-GRAM between 87
1 2-GRAM 87 and
1 2-GRAM and 120
1 2-GRAM 120 %.
2 2-GRAM %. STOP
1 2-GRAM This shows
1 2-GRAM shows that
1 2-GRAM in situations
1 2-GRAM situations of
1 2-GRAM of separated
1 2-GRAM separated breaks
1 2-GRAM breaks ,
1 2-GRAM , NHEJ
1 2-GRAM NHEJ deficiency
1 2-GRAM deficiency leads
3 2-GRAM leads to
1 2-GRAM to genomic
1 2-GRAM genomic rearrangements
1 2-GRAM rearrangements ,
1 2-GRAM in agreement
1 2-GRAM agreement with
1 2-GRAM with chromosomal
1 2-GRAM chromosomal studies
2 2-GRAM studies .
1 2-GRAM 2001 S
1 2-GRAM * After
1 2-GRAM After nerve
1 2-GRAM nerve injury
1 2-GRAM injury ,
1 2-GRAM the nociceptive
1 2-GRAM nociceptive responses
1 2-GRAM responses through
1 2-GRAM through type
1 2-GRAM type I
1 2-GRAM I neurons
1 2-GRAM neurons ,
2 2-GRAM are polymodal
2 2-GRAM polymodal C
3 2-GRAM - fibers
2 2-GRAM fibers and
3 2-GRAM and drive
1 2-GRAM drive NK1
1 2-GRAM NK1 -
2 2-GRAM - receptor
2 2-GRAM receptor mechanisms
1 2-GRAM mechanisms in
1 2-GRAM in spinal
1 2-GRAM spinal pain
1 2-GRAM pain transmission
1 2-GRAM transmission ,
3 2-GRAM , were
1 2-GRAM were completely
1 2-GRAM completely lost
1 2-GRAM lost ,
1 2-GRAM but without
1 2-GRAM without changes
5 2-GRAM changes in
1 2-GRAM in type
1 2-GRAM type II
1 2-GRAM II ones
2 2-GRAM ones ,
2 2-GRAM drive NMDA
1 2-GRAM NMDA receptor
4 2-GRAM receptor -
1 2-GRAM - mechanisms
1 2-GRAM while type
1 2-GRAM type III
1 2-GRAM III ones
1 2-GRAM are capsaicin
1 2-GRAM capsaicin -
1 2-GRAM - insensitive
1 2-GRAM insensitive (
1 2-GRAM ( possibly
1 2-GRAM possibly A
1 2-GRAM A -
1 2-GRAM fibers )
1 2-GRAM NMDA -
1 2-GRAM were markedly
1 2-GRAM markedly enhanced
1 2-GRAM enhanced .
1 2-GRAM * SV1
1 2-GRAM SV1 has
3 2-GRAM has a
1 2-GRAM a 33
1 2-GRAM 33 -
1 2-GRAM acid insert
1 2-GRAM insert in
1 2-GRAM the S1
1 2-GRAM S1 transmembrane
1 2-GRAM transmembrane domain
1 2-GRAM domain that
1 2-GRAM that does
1 2-GRAM not alter
1 2-GRAM alter S1
1 2-GRAM S1 overall
1 2-GRAM overall hydrophobicity
1 2-GRAM hydrophobicity ,
1 2-GRAM but makes
1 2-GRAM makes the
1 2-GRAM the S0
1 2-GRAM S0 -
1 2-GRAM - S1
1 2-GRAM S1 linker
1 2-GRAM linker longer
1 2-GRAM longer .
1 2-GRAM A variety
2 2-GRAM variety of
2 2-GRAM of receptor
1 2-GRAM mediated signaling
1 2-GRAM signaling pathways
1 2-GRAM pathways are
1 2-GRAM are controlled
1 2-GRAM controlled by
1 2-GRAM by both
2 2-GRAM both positive
1 2-GRAM positive and
2 2-GRAM and negative
1 2-GRAM negative extracellular
1 2-GRAM extracellular regulators
1 2-GRAM regulators .
1 2-GRAM A 20
2 2-GRAM 20 -
2 2-GRAM - base
2 2-GRAM base pair
1 2-GRAM pair oligonucleotide
1 2-GRAM oligonucleotide containing
1 2-GRAM containing this
1 2-GRAM this nonamer
1 2-GRAM nonamer confers
1 2-GRAM confers up
2 2-GRAM up -
2 2-GRAM regulation by
1 2-GRAM by hypoxia
1 2-GRAM hypoxia and
1 2-GRAM and inhibition
1 2-GRAM inhibition by
1 2-GRAM by unsaturated
1 2-GRAM unsaturated fatty
2 2-GRAM fatty acids
1 2-GRAM acids when
2 2-GRAM when placed
1 2-GRAM placed upstream
3 2-GRAM upstream of
2 2-GRAM a heterologous
2 2-GRAM heterologous promoter
3 2-GRAM promoter in
1 2-GRAM a lacZ
1 2-GRAM lacZ reporter
1 2-GRAM reporter construct
1 2-GRAM construct .
1 2-GRAM that D
2 2-GRAM D (
1 2-GRAM ( 4
5 2-GRAM 4 )
1 2-GRAM and D
1 2-GRAM ( 2L
1 2-GRAM 2L )
1 2-GRAM ) receptors
1 2-GRAM receptors activate
2 2-GRAM activate the
1 2-GRAM the ERK
3 2-GRAM ERK kinase
2 2-GRAM kinase cascade
1 2-GRAM cascade by
1 2-GRAM by first
1 2-GRAM first mobilizing
1 2-GRAM mobilizing signaling
1 2-GRAM signaling by
1 2-GRAM the PDGF
1 2-GRAM PDGF receptor
1 2-GRAM , followed
2 2-GRAM followed by
1 2-GRAM the subsequent
1 2-GRAM subsequent activation
1 2-GRAM of ERK1
1 2-GRAM ERK1 /
2 2-GRAM / 2
1 2-GRAM 2 by
1 2-GRAM by pathways
1 2-GRAM pathways associated
1 2-GRAM with this
1 2-GRAM this receptor
2 2-GRAM receptor tyrosine
3 2-GRAM kinase .
1 2-GRAM * Raes
1 2-GRAM Raes ,
2 2-GRAM P .
2 2-GRAM the differential
1 2-GRAM differential screening
1 2-GRAM screening techniques
1 2-GRAM techniques in
1 2-GRAM in terms
1 2-GRAM terms of
1 2-GRAM sensitivity ,
1 2-GRAM , efficiency
1 2-GRAM efficiency and
1 2-GRAM and occurrence
1 2-GRAM occurrence of
1 2-GRAM of false
1 2-GRAM false positives
1 2-GRAM positives .
1 2-GRAM * C
1 2-GRAM / EBPbeta
1 2-GRAM EBPbeta LIP
1 2-GRAM LIP overexpressing
1 2-GRAM overexpressing HC11
1 2-GRAM HC11 cells
1 2-GRAM cells did
12 2-GRAM did not
1 2-GRAM not express
1 2-GRAM express beta
1 2-GRAM - casein
1 2-GRAM casein mRNA
1 2-GRAM mRNA (
1 2-GRAM ( mammary
1 2-GRAM mammary epithelial
1 2-GRAM epithelial cell
1 2-GRAM cell differentiation
1 2-GRAM differentiation marker
1 2-GRAM marker )
6 2-GRAM in response
6 2-GRAM response to
1 2-GRAM to lactogenic
1 2-GRAM lactogenic hormones
1 2-GRAM hormones .
1 2-GRAM * NF
1 2-GRAM kappaB is
1 2-GRAM is involved
2 2-GRAM the regulation
1 2-GRAM of CD154
1 2-GRAM CD154 (
1 2-GRAM ( CD40
1 2-GRAM CD40 ligand
1 2-GRAM ligand )
1 2-GRAM ) expression
2 2-GRAM in primary
1 2-GRAM primary human
1 2-GRAM T cells
1 2-GRAM * Subacute
1 2-GRAM Subacute diencephalic
1 2-GRAM diencephalic angioencephalopathy
1 2-GRAM angioencephalopathy (
1 2-GRAM ( SDAE
1 2-GRAM SDAE )
1 2-GRAM a rare
1 2-GRAM rare and
1 2-GRAM and fatal
1 2-GRAM fatal disease
1 2-GRAM disease of
2 2-GRAM of unknown
1 2-GRAM unknown etiology
1 2-GRAM etiology that
2 2-GRAM that involves
2 2-GRAM involves the
1 2-GRAM the thalami
1 2-GRAM thalami bilaterally
1 2-GRAM bilaterally .
2 2-GRAM * NGF
1 2-GRAM NGF elicits
1 2-GRAM elicits a
2 2-GRAM a more
1 2-GRAM more delayed
1 2-GRAM delayed and
2 2-GRAM and sustained
2 2-GRAM sustained ERK
1 2-GRAM ERK phosphorylation
1 2-GRAM phosphorylation than
1 2-GRAM than EGF
2 2-GRAM EGF ,
1 2-GRAM with previous
1 2-GRAM previous reports
1 2-GRAM reports .
1 2-GRAM * TBARS
1 2-GRAM TBARS levels
1 2-GRAM , oxygen
1 2-GRAM oxygen -
1 2-GRAM - radical
1 2-GRAM radical absorbing
1 2-GRAM absorbing capacity
1 2-GRAM capacity assay
1 2-GRAM assay and
1 2-GRAM and AFR
1 2-GRAM AFR release
1 2-GRAM release assessed
2 2-GRAM assessed by
1 2-GRAM by electron
1 2-GRAM electron paramagnetic
1 2-GRAM paramagnetic resonance
3 2-GRAM resonance (
1 2-GRAM ( EPR
1 2-GRAM EPR )
1 2-GRAM were used
3 2-GRAM used to
2 2-GRAM to explore
2 2-GRAM explore the
1 2-GRAM the existence
1 2-GRAM existence of
1 2-GRAM of oxidative
1 2-GRAM oxidative stress
1 2-GRAM stress in
2 2-GRAM in diabetes
2 2-GRAM diabetes .
1 2-GRAM * Pulmonary
1 2-GRAM Pulmonary vein
1 2-GRAM vein varix
1 2-GRAM varix in
1 2-GRAM in association
2 2-GRAM association with
1 2-GRAM with bilateral
1 2-GRAM bilateral pulmonary
1 2-GRAM pulmonary vein
1 2-GRAM vein stenosis
1 2-GRAM stenosis .
1 2-GRAM * Derivation
1 2-GRAM Derivation and
2 2-GRAM and initial
1 2-GRAM initial characterization
2 2-GRAM a mouse
1 2-GRAM mouse mammary
1 2-GRAM mammary tumor
1 2-GRAM tumor cell
1 2-GRAM line carrying
2 2-GRAM carrying the
1 2-GRAM the polyomavirus
1 2-GRAM polyomavirus middle
1 2-GRAM middle T
2 2-GRAM T antigen
1 2-GRAM antigen :
1 2-GRAM : utility
1 2-GRAM utility in
3 2-GRAM the development
1 2-GRAM of novel
1 2-GRAM novel cancer
1 2-GRAM cancer therapeutics
1 2-GRAM therapeutics .
1 2-GRAM The images
1 2-GRAM images showed
1 2-GRAM showed rapid
1 2-GRAM rapid ,
1 2-GRAM , predominantly
1 2-GRAM predominantly urinary
1 2-GRAM urinary excretion
1 2-GRAM excretion of
1 2-GRAM of 99mTc
1 2-GRAM 99mTc ciprofloxacin
1 2-GRAM ciprofloxacin ,
3 2-GRAM with low
1 2-GRAM low to
1 2-GRAM to absent
1 2-GRAM absent brain
1 2-GRAM , lung
1 2-GRAM lung and
1 2-GRAM and bone
1 2-GRAM bone marrow
1 2-GRAM marrow uptake
2 2-GRAM uptake and
1 2-GRAM and low
1 2-GRAM low liver
1 2-GRAM liver uptake
1 2-GRAM and excretion
1 2-GRAM excretion .
1 2-GRAM the anti
1 2-GRAM - interferon
1 2-GRAM interferon functions
1 2-GRAM functions of
1 2-GRAM of vIRF
1 2-GRAM vIRF -
1 2-GRAM 2 may
1 2-GRAM may contribute
1 2-GRAM contribute to
1 2-GRAM the establishment
1 2-GRAM establishment of
1 2-GRAM a chronic
1 2-GRAM chronic or
1 2-GRAM or latent
1 2-GRAM latent infection
2 2-GRAM infection .
1 2-GRAM * Topological
1 2-GRAM Topological and
1 2-GRAM and mutational
1 2-GRAM mutational analysis
1 2-GRAM of Saccharomyces
1 2-GRAM cerevisiae Ste14p
1 2-GRAM Ste14p ,
1 2-GRAM , founding
1 2-GRAM founding member
1 2-GRAM the isoprenylcysteine
1 2-GRAM isoprenylcysteine carboxyl
1 2-GRAM carboxyl methyltransferase
1 2-GRAM methyltransferase family
3 2-GRAM * Two
1 2-GRAM Two remotely
1 2-GRAM remotely situated
1 2-GRAM situated exons
1 2-GRAM exons within
1 2-GRAM the complement
1 2-GRAM complement C3
1 2-GRAM C3 gene
1 2-GRAM gene locus
1 2-GRAM locus encode
1 2-GRAM encode an
1 2-GRAM an alternate
1 2-GRAM alternate 5
2 2-GRAM ' end
1 2-GRAM end and
1 2-GRAM and proximal
1 2-GRAM proximal ORF
1 2-GRAM ORF under
3 2-GRAM under the
4 2-GRAM the control
3 2-GRAM control of
1 2-GRAM a bidirectional
1 2-GRAM bidirectional promoter
2 2-GRAM * Although
1 2-GRAM Although there
1 2-GRAM there was
1 2-GRAM a high
1 2-GRAM high correlation
1 2-GRAM between sap
2 2-GRAM sap flux
2 2-GRAM flux densities
1 2-GRAM densities registered
1 2-GRAM registered by
1 2-GRAM the old
1 2-GRAM old and
1 2-GRAM and new
1 2-GRAM new sensors
1 2-GRAM sensors ,
1 2-GRAM , significant
3 2-GRAM significant differences
4 2-GRAM differences in
1 2-GRAM in sap
1 2-GRAM densities between
6 2-GRAM between the
1 2-GRAM duplicated sensors
1 2-GRAM sensors were
1 2-GRAM were detected
1 2-GRAM detected .
1 2-GRAM * Their
1 2-GRAM Their numbers
1 2-GRAM numbers have
1 2-GRAM have regularly
1 2-GRAM regularly increased
1 2-GRAM increased since
1 2-GRAM since the
1 2-GRAM the mid
1 2-GRAM mid -
1 2-GRAM - 1970s
1 2-GRAM 1970s .
1 2-GRAM The hcKrox
1 2-GRAM hcKrox gene
1 2-GRAM family regulates
1 2-GRAM regulates multiple
1 2-GRAM multiple extracellular
1 2-GRAM extracellular matrix
1 2-GRAM matrix genes
4 2-GRAM genes .
1 2-GRAM * NB
1 2-GRAM NB -
1 2-GRAM - 506
1 2-GRAM 506 completely
1 2-GRAM completely inhibits
1 2-GRAM capacity of
1 2-GRAM of topoisomerase
1 2-GRAM topoisomerase I
1 2-GRAM I to
1 2-GRAM to phosphorylate
1 2-GRAM phosphorylate ,
1 2-GRAM vitro ,
6 2-GRAM the human
1 2-GRAM human splicing
3 2-GRAM splicing factor
1 2-GRAM factor 2
1 2-GRAM 2 /
1 2-GRAM / alternative
1 2-GRAM alternative splicing
6 2-GRAM factor (
1 2-GRAM ( SF2
1 2-GRAM SF2 /
1 2-GRAM / ASF
1 2-GRAM ASF ).
2 2-GRAM * Recent
1 2-GRAM Recent studies
1 2-GRAM studies using
1 2-GRAM using isolated
1 2-GRAM isolated rat
1 2-GRAM rat adipocytes
1 2-GRAM adipocytes and
1 2-GRAM and chemically
1 2-GRAM chemically synthesized
1 2-GRAM synthesized PIG
1 2-GRAM PIG compounds
1 2-GRAM compounds point
1 2-GRAM point to
1 2-GRAM to IRS1
1 2-GRAM IRS1 /
1 2-GRAM 3 tyrosine
2 2-GRAM tyrosine phosphorylation
2 2-GRAM phosphorylation by
1 2-GRAM by p59Lyn
1 2-GRAM p59Lyn kinase
1 2-GRAM kinase as
9 2-GRAM as the
1 2-GRAM the site
1 2-GRAM of cross
2 2-GRAM cross -
1 2-GRAM - talk
1 2-GRAM talk ,
3 2-GRAM negative regulation
3 2-GRAM of which
1 2-GRAM which by
2 2-GRAM by interaction
3 2-GRAM interaction with
1 2-GRAM with caveolin
1 2-GRAM caveolin is
1 2-GRAM is apparently
1 2-GRAM apparently abrogated
1 2-GRAM abrogated by
1 2-GRAM by PIG
1 2-GRAM PIG .
2 2-GRAM To investigate
1 2-GRAM the effects
3 2-GRAM effects of
1 2-GRAM of exogenous
1 2-GRAM exogenous hyaluronic
1 2-GRAM hyaluronic acid
1 2-GRAM acid ,
1 2-GRAM of port
1 2-GRAM port -
1 2-GRAM site metastasis
1 2-GRAM metastasis was
1 2-GRAM was examined
1 2-GRAM examined using
1 2-GRAM using mouse
1 2-GRAM mouse adenocarcinoma
1 2-GRAM adenocarcinoma cell
2 2-GRAM - line
1 2-GRAM line colon
1 2-GRAM colon 26
1 2-GRAM 26 cells
8 2-GRAM * METHODS
8 2-GRAM METHODS :
1 2-GRAM : Thyroid
1 2-GRAM Thyroid status
1 2-GRAM status was
1 2-GRAM measured at
2 2-GRAM at baseline
1 2-GRAM baseline (
1 2-GRAM ( 1990
1 2-GRAM 1990 -
1 2-GRAM - 93
1 2-GRAM 93 ),
1 2-GRAM ), through
1 2-GRAM through assessment
1 2-GRAM assessment of
1 2-GRAM serum antibodies
1 2-GRAM antibodies to
1 2-GRAM to thyroid
1 2-GRAM thyroid peroxidase
1 2-GRAM peroxidase (
1 2-GRAM ( TPO
1 2-GRAM TPO -
1 2-GRAM - Abs
1 2-GRAM Abs ,
1 2-GRAM , positive
1 2-GRAM positive :
1 2-GRAM : >
1 2-GRAM > 10
1 2-GRAM 10 IU
1 2-GRAM IU /
5 2-GRAM / ml
3 2-GRAM ml ),
3 2-GRAM ), serum
1 2-GRAM serum TSH
1 2-GRAM TSH levels
1 2-GRAM and when
1 2-GRAM when TSH
1 2-GRAM TSH was
1 2-GRAM was abnormal
1 2-GRAM abnormal (<
1 2-GRAM (< 0
1 2-GRAM 4 or
1 2-GRAM or >
2 2-GRAM > 4
2 2-GRAM 4 .
1 2-GRAM 0 mU
1 2-GRAM mU /
2 2-GRAM / l
1 2-GRAM l ),
1 2-GRAM serum thyroxin
1 2-GRAM thyroxin levels
1 2-GRAM levels (
1 2-GRAM ( T4
1 2-GRAM T4 ).
1 2-GRAM * Mechanical
1 2-GRAM Mechanical ventilation
1 2-GRAM ventilation in
1 2-GRAM in control
1 2-GRAM control lungs
1 2-GRAM lungs produced
1 2-GRAM produced a
1 2-GRAM a 47
1 2-GRAM 47 %
1 2-GRAM % decrease
1 2-GRAM in chord
1 2-GRAM chord compliance
1 2-GRAM compliance ,
5 2-GRAM , an
1 2-GRAM in lung
1 2-GRAM lung lavage
1 2-GRAM lavage levels
1 2-GRAM of tumor
2 2-GRAM tumor necrosis
2 2-GRAM necrosis factor
2 2-GRAM ( TNF
1 2-GRAM TNF )-
1 2-GRAM )- alpha
1 2-GRAM alpha (
1 2-GRAM ( 722
1 2-GRAM 722 +/-
1 2-GRAM +/- 306
1 2-GRAM 306 pg
4 2-GRAM pg /
1 2-GRAM ), interleukin
1 2-GRAM interleukin (
1 2-GRAM ( IL
1 2-GRAM IL )-
1 2-GRAM )- 1beta
1 2-GRAM 1beta (
1 2-GRAM ( 902
1 2-GRAM 902 +/-
1 2-GRAM +/- 322
1 2-GRAM 322 pg
2 2-GRAM ), and
1 2-GRAM and macrophage
2 2-GRAM macrophage inflammatory
2 2-GRAM inflammatory protein
2 2-GRAM 2 (
1 2-GRAM ( MIP
1 2-GRAM MIP -
8 2-GRAM 2 )
1 2-GRAM ) (
1 2-GRAM ( 363
1 2-GRAM 363 +/-
1 2-GRAM +/- 104
1 2-GRAM 104 pg
1 2-GRAM ml )
2 2-GRAM ) as
2 2-GRAM as compared
5 2-GRAM compared with
1 2-GRAM low levels
1 2-GRAM of cytokines
1 2-GRAM cytokines detected
1 2-GRAM detected in
1 2-GRAM in preventilation
1 2-GRAM preventilation data
1 2-GRAM and no
1 2-GRAM no change
1 2-GRAM in percentage
3 2-GRAM percentage of
1 2-GRAM of surfactant
1 2-GRAM surfactant large
1 2-GRAM large aggregates
1 2-GRAM aggregates (
1 2-GRAM ( LA
1 2-GRAM LA ).
1 2-GRAM * Autoregulation
1 2-GRAM Autoregulation enables
1 2-GRAM enables different
1 2-GRAM different pathways
1 2-GRAM pathways to
2 2-GRAM to control
1 2-GRAM control CCAAT
1 2-GRAM CCAAT /
1 2-GRAM / enhancer
1 2-GRAM enhancer binding
4 2-GRAM binding protein
1 2-GRAM protein beta
2 2-GRAM beta (
2 2-GRAM ( C
5 2-GRAM / EBP
2 2-GRAM EBP beta
1 2-GRAM beta )
1 2-GRAM ) transcription
1 2-GRAM transcription .
1 2-GRAM the past
1 2-GRAM past decade
1 2-GRAM decade ,
1 2-GRAM , there
1 2-GRAM there have
1 2-GRAM been enormous
1 2-GRAM enormous advances
1 2-GRAM advances in
1 2-GRAM of Bayesian
1 2-GRAM Bayesian methodology
1 2-GRAM methodology for
1 2-GRAM for analysis
1 2-GRAM of epidemiologic
1 2-GRAM epidemiologic data
1 2-GRAM and there
1 2-GRAM are now
1 2-GRAM now many
1 2-GRAM many practical
1 2-GRAM practical advantages
1 2-GRAM advantages to
1 2-GRAM the Bayesian
1 2-GRAM Bayesian approach
1 2-GRAM approach .
1 2-GRAM In strains
1 2-GRAM strains lacking
1 2-GRAM lacking tup11
1 2-GRAM tup11 and
1 2-GRAM and tup12
1 2-GRAM tup12 ,
1 2-GRAM the atf1
1 2-GRAM atf1 -
1 2-GRAM - pcr1
1 2-GRAM pcr1 transcriptional
1 2-GRAM transcriptional activator
1 2-GRAM activator continues
1 2-GRAM continues to
1 2-GRAM a central
1 2-GRAM central role
1 2-GRAM in fbp1
1 2-GRAM fbp1 -
1 2-GRAM - lacZ
1 2-GRAM lacZ expression
1 2-GRAM expression ;
1 2-GRAM ; however
3 2-GRAM however ,
1 2-GRAM , spc1
1 2-GRAM spc1 MAPK
1 2-GRAM MAPK phosphorylation
1 2-GRAM of atf1
1 2-GRAM atf1 is
1 2-GRAM is no
1 2-GRAM no longer
1 2-GRAM longer essential
3 2-GRAM essential for
1 2-GRAM for its
2 2-GRAM its activation
1 2-GRAM * Single
1 2-GRAM Single amino
1 2-GRAM acid substitutions
1 2-GRAM substitutions at
1 2-GRAM the acyl
2 2-GRAM acyl -
5 2-GRAM - CoA
2 2-GRAM CoA -
2 2-GRAM binding domain
1 2-GRAM domain interrupt
1 2-GRAM interrupt 14
1 2-GRAM 14 [
1 2-GRAM [ C
1 2-GRAM C ]
1 2-GRAM ] palmitoyl
1 2-GRAM palmitoyl -
1 2-GRAM CoA binding
1 2-GRAM of ACBP2
1 2-GRAM ACBP2 ,
1 2-GRAM an Arabidopsis
1 2-GRAM Arabidopsis acyl
1 2-GRAM with ankyrin
1 2-GRAM ankyrin repeats
1 2-GRAM repeats .
1 2-GRAM : Sixty
1 2-GRAM Sixty per
1 2-GRAM per cent
1 2-GRAM cent of
1 2-GRAM of African
1 2-GRAM African Americans
1 2-GRAM Americans exposed
1 2-GRAM exposed in
1 2-GRAM in 26
1 2-GRAM 26 community
1 2-GRAM community outbreaks
1 2-GRAM outbreaks were
1 2-GRAM were TST
1 2-GRAM TST positive
1 2-GRAM positive compared
4 2-GRAM compared to
1 2-GRAM to only
1 2-GRAM only 40
1 2-GRAM 40 %
1 2-GRAM of whites
1 2-GRAM whites following
1 2-GRAM following comparable
1 2-GRAM comparable exposures
1 2-GRAM exposures .
4 2-GRAM * For
1 2-GRAM For immunological
1 2-GRAM immunological methods
1 2-GRAM , identification
5 2-GRAM identification of
1 2-GRAM of such
1 2-GRAM such antigens
1 2-GRAM antigens with
1 2-GRAM with intermolecular
1 2-GRAM intermolecular variability
1 2-GRAM variability ,
1 2-GRAM , e
1 2-GRAM e .
1 2-GRAM . g
1 2-GRAM g .,
1 2-GRAM ., the
1 2-GRAM the structural
1 2-GRAM structural aescin
1 2-GRAM aescin analogs
1 2-GRAM analogs ,
1 2-GRAM is of
1 2-GRAM unknown validity
1 2-GRAM validity .
3 2-GRAM * It
1 2-GRAM It was
1 2-GRAM that intrathecal
1 2-GRAM intrathecal administration
1 2-GRAM administration (
1 2-GRAM . t
1 2-GRAM t .)
1 2-GRAM .) of
1 2-GRAM of D2
2 2-GRAM D2 receptor
2 2-GRAM receptor agonist
1 2-GRAM agonist LY171555
1 2-GRAM LY171555 or
1 2-GRAM or D1
1 2-GRAM D1 /
1 2-GRAM / D2
1 2-GRAM agonist apomorphine
1 2-GRAM apomorphine increased
1 2-GRAM increased pain
1 2-GRAM pain threshold
1 2-GRAM threshold and
1 2-GRAM and had
3 2-GRAM had a
1 2-GRAM a potentiating
1 2-GRAM potentiating effect
1 2-GRAM on AA
1 2-GRAM AA .
1 2-GRAM * Interactions
1 2-GRAM Interactions between
1 2-GRAM the checkpoint
1 2-GRAM checkpoint abrogator
1 2-GRAM abrogator UCN
1 2-GRAM UCN -
1 2-GRAM - 01
1 2-GRAM 01 and
1 2-GRAM and several
1 2-GRAM several pharmacological
1 2-GRAM pharmacological inhibitors
1 2-GRAM inhibitors of
3 2-GRAM the mitogen
3 2-GRAM mitogen -
3 2-GRAM - activated
3 2-GRAM activated protein
1 2-GRAM ) kinase
2 2-GRAM ( MEK
1 2-GRAM MEK )/
1 2-GRAM )/ MAPK
1 2-GRAM MAPK pathway
1 2-GRAM pathway have
1 2-GRAM been examined
1 2-GRAM examined in
1 2-GRAM a variety
2 2-GRAM human leukemia
1 2-GRAM leukemia cell
3 2-GRAM * Analysis
3 2-GRAM Analysis of
1 2-GRAM of regulatory
1 2-GRAM regulatory regions
1 2-GRAM regions in
5 2-GRAM the promoter
2 2-GRAM promoter of
1 2-GRAM the ctr4
1 2-GRAM ctr4 (+)
1 2-GRAM (+) copper
1 2-GRAM copper transporter
1 2-GRAM transporter gene
1 2-GRAM in fission
1 2-GRAM fission yeast
1 2-GRAM yeast Schizosaccharomyces
1 2-GRAM Schizosaccharomyces pombe
1 2-GRAM pombe reveals
1 2-GRAM reveals the
1 2-GRAM the identity
1 2-GRAM identity of
1 2-GRAM conserved copper
1 2-GRAM copper -
1 2-GRAM - signaling
1 2-GRAM signaling element
1 2-GRAM ( CuSE
1 2-GRAM CuSE ),
2 2-GRAM ), which
1 2-GRAM is recognized
1 2-GRAM recognized by
2 2-GRAM the transcription
3 2-GRAM transcription factor
1 2-GRAM factor Cuf1
1 2-GRAM Cuf1 .
1 2-GRAM , during
1 2-GRAM during our
1 2-GRAM our work
1 2-GRAM work with
1 2-GRAM a replication
1 2-GRAM replication -
3 2-GRAM - deficient
1 2-GRAM deficient virus
1 2-GRAM virus expressing
2 2-GRAM expressing the
1 2-GRAM the ASF
2 2-GRAM ASF /
2 2-GRAM / SF2
1 2-GRAM SF2 splicing
1 2-GRAM factor from
1 2-GRAM a progesterone
1 2-GRAM progesterone antagonist
1 2-GRAM antagonist -
3 2-GRAM - inducible
1 2-GRAM inducible gene
1 2-GRAM gene cassette
1 2-GRAM cassette ,
2 2-GRAM we discovered
2 2-GRAM discovered that
1 2-GRAM that ASF
1 2-GRAM SF2 was
3 2-GRAM was expressed
1 2-GRAM expressed at
2 2-GRAM at a
3 2-GRAM a significant
1 2-GRAM significant level
1 2-GRAM level in
1 2-GRAM the 293
1 2-GRAM 293 producer
1 2-GRAM producer cell
1 2-GRAM line ,
2 2-GRAM , even
2 2-GRAM even in
4 2-GRAM the absence
4 2-GRAM absence of
1 2-GRAM of inducer
1 2-GRAM inducer .
3 2-GRAM This study
1 2-GRAM study suggests
3 2-GRAM suggests that
1 2-GRAM that PSP
1 2-GRAM PSP is
1 2-GRAM is more
1 2-GRAM more common
1 2-GRAM common than
1 2-GRAM than previously
1 2-GRAM previously considered
1 2-GRAM considered ,
2 2-GRAM is commonly
1 2-GRAM commonly misdiagnosed
1 2-GRAM misdiagnosed and
1 2-GRAM the majority
1 2-GRAM majority of
1 2-GRAM of cases
1 2-GRAM cases are
1 2-GRAM not initially
1 2-GRAM initially referred
1 2-GRAM referred to
1 2-GRAM to neurologists
1 2-GRAM neurologists .
1 2-GRAM * Between
1 2-GRAM Between 1967
1 2-GRAM 1967 and
1 2-GRAM and 1994
1 2-GRAM 1994 ,
1 2-GRAM , 495
1 2-GRAM 495 patients
1 2-GRAM patients underwent
2 2-GRAM underwent surgery
2 2-GRAM surgery for
2 2-GRAM for primary
1 2-GRAM primary PTC
1 2-GRAM PTC at
1 2-GRAM of Surgery
1 2-GRAM Surgery ,
1 2-GRAM , Helsinki
1 2-GRAM Helsinki University
1 2-GRAM University Central
1 2-GRAM Central Hospital
1 2-GRAM Hospital .
1 2-GRAM The described
1 2-GRAM described results
2 2-GRAM results show
1 2-GRAM that DTD
1 2-GRAM DTD is
1 2-GRAM is fast
1 2-GRAM fast ,
1 2-GRAM , simple
1 2-GRAM simple ,
1 2-GRAM and easy
1 2-GRAM easy to
1 2-GRAM to automate
1 2-GRAM automate ;
1 2-GRAM ; requires
1 2-GRAM requires only
1 2-GRAM only a
2 2-GRAM a small
1 2-GRAM small amount
1 2-GRAM of sample
1 2-GRAM sample (
1 2-GRAM ( approximately
1 2-GRAM approximately 50
3 2-GRAM 50 mg
1 2-GRAM mg );
1 2-GRAM ); and
1 2-GRAM and affords
1 2-GRAM affords quantitative
1 2-GRAM quantitative information
1 2-GRAM information about
1 2-GRAM about the
2 2-GRAM the main
1 2-GRAM main groups
1 2-GRAM groups of
1 2-GRAM of compounds
1 2-GRAM compounds present
2 2-GRAM present in
1 2-GRAM in cheeses
1 2-GRAM * Srb10
1 2-GRAM Srb10 is
1 2-GRAM a physiological
1 2-GRAM physiological regulator
2 2-GRAM of Gcn4
1 2-GRAM Gcn4 stability
1 2-GRAM stability because
1 2-GRAM because both
1 2-GRAM both phosphorylation
1 2-GRAM phosphorylation and
1 2-GRAM and turnover
1 2-GRAM turnover of
1 2-GRAM Gcn4 are
1 2-GRAM are diminished
1 2-GRAM diminished in
1 2-GRAM in srb10
1 2-GRAM srb10 mutants
2 2-GRAM mutants .
1 2-GRAM The promoter
2 2-GRAM promoter activity
9 2-GRAM activity of
3 2-GRAM the proximal
1 2-GRAM proximal region
1 2-GRAM region was
2 2-GRAM found to
1 2-GRAM be restricted
1 2-GRAM restricted to
1 2-GRAM a subset
1 2-GRAM subset of
1 2-GRAM of prestalk
1 2-GRAM prestalk cells
1 2-GRAM Two nuclear
1 2-GRAM nuclear medicine
1 2-GRAM medicine physicians
1 2-GRAM physicians blinded
1 2-GRAM blinded to
1 2-GRAM the surgical
1 2-GRAM surgical findings
1 2-GRAM findings interpreted
1 2-GRAM interpreted all
1 2-GRAM all available
1 2-GRAM available images
1 2-GRAM images and
1 2-GRAM and various
1 2-GRAM various Tc
1 2-GRAM Tc -
1 2-GRAM - 99m
1 2-GRAM 99m MIBI
1 2-GRAM MIBI image
1 2-GRAM image combinations
1 2-GRAM combinations at
1 2-GRAM at 15
4 2-GRAM 15 minutes
1 2-GRAM minutes alone
1 2-GRAM alone ;
1 2-GRAM ; 15
3 2-GRAM minutes and
2 2-GRAM and 2
1 2-GRAM 2 hours
1 2-GRAM hours ,
2 2-GRAM , 15
3 2-GRAM and 4
2 2-GRAM 4 hours
1 2-GRAM hours ;
2 2-GRAM ; and
1 2-GRAM and 15
2 2-GRAM 2 and
1 2-GRAM hours each
1 2-GRAM each with
1 2-GRAM without correlative
1 2-GRAM correlative pertechnetate
1 2-GRAM pertechnetate thyroid
1 2-GRAM thyroid imaging
1 2-GRAM imaging .
1 2-GRAM We demonstrated
2 2-GRAM that ,
2 2-GRAM , under
1 2-GRAM under serum
1 2-GRAM serum -
2 2-GRAM - starved
1 2-GRAM starved conditions
2 2-GRAM conditions ,
1 2-GRAM , KMS
1 2-GRAM KMS -
2 2-GRAM - 11
1 2-GRAM 11 and
1 2-GRAM and OPM
1 2-GRAM OPM -
2 2-GRAM 2 cells
1 2-GRAM cells express
1 2-GRAM express appreciable
1 2-GRAM appreciable levels
1 2-GRAM of phosphorylated
1 2-GRAM phosphorylated FGFR3
1 2-GRAM FGFR3 mutants
1 2-GRAM mutants indicating
2 2-GRAM indicating a
1 2-GRAM a constitutive
1 2-GRAM the Y373C
1 2-GRAM Y373C and
1 2-GRAM and K650E
1 2-GRAM K650E receptors
1 2-GRAM receptors ;
1 2-GRAM ; the
2 2-GRAM the addition
2 2-GRAM addition of
1 2-GRAM the aFGF
1 2-GRAM aFGF ligand
1 2-GRAM ligand further
1 2-GRAM further increased
2 2-GRAM the level
1 2-GRAM level of
1 2-GRAM receptor phosphorylation
1 2-GRAM * Identical
1 2-GRAM Identical effects
2 2-GRAM effects were
3 2-GRAM were obtained
1 2-GRAM obtained when
1 2-GRAM when inhibitors
1 2-GRAM inhibitors and
1 2-GRAM and dominant
2 2-GRAM dominant negative
1 2-GRAM negative mutants
2 2-GRAM mutants were
1 2-GRAM were tested
1 2-GRAM tested on
2 2-GRAM the -
1 2-GRAM - 29
1 2-GRAM 29 to
3 2-GRAM to +
1 2-GRAM + 139
1 2-GRAM 139 bp
1 2-GRAM bp region
8 2-GRAM region of
3 2-GRAM the cyclin
2 2-GRAM cyclin D1
1 2-GRAM D1 promoter
1 2-GRAM In this
2 2-GRAM this paper
1 2-GRAM paper the
2 2-GRAM the tyrosine
1 2-GRAM tyrosine dephosphorylating
1 2-GRAM dephosphorylating enzymes
1 2-GRAM enzymes ,
1 2-GRAM - tyrosine
1 2-GRAM tyrosine phosphatases
1 2-GRAM phosphatases (
1 2-GRAM ( PTPs
1 2-GRAM PTPs ),
1 2-GRAM ), are
1 2-GRAM are studied
1 2-GRAM studied which
1 2-GRAM which can
4 2-GRAM can be
1 2-GRAM be grouped
1 2-GRAM grouped into
2 2-GRAM into two
1 2-GRAM two subfamilies
1 2-GRAM subfamilies ,
1 2-GRAM the soluble
1 2-GRAM soluble PTPs
1 2-GRAM PTPs and
1 2-GRAM the receptor
1 2-GRAM receptor PTPs
1 2-GRAM PTPs (
1 2-GRAM ( RPTPs
1 2-GRAM RPTPs ).
1 2-GRAM * Coexposure
1 2-GRAM Coexposure to
1 2-GRAM to FP
1 2-GRAM FP also
1 2-GRAM also resulted
1 2-GRAM more pronounced
1 2-GRAM pronounced and
1 2-GRAM sustained activation
2 2-GRAM kinase kinase
1 2-GRAM kinase /
2 2-GRAM / extracellular
2 2-GRAM extracellular signal
2 2-GRAM signal -
1 2-GRAM regulated protein
1 2-GRAM cascade after
1 2-GRAM after PMA
1 2-GRAM PMA treatment
1 2-GRAM treatment ,
4 2-GRAM , although
1 2-GRAM although disruption
1 2-GRAM this pathway
2 2-GRAM pathway by
1 2-GRAM kinase 1
1 2-GRAM 1 inhibitor
1 2-GRAM inhibitor U0126
1 2-GRAM U0126 did
1 2-GRAM not prevent
1 2-GRAM prevent potentiation
1 2-GRAM potentiation of
1 2-GRAM of apoptosis
1 2-GRAM apoptosis .
1 2-GRAM The LA
1 2-GRAM LA 50s
1 2-GRAM 50s derived
1 2-GRAM derived from
1 2-GRAM from this
1 2-GRAM this combined
1 2-GRAM combined data
1 2-GRAM data when
1 2-GRAM when compared
1 2-GRAM with our
1 2-GRAM our earlier
1 2-GRAM earlier series
1 2-GRAM series from
1 2-GRAM from 1965
1 2-GRAM 1965 to
1 2-GRAM to 1970
1 2-GRAM 1970 also
1 2-GRAM also did
1 2-GRAM not show
1 2-GRAM show a
1 2-GRAM significant change
1 2-GRAM in mortality
1 2-GRAM mortality .
1 2-GRAM Most patients
1 2-GRAM patients harboring
1 2-GRAM harboring metronidazole
1 2-GRAM metronidazole -
1 2-GRAM and clarithromycin
1 2-GRAM clarithromycin -
2 2-GRAM - resistant
1 2-GRAM resistant strains
2 2-GRAM strains were
1 2-GRAM were eradicated
1 2-GRAM eradicated at
3 2-GRAM at an
1 2-GRAM an equal
1 2-GRAM equal rate
1 2-GRAM rate by
1 2-GRAM by each
1 2-GRAM each of
3 2-GRAM the three
1 2-GRAM three regimens
1 2-GRAM regimens .
1 2-GRAM - unit
1 2-GRAM unit carotid
1 2-GRAM carotid body
1 2-GRAM body chemoreceptors
1 2-GRAM chemoreceptors in
1 2-GRAM in adult
1 2-GRAM adult rats
1 2-GRAM rats .
1 2-GRAM , MKK7
1 2-GRAM MKK7 is
2 2-GRAM is an
1 2-GRAM an essential
1 2-GRAM essential and
1 2-GRAM and specific
1 2-GRAM specific regulator
1 2-GRAM of stress
2 2-GRAM stress -
1 2-GRAM induced SAPK
2 2-GRAM SAPK /
2 2-GRAM / JNK
2 2-GRAM JNK activation
1 2-GRAM activation in
1 2-GRAM in mast
1 2-GRAM mast cells
1 2-GRAM cells and
1 2-GRAM and MKK7
1 2-GRAM MKK7 negatively
2 2-GRAM negatively regulates
1 2-GRAM regulates growth
3 2-GRAM growth factor
1 2-GRAM and antigen
1 2-GRAM antigen receptor
1 2-GRAM - driven
1 2-GRAM driven proliferation
1 2-GRAM proliferation in
1 2-GRAM in hematopoietic
1 2-GRAM hematopoietic cells
1 2-GRAM The N
2 2-GRAM terminal portion
3 2-GRAM portion of
1 2-GRAM of Notch
1 2-GRAM Notch (
1 2-GRAM ( IC
1 2-GRAM IC )
1 2-GRAM ) inhibited
1 2-GRAM inhibited p50
1 2-GRAM p50 DNA
2 2-GRAM binding and
1 2-GRAM and interacted
1 2-GRAM interacted specifically
1 2-GRAM specifically with
1 2-GRAM with p50
1 2-GRAM p50 subunit
1 2-GRAM subunit ,
1 2-GRAM , not
1 2-GRAM not p65
1 2-GRAM p65 of
1 2-GRAM of NF
1 2-GRAM kappaB .
1 2-GRAM To account
1 2-GRAM account for
1 2-GRAM for this
1 2-GRAM this observation
1 2-GRAM observation ,
1 2-GRAM , other
1 2-GRAM other possible
1 2-GRAM possible causes
1 2-GRAM causes include
1 2-GRAM include increased
1 2-GRAM increased CSF
1 2-GRAM CSF pulsation
1 2-GRAM pulsation in
3 2-GRAM in children
1 2-GRAM children creating
1 2-GRAM creating motion
1 2-GRAM motion artifact
1 2-GRAM artifact ,
2 2-GRAM , changes
1 2-GRAM in arterial
1 2-GRAM arterial oxygen
1 2-GRAM oxygen concentration
1 2-GRAM concentration intrinsic
1 2-GRAM intrinsic to
2 2-GRAM to propofol
1 2-GRAM propofol or
1 2-GRAM or related
3 2-GRAM related to
1 2-GRAM the supplemental
1 2-GRAM supplemental oxygen
1 2-GRAM oxygen normally
1 2-GRAM normally administered
1 2-GRAM administered ,
5 2-GRAM , or
1 2-GRAM or changes
1 2-GRAM in CSF
1 2-GRAM CSF protein
1 2-GRAM levels related
1 2-GRAM propofol binding
3 2-GRAM binding to
1 2-GRAM to proteins
1 2-GRAM proteins for
1 2-GRAM for uptake
1 2-GRAM uptake into
1 2-GRAM into CSF
1 2-GRAM CSF .
3 2-GRAM * Molecular
1 2-GRAM Molecular cloning
1 2-GRAM cloning and
1 2-GRAM of OsPSK
1 2-GRAM OsPSK ,
2 2-GRAM a gene
2 2-GRAM gene encoding
1 2-GRAM a precursor
1 2-GRAM precursor for
1 2-GRAM for phytosulfokine
1 2-GRAM phytosulfokine -
1 2-GRAM alpha ,
2 2-GRAM , required
1 2-GRAM for rice
1 2-GRAM rice cell
2 2-GRAM cell proliferation
2 2-GRAM proliferation .
2 2-GRAM The present
1 2-GRAM present study
1 2-GRAM was initiated
1 2-GRAM initiated to
2 2-GRAM the potential
1 2-GRAM potential of
1 2-GRAM a hybrid
1 2-GRAM hybrid biological
1 2-GRAM biological reactor
1 2-GRAM reactor ,
1 2-GRAM , combining
1 2-GRAM combining trickling
1 2-GRAM trickling filter
1 2-GRAM filter (
1 2-GRAM ( TF
1 2-GRAM TF )
1 2-GRAM and activated
1 2-GRAM activated sludge
1 2-GRAM sludge process
1 2-GRAM process (
1 2-GRAM ( ASP
1 2-GRAM ASP ),
2 2-GRAM ), to
1 2-GRAM to treat
1 2-GRAM treat wastewater
1 2-GRAM wastewater containing
1 2-GRAM containing trichloroethylene
1 2-GRAM trichloroethylene (
1 2-GRAM ( TCE
1 2-GRAM TCE )
1 2-GRAM ) at
1 2-GRAM at ambient
1 2-GRAM ambient temperature
1 2-GRAM temperature at
1 2-GRAM at different
1 2-GRAM different hydraulic
1 2-GRAM hydraulic retention
1 2-GRAM retention time
1 2-GRAM time (
1 2-GRAM ( HRT
1 2-GRAM HRT ).
1 2-GRAM * If
1 2-GRAM If you
1 2-GRAM you think
1 2-GRAM think education
1 2-GRAM education is
1 2-GRAM is expensive
1 2-GRAM expensive --
1 2-GRAM -- try
1 2-GRAM try ignorance
1 2-GRAM ignorance --
1 2-GRAM -- Bok
1 2-GRAM Bok '
1 2-GRAM s Law
1 2-GRAM Law .
1 2-GRAM The COD
1 2-GRAM COD and
1 2-GRAM and color
1 2-GRAM color removals
1 2-GRAM removals were
2 2-GRAM were both
1 2-GRAM both more
1 2-GRAM than 90
2 2-GRAM 90 %
1 2-GRAM % when
1 2-GRAM when FeCl3
1 2-GRAM FeCl3 was
1 2-GRAM used as
1 2-GRAM the coagulation
1 2-GRAM coagulation (
1 2-GRAM ( dosages
1 2-GRAM dosages of
6 2-GRAM of two
1 2-GRAM - step
1 2-GRAM step coagulation
1 2-GRAM coagulation were
1 2-GRAM were 0
1 2-GRAM . 031
1 2-GRAM 031 and
2 2-GRAM and 0
1 2-GRAM . 012
1 2-GRAM 012 mol
2 2-GRAM mol /
1 2-GRAM L respectively
1 2-GRAM respectively )
1 2-GRAM ) after
1 2-GRAM after a
1 2-GRAM a ferrous
1 2-GRAM ferrous hydrogen
1 2-GRAM hydrogen peroxide
1 2-GRAM peroxide oxidation
1 2-GRAM oxidation pretreatment
1 2-GRAM pretreatment at
1 2-GRAM a H2O2
1 2-GRAM H2O2 dosage
1 2-GRAM dosage of
1 2-GRAM of 0
2 2-GRAM . 06
1 2-GRAM 06 mol
1 2-GRAM L .
1 2-GRAM An element
1 2-GRAM element within
1 2-GRAM ' untranslated
2 2-GRAM untranslated region
1 2-GRAM human Hsp70
1 2-GRAM Hsp70 mRNA
1 2-GRAM mRNA which
1 2-GRAM which acts
2 2-GRAM acts as
1 2-GRAM a general
1 2-GRAM general enhancer
1 2-GRAM enhancer of
1 2-GRAM of mRNA
1 2-GRAM mRNA translation
1 2-GRAM translation .
1 2-GRAM The selective
1 2-GRAM selective alteration
1 2-GRAM alteration of
2 2-GRAM the genome
1 2-GRAM genome using
1 2-GRAM using Cre
1 2-GRAM Cre recombinase
1 2-GRAM recombinase to
1 2-GRAM to target
1 2-GRAM target the
1 2-GRAM the rearrangement
1 2-GRAM rearrangement of
1 2-GRAM genes flanked
2 2-GRAM flanked by
2 2-GRAM by LOX
1 2-GRAM LOX recognition
1 2-GRAM recognition sequences
1 2-GRAM sequences has
1 2-GRAM has required
1 2-GRAM required the
1 2-GRAM two separate
1 2-GRAM separate genetic
1 2-GRAM genetic constructs
1 2-GRAM constructs in
1 2-GRAM in trans
1 2-GRAM trans ,
1 2-GRAM one containing
1 2-GRAM containing cre
1 2-GRAM cre and
4 2-GRAM the other
1 2-GRAM other containing
3 2-GRAM containing the
1 2-GRAM gene of
1 2-GRAM interest flanked
1 2-GRAM LOX sites
2 2-GRAM sites .
1 2-GRAM It has
5 2-GRAM has been
1 2-GRAM been suggested
1 2-GRAM that members
1 2-GRAM members of
1 2-GRAM this protein
1 2-GRAM protein family
1 2-GRAM family exhibit
1 2-GRAM exhibit both
1 2-GRAM both prolyl
1 2-GRAM prolyl isomerase
1 2-GRAM isomerase and
1 2-GRAM and chaperone
1 2-GRAM chaperone activity
1 2-GRAM * Newcastle
1 2-GRAM Newcastle disease
1 2-GRAM disease antibody
1 2-GRAM antibody titre
1 2-GRAM titre is
2 2-GRAM is dependent
1 2-GRAM dependent on
1 2-GRAM on serum
1 2-GRAM serum calcium
1 2-GRAM calcium concentration
2 2-GRAM concentration .
1 2-GRAM In three
1 2-GRAM three cases
1 2-GRAM cases (
2 2-GRAM ( 21
1 2-GRAM 21 .
1 2-GRAM 4 %),
1 2-GRAM %), the
1 2-GRAM the MR
2 2-GRAM MR imaging
1 2-GRAM imaging was
1 2-GRAM was interpreted
1 2-GRAM interpreted as
1 2-GRAM as negative
1 2-GRAM negative ,
1 2-GRAM but microscopic
1 2-GRAM microscopic tumor
1 2-GRAM tumor was
1 2-GRAM shown around
1 2-GRAM around seroma
1 2-GRAM seroma on
1 2-GRAM on reexcision
1 2-GRAM reexcision .
1 2-GRAM 2 were
1 2-GRAM were nonviable
1 2-GRAM nonviable ,
1 2-GRAM the mutant
1 2-GRAM mutant Vp1s
1 2-GRAM Vp1s unexpectedly
1 2-GRAM unexpectedly failed
1 2-GRAM failed to
1 2-GRAM to localize
2 2-GRAM localize to
2 2-GRAM the nucleus
1 2-GRAM nucleus though
1 2-GRAM though Vp2
1 2-GRAM Vp2 and
1 2-GRAM and Vp3
1 2-GRAM Vp3 did
1 2-GRAM did ,
1 2-GRAM suggesting that
1 2-GRAM the mutated
1 2-GRAM mutated NLS1
1 2-GRAM NLS1 acted
1 2-GRAM acted as
1 2-GRAM a dominant
1 2-GRAM dominant signal
1 2-GRAM signal for
3 2-GRAM the cytoplasmic
1 2-GRAM cytoplasmic localization
2 2-GRAM localization of
1 2-GRAM of Vp1
1 2-GRAM Vp1 .
1 2-GRAM * Compared
1 2-GRAM Compared with
1 2-GRAM with normal
1 2-GRAM normal control
2 2-GRAM control subjects
1 2-GRAM subjects ,
1 2-GRAM all 74
1 2-GRAM 74 TOF
1 2-GRAM TOF patients
1 2-GRAM patients had
1 2-GRAM had decreased
1 2-GRAM decreased systolic
1 2-GRAM systolic and
1 2-GRAM and diastolic
1 2-GRAM diastolic myocardial
1 2-GRAM myocardial velocities
1 2-GRAM velocities and
7 2-GRAM and a
1 2-GRAM a longer
1 2-GRAM longer isovolumic
1 2-GRAM isovolumic relaxation
1 2-GRAM relaxation time
1 2-GRAM time .
1 2-GRAM The corresponding
1 2-GRAM corresponding orifice
1 2-GRAM orifice voltages
1 2-GRAM voltages for
1 2-GRAM three instruments
1 2-GRAM instruments were
1 2-GRAM were 20
1 2-GRAM 20 /
1 2-GRAM / 50
1 2-GRAM 50 /
2 2-GRAM / 80
1 2-GRAM 80 V
3 2-GRAM V (
3 2-GRAM ( API
1 2-GRAM API 365
1 2-GRAM 365 ),
1 2-GRAM ), 30
1 2-GRAM 30 /
1 2-GRAM / 90
1 2-GRAM 90 /
1 2-GRAM / 130
1 2-GRAM 130 V
1 2-GRAM API 2000
1 2-GRAM 2000 )
1 2-GRAM and 40
1 2-GRAM 40 /
1 2-GRAM 80 /
1 2-GRAM / 120
1 2-GRAM 120 V
1 2-GRAM API 3000
1 2-GRAM 3000 ).
1 2-GRAM We compared
1 2-GRAM compared previously
1 2-GRAM previously the
1 2-GRAM the methylation
1 2-GRAM methylation status
1 2-GRAM status between
1 2-GRAM between normal
1 2-GRAM normal liver
1 2-GRAM liver and
2 2-GRAM liver tumors
2 2-GRAM tumors in
1 2-GRAM in SV40
2 2-GRAM SV40 T
1 2-GRAM T /
1 2-GRAM / t
1 2-GRAM t antigen
1 2-GRAM antigen transgenic
1 2-GRAM transgenic mice
1 2-GRAM mice (
1 2-GRAM ( MT
1 2-GRAM MT -
1 2-GRAM - D2
1 2-GRAM D2 mice
1 2-GRAM mice )
1 2-GRAM ) using
1 2-GRAM using Restriction
1 2-GRAM Restriction Landmark
1 2-GRAM Landmark Genomic
1 2-GRAM Genomic Scanning
1 2-GRAM Scanning for
1 2-GRAM for Methylation
1 2-GRAM Methylation (
1 2-GRAM ( RLGS
1 2-GRAM RLGS -
1 2-GRAM - M
1 2-GRAM M )
1 2-GRAM identified several
1 2-GRAM several loci
1 2-GRAM loci /
1 2-GRAM / spots
1 2-GRAM spots that
1 2-GRAM that appeared
1 2-GRAM appeared to
1 2-GRAM be methylated
1 2-GRAM methylated frequently
1 2-GRAM frequently in
1 2-GRAM in liver
2 2-GRAM tumors .
1 2-GRAM have cloned
1 2-GRAM cloned a
1 2-GRAM novel mouse
1 2-GRAM mouse protein
1 2-GRAM , TAF
1 2-GRAM TAF (
2 2-GRAM ( II
2 2-GRAM II )
1 2-GRAM ) 140
1 2-GRAM 140 ,
1 2-GRAM , containing
1 2-GRAM an HFD
1 2-GRAM HFD and
1 2-GRAM plant homeodomain
1 2-GRAM homeodomain (
1 2-GRAM ( PHD
1 2-GRAM PHD )
1 2-GRAM ) finger
1 2-GRAM finger ,
2 2-GRAM which we
1 2-GRAM we demonstrated
1 2-GRAM demonstrated by
2 2-GRAM by immunoprecipitation
1 2-GRAM immunoprecipitation to
1 2-GRAM a mammalian
1 2-GRAM mammalian TFIID
1 2-GRAM TFIID component
1 2-GRAM component .
1 2-GRAM * 3D
1 2-GRAM 3D image
1 2-GRAM image -
1 2-GRAM - processing
1 2-GRAM processing permits
1 2-GRAM permits to
1 2-GRAM to analyse
1 2-GRAM analyse ultrasound
1 2-GRAM ultrasound data
1 2-GRAM data interactively
1 2-GRAM interactively in
1 2-GRAM in three
1 2-GRAM three orthogonal
1 2-GRAM orthogonal planes
1 2-GRAM planes (
1 2-GRAM ( section
1 2-GRAM section mode
1 2-GRAM mode )
2 2-GRAM or in
1 2-GRAM in realistic
1 2-GRAM realistic 3D
1 2-GRAM 3D views
1 2-GRAM views (
1 2-GRAM ( rendering
1 2-GRAM rendering mode
1 2-GRAM mode ).
1 2-GRAM A proposal
1 2-GRAM proposal of
1 2-GRAM of 50
1 2-GRAM 50 performance
1 2-GRAM performance indicators
1 2-GRAM indicators divided
1 2-GRAM divided into
1 2-GRAM into five
1 2-GRAM five different
1 2-GRAM different groups
1 2-GRAM groups is
2 2-GRAM is presented
2 2-GRAM presented here
1 2-GRAM here ,
1 2-GRAM , namely
1 2-GRAM namely structural
1 2-GRAM structural indicators
3 2-GRAM indicators ,
1 2-GRAM , operational
1 2-GRAM operational indicators
1 2-GRAM , water
1 2-GRAM water and
1 2-GRAM and service
1 2-GRAM service quality
1 2-GRAM quality indicators
1 2-GRAM , personnel
1 2-GRAM personnel indicators
1 2-GRAM indicators and
1 2-GRAM and economic
1 2-GRAM economic indicators
1 2-GRAM indicators .
1 2-GRAM These analyses
1 2-GRAM analyses re
1 2-GRAM - open
1 2-GRAM open the
1 2-GRAM the question
1 2-GRAM question whether
1 2-GRAM whether all
1 2-GRAM all the
1 2-GRAM the CesA
1 2-GRAM CesA genes
1 2-GRAM encode cellulose
1 2-GRAM cellulose synthases
1 2-GRAM synthases or
1 2-GRAM or whether
1 2-GRAM whether some
1 2-GRAM some of
1 2-GRAM the sub
1 2-GRAM sub -
1 2-GRAM - class
1 2-GRAM class members
1 2-GRAM members may
1 2-GRAM may encode
1 2-GRAM encode other
1 2-GRAM other non
1 2-GRAM - cellulosic
1 2-GRAM cellulosic (
2 2-GRAM ( 1
1 2-GRAM 1 -->
1 2-GRAM --> 4
1 2-GRAM ) beta
1 2-GRAM - glycan
1 2-GRAM glycan synthases
1 2-GRAM synthases in
1 2-GRAM in plants
1 2-GRAM plants .
1 2-GRAM The relationship
1 2-GRAM relationship of
1 2-GRAM the factor
1 2-GRAM factor V
1 2-GRAM V Leiden
1 2-GRAM Leiden mutation
1 2-GRAM mutation or
3 2-GRAM or the
1 2-GRAM the deletion
1 2-GRAM deletion -
1 2-GRAM - deletion
1 2-GRAM deletion polymorphism
1 2-GRAM polymorphism of
1 2-GRAM the angiotensin
1 2-GRAM angiotensin converting
1 2-GRAM converting enzyme
1 2-GRAM enzyme to
1 2-GRAM to postoperative
1 2-GRAM postoperative thromboembolic
1 2-GRAM thromboembolic events
1 2-GRAM events following
1 2-GRAM following total
1 2-GRAM total joint
1 2-GRAM joint arthroplasty
1 2-GRAM arthroplasty .
2 2-GRAM , exogenous
1 2-GRAM exogenous PTHrP1
1 2-GRAM PTHrP1 -
1 2-GRAM - 34
1 2-GRAM 34 and
1 2-GRAM and 1
1 2-GRAM - 86
1 2-GRAM 86 peptides
1 2-GRAM peptides did
1 2-GRAM significantly affect
1 2-GRAM affect IL
4 2-GRAM IL -
1 2-GRAM 8 production
1 2-GRAM production ;
1 2-GRAM ; moreover
1 2-GRAM moreover ,
1 2-GRAM , PTHrP
1 2-GRAM PTHrP -
1 2-GRAM - neutralizing
1 2-GRAM neutralizing antibodies
1 2-GRAM antibodies did
1 2-GRAM not inhibit
1 2-GRAM inhibit the
3 2-GRAM the production
4 2-GRAM production of
1 2-GRAM of IL
1 2-GRAM 8 by
1 2-GRAM by transfected
1 2-GRAM transfected PTHrP
1 2-GRAM PTHrP .
3 2-GRAM * Furthermore
3 2-GRAM Furthermore ,
2 2-GRAM , this
1 2-GRAM this kinase
2 2-GRAM kinase -
1 2-GRAM deficient mutant
1 2-GRAM mutant inhibited
1 2-GRAM inhibited 2
9 2-GRAM 2 -
1 2-GRAM - MeSADP
1 2-GRAM MeSADP -
1 2-GRAM induced caspase
1 2-GRAM caspase -
5 2-GRAM - 3
1 2-GRAM 3 stimulation
1 2-GRAM stimulation and
2 2-GRAM the associated
1 2-GRAM associated decrease
1 2-GRAM in cell
1 2-GRAM cell number
1 2-GRAM number .
1 2-GRAM * Against
1 2-GRAM Against gram
1 2-GRAM gram -
1 2-GRAM - positive
1 2-GRAM positive organisms
1 2-GRAM organisms ,
1 2-GRAM , E
2 2-GRAM E -
1 2-GRAM - 4767
1 2-GRAM 4767 and
1 2-GRAM and E
1 2-GRAM - 5065
1 2-GRAM 5065 were
1 2-GRAM were ,
1 2-GRAM in general
1 2-GRAM general ,
1 2-GRAM , eight
1 2-GRAM eight -
1 2-GRAM and fourfold
1 2-GRAM fourfold more
1 2-GRAM more active
1 2-GRAM active than
1 2-GRAM than tosufloxacin
1 2-GRAM tosufloxacin ,
5 2-GRAM is the
3 2-GRAM the most
1 2-GRAM most potent
1 2-GRAM potent of
1 2-GRAM the reference
1 2-GRAM reference compounds
1 2-GRAM compounds .
2 2-GRAM The results
1 2-GRAM results presented
1 2-GRAM here show
1 2-GRAM that AR1
1 2-GRAM AR1 of
1 2-GRAM promoter -
1 2-GRAM - proximal
1 2-GRAM proximal CAP
1 2-GRAM CAP subunit
1 2-GRAM subunit was
1 2-GRAM was required
1 2-GRAM for papBA
1 2-GRAM papBA transcription
1 2-GRAM transcription even
1 2-GRAM the histone
1 2-GRAM histone -
1 2-GRAM like protein
1 2-GRAM protein H
2 2-GRAM H -
1 2-GRAM - NS
1 2-GRAM NS .
1 2-GRAM : Under
1 2-GRAM Under current
1 2-GRAM current immunization
1 2-GRAM immunization practices
1 2-GRAM practices ,
1 2-GRAM the authors
1 2-GRAM authors estimate
1 2-GRAM estimate that
1 2-GRAM that nearly
1 2-GRAM nearly 13
1 2-GRAM 13 ,
3 2-GRAM , 000
1 2-GRAM 000 Asian
1 2-GRAM Asian and
1 2-GRAM and Pacific
1 2-GRAM Pacific Islander
1 2-GRAM Islander children
1 2-GRAM children living
1 2-GRAM living in
2 2-GRAM the United
2 2-GRAM United States
1 2-GRAM States today
1 2-GRAM today will
1 2-GRAM will become
1 2-GRAM become infected
1 2-GRAM with HBV
1 2-GRAM HBV in
1 2-GRAM the future
1 2-GRAM future ,
1 2-GRAM , resulting
2 2-GRAM resulting in
1 2-GRAM in more
1 2-GRAM than 600
1 2-GRAM 600 liver
1 2-GRAM liver carcinoma
1 2-GRAM carcinoma deaths
1 2-GRAM deaths .
2 2-GRAM : A
1 2-GRAM A structured
1 2-GRAM structured interview
1 2-GRAM interview was
1 2-GRAM was undertaken
1 2-GRAM undertaken at
1 2-GRAM the time
2 2-GRAM time of
1 2-GRAM of initial
1 2-GRAM initial consultation
1 2-GRAM consultation and
2 2-GRAM and at
1 2-GRAM at subsequent
1 2-GRAM subsequent 1
2 2-GRAM - year
1 2-GRAM year intervals
1 2-GRAM intervals regarding
1 2-GRAM regarding type
2 2-GRAM type of
1 2-GRAM of BHS
1 2-GRAM BHS ,
1 2-GRAM , frequency
1 2-GRAM frequency of
2 2-GRAM of spells
1 2-GRAM spells ,
1 2-GRAM , associated
1 2-GRAM associated phenomenon
1 2-GRAM phenomenon ,
1 2-GRAM , sequelae
1 2-GRAM sequelae ,
1 2-GRAM , family
1 2-GRAM family history
1 2-GRAM history ,
1 2-GRAM and age
1 2-GRAM age at
1 2-GRAM at termination
1 2-GRAM termination of
1 2-GRAM spells .
1 2-GRAM * Cell
1 2-GRAM Cell .
1 2-GRAM * Rapid
1 2-GRAM Rapid evolution
1 2-GRAM the DNA
2 2-GRAM DNA -
1 2-GRAM binding site
1 2-GRAM in LAGLIDADG
1 2-GRAM LAGLIDADG homing
1 2-GRAM homing endonucleases
1 2-GRAM endonucleases .
1 2-GRAM These mutations
1 2-GRAM mutations ,
1 2-GRAM , when
1 2-GRAM placed in
1 2-GRAM a wild
1 2-GRAM type fliF
1 2-GRAM fliF background
1 2-GRAM background ,
2 2-GRAM , had
1 2-GRAM no mutant
1 2-GRAM mutant phenotype
2 2-GRAM * Inhibition
2 2-GRAM Inhibition of
1 2-GRAM of JNK1
1 2-GRAM JNK1 and
1 2-GRAM and ERK
1 2-GRAM activities either
1 2-GRAM either by
1 2-GRAM by expression
1 2-GRAM the dominant
1 2-GRAM negative mutant
1 2-GRAM mutant JNK1
1 2-GRAM JNK1 or
1 2-GRAM or by
1 2-GRAM by treatment
2 2-GRAM treatment with
1 2-GRAM selective chemical
1 2-GRAM chemical inhibitor
1 2-GRAM inhibitor of
1 2-GRAM of ERK
1 2-GRAM ERK (
1 2-GRAM ( PD098059
1 2-GRAM PD098059 )
1 2-GRAM ) substantially
1 2-GRAM substantially abrogates
1 2-GRAM abrogates the
1 2-GRAM the UV
1 2-GRAM UV induction
5 2-GRAM induction of
1 2-GRAM the GADD45
1 2-GRAM GADD45 promoter
1 2-GRAM At termination
1 2-GRAM termination (
1 2-GRAM ( gd
1 2-GRAM gd 20
1 2-GRAM 20 ),
1 2-GRAM ), confirmed
1 2-GRAM confirmed -
1 2-GRAM - pregnant
1 2-GRAM pregnant females
1 2-GRAM females (
1 2-GRAM 21 to
1 2-GRAM to 25
1 2-GRAM 25 per
1 2-GRAM per group
1 2-GRAM group )
1 2-GRAM were evaluated
1 2-GRAM evaluated for
2 2-GRAM for clinical
1 2-GRAM clinical status
1 2-GRAM status and
1 2-GRAM and gestational
1 2-GRAM gestational outcome
1 2-GRAM outcome ;
1 2-GRAM ; live
1 2-GRAM live fetuses
1 2-GRAM fetuses were
2 2-GRAM were examined
1 2-GRAM examined for
1 2-GRAM for external
1 2-GRAM external ,
1 2-GRAM , visceral
1 2-GRAM visceral ,
1 2-GRAM and skeletal
1 2-GRAM skeletal malformations
1 2-GRAM malformations .
1 2-GRAM In mammals
1 2-GRAM mammals ,
3 2-GRAM the transcriptional
1 2-GRAM transcriptional repressors
1 2-GRAM repressors in
1 2-GRAM the Wnt
1 2-GRAM Wnt pathway
1 2-GRAM pathway are
1 2-GRAM not well
1 2-GRAM well defined
1 2-GRAM defined .
1 2-GRAM * Intravenous
1 2-GRAM Intravenous L
3 2-GRAM L -
1 2-GRAM - carnitine
1 2-GRAM carnitine treatment
1 2-GRAM treatment increased
2 2-GRAM increased plasma
1 2-GRAM plasma carnitine
1 2-GRAM carnitine concentrations
1 2-GRAM concentrations ,
1 2-GRAM , improved
1 2-GRAM improved patient
1 2-GRAM patient -
1 2-GRAM - assessed
1 2-GRAM assessed fatigue
1 2-GRAM fatigue ,
1 2-GRAM and may
1 2-GRAM may prevent
1 2-GRAM prevent the
1 2-GRAM the decline
1 2-GRAM in peak
1 2-GRAM peak exercise
1 2-GRAM exercise capacity
1 2-GRAM capacity in
1 2-GRAM in hemodialysis
1 2-GRAM hemodialysis patients
2 2-GRAM patients .
1 2-GRAM The Van
1 2-GRAM Van der
1 2-GRAM der Hoeve
1 2-GRAM Hoeve '
2 2-GRAM s syndrome
1 2-GRAM syndrome lesions
1 2-GRAM lesions as
1 2-GRAM as poorly
1 2-GRAM poorly mineralized
1 2-GRAM mineralized ,
1 2-GRAM low calcium
1 2-GRAM calcium salt
1 2-GRAM salt and
1 2-GRAM and apparent
1 2-GRAM apparent increase
1 2-GRAM increase of
1 2-GRAM of phosphates
1 2-GRAM phosphates .
1 2-GRAM A computerized
1 2-GRAM computerized method
2 2-GRAM method of
1 2-GRAM of determining
1 2-GRAM determining the
1 2-GRAM the focal
1 2-GRAM focal point
1 2-GRAM point of
1 2-GRAM of electrical
1 2-GRAM electrical activity
3 2-GRAM activity in
1 2-GRAM the pallidum
1 2-GRAM pallidum of
1 2-GRAM of parkinsonian
1 2-GRAM parkinsonian patients
1 2-GRAM patients was
1 2-GRAM was developed
1 2-GRAM developed using
1 2-GRAM using on
1 2-GRAM on -
1 2-GRAM line quantitative
1 2-GRAM quantitative physiological
1 2-GRAM physiological data
1 2-GRAM data analysis
2 2-GRAM The first
1 2-GRAM first hypothesis
1 2-GRAM hypothesis was
1 2-GRAM was supported
1 2-GRAM supported in
1 2-GRAM the sense
1 2-GRAM sense that
1 2-GRAM that stimulus
1 2-GRAM stimulus differences
1 2-GRAM differences might
1 2-GRAM might affect
1 2-GRAM affect behaviour
1 2-GRAM behaviour even
2 2-GRAM even without
1 2-GRAM without their
1 2-GRAM their successful
1 2-GRAM successful attentive
1 2-GRAM attentive processing
1 2-GRAM processing in
1 2-GRAM in normal
1 2-GRAM normal participants
1 2-GRAM participants .
1 2-GRAM We interpret
1 2-GRAM interpret these
1 2-GRAM data as
1 2-GRAM as further
1 2-GRAM further evidence
1 2-GRAM evidence that
1 2-GRAM that interaction
1 2-GRAM small GTPase
1 2-GRAM GTPase is
1 2-GRAM main regulatory
1 2-GRAM regulatory function
2 2-GRAM function of
1 2-GRAM the C1
1 2-GRAM C1 domain
2 2-GRAM in yeast
1 2-GRAM yeast .
1 2-GRAM This effect
1 2-GRAM effect was
1 2-GRAM was observed
1 2-GRAM observed in
1 2-GRAM of de
2 2-GRAM de novo
2 2-GRAM novo protein
2 2-GRAM protein synthesis
1 2-GRAM synthesis and
2 2-GRAM and was
1 2-GRAM was independent
1 2-GRAM of histone
1 2-GRAM histone deacetylase
1 2-GRAM deacetylase activity
1 2-GRAM Mutation analyses
1 2-GRAM analyses identified
1 2-GRAM identified the
1 2-GRAM the cobalt
1 2-GRAM cobalt -
1 2-GRAM responsive sequences
1 2-GRAM sequences as
1 2-GRAM the stress
1 2-GRAM response elements
1 2-GRAM elements (
1 2-GRAM ( StREs
1 2-GRAM StREs ).
1 2-GRAM In order
1 2-GRAM to quantify
1 2-GRAM quantify these
1 2-GRAM these effects
1 2-GRAM effects ,
1 2-GRAM , tests
1 2-GRAM were conducted
1 2-GRAM conducted in
2 2-GRAM the NASA
1 2-GRAM NASA MSFC
1 2-GRAM MSFC Neutral
1 2-GRAM Neutral Buoyancy
1 2-GRAM Buoyancy Simulator
1 2-GRAM Simulator ,
1 2-GRAM NASA KC
1 2-GRAM KC -
1 2-GRAM - 135
1 2-GRAM 135 in
1 2-GRAM in parabolic
1 2-GRAM parabolic flight
1 2-GRAM flight ,
2 2-GRAM in space
1 2-GRAM space with
1 2-GRAM the EASE
1 2-GRAM EASE program
1 2-GRAM program during
4 2-GRAM during the
1 2-GRAM the Shuttle
1 2-GRAM Shuttle Atlantis
1 2-GRAM Atlantis mission
1 2-GRAM mission 61
1 2-GRAM 61 -
1 2-GRAM - B
1 2-GRAM B .
2 2-GRAM association between
1 2-GRAM between complete
1 2-GRAM complete congenital
1 2-GRAM congenital heart
1 2-GRAM heart block
1 2-GRAM block (
1 2-GRAM ( CCHB
1 2-GRAM CCHB )
1 2-GRAM the fetus
1 2-GRAM fetus and
1 2-GRAM and adult
1 2-GRAM adult disease
1 2-GRAM disease .
1 2-GRAM present chemotherapy
1 2-GRAM chemotherapy of
1 2-GRAM of AE
1 2-GRAM AE is
1 2-GRAM the administration
1 2-GRAM administration of
1 2-GRAM of benzimidazole
1 2-GRAM benzimidazole carbamate
1 2-GRAM carbamate derivatives
1 2-GRAM derivatives ,
1 2-GRAM , such
5 2-GRAM such as
1 2-GRAM as mebendazole
1 2-GRAM mebendazole and
1 2-GRAM and albendazole
1 2-GRAM albendazole .
1 2-GRAM The uptake
1 2-GRAM uptake of
1 2-GRAM of fluorine
1 2-GRAM fluorine -
2 2-GRAM - 18
1 2-GRAM 18 fluorodeoxyglucose
1 2-GRAM fluorodeoxyglucose (
1 2-GRAM ( F
1 2-GRAM F -
1 2-GRAM 18 FDG
1 2-GRAM FDG )
2 2-GRAM ) by
1 2-GRAM a malignant
1 2-GRAM malignant tumor
1 2-GRAM tumor depends
1 2-GRAM depends on
1 2-GRAM the blood
1 2-GRAM blood glucose
1 2-GRAM glucose level
1 2-GRAM level .
1 2-GRAM * Deterministic
1 2-GRAM Deterministic effects
1 2-GRAM effects .
1 2-GRAM A retrospective
1 2-GRAM retrospective chart
1 2-GRAM chart review
2 2-GRAM review of
1 2-GRAM 9 ,
1 2-GRAM , 322
1 2-GRAM 322 patients
1 2-GRAM undergoing surgical
1 2-GRAM surgical procedures
1 2-GRAM procedures in
1 2-GRAM the period
1 2-GRAM period January
1 2-GRAM January 1993
1 2-GRAM 1993 to
1 2-GRAM to December
1 2-GRAM December 1998
1 2-GRAM 1998 .
1 2-GRAM * Peripheral
1 2-GRAM Peripheral and
1 2-GRAM and preemptive
1 2-GRAM preemptive opioid
1 2-GRAM opioid antinociception
1 2-GRAM antinociception in
1 2-GRAM mouse visceral
1 2-GRAM visceral pain
1 2-GRAM pain model
1 2-GRAM model .
2 2-GRAM : We
1 2-GRAM We studied
1 2-GRAM studied the
2 2-GRAM the clinical
1 2-GRAM clinical benefit
1 2-GRAM benefit of
1 2-GRAM of depth
1 2-GRAM depth -
7 2-GRAM - dependent
1 2-GRAM dependent RR
1 2-GRAM RR ,
1 2-GRAM , nonuniform
1 2-GRAM nonuniform AC
1 2-GRAM AC using
3 2-GRAM using a
1 2-GRAM a scanning
1 2-GRAM scanning line
1 2-GRAM line source
1 2-GRAM source ,
1 2-GRAM and scatter
1 2-GRAM scatter correction
1 2-GRAM correction (
1 2-GRAM ( photon
1 2-GRAM photon energy
1 2-GRAM energy recovery
1 2-GRAM recovery [
1 2-GRAM [ PER
1 2-GRAM PER ])
1 2-GRAM ]) compared
1 2-GRAM with filtered
1 2-GRAM filtered backprojection
1 2-GRAM backprojection alone
1 2-GRAM alone .
1 2-GRAM * Cloning
1 2-GRAM Cloning and
1 2-GRAM the murine
1 2-GRAM murine beta
1 2-GRAM ) integrin
1 2-GRAM integrin gene
1 2-GRAM promoter :
1 2-GRAM : identification
1 2-GRAM an interleukin
2 2-GRAM interleukin -
3 2-GRAM - 4
1 2-GRAM 4 responsive
2 2-GRAM responsive element
1 2-GRAM and regulation
1 2-GRAM by STAT
1 2-GRAM STAT -
5 2-GRAM - 6
2 2-GRAM * DNA
1 2-GRAM binding assays
2 2-GRAM assays confirmed
2 2-GRAM confirmed the
1 2-GRAM the interference
1 2-GRAM interference of
1 2-GRAM of p30
1 2-GRAM p30 (
2 2-GRAM ) with
1 2-GRAM the assembly
1 2-GRAM assembly of
2 2-GRAM CREB -
1 2-GRAM - Tax
1 2-GRAM Tax -
1 2-GRAM - p300
2 2-GRAM p300 /
1 2-GRAM / CBP
1 2-GRAM CBP multiprotein
1 2-GRAM multiprotein complexes
1 2-GRAM complexes on
1 2-GRAM on 21
1 2-GRAM 21 -
1 2-GRAM bp repeat
1 2-GRAM repeat oligonucleotides
1 2-GRAM oligonucleotides in
1 2-GRAM vitro .
1 2-GRAM * Transient
1 2-GRAM Transient transfections
1 2-GRAM transfections showed
1 2-GRAM that a
1 2-GRAM single mutation
1 2-GRAM mutation (
1 2-GRAM ( 556M
1 2-GRAM 556M )
1 2-GRAM ) decreased
1 2-GRAM decreased TBLV
1 2-GRAM TBLV enhancer
2 2-GRAM enhancer activity
1 2-GRAM activity at
4 2-GRAM at least
1 2-GRAM least 20
4 2-GRAM - fold
1 2-GRAM fold in
2 2-GRAM in two
2 2-GRAM two different
1 2-GRAM different T
4 2-GRAM In conclusion
4 2-GRAM conclusion ,
1 2-GRAM , tube
3 2-GRAM tube size
1 2-GRAM size estimated
1 2-GRAM estimated by
1 2-GRAM by Cole
1 2-GRAM Cole '
1 2-GRAM s formula
1 2-GRAM formula tends
1 2-GRAM tends to
1 2-GRAM be smaller
1 2-GRAM smaller than
1 2-GRAM than practically
1 2-GRAM practically appropriate
1 2-GRAM appropriate tube
1 2-GRAM size for
1 2-GRAM for pediatric
1 2-GRAM pediatric cardiac
1 2-GRAM cardiac anesthesia
1 2-GRAM anesthesia ,
1 2-GRAM and therefore
1 2-GRAM therefore we
2 2-GRAM we suggest
1 2-GRAM suggest new
1 2-GRAM new formula
1 2-GRAM formula to
1 2-GRAM to estimate
1 2-GRAM estimate the
1 2-GRAM the tube
1 2-GRAM size .
1 2-GRAM in T47D
1 2-GRAM T47D breast
1 2-GRAM breast carcinoma
1 2-GRAM carcinoma cells
1 2-GRAM , IL
1 2-GRAM 6 acts
2 2-GRAM acts in
1 2-GRAM in synergy
1 2-GRAM synergy with
1 2-GRAM with EGF
1 2-GRAM EGF receptor
1 2-GRAM receptor autocrine
1 2-GRAM autocrine activity
1 2-GRAM activity to
1 2-GRAM to signal
1 2-GRAM signal through
1 2-GRAM the MAPK
2 2-GRAM MAPK /
1 2-GRAM / PI3K
1 2-GRAM PI3K pathways
1 2-GRAM pathways .
1 2-GRAM * Nerve
1 2-GRAM Nerve growth
1 2-GRAM ( NGF
1 2-GRAM NGF )
1 2-GRAM and retinoic
1 2-GRAM retinoic acid
3 2-GRAM acid (
1 2-GRAM ( RA
1 2-GRAM RA )
1 2-GRAM ) exert
1 2-GRAM exert important
1 2-GRAM important actions
1 2-GRAM actions on
1 2-GRAM on PC12
1 2-GRAM PC12 cells
1 2-GRAM * HexA71
1 2-GRAM HexA71 negatively
1 2-GRAM negatively affects
1 2-GRAM affects RpoS
1 2-GRAM RpoS ,
1 2-GRAM this alternative
1 2-GRAM alternative sigma
1 2-GRAM sigma factor
1 2-GRAM factor are
1 2-GRAM are higher
3 2-GRAM higher in
2 2-GRAM the HexA
1 2-GRAM HexA -
1 2-GRAM - mutant
1 2-GRAM mutant than
2 2-GRAM than in
1 2-GRAM HexA +
1 2-GRAM + strain
2 2-GRAM strain .
1 2-GRAM * Moreover
1 2-GRAM Moreover ,
1 2-GRAM , elderly
1 2-GRAM elderly men
2 2-GRAM men with
2 2-GRAM with bioavailable
2 2-GRAM bioavailable estradiol
2 2-GRAM estradiol levels
1 2-GRAM levels below
1 2-GRAM below the
2 2-GRAM the median
1 2-GRAM median [
1 2-GRAM [ 40
2 2-GRAM 40 pmol
2 2-GRAM pmol /
2 2-GRAM / liter
1 2-GRAM liter (
1 2-GRAM ( 11
1 2-GRAM 11 pg
1 2-GRAM ml )]
1 2-GRAM )] had
1 2-GRAM had significantly
1 2-GRAM significantly higher
1 2-GRAM higher rates
2 2-GRAM rates of
2 2-GRAM of bone
1 2-GRAM bone loss
1 2-GRAM loss and
1 2-GRAM and levels
1 2-GRAM bone resorption
1 2-GRAM resorption markers
1 2-GRAM markers than
1 2-GRAM than men
1 2-GRAM levels above
1 2-GRAM above 40
1 2-GRAM liter .
1 2-GRAM The histamine
1 2-GRAM histamine H1
1 2-GRAM H1 receptor
1 2-GRAM receptor antagonists
1 2-GRAM antagonists (
1 2-GRAM ( antihistamines
1 2-GRAM antihistamines )
2 2-GRAM ) are
1 2-GRAM are an
1 2-GRAM an important
1 2-GRAM important class
1 2-GRAM class of
1 2-GRAM of medications
1 2-GRAM medications used
3 2-GRAM used for
1 2-GRAM the relief
1 2-GRAM relief of
1 2-GRAM of common
1 2-GRAM common symptoms
1 2-GRAM symptoms associated
1 2-GRAM with hyperhistaminic
1 2-GRAM hyperhistaminic conditions
1 2-GRAM conditions occurring
1 2-GRAM occurring in
1 2-GRAM children and
1 2-GRAM The production
1 2-GRAM of ceramide
1 2-GRAM ceramide is
1 2-GRAM is emerging
1 2-GRAM emerging as
1 2-GRAM a fixture
1 2-GRAM fixture of
1 2-GRAM of programmed
1 2-GRAM death .
1 2-GRAM The flux
1 2-GRAM flux rates
1 2-GRAM of p
1 2-GRAM p -
1 2-GRAM - toluidine
1 2-GRAM toluidine decreased
1 2-GRAM decreased as
1 2-GRAM the pH
1 2-GRAM pH value
1 2-GRAM value in
1 2-GRAM the donor
1 2-GRAM donor solution
1 2-GRAM solution increased
1 2-GRAM increased .
2 2-GRAM * Managing
1 2-GRAM Managing HIV
2 2-GRAM * BACKGROUND
2 2-GRAM BACKGROUND :
2 2-GRAM : There
2 2-GRAM There is
1 2-GRAM is increasing
1 2-GRAM increasing interest
1 2-GRAM interest on
1 2-GRAM the part
1 2-GRAM part of
1 2-GRAM of investigators
1 2-GRAM investigators and
1 2-GRAM the public
1 2-GRAM public at
1 2-GRAM at large
1 2-GRAM large in
1 2-GRAM in finding
1 2-GRAM finding ways
1 2-GRAM ways to
2 2-GRAM to study
1 2-GRAM study and
1 2-GRAM and improve
1 2-GRAM improve treatments
1 2-GRAM treatments for
1 2-GRAM the seriously
1 2-GRAM seriously mentally
1 2-GRAM mentally ill
1 2-GRAM ill without
1 2-GRAM without exposing
1 2-GRAM exposing such
1 2-GRAM such individuals
1 2-GRAM individuals to
1 2-GRAM to unnecessary
1 2-GRAM unnecessary risks
1 2-GRAM risks .
1 2-GRAM * Multidrug
1 2-GRAM Multidrug resistance
1 2-GRAM resistance in
1 2-GRAM in Saccharomyces
1 2-GRAM cerevisiae mainly
1 2-GRAM mainly results
1 2-GRAM results from
1 2-GRAM the overexpression
3 2-GRAM overexpression of
1 2-GRAM genes coding
1 2-GRAM coding for
1 2-GRAM the membrane
1 2-GRAM membrane efflux
1 2-GRAM efflux pumps
1 2-GRAM pumps ,
1 2-GRAM major facilitators
1 2-GRAM facilitators and
1 2-GRAM the ABC
1 2-GRAM ABC binding
1 2-GRAM cassette transporters
1 2-GRAM transporters ,
1 2-GRAM of key
1 2-GRAM key transcription
1 2-GRAM transcription regulators
1 2-GRAM regulators encoded
1 2-GRAM the PDR1
1 2-GRAM PDR1 and
1 2-GRAM and PDR3
1 2-GRAM PDR3 genes
1 2-GRAM * Serum
1 2-GRAM Serum PTH
1 2-GRAM PTH tended
1 2-GRAM tended to
2 2-GRAM to increase
1 2-GRAM the WL
1 2-GRAM WL group
1 2-GRAM group but
5 2-GRAM but not
1 2-GRAM not in
1 2-GRAM the WM
1 2-GRAM WM group
1 2-GRAM group (
1 2-GRAM 06 ).
1 2-GRAM * Bandshift
1 2-GRAM Bandshift experiments
1 2-GRAM experiments demonstrate
1 2-GRAM that BmHR3A
1 2-GRAM BmHR3A binds
1 2-GRAM binds specifically
1 2-GRAM specifically to
1 2-GRAM to RORE
1 2-GRAM RORE (
1 2-GRAM ( Retinoic
1 2-GRAM Retinoic acid
1 2-GRAM acid -
1 2-GRAM related Orphan
1 2-GRAM Orphan receptor
1 2-GRAM receptor Response
1 2-GRAM Response Element
1 2-GRAM Element )-
1 2-GRAM )- like
1 2-GRAM like sequences
1 2-GRAM sequences in
1 2-GRAM the promoters
1 2-GRAM promoters of
2 2-GRAM of both
2 2-GRAM both genes
3 2-GRAM genes ,
1 2-GRAM , thus
1 2-GRAM thus suggesting
2 2-GRAM suggesting a
1 2-GRAM a direct
1 2-GRAM direct role
3 2-GRAM role for
1 2-GRAM for BmHR3A
1 2-GRAM BmHR3A in
1 2-GRAM regulating the
1 2-GRAM the expression
1 2-GRAM of BmGATAbeta
1 2-GRAM BmGATAbeta and
1 2-GRAM and ESP
1 2-GRAM ESP genes
1 2-GRAM genes during
1 2-GRAM during vitellogenesis
1 2-GRAM vitellogenesis .
1 2-GRAM * Efficacy
1 2-GRAM Efficacy of
1 2-GRAM of first
1 2-GRAM first -
1 2-GRAM - generation
1 2-GRAM generation Cavermap
1 2-GRAM Cavermap to
1 2-GRAM to verify
1 2-GRAM verify location
1 2-GRAM location and
1 2-GRAM and function
1 2-GRAM of cavernous
1 2-GRAM cavernous nerves
1 2-GRAM nerves during
1 2-GRAM during radical
1 2-GRAM radical prostatectomy
1 2-GRAM prostatectomy :
1 2-GRAM : a
1 2-GRAM a multi
1 2-GRAM multi -
1 2-GRAM - institutional
1 2-GRAM institutional evaluation
1 2-GRAM evaluation by
1 2-GRAM by experienced
1 2-GRAM experienced surgeons
1 2-GRAM surgeons .
1 2-GRAM * During
1 2-GRAM During most
1 2-GRAM most of
1 2-GRAM cycle ,
1 2-GRAM , separase
1 2-GRAM separase is
1 2-GRAM is kept
1 2-GRAM kept inactive
1 2-GRAM inactive by
1 2-GRAM by binding
1 2-GRAM an inhibitory
1 2-GRAM inhibitory protein
1 2-GRAM protein called
1 2-GRAM called securin
1 2-GRAM securin .
1 2-GRAM , obesity
1 2-GRAM obesity ,
1 2-GRAM , alcohol
1 2-GRAM alcohol intake
1 2-GRAM intake ,
1 2-GRAM and multimetabolic
1 2-GRAM multimetabolic disorders
1 2-GRAM disorders were
1 2-GRAM determined to
1 2-GRAM be independent
1 2-GRAM independent predictors
1 2-GRAM predictors for
1 2-GRAM of hyperuricemia
1 2-GRAM hyperuricemia .
1 2-GRAM study examined
1 2-GRAM examined the
1 2-GRAM of cholesteryl
2 2-GRAM cholesteryl ester
2 2-GRAM ester transfer
1 2-GRAM transfer (
1 2-GRAM ( CET
1 2-GRAM CET ),
1 2-GRAM ), cholesteryl
4 2-GRAM protein (
1 2-GRAM ( CETP
1 2-GRAM CETP )
2 2-GRAM ) activity
1 2-GRAM and phospholipid
1 2-GRAM phospholipid transfer
1 2-GRAM ( PLTP
1 2-GRAM PLTP )
1 2-GRAM the increased
1 2-GRAM increased prevalence
1 2-GRAM prevalence of
1 2-GRAM of coronary
1 2-GRAM artery calcification
1 2-GRAM calcification (
1 2-GRAM ( CAC
1 2-GRAM CAC )
1 2-GRAM in diabetic
1 2-GRAM diabetic subjects
1 2-GRAM subjects compared
1 2-GRAM with nondiabetic
1 2-GRAM nondiabetic subjects
1 2-GRAM subjects and
1 2-GRAM the loss
3 2-GRAM loss of
1 2-GRAM the sex
1 2-GRAM sex difference
2 2-GRAM difference in
1 2-GRAM in CAC
1 2-GRAM CAC in
2 2-GRAM the mouse
1 2-GRAM , both
1 2-GRAM genes reside
1 2-GRAM reside in
1 2-GRAM the syntenic
1 2-GRAM syntenic region
1 2-GRAM region 8E1
1 2-GRAM 8E1 on
1 2-GRAM on chromosome
1 2-GRAM chromosome 8
1 2-GRAM We observed
1 2-GRAM observed NP
1 2-GRAM NP /
1 2-GRAM / NMP4
1 2-GRAM NMP4 /
1 2-GRAM / CIZ
1 2-GRAM CIZ expression
1 2-GRAM in osteocytes
1 2-GRAM osteocytes ,
1 2-GRAM , osteoblasts
1 2-GRAM osteoblasts ,
1 2-GRAM and chondrocytes
1 2-GRAM chondrocytes in
1 2-GRAM in rat
1 2-GRAM rat bone
1 2-GRAM bone .
1 2-GRAM * Following
1 2-GRAM Following baseline
1 2-GRAM baseline clinical
2 2-GRAM clinical examination
1 2-GRAM examination and
1 2-GRAM initial periodontal
1 2-GRAM periodontal therapy
1 2-GRAM therapy ,
1 2-GRAM , 32
1 2-GRAM 32 patients
1 2-GRAM received mucogingival
1 2-GRAM mucogingival surgery
1 2-GRAM surgery with
1 2-GRAM with free
1 2-GRAM free gingival
1 2-GRAM gingival grafts
1 2-GRAM grafts for
1 2-GRAM of insufficient
1 2-GRAM insufficient attached
1 2-GRAM attached gingiva
1 2-GRAM gingiva .
1 2-GRAM the failure
1 2-GRAM failure of
1 2-GRAM the QKTT
1 2-GRAM QKTT motif
1 2-GRAM motif and
1 2-GRAM and TGN46
1 2-GRAM TGN46 cytoplasmic
1 2-GRAM cytoplasmic tail
1 2-GRAM tail to
1 2-GRAM to induce
1 2-GRAM induce steady
1 2-GRAM steady -
1 2-GRAM - state
1 2-GRAM state ER
1 2-GRAM ER localization
1 2-GRAM of vesicular
1 2-GRAM vesicular stomatitis
1 2-GRAM stomatitis virus
1 2-GRAM virus glycoprotein
1 2-GRAM glycoprotein (
1 2-GRAM ( VSVG
1 2-GRAM VSVG )
1 2-GRAM ) chimeras
1 2-GRAM chimeras in
1 2-GRAM in HeLa
2 2-GRAM HeLa and
1 2-GRAM and NRK
1 2-GRAM NRK cells
1 2-GRAM cells indicates
1 2-GRAM indicates that
1 2-GRAM that significant
1 2-GRAM early secretory
1 2-GRAM secretory trafficking
1 2-GRAM trafficking also
1 2-GRAM also exist
1 2-GRAM exist .
1 2-GRAM previously showed
2 2-GRAM that this
1 2-GRAM this proteolysis
1 2-GRAM proteolysis 1
1 2-GRAM ) can
1 2-GRAM be acutely
1 2-GRAM acutely promoted
1 2-GRAM promoted by
1 2-GRAM the phorbol
1 2-GRAM phorbol ester
1 2-GRAM ester phorbol
2 2-GRAM phorbol 12
2 2-GRAM - myristate
2 2-GRAM myristate 13
2 2-GRAM 13 -
2 2-GRAM - acetate
2 2-GRAM acetate (
2 2-GRAM ( PMA
1 2-GRAM PMA ),
1 2-GRAM ), 2
1 2-GRAM ) requires
1 2-GRAM requires a
1 2-GRAM a metalloprotease
1 2-GRAM metalloprotease activity
1 2-GRAM ) generates
1 2-GRAM generates both
1 2-GRAM both shed
1 2-GRAM shed GHBP
1 2-GRAM GHBP and
1 2-GRAM a membrane
1 2-GRAM membrane -
2 2-GRAM - associated
1 2-GRAM associated GHR
1 2-GRAM GHR transmembrane
1 2-GRAM transmembrane /
1 2-GRAM / cytoplasmic
1 2-GRAM cytoplasmic domain
1 2-GRAM domain remnant
1 2-GRAM remnant ,
1 2-GRAM ) results
2 2-GRAM results in
1 2-GRAM in down
1 2-GRAM of GHR
1 2-GRAM GHR abundance
1 2-GRAM abundance and
1 2-GRAM and GH
1 2-GRAM GH signaling
2 2-GRAM signaling .
1 2-GRAM Our data
1 2-GRAM data indicate
1 2-GRAM that SIP1
1 2-GRAM SIP1 is
1 2-GRAM required to
1 2-GRAM to confine
1 2-GRAM confine XBra
1 2-GRAM XBra gene
1 2-GRAM expression to
1 2-GRAM the mesoderm
1 2-GRAM mesoderm .
1 2-GRAM * Changes
1 2-GRAM Changes of
1 2-GRAM the DB
1 2-GRAM DB sequence
1 2-GRAM sequence without
1 2-GRAM without affecting
1 2-GRAM affecting the
1 2-GRAM the postulated
1 2-GRAM postulated stem
1 2-GRAM stem structure
1 2-GRAM structure led
3 2-GRAM led to
1 2-GRAM to drastic
1 2-GRAM drastic losses
1 2-GRAM losses of
1 2-GRAM of translation
1 2-GRAM translation efficiency
2 2-GRAM efficiency .
1 2-GRAM This subfamily
1 2-GRAM subfamily of
1 2-GRAM genes all
1 2-GRAM all have
2 2-GRAM have a
1 2-GRAM single ATP
1 2-GRAM domain at
3 2-GRAM - terminus
1 2-GRAM terminus and
1 2-GRAM single C
1 2-GRAM terminal set
1 2-GRAM set of
1 2-GRAM of transmembrane
1 2-GRAM transmembrane segments
1 2-GRAM segments .
1 2-GRAM * Subsequently
1 2-GRAM Subsequently ,
1 2-GRAM , these
1 2-GRAM these coordinates
1 2-GRAM coordinates must
1 2-GRAM must be
1 2-GRAM be interpreted
1 2-GRAM interpreted to
1 2-GRAM define particular
1 2-GRAM particular tissues
1 2-GRAM tissues and
1 2-GRAM and organs
1 2-GRAM organs .
1 2-GRAM The cyclins
1 2-GRAM cyclins bind
3 2-GRAM bind to
2 2-GRAM to and
1 2-GRAM and activate
1 2-GRAM the CDK
1 2-GRAM CDK ,
1 2-GRAM which leads
1 2-GRAM to phosphorylation
1 2-GRAM phosphorylation (
1 2-GRAM ( and
2 2-GRAM and then
1 2-GRAM then inhibition
1 2-GRAM inhibition )
1 2-GRAM the tumor
2 2-GRAM tumor suppressor
2 2-GRAM suppressor protein
1 2-GRAM , pRb
1 2-GRAM pRb .
1 2-GRAM . pRb
1 2-GRAM pRb controls
1 2-GRAM controls commitment
1 2-GRAM commitment to
1 2-GRAM to progress
1 2-GRAM progress from
1 2-GRAM the G1
1 2-GRAM G1 to
1 2-GRAM phase ,
1 2-GRAM least in
1 2-GRAM in part
1 2-GRAM part by
1 2-GRAM by repressing
1 2-GRAM repressing the
1 2-GRAM the activity
1 2-GRAM the E2F
1 2-GRAM E2F transcription
1 2-GRAM transcription factors
1 2-GRAM factors known
2 2-GRAM known to
1 2-GRAM to promote
1 2-GRAM promote cell
1 2-GRAM mean serum
1 2-GRAM serum creatinine
1 2-GRAM creatinine level
1 2-GRAM level did
1 2-GRAM not change
1 2-GRAM change during
4 2-GRAM the first
1 2-GRAM first 6
1 2-GRAM 6 months
1 2-GRAM months after
1 2-GRAM after withdrawal
1 2-GRAM withdrawal of
1 2-GRAM of MMF
1 2-GRAM MMF .
2 2-GRAM The severity
2 2-GRAM severity of
1 2-GRAM of pathologic
1 2-GRAM pathologic changes
1 2-GRAM changes increased
1 2-GRAM increased with
1 2-GRAM the magnitude
1 2-GRAM magnitude of
1 2-GRAM of percussion
1 2-GRAM percussion .
1 2-GRAM * Patients
1 2-GRAM Patients with
1 2-GRAM with antibody
3 2-GRAM antibody peaks
1 2-GRAM peaks ,
1 2-GRAM , defined
1 2-GRAM as fivefold
1 2-GRAM fivefold or
1 2-GRAM or higher
1 2-GRAM higher increase
1 2-GRAM in antibody
3 2-GRAM antibody titer
1 2-GRAM titer compared
1 2-GRAM the lowest
1 2-GRAM lowest antibody
1 2-GRAM titer over
1 2-GRAM over the
1 2-GRAM the course
1 2-GRAM course of
2 2-GRAM of GBS
1 2-GRAM GBS ,
1 2-GRAM had higher
1 2-GRAM higher disability
1 2-GRAM disability scores
1 2-GRAM scores during
1 2-GRAM first two
1 2-GRAM two weeks
2 2-GRAM weeks of
1 2-GRAM GBS and
1 2-GRAM a worse
1 2-GRAM worse clinical
1 2-GRAM clinical outcome
1 2-GRAM outcome (
2 2-GRAM ( anti
1 2-GRAM - GM1
1 2-GRAM GM1 IgG
1 2-GRAM IgG and
1 2-GRAM and anti
2 2-GRAM - GD1a
2 2-GRAM GD1a IgM
2 2-GRAM IgM antibody
1 2-GRAM peaks )
1 2-GRAM and axonal
1 2-GRAM axonal damage
1 2-GRAM damage (
1 2-GRAM peaks ),
1 2-GRAM ), compared
1 2-GRAM to patients
1 2-GRAM patients without
1 2-GRAM without peak
1 2-GRAM peak antibody
1 2-GRAM antibody titers
1 2-GRAM titers .
1 2-GRAM At 20
1 2-GRAM 20 days
1 2-GRAM days (
1 2-GRAM ( D
1 2-GRAM D )
1 2-GRAM at 3
1 2-GRAM 3 months
2 2-GRAM months post
7 2-GRAM post -
2 2-GRAM - TBI
1 2-GRAM TBI ,
1 2-GRAM , irradiated
1 2-GRAM irradiated rats
1 2-GRAM rats had
1 2-GRAM a significantly
1 2-GRAM lower percentage
1 2-GRAM of avoidance
1 2-GRAM avoidance than
1 2-GRAM than controls
1 2-GRAM controls but
1 2-GRAM but no
1 2-GRAM no statistical
1 2-GRAM statistical difference
1 2-GRAM difference was
1 2-GRAM found at
1 2-GRAM at 5
1 2-GRAM 5 months
2 2-GRAM TBI .
1 2-GRAM . b
1 2-GRAM b /
1 2-GRAM / Two
1 2-GRAM Two -
1 2-GRAM - way
1 2-GRAM way avoidance
1 2-GRAM avoidance test
1 2-GRAM test :
1 2-GRAM : this
1 2-GRAM this test
1 2-GRAM test was
1 2-GRAM was performed
1 2-GRAM performed only
2 2-GRAM only after
1 2-GRAM after TBI
1 2-GRAM * TE
1 2-GRAM TE -
1 2-GRAM - 671
1 2-GRAM 671 cells
2 2-GRAM cells that
1 2-GRAM that were
1 2-GRAM were transfected
2 2-GRAM transfected with
1 2-GRAM with cAMP
1 2-GRAM cAMP response
1 2-GRAM response element
1 2-GRAM element mutant
1 2-GRAM mutant constructs
1 2-GRAM constructs demonstrated
1 2-GRAM demonstrated a
1 2-GRAM a diminished
1 2-GRAM diminished basal
1 2-GRAM basal activity
1 2-GRAM the GnRH
1 2-GRAM GnRH -
2 2-GRAM - II
1 2-GRAM II promoter
1 2-GRAM of clinical
1 2-GRAM clinical course
1 2-GRAM course was
1 2-GRAM expressed by
1 2-GRAM of SOFA
1 2-GRAM SOFA score
2 2-GRAM score (
6 2-GRAM ( group
3 2-GRAM group A
1 2-GRAM A 0
2 2-GRAM 3 point
4 2-GRAM point ,
4 2-GRAM , group
2 2-GRAM group B
1 2-GRAM B 2
1 2-GRAM 9 -
1 2-GRAM 6 point
2 2-GRAM group C
1 2-GRAM C 7
4 2-GRAM 4 -
5 2-GRAM - 7
1 2-GRAM 7 point
1 2-GRAM point )
1 2-GRAM and APACHE
1 2-GRAM APACHE II
1 2-GRAM II score
1 2-GRAM A 3
1 2-GRAM 7 -
1 2-GRAM 1 point
1 2-GRAM B 8
1 2-GRAM 11 .
1 2-GRAM - 10
1 2-GRAM 5 point
1 2-GRAM C 16
1 2-GRAM 16 .
1 2-GRAM - 15
1 2-GRAM 15 .
1 2-GRAM - 14
2 2-GRAM 14 .
1 2-GRAM point ).
1 2-GRAM novel potential
1 2-GRAM potential effector
1 2-GRAM effector of
1 2-GRAM of M
2 2-GRAM M -
2 2-GRAM - Ras
2 2-GRAM Ras and
2 2-GRAM and p21
3 2-GRAM p21 Ras
1 2-GRAM Ras negatively
1 2-GRAM regulates p21
1 2-GRAM Ras -
1 2-GRAM mediated gene
1 2-GRAM gene induction
1 2-GRAM induction and
1 2-GRAM cell growth
2 2-GRAM growth .
1 2-GRAM * Promoter
1 2-GRAM Promoter transcriptional
4 2-GRAM transcriptional activity
1 2-GRAM activity was
1 2-GRAM determined for
1 2-GRAM a wide
1 2-GRAM wide 5
1 2-GRAM ' portion
1 2-GRAM human annexin
1 2-GRAM annexin A5
1 2-GRAM A5 gene
1 2-GRAM , from
1 2-GRAM from bp
1 2-GRAM bp -
1 2-GRAM - 1275
1 2-GRAM 1275 to
1 2-GRAM + 79
1 2-GRAM 79 relative
1 2-GRAM most 5
1 2-GRAM ' of
1 2-GRAM of several
1 2-GRAM several discrete
1 2-GRAM discrete transcription
1 2-GRAM transcription start
1 2-GRAM start points
1 2-GRAM points .
1 2-GRAM * Structure
1 2-GRAM Structure of
1 2-GRAM the EMAPII
1 2-GRAM EMAPII domain
1 2-GRAM human aminoacyl
1 2-GRAM aminoacyl -
1 2-GRAM - tRNA
1 2-GRAM tRNA synthetase
1 2-GRAM synthetase complex
1 2-GRAM complex reveals
1 2-GRAM reveals evolutionary
1 2-GRAM evolutionary dimer
1 2-GRAM dimer mimicry
1 2-GRAM mimicry .
1 2-GRAM * Adding
1 2-GRAM Adding 10
1 2-GRAM 10 mmol
1 2-GRAM mmol SDS
1 2-GRAM SDS /
1 2-GRAM l led
1 2-GRAM to transient
1 2-GRAM transient inhibition
1 2-GRAM inhibition of
1 2-GRAM of acidification
1 2-GRAM acidification ,
1 2-GRAM , metal
1 2-GRAM metal solubilization
1 2-GRAM solubilization and
1 2-GRAM and sulfur
1 2-GRAM sulfur oxidation
1 2-GRAM oxidation .
1 2-GRAM * Competition
1 2-GRAM Competition electrophoretic
1 2-GRAM electrophoretic mobility
1 2-GRAM mobility shift
1 2-GRAM shift and
1 2-GRAM and immunoshift
1 2-GRAM immunoshift assays
1 2-GRAM confirmed that
1 2-GRAM that NF1
1 2-GRAM NF1 factors
1 2-GRAM factors present
1 2-GRAM in nuclear
1 2-GRAM nuclear extracts
1 2-GRAM extracts of
1 2-GRAM of HeLa
1 2-GRAM and CV
1 2-GRAM CV -
1 2-GRAM cells bind
1 2-GRAM the BKV
1 2-GRAM BKV -
1 2-GRAM - MLP
1 2-GRAM MLP .
1 2-GRAM Northern and
1 2-GRAM and Western
1 2-GRAM blot analyses
1 2-GRAM analyses demonstrated
1 2-GRAM that Graf2
1 2-GRAM Graf2 is
2 2-GRAM is expressed
1 2-GRAM in several
1 2-GRAM several tissues
1 2-GRAM tissues ,
3 2-GRAM the highest
1 2-GRAM highest expression
1 2-GRAM in skeletal
1 2-GRAM skeletal muscle
1 2-GRAM muscle .
1 2-GRAM A minimal
1 2-GRAM minimal ER3
1 2-GRAM ER3 sequence
2 2-GRAM of DNA
1 2-GRAM DNA was
1 2-GRAM was further
1 2-GRAM further demonstrated
1 2-GRAM demonstrated to
1 2-GRAM to function
1 2-GRAM function as
1 2-GRAM a FXR
1 2-GRAM FXR HRE
1 2-GRAM HRE and
1 2-GRAM was bound
3 2-GRAM vitro by
1 2-GRAM by FXR
1 2-GRAM FXR -
1 2-GRAM - expressing
1 2-GRAM expressing yeast
1 2-GRAM yeast extracts
1 2-GRAM extracts .
1 2-GRAM In Ka13
1 2-GRAM Ka13 cells
1 2-GRAM , CoCl
1 2-GRAM CoCl (
10 2-GRAM ( 2
1 2-GRAM ) stimulated
1 2-GRAM stimulated expression
1 2-GRAM a luciferase
1 2-GRAM luciferase reporter
1 2-GRAM gene under
1 2-GRAM a 15
2 2-GRAM 15 -
1 2-GRAM - kilobase
1 2-GRAM kilobase pair
1 2-GRAM pair mouse
1 2-GRAM mouse ho
2 2-GRAM ho -
1 2-GRAM 1 promoter
1 2-GRAM ( pHO15luc
1 2-GRAM pHO15luc ).
1 2-GRAM Nine strains
1 2-GRAM were subtyped
1 2-GRAM subtyped as
1 2-GRAM as Camp
1 2-GRAM Camp .
2 2-GRAM . jejuni
1 2-GRAM jejuni subsp
1 2-GRAM subsp .
1 2-GRAM jejuni biotype
1 2-GRAM biotype II
2 2-GRAM II and
2 2-GRAM the remaining
1 2-GRAM remaining ones
1 2-GRAM ones as
1 2-GRAM as biotype
1 2-GRAM biotype I
1 2-GRAM The Ig
1 2-GRAM Ig -
1 2-GRAM related ,
1 2-GRAM , typical
1 2-GRAM typical metazoan
1 2-GRAM metazoan ,
1 2-GRAM , module
1 2-GRAM module is
1 2-GRAM is classified
1 2-GRAM classified to
1 2-GRAM the disulphide
1 2-GRAM disulphide lacking
1 2-GRAM lacking Ig
1 2-GRAM Ig members
1 2-GRAM members and
1 2-GRAM and represents
1 2-GRAM represents the
1 2-GRAM the phylogenetic
1 2-GRAM phylogenetic earliest
1 2-GRAM earliest member
1 2-GRAM this group
2 2-GRAM group .
1 2-GRAM In budding
1 2-GRAM budding yeast
1 2-GRAM yeast ,
1 2-GRAM this latter
1 2-GRAM latter checkpoint
1 2-GRAM checkpoint response
1 2-GRAM response involves
2 2-GRAM the proteins
1 2-GRAM proteins Mad1
1 2-GRAM Mad1 ,
2 2-GRAM , 2
1 2-GRAM , Bub1
1 2-GRAM Bub1 and
1 2-GRAM and Bub3
1 2-GRAM Bub3 ,
1 2-GRAM , whose
1 2-GRAM whose vertebrate
1 2-GRAM vertebrate counterparts
1 2-GRAM counterparts localize
1 2-GRAM to unattached
1 2-GRAM unattached kinetochores
1 2-GRAM kinetochores .
1 2-GRAM We investigated
1 2-GRAM of hyaluronan
1 2-GRAM hyaluronan (
2 2-GRAM ( HA
2 2-GRAM HA )
3 2-GRAM and its
1 2-GRAM its effect
1 2-GRAM on cell
1 2-GRAM cell motility
1 2-GRAM motility in
2 2-GRAM in cells
1 2-GRAM cells expressing
1 2-GRAM the v
2 2-GRAM v -
1 2-GRAM - src
1 2-GRAM src mutants
1 2-GRAM * Oral
1 2-GRAM Oral supplementation
1 2-GRAM supplementation of
1 2-GRAM of L
1 2-GRAM - arginine
1 2-GRAM arginine significantly
1 2-GRAM significantly increased
1 2-GRAM plasma L
1 2-GRAM - citrulline
1 2-GRAM citrulline ,
1 2-GRAM which indicated
1 2-GRAM indicated enhancement
1 2-GRAM enhancement of
1 2-GRAM of NO
1 2-GRAM NO production
1 2-GRAM production .
1 2-GRAM We can
1 2-GRAM can classify
1 2-GRAM classify antibiotics
1 2-GRAM antibiotics into
1 2-GRAM two groups
1 2-GRAM groups based
1 2-GRAM on initial
1 2-GRAM initial bactericidal
1 2-GRAM bactericidal activity
1 2-GRAM activity against
1 2-GRAM against P
1 2-GRAM . aeruginosa
1 2-GRAM aeruginosa ;
1 2-GRAM ; one
1 2-GRAM one class
1 2-GRAM class is
1 2-GRAM is antibiotics
1 2-GRAM antibiotics having
1 2-GRAM having rapid
1 2-GRAM rapid initial
2 2-GRAM initial killing
1 2-GRAM killing such
1 2-GRAM as AMK
1 2-GRAM AMK ,
1 2-GRAM , IPM
1 2-GRAM IPM and
1 2-GRAM and PAPM
1 2-GRAM PAPM ,
1 2-GRAM other is
1 2-GRAM is CAZ
1 2-GRAM CAZ ,
1 2-GRAM , MEPM
1 2-GRAM MEPM showing
1 2-GRAM showing slow
1 2-GRAM slow initial
1 2-GRAM killing .
1 2-GRAM of truncated
1 2-GRAM truncated receptor
1 2-GRAM receptor isoforms
2 2-GRAM isoforms in
1 2-GRAM in diverse
1 2-GRAM diverse species
1 2-GRAM species suggests
1 2-GRAM that these
1 2-GRAM these proteins
1 2-GRAM proteins may
2 2-GRAM may have
1 2-GRAM have important
1 2-GRAM important functional
1 2-GRAM functional roles
1 2-GRAM roles in
1 2-GRAM regulating EGFR
1 2-GRAM EGFR activity
3 2-GRAM * Of
1 2-GRAM Of its
1 2-GRAM its gene
1 2-GRAM gene products
2 2-GRAM products ,
1 2-GRAM , E6
1 2-GRAM E6 binds
1 2-GRAM binds to
1 2-GRAM and inactivates
1 2-GRAM inactivates p53
1 2-GRAM p53 tumor
1 2-GRAM protein by
1 2-GRAM by ubiquitin
1 2-GRAM ubiquitin /
1 2-GRAM / proteasome
1 2-GRAM proteasome -
1 2-GRAM dependent degradation
1 2-GRAM degradation .
2 2-GRAM * Low
1 2-GRAM Low affinity
1 2-GRAM affinity binding
1 2-GRAM of Rab6A
1 2-GRAM Rab6A -
1 2-GRAM - GTP
1 2-GRAM GTP was
1 2-GRAM was also
1 2-GRAM also observed
1 2-GRAM observed (
1 2-GRAM ( K
1 2-GRAM K (
1 2-GRAM ( d
1 2-GRAM d )
1 2-GRAM = 16
1 2-GRAM 16 microm
1 2-GRAM microm ),
1 2-GRAM ), whereas
1 2-GRAM whereas Rab1B
1 2-GRAM Rab1B ,
2 2-GRAM - 5
1 2-GRAM 5 ,
1 2-GRAM 7 ,
2 2-GRAM 8 ,
1 2-GRAM or -
1 2-GRAM - 11A
1 2-GRAM 11A did
1 2-GRAM not bind
1 2-GRAM bind .
1 2-GRAM * (
1 2-GRAM ( 1997
1 2-GRAM 1997 )
1 2-GRAM ) Nature
1 2-GRAM Nature 387
1 2-GRAM 387 ,
1 2-GRAM , 370
1 2-GRAM 370 -
1 2-GRAM - 376
1 2-GRAM 376 )],
1 2-GRAM )], we
1 2-GRAM the metal
1 2-GRAM metal fluoride
1 2-GRAM fluoride ions
1 2-GRAM ions replaced
1 2-GRAM replaced phosphate
1 2-GRAM phosphate at
1 2-GRAM two ATP
3 2-GRAM binding sites
1 2-GRAM sites of
1 2-GRAM the iron
1 2-GRAM iron protein
1 2-GRAM , Kp2
1 2-GRAM Kp2 .
1 2-GRAM A 1
1 2-GRAM pair mismatch
1 2-GRAM mismatch within
1 2-GRAM the corresponding
1 2-GRAM corresponding region
1 2-GRAM the CYP3A4
1 2-GRAM CYP3A4 gene
1 2-GRAM gene was
1 2-GRAM was sufficient
1 2-GRAM sufficient for
1 2-GRAM a differential
1 2-GRAM differential enhancer
1 2-GRAM * AIMS
2 2-GRAM AIMS :
1 2-GRAM To establish
1 2-GRAM a baseline
1 2-GRAM baseline and
2 2-GRAM and intraindividual
2 2-GRAM intraindividual fluctuations
1 2-GRAM fluctuations of
1 2-GRAM the tumour
1 2-GRAM tumour markers
1 2-GRAM markers CEA
1 2-GRAM CEA ,
1 2-GRAM , CA
1 2-GRAM CA 50
1 2-GRAM 50 and
1 2-GRAM and CA
1 2-GRAM CA 242
1 2-GRAM 242 in
1 2-GRAM patients cured
1 2-GRAM cured from
1 2-GRAM from colorectal
1 2-GRAM colorectal cancer
3 2-GRAM and to
1 2-GRAM to test
1 2-GRAM test the
1 2-GRAM that serum
1 2-GRAM serum concentrations
1 2-GRAM concentrations and
1 2-GRAM fluctuations do
1 2-GRAM do not
1 2-GRAM not differ
1 2-GRAM differ from
1 2-GRAM the concentrations
1 2-GRAM in cancer
1 2-GRAM cancer -
1 2-GRAM - free
1 2-GRAM free individuals
2 2-GRAM individuals .
1 2-GRAM * Substitution
1 2-GRAM Substitution of
1 2-GRAM of serine
1 2-GRAM serine residues
1 2-GRAM residues at
1 2-GRAM terminus indicated
3 2-GRAM indicated that
1 2-GRAM that loss
1 2-GRAM of phosphorylation
1 2-GRAM phosphorylation sites
1 2-GRAM sites did
1 2-GRAM not appear
1 2-GRAM appear to
1 2-GRAM to have
1 2-GRAM have any
1 2-GRAM on transcription
2 2-GRAM transcription and
1 2-GRAM and replication
1 2-GRAM Molecular analysis
1 2-GRAM the pRA2
1 2-GRAM pRA2 partitioning
1 2-GRAM partitioning region
2 2-GRAM region :
1 2-GRAM : ParB
1 2-GRAM ParB autoregulates
1 2-GRAM autoregulates parAB
1 2-GRAM parAB transcription
1 2-GRAM and forms
1 2-GRAM forms a
1 2-GRAM a nucleoprotein
1 2-GRAM nucleoprotein complex
3 2-GRAM complex with
1 2-GRAM the plasmid
1 2-GRAM plasmid partition
1 2-GRAM partition site
1 2-GRAM site ,
1 2-GRAM , parS
1 2-GRAM parS .
1 2-GRAM Tumor cell
1 2-GRAM lines transduced
1 2-GRAM transduced at
1 2-GRAM an MOI
1 2-GRAM MOI of
1 2-GRAM of 8
1 2-GRAM 8 for
1 2-GRAM for 3
1 2-GRAM 3 days
1 2-GRAM days led
1 2-GRAM to >
1 2-GRAM > 90
1 2-GRAM % gene
1 2-GRAM gene transfer
1 2-GRAM transfer efficiency
1 2-GRAM No ISREs
1 2-GRAM ISREs could
1 2-GRAM could be
1 2-GRAM be identified
1 2-GRAM identified in
1 2-GRAM mouse promoter
1 2-GRAM * GABA
1 2-GRAM GABA (
4 2-GRAM ( B
1 2-GRAM B )
1 2-GRAM ) R1g
1 2-GRAM R1g was
3 2-GRAM in both
1 2-GRAM both brain
1 2-GRAM brain and
1 2-GRAM and peripheral
1 2-GRAM peripheral tissues
1 2-GRAM tissues .
1 2-GRAM * Granulocyte
1 2-GRAM Granulocyte colony
1 2-GRAM colony -
1 2-GRAM - stimulating
1 2-GRAM stimulating factor
1 2-GRAM ( G
1 2-GRAM G -
1 2-GRAM - CSF
1 2-GRAM CSF )
1 2-GRAM ) administration
1 2-GRAM administration in
1 2-GRAM vivo has
1 2-GRAM to improve
1 2-GRAM improve the
1 2-GRAM the defence
1 2-GRAM defence mechanisms
1 2-GRAM mechanisms against
1 2-GRAM against infection
1 2-GRAM infection by
1 2-GRAM by different
1 2-GRAM different microbes
1 2-GRAM microbes .
1 2-GRAM * Use
1 2-GRAM Use of
1 2-GRAM a dual
1 2-GRAM dual -
1 2-GRAM - pulse
1 2-GRAM pulse lithotripter
1 2-GRAM lithotripter to
1 2-GRAM generate a
1 2-GRAM a localized
1 2-GRAM localized and
1 2-GRAM and intensified
1 2-GRAM intensified cavitation
1 2-GRAM cavitation field
1 2-GRAM field .
1 2-GRAM The best
1 2-GRAM best regression
1 2-GRAM regression model
1 2-GRAM model for
1 2-GRAM for predicting
1 2-GRAM predicting changes
1 2-GRAM the WCXR
1 2-GRAM WCXR included
1 2-GRAM included time
1 2-GRAM to first
1 2-GRAM first positive
1 2-GRAM positive culture
2 2-GRAM culture and
1 2-GRAM and antibody
1 2-GRAM titer for
1 2-GRAM for Pa
1 2-GRAM Pa elastase
1 2-GRAM elastase .
1 2-GRAM The parameters
1 2-GRAM parameters SF2
1 2-GRAM SF2 and
1 2-GRAM and plating
1 2-GRAM plating efficiency
1 2-GRAM efficiency were
1 2-GRAM were stable
1 2-GRAM stable throughout
2 2-GRAM throughout the
1 2-GRAM the 4
1 2-GRAM year test
1 2-GRAM test period
1 2-GRAM period .
1 2-GRAM The process
1 2-GRAM process has
1 2-GRAM been applied
1 2-GRAM applied to
1 2-GRAM the river
1 2-GRAM river reclamation
1 2-GRAM reclamation in
1 2-GRAM in Yangpu
1 2-GRAM Yangpu District
1 2-GRAM District of
1 2-GRAM of Shanghai
1 2-GRAM Shanghai City
1 2-GRAM City ,
1 2-GRAM , China
1 2-GRAM China .
2 2-GRAM * Multiple
1 2-GRAM Multiple regression
1 2-GRAM analysis performed
1 2-GRAM performed between
1 2-GRAM between these
1 2-GRAM these long
1 2-GRAM long -
1 2-GRAM - term
1 2-GRAM term abiotic
1 2-GRAM abiotic factors
1 2-GRAM factors and
1 2-GRAM and nymphal
1 2-GRAM nymphal abundance
1 2-GRAM abundance in
1 2-GRAM in positive
1 2-GRAM positive sites
1 2-GRAM sites showed
1 2-GRAM showed high
1 2-GRAM high relationship
1 2-GRAM relationship (
1 2-GRAM ( R2
1 2-GRAM R2 coefficients
1 2-GRAM coefficients )
1 2-GRAM for every
1 2-GRAM every habitat
1 2-GRAM habitat category
1 2-GRAM category and
1 2-GRAM and explained
1 2-GRAM explained >
1 2-GRAM > 50
1 2-GRAM the variation
1 2-GRAM variation in
1 2-GRAM in tick
1 2-GRAM tick abundance
1 2-GRAM abundance .
1 2-GRAM The v
1 2-GRAM - Src
1 2-GRAM Src SH3
2 2-GRAM SH3 domain
1 2-GRAM domain facilitates
1 2-GRAM facilitates a
2 2-GRAM a cell
1 2-GRAM cell adhesion
1 2-GRAM adhesion -
3 2-GRAM - independent
1 2-GRAM independent association
1 2-GRAM with focal
1 2-GRAM focal adhesion
1 2-GRAM adhesion kinase
2 2-GRAM Of the
1 2-GRAM the six
1 2-GRAM six cases
1 2-GRAM cases of
1 2-GRAM of malignant
1 2-GRAM malignant polyposis
1 2-GRAM polyposis ,
1 2-GRAM , none
1 2-GRAM none were
1 2-GRAM were identified
1 2-GRAM identified using
1 2-GRAM using CT
1 2-GRAM CT ,
1 2-GRAM and only
1 2-GRAM only two
1 2-GRAM two were
1 2-GRAM were diagnosed
1 2-GRAM diagnosed by
1 2-GRAM by small
1 2-GRAM small bowel
1 2-GRAM bowel follow
2 2-GRAM follow -
1 2-GRAM - through
1 2-GRAM through .
1 2-GRAM * Right
1 2-GRAM Right LHR
1 2-GRAM LHR (
1 2-GRAM - LHR
1 2-GRAM LHR )
1 2-GRAM ) provided
1 2-GRAM provided the
2 2-GRAM the best
1 2-GRAM best interobserver
1 2-GRAM interobserver and
1 2-GRAM and intraobserver
1 2-GRAM intraobserver reproducibility
1 2-GRAM reproducibility .
1 2-GRAM We also
1 2-GRAM also reported
1 2-GRAM reported the
2 2-GRAM the identification
2 2-GRAM of three
1 2-GRAM three corresponding
1 2-GRAM corresponding alternative
1 2-GRAM alternative first
1 2-GRAM first exons
1 2-GRAM exons and
1 2-GRAM an intronic
2 2-GRAM intronic promoter
1 2-GRAM human PDE5A
1 2-GRAM PDE5A gene
1 2-GRAM Of major
1 2-GRAM major concern
1 2-GRAM concern to
1 2-GRAM to food
1 2-GRAM food processors
1 2-GRAM processors is
1 2-GRAM the inadvertent
1 2-GRAM inadvertent cross
1 2-GRAM - contact
1 2-GRAM contact of
1 2-GRAM of food
1 2-GRAM food products
1 2-GRAM products with
1 2-GRAM with allergenic
1 2-GRAM allergenic residues
1 2-GRAM residues ,
1 2-GRAM which could
1 2-GRAM could result
1 2-GRAM result in
1 2-GRAM in potentially
1 2-GRAM potentially life
1 2-GRAM life -
1 2-GRAM - threatening
1 2-GRAM threatening reactions
1 2-GRAM reactions in
3 2-GRAM in those
2 2-GRAM those with
1 2-GRAM a food
1 2-GRAM food allergy
1 2-GRAM allergy .
1 2-GRAM * Diffuse
1 2-GRAM Diffuse myalgias
1 2-GRAM myalgias were
1 2-GRAM were more
1 2-GRAM more frequent
1 2-GRAM frequent in
1 2-GRAM with than
1 2-GRAM than without
1 2-GRAM without an
1 2-GRAM an MMF
1 2-GRAM MMF lesion
1 2-GRAM lesion at
1 2-GRAM at deltoid
1 2-GRAM deltoid muscle
1 2-GRAM muscle biopsy
1 2-GRAM biopsy (
1 2-GRAM . 0001
1 2-GRAM 0001 ).
1 2-GRAM * Functional
1 2-GRAM Functional analysis
1 2-GRAM of various
1 2-GRAM various PTP
1 2-GRAM PTP -
1 2-GRAM deficient DT40
1 2-GRAM DT40 B
3 2-GRAM B cell
1 2-GRAM lines stably
1 2-GRAM stably expressing
1 2-GRAM expressing wild
1 2-GRAM type chimeric
1 2-GRAM chimeric Fc
1 2-GRAM Fc gamma
1 2-GRAM gamma RIIB1
1 2-GRAM RIIB1 -
1 2-GRAM - PECAM
1 2-GRAM PECAM -
1 2-GRAM 1 receptor
1 2-GRAM receptor indicated
1 2-GRAM that cytoplasmic
1 2-GRAM cytoplasmic Src
2 2-GRAM Src homology
1 2-GRAM homology 2
2 2-GRAM - domain
1 2-GRAM domain -
1 2-GRAM - containing
1 2-GRAM containing phosphatases
1 2-GRAM phosphatases ,
1 2-GRAM , SHP
2 2-GRAM SHP -
2 2-GRAM 1 and
1 2-GRAM and SHP
1 2-GRAM both necessary
1 2-GRAM necessary and
1 2-GRAM and sufficient
1 2-GRAM sufficient to
1 2-GRAM to deliver
1 2-GRAM deliver inhibitory
1 2-GRAM inhibitory negative
1 2-GRAM regulation upon
1 2-GRAM upon coligation
1 2-GRAM coligation of
1 2-GRAM BCR complex
1 2-GRAM with inhibitory
1 2-GRAM inhibitory receptor
2 2-GRAM receptor .
1 2-GRAM * Subtraction
1 2-GRAM Subtraction hybridization
1 2-GRAM hybridization identified
1 2-GRAM identified melanoma
1 2-GRAM melanoma differentiation
1 2-GRAM differentiation associated
1 2-GRAM associated gene
1 2-GRAM gene -
1 2-GRAM ( mda
1 2-GRAM mda -
1 2-GRAM 7 ),
2 2-GRAM ), as
1 2-GRAM gene induced
1 2-GRAM induced during
1 2-GRAM during these
1 2-GRAM these physiological
1 2-GRAM physiological changes
1 2-GRAM human melanoma
1 2-GRAM melanoma cells
1 2-GRAM A rare
1 2-GRAM rare case
2 2-GRAM case of
1 2-GRAM of primary
1 2-GRAM primary group
1 2-GRAM A streptococcal
1 2-GRAM streptococcal peritonitis
1 2-GRAM peritonitis .
1 2-GRAM * Among
1 2-GRAM Among individuals
1 2-GRAM individuals ,
3 2-GRAM , however
1 2-GRAM changes were
1 2-GRAM were strongly
1 2-GRAM strongly correlated
2 2-GRAM correlated with
1 2-GRAM with ACR
1 2-GRAM ACR levels
1 2-GRAM levels at
1 2-GRAM baseline .
1 2-GRAM The subjects
1 2-GRAM subjects in
1 2-GRAM the augmented
1 2-GRAM augmented feedback
1 2-GRAM feedback group
1 2-GRAM group significantly
1 2-GRAM significantly reduced
1 2-GRAM reduced their
1 2-GRAM their peak
1 2-GRAM peak vertical
1 2-GRAM vertical ground
1 2-GRAM ground reaction
1 2-GRAM reaction force
1 2-GRAM force in
1 2-GRAM both post
3 2-GRAM - test
1 2-GRAM test conditions
1 2-GRAM conditions (
1 2-GRAM - minute
1 2-GRAM minute post
2 2-GRAM test reduction
2 2-GRAM reduction ,
6 2-GRAM , 0
1 2-GRAM . 85
1 2-GRAM 85 +/-
1 2-GRAM 62 ;
1 2-GRAM ; 1
1 2-GRAM - week
1 2-GRAM week post
1 2-GRAM . 74
1 2-GRAM 74 +/-
1 2-GRAM 58 )
1 2-GRAM the sensory
1 2-GRAM sensory ,
2 2-GRAM , control
1 2-GRAM control I
1 2-GRAM I ,
1 2-GRAM and control
1 2-GRAM control II
1 2-GRAM II feedback
1 2-GRAM feedback groups
4 2-GRAM groups .
1 2-GRAM The blood
1 2-GRAM blood levels
1 2-GRAM of lactate
1 2-GRAM lactate ,
1 2-GRAM , pyruvate
1 2-GRAM pyruvate and
1 2-GRAM and amino
1 2-GRAM acids were
1 2-GRAM not elevated
1 2-GRAM elevated .
1 2-GRAM * Histological
1 2-GRAM Histological examination
1 2-GRAM examination showed
1 2-GRAM showed lichenoid
1 2-GRAM lichenoid changes
1 2-GRAM changes ,
1 2-GRAM , acantholytic
1 2-GRAM acantholytic blister
1 2-GRAM blister formation
1 2-GRAM formation and
1 2-GRAM and apoptotic
1 2-GRAM apoptotic keratinocytes
1 2-GRAM keratinocytes .
1 2-GRAM * Enantiomer
1 2-GRAM Enantiomer separation
1 2-GRAM separation of
1 2-GRAM of venlafaxine
1 2-GRAM venlafaxine and
1 2-GRAM and O
1 2-GRAM O -
1 2-GRAM - desmethylvenlafaxine
1 2-GRAM desmethylvenlafaxine in
1 2-GRAM human plasma
1 2-GRAM plasma .
1 2-GRAM * Paul
1 2-GRAM Paul Monagle
1 2-GRAM Monagle addresses
1 2-GRAM addresses the
1 2-GRAM the epidemiology
1 2-GRAM epidemiology of
1 2-GRAM of neonatal
1 2-GRAM neonatal thrombosis
1 2-GRAM thrombosis outside
1 2-GRAM outside of
1 2-GRAM the central
1 2-GRAM central nervous
1 2-GRAM nervous system
1 2-GRAM system in
1 2-GRAM both arterial
1 2-GRAM arterial and
1 2-GRAM and venous
1 2-GRAM venous locations
1 2-GRAM locations ,
3 2-GRAM and those
1 2-GRAM those that
1 2-GRAM that occur
1 2-GRAM occur in
2 2-GRAM in utero
1 2-GRAM utero .
1 2-GRAM The MSL
1 2-GRAM MSL complex
1 2-GRAM specifically localized
1 2-GRAM localized on
1 2-GRAM the male
1 2-GRAM male X
1 2-GRAM X chromosome
1 2-GRAM chromosome to
1 2-GRAM increase its
2 2-GRAM its expression
1 2-GRAM expression approximately
1 2-GRAM approximately 2
1 2-GRAM fold .
1 2-GRAM a booster
1 2-GRAM booster dose
2 2-GRAM dose of
1 2-GRAM of tetanus
1 2-GRAM tetanus toxoid
1 2-GRAM toxoid after
1 2-GRAM after different
1 2-GRAM different primary
1 2-GRAM primary courses
1 2-GRAM courses of
1 2-GRAM of vaccination
1 2-GRAM vaccination :
1 2-GRAM : implications
1 2-GRAM implications on
2 2-GRAM of immune
1 2-GRAM immune globulin
1 2-GRAM globulin .
2 2-GRAM terminal region
1 2-GRAM of Crk
1 2-GRAM Crk contains
1 2-GRAM contains negative
2 2-GRAM negative regulatory
1 2-GRAM elements important
1 2-GRAM important for
2 2-GRAM for both
1 2-GRAM both Abl
1 2-GRAM Abl and
1 2-GRAM and FAK
1 2-GRAM FAK dependent
1 2-GRAM dependent signal
1 2-GRAM signal pathways
1 2-GRAM pathways ,
1 2-GRAM and offers
1 2-GRAM offers a
1 2-GRAM a paradigm
1 2-GRAM paradigm for
1 2-GRAM for an
1 2-GRAM an autoinhibitory
1 2-GRAM autoinhibitory region
1 2-GRAM region in
1 2-GRAM the SH3
1 2-GRAM SH3 linker
1 2-GRAM linker /
1 2-GRAM / C
1 2-GRAM terminal SH3
1 2-GRAM The distribution
1 2-GRAM distribution of
1 2-GRAM of red
1 2-GRAM red rice
1 2-GRAM rice cultivation
1 2-GRAM cultivation in
1 2-GRAM in Sri
1 2-GRAM Sri Lanka
1 2-GRAM Lanka is
1 2-GRAM is coincident
1 2-GRAM coincident with
1 2-GRAM the HIDD
1 2-GRAM HIDD villages
1 2-GRAM villages .
1 2-GRAM * Prophylactic
1 2-GRAM Prophylactic lymph
1 2-GRAM lymph node
1 2-GRAM node dissection
1 2-GRAM dissection or
1 2-GRAM or radiation
1 2-GRAM radiation therapy
1 2-GRAM therapy to
1 2-GRAM the nodal
1 2-GRAM nodal chain
1 2-GRAM chain may
1 2-GRAM may decrease
1 2-GRAM decrease local
1 2-GRAM local recurrence
1 2-GRAM recurrence but
1 2-GRAM but does
1 2-GRAM not consistently
1 2-GRAM consistently affect
1 2-GRAM affect overall
1 2-GRAM overall survival
1 2-GRAM survival .
1 2-GRAM * Secretion
1 2-GRAM Secretion of
1 2-GRAM of interleukin
1 2-GRAM , RANTES
1 2-GRAM RANTES ,
1 2-GRAM , macrophage
1 2-GRAM protein 1alpha
1 2-GRAM 1alpha ,
1 2-GRAM and 10
1 2-GRAM 10 -
1 2-GRAM - kappaDa
1 2-GRAM kappaDa IFN
1 2-GRAM IFN -
1 2-GRAM - gamma
1 2-GRAM gamma -
1 2-GRAM inducible protein
1 2-GRAM protein were
1 2-GRAM were increased
1 2-GRAM increased in
1 2-GRAM in differentiating
1 2-GRAM differentiating keratinocytes
1 2-GRAM keratinocytes by
1 2-GRAM by E6
1 2-GRAM E6 .
1 2-GRAM : ChromaFlo
1 2-GRAM ChromaFlo -
1 2-GRAM - enhanced
1 2-GRAM enhanced IVUS
1 2-GRAM IVUS demonstrates
1 2-GRAM demonstrates colorized
1 2-GRAM colorized blood
4 2-GRAM blood flow
1 2-GRAM flow inside
1 2-GRAM inside the
1 2-GRAM the vessel
1 2-GRAM vessel lumen
1 2-GRAM lumen ,
1 2-GRAM is helpful
1 2-GRAM helpful in
1 2-GRAM in distinguishing
1 2-GRAM distinguishing echolucent
1 2-GRAM echolucent disease
1 2-GRAM disease from
1 2-GRAM from luminal
1 2-GRAM luminal blood
1 2-GRAM flow and
1 2-GRAM and can
1 2-GRAM can also
1 2-GRAM be used
1 2-GRAM to perform
1 2-GRAM perform peripheral
1 2-GRAM peripheral interventions
1 2-GRAM interventions in
1 2-GRAM with renal
1 2-GRAM renal failure
1 2-GRAM failure or
1 2-GRAM or allergy
1 2-GRAM allergy ,
1 2-GRAM , avoiding
1 2-GRAM avoiding the
1 2-GRAM of contrast
1 2-GRAM contrast media
1 2-GRAM media .
1 2-GRAM Additional factors
1 2-GRAM factors such
1 2-GRAM as advanced
1 2-GRAM advanced age
1 2-GRAM , concomitant
1 2-GRAM concomitant use
1 2-GRAM of corticosteroids
1 2-GRAM corticosteroids or
1 2-GRAM or anticoagulants
1 2-GRAM anticoagulants ,
1 2-GRAM , prior
1 2-GRAM prior ulcer
1 2-GRAM ulcer complications
1 2-GRAM complications and
1 2-GRAM and co
1 2-GRAM - morbid
1 2-GRAM morbid diseases
1 2-GRAM diseases may
1 2-GRAM may further
1 2-GRAM further increase
1 2-GRAM increase the
1 2-GRAM the risk
1 2-GRAM risk of
1 2-GRAM of bleeding
1 2-GRAM bleeding .
1 2-GRAM : Using
1 2-GRAM Using icodextrin
1 2-GRAM icodextrin -
3 2-GRAM - based
1 2-GRAM based instead
1 2-GRAM instead of
1 2-GRAM of glucose
1 2-GRAM glucose -
1 2-GRAM based PD
1 2-GRAM PD fluids
1 2-GRAM fluids can
1 2-GRAM can largely
1 2-GRAM largely reduce
1 2-GRAM reduce the
1 2-GRAM the formation
1 2-GRAM formation of
1 2-GRAM of Amadori
1 2-GRAM Amadori albumin
1 2-GRAM albumin and
1 2-GRAM and AGEs
1 2-GRAM AGEs .
1 2-GRAM A central
1 2-GRAM central finding
1 2-GRAM finding is
1 2-GRAM a GC
1 2-GRAM GC -
2 2-GRAM - rich
1 2-GRAM rich sequence
1 2-GRAM sequence in
1 2-GRAM - 99
1 2-GRAM 99 /-
1 2-GRAM /- 91
1 2-GRAM 91 Cp
1 2-GRAM Cp region
1 2-GRAM region that
2 2-GRAM is essential
1 2-GRAM for oriPI
2 2-GRAM oriPI -
2 2-GRAM - EBNA1
2 2-GRAM EBNA1 -
1 2-GRAM independent as
1 2-GRAM as oriPI
1 2-GRAM dependent activity
1 2-GRAM , SB203580
1 2-GRAM SB203580 inhibited
1 2-GRAM inhibited LPS
1 2-GRAM LPS -
1 2-GRAM induced activation
1 2-GRAM of Sp1
2 2-GRAM Sp1 ,
1 2-GRAM cells transfected
1 2-GRAM a plasmid
1 2-GRAM plasmid containing
1 2-GRAM the Sp1
1 2-GRAM Sp1 consensus
1 2-GRAM consensus sequence
1 2-GRAM sequence .
1 2-GRAM A new
1 2-GRAM new echocardiographic
1 2-GRAM echocardiographic technique
1 2-GRAM technique is
1 2-GRAM is described
1 2-GRAM described with
1 2-GRAM a conventional
1 2-GRAM conventional M
1 2-GRAM M mode
1 2-GRAM mode ,
1 2-GRAM , digitalised
1 2-GRAM digitalised 2D
1 2-GRAM 2D and
1 2-GRAM and tissular
1 2-GRAM tissular Doppler
1 2-GRAM Doppler which
1 2-GRAM which has
1 2-GRAM a comparable
1 2-GRAM comparable ability
1 2-GRAM to identify
1 2-GRAM the anomalous
1 2-GRAM anomalous pathways
1 2-GRAM pathways of
1 2-GRAM of electric
1 2-GRAM electric conduction
1 2-GRAM conduction using
1 2-GRAM a non
1 2-GRAM - invasive
1 2-GRAM invasive method
2 2-GRAM method .
1 2-GRAM * Is
1 2-GRAM Is clopidogrel
1 2-GRAM clopidogrel superior
2 2-GRAM superior to
1 2-GRAM to aspirin
2 2-GRAM aspirin in
1 2-GRAM in secondary
2 2-GRAM secondary prevention
2 2-GRAM prevention of
2 2-GRAM of vascular
2 2-GRAM vascular disease
1 2-GRAM disease ?
1 2-GRAM ? The
1 2-GRAM The cornerstone
1 2-GRAM cornerstone in
1 2-GRAM in clinical
1 2-GRAM clinical evidence
2 2-GRAM evidence of
1 2-GRAM the relative
1 2-GRAM relative efficacy
1 2-GRAM efficacy of
1 2-GRAM of thienopyridines
1 2-GRAM thienopyridines (
1 2-GRAM ( clopidogrel
1 2-GRAM clopidogrel ,
1 2-GRAM , ticlopidine
1 2-GRAM ticlopidine )
1 2-GRAM ) versus
1 2-GRAM versus aspirin
1 2-GRAM the secondary
1 2-GRAM disease is
1 2-GRAM the Clopidogrel
1 2-GRAM Clopidogrel versus
1 2-GRAM versus Aspirin
1 2-GRAM Aspirin in
1 2-GRAM in Patients
1 2-GRAM Patients at
1 2-GRAM at Risk
1 2-GRAM Risk of
1 2-GRAM of Ischaemic
1 2-GRAM Ischaemic Events
1 2-GRAM Events trial
1 2-GRAM trial .
1 2-GRAM The role
1 2-GRAM the Vp1
1 2-GRAM Vp1 DBD
1 2-GRAM DBD during
1 2-GRAM during infection
1 2-GRAM infection was
1 2-GRAM was investigated
1 2-GRAM investigated by
1 2-GRAM by taking
1 2-GRAM taking advantage
1 2-GRAM advantage of
1 2-GRAM of NLS
1 2-GRAM NLS phenotypic
1 2-GRAM phenotypic complementation
1 2-GRAM complementation (
1 2-GRAM ( N
1 2-GRAM N .
1 2-GRAM The probability
1 2-GRAM probability of
1 2-GRAM with lamotrigine
1 2-GRAM lamotrigine being
1 2-GRAM being maintained
1 2-GRAM maintained for
1 2-GRAM for six
2 2-GRAM six months
2 2-GRAM months was
1 2-GRAM was 86
1 2-GRAM 86 %,
1 2-GRAM %, for
1 2-GRAM for twelve
1 2-GRAM twelve months
1 2-GRAM months 61
1 2-GRAM 61 %
1 2-GRAM % and
1 2-GRAM and for
1 2-GRAM for three
1 2-GRAM three years
1 2-GRAM years 31
1 2-GRAM 31 %.
1 2-GRAM Recent advances
1 2-GRAM advances have
1 2-GRAM have shown
1 2-GRAM shown that
1 2-GRAM that volatile
1 2-GRAM volatile sulfur
1 2-GRAM sulfur is
1 2-GRAM a result
1 2-GRAM result of
1 2-GRAM of ecological
1 2-GRAM ecological interactions
1 2-GRAM interactions and
1 2-GRAM and transformation
1 2-GRAM transformation processes
1 2-GRAM processes through
1 2-GRAM through planktonic
1 2-GRAM planktonic food
1 2-GRAM food webs
1 2-GRAM webs .
1 2-GRAM * OsBBPI
1 2-GRAM OsBBPI was
1 2-GRAM be rapidly
1 2-GRAM rapidly induced
1 2-GRAM induced in
1 2-GRAM in rice
1 2-GRAM rice seedling
1 2-GRAM seedling leaf
1 2-GRAM leaf in
1 2-GRAM to cut
1 2-GRAM cut ,
1 2-GRAM exogenous jasmonic
1 2-GRAM jasmonic acid
1 2-GRAM ( JA
1 2-GRAM JA ),
1 2-GRAM two potent
2 2-GRAM potent protein
4 2-GRAM protein phosphatase
2 2-GRAM phosphatase 2A
2 2-GRAM 2A (
2 2-GRAM ( PP2A
2 2-GRAM PP2A )
1 2-GRAM ) inhibitors
1 2-GRAM inhibitors ,
1 2-GRAM , cantharidin
1 2-GRAM cantharidin (
1 2-GRAM ( CN
1 2-GRAM CN )
1 2-GRAM and endothall
1 2-GRAM endothall (
1 2-GRAM ( EN
1 2-GRAM EN ),
1 2-GRAM ), in
1 2-GRAM a light
1 2-GRAM light /
1 2-GRAM / dark
1 2-GRAM dark -,
1 2-GRAM -, time
1 2-GRAM time -
1 2-GRAM and dose
1 2-GRAM dose -
1 2-GRAM dependent manner
1 2-GRAM manner ;
1 2-GRAM ; this
1 2-GRAM this induction
1 2-GRAM induction was
2 2-GRAM was completely
1 2-GRAM completely inhibited
1 2-GRAM inhibited by
1 2-GRAM by cycloheximide
1 2-GRAM cycloheximide (
1 2-GRAM ( CHX
1 2-GRAM CHX ),
1 2-GRAM ), indicating
1 2-GRAM a requirement
1 2-GRAM requirement for
1 2-GRAM for de
1 2-GRAM synthesis in
1 2-GRAM in its
1 2-GRAM induction .
1 2-GRAM of ace2Delta
1 2-GRAM ace2Delta cells
1 2-GRAM cells reveals
1 2-GRAM reveals that
1 2-GRAM that Ace2p
1 2-GRAM Ace2p is
1 2-GRAM for cell
1 2-GRAM cell separation
1 2-GRAM separation but
1 2-GRAM not for
1 2-GRAM for polarized
1 2-GRAM polarized growth
1 2-GRAM this investigation
1 2-GRAM investigation was
1 2-GRAM study the
1 2-GRAM the morphological
1 2-GRAM morphological characteristics
1 2-GRAM characteristics of
1 2-GRAM the fibrous
1 2-GRAM fibrous tissue
1 2-GRAM tissue capsule
1 2-GRAM capsule resulting
2 2-GRAM resulting from
1 2-GRAM the implantation
1 2-GRAM implantation of
1 2-GRAM of aluminum
1 2-GRAM aluminum calcium
1 2-GRAM calcium phosphate
1 2-GRAM phosphate (
1 2-GRAM ( ALCAP
1 2-GRAM ALCAP )
1 2-GRAM and hydroxyapetite
1 2-GRAM hydroxyapetite (
1 2-GRAM ) bioceramics
1 2-GRAM bioceramics .
1 2-GRAM The event
1 2-GRAM event rate
1 2-GRAM rate in
1 2-GRAM with chronic
1 2-GRAM chronic Irr
1 2-GRAM Irr -
2 2-GRAM - rMFP
2 2-GRAM rMFP or
1 2-GRAM or Un
1 2-GRAM Un -
2 2-GRAM - nrMFP
1 2-GRAM nrMFP was
1 2-GRAM was markedly
1 2-GRAM markedly higher
1 2-GRAM higher than
1 2-GRAM than it
2 2-GRAM it was
1 2-GRAM was in
1 2-GRAM with Rev
1 2-GRAM or Sta
1 2-GRAM Sta -
1 2-GRAM nrMFP .
1 2-GRAM In summary
1 2-GRAM summary ,
1 2-GRAM we conclude
1 2-GRAM conclude that
1 2-GRAM the adenoviral
1 2-GRAM adenoviral oncoprotein
1 2-GRAM oncoprotein E1A
1 2-GRAM E1A activates
2 2-GRAM transcription from
1 2-GRAM the endogenous
1 2-GRAM endogenous AP
5 2-GRAM AP -
2 2-GRAM - 2alpha
1 2-GRAM 2alpha gene
1 2-GRAM an effect
1 2-GRAM effect that
1 2-GRAM involves transcriptional
1 2-GRAM transcriptional derepression
1 2-GRAM derepression of
4 2-GRAM the AP
1 2-GRAM 2alpha promoter
2 2-GRAM promoter by
1 2-GRAM of E1A
1 2-GRAM E1A with
1 2-GRAM - 2rep
1 2-GRAM 2rep corepressor
1 2-GRAM corepressor CtBP1
1 2-GRAM CtBP1 .
1 2-GRAM * Unusual
1 2-GRAM Unusual two
1 2-GRAM domain arginine
1 2-GRAM arginine kinases
1 2-GRAM kinases (
1 2-GRAM ( AKs
1 2-GRAM AKs )
1 2-GRAM ) arose
1 2-GRAM arose independently
1 2-GRAM independently at
1 2-GRAM least two
1 2-GRAM two times
1 2-GRAM times during
1 2-GRAM during molecular
1 2-GRAM molecular evolution
1 2-GRAM of phosphagen
1 2-GRAM phosphagen kinases
1 2-GRAM kinases :
1 2-GRAM : AKs
1 2-GRAM AKs from
1 2-GRAM the primitive
1 2-GRAM primitive sea
1 2-GRAM sea anemone
1 2-GRAM anemone Anthopleurura
1 2-GRAM Anthopleurura japonicus
1 2-GRAM japonicus and
1 2-GRAM and from
1 2-GRAM the clam
1 2-GRAM clam Pseudocardium
1 2-GRAM Pseudocardium sachalinensis
1 2-GRAM sachalinensis .
1 2-GRAM * Mutagenesis
1 2-GRAM Mutagenesis of
1 2-GRAM of SNT1
1 2-GRAM SNT1 (
1 2-GRAM ( IRS
1 2-GRAM IRS )
1 2-GRAM ) CX
1 2-GRAM CX identified
1 2-GRAM identified three
1 2-GRAM three classes
2 2-GRAM classes of
1 2-GRAM of effector
1 2-GRAM effector motifs
1 2-GRAM motifs within
1 2-GRAM within SNT
1 2-GRAM SNT critical
1 2-GRAM critical for
1 2-GRAM both sustained
2 2-GRAM ERK activation
1 2-GRAM activation and
1 2-GRAM and neuronal
1 2-GRAM neuronal differentiation
1 2-GRAM differentiation :
2 2-GRAM : 1
1 2-GRAM ) four
1 2-GRAM four phosphotyrosine
2 2-GRAM phosphotyrosine motifs
2 2-GRAM motifs that
2 2-GRAM that mediate
2 2-GRAM mediate recruitment
2 2-GRAM recruitment of
1 2-GRAM of Grb2
1 2-GRAM Grb2 ,
1 2-GRAM ) two
1 2-GRAM two phosphotyrosine
1 2-GRAM of Shp2
1 2-GRAM Shp2 ,
2 2-GRAM and 3
1 2-GRAM a C
1 2-GRAM terminal motif
1 2-GRAM motif that
1 2-GRAM that functions
1 2-GRAM functions by
1 2-GRAM by helping
1 2-GRAM helping to
1 2-GRAM to recruit
1 2-GRAM recruit Sos
1 2-GRAM Sos .
1 2-GRAM : Our
1 2-GRAM Our meta
1 2-GRAM meta -
1 2-GRAM - analysis
1 2-GRAM of randomized
1 2-GRAM randomized controlled
1 2-GRAM trials of
1 2-GRAM of HRT
1 2-GRAM HRT noted
1 2-GRAM noted a
1 2-GRAM significant reduction
1 2-GRAM reduction in
1 2-GRAM in nonvertebral
1 2-GRAM nonvertebral fractures
1 2-GRAM fractures .
1 2-GRAM , C4B
1 2-GRAM C4B proteins
1 2-GRAM proteins encoded
1 2-GRAM by monomodular
1 2-GRAM monomodular short
1 2-GRAM short genes
1 2-GRAM genes may
1 2-GRAM have relatively
1 2-GRAM relatively higher
1 2-GRAM higher concentrations
1 2-GRAM concentrations than
1 2-GRAM than those
1 2-GRAM those from
1 2-GRAM from long
1 2-GRAM long C4A
1 2-GRAM C4A genes
1 2-GRAM * CSR
1 2-GRAM CSR is
1 2-GRAM is directed
1 2-GRAM directed to
1 2-GRAM to specific
1 2-GRAM specific heavy
1 2-GRAM heavy chain
1 2-GRAM chain isotypes
1 2-GRAM isotypes by
1 2-GRAM by cytokines
1 2-GRAM cytokines and
1 2-GRAM and B
1 2-GRAM cell activators
1 2-GRAM activators that
1 2-GRAM that induce
1 2-GRAM induce transcription
1 2-GRAM the unrearranged
1 2-GRAM unrearranged ,
1 2-GRAM or germline
1 2-GRAM germline (
1 2-GRAM ( GL
1 2-GRAM GL ),
1 2-GRAM ), C
1 2-GRAM C (
1 2-GRAM ( H
1 2-GRAM H )
1 2-GRAM ) region
1 2-GRAM region genes
1 2-GRAM The patterns
1 2-GRAM patterns of
1 2-GRAM of early
1 2-GRAM early mRNA
2 2-GRAM mRNA and
2 2-GRAM and protein
1 2-GRAM protein expression
1 2-GRAM in these
1 2-GRAM these seven
1 2-GRAM seven mutants
1 2-GRAM examined ,
1 2-GRAM and it
1 2-GRAM that mutation
2 2-GRAM mutation of
1 2-GRAM the T
1 2-GRAM T '(
1 2-GRAM '( 135
1 2-GRAM 135 )
1 2-GRAM ) acceptor
1 2-GRAM acceptor site
1 2-GRAM site resulted
1 2-GRAM the utilization
1 2-GRAM utilization of
1 2-GRAM of cryptic
1 2-GRAM cryptic splice
1 2-GRAM splice sites
1 2-GRAM sites and
1 2-GRAM the generation
1 2-GRAM generation of
1 2-GRAM of new
1 2-GRAM new T
1 2-GRAM T '
1 2-GRAM ' species
1 2-GRAM species .
1 2-GRAM * Mutational
1 2-GRAM Mutational analysis
1 2-GRAM analysis showed
1 2-GRAM the U
1 2-GRAM U -
2 2-GRAM - box
1 2-GRAM box ,
1 2-GRAM , like
1 2-GRAM like the
1 2-GRAM the RING
1 2-GRAM RING finger
1 2-GRAM finger in
1 2-GRAM in other
1 2-GRAM other proteins
2 2-GRAM proteins ,
1 2-GRAM , forms
1 2-GRAM forms the
1 2-GRAM the physical
1 2-GRAM physical basis
1 2-GRAM basis for
1 2-GRAM with E2
1 2-GRAM E2 enzymes
1 2-GRAM enzymes .
1 2-GRAM * GafChromic
1 2-GRAM GafChromic (
1 2-GRAM ( MD
1 2-GRAM MD -
2 2-GRAM - 55
1 2-GRAM 55 -
1 2-GRAM ) radiochromic
1 2-GRAM radiochromic film
1 2-GRAM film has
1 2-GRAM has become
1 2-GRAM become increasingly
1 2-GRAM increasingly popular
1 2-GRAM popular for
1 2-GRAM for medical
1 2-GRAM medical applications
1 2-GRAM applications and
2 2-GRAM and has
1 2-GRAM has proven
1 2-GRAM proven to
2 2-GRAM be useful
1 2-GRAM useful for
1 2-GRAM for brachytherapy
1 2-GRAM brachytherapy dosimetry
2 2-GRAM dosimetry .
1 2-GRAM The 438
1 2-GRAM 438 bp
1 2-GRAM bp EcoRI
1 2-GRAM EcoRI fragment
1 2-GRAM fragment ,
1 2-GRAM was detected
1 2-GRAM detected by
1 2-GRAM by Southern
1 2-GRAM Southern hybridization
1 2-GRAM hybridization ,
1 2-GRAM , reveals
1 2-GRAM reveals an
1 2-GRAM an open
1 2-GRAM frame which
2 2-GRAM which encodes
1 2-GRAM a protein
1 2-GRAM of 103
1 2-GRAM 103 amino
2 2-GRAM acids .
1 2-GRAM , hormonal
1 2-GRAM hormonal regulation
1 2-GRAM of G
1 2-GRAM G (
4 2-GRAM ) gene
1 2-GRAM transcription can
1 2-GRAM can occur
1 2-GRAM occur even
1 2-GRAM without additional
1 2-GRAM additional activation
1 2-GRAM the Mek
1 2-GRAM Mek -
1 2-GRAM - Erk1
1 2-GRAM Erk1 /
1 2-GRAM 2 pathway
1 2-GRAM by estrogen
1 2-GRAM estrogen receptors
2 2-GRAM receptors .
1 2-GRAM In mammalian
1 2-GRAM mammalian tissue
1 2-GRAM tissue culture
1 2-GRAM culture cells
1 2-GRAM , overexpression
1 2-GRAM of any
1 2-GRAM any of
1 2-GRAM the four
1 2-GRAM four mouse
1 2-GRAM mouse deltex
1 2-GRAM deltex homologs
1 2-GRAM homologs suppressed
1 2-GRAM suppressed the
1 2-GRAM of E47
1 2-GRAM E47 ,
1 2-GRAM a basic
1 2-GRAM basic helix
1 2-GRAM helix -
1 2-GRAM - loop
1 2-GRAM loop -
1 2-GRAM - helix
1 2-GRAM helix (
1 2-GRAM ( bHLH
1 2-GRAM bHLH )
1 2-GRAM ) protein
1 2-GRAM manner similar
1 2-GRAM to suppression
1 2-GRAM suppression by
1 2-GRAM by an
1 2-GRAM an activated
1 2-GRAM activated form
2 2-GRAM form of
1 2-GRAM human Notch1
1 2-GRAM Notch1 or
1 2-GRAM or human
1 2-GRAM human DTX1
1 2-GRAM DTX1 .
1 2-GRAM The authors
1 2-GRAM authors undertook
1 2-GRAM undertook a
1 2-GRAM a retrospective
1 2-GRAM retrospective analysis
1 2-GRAM of pathology
1 2-GRAM pathology with
1 2-GRAM with quantification
1 2-GRAM quantification of
1 2-GRAM the percentage
1 2-GRAM of papillary
1 2-GRAM papillary serous
1 2-GRAM serous component
1 2-GRAM component (%
1 2-GRAM (% PSC
1 2-GRAM PSC )
1 2-GRAM and p53
1 2-GRAM p53 expression
1 2-GRAM expression .
1 2-GRAM This function
1 2-GRAM function requires
1 2-GRAM requires not
2 2-GRAM not only
1 2-GRAM only the
2 2-GRAM the kinase
1 2-GRAM kinase domain
1 2-GRAM of Csk
1 2-GRAM Csk ,
2 2-GRAM but also
1 2-GRAM also its
1 2-GRAM its Src
2 2-GRAM homology 3
2 2-GRAM 3 (
2 2-GRAM ( SH3
1 2-GRAM SH3 )
1 2-GRAM and SH2
1 2-GRAM SH2 regions
1 2-GRAM * Nucleotide
1 2-GRAM Nucleotide sequence
1 2-GRAM , transcription
1 2-GRAM transcription map
1 2-GRAM map ,
1 2-GRAM and mutation
1 2-GRAM mutation analysis
1 2-GRAM the 13q14
1 2-GRAM 13q14 chromosomal
1 2-GRAM chromosomal region
1 2-GRAM region deleted
1 2-GRAM deleted in
1 2-GRAM in B
1 2-GRAM cell chronic
1 2-GRAM chronic lymphocytic
1 2-GRAM lymphocytic leukemia
1 2-GRAM , primary
1 2-GRAM primary chemotherapy
1 2-GRAM chemotherapy based
1 2-GRAM on high
1 2-GRAM high dose
1 2-GRAM dose MTX
1 2-GRAM MTX and
1 2-GRAM and ara
1 2-GRAM ara -
2 2-GRAM - C
1 2-GRAM C is
1 2-GRAM highly efficient
1 2-GRAM efficient in
1 2-GRAM in PCNSL
1 2-GRAM PCNSL .
1 2-GRAM NGF ,
1 2-GRAM not EGF
1 2-GRAM , enhances
1 2-GRAM enhances the
1 2-GRAM the upper
1 2-GRAM upper bands
1 2-GRAM bands ,
1 2-GRAM , corresponding
1 2-GRAM corresponding to
1 2-GRAM to phosphorylated
1 2-GRAM phosphorylated Fra
2 2-GRAM Fra -
1 2-GRAM METHODS AND
1 2-GRAM AND RESULTS
1 2-GRAM : Palmaz
1 2-GRAM Palmaz -
1 2-GRAM - Schatz
1 2-GRAM Schatz stents
1 2-GRAM stents were
1 2-GRAM were dip
1 2-GRAM dip -
1 2-GRAM - coated
1 2-GRAM coated with
1 2-GRAM with paclitaxel
1 2-GRAM paclitaxel (
1 2-GRAM 0 ,
2 2-GRAM 15 ,
1 2-GRAM or 187
1 2-GRAM 187 microgram
1 2-GRAM microgram /
1 2-GRAM / stent
1 2-GRAM stent )
1 2-GRAM by immersion
1 2-GRAM immersion in
1 2-GRAM in ethanolic
1 2-GRAM ethanolic paclitaxel
1 2-GRAM and evaporation
1 2-GRAM evaporation of
1 2-GRAM the solvent
1 2-GRAM solvent .
1 2-GRAM * Currently
1 2-GRAM Currently ,
2 2-GRAM clinical use
1 2-GRAM - aminolaevulinic
1 2-GRAM aminolaevulinic acid
1 2-GRAM ( ALA
1 2-GRAM ALA )
1 2-GRAM ) induced
1 2-GRAM induced protoporphyrin
1 2-GRAM protoporphyrin IX
1 2-GRAM IX (
1 2-GRAM ( PPIX
1 2-GRAM PPIX )
1 2-GRAM for photodynamic
1 2-GRAM photodynamic therapy
1 2-GRAM therapy (
1 2-GRAM ( PDT
1 2-GRAM PDT )
1 2-GRAM is limited
1 2-GRAM limited by
1 2-GRAM the maximum
1 2-GRAM maximum tolerated
1 2-GRAM tolerated oral
1 2-GRAM oral ALA
1 2-GRAM ALA dose
1 2-GRAM dose (
1 2-GRAM ( 60
1 2-GRAM 60 mg
3 2-GRAM mg /
1 2-GRAM / kg
1 2-GRAM kg ).
1 2-GRAM A twelfth
1 2-GRAM twelfth insertion
1 2-GRAM insertion disrupts
1 2-GRAM disrupts two
1 2-GRAM two genes
1 2-GRAM , Nrk
1 2-GRAM Nrk ,
1 2-GRAM a "
1 2-GRAM " neurospecific
1 2-GRAM neurospecific "
1 2-GRAM " receptor
1 2-GRAM kinase ,
1 2-GRAM and Tpp
1 2-GRAM Tpp ,
1 2-GRAM a neuropeptidase
1 2-GRAM neuropeptidase .
1 2-GRAM that ATF4
1 2-GRAM ATF4 regulates
1 2-GRAM regulates basal
1 2-GRAM basal and
1 2-GRAM and CdCl
1 2-GRAM CdCl (
1 2-GRAM 2 )-
1 2-GRAM )- induced
1 2-GRAM induced expression
1 2-GRAM the ho
1 2-GRAM specific manner
1 2-GRAM manner and
1 2-GRAM and possibly
1 2-GRAM possibly in
2 2-GRAM a complex
1 2-GRAM with Nrf2
1 2-GRAM Nrf2 .
1 2-GRAM * Adjuvant
1 2-GRAM Adjuvant and
1 2-GRAM and neoadjuvant
1 2-GRAM neoadjuvant treatment
1 2-GRAM of breast
2 2-GRAM breast cancer
1 2-GRAM The %
1 2-GRAM % SVend
1 2-GRAM SVend of
1 2-GRAM of HCM
2 2-GRAM HCM -
1 2-GRAM - I
1 2-GRAM I was
1 2-GRAM lower than
1 2-GRAM than the
2 2-GRAM the respective
1 2-GRAM respective values
1 2-GRAM values of
1 2-GRAM the HCM
1 2-GRAM and Control
1 2-GRAM Control groups
1 2-GRAM the Raf
2 2-GRAM Raf -
1 2-GRAM 1 target
1 2-GRAM target ERK
1 2-GRAM MEK )
1 2-GRAM ) either
1 2-GRAM either attenuated
1 2-GRAM attenuated or
1 2-GRAM or abolished
1 2-GRAM abolished Rp
1 2-GRAM Rp -
1 2-GRAM - cAMPS
1 2-GRAM cAMPS -
1 2-GRAM and PKI
1 2-GRAM PKI -
1 2-GRAM induced ERK
1 2-GRAM activation ,
1 2-GRAM , caldesmon
1 2-GRAM caldesmon phosphorylation
1 2-GRAM phosphorylation ,
1 2-GRAM and stress
1 2-GRAM stress fiber
1 2-GRAM fiber formation
1 2-GRAM the TVD
1 2-GRAM TVD -
1 2-GRAM - patients
1 2-GRAM patients decreases
1 2-GRAM decreases in
1 2-GRAM in skin
1 2-GRAM skin blood
1 2-GRAM flow were
1 2-GRAM were similar
1 2-GRAM similar compared
1 2-GRAM the healthy
1 2-GRAM healthy controls
1 2-GRAM controls .
1 2-GRAM of mCTR
1 2-GRAM mCTR mRNAs
1 2-GRAM mRNAs has
1 2-GRAM has revealed
1 2-GRAM three alternative
1 2-GRAM alternative promoters
1 2-GRAM promoters give
1 2-GRAM give rise
1 2-GRAM rise to
1 2-GRAM to at
1 2-GRAM least seven
1 2-GRAM seven mCTR
1 2-GRAM mCTR isoforms
1 2-GRAM ' region
1 2-GRAM gene and
1 2-GRAM and generate
1 2-GRAM generate 5
3 2-GRAM 5 '-
2 2-GRAM '- untranslated
1 2-GRAM untranslated regions
1 2-GRAM very different
1 2-GRAM different lengths
1 2-GRAM lengths .
1 2-GRAM The regulation
1 2-GRAM of PGHS
1 2-GRAM PGHS -
1 2-GRAM 2 mRNA
1 2-GRAM protein was
1 2-GRAM was studied
1 2-GRAM studied in
1 2-GRAM primary cultures
1 2-GRAM cultures of
1 2-GRAM of bovine
1 2-GRAM bovine uterine
1 2-GRAM uterine stromal
1 2-GRAM stromal cells
1 2-GRAM cells stimulated
1 2-GRAM stimulated with
1 2-GRAM with phorbol
1 2-GRAM PMA ;
1 2-GRAM ; 100
1 2-GRAM 100 nM
1 2-GRAM nM ).
2 2-GRAM was no
1 2-GRAM no evidence
1 2-GRAM of linkage
1 2-GRAM linkage disequilibrium
1 2-GRAM disequilibrium between
1 2-GRAM the polymorphic
1 2-GRAM polymorphic site
1 2-GRAM the B
1 2-GRAM cell specific
1 2-GRAM specific promoter
1 2-GRAM promoter and
1 2-GRAM those in
1 2-GRAM the 3
2 2-GRAM 3 '
1 2-GRAM ' UTR
1 2-GRAM UTR .
1 2-GRAM * Several
1 2-GRAM Several dozen
1 2-GRAM dozen HIF
1 2-GRAM 1 targets
1 2-GRAM targets are
1 2-GRAM are known
1 2-GRAM known ,
1 2-GRAM , including
1 2-GRAM including the
1 2-GRAM encoding vascular
1 2-GRAM vascular endothelial
1 2-GRAM endothelial growth
1 2-GRAM ( VEGF
1 2-GRAM VEGF ).
1 2-GRAM In Klinefelter
1 2-GRAM Klinefelter '
2 2-GRAM syndrome (
1 2-GRAM ( 47XXY
1 2-GRAM 47XXY ),
1 2-GRAM serum testosterone
1 2-GRAM testosterone levels
2 2-GRAM levels are
1 2-GRAM are at
2 2-GRAM the lower
1 2-GRAM lower end
1 2-GRAM the normal
1 2-GRAM normal range
1 2-GRAM range and
1 2-GRAM and dihydrotestosterone
1 2-GRAM dihydrotestosterone levels
1 2-GRAM are low
1 2-GRAM low .
1 2-GRAM The protein
1 2-GRAM protein is
1 2-GRAM is composed
1 2-GRAM composed of
1 2-GRAM two major
1 2-GRAM major domains
1 2-GRAM domains separated
1 2-GRAM separated by
1 2-GRAM a hydrophobic
1 2-GRAM hydrophobic linker
1 2-GRAM linker region
1 2-GRAM of 20
1 2-GRAM 20 amino
1 2-GRAM acid residues
1 2-GRAM residues .
1 2-GRAM * When
1 2-GRAM When mixed
1 2-GRAM mixed with
1 2-GRAM with aqueous
2 2-GRAM aqueous solutions
2 2-GRAM solutions of
1 2-GRAM of TMT
1 2-GRAM TMT -
1 2-GRAM 55 ,
1 2-GRAM , aqueous
2 2-GRAM of either
1 2-GRAM either reagent
1 2-GRAM reagent -
1 2-GRAM - grade
1 2-GRAM grade zinc
1 2-GRAM zinc ,
1 2-GRAM , cadmium
1 2-GRAM cadmium ,
1 2-GRAM or lead
1 2-GRAM lead salts
1 2-GRAM salts precipitate
1 2-GRAM precipitate crystalline
2 2-GRAM crystalline "
1 2-GRAM " Zn
1 2-GRAM Zn -
3 2-GRAM - TMT
1 2-GRAM TMT ",
1 2-GRAM ", amorphous
1 2-GRAM amorphous or
1 2-GRAM or crystalline
1 2-GRAM " Cd
1 2-GRAM Cd -
2 2-GRAM TMT "
1 2-GRAM " or
1 2-GRAM or amorphous
1 2-GRAM amorphous "
1 2-GRAM " Pb
1 2-GRAM Pb -
1 2-GRAM " (
1 2-GRAM ( M3
1 2-GRAM M3 [
1 2-GRAM [ S3C3N3
1 2-GRAM S3C3N3 ]
1 2-GRAM ] 2
1 2-GRAM . nH2O
1 2-GRAM nH2O ,
1 2-GRAM , where
1 2-GRAM where M
1 2-GRAM M =
1 2-GRAM = Cd2
1 2-GRAM Cd2 +,
1 2-GRAM +, Pb2
1 2-GRAM Pb2 +,
1 2-GRAM +, and
1 2-GRAM and Zn2
1 2-GRAM Zn2 +
1 2-GRAM + and
1 2-GRAM and n
1 2-GRAM n >
1 2-GRAM > or
1 2-GRAM 0 )
2 2-GRAM ) that
2 2-GRAM that may
1 2-GRAM may eventually
1 2-GRAM eventually crystallize
1 2-GRAM crystallize if
1 2-GRAM if stored
1 2-GRAM stored in
1 2-GRAM in air
1 2-GRAM air .
1 2-GRAM * Online
1 2-GRAM Online teaching
1 2-GRAM teaching :
1 2-GRAM : design
1 2-GRAM design and
1 2-GRAM and techniques
1 2-GRAM techniques .
1 2-GRAM This interaction
1 2-GRAM interaction is
1 2-GRAM is reciprocal
1 2-GRAM reciprocal ,
1 2-GRAM , since
1 2-GRAM since C
1 2-GRAM EBP dimer
1 2-GRAM dimer binding
1 2-GRAM a strong
1 2-GRAM strong C
1 2-GRAM EBP site
1 2-GRAM site leads
1 2-GRAM to enhanced
1 2-GRAM enhanced CREB
1 2-GRAM 1 recruitment
1 2-GRAM recruitment to
1 2-GRAM to ATF
1 2-GRAM ATF /
1 2-GRAM / CREB
1 2-GRAM CREB sites
1 2-GRAM sites that
1 2-GRAM that are
1 2-GRAM are weakly
1 2-GRAM weakly bound
1 2-GRAM bound by
1 2-GRAM by CREB
1 2-GRAM CREB .
1 2-GRAM The absorbed
1 2-GRAM absorbed dose
1 2-GRAM dose was
1 2-GRAM by combination
1 2-GRAM combination of
1 2-GRAM two integrating
1 2-GRAM integrating detectors
1 2-GRAM detectors :
1 2-GRAM : thermo
1 2-GRAM thermo -
1 2-GRAM - luminescent
1 2-GRAM luminescent dosemeter
1 2-GRAM dosemeter of
1 2-GRAM of Mg2SiO4
1 2-GRAM Tb (
1 2-GRAM ( TDMS
1 2-GRAM TDMS )
1 2-GRAM and plastic
1 2-GRAM plastic nuclear
1 2-GRAM nuclear track
1 2-GRAM track detector
1 2-GRAM detector (
1 2-GRAM ( PNTD
1 2-GRAM PNTD ).
3 2-GRAM the genomic
1 2-GRAM genomic complexity
1 2-GRAM complexity of
1 2-GRAM the deleted
1 2-GRAM deleted region
1 2-GRAM region shared
1 2-GRAM shared among
1 2-GRAM among tumors
1 2-GRAM tumors ,
1 2-GRAM we assembled
1 2-GRAM assembled a
1 2-GRAM a physical
1 2-GRAM physical map
1 2-GRAM map of
1 2-GRAM the I
1 2-GRAM I Mbp
1 2-GRAM Mbp SRO
1 2-GRAM SRO consisting
1 2-GRAM consisting predominantly
1 2-GRAM predominantly of
1 2-GRAM of bacteriophage
1 2-GRAM bacteriophage P1
1 2-GRAM P1 -
1 2-GRAM - derived
1 2-GRAM derived artificial
1 2-GRAM artificial chromosome
1 2-GRAM chromosome (
1 2-GRAM ( PAC
1 2-GRAM PAC )
1 2-GRAM ) clones
1 2-GRAM clones .
1 2-GRAM , Xlim
2 2-GRAM Xlim -
1 2-GRAM 1 not
1 2-GRAM only contains
1 2-GRAM a unique
1 2-GRAM unique tyrosine
1 2-GRAM tyrosine -
1 2-GRAM rich activation
1 2-GRAM domain but
1 2-GRAM also contains
1 2-GRAM regulatory domain
1 2-GRAM in CT239
1 2-GRAM CT239 -
1 2-GRAM - 403
1 2-GRAM 403 ,
1 2-GRAM complex regulatory
1 2-GRAM regulatory mechanism
1 2-GRAM mechanism underlying
1 2-GRAM underlying the
1 2-GRAM of Xlim
1 2-GRAM 1 in
1 2-GRAM the organizer
1 2-GRAM organizer .
1 2-GRAM Low -
1 2-GRAM - selenium
1 2-GRAM selenium diet
1 2-GRAM diet has
1 2-GRAM a human
1 2-GRAM human unfavourable
1 2-GRAM unfavourable impact
1 2-GRAM impact .
1 2-GRAM the next
1 2-GRAM next week
1 2-GRAM week ,
1 2-GRAM - adrenergic
1 2-GRAM adrenergic antagonist
1 2-GRAM antagonist atenolol
1 2-GRAM atenolol was
1 2-GRAM was added
1 2-GRAM added at
1 2-GRAM an initial
1 2-GRAM initial dose
1 2-GRAM of 25
2 2-GRAM 25 mg
2 2-GRAM / day
1 2-GRAM day and
1 2-GRAM and titrated
1 2-GRAM titrated to
1 2-GRAM to 50
1 2-GRAM day within
1 2-GRAM within 1
1 2-GRAM 1 week
1 2-GRAM week .
1 2-GRAM To assess
1 2-GRAM assess more
1 2-GRAM more specific
1 2-GRAM specific PKA
1 2-GRAM PKA -
1 2-GRAM dependent mediation
1 2-GRAM mediation of
1 2-GRAM of LH
1 2-GRAM LH '
1 2-GRAM s contribution
1 2-GRAM contribution to
1 2-GRAM to combined
1 2-GRAM combined hormonal
1 2-GRAM hormonal drive
1 2-GRAM drive ,
1 2-GRAM the LDL
1 2-GRAM LDL receptor
1 2-GRAM receptor (-
1 2-GRAM (- 1076
1 2-GRAM 1076 to
1 2-GRAM + 11
1 2-GRAM 11 bp
1 2-GRAM bp )
1 2-GRAM ) reporter
1 2-GRAM reporter plasmid
1 2-GRAM plasmid was
1 2-GRAM was cotransfected
1 2-GRAM cotransfected with
1 2-GRAM a full
1 2-GRAM - sequence
1 2-GRAM sequence rabbit
1 2-GRAM rabbit muscle
1 2-GRAM muscle protein
1 2-GRAM kinase inhibitor
1 2-GRAM inhibitor (
1 2-GRAM ( PKI
1 2-GRAM PKI )
1 2-GRAM ) minigene
1 2-GRAM minigene driven
1 2-GRAM driven constitutively
1 2-GRAM constitutively by
1 2-GRAM a Rous
1 2-GRAM Rous sarcoma
1 2-GRAM sarcoma virus
1 2-GRAM virus promoter
1 2-GRAM In SN
1 2-GRAM SN -
1 2-GRAM - 48
1 2-GRAM 48 neuronal
1 2-GRAM neuronal cells
1 2-GRAM that express
1 2-GRAM express MR
1 2-GRAM MR ,
1 2-GRAM , GR
1 2-GRAM GR ,
2 2-GRAM - HT1A
1 2-GRAM HT1A receptors
1 2-GRAM receptors ,
1 2-GRAM , deletion
1 2-GRAM deletion or
1 2-GRAM or inactivation
1 2-GRAM inactivation of
1 2-GRAM the nGRE
1 2-GRAM nGRE (
1 2-GRAM ( negative
1 2-GRAM negative GRE
1 2-GRAM GRE )
1 2-GRAM ) eliminated
1 2-GRAM eliminated negative
1 2-GRAM rat 5
1 2-GRAM HT1A or
1 2-GRAM or heterologous
1 2-GRAM heterologous promoters
1 2-GRAM promoters by
1 2-GRAM by corticosteroids
1 2-GRAM corticosteroids ,
1 2-GRAM whereas its
1 2-GRAM its inclusion
1 2-GRAM inclusion conferred
1 2-GRAM conferred corticosteroid
1 2-GRAM corticosteroid -
1 2-GRAM induced inhibition
1 2-GRAM inhibition to
1 2-GRAM * Transition
1 2-GRAM Transition between
1 2-GRAM between P
2 2-GRAM P -
1 2-GRAM and H
1 2-GRAM - BPPV
1 2-GRAM BPPV was
2 2-GRAM found in
1 2-GRAM in 6
1 2-GRAM 6 cases
2 2-GRAM cases .
1 2-GRAM These included
1 2-GRAM included HNF
1 2-GRAM HNF -
1 2-GRAM 3 beta
3 2-GRAM , HFH
3 2-GRAM HFH -
2 2-GRAM , C
1 2-GRAM EBP ,
1 2-GRAM and C
1 2-GRAM all of
2 2-GRAM are consistent
1 2-GRAM tissue -
1 2-GRAM expression profiles
1 2-GRAM profiles of
1 2-GRAM : Of
1 2-GRAM the 24
1 2-GRAM 24 patients
1 2-GRAM patients ,
1 2-GRAM 6 had
2 2-GRAM had Grade
1 2-GRAM Grade 1
1 2-GRAM 1 pneumonitis
1 2-GRAM pneumonitis ,
1 2-GRAM and 13
1 2-GRAM 13 had
1 2-GRAM Grade 2
1 2-GRAM 2 pneumonitis
2 2-GRAM pneumonitis .
1 2-GRAM The passive
1 2-GRAM passive and
1 2-GRAM and active
1 2-GRAM active transport
1 2-GRAM transport of
1 2-GRAM of fluorescein
1 2-GRAM fluorescein through
1 2-GRAM the BRB
1 2-GRAM BRB was
1 2-GRAM was quantitated
1 2-GRAM quantitated by
1 2-GRAM by vitreous
1 2-GRAM vitreous fluorometry
1 2-GRAM fluorometry .
1 2-GRAM * Sixteen
1 2-GRAM Sixteen out
1 2-GRAM out of
1 2-GRAM of 52
1 2-GRAM 52 seropositive
1 2-GRAM seropositive MS
1 2-GRAM MS patients
1 2-GRAM patients (
1 2-GRAM ( 30
1 2-GRAM 30 .
1 2-GRAM 8 %)
1 2-GRAM %) showed
1 2-GRAM showed intrathecal
1 2-GRAM intrathecal synthesis
1 2-GRAM synthesis of
2 2-GRAM C .
1 2-GRAM . pneumoniae
1 2-GRAM pneumoniae -
1 2-GRAM specific IgG
1 2-GRAM IgG but
1 2-GRAM but only
1 2-GRAM only one
1 2-GRAM of 43
1 2-GRAM 43 seropositive
1 2-GRAM seropositive controls
1 2-GRAM controls (
1 2-GRAM 3 %).
2 2-GRAM %). STOP
1 2-GRAM * Consistent
1 2-GRAM Consistent with
1 2-GRAM the specificity
1 2-GRAM specificity observed
1 2-GRAM observed for
1 2-GRAM of DmCKIIalpha
1 2-GRAM DmCKIIalpha with
1 2-GRAM these bHLH
1 2-GRAM bHLH proteins
1 2-GRAM , sequence
1 2-GRAM sequence alignment
1 2-GRAM alignment suggests
1 2-GRAM that only
1 2-GRAM only m5
1 2-GRAM m5 ,
1 2-GRAM , m7
1 2-GRAM m7 ,
1 2-GRAM and m8
1 2-GRAM m8 contain
1 2-GRAM a consensus
1 2-GRAM consensus site
1 2-GRAM site for
1 2-GRAM for phosphorylation
1 2-GRAM by CKII
1 2-GRAM CKII within
1 2-GRAM a subdomain
1 2-GRAM subdomain unique
1 2-GRAM unique to
1 2-GRAM to these
1 2-GRAM these three
1 2-GRAM three proteins
2 2-GRAM proteins .
1 2-GRAM * Deletion
1 2-GRAM Deletion of
1 2-GRAM potential initiator
1 2-GRAM element does
1 2-GRAM affect repression
3 2-GRAM repression of
1 2-GRAM the p21
1 2-GRAM p21 promoter
1 2-GRAM by c
1 2-GRAM - Myc
1 2-GRAM Myc .
1 2-GRAM * PATIENTS
1 2-GRAM PATIENTS AND
1 2-GRAM AND METHODS
1 2-GRAM : Between
1 2-GRAM Between June
1 2-GRAM June 1991
1 2-GRAM 1991 and
1 2-GRAM and December
1 2-GRAM December 1996
1 2-GRAM 1996 ,
1 2-GRAM we administered
1 2-GRAM administered the
1 2-GRAM the nucleoside
1 2-GRAM nucleoside analog
1 2-GRAM analog 2
1 2-GRAM - chlorodeoxyadenosine
1 2-GRAM chlorodeoxyadenosine (
1 2-GRAM - CDA
1 2-GRAM CDA )
1 2-GRAM to 73
1 2-GRAM 73 children
3 2-GRAM children with
1 2-GRAM with primary
1 2-GRAM primary AML
1 2-GRAM AML and
1 2-GRAM and 20
1 2-GRAM 20 children
1 2-GRAM with secondary
1 2-GRAM secondary AML
1 2-GRAM AML or
1 2-GRAM or myelodysplastic
1 2-GRAM myelodysplastic syndrome
1 2-GRAM ( MDS
1 2-GRAM MDS ).
1 2-GRAM * Drosophila
1 2-GRAM Drosophila Menin1
1 2-GRAM Menin1 gene
1 2-GRAM gene transcripts
1 2-GRAM transcripts use
1 2-GRAM use alternative
1 2-GRAM alternative polyadenylation
1 2-GRAM polyadenylation sites
1 2-GRAM sites resulting
1 2-GRAM in 4
1 2-GRAM 3 and
1 2-GRAM kb messages
1 2-GRAM messages .
1 2-GRAM * Mice
1 2-GRAM Mice homozygous
1 2-GRAM homozygous for
1 2-GRAM the dlg
1 2-GRAM dlg mutation
1 2-GRAM mutation exhibit
1 2-GRAM exhibit growth
1 2-GRAM growth retardation
1 2-GRAM retardation in
1 2-GRAM utero ,
3 2-GRAM , have
1 2-GRAM have hypoplasia
1 2-GRAM hypoplasia of
1 2-GRAM the premaxilla
1 2-GRAM premaxilla and
1 2-GRAM and mandible
1 2-GRAM mandible ,
1 2-GRAM a cleft
1 2-GRAM cleft secondary
1 2-GRAM secondary palate
1 2-GRAM palate ,
1 2-GRAM and die
1 2-GRAM die perinatally
1 2-GRAM perinatally .
2 2-GRAM we did
2 2-GRAM not detect
1 2-GRAM detect a
1 2-GRAM between plasma
1 2-GRAM plasma TNFalpha
1 2-GRAM TNFalpha and
1 2-GRAM and radiation
1 2-GRAM radiation pneumonitis
1 2-GRAM * Its
1 2-GRAM Its transcription
1 2-GRAM by pol
1 2-GRAM pol III
1 2-GRAM III requires
1 2-GRAM requires the
1 2-GRAM same factors
1 2-GRAM factors as
1 2-GRAM the U6
1 2-GRAM U6 gene
2 2-GRAM gene with
1 2-GRAM major exception
1 2-GRAM exception that
1 2-GRAM the modified
1 2-GRAM modified TATA
2 2-GRAM TATA -
1 2-GRAM this construct
1 2-GRAM construct only
1 2-GRAM only interacts
1 2-GRAM a TATA
2 2-GRAM ( TBP
1 2-GRAM TBP )
1 2-GRAM ) mutant
1 2-GRAM mutant (
1 2-GRAM TBP -
1 2-GRAM - DR2
1 2-GRAM DR2 )
1 2-GRAM ) but
1 2-GRAM not with
1 2-GRAM with TBP
1 2-GRAM TBP wild
1 2-GRAM type (
1 2-GRAM ( TBPwt
1 2-GRAM TBPwt ).
1 2-GRAM * Expression
1 2-GRAM Expression of
1 2-GRAM the src
1 2-GRAM src homology
1 2-GRAM SH3 )-
1 2-GRAM )- encoding
1 2-GRAM encoding ,
1 2-GRAM , expressed
1 2-GRAM in tumorigenic
1 2-GRAM tumorigenic astrocytes
1 2-GRAM astrocytes (
1 2-GRAM ( SETA
1 2-GRAM SETA )
3 2-GRAM gene is
1 2-GRAM is associated
1 2-GRAM with astrocyte
1 2-GRAM astrocyte transformation
1 2-GRAM transformation in
1 2-GRAM in culture
1 2-GRAM and tumors
1 2-GRAM the adult
1 2-GRAM adult brain
1 2-GRAM brain .
1 2-GRAM In such
1 2-GRAM such conditions
1 2-GRAM the following
1 2-GRAM following kinetic
1 2-GRAM kinetic reactions
1 2-GRAM reactions have
1 2-GRAM been studied
1 2-GRAM studied :
1 2-GRAM : N2
11 2-GRAM N2 (
4 2-GRAM ( A
4 2-GRAM A )
6 2-GRAM ) +
4 2-GRAM + N2
2 2-GRAM ) -->
3 2-GRAM --> N2
1 2-GRAM , B
7 2-GRAM , V
3 2-GRAM V ')
2 2-GRAM ') +
5 2-GRAM ( X
1 2-GRAM X ),
1 2-GRAM ), N2
2 2-GRAM X ,
2 2-GRAM V >
1 2-GRAM > 5
1 2-GRAM 5 )
2 2-GRAM X )
1 2-GRAM ') in
1 2-GRAM in pure
1 2-GRAM pure N2
1 2-GRAM N2 post
2 2-GRAM - discharges
1 2-GRAM discharges and
1 2-GRAM and N2
1 2-GRAM + CH4
1 2-GRAM CH4 -->
1 2-GRAM --> products
1 2-GRAM C +
1 2-GRAM + N
1 2-GRAM N +
2 2-GRAM + M2
1 2-GRAM M2 -->
1 2-GRAM --> CN
2 2-GRAM CN (
1 2-GRAM M2 ,
1 2-GRAM , N2
2 2-GRAM + CN
1 2-GRAM CN -->
1 2-GRAM , A
2 2-GRAM A ,
1 2-GRAM V '),
1 2-GRAM '), in
1 2-GRAM in N2
1 2-GRAM N2 -
1 2-GRAM 1 %
1 2-GRAM % CH4
1 2-GRAM CH4 post
1 2-GRAM discharges .
1 2-GRAM BACKGROUND /
1 2-GRAM / AIMS
1 2-GRAM : Hepatitis
1 2-GRAM Hepatitis C
1 2-GRAM C and
1 2-GRAM and nonalcoholic
1 2-GRAM nonalcoholic fatty
1 2-GRAM fatty liver
2 2-GRAM liver disease
2 2-GRAM disease (
1 2-GRAM ( NAFL
1 2-GRAM NAFL )
1 2-GRAM are the
1 2-GRAM two most
1 2-GRAM most common
1 2-GRAM common forms
1 2-GRAM of liver
1 2-GRAM disease in
1 2-GRAM States .
1 2-GRAM results suggested
1 2-GRAM suggested a
1 2-GRAM a critical
1 2-GRAM critical role
1 2-GRAM for tyrosine
1 2-GRAM tyrosine residue
1 2-GRAM residue 1229
1 2-GRAM 1229 in
1 2-GRAM of L1
1 2-GRAM L1 endocytosis
1 2-GRAM endocytosis .
1 2-GRAM The androgen
1 2-GRAM androgen receptor
1 2-GRAM ( AR
1 2-GRAM AR )
1 2-GRAM ) amino
1 2-GRAM terminus imposes
1 2-GRAM imposes androgen
1 2-GRAM androgen -
1 2-GRAM specific regulation
1 2-GRAM of AR
1 2-GRAM AR gene
1 2-GRAM expression via
1 2-GRAM via an
1 2-GRAM an exonic
1 2-GRAM exonic enhancer
1 2-GRAM enhancer .
1 2-GRAM * Can
1 2-GRAM Can survival
1 2-GRAM survival be
1 2-GRAM be prolonged
1 2-GRAM prolonged for
1 2-GRAM for patients
1 2-GRAM with hormone
1 2-GRAM hormone -
1 2-GRAM resistant prostate
1 2-GRAM prostate cancer
1 2-GRAM cancer ?
1 2-GRAM , NF
1 2-GRAM - Y
1 2-GRAM Y and
1 2-GRAM and Sp1
1 2-GRAM Sp1 binding
1 2-GRAM sites play
1 2-GRAM a decisive
1 2-GRAM decisive role
1 2-GRAM the basal
1 2-GRAM basal expression
1 2-GRAM rat mrp2
1 2-GRAM mrp2 gene
1 2-GRAM while the
1 2-GRAM human MRP2
1 2-GRAM MRP2 gene
1 2-GRAM is regulated
1 2-GRAM regulated differently
1 2-GRAM differently .
1 2-GRAM * Intact
1 2-GRAM Intact Flag
1 2-GRAM Flag -
1 2-GRAM - tagged
1 2-GRAM tagged protein
1 2-GRAM protein products
1 2-GRAM products from
1 2-GRAM from all
1 2-GRAM all six
1 2-GRAM six were
1 2-GRAM were produced
1 2-GRAM produced from
1 2-GRAM from genomic
1 2-GRAM genomic expression
1 2-GRAM expression vectors
1 2-GRAM vectors ,
2 2-GRAM although the
1 2-GRAM the ORF40
1 2-GRAM ORF40 /
1 2-GRAM / 41
1 2-GRAM 41 transcript
1 2-GRAM transcript encoding
1 2-GRAM a primase
1 2-GRAM primase -
1 2-GRAM - helicase
1 2-GRAM helicase component
1 2-GRAM component proved
1 2-GRAM proved to
1 2-GRAM be spliced
1 2-GRAM spliced with
1 2-GRAM a 127
1 2-GRAM 127 -
1 2-GRAM bp intron
1 2-GRAM intron .
1 2-GRAM * Hypomorphic
1 2-GRAM Hypomorphic dSLBP
1 2-GRAM dSLBP alleles
1 2-GRAM alleles support
1 2-GRAM support zygotic
1 2-GRAM zygotic development
1 2-GRAM development but
1 2-GRAM but cause
1 2-GRAM cause female
1 2-GRAM female sterility
1 2-GRAM sterility .
1 2-GRAM In hypertensive
1 2-GRAM hypertensive nephrosclerosis
1 2-GRAM nephrosclerosis ,
1 2-GRAM , therapy
1 2-GRAM therapy containing
1 2-GRAM an ACEI
1 2-GRAM ACEI alone
1 2-GRAM alone or
1 2-GRAM in combination
1 2-GRAM combination significantly
1 2-GRAM significantly reduces
1 2-GRAM reduces the
1 2-GRAM the incidence
1 2-GRAM incidence of
1 2-GRAM of renal
1 2-GRAM renal events
1 2-GRAM events .
1 2-GRAM We confirmed
1 2-GRAM interaction between
1 2-GRAM between TLS
1 2-GRAM TLS and
1 2-GRAM and p65
1 2-GRAM p65 by
1 2-GRAM the pull
1 2-GRAM pull -
1 2-GRAM - down
1 2-GRAM down assay
1 2-GRAM assay in
1 2-GRAM vitro and
1 2-GRAM and by
1 2-GRAM a coimmunoprecipitation
1 2-GRAM coimmunoprecipitation experiment
1 2-GRAM experiment followed
1 2-GRAM by Western
1 2-GRAM blot of
1 2-GRAM the cultured
1 2-GRAM cultured cell
1 2-GRAM cell in
3 2-GRAM In addition
2 2-GRAM addition ,
1 2-GRAM detect significant
1 2-GRAM in CDR3
1 2-GRAM CDR3 sequences
2 2-GRAM sequences of
1 2-GRAM of endogenous
1 2-GRAM endogenous Ig
1 2-GRAM Ig lambdaL
1 2-GRAM lambdaL and
1 2-GRAM and kappaL
1 2-GRAM kappaL chain
1 2-GRAM gene loci
1 2-GRAM loci cloned
1 2-GRAM cloned from
1 2-GRAM from peripheral
1 2-GRAM peripheral blood
1 2-GRAM blood lymphocytes
1 2-GRAM lymphocytes of
1 2-GRAM an NBS
1 2-GRAM NBS patient
1 2-GRAM and of
1 2-GRAM of healthy
1 2-GRAM healthy individuals
1 2-GRAM The diet
1 2-GRAM diet of
1 2-GRAM of migrants
1 2-GRAM migrants showed
1 2-GRAM showed both
1 2-GRAM positive (
1 2-GRAM ( macronutrients
1 2-GRAM macronutrients )
1 2-GRAM negative (
1 2-GRAM ( micronutrients
1 2-GRAM micronutrients )
1 2-GRAM ) differences
1 2-GRAM differences with
1 2-GRAM the general
1 2-GRAM general Dutch
1 2-GRAM Dutch diet
1 2-GRAM diet .
1 2-GRAM * Experimental
1 2-GRAM Experimental study
2 2-GRAM of ta
2 2-GRAM ta chengchi
2 2-GRAM chengchi tang
1 2-GRAM tang decoction
1 2-GRAM decoction for
1 2-GRAM for relieving
1 2-GRAM relieving lung
2 2-GRAM lung injury
1 2-GRAM injury during
1 2-GRAM during acute
2 2-GRAM acute necrotizing
2 2-GRAM necrotizing pancreatitis
1 2-GRAM pancreatitis ]
1 2-GRAM The objectives
1 2-GRAM objectives of
1 2-GRAM the study
1 2-GRAM study were
1 2-GRAM were to
1 2-GRAM the changes
1 2-GRAM changes of
1 2-GRAM of leukocyte
1 2-GRAM leukocyte adhesiveness
1 2-GRAM adhesiveness and
1 2-GRAM and tumor
1 2-GRAM TNF )
1 2-GRAM early stage
1 2-GRAM stage of
1 2-GRAM of acute
1 2-GRAM pancreatitis (
1 2-GRAM ( ANP
1 2-GRAM ANP ),
1 2-GRAM to go
1 2-GRAM go further
1 2-GRAM further into
1 2-GRAM the relation
1 2-GRAM relation of
1 2-GRAM of those
1 2-GRAM those changes
1 2-GRAM changes to
1 2-GRAM to lung
1 2-GRAM injury of
1 2-GRAM of ANP
1 2-GRAM ANP ,
1 2-GRAM evaluate the
1 2-GRAM the prohibitive
1 2-GRAM prohibitive effect
1 2-GRAM tang Decoction
1 2-GRAM Decoction on
1 2-GRAM on leukocyte
1 2-GRAM leukocyte adhesion
1 2-GRAM adhesion and
2 2-GRAM and TNF
1 2-GRAM TNF secretion
1 2-GRAM secretion .
1 2-GRAM We suggest
1 2-GRAM that ventriculopleural
1 2-GRAM ventriculopleural shunting
1 2-GRAM shunting should
2 2-GRAM be considered
1 2-GRAM considered as
1 2-GRAM the preferred
1 2-GRAM preferred alternative
1 2-GRAM alternative to
1 2-GRAM to peritoneal
1 2-GRAM peritoneal drainage
1 2-GRAM drainage in
1 2-GRAM with intra
2 2-GRAM intra -
1 2-GRAM - abdominal
1 2-GRAM abdominal adhesions
1 2-GRAM adhesions or
1 2-GRAM or with
1 2-GRAM a history
1 2-GRAM history of
1 2-GRAM of recent
1 2-GRAM recent peritoneal
1 2-GRAM peritoneal infection
1 2-GRAM * Positive
1 2-GRAM Positive and
1 2-GRAM and significant
1 2-GRAM significant correlations
1 2-GRAM correlations were
1 2-GRAM were found
1 2-GRAM found between
1 2-GRAM the weeks
1 2-GRAM of pregnancy
1 2-GRAM pregnancy and
1 2-GRAM and Se
1 2-GRAM Se levels
1 2-GRAM in kidney
1 2-GRAM kidney (
2 2-GRAM ( r
2 2-GRAM r =
1 2-GRAM . 433
1 2-GRAM 433 ,
1 2-GRAM . 023
1 2-GRAM 023 )
1 2-GRAM and heart
1 2-GRAM heart (
1 2-GRAM . 313
1 2-GRAM 313 ,
1 2-GRAM . 030
1 2-GRAM 030 ).
1 2-GRAM * Doxorubicin
1 2-GRAM Doxorubicin (
1 2-GRAM ( DOX
1 2-GRAM DOX )
1 2-GRAM commonly used
1 2-GRAM of hematological
1 2-GRAM hematological and
1 2-GRAM and solid
1 2-GRAM solid tumors
1 2-GRAM no significant
1 2-GRAM significant difference
1 2-GRAM in developmental
1 2-GRAM developmental scores
1 2-GRAM scores at
1 2-GRAM at 9
1 2-GRAM 9 or
1 2-GRAM or 18
1 2-GRAM 18 months
1 2-GRAM months ,
1 2-GRAM although PDF
1 2-GRAM PDF infants
1 2-GRAM infants had
2 2-GRAM a 2
1 2-GRAM 8 (-
1 2-GRAM 8 )
1 2-GRAM ) point
1 2-GRAM point advantage
1 2-GRAM advantage in
1 2-GRAM in Bayley
1 2-GRAM Bayley motor
1 2-GRAM motor score
1 2-GRAM score scales
1 2-GRAM scales .
1 2-GRAM * Immunofixation
1 2-GRAM Immunofixation experiments
1 2-GRAM experiments of
1 2-GRAM of C4A
1 2-GRAM C4A and
1 2-GRAM and C4B
1 2-GRAM C4B demonstrate
1 2-GRAM demonstrate >
1 2-GRAM > 41
1 2-GRAM 41 allotypes
1 2-GRAM allotypes in
1 2-GRAM two classes
1 2-GRAM of proteins
1 2-GRAM These effects
1 2-GRAM not seen
1 2-GRAM seen with
1 2-GRAM with SHIP2
1 2-GRAM SHIP2 possessing
1 2-GRAM possessing a
1 2-GRAM a mutation
1 2-GRAM the SH2
1 2-GRAM SH2 domain
2 2-GRAM domain (
1 2-GRAM ( R47G
1 2-GRAM R47G ).
1 2-GRAM * Myasthenia
1 2-GRAM Myasthenia gravis
1 2-GRAM gravis is
1 2-GRAM an autoimmune
1 2-GRAM autoimmune disease
1 2-GRAM disease resulting
1 2-GRAM of antibodies
1 2-GRAM the ACh
1 2-GRAM ACh receptors
1 2-GRAM receptors of
1 2-GRAM the neuromuscular
1 2-GRAM neuromuscular synapse
1 2-GRAM synapse .
1 2-GRAM Human homologue
1 2-GRAM homologue of
1 2-GRAM of yeast
1 2-GRAM yeast Rad23
1 2-GRAM Rad23 protein
1 2-GRAM protein A
1 2-GRAM A interacts
1 2-GRAM with p300
1 2-GRAM / cyclic
1 2-GRAM cyclic AMP
1 2-GRAM AMP -
1 2-GRAM element binding
1 2-GRAM binding (
1 2-GRAM ( CREB
1 2-GRAM CREB )-
1 2-GRAM )- binding
1 2-GRAM protein to
2 2-GRAM - regulate
1 2-GRAM regulate transcriptional
1 2-GRAM : Sixteen
1 2-GRAM Sixteen pigs
1 2-GRAM pigs were
1 2-GRAM were assigned
1 2-GRAM assigned randomly
1 2-GRAM randomly to
1 2-GRAM control and
1 2-GRAM and shock
1 2-GRAM shock groups
1 2-GRAM a considerable
1 2-GRAM considerable amount
1 2-GRAM of variation
1 2-GRAM variation between
3 2-GRAM the results
3 2-GRAM results of
1 2-GRAM of TRA1
1 2-GRAM TRA1 and
1 2-GRAM and TRA2
1 2-GRAM TRA2 and
1 2-GRAM and between
1 2-GRAM both TRA
1 2-GRAM TRA '
1 2-GRAM s and
1 2-GRAM the door
1 2-GRAM door -
1 2-GRAM - to
1 2-GRAM - door
1 2-GRAM door survey
1 2-GRAM survey .
1 2-GRAM , our
1 2-GRAM our studies
1 2-GRAM studies define
1 2-GRAM define Rac
1 2-GRAM Rac /
1 2-GRAM / Cdc42
1 2-GRAM Cdc42 /
1 2-GRAM / Pak
1 2-GRAM Pak as
1 2-GRAM a module
1 2-GRAM module upstream
1 2-GRAM of Raf
1 2-GRAM 1 during
1 2-GRAM during its
1 2-GRAM activation by
1 2-GRAM by microtubule
1 2-GRAM microtubule disruption
1 2-GRAM disruption .
1 2-GRAM * Zhu
1 2-GRAM Zhu ,
1 2-GRAM V .
1 2-GRAM , plasmids
1 2-GRAM plasmids carrying
1 2-GRAM the yeast
1 2-GRAM yeast TyrRS
1 2-GRAM TyrRS gene
1 2-GRAM gene could
1 2-GRAM could not
1 2-GRAM not be
1 2-GRAM be stably
1 2-GRAM stably maintained
1 2-GRAM maintained in
1 2-GRAM in E
1 2-GRAM coli .
1 2-GRAM This supports
1 2-GRAM supports previous
1 2-GRAM previous arguments
1 2-GRAM arguments for
1 2-GRAM the improbability
1 2-GRAM improbability of
1 2-GRAM of biological
1 2-GRAM biological effects
1 2-GRAM effects at
1 2-GRAM at UHF
1 2-GRAM UHF frequencies
1 2-GRAM frequencies unless
1 2-GRAM unless a
1 2-GRAM mechanism can
1 2-GRAM be found
1 2-GRAM found for
1 2-GRAM for accumulating
1 2-GRAM accumulating energy
1 2-GRAM energy over
1 2-GRAM over time
1 2-GRAM time and
1 2-GRAM space and
1 2-GRAM and focussing
1 2-GRAM focussing it
1 2-GRAM it .
1 2-GRAM The students
1 2-GRAM students who
1 2-GRAM who had
1 2-GRAM had abnormal
2 2-GRAM abnormal urine
1 2-GRAM urine screening
1 2-GRAM screening results
1 2-GRAM results at
2 2-GRAM first time
1 2-GRAM time received
1 2-GRAM second urine
2 2-GRAM urine analysis
1 2-GRAM analysis 10
1 2-GRAM 10 to
1 2-GRAM to 15
1 2-GRAM 15 days
1 2-GRAM days later
1 2-GRAM later to
1 2-GRAM to confirm
1 2-GRAM confirm the
1 2-GRAM the abnormal
1 2-GRAM * Cells
1 2-GRAM Cells containing
1 2-GRAM containing alpha
1 2-GRAM alpha subunits
1 2-GRAM subunits that
1 2-GRAM that lacked
1 2-GRAM lacked a
1 2-GRAM a distal
2 2-GRAM distal domain
1 2-GRAM ( term
1 2-GRAM term -
1 2-GRAM or had
1 2-GRAM had the
1 2-GRAM the alternatively
1 2-GRAM alternatively spliced
1 2-GRAM spliced alpha
1 2-GRAM 2 distal
1 2-GRAM domain showed
1 2-GRAM showed markedly
1 2-GRAM markedly decreased
1 2-GRAM decreased ability
1 2-GRAM to support
1 2-GRAM support tyrosine
1 2-GRAM of Jak
1 2-GRAM Jak -
1 2-GRAM its substrates
1 2-GRAM substrates or
1 2-GRAM or to
1 2-GRAM to up
1 2-GRAM regulate CD86
1 2-GRAM CD86 .
1 2-GRAM * Despite
1 2-GRAM Despite abundant
1 2-GRAM abundant expression
1 2-GRAM of NtmybAS
1 2-GRAM NtmybAS transcripts
1 2-GRAM transcripts in
1 2-GRAM in mature
1 2-GRAM mature pollen
1 2-GRAM pollen ,
1 2-GRAM , gPAL1
1 2-GRAM gPAL1 transcripts
1 2-GRAM transcripts were
1 2-GRAM not detectable
1 2-GRAM detectable in
1 2-GRAM in pollen
1 2-GRAM pollen .
1 2-GRAM , profiling
1 2-GRAM profiling of
1 2-GRAM a gcn4Delta
1 2-GRAM gcn4Delta mutant
1 2-GRAM mutant uncovered
1 2-GRAM uncovered an
2 2-GRAM an alternative
1 2-GRAM alternative induction
1 2-GRAM induction pathway
1 2-GRAM pathway operating
1 2-GRAM operating at
1 2-GRAM at many
1 2-GRAM many Gcn4p
1 2-GRAM Gcn4p target
1 2-GRAM target genes
1 2-GRAM genes in
1 2-GRAM in histidine
1 2-GRAM histidine -
1 2-GRAM starved cells
1 2-GRAM The R2
1 2-GRAM R2 between
1 2-GRAM between MFI
1 2-GRAM MFI of
1 2-GRAM of fresh
1 2-GRAM fresh and
1 2-GRAM and frozen
1 2-GRAM frozen muscle
1 2-GRAM muscle was
1 2-GRAM was 0
1 2-GRAM . 94
1 2-GRAM 94 and
1 2-GRAM . 92
1 2-GRAM 92 for
1 2-GRAM for lamb
1 2-GRAM lamb and
1 2-GRAM and pork
1 2-GRAM pork longissimus
1 2-GRAM longissimus ,
1 2-GRAM , respectively
1 2-GRAM respectively .
1 2-GRAM To this
1 2-GRAM this end
1 2-GRAM end ,
2 2-GRAM an expression
1 2-GRAM expression cassette
1 2-GRAM cassette consisting
1 2-GRAM gene for
1 2-GRAM a green
1 2-GRAM green fluorescent
1 2-GRAM fluorescent protein
1 2-GRAM ( GFP
1 2-GRAM GFP )
1 2-GRAM ) flanked
1 2-GRAM flanked at
1 2-GRAM at its
1 2-GRAM its 3
1 2-GRAM end by
1 2-GRAM by EAV
1 2-GRAM EAV -
1 2-GRAM specific transcription
1 2-GRAM transcription -
1 2-GRAM - regulating
1 2-GRAM regulating sequences
1 2-GRAM sequences was
1 2-GRAM was constructed
1 2-GRAM constructed .
1 2-GRAM * Significantly
1 2-GRAM Significantly higher
1 2-GRAM higher lung
1 2-GRAM lung function
1 2-GRAM function parameters
1 2-GRAM parameters were
1 2-GRAM obtained in
1 2-GRAM in extubated
1 2-GRAM extubated recipients
1 2-GRAM recipients of
1 2-GRAM of LPD
1 2-GRAM LPD preserved
1 2-GRAM preserved grafts
1 2-GRAM grafts 2
2 2-GRAM 2 weeks
1 2-GRAM weeks after
1 2-GRAM after TX
1 2-GRAM TX .
1 2-GRAM * Lack
1 2-GRAM Lack of
1 2-GRAM of association
1 2-GRAM between Kawasaki
1 2-GRAM Kawasaki syndrome
1 2-GRAM syndrome and
1 2-GRAM and infection
1 2-GRAM infection with
1 2-GRAM with Rickettsia
1 2-GRAM Rickettsia conorii
1 2-GRAM conorii ,
1 2-GRAM , Rickettsia
1 2-GRAM Rickettsia typhi
1 2-GRAM typhi ,
1 2-GRAM , Coxiella
1 2-GRAM Coxiella burnetii
1 2-GRAM burnetii or
1 2-GRAM or Ehrlichia
1 2-GRAM Ehrlichia phagocytophila
1 2-GRAM phagocytophila group
1 2-GRAM These utilisation
1 2-GRAM utilisation data
2 2-GRAM data imply
1 2-GRAM imply annual
1 2-GRAM annual drug
1 2-GRAM drug costs
1 2-GRAM costs in
1 2-GRAM of $
2 2-GRAM $ US
1 2-GRAM US 480
1 2-GRAM 480 ,
1 2-GRAM 000 to
1 2-GRAM to $
1 2-GRAM US 3
1 2-GRAM , 600
1 2-GRAM 600 ,
1 2-GRAM 000 for
1 2-GRAM for TNF
1 2-GRAM TNF antagonists
1 2-GRAM antagonists for
1 2-GRAM for RA
1 2-GRAM RA per
1 2-GRAM per 1
1 2-GRAM 1 million
1 2-GRAM million population
1 2-GRAM population .
1 2-GRAM * Alignment
1 2-GRAM Alignment of
2 2-GRAM of different
1 2-GRAM different cDNAs
1 2-GRAM cDNAs of
1 2-GRAM the NR5A2
1 2-GRAM NR5A2 (
1 2-GRAM ( hB1F
1 2-GRAM hB1F )
1 2-GRAM genomic sequence
1 2-GRAM sequence facilitated
1 2-GRAM facilitated the
1 2-GRAM the delineation
1 2-GRAM delineation of
1 2-GRAM its structural
1 2-GRAM structural organization
1 2-GRAM organization ,
1 2-GRAM which spans
1 2-GRAM spans over
1 2-GRAM over 150
1 2-GRAM 150 kb
1 2-GRAM kb and
1 2-GRAM and consists
1 2-GRAM consists of
1 2-GRAM of eight
1 2-GRAM eight exons
1 2-GRAM exons interrupted
1 2-GRAM interrupted by
1 2-GRAM by seven
1 2-GRAM seven introns
1 2-GRAM introns .
1 2-GRAM : Ketamine
1 2-GRAM Ketamine -
1 2-GRAM induced dissociative
1 2-GRAM dissociative anesthesia
1 2-GRAM anesthesia produces
1 2-GRAM produces persistently
1 2-GRAM persistently elevated
1 2-GRAM elevated BIS
1 2-GRAM BIS index
1 2-GRAM index which
1 2-GRAM is different
1 2-GRAM different from
1 2-GRAM from thiamylal
1 2-GRAM thiamylal and
1 2-GRAM those reported
1 2-GRAM reported with
1 2-GRAM other conventional
1 2-GRAM conventional anesthetic
1 2-GRAM anesthetic agents
1 2-GRAM agents .
1 2-GRAM remaining case
1 2-GRAM case ,
1 2-GRAM the aneurysm
1 2-GRAM aneurysm originated
1 2-GRAM originated from
1 2-GRAM proximal end
1 2-GRAM associated A1
1 2-GRAM A1 fenestration
1 2-GRAM fenestration .
1 2-GRAM This domain
1 2-GRAM domain without
1 2-GRAM without the
1 2-GRAM the canonical
1 2-GRAM canonical anticodon
1 2-GRAM anticodon loop
1 2-GRAM loop or
1 2-GRAM tyrosine anticodon
1 2-GRAM anticodon acts
2 2-GRAM as an
1 2-GRAM an anchor
1 2-GRAM anchor for
1 2-GRAM for TyrRS
1 2-GRAM TyrRS interaction
1 2-GRAM interaction leading
1 2-GRAM leading to
1 2-GRAM a better
1 2-GRAM better efficiency
1 2-GRAM efficiency of
1 2-GRAM of tyrosylation
1 2-GRAM tyrosylation .
1 2-GRAM * Temperature
1 2-GRAM Temperature measurement
1 2-GRAM measurement in
1 2-GRAM in microfluidic
1 2-GRAM microfluidic systems
1 2-GRAM systems using
1 2-GRAM a temperature
1 2-GRAM temperature -
1 2-GRAM dependent fluorescent
1 2-GRAM fluorescent dye
1 2-GRAM dye .
1 2-GRAM first exon
1 2-GRAM exon (
1 2-GRAM ( exon
1 2-GRAM exon 1A
1 2-GRAM 1A )
1 2-GRAM that corresponded
1 2-GRAM corresponded to
2 2-GRAM the GHR
1 2-GRAM GHR 1A
1 2-GRAM 1A mRNA
1 2-GRAM mRNA was
1 2-GRAM was 15
1 2-GRAM , 250
1 2-GRAM 250 bp
2 2-GRAM bp upstream
1 2-GRAM upstream from
1 2-GRAM from exon
1 2-GRAM exon 2
1 2-GRAM 2 in
1 2-GRAM GHR gene
1 2-GRAM The NAUSICAA
1 2-GRAM NAUSICAA system
1 2-GRAM system gives
1 2-GRAM gives a
1 2-GRAM a good
1 2-GRAM good knowledge
1 2-GRAM knowledge of
1 2-GRAM of LET
1 2-GRAM LET spectra
1 2-GRAM spectra for
1 2-GRAM time in
1 2-GRAM space dosimetry
1 2-GRAM The MABP
1 2-GRAM MABP and
1 2-GRAM and MCBFV
1 2-GRAM MCBFV signals
1 2-GRAM signals were
1 2-GRAM were bandpass
1 2-GRAM bandpass filtered
1 2-GRAM filtered in
1 2-GRAM the very
1 2-GRAM very low
3 2-GRAM - frequency
3 2-GRAM frequency range
3 2-GRAM range (
1 2-GRAM ( VLF
1 2-GRAM VLF ,
1 2-GRAM . 015
1 2-GRAM 015 -
2 2-GRAM . 07
1 2-GRAM 07 Hz
1 2-GRAM Hz ),
1 2-GRAM ), low
1 2-GRAM ( LF
1 2-GRAM LF ,
1 2-GRAM 07 -
2 2-GRAM . 15
1 2-GRAM 15 Hz
2 2-GRAM Hz )
1 2-GRAM and high
1 2-GRAM ( HF
1 2-GRAM HF ,
1 2-GRAM 40 Hz
1 2-GRAM ) before
1 2-GRAM before applying
1 2-GRAM applying CCF
1 2-GRAM CCF for
1 2-GRAM the purpose
1 2-GRAM of studying
1 2-GRAM studying the
1 2-GRAM different bandwidths
1 2-GRAM bandwidths on
1 2-GRAM the resulting
1 2-GRAM resulting mean
1 2-GRAM mean CCFs
1 2-GRAM CCFs .
1 2-GRAM At cross
1 2-GRAM cross purposes
1 2-GRAM purposes .
1 2-GRAM For these
1 2-GRAM these patients
1 2-GRAM patients the
1 2-GRAM the introduction
1 2-GRAM introduction of
1 2-GRAM a separate
1 2-GRAM separate category
1 2-GRAM category "
1 2-GRAM " extended
1 2-GRAM extended oligoarthritis
1 2-GRAM oligoarthritis at
1 2-GRAM at onset
1 2-GRAM onset "
1 2-GRAM " should
1 2-GRAM considered to
1 2-GRAM establish comparable
1 2-GRAM comparable patient
1 2-GRAM patient groups
1 2-GRAM The susceptibility
1 2-GRAM susceptibility of
1 2-GRAM of Aspergillus
1 2-GRAM Aspergillus fumigatus
1 2-GRAM fumigatus to
1 2-GRAM to mulundocandin
1 2-GRAM mulundocandin ,
1 2-GRAM an echinocandin
1 2-GRAM echinocandin -
1 2-GRAM like compound
1 2-GRAM compound ,
1 2-GRAM and other
1 2-GRAM other antifungal
1 2-GRAM antifungal agents
1 2-GRAM agents was
1 2-GRAM was assessed
1 2-GRAM the National
1 2-GRAM National Committee
1 2-GRAM Committee for
1 2-GRAM for Clinical
1 2-GRAM Clinical Laboratory
1 2-GRAM Laboratory Standards
1 2-GRAM Standards (
1 2-GRAM ( NCCLS
1 2-GRAM NCCLS )
1 2-GRAM ) M38
1 2-GRAM M38 -
1 2-GRAM - P
1 2-GRAM P method
1 2-GRAM method ,
1 2-GRAM - bis
1 2-GRAM bis (
1 2-GRAM - methoxy
1 2-GRAM methoxy -
1 2-GRAM - nitro
1 2-GRAM nitro -
1 2-GRAM - sulfophenyl
1 2-GRAM sulfophenyl )-
1 2-GRAM )- 5
1 2-GRAM 5 -[(
1 2-GRAM -[( phenyl
1 2-GRAM phenyl -
1 2-GRAM amino )
1 2-GRAM ) carbonyl
1 2-GRAM carbonyl ]-
1 2-GRAM ]- 2H
1 2-GRAM 2H -
1 2-GRAM - tetrazolium
1 2-GRAM tetrazolium hydroxide
1 2-GRAM hydroxide (
1 2-GRAM ( XTT
1 2-GRAM XTT )-
1 2-GRAM )- based
1 2-GRAM based colorimetric
1 2-GRAM colorimetric assay
1 2-GRAM assay ,
1 2-GRAM and determination
1 2-GRAM determination of
1 2-GRAM of morphologic
1 2-GRAM morphologic alterations
1 2-GRAM alterations by
1 2-GRAM by microscopy
1 2-GRAM microscopy .
1 2-GRAM The most
1 2-GRAM most important
1 2-GRAM important risk
1 2-GRAM factors are
1 2-GRAM are :
1 2-GRAM ) genetic
1 2-GRAM genetic ;
1 2-GRAM ; 2
1 2-GRAM ) Epstein
1 2-GRAM Epstein -
1 2-GRAM - Barr
1 2-GRAM Barr virus
1 2-GRAM virus (
1 2-GRAM ( infectious
1 2-GRAM infectious mononucleosis
1 2-GRAM mononucleosis );
1 2-GRAM ); 3
1 2-GRAM ) congenital
1 2-GRAM congenital and
1 2-GRAM and acquired
1 2-GRAM acquired immunodeficiency
1 2-GRAM immunodeficiency ;
1 2-GRAM ; 4
1 2-GRAM ) occupational
1 2-GRAM occupational exposure
1 2-GRAM exposure (
1 2-GRAM ( the
1 2-GRAM the wood
1 2-GRAM wood industry
1 2-GRAM industry ).
1 2-GRAM * Members
1 2-GRAM Members of
1 2-GRAM 1 superfamily
1 2-GRAM of basic
1 2-GRAM basic -
1 2-GRAM - leucine
1 2-GRAM leucine zipper
1 2-GRAM zipper factors
1 2-GRAM factors bind
1 2-GRAM the StRE
1 2-GRAM StRE .
1 2-GRAM DNA recognition
1 2-GRAM recognition by
1 2-GRAM by F
1 2-GRAM F factor
1 2-GRAM factor TraI36
1 2-GRAM TraI36 :
1 2-GRAM : highly
1 2-GRAM highly sequence
1 2-GRAM sequence -
1 2-GRAM specific binding
1 2-GRAM - stranded
1 2-GRAM stranded DNA
1 2-GRAM DNA .
1 2-GRAM * Overexpression
1 2-GRAM Overexpression of
1 2-GRAM of RORgamma
1 2-GRAM RORgamma has
2 2-GRAM to inhibit
1 2-GRAM inhibit T
2 2-GRAM T cell
1 2-GRAM cell receptor
1 2-GRAM mediated apoptosis
1 2-GRAM apoptosis in
1 2-GRAM in T
1 2-GRAM cell hybridomas
1 2-GRAM hybridomas and
1 2-GRAM to repress
1 2-GRAM repress the
1 2-GRAM the induction
1 2-GRAM of Fas
1 2-GRAM Fas -
1 2-GRAM - ligand
1 2-GRAM ligand and
1 2-GRAM and interleukin
1 2-GRAM interleukin 2
1 2-GRAM Although metabolized
1 2-GRAM metabolized by
1 2-GRAM the cytochrome
1 2-GRAM cytochrome P
1 2-GRAM - 450
1 2-GRAM 450 (
1 2-GRAM ( CYP
1 2-GRAM CYP )
1 2-GRAM ) system
1 2-GRAM , venlafaxine
1 2-GRAM venlafaxine inhibits
1 2-GRAM inhibits CYP
1 2-GRAM CYP 2D6
1 2-GRAM 2D6 and
1 2-GRAM and 3A4
1 2-GRAM 3A4 to
1 2-GRAM a far
1 2-GRAM far lesser
1 2-GRAM lesser extent
1 2-GRAM extent than
1 2-GRAM than do
1 2-GRAM do the
1 2-GRAM the SSRIs
1 2-GRAM SSRIs .
1 2-GRAM * SAPK
2 2-GRAM activation was
1 2-GRAM completely abolished
1 2-GRAM abolished in
1 2-GRAM of MKK7
1 2-GRAM MKK7 ,
1 2-GRAM though expression
2 2-GRAM of MKK4
1 2-GRAM MKK4 was
1 2-GRAM was strongly
1 2-GRAM strongly upregulated
1 2-GRAM upregulated in
1 2-GRAM in mkk7
1 2-GRAM mkk7 (-/-)
1 2-GRAM (-/-) mast
1 2-GRAM mast cell
1 2-GRAM lines ,
1 2-GRAM and phosphorylation
1 2-GRAM MKK4 occurred
1 2-GRAM occurred normally
1 2-GRAM normally in
1 2-GRAM to multiple
1 2-GRAM multiple stress
1 2-GRAM stress stimuli
1 2-GRAM stimuli .
1 2-GRAM However these
1 2-GRAM these search
1 2-GRAM search engines
1 2-GRAM engines respond
1 2-GRAM respond with
1 2-GRAM with such
1 2-GRAM such cumbersome
1 2-GRAM cumbersome results
1 2-GRAM results that
1 2-GRAM that domain
1 2-GRAM domain specific
1 2-GRAM specific experts
1 2-GRAM experts can
1 2-GRAM can not
1 2-GRAM not tolerate
1 2-GRAM tolerate .
1 2-GRAM The titer
1 2-GRAM titer of
1 2-GRAM of TSH
1 2-GRAM TSH binding
1 2-GRAM binding inhibitor
1 2-GRAM inhibitor immunoglobulin
1 2-GRAM immunoglobulin (
1 2-GRAM ( TBII
1 2-GRAM TBII ),
1 2-GRAM which had
1 2-GRAM had been
1 2-GRAM been 8
1 2-GRAM 6 %
1 2-GRAM % at
1 2-GRAM at initial
1 2-GRAM initial presentation
1 2-GRAM presentation ,
1 2-GRAM , rose
1 2-GRAM rose to
1 2-GRAM to 14
1 2-GRAM 9 %
1 2-GRAM % in
1 2-GRAM in 2
1 2-GRAM weeks .
1 2-GRAM The extraordinary
1 2-GRAM extraordinary stability
1 2-GRAM stability of
1 2-GRAM of peptide
1 2-GRAM peptide --
1 2-GRAM -- gp96
1 2-GRAM gp96 complexes
1 2-GRAM complexes and
1 2-GRAM the plasticity
1 2-GRAM plasticity of
1 2-GRAM the peptide
1 2-GRAM peptide -
1 2-GRAM binding pocket
1 2-GRAM pocket support
1 2-GRAM support the
1 2-GRAM the proposed
1 2-GRAM proposed relay
1 2-GRAM relay of
1 2-GRAM of diverse
1 2-GRAM diverse peptides
1 2-GRAM peptides to
1 2-GRAM to MHC
1 2-GRAM MHC and
3 2-GRAM and /
3 2-GRAM / or
1 2-GRAM or other
1 2-GRAM other molecules
1 2-GRAM molecules via
1 2-GRAM via molecular
1 2-GRAM molecular recognition
1 2-GRAM recognition .
1 2-GRAM * Elevated
1 2-GRAM Elevated expression
1 2-GRAM of full
1 2-GRAM length UhpB
1 2-GRAM UhpB or
1 2-GRAM or of
1 2-GRAM a soluble
1 2-GRAM soluble hybrid
1 2-GRAM hybrid protein
1 2-GRAM , GST
1 2-GRAM GST -
1 2-GRAM - Bc
1 2-GRAM Bc ,
1 2-GRAM is glutathione
1 2-GRAM glutathione S
1 2-GRAM - transferase
1 2-GRAM transferase (
1 2-GRAM ( GST
1 2-GRAM GST )
1 2-GRAM ) fused
1 2-GRAM fused to
1 2-GRAM cytoplasmic C
1 2-GRAM of UhpB
1 2-GRAM UhpB ,
1 2-GRAM , results
1 2-GRAM in complete
1 2-GRAM complete blockage
1 2-GRAM blockage of
1 2-GRAM of uhpT
1 2-GRAM uhpT expression
1 2-GRAM a uhp
1 2-GRAM uhp (+)
1 2-GRAM (+) strain
1 2-GRAM * Physical
1 2-GRAM Physical principles
1 2-GRAM principles in
1 2-GRAM in therapeutic
1 2-GRAM therapeutic apheresis
1 2-GRAM apheresis .
1 2-GRAM * Evidence
1 2-GRAM Evidence from
1 2-GRAM a Northern
1 2-GRAM Northern hybridization
1 2-GRAM hybridization indicated
1 2-GRAM that jadM
1 2-GRAM jadM expression
1 2-GRAM expression is
1 2-GRAM is correlated
1 2-GRAM with jadomycin
1 2-GRAM jadomycin B
1 2-GRAM B synthesis
2 2-GRAM synthesis .
1 2-GRAM Multiple copies
1 2-GRAM copies of
1 2-GRAM of rsmB
1 2-GRAM rsmB +
1 2-GRAM + DNA
1 2-GRAM , on
2 2-GRAM other hand
2 2-GRAM hand ,
1 2-GRAM , stimulate
1 2-GRAM stimulate exoenzyme
1 2-GRAM exoenzyme production
1 2-GRAM production by
1 2-GRAM by relieving
1 2-GRAM relieving the
1 2-GRAM negative effects
1 2-GRAM a chromosomal
1 2-GRAM chromosomal copy
1 2-GRAM of hexA
1 2-GRAM hexA +.
1 2-GRAM +. STOP
1 2-GRAM * Systematic
1 2-GRAM Systematic review
1 2-GRAM of diagnostic
1 2-GRAM diagnostic tests
1 2-GRAM tests for
1 2-GRAM for vaginal
1 2-GRAM vaginal trichomoniasis
1 2-GRAM trichomoniasis .
1 2-GRAM * Anecdotal
1 2-GRAM Anecdotal observations
1 2-GRAM observations scattered
1 2-GRAM scattered throughout
1 2-GRAM the literature
1 2-GRAM literature have
1 2-GRAM have often
1 2-GRAM often provided
1 2-GRAM provided clues
1 2-GRAM clues to
1 2-GRAM to underlying
1 2-GRAM underlying variations
1 2-GRAM variations in
1 2-GRAM in humans
1 2-GRAM humans '
1 2-GRAM ' ability
1 2-GRAM to handle
1 2-GRAM handle dietary
1 2-GRAM dietary chemicals
1 2-GRAM chemicals .
1 2-GRAM that phosphorylation
1 2-GRAM phosphorylation -
1 2-GRAM induced loss
2 2-GRAM kinase activity
1 2-GRAM - PK
1 2-GRAM PK is
1 2-GRAM is restored
1 2-GRAM restored by
1 2-GRAM the purified
1 2-GRAM purified catalytic
1 2-GRAM catalytic subunit
1 2-GRAM subunit of
1 2-GRAM either protein
1 2-GRAM phosphatase 1
1 2-GRAM 1 or
1 2-GRAM or protein
1 2-GRAM this reactivation
1 2-GRAM reactivation is
1 2-GRAM is blocked
1 2-GRAM blocked by
1 2-GRAM the potent
1 2-GRAM phosphatase inhibitor
1 2-GRAM inhibitor ,
1 2-GRAM , microcystin
1 2-GRAM microcystin .
1 2-GRAM * Herein
1 2-GRAM Herein PPARgamma
1 2-GRAM PPARgamma ,
1 2-GRAM , liganded
1 2-GRAM liganded by
1 2-GRAM by either
1 2-GRAM either natural
1 2-GRAM natural (
1 2-GRAM ( 15d
1 2-GRAM 15d -
1 2-GRAM - PGJ
1 2-GRAM PGJ (
1 2-GRAM and PGD
1 2-GRAM PGD (
2 2-GRAM 2 ))
1 2-GRAM )) or
1 2-GRAM or synthetic
1 2-GRAM synthetic ligands
1 2-GRAM ligands (
1 2-GRAM ( BRL49653
1 2-GRAM BRL49653 and
1 2-GRAM and troglitazone
1 2-GRAM troglitazone ),
1 2-GRAM ), selectively
1 2-GRAM selectively inhibited
1 2-GRAM inhibited expression
1 2-GRAM D1 gene
1 2-GRAM An integrated
1 2-GRAM integrated RTC
1 2-GRAM RTC algorithm
1 2-GRAM algorithm for
1 2-GRAM the urban
1 2-GRAM urban wastewater
1 2-GRAM wastewater system
1 2-GRAM system is
1 2-GRAM is formulated
1 2-GRAM formulated ,
1 2-GRAM the parameters
1 2-GRAM parameters of
1 2-GRAM are optimized
1 2-GRAM optimized using
1 2-GRAM using various
1 2-GRAM various global
1 2-GRAM global optimization
1 2-GRAM optimization routines
1 2-GRAM routines .
1 2-GRAM * Recently
1 2-GRAM Recently ,
1 2-GRAM that alanine
1 2-GRAM alanine substitutions
1 2-GRAM substitutions of
1 2-GRAM the active
1 2-GRAM active center
1 2-GRAM center cleft
1 2-GRAM cleft residues
1 2-GRAM residues significantly
1 2-GRAM significantly impair
1 2-GRAM impair the
1 2-GRAM the depurinating
1 2-GRAM depurinating and
1 2-GRAM and ribosome
1 2-GRAM ribosome inhibitory
1 2-GRAM inhibitory activity
1 2-GRAM of PAP
1 2-GRAM PAP .
1 2-GRAM This partial
1 2-GRAM partial transection
1 2-GRAM transection could
1 2-GRAM could permit
1 2-GRAM permit vasopressin
1 2-GRAM vasopressin to
1 2-GRAM be secreted
1 2-GRAM secreted in
1 2-GRAM a larger
1 2-GRAM larger rise
1 2-GRAM rise in
1 2-GRAM plasma sodium
1 2-GRAM sodium concentration
1 2-GRAM * Reciprocally
1 2-GRAM Reciprocally ,
1 2-GRAM , HMGI
1 2-GRAM HMGI -
1 2-GRAM C expression
1 2-GRAM expression also
1 2-GRAM also coordinately
1 2-GRAM coordinately enhances
1 2-GRAM enhances PIAS3
1 2-GRAM PIAS3 -
1 2-GRAM mediated repression
1 2-GRAM of STAT3
1 2-GRAM STAT3 -
1 2-GRAM dependent transactivation
1 2-GRAM transactivation .
1 2-GRAM The genomic
1 2-GRAM genomic structure
1 2-GRAM structure of
1 2-GRAM human SPEC1
1 2-GRAM SPEC1 gene
1 2-GRAM gene reveals
1 2-GRAM reveals complex
1 2-GRAM complex splicing
1 2-GRAM splicing and
1 2-GRAM and close
1 2-GRAM close promoter
1 2-GRAM promoter proximity
1 2-GRAM proximity to
1 2-GRAM the AF1q
1 2-GRAM AF1q translocation
1 2-GRAM translocation gene
1 2-GRAM Here ,
1 2-GRAM the PEX5
1 2-GRAM PEX5 -
1 2-GRAM - TPR
1 2-GRAM TPR domains
1 2-GRAM domains from
1 2-GRAM from human
1 2-GRAM human ,
1 2-GRAM , tobacco
1 2-GRAM tobacco ,
1 2-GRAM and nematode
1 2-GRAM nematode were
1 2-GRAM were inserted
1 2-GRAM inserted into
1 2-GRAM into a
1 2-GRAM a TPR
1 2-GRAM TPR -
1 2-GRAM - less
1 2-GRAM less yeast
1 2-GRAM yeast Pex5p
1 2-GRAM Pex5p construct
1 2-GRAM construct to
1 2-GRAM generate Pex5p
1 2-GRAM Pex5p chimaeras
1 2-GRAM chimaeras .
1 2-GRAM study demonstrates
1 2-GRAM demonstrates that
1 2-GRAM that inducible
1 2-GRAM inducible expression
1 2-GRAM to either
1 2-GRAM either PMA
1 2-GRAM PMA or
1 2-GRAM or TPO
1 2-GRAM TPO is
1 2-GRAM mediated through
1 2-GRAM the Ets
1 2-GRAM Ets site
1 2-GRAM proximal promoter
1 2-GRAM of GPIX
1 2-GRAM GPIX and
1 2-GRAM dependent upon
1 2-GRAM upon the
1 2-GRAM the upstream
1 2-GRAM upstream activation
1 2-GRAM of MAPK
1 2-GRAM regulated kinase
1 2-GRAM Molecular identification
1 2-GRAM of smg
1 2-GRAM smg -
1 2-GRAM 4 ,
1 2-GRAM for mRNA
1 2-GRAM mRNA surveillance
1 2-GRAM surveillance in
1 2-GRAM in C
1 2-GRAM . elegans
1 2-GRAM elegans .
1 2-GRAM * Cytosolic
1 2-GRAM Cytosolic acetyl
2 2-GRAM acetyl -
1 2-GRAM CoA synthetase
1 2-GRAM synthetase (
1 2-GRAM ( AceCS1
1 2-GRAM AceCS1 )
1 2-GRAM ) activates
1 2-GRAM activates acetate
1 2-GRAM acetate to
1 2-GRAM to supply
1 2-GRAM supply the
1 2-GRAM the cells
2 2-GRAM cells with
1 2-GRAM with acetyl
1 2-GRAM CoA for
1 2-GRAM for lipid
1 2-GRAM lipid synthesis
1 2-GRAM was an
1 2-GRAM in protein
1 2-GRAM protein binding
1 2-GRAM binding onto
1 2-GRAM onto this
1 2-GRAM this element
1 2-GRAM element only
1 2-GRAM after peptide
1 2-GRAM peptide treatment
1 2-GRAM treatment .
1 2-GRAM * While
1 2-GRAM While these
1 2-GRAM these results
1 2-GRAM with previously
1 2-GRAM reported effects
1 2-GRAM terminal domain
1 2-GRAM domain on
1 2-GRAM on nucleotide
1 2-GRAM nucleotide binding
1 2-GRAM binding ,
1 2-GRAM , they
1 2-GRAM they also
1 2-GRAM also demonstrate
1 2-GRAM that interactions
1 2-GRAM interactions with
1 2-GRAM terminal domains
1 2-GRAM domains are
1 2-GRAM are necessary
1 2-GRAM necessary to
1 2-GRAM inhibit proton
1 2-GRAM proton transport
2 2-GRAM transport .
1 2-GRAM that an
1 2-GRAM an intracellular
1 2-GRAM intracellular WT
1 2-GRAM WT -
1 2-GRAM 1 /
1 2-GRAM / HSAL2
1 2-GRAM HSAL2 pathway
1 2-GRAM pathway may
1 2-GRAM may play
1 2-GRAM a role
1 2-GRAM in development
1 2-GRAM development and
1 2-GRAM and hematopoiesis
1 2-GRAM hematopoiesis .
1 2-GRAM The radial
1 2-GRAM radial forearm
1 2-GRAM forearm flap
1 2-GRAM flap is
1 2-GRAM is used
1 2-GRAM used most
1 2-GRAM most commonly
1 2-GRAM commonly ,
1 2-GRAM however the
1 2-GRAM the lateral
1 2-GRAM lateral arm
1 2-GRAM arm flap
1 2-GRAM flap may
1 2-GRAM be the
1 2-GRAM the flap
1 2-GRAM flap of
1 2-GRAM of choice
1 2-GRAM choice in
1 2-GRAM in certain
1 2-GRAM certain situations
1 2-GRAM situations .
1 2-GRAM The procedure
1 2-GRAM procedure is
1 2-GRAM is less
1 2-GRAM less aggressive
1 2-GRAM aggressive and
1 2-GRAM and painful
1 2-GRAM painful than
1 2-GRAM than sternotomy
1 2-GRAM sternotomy .
2 2-GRAM we have
1 2-GRAM have isolated
1 2-GRAM isolated a
1 2-GRAM a genomic
1 2-GRAM genomic fragment
1 2-GRAM fragment containing
1 2-GRAM most distal
1 2-GRAM distal 5
1 2-GRAM ' sequences
1 2-GRAM major GGT
1 2-GRAM GGT mRNA
1 2-GRAM mRNA in
1 2-GRAM in HepG2
1 2-GRAM HepG2 cells
1 2-GRAM * Further
1 2-GRAM Further ,
1 2-GRAM the osteo
1 2-GRAM osteo -
1 2-GRAM - retentive
1 2-GRAM retentive ability
1 2-GRAM the hydroxyapatite
1 2-GRAM hydroxyapatite in
1 2-GRAM the sockets
1 2-GRAM sockets was
1 2-GRAM was seen
1 2-GRAM seen to
1 2-GRAM be close
1 2-GRAM close to
1 2-GRAM to significance
1 2-GRAM significance (
2 2-GRAM ( after
1 2-GRAM after six
1 2-GRAM months width
1 2-GRAM width differences
1 2-GRAM differences ,
1 2-GRAM the canine
1 2-GRAM canine region
1 2-GRAM : P
1 2-GRAM . 059
1 2-GRAM 059 ,
1 2-GRAM , LHS
1 2-GRAM LHS ,
1 2-GRAM and P
1 2-GRAM . 065
1 2-GRAM 065 ,
1 2-GRAM , RHS
1 2-GRAM RHS ).
1 2-GRAM suggest a
1 2-GRAM novel ankyrin
1 2-GRAM ankyrin -
1 2-GRAM independent role
1 2-GRAM for LAD
1 2-GRAM LAD -
1 2-GRAM 1 related
1 2-GRAM to FGFR
1 2-GRAM FGFR signaling
1 2-GRAM Managing vertigo
1 2-GRAM vertigo and
1 2-GRAM and vertigo
1 2-GRAM vertigo syndromes
1 2-GRAM syndromes in
1 2-GRAM the elderly
1 2-GRAM elderly STOP
1 2-GRAM A single
1 2-GRAM single base
1 2-GRAM base change
1 2-GRAM ( A8G
1 2-GRAM A8G )
1 2-GRAM in either
1 2-GRAM either sequence
1 2-GRAM sequence reduces
1 2-GRAM reduces hnRNP
1 2-GRAM hnRNP A2
1 2-GRAM A2 binding
1 2-GRAM and ,
1 2-GRAM the case
1 2-GRAM of A2RE
1 2-GRAM A2RE -
1 2-GRAM , inhibits
1 2-GRAM inhibits RNA
1 2-GRAM RNA transport
1 2-GRAM A method
2 2-GRAM three -
1 2-GRAM - station
1 2-GRAM station three
1 2-GRAM - dimensional
1 2-GRAM dimensional magnetic
2 2-GRAM magnetic resonance
2 2-GRAM ( MR
1 2-GRAM MR )
1 2-GRAM ) angiography
1 2-GRAM angiography of
1 2-GRAM lower extremities
1 2-GRAM extremities with
1 2-GRAM with segmented
1 2-GRAM segmented volume
1 2-GRAM volume acquisition
1 2-GRAM acquisition is
1 2-GRAM presented .
1 2-GRAM * Treatment
1 2-GRAM Treatment of
1 2-GRAM of N18TG
1 2-GRAM N18TG -
1 2-GRAM a demethylating
1 2-GRAM demethylating agent
1 2-GRAM agent ,
1 2-GRAM , 5
1 2-GRAM - aza
1 2-GRAM aza -
1 2-GRAM - deoxycytidine
1 2-GRAM deoxycytidine ,
1 2-GRAM , resulted
1 2-GRAM in an
2 2-GRAM of mlt
1 2-GRAM , indicating
1 2-GRAM indicating that
1 2-GRAM the repression
1 2-GRAM is attributable
1 2-GRAM attributable to
1 2-GRAM to methylation
1 2-GRAM methylation Thus
1 2-GRAM , mlt
1 2-GRAM novel target
1 2-GRAM target gene
1 2-GRAM gene that
1 2-GRAM is silenced
1 2-GRAM silenced by
1 2-GRAM by methylation
1 2-GRAM methylation during
1 2-GRAM during liver
1 2-GRAM liver tumorigenesis
1 2-GRAM tumorigenesis initiated
1 2-GRAM by SV40
1 2-GRAM antigen .
1 2-GRAM We found
1 2-GRAM subjects rCBF
1 2-GRAM rCBF increases
1 2-GRAM increases in
1 2-GRAM in regions
1 2-GRAM regions associated
1 2-GRAM the meso
2 2-GRAM meso -
1 2-GRAM - striatal
1 2-GRAM striatal and
1 2-GRAM and meso
1 2-GRAM - corticolimbic
1 2-GRAM corticolimbic circuits
1 2-GRAM circuits in
1 2-GRAM to both
1 2-GRAM both monetary
1 2-GRAM monetary reward
1 2-GRAM reward and
1 2-GRAM and nonmonetary
1 2-GRAM nonmonetary reinforcement
1 2-GRAM reinforcement .
1 2-GRAM * Reverse
1 2-GRAM Reverse transcriptase
1 2-GRAM transcriptase -
1 2-GRAM - polymerase
2 2-GRAM polymerase chain
2 2-GRAM chain reaction
1 2-GRAM reaction assays
1 2-GRAM assays showed
1 2-GRAM that PKRDeltaE7
1 2-GRAM PKRDeltaE7 is
1 2-GRAM a broad
1 2-GRAM broad range
1 2-GRAM human tissues
1 2-GRAM tissues at
1 2-GRAM at variable
1 2-GRAM variable levels
1 2-GRAM For this
1 2-GRAM this purpose
1 2-GRAM purpose ,
1 2-GRAM the immediate
1 2-GRAM immediate and
1 2-GRAM the final
1 2-GRAM final (
1 2-GRAM after swelling
1 2-GRAM swelling )
1 2-GRAM ) fixation
1 2-GRAM fixation strengths
1 2-GRAM strengths of
1 2-GRAM two variations
1 2-GRAM variations of
1 2-GRAM the swellable
1 2-GRAM swellable bone
1 2-GRAM bone anchor
1 2-GRAM anchor designs
1 2-GRAM designs (
1 2-GRAM ( a
1 2-GRAM a smooth
1 2-GRAM smooth anchor
1 2-GRAM anchor and
1 2-GRAM a screw
1 2-GRAM screw anchor
1 2-GRAM anchor )
1 2-GRAM were measured
1 2-GRAM measured in
1 2-GRAM different foams
1 2-GRAM foams (
1 2-GRAM ( used
1 2-GRAM to simulate
1 2-GRAM simulate bone
1 2-GRAM bone )
1 2-GRAM with different
1 2-GRAM different densities
1 2-GRAM densities .
1 2-GRAM * CYP2C19
1 2-GRAM CYP2C19 genotype
1 2-GRAM genotype was
1 2-GRAM the polymerase
1 2-GRAM reaction -
1 2-GRAM - restriction
1 2-GRAM restriction fragment
1 2-GRAM fragment length
1 2-GRAM length polymorphism
1 2-GRAM polymorphism method
1 2-GRAM It is
1 2-GRAM is useful
1 2-GRAM useful as
1 2-GRAM an adjunct
1 2-GRAM adjunct to
1 2-GRAM to mammography
1 2-GRAM mammography in
1 2-GRAM those patients
1 2-GRAM with radiographically
1 2-GRAM radiographically dense
1 2-GRAM dense breasts
1 2-GRAM breasts for
1 2-GRAM the characterization
1 2-GRAM of palpable
1 2-GRAM palpable masses
1 2-GRAM masses .
1 2-GRAM * Activation
1 2-GRAM Activation of
1 2-GRAM of transcription
1 2-GRAM transcription through
1 2-GRAM 1 site
1 2-GRAM in Jurkat
1 2-GRAM Jurkat cells
1 2-GRAM cells by
1 2-GRAM by JunD
1 2-GRAM JunD and
1 2-GRAM or Fra
3 2-GRAM 2 was
1 2-GRAM was weak
1 2-GRAM weak .
1 2-GRAM . c
1 2-GRAM Jun ,
1 2-GRAM , JunB
1 2-GRAM JunB ,
1 2-GRAM and c
1 2-GRAM - Fos
1 2-GRAM Fos activation
1 2-GRAM was greater
1 2-GRAM greater ,
1 2-GRAM level was
1 2-GRAM was still
1 2-GRAM still less
1 2-GRAM less than
1 2-GRAM that with
1 2-GRAM with Tax
1 2-GRAM Tax .
1 2-GRAM the screen
1 2-GRAM screen for
1 2-GRAM for toxic
1 2-GRAM toxic p53
1 2-GRAM p53 mutants
1 2-GRAM mutants in
1 2-GRAM yeast can
1 2-GRAM can identify
1 2-GRAM identify novel
1 2-GRAM novel p53
1 2-GRAM p53 variants
1 2-GRAM variants that
1 2-GRAM useful in
1 2-GRAM in dissecting
1 2-GRAM dissecting p53
1 2-GRAM p53 regulated
1 2-GRAM regulated cellular
1 2-GRAM cellular responses
1 2-GRAM responses and
1 2-GRAM in developing
1 2-GRAM developing p53
1 2-GRAM p53 -
1 2-GRAM based cancer
1 2-GRAM cancer therapies
1 2-GRAM therapies .
1 2-GRAM * Local
1 2-GRAM Local control
1 2-GRAM control rates
1 2-GRAM rates were
1 2-GRAM were 91
2 2-GRAM 91 %
3 2-GRAM % for
1 2-GRAM for metastatic
1 2-GRAM metastatic lung
1 2-GRAM , 89
1 2-GRAM 89 %
1 2-GRAM primary lung
1 2-GRAM cancer and
1 2-GRAM and 85
1 2-GRAM 85 %
1 2-GRAM for T1
1 2-GRAM T1 ,
1 2-GRAM , 2N0M0
1 2-GRAM 2N0M0 cases
1 2-GRAM that cognitive
1 2-GRAM cognitive stimulation
1 2-GRAM stimulation enhanced
1 2-GRAM enhanced performance
1 2-GRAM performance on
1 2-GRAM the Boston
1 2-GRAM Boston Naming
1 2-GRAM Naming Test
1 2-GRAM Test and
1 2-GRAM a Word
1 2-GRAM Word List
1 2-GRAM List Recognition
1 2-GRAM Recognition Task
1 2-GRAM Task ;
1 2-GRAM ; physical
1 2-GRAM physical intervention
1 2-GRAM intervention ,
1 2-GRAM , did
1 2-GRAM not reach
1 2-GRAM reach statistical
1 2-GRAM statistical significance
1 2-GRAM significance .
1 2-GRAM * Gimpl
1 2-GRAM Gimpl ,
1 2-GRAM , F
1 2-GRAM F .
1 2-GRAM The actA
1 2-GRAM actA gene
1 2-GRAM is present
1 2-GRAM present as
1 2-GRAM single copy
1 2-GRAM copy in
1 2-GRAM genome of
1 2-GRAM of A
1 2-GRAM A .
1 2-GRAM . chrysogenum
1 2-GRAM chrysogenum ;
1 2-GRAM expression level
1 2-GRAM level ,
1 2-GRAM , opposite
1 2-GRAM opposite to
1 2-GRAM to pcbC
1 2-GRAM pcbC and
1 2-GRAM and cefEF
1 2-GRAM cefEF cephalosporin
1 2-GRAM cephalosporin biosynthetic
1 2-GRAM biosynthetic genes
1 2-GRAM , was
1 2-GRAM was steady
1 2-GRAM steady during
1 2-GRAM during cephalosporin
1 2-GRAM cephalosporin fermentation
1 2-GRAM fermentation ,
1 2-GRAM , showing
1 2-GRAM showing a
1 2-GRAM single 1
1 2-GRAM kb transcript
1 2-GRAM transcript .
1 2-GRAM * Maternal
1 2-GRAM Maternal p
1 2-GRAM p ,
1 2-GRAM , p
1 2-GRAM p '
1 2-GRAM ' DDE
1 2-GRAM DDE and
1 2-GRAM and beta
1 2-GRAM - HCH
1 2-GRAM HCH levels
1 2-GRAM levels were
1 2-GRAM also associated
1 2-GRAM with newborn
1 2-GRAM newborn levels
1 2-GRAM but levels
1 2-GRAM of PCBs
1 2-GRAM PCBs were
1 2-GRAM not .
1 2-GRAM The patients
1 2-GRAM patients and
1 2-GRAM and their
1 2-GRAM their families
1 2-GRAM families were
1 2-GRAM were closely
1 2-GRAM closely questioned
1 2-GRAM questioned ,
1 2-GRAM and full
1 2-GRAM full clinical
1 2-GRAM examination included
1 2-GRAM included a
1 2-GRAM a test
1 2-GRAM test for
1 2-GRAM for orthostasia
1 2-GRAM orthostasia .
1 2-GRAM The expression
1 2-GRAM of alpha
1 2-GRAM amylase can
1 2-GRAM be transactivated
1 2-GRAM transactivated by
1 2-GRAM factor GAMyb
1 2-GRAM GAMyb ,
1 2-GRAM is itself
1 2-GRAM itself induced
1 2-GRAM induced by
1 2-GRAM by GA
1 2-GRAM GA .
1 2-GRAM * Cardiac
1 2-GRAM Cardiac output
1 2-GRAM output at
1 2-GRAM at anaerobic
1 2-GRAM anaerobic threshold
1 2-GRAM threshold (
1 2-GRAM ( COAT
1 2-GRAM COAT )
1 2-GRAM = 7
1 2-GRAM 3 L
1 2-GRAM L /
1 2-GRAM / min
1 2-GRAM min was
1 2-GRAM was the
1 2-GRAM best cutoff
1 2-GRAM cutoff value
1 2-GRAM value for
1 2-GRAM for identifying
1 2-GRAM identifying multivessel
1 2-GRAM multivessel coronary
1 2-GRAM ( relative
1 2-GRAM relative risk
1 2-GRAM 1 ).
1 2-GRAM * Tolerance
1 2-GRAM Tolerance to
2 2-GRAM to ADAL
2 2-GRAM ADAL -
1 2-GRAM was similar
3 2-GRAM to that
1 2-GRAM of Vicryl
1 2-GRAM Vicryl suture
1 2-GRAM suture and
1 2-GRAM and tolerance
1 2-GRAM tolerance to
1 2-GRAM was superior
1 2-GRAM that to
1 2-GRAM to Tisuacryl
1 2-GRAM Tisuacryl .
1 2-GRAM the base
1 2-GRAM base -
1 2-GRAM - case
1 2-GRAM case analysis
1 2-GRAM analysis ,
1 2-GRAM , total
1 2-GRAM total direct
1 2-GRAM direct costs
1 2-GRAM costs per
1 2-GRAM per patient
1 2-GRAM patient were
1 2-GRAM were $
1 2-GRAM $ 728
1 2-GRAM 728 for
1 2-GRAM for zoledronic
1 2-GRAM zoledronic acid
1 2-GRAM acid and
1 2-GRAM and $
1 2-GRAM $ 776
1 2-GRAM 776 for
1 2-GRAM for pamidronate
1 2-GRAM pamidronate .
1 2-GRAM We retrospectively
1 2-GRAM retrospectively selected
1 2-GRAM selected 13
1 2-GRAM 13 TFCD
1 2-GRAM TFCD patients
1 2-GRAM patients who
1 2-GRAM who underwent
1 2-GRAM for intractable
1 2-GRAM intractable epilepsy
1 2-GRAM epilepsy with
1 2-GRAM the aim
1 2-GRAM aim of
1 2-GRAM of removing
1 2-GRAM removing the
1 2-GRAM the magnetic
1 2-GRAM MR )-
1 2-GRAM )- detectable
1 2-GRAM detectable lesion
1 2-GRAM lesion and
1 2-GRAM the epileptogenic
1 2-GRAM epileptogenic zone
1 2-GRAM zone defined
1 2-GRAM defined by
1 2-GRAM by stereoelectroencephalographic
1 2-GRAM stereoelectroencephalographic recordings
1 2-GRAM recordings .
1 2-GRAM To gain
1 2-GRAM gain an
1 2-GRAM an understanding
1 2-GRAM understanding of
1 2-GRAM the mGSTM2
1 2-GRAM mGSTM2 regulation
1 2-GRAM have also
1 2-GRAM also cloned
1 2-GRAM cloned and
1 2-GRAM and analyzed
1 2-GRAM analyzed its
1 2-GRAM its promoter
2 2-GRAM promoter region
1 2-GRAM region .
1 2-GRAM * Cyclins
1 2-GRAM Cyclins are
1 2-GRAM are one
1 2-GRAM the pivotal
1 2-GRAM pivotal determinants
1 2-GRAM determinants regulating
1 2-GRAM regulating cell
1 2-GRAM progression .
1 2-GRAM * Architecture
1 2-GRAM Architecture and
1 2-GRAM and anatomy
1 2-GRAM anatomy of
1 2-GRAM genomic locus
1 2-GRAM locus encoding
1 2-GRAM encoding the
1 2-GRAM leukemia -
1 2-GRAM associated transcription
1 2-GRAM factor RUNX1
1 2-GRAM RUNX1 /
1 2-GRAM / AML1
1 2-GRAM AML1 .
1 2-GRAM Three of
1 2-GRAM proteins involved
1 2-GRAM in checkpoint
1 2-GRAM checkpoint signaling
1 2-GRAM signaling ,
1 2-GRAM , Rad1
1 2-GRAM Rad1 ,
1 2-GRAM , Hus1
1 2-GRAM Hus1 ,
1 2-GRAM and Rad9
1 2-GRAM Rad9 ,
1 2-GRAM interact by
1 2-GRAM immunoprecipitation and
1 2-GRAM and yeast
1 2-GRAM yeast two
1 2-GRAM hybrid studies
1 2-GRAM * Together
1 2-GRAM Together these
1 2-GRAM imply that
1 2-GRAM the HFV
1 2-GRAM HFV R
1 2-GRAM R region
1 2-GRAM region acts
1 2-GRAM nucleus to
1 2-GRAM to modify
1 2-GRAM modify the
1 2-GRAM cytoplasmic fate
1 2-GRAM fate of
1 2-GRAM of target
1 2-GRAM target HFV
1 2-GRAM HFV mRNA
1 2-GRAM mRNA .
1 2-GRAM , patients
1 2-GRAM with isolated
1 2-GRAM isolated office
1 2-GRAM office hypertension
1 2-GRAM hypertension had
1 2-GRAM had fewer
1 2-GRAM fewer previous
1 2-GRAM previous cardiovascular
1 2-GRAM cardiovascular complications
1 2-GRAM complications .
1 2-GRAM Through deletion
1 2-GRAM deletion mutagenesis
1 2-GRAM mutagenesis ,
1 2-GRAM we identify
1 2-GRAM identify amino
1 2-GRAM acids 2003
1 2-GRAM 2003 to
1 2-GRAM to 2212
1 2-GRAM 2212 of
1 2-GRAM of CBP
1 2-GRAM CBP ,
1 2-GRAM we call
1 2-GRAM call carboxy
1 2-GRAM carboxy -
1 2-GRAM region 2
1 2-GRAM ( CR2
1 2-GRAM CR2 ),
1 2-GRAM the minimal
1 2-GRAM minimal region
1 2-GRAM region for
1 2-GRAM for Tax
1 2-GRAM Tax interaction
1 2-GRAM interaction .
1 2-GRAM * Fetal
1 2-GRAM Fetal lung
1 2-GRAM lung volume
1 2-GRAM volume :
1 2-GRAM : estimation
1 2-GRAM estimation at
1 2-GRAM at MR
1 2-GRAM imaging -
1 2-GRAM - initial
1 2-GRAM initial results
1 2-GRAM results .
1 2-GRAM * Plane
1 2-GRAM Plane wave
1 2-GRAM wave geometry
1 2-GRAM geometry is
1 2-GRAM is impractical
1 2-GRAM impractical for
1 2-GRAM use but
1 2-GRAM this work
1 2-GRAM work encouraged
1 2-GRAM encouraged us
1 2-GRAM us to
1 2-GRAM to further
1 2-GRAM further develop
1 2-GRAM develop the
1 2-GRAM the P3
1 2-GRAM P3 approximation
1 2-GRAM approximation for
1 2-GRAM a spherical
1 2-GRAM spherical geometry
1 2-GRAM geometry ,
1 2-GRAM , described
1 2-GRAM in this
1 2-GRAM paper .
1 2-GRAM For the
1 2-GRAM the sample
1 2-GRAM sample of
1 2-GRAM of systematic
1 2-GRAM systematic reviews
1 2-GRAM reviews drawn
1 2-GRAM drawn from
1 2-GRAM from ACP
1 2-GRAM ACP Journal
1 2-GRAM Journal Club
1 2-GRAM Club (
1 2-GRAM ( n
1 2-GRAM n =
1 2-GRAM = 103
1 2-GRAM 103 ),
1 2-GRAM ), the
1 2-GRAM the PubMed
1 2-GRAM PubMed strategy
1 2-GRAM strategy achieved
1 2-GRAM achieved a
1 2-GRAM a sensitivity
1 2-GRAM sensitivity of
1 2-GRAM of 97
1 2-GRAM 97 %
1 2-GRAM % (
1 2-GRAM ( CI
1 2-GRAM CI ,
1 2-GRAM , 91
1 2-GRAM % to
1 2-GRAM to 99
1 2-GRAM 99 %).
1 2-GRAM , she
1 2-GRAM she received
1 2-GRAM received hepatic
1 2-GRAM hepatic intra
1 2-GRAM - arterial
1 2-GRAM arterial infusion
1 2-GRAM infusion of
1 2-GRAM of levoforinate
1 2-GRAM levoforinate (
1 2-GRAM ( l
1 2-GRAM l -
1 2-GRAM - LV
1 2-GRAM LV )
1 2-GRAM ) 250
1 2-GRAM 250 mg
1 2-GRAM mg and
1 2-GRAM fluorouracil (
1 2-GRAM ( 5
1 2-GRAM - FU
1 2-GRAM FU )
1 2-GRAM ) 500
1 2-GRAM 500 mg
1 2-GRAM mg for
1 2-GRAM for combined
1 2-GRAM combined multiple
1 2-GRAM multiple hepatic
1 2-GRAM hepatic metastases
1 2-GRAM metastases starting
1 2-GRAM starting on
1 2-GRAM on postoperative
1 2-GRAM postoperative day
1 2-GRAM day 14
1 2-GRAM 14 ,
1 2-GRAM and these
1 2-GRAM these medications
1 2-GRAM medications were
1 2-GRAM were administered
1 2-GRAM administered over
1 2-GRAM over 48
1 2-GRAM 48 hours
1 2-GRAM hours once
1 2-GRAM once weekly
1 2-GRAM weekly by
1 2-GRAM by infuser
1 2-GRAM infuser pump
1 2-GRAM pump .
1 2-GRAM * Because
1 2-GRAM Because of
1 2-GRAM of differences
1 2-GRAM in patient
1 2-GRAM patient characteristics
1 2-GRAM characteristics ,
1 2-GRAM control measurements
1 2-GRAM measurements were
1 2-GRAM obtained from
1 2-GRAM from normal
1 2-GRAM normal muscle
1 2-GRAM muscle in
1 2-GRAM in all
1 2-GRAM all patients
1 2-GRAM Two families
1 2-GRAM families with
1 2-GRAM with concordant
1 2-GRAM concordant inheritance
1 2-GRAM inheritance of
1 2-GRAM of DNAH9
1 2-GRAM DNAH9 alleles
1 2-GRAM alleles in
1 2-GRAM in affected
1 2-GRAM affected individuals
1 2-GRAM individuals were
1 2-GRAM were observed
1 2-GRAM observed .
1 2-GRAM * NIRS
1 2-GRAM NIRS was
1 2-GRAM the quantitative
1 2-GRAM quantitative measurement
1 2-GRAM of muscle
1 2-GRAM muscle O
2 2-GRAM O (
1 2-GRAM ) consumption
1 2-GRAM consumption (
1 2-GRAM ( mV
1 2-GRAM mV .
1 2-GRAM . O
1 2-GRAM )) and
1 2-GRAM and forearm
1 2-GRAM forearm blood
1 2-GRAM flow (
1 2-GRAM ( FBF
1 2-GRAM FBF )
1 2-GRAM in 78
1 2-GRAM 78 healthy
1 2-GRAM healthy subjects
1 2-GRAM subjects .
1 2-GRAM Many factors
1 2-GRAM factors do
1 2-GRAM do influence
1 2-GRAM influence the
1 2-GRAM the educational
1 2-GRAM educational outcome
1 2-GRAM outcome in
1 2-GRAM in students
1 2-GRAM students and
1 2-GRAM and large
1 2-GRAM large statistical
1 2-GRAM statistical power
1 2-GRAM power (
1 2-GRAM ( such
1 2-GRAM as meta
1 2-GRAM meta analysis
1 2-GRAM analysis )
1 2-GRAM ) should
1 2-GRAM be helpful
1 2-GRAM helpful to
1 2-GRAM to eliminate
1 2-GRAM eliminate many
1 2-GRAM many sources
1 2-GRAM sources of
1 2-GRAM of error
1 2-GRAM error .
1 2-GRAM * B
1 2-GRAM - myb
1 2-GRAM myb is
1 2-GRAM for G1
1 2-GRAM G1 /
1 2-GRAM / S
1 2-GRAM S transition
1 2-GRAM transition and
1 2-GRAM be phosphorylated
1 2-GRAM phosphorylated by
1 2-GRAM cyclin A2
1 2-GRAM A2 /
1 2-GRAM / cdk2
1 2-GRAM cdk2 complex
1 2-GRAM complex .
1 2-GRAM * Like
1 2-GRAM Like the
1 2-GRAM the consensus
1 2-GRAM consensus mammalian
1 2-GRAM mammalian LHbeta
1 2-GRAM LHbeta gene
1 2-GRAM '- flanking
1 2-GRAM flanking region
1 2-GRAM the gpLH
1 2-GRAM gpLH /
1 2-GRAM / CGbeta
1 2-GRAM CGbeta gene
1 2-GRAM gene contains
1 2-GRAM single TATA
1 2-GRAM TATA sequence
1 2-GRAM sequence 37
1 2-GRAM 37 bp
1 2-GRAM the translation
1 2-GRAM translation start
1 2-GRAM start codon
1 2-GRAM codon .
1 2-GRAM * HTLV
1 2-GRAM HTLV -
1 2-GRAM 1 decreases
1 2-GRAM decreases Th2
1 2-GRAM Th2 type
1 2-GRAM immune response
1 2-GRAM response in
1 2-GRAM with strongyloidiasis
1 2-GRAM strongyloidiasis .
1 2-GRAM * Indeed
1 2-GRAM Indeed ,
1 2-GRAM , mutation
1 2-GRAM two of
1 2-GRAM these motifs
1 2-GRAM motifs ,
1 2-GRAM , known
1 2-GRAM be important
1 2-GRAM to regulation
1 2-GRAM of sid1
1 2-GRAM sid1 ,
1 2-GRAM , altered
1 2-GRAM altered the
1 2-GRAM differential regulation
1 2-GRAM of sid2
1 2-GRAM sid2 by
1 2-GRAM by iron
1 2-GRAM iron .
1 2-GRAM * Nutritional
1 2-GRAM Nutritional status
1 2-GRAM status in
1 2-GRAM in adults
1 2-GRAM adults on
1 2-GRAM on an
1 2-GRAM alternative or
1 2-GRAM or traditional
1 2-GRAM traditional diet
1 2-GRAM diet ]
1 2-GRAM ] BACKGROUND
1 2-GRAM : Plant
1 2-GRAM Plant food
1 2-GRAM food lacks
1 2-GRAM lacks vitamin
1 2-GRAM vitamin B12
1 2-GRAM B12 ,
1 2-GRAM , vitamin
1 2-GRAM vitamin D
1 2-GRAM D and
1 2-GRAM and higher
1 2-GRAM higher n
1 2-GRAM n -
1 2-GRAM 3 polyunsaturated
1 2-GRAM polyunsaturated fatty
1 2-GRAM * On
1 2-GRAM On the
1 2-GRAM , forced
1 2-GRAM forced overexpression
1 2-GRAM wild type
1 2-GRAM type ,
1 2-GRAM not the
1 2-GRAM - inactivated
1 2-GRAM inactivated mutant
1 2-GRAM mutant of
1 2-GRAM of nm23H1
1 2-GRAM nm23H1 ,
1 2-GRAM , converted
1 2-GRAM converted the
1 2-GRAM the GDP
1 2-GRAM GDP -
3 2-GRAM - bound
2 2-GRAM bound forms
1 2-GRAM of Rac1
1 2-GRAM Rac1 ,
1 2-GRAM , Cdc42
1 2-GRAM Cdc42 ,
1 2-GRAM and RhoA
1 2-GRAM RhoA to
1 2-GRAM their GTP
2 2-GRAM GTP -
1 2-GRAM forms in
1 2-GRAM by its
1 2-GRAM its nucleoside
1 2-GRAM nucleoside diphosphate
1 2-GRAM diphosphate kinase
1 2-GRAM but nm23H1
1 2-GRAM nm23H1 alone
1 2-GRAM alone apparently
1 2-GRAM apparently did
1 2-GRAM not produce
1 2-GRAM produce the
1 2-GRAM the GTP
1 2-GRAM bound form
1 2-GRAM these GTPases
1 2-GRAM GTPases in
1 2-GRAM * Novel
1 2-GRAM Novel intronic
1 2-GRAM rat ER
1 2-GRAM ER alpha
1 2-GRAM alpha gene
1 2-GRAM gene responsible
1 2-GRAM the transient
1 2-GRAM transient transcription
1 2-GRAM transcription of
1 2-GRAM a variant
1 2-GRAM variant receptor
1 2-GRAM : Coronary
1 2-GRAM Coronary mortality
1 2-GRAM mortality during
1 2-GRAM median follow
1 2-GRAM - up
1 2-GRAM up time
1 2-GRAM of 17
1 2-GRAM 17 months
1 2-GRAM was 6
2 2-GRAM fold higher
2 2-GRAM highest tertile
2 2-GRAM tertile for
1 2-GRAM for CRP
1 2-GRAM CRP and
1 2-GRAM and IL
2 2-GRAM 6 and
1 2-GRAM for fibrinogen
1 2-GRAM fibrinogen and
1 2-GRAM alpha than
1 2-GRAM respective combined
1 2-GRAM combined lower
1 2-GRAM lower tertiles
1 2-GRAM tertiles .
1 2-GRAM * HIV
1 2-GRAM and hepatitis
1 2-GRAM hepatitis B
1 2-GRAM B virus
1 2-GRAM virus infections
1 2-GRAM infections in
1 2-GRAM in adolescents
1 2-GRAM adolescents lodged
1 2-GRAM lodged in
1 2-GRAM in security
1 2-GRAM security institutes
1 2-GRAM institutes of
1 2-GRAM of Buenos
1 2-GRAM Buenos Aires
1 2-GRAM Aires .
1 2-GRAM region contains
1 2-GRAM contains several
1 2-GRAM several potential
1 2-GRAM potential cis
1 2-GRAM - regulatory
1 2-GRAM elements such
1 2-GRAM as Sp1
1 2-GRAM , early
1 2-GRAM early growth
1 2-GRAM growth response
1 2-GRAM response -
1 2-GRAM , activator
1 2-GRAM activator protein
1 2-GRAM , MyoD
1 2-GRAM MyoD ,
1 2-GRAM , p300
1 2-GRAM p300 ,
1 2-GRAM , nuclear
1 2-GRAM factor -
1 2-GRAM kappaB ,
1 2-GRAM , myeloid
1 2-GRAM myeloid zinc
1 2-GRAM zinc finger
1 2-GRAM finger protein
1 2-GRAM , caudal
1 2-GRAM caudal -
1 2-GRAM related homeobox
1 2-GRAM homeobox (
1 2-GRAM ( Cdx
1 2-GRAM Cdx )
1 2-GRAM gene A
1 2-GRAM and Cdx
1 2-GRAM Cdx protein
1 2-GRAM 2 binding
1 2-GRAM * RPM
1 2-GRAM RPM /
1 2-GRAM / RGL3
1 2-GRAM RGL3 resembled
1 2-GRAM resembled AF
1 2-GRAM AF -
1 2-GRAM and Nore1
1 2-GRAM Nore1 in
1 2-GRAM in interacting
1 2-GRAM interacting strongly
1 2-GRAM strongly with
1 2-GRAM with constitutively
1 2-GRAM constitutively active
1 2-GRAM active M
1 2-GRAM Ras .
1 2-GRAM : 93
1 2-GRAM 93 female
1 2-GRAM female and
1 2-GRAM and 43
1 2-GRAM 43 male
1 2-GRAM male patients
1 2-GRAM undergoing thyroid
1 2-GRAM thyroid surgery
1 2-GRAM surgery were
1 2-GRAM were stratified
1 2-GRAM stratified according
1 2-GRAM to gender
1 2-GRAM gender and
1 2-GRAM then randomised
1 2-GRAM randomised to
1 2-GRAM receive double
1 2-GRAM double -
1 2-GRAM - blind
1 2-GRAM blind one
1 2-GRAM of four
1 2-GRAM four antiemetic
1 2-GRAM antiemetic regimes
1 2-GRAM regimes :
1 2-GRAM : 50
2 2-GRAM mg dolasetron
2 2-GRAM dolasetron given
1 2-GRAM given orally
1 2-GRAM orally 45
1 2-GRAM 45 minutes
1 2-GRAM minutes prior
1 2-GRAM prior to
1 2-GRAM to induction
3 2-GRAM of anaesthesia
3 2-GRAM anaesthesia (
1 2-GRAM group I
1 2-GRAM I ),
1 2-GRAM ), 12
1 2-GRAM 12 .
1 2-GRAM 5 mg
2 2-GRAM given intravenously
2 2-GRAM intravenously during
2 2-GRAM during induction
1 2-GRAM group II
1 2-GRAM II ),
1 2-GRAM ), 1
1 2-GRAM mg DHB
1 2-GRAM DHB given
1 2-GRAM group III
1 2-GRAM III )
1 2-GRAM or placebo
1 2-GRAM placebo (
1 2-GRAM group IV
1 2-GRAM IV ).
1 2-GRAM * Transcriptional
1 2-GRAM Transcriptional regulation
1 2-GRAM the estrogen
1 2-GRAM estrogen -
1 2-GRAM inducible pS2
1 2-GRAM pS2 breast
1 2-GRAM cancer marker
1 2-GRAM marker gene
1 2-GRAM gene by
1 2-GRAM the ERR
1 2-GRAM ERR family
1 2-GRAM family of
1 2-GRAM of orphan
1 2-GRAM orphan nuclear
1 2-GRAM nuclear receptors
1 3-GRAM * * Third
1 3-GRAM * Third ,
1 3-GRAM Third , consistent
2 3-GRAM , consistent with
1 3-GRAM consistent with these
1 3-GRAM with these data
1 3-GRAM these data ,
1 3-GRAM data , N
1 3-GRAM , N -
1 3-GRAM N - acetylcysteine
1 3-GRAM - acetylcysteine reduced
1 3-GRAM acetylcysteine reduced the
1 3-GRAM reduced the stimulatory
1 3-GRAM the stimulatory effect
1 3-GRAM stimulatory effect of
1 3-GRAM effect of HGF
1 3-GRAM of HGF on
1 3-GRAM HGF on stress
1 3-GRAM on stress kinase
1 3-GRAM stress kinase activities
1 3-GRAM kinase activities ,
1 3-GRAM activities , while
1 3-GRAM , while p42
1 3-GRAM while p42 /
1 3-GRAM p42 / 44
1 3-GRAM / 44 mitogen
1 3-GRAM 44 mitogen activated
1 3-GRAM mitogen activated kinase
1 3-GRAM activated kinase (
2 3-GRAM kinase ( MAPK
2 3-GRAM ( MAPK )
1 3-GRAM MAPK ) was
1 3-GRAM ) was unmodified
1 3-GRAM was unmodified ,
1 3-GRAM unmodified , suggesting
1 3-GRAM , suggesting an
1 3-GRAM suggesting an involvement
1 3-GRAM an involvement of
1 3-GRAM involvement of c
1 3-GRAM of c -
2 3-GRAM c - Jun
1 3-GRAM - Jun -
1 3-GRAM Jun - N
1 3-GRAM - N -
6 3-GRAM N - terminal
1 3-GRAM - terminal kinase
1 3-GRAM terminal kinase (
1 3-GRAM kinase ( JNK
1 3-GRAM ( JNK )
1 3-GRAM JNK ) and
1 3-GRAM ) and p38
1 3-GRAM and p38 MAPK
1 3-GRAM p38 MAPK in
1 3-GRAM MAPK in HIF
1 3-GRAM in HIF -
2 3-GRAM HIF - 1
1 3-GRAM - 1 activation
1 3-GRAM 1 activation .
3 3-GRAM activation . STOP
77 3-GRAM * * The
1 3-GRAM * The Sox
1 3-GRAM The Sox gene
1 3-GRAM Sox gene family
1 3-GRAM gene family (
1 3-GRAM family ( Sry
1 3-GRAM ( Sry like
1 3-GRAM Sry like HMG
1 3-GRAM like HMG box
1 3-GRAM HMG box gene
1 3-GRAM box gene )
1 3-GRAM gene ) is
1 3-GRAM ) is characterised
1 3-GRAM is characterised by
1 3-GRAM characterised by a
1 3-GRAM by a conserved
1 3-GRAM a conserved DNA
1 3-GRAM conserved DNA sequence
1 3-GRAM DNA sequence encoding
1 3-GRAM sequence encoding a
1 3-GRAM encoding a domain
1 3-GRAM a domain of
1 3-GRAM domain of approximately
1 3-GRAM of approximately 80
1 3-GRAM approximately 80 amino
1 3-GRAM 80 amino acids
1 3-GRAM amino acids which
1 3-GRAM acids which is
1 3-GRAM which is responsible
1 3-GRAM is responsible for
1 3-GRAM responsible for sequence
1 3-GRAM for sequence specific
1 3-GRAM sequence specific DNA
1 3-GRAM specific DNA binding
1 3-GRAM DNA binding .
1 3-GRAM binding . STOP
1 3-GRAM * * Respiratory
1 3-GRAM * Respiratory parameters
1 3-GRAM Respiratory parameters suggested
1 3-GRAM parameters suggested that
1 3-GRAM suggested that M6G
1 3-GRAM that M6G produced
1 3-GRAM M6G produced less
1 3-GRAM produced less respiratory
1 3-GRAM less respiratory depression
1 3-GRAM respiratory depression than
1 3-GRAM depression than morphine
1 3-GRAM than morphine .
1 3-GRAM morphine . STOP
14 3-GRAM * * This
1 3-GRAM * This slow
1 3-GRAM This slow progression
1 3-GRAM slow progression through
1 3-GRAM progression through the
1 3-GRAM through the early
1 3-GRAM the early G1
1 3-GRAM early G1 -
1 3-GRAM G1 - phase
1 3-GRAM - phase resulted
1 3-GRAM phase resulted in
1 3-GRAM resulted in decreased
1 3-GRAM in decreased phosphorylation
1 3-GRAM decreased phosphorylation of
1 3-GRAM phosphorylation of the
1 3-GRAM of the RB
1 3-GRAM the RB protein
1 3-GRAM RB protein and
1 3-GRAM protein and subsequent
1 3-GRAM and subsequent delay
1 3-GRAM subsequent delay into
1 3-GRAM delay into the
1 3-GRAM into the S
1 3-GRAM the S phase
1 3-GRAM S phase transition
1 3-GRAM phase transition .
1 3-GRAM transition . STOP
2 3-GRAM * * Responses
2 3-GRAM * Responses of
1 3-GRAM Responses of TLD
1 3-GRAM of TLD Mg2SiO4
1 3-GRAM TLD Mg2SiO4 :
2 3-GRAM Mg2SiO4 : Tb
1 3-GRAM : Tb and
1 3-GRAM Tb and radiophotoluminescent
1 3-GRAM and radiophotoluminescent glass
1 3-GRAM radiophotoluminescent glass to
1 3-GRAM glass to heavy
1 3-GRAM to heavy charged
1 3-GRAM heavy charged particles
1 3-GRAM charged particles and
1 3-GRAM particles and space
1 3-GRAM and space radiation
1 3-GRAM space radiation .
1 3-GRAM radiation . STOP
37 3-GRAM * * In
8 3-GRAM * In the
1 3-GRAM In the meantime
1 3-GRAM the meantime ,
1 3-GRAM meantime , one
1 3-GRAM , one has
1 3-GRAM one has succeeded
1 3-GRAM has succeeded to
1 3-GRAM succeeded to establish
1 3-GRAM to establish the
1 3-GRAM establish the deammonification
1 3-GRAM the deammonification processes
1 3-GRAM deammonification processes in
1 3-GRAM processes in a
1 3-GRAM in a continuous
1 3-GRAM a continuous flow
1 3-GRAM continuous flow moving
1 3-GRAM flow moving -
1 3-GRAM moving - bed
1 3-GRAM - bed pilot
1 3-GRAM bed pilot plant
1 3-GRAM pilot plant .
1 3-GRAM plant . STOP
3 3-GRAM * * An
1 3-GRAM * An 18
1 3-GRAM An 18 -
1 3-GRAM 18 - kb
1 3-GRAM - kb genomic
1 3-GRAM kb genomic clone
1 3-GRAM genomic clone including
1 3-GRAM clone including sequences
1 3-GRAM including sequences encoding
1 3-GRAM sequences encoding for
1 3-GRAM encoding for the
1 3-GRAM for the two
1 3-GRAM the two GHS
1 3-GRAM two GHS -
1 3-GRAM GHS - R
1 3-GRAM - R variants
1 3-GRAM R variants was
1 3-GRAM variants was isolated
1 3-GRAM was isolated .
1 3-GRAM isolated . STOP
1 3-GRAM In the further
1 3-GRAM the further development
1 3-GRAM further development of
1 3-GRAM development of bladder
1 3-GRAM of bladder neck
1 3-GRAM bladder neck suspension
1 3-GRAM neck suspension according
1 3-GRAM suspension according to
1 3-GRAM according to Stamey
1 3-GRAM to Stamey -
1 3-GRAM Stamey - Pereyra
1 3-GRAM - Pereyra ,
1 3-GRAM Pereyra , the
1 3-GRAM , the use
5 3-GRAM the use of
1 3-GRAM use of miniature
1 3-GRAM of miniature bone
1 3-GRAM miniature bone anchors
1 3-GRAM bone anchors received
1 3-GRAM anchors received considerable
1 3-GRAM received considerable support
1 3-GRAM considerable support .
1 3-GRAM support . STOP
1 3-GRAM * * CHAP
1 3-GRAM * CHAP and
1 3-GRAM CHAP and the
1 3-GRAM and the Department
2 3-GRAM the Department of
1 3-GRAM Department of Veterans
1 3-GRAM of Veterans Affairs
1 3-GRAM Veterans Affairs .
1 3-GRAM Affairs . STOP
3 3-GRAM * * Finally
3 3-GRAM * Finally ,
1 3-GRAM Finally , a
1 3-GRAM , a chromogenic
1 3-GRAM a chromogenic method
1 3-GRAM chromogenic method was
1 3-GRAM method was used
1 3-GRAM was used ,
1 3-GRAM used , based
1 3-GRAM , based on
1 3-GRAM based on thrombin
1 3-GRAM on thrombin inhibition
1 3-GRAM thrombin inhibition and
1 3-GRAM inhibition and the
1 3-GRAM and the substrate
1 3-GRAM the substrate S
1 3-GRAM substrate S -
1 3-GRAM S - 2238
1 3-GRAM - 2238 .
1 3-GRAM 2238 . STOP
3 3-GRAM * * As
2 3-GRAM * As an
1 3-GRAM As an oral
1 3-GRAM an oral ,
1 3-GRAM oral , nontoxic
1 3-GRAM , nontoxic compound
1 3-GRAM nontoxic compound with
1 3-GRAM compound with a
1 3-GRAM with a mechanism
1 3-GRAM a mechanism of
1 3-GRAM mechanism of action
1 3-GRAM of action distinct
1 3-GRAM action distinct from
1 3-GRAM distinct from that
1 3-GRAM from that of
1 3-GRAM that of ABL
1 3-GRAM of ABL tyrosine
1 3-GRAM ABL tyrosine kinase
1 3-GRAM tyrosine kinase inhibition
1 3-GRAM kinase inhibition ,
1 3-GRAM inhibition , FTI
1 3-GRAM , FTI SCH66336
1 3-GRAM FTI SCH66336 shows
1 3-GRAM SCH66336 shows promise
1 3-GRAM shows promise for
1 3-GRAM promise for the
2 3-GRAM for the treatment
2 3-GRAM the treatment of
1 3-GRAM treatment of BCR
1 3-GRAM of BCR /
1 3-GRAM BCR / ABL
1 3-GRAM / ABL -
1 3-GRAM ABL - induced
1 3-GRAM - induced leukemia
1 3-GRAM induced leukemia .
2 3-GRAM leukemia . STOP
1 3-GRAM * * Recruitment
1 3-GRAM * Recruitment of
1 3-GRAM Recruitment of an
1 3-GRAM of an RNA
1 3-GRAM an RNA polymerase
2 3-GRAM RNA polymerase II
1 3-GRAM polymerase II complex
1 3-GRAM II complex is
1 3-GRAM complex is mediated
1 3-GRAM is mediated by
1 3-GRAM mediated by the
1 3-GRAM by the constitutive
1 3-GRAM the constitutive activation
1 3-GRAM constitutive activation domain
1 3-GRAM activation domain in
1 3-GRAM domain in CREB
1 3-GRAM in CREB ,
1 3-GRAM CREB , independently
1 3-GRAM , independently of
1 3-GRAM independently of CREB
1 3-GRAM of CREB phosphorylation
1 3-GRAM CREB phosphorylation .
2 3-GRAM phosphorylation . STOP
6 3-GRAM * * Our
5 3-GRAM * Our results
1 3-GRAM Our results are
1 3-GRAM results are reassuring
1 3-GRAM are reassuring and
1 3-GRAM reassuring and we
1 3-GRAM and we therefore
1 3-GRAM we therefore advise
1 3-GRAM therefore advise that
1 3-GRAM advise that in
1 3-GRAM that in patients
1 3-GRAM in patients undergoing
1 3-GRAM patients undergoing free
1 3-GRAM undergoing free jejunum
1 3-GRAM free jejunum flap
1 3-GRAM jejunum flap reconstruction
1 3-GRAM flap reconstruction of
1 3-GRAM reconstruction of the
1 3-GRAM of the hypopharyngo
1 3-GRAM the hypopharyngo -
1 3-GRAM hypopharyngo - esophageal
1 3-GRAM - esophageal tract
1 3-GRAM esophageal tract voice
1 3-GRAM tract voice restoration
1 3-GRAM voice restoration should
1 3-GRAM restoration should be
1 3-GRAM should be attempted
1 3-GRAM be attempted by
1 3-GRAM attempted by placing
1 3-GRAM by placing a
1 3-GRAM placing a voice
1 3-GRAM a voice prosthesis
1 3-GRAM voice prosthesis through
1 3-GRAM prosthesis through a
1 3-GRAM through a secondary
1 3-GRAM a secondary tracheo
1 3-GRAM secondary tracheo -
1 3-GRAM tracheo - esophageal
1 3-GRAM - esophageal puncture
1 3-GRAM esophageal puncture and
1 3-GRAM puncture and providing
1 3-GRAM and providing intensive
1 3-GRAM providing intensive speech
1 3-GRAM intensive speech training
1 3-GRAM speech training .
1 3-GRAM training . STOP
1 3-GRAM * * Regarding
1 3-GRAM * Regarding gestational
1 3-GRAM Regarding gestational risk
1 3-GRAM gestational risk ,
2 3-GRAM risk , 3
3 3-GRAM , 3 ,
1 3-GRAM 3 , 243
1 3-GRAM , 243 drugs
1 3-GRAM 243 drugs used
1 3-GRAM drugs used (
1 3-GRAM used ( 34
1 3-GRAM ( 34 %)
1 3-GRAM 34 %) belonged
1 3-GRAM %) belonged to
1 3-GRAM belonged to category
1 3-GRAM to category A
1 3-GRAM category A risk
1 3-GRAM A risk ,
1 3-GRAM risk , 1
1 3-GRAM , 1 ,
1 3-GRAM 1 , 923
1 3-GRAM , 923 (
1 3-GRAM 923 ( 22
1 3-GRAM ( 22 .
1 3-GRAM 22 . 6
2 3-GRAM . 6 %)
2 3-GRAM 6 %) to
4 3-GRAM %) to category
1 3-GRAM to category B
1 3-GRAM category B ,
1 3-GRAM B , 3
1 3-GRAM 3 , 798
1 3-GRAM , 798 (
1 3-GRAM 798 ( 39
1 3-GRAM ( 39 .
1 3-GRAM 39 . 7
1 3-GRAM . 7 %)
1 3-GRAM 7 %) to
1 3-GRAM to category C
1 3-GRAM category C ,
1 3-GRAM C , 289
1 3-GRAM , 289 (
1 3-GRAM 289 ( 3
1 3-GRAM ( 3 .
1 3-GRAM 3 . 0
1 3-GRAM . 0 %)
1 3-GRAM 0 %) to
1 3-GRAM to category D
1 3-GRAM category D ,
1 3-GRAM D , and
1 3-GRAM , and 55
1 3-GRAM and 55 (
1 3-GRAM 55 ( 0
2 3-GRAM ( 0 .
1 3-GRAM 0 . 6
1 3-GRAM to category X
1 3-GRAM category X .
1 3-GRAM X . STOP
1 3-GRAM * The human
1 3-GRAM The human ABCG1
1 3-GRAM human ABCG1 gene
1 3-GRAM ABCG1 gene encodes
1 3-GRAM gene encodes a
1 3-GRAM encodes a member
1 3-GRAM a member of
3 3-GRAM member of the
1 3-GRAM of the ATP
1 3-GRAM the ATP -
3 3-GRAM ATP - binding
1 3-GRAM - binding cassette
1 3-GRAM binding cassette (
1 3-GRAM cassette ( ABC
1 3-GRAM ( ABC )
1 3-GRAM ABC ) superfamily
1 3-GRAM ) superfamily of
1 3-GRAM superfamily of transporter
1 3-GRAM of transporter proteins
1 3-GRAM transporter proteins and
1 3-GRAM proteins and is
1 3-GRAM and is highly
1 3-GRAM is highly induced
1 3-GRAM highly induced when
1 3-GRAM induced when macrophages
1 3-GRAM when macrophages are
1 3-GRAM macrophages are incubated
1 3-GRAM are incubated with
1 3-GRAM incubated with oxysterols
1 3-GRAM with oxysterols .
1 3-GRAM oxysterols . STOP
5 3-GRAM * * At
1 3-GRAM * At the
1 3-GRAM At the end
1 3-GRAM the end of
1 3-GRAM end of each
1 3-GRAM of each day
1 3-GRAM each day of
1 3-GRAM day of migration
1 3-GRAM of migration the
1 3-GRAM migration the pulmonary
1 3-GRAM the pulmonary hemolymph
1 3-GRAM pulmonary hemolymph PO2
1 3-GRAM hemolymph PO2 decreased
1 3-GRAM PO2 decreased by
1 3-GRAM decreased by 1
1 3-GRAM by 1 -
1 3-GRAM 1 - 2
4 3-GRAM - 2 .
1 3-GRAM 2 . 5
1 3-GRAM . 5 kPa
1 3-GRAM 5 kPa ,
1 3-GRAM kPa , but
1 3-GRAM , but the
1 3-GRAM but the hemocyanin
1 3-GRAM the hemocyanin remained
1 3-GRAM hemocyanin remained saturated
1 3-GRAM remained saturated with
1 3-GRAM saturated with O2
1 3-GRAM with O2 and
1 3-GRAM O2 and the
1 3-GRAM and the venous
1 3-GRAM the venous reserve
1 3-GRAM venous reserve was
1 3-GRAM reserve was largely
1 3-GRAM was largely unchanged
1 3-GRAM largely unchanged (
1 3-GRAM unchanged ( O2
1 3-GRAM ( O2 >
1 3-GRAM O2 > 0
1 3-GRAM > 0 .
2 3-GRAM 0 . 4
1 3-GRAM . 4 mmol
1 3-GRAM 4 mmol x
1 3-GRAM mmol x l
1 3-GRAM x l (-
1 3-GRAM l (- 1
1 3-GRAM (- 1 )).
1 3-GRAM 1 )). STOP
17 3-GRAM * * We
2 3-GRAM * We have
1 3-GRAM We have investigated
1 3-GRAM have investigated the
1 3-GRAM investigated the role
2 3-GRAM the role of
1 3-GRAM role of NGF
1 3-GRAM of NGF in
1 3-GRAM NGF in regulating
1 3-GRAM in regulating gene
1 3-GRAM regulating gene transcription
1 3-GRAM gene transcription in
1 3-GRAM transcription in PC12
1 3-GRAM in PC12 and
1 3-GRAM PC12 and INS
1 3-GRAM and INS -
1 3-GRAM INS - 1
2 3-GRAM - 1 cells
1 3-GRAM 1 cells ,
1 3-GRAM cells , in
1 3-GRAM , in order
1 3-GRAM in order to
1 3-GRAM order to define
1 3-GRAM to define if
1 3-GRAM define if there
1 3-GRAM if there are
1 3-GRAM there are NGF
1 3-GRAM are NGF -
1 3-GRAM NGF - regulated
1 3-GRAM - regulated genes
1 3-GRAM regulated genes per
1 3-GRAM genes per se
1 3-GRAM per se .
1 3-GRAM se . STOP
7 3-GRAM * * Thus
7 3-GRAM * Thus ,
1 3-GRAM Thus , through
1 3-GRAM , through a
1 3-GRAM through a change
1 3-GRAM a change in
1 3-GRAM change in conformation
1 3-GRAM in conformation upon
1 3-GRAM conformation upon repair
1 3-GRAM upon repair of
1 3-GRAM repair of the
1 3-GRAM of the 6RG
1 3-GRAM the 6RG lesion
1 3-GRAM 6RG lesion ,
1 3-GRAM lesion , MGMT
1 3-GRAM , MGMT switches
1 3-GRAM MGMT switches from
1 3-GRAM switches from a
1 3-GRAM from a DNA
1 3-GRAM a DNA repair
1 3-GRAM DNA repair factor
1 3-GRAM repair factor to
1 3-GRAM factor to a
1 3-GRAM to a transcription
1 3-GRAM a transcription regulator
1 3-GRAM transcription regulator (
1 3-GRAM regulator ( R
2 3-GRAM ( R -
1 3-GRAM R - MGMT
1 3-GRAM - MGMT ),
1 3-GRAM MGMT ), enabling
1 3-GRAM ), enabling the
1 3-GRAM enabling the cell
1 3-GRAM the cell to
1 3-GRAM cell to sense
1 3-GRAM to sense as
1 3-GRAM sense as well
3 3-GRAM as well as
1 3-GRAM well as respond
1 3-GRAM as respond to
1 3-GRAM respond to mutagens
1 3-GRAM to mutagens .
1 3-GRAM mutagens . STOP
1 3-GRAM * * TaqMan
1 3-GRAM * TaqMan analysis
1 3-GRAM TaqMan analysis of
1 3-GRAM analysis of gene
1 3-GRAM of gene expression
1 3-GRAM gene expression following
1 3-GRAM expression following chronic
1 3-GRAM following chronic FA
1 3-GRAM chronic FA treatment
1 3-GRAM FA treatment showed
1 3-GRAM treatment showed neither
1 3-GRAM showed neither a
1 3-GRAM neither a decrease
2 3-GRAM a decrease in
1 3-GRAM decrease in the
1 3-GRAM in the amount
1 3-GRAM the amount of
1 3-GRAM amount of leptin
1 3-GRAM of leptin receptor
1 3-GRAM leptin receptor (
1 3-GRAM receptor ( Ob
1 3-GRAM ( Ob -
1 3-GRAM Ob - R
1 3-GRAM - R )
1 3-GRAM R ) mRNA
1 3-GRAM ) mRNA ,
1 3-GRAM mRNA , nor
1 3-GRAM , nor an
1 3-GRAM nor an increase
4 3-GRAM an increase in
2 3-GRAM increase in the
1 3-GRAM in the negative
1 3-GRAM the negative regulators
1 3-GRAM negative regulators of
1 3-GRAM regulators of STAT
1 3-GRAM of STAT signalling
1 3-GRAM STAT signalling ,
1 3-GRAM signalling , SOCS3
1 3-GRAM , SOCS3 (
1 3-GRAM SOCS3 ( suppressors
1 3-GRAM ( suppressors of
1 3-GRAM suppressors of cytokine
1 3-GRAM of cytokine signalling
1 3-GRAM cytokine signalling )
1 3-GRAM signalling ) or
1 3-GRAM ) or cytokine
1 3-GRAM or cytokine inducible
1 3-GRAM cytokine inducible sequence
1 3-GRAM inducible sequence (
1 3-GRAM sequence ( CIS
1 3-GRAM ( CIS ).
1 3-GRAM CIS ). STOP
2 3-GRAM * * Nine
1 3-GRAM * Nine animals
1 3-GRAM Nine animals served
1 3-GRAM animals served as
1 3-GRAM served as control
1 3-GRAM as control animals
1 3-GRAM control animals ,
1 3-GRAM animals , whereas
1 3-GRAM , whereas 20
1 3-GRAM whereas 20 animals
1 3-GRAM 20 animals received
1 3-GRAM animals received a
1 3-GRAM received a focal
1 3-GRAM a focal arachnoid
1 3-GRAM focal arachnoid scar
1 3-GRAM arachnoid scar at
1 3-GRAM scar at C1
1 3-GRAM at C1 -
1 3-GRAM C1 - C2
1 3-GRAM - C2 ,
1 3-GRAM C2 , which
2 3-GRAM , which was
1 3-GRAM which was produced
1 3-GRAM was produced by
1 3-GRAM produced by placement
1 3-GRAM by placement of
1 3-GRAM placement of a
1 3-GRAM of a kaolin
1 3-GRAM a kaolin -
1 3-GRAM kaolin - soaked
1 3-GRAM - soaked fibrin
1 3-GRAM soaked fibrin sponge
1 3-GRAM fibrin sponge on
1 3-GRAM sponge on the
1 3-GRAM on the posterior
1 3-GRAM the posterior surface
1 3-GRAM posterior surface of
1 3-GRAM surface of the
1 3-GRAM of the spinal
1 3-GRAM the spinal cord
1 3-GRAM spinal cord .
1 3-GRAM cord . STOP
15 3-GRAM * * A
1 3-GRAM * A comparison
1 3-GRAM A comparison of
1 3-GRAM comparison of the
2 3-GRAM of the duplicated
1 3-GRAM the duplicated Vkappa
1 3-GRAM duplicated Vkappa genes
1 3-GRAM Vkappa genes suggests
1 3-GRAM genes suggests positive
1 3-GRAM suggests positive selection
1 3-GRAM positive selection on
1 3-GRAM selection on the
1 3-GRAM on the complementarity
1 3-GRAM the complementarity -
1 3-GRAM complementarity - determining
1 3-GRAM - determining regions
1 3-GRAM determining regions of
2 3-GRAM regions of the
1 3-GRAM the duplicated genes
1 3-GRAM duplicated genes by
1 3-GRAM genes by point
1 3-GRAM by point mutations
1 3-GRAM point mutations .
1 3-GRAM mutations . STOP
1 3-GRAM * * They
1 3-GRAM * They have
1 3-GRAM They have not
1 3-GRAM have not been
2 3-GRAM not been previously
1 3-GRAM been previously reported
1 3-GRAM previously reported as
1 3-GRAM reported as a
1 3-GRAM as a reaction
1 3-GRAM a reaction to
1 3-GRAM reaction to i
1 3-GRAM to i .
1 3-GRAM i . v
1 3-GRAM . v .
1 3-GRAM v . contrast
1 3-GRAM . contrast material
1 3-GRAM contrast material .
1 3-GRAM material . STOP
2 3-GRAM * The presence
2 3-GRAM The presence of
1 3-GRAM presence of AS
1 3-GRAM of AS -
1 3-GRAM AS - oligo
1 3-GRAM - oligo had
1 3-GRAM oligo had no
1 3-GRAM had no further
1 3-GRAM no further effect
1 3-GRAM further effect on
2 3-GRAM effect on the
1 3-GRAM on the FSH
1 3-GRAM the FSH -
1 3-GRAM FSH - mediated
2 3-GRAM - mediated activation
1 3-GRAM mediated activation of
4 3-GRAM activation of the
1 3-GRAM of the EB
1 3-GRAM the EB *-
1 3-GRAM EB *- mTf
1 3-GRAM *- mTf -
1 3-GRAM mTf - CAT
1 3-GRAM - CAT construct
1 3-GRAM CAT construct but
1 3-GRAM construct but reduced
1 3-GRAM but reduced cAMP
1 3-GRAM reduced cAMP -
1 3-GRAM cAMP - mediated
1 3-GRAM mediated activation .
1 3-GRAM * The homologous
1 3-GRAM The homologous active
1 3-GRAM homologous active -
1 3-GRAM active - site
1 3-GRAM - site framework
1 3-GRAM site framework of
1 3-GRAM framework of these
1 3-GRAM of these enzymes
1 3-GRAM these enzymes with
1 3-GRAM enzymes with distinct
1 3-GRAM with distinct structures
1 3-GRAM distinct structures suggests
1 3-GRAM structures suggests convergent
1 3-GRAM suggests convergent evolution
1 3-GRAM convergent evolution of
1 3-GRAM evolution of a
1 3-GRAM of a common
1 3-GRAM a common catalytic
1 3-GRAM common catalytic mechanism
1 3-GRAM catalytic mechanism .
1 3-GRAM mechanism . STOP
2 3-GRAM * * Additional
1 3-GRAM * Additional education
1 3-GRAM Additional education and
1 3-GRAM education and research
1 3-GRAM and research is
1 3-GRAM research is needed
1 3-GRAM is needed to
1 3-GRAM needed to provide
1 3-GRAM to provide further
1 3-GRAM provide further direction
1 3-GRAM further direction for
1 3-GRAM direction for intervention
1 3-GRAM for intervention and
1 3-GRAM intervention and incorporation
1 3-GRAM and incorporation into
1 3-GRAM incorporation into practice
1 3-GRAM into practice .
1 3-GRAM practice . STOP
2 3-GRAM * * Many
1 3-GRAM * Many of
1 3-GRAM Many of the
1 3-GRAM of the important
1 3-GRAM the important genes
1 3-GRAM important genes associated
1 3-GRAM genes associated with
1 3-GRAM associated with G1
1 3-GRAM with G1 regulation
1 3-GRAM G1 regulation have
1 3-GRAM regulation have been
2 3-GRAM have been shown
5 3-GRAM been shown to
1 3-GRAM shown to play
2 3-GRAM to play a
1 3-GRAM play a key
1 3-GRAM a key role
1 3-GRAM key role in
1 3-GRAM role in proliferation
1 3-GRAM in proliferation ,
1 3-GRAM proliferation , differentiation
1 3-GRAM , differentiation and
1 3-GRAM differentiation and oncogenic
1 3-GRAM and oncogenic transformation
1 3-GRAM oncogenic transformation and
1 3-GRAM transformation and programmed
1 3-GRAM and programmed cell
2 3-GRAM programmed cell death
1 3-GRAM cell death (
1 3-GRAM death ( apoptosis
1 3-GRAM ( apoptosis ).
1 3-GRAM apoptosis ). STOP
1 3-GRAM * * Drug
1 3-GRAM * Drug interactions
1 3-GRAM Drug interactions have
1 3-GRAM interactions have been
1 3-GRAM have been found
1 3-GRAM been found with
1 3-GRAM found with drugs
1 3-GRAM with drugs that
1 3-GRAM drugs that compete
1 3-GRAM that compete for
1 3-GRAM compete for the
1 3-GRAM for the same
1 3-GRAM the same CYP450
1 3-GRAM same CYP450 isoenzymes
1 3-GRAM CYP450 isoenzymes as
1 3-GRAM isoenzymes as statins
1 3-GRAM as statins .
1 3-GRAM statins . STOP
1 3-GRAM * * Regulation
1 3-GRAM * Regulation of
1 3-GRAM Regulation of laminin
1 3-GRAM of laminin beta2
1 3-GRAM laminin beta2 chain
1 3-GRAM beta2 chain gene
1 3-GRAM chain gene expression
1 3-GRAM gene expression in
1 3-GRAM expression in human
1 3-GRAM in human cancer
1 3-GRAM human cancer cell
1 3-GRAM cancer cell lines
3 3-GRAM cell lines .
3 3-GRAM lines . STOP
2 3-GRAM * * Mutation
1 3-GRAM * Mutation of
1 3-GRAM Mutation of the
1 3-GRAM of the NF
1 3-GRAM the NF -
3 3-GRAM NF - kappaB
1 3-GRAM - kappaB site
1 3-GRAM kappaB site in
3 3-GRAM site in the
1 3-GRAM in the Mdr1b
1 3-GRAM the Mdr1b promoter
1 3-GRAM Mdr1b promoter prevents
1 3-GRAM promoter prevents its
1 3-GRAM prevents its induction
1 3-GRAM its induction by
1 3-GRAM induction by TNF
1 3-GRAM by TNF -
2 3-GRAM TNF - alpha
1 3-GRAM - alpha .
1 3-GRAM alpha . STOP
1 3-GRAM * * Effect
1 3-GRAM * Effect of
1 3-GRAM Effect of heat
1 3-GRAM of heat treatments
1 3-GRAM heat treatments on
1 3-GRAM treatments on the
1 3-GRAM on the meltability
1 3-GRAM the meltability of
1 3-GRAM meltability of cheeses
1 3-GRAM of cheeses .
2 3-GRAM cheeses . STOP
1 3-GRAM * In vitro
1 3-GRAM In vitro binding
1 3-GRAM vitro binding studies
1 3-GRAM binding studies demonstrate
1 3-GRAM studies demonstrate that
1 3-GRAM demonstrate that eIF
2 3-GRAM that eIF -
2 3-GRAM eIF - 5A
1 3-GRAM - 5A is
1 3-GRAM 5A is required
2 3-GRAM is required for
1 3-GRAM required for efficient
1 3-GRAM for efficient interaction
1 3-GRAM efficient interaction of
1 3-GRAM interaction of Rev
1 3-GRAM of Rev -
1 3-GRAM Rev - NES
1 3-GRAM - NES with
1 3-GRAM NES with CRM1
1 3-GRAM with CRM1 /
1 3-GRAM CRM1 / exportin1
1 3-GRAM / exportin1 and
1 3-GRAM exportin1 and that
1 3-GRAM and that eIF
1 3-GRAM - 5A interacts
1 3-GRAM 5A interacts with
1 3-GRAM interacts with the
1 3-GRAM with the nucleoporins
1 3-GRAM the nucleoporins CAN
1 3-GRAM nucleoporins CAN /
1 3-GRAM CAN / nup214
1 3-GRAM / nup214 ,
1 3-GRAM nup214 , nup153
1 3-GRAM , nup153 ,
1 3-GRAM nup153 , nup98
1 3-GRAM , nup98 ,
1 3-GRAM nup98 , and
1 3-GRAM , and nup62
1 3-GRAM and nup62 .
1 3-GRAM nup62 . STOP
1 3-GRAM * * Forced
1 3-GRAM * Forced expression
1 3-GRAM Forced expression of
1 3-GRAM expression of BZAP45
1 3-GRAM of BZAP45 strongly
1 3-GRAM BZAP45 strongly stimulates
1 3-GRAM strongly stimulates H4
1 3-GRAM stimulates H4 promoter
1 3-GRAM H4 promoter (
1 3-GRAM promoter ( nt
1 3-GRAM ( nt -
1 3-GRAM nt - 215
1 3-GRAM - 215 to
1 3-GRAM 215 to -
1 3-GRAM to - 1
1 3-GRAM - 1 )/
1 3-GRAM 1 )/ CAT
1 3-GRAM )/ CAT reporter
1 3-GRAM CAT reporter gene
1 3-GRAM reporter gene activity
1 3-GRAM gene activity .
5 3-GRAM activity . STOP
4 3-GRAM * * Copyright
4 3-GRAM * Copyright 2001
3 3-GRAM Copyright 2001 Academic
3 3-GRAM 2001 Academic Press
3 3-GRAM Academic Press .
3 3-GRAM Press . STOP
1 3-GRAM * The diagnosis
1 3-GRAM The diagnosis of
1 3-GRAM diagnosis of HCV
1 3-GRAM of HCV arthritis
1 3-GRAM HCV arthritis in
1 3-GRAM arthritis in patients
6 3-GRAM in patients with
1 3-GRAM patients with positive
1 3-GRAM with positive rheumatoid
1 3-GRAM positive rheumatoid factor
1 3-GRAM rheumatoid factor and
1 3-GRAM factor and chronic
1 3-GRAM and chronic inflammatory
1 3-GRAM chronic inflammatory polyarthritis
1 3-GRAM inflammatory polyarthritis may
1 3-GRAM polyarthritis may be
1 3-GRAM may be difficult
1 3-GRAM be difficult .
1 3-GRAM difficult . STOP
1 3-GRAM * The UBA
1 3-GRAM The UBA domains
1 3-GRAM UBA domains of
1 3-GRAM domains of RAD23
1 3-GRAM of RAD23 and
1 3-GRAM RAD23 and DDI1
1 3-GRAM and DDI1 are
1 3-GRAM DDI1 are required
1 3-GRAM are required for
1 3-GRAM required for these
1 3-GRAM for these interactions
1 3-GRAM these interactions .
1 3-GRAM interactions . STOP
1 3-GRAM * * E47
1 3-GRAM * E47 protein
1 3-GRAM E47 protein levels
1 3-GRAM protein levels remain
1 3-GRAM levels remain high
1 3-GRAM remain high until
1 3-GRAM high until the
1 3-GRAM until the double
1 3-GRAM the double positive
1 3-GRAM double positive developmental
1 3-GRAM positive developmental stage
1 3-GRAM developmental stage ,
1 3-GRAM stage , at
1 3-GRAM , at which
1 3-GRAM at which point
1 3-GRAM which point they
1 3-GRAM point they drop
1 3-GRAM they drop to
1 3-GRAM drop to relatively
1 3-GRAM to relatively moderate
1 3-GRAM relatively moderate levels
1 3-GRAM moderate levels ,
2 3-GRAM levels , and
1 3-GRAM , and are
1 3-GRAM and are further
1 3-GRAM are further downregulated
1 3-GRAM further downregulated upon
1 3-GRAM downregulated upon transition
1 3-GRAM upon transition to
1 3-GRAM transition to the
1 3-GRAM to the single
1 3-GRAM the single positive
1 3-GRAM single positive stage
1 3-GRAM positive stage .
1 3-GRAM stage . STOP
1 3-GRAM * * By
1 3-GRAM * By Caveman
1 3-GRAM By Caveman .
1 3-GRAM Caveman . STOP
12 3-GRAM * * These
3 3-GRAM * These findings
3 3-GRAM These findings suggest
2 3-GRAM findings suggest that
3 3-GRAM suggest that the
1 3-GRAM that the adapter
1 3-GRAM the adapter Gab1
1 3-GRAM adapter Gab1 may
1 3-GRAM Gab1 may redirect
1 3-GRAM may redirect c
1 3-GRAM redirect c -
1 3-GRAM c - Met
1 3-GRAM - Met signaling
1 3-GRAM Met signaling through
1 3-GRAM signaling through PI3K
1 3-GRAM through PI3K away
1 3-GRAM PI3K away from
1 3-GRAM away from a
1 3-GRAM from a c
1 3-GRAM a c -
1 3-GRAM c - Akt
1 3-GRAM - Akt /
1 3-GRAM Akt / Pak1
1 3-GRAM / Pak1 cell
1 3-GRAM Pak1 cell survival
1 3-GRAM cell survival pathway
1 3-GRAM survival pathway .
1 3-GRAM pathway . STOP
1 3-GRAM * * Another
1 3-GRAM * Another mutant
1 3-GRAM Another mutant ,
1 3-GRAM mutant , T255A
1 3-GRAM , T255A ,
1 3-GRAM T255A , lost
1 3-GRAM , lost the
1 3-GRAM lost the ability
1 3-GRAM the ability to
1 3-GRAM ability to bind
1 3-GRAM to bind E4orf6
1 3-GRAM bind E4orf6 ,
1 3-GRAM E4orf6 , but
1 3-GRAM , but unexpectedly
1 3-GRAM but unexpectedly ,
1 3-GRAM unexpectedly , viral
1 3-GRAM , viral late
1 3-GRAM viral late -
1 3-GRAM late - gene
1 3-GRAM - gene expression
1 3-GRAM gene expression was
1 3-GRAM expression was not
1 3-GRAM was not affected
1 3-GRAM not affected .
1 3-GRAM affected . STOP
8 3-GRAM * * However
7 3-GRAM * However ,
3 3-GRAM However , the
1 3-GRAM , the N63S
1 3-GRAM the N63S mutation
1 3-GRAM N63S mutation in
2 3-GRAM mutation in the
1 3-GRAM in the wild
1 3-GRAM the wild -
4 3-GRAM wild - type
1 3-GRAM - type VP5
1 3-GRAM type VP5 background
1 3-GRAM VP5 background increased
1 3-GRAM background increased the
1 3-GRAM increased the interaction
1 3-GRAM the interaction ,
1 3-GRAM interaction , as
1 3-GRAM , as judged
1 3-GRAM as judged by
1 3-GRAM judged by the
1 3-GRAM by the beta
2 3-GRAM the beta -
1 3-GRAM beta - galactosidase
1 3-GRAM - galactosidase activity
1 3-GRAM galactosidase activity ,
1 3-GRAM activity , by
1 3-GRAM , by a
1 3-GRAM by a factor
1 3-GRAM a factor of
1 3-GRAM factor of 9
1 3-GRAM of 9 relative
1 3-GRAM 9 relative to
1 3-GRAM relative to when
1 3-GRAM to when the
1 3-GRAM when the PR7
1 3-GRAM the PR7 mutation
1 3-GRAM PR7 mutation was
1 3-GRAM mutation was present
1 3-GRAM was present .
1 3-GRAM present . STOP
4 3-GRAM * * Here
3 3-GRAM * Here we
1 3-GRAM Here we report
1 3-GRAM we report the
1 3-GRAM report the isolation
1 3-GRAM the isolation and
1 3-GRAM isolation and characterization
3 3-GRAM and characterization of
2 3-GRAM characterization of the
1 3-GRAM of the forkhead
1 3-GRAM the forkhead homologue
1 3-GRAM forkhead homologue in
1 3-GRAM homologue in rhabdomyosarcoma
1 3-GRAM in rhabdomyosarcoma (
1 3-GRAM rhabdomyosarcoma ( FKHR
1 3-GRAM ( FKHR ),
1 3-GRAM FKHR ), a
1 3-GRAM ), a recently
1 3-GRAM a recently described
1 3-GRAM recently described member
1 3-GRAM described member of
1 3-GRAM of the hepatocyte
1 3-GRAM the hepatocyte nuclear
1 3-GRAM hepatocyte nuclear factor
1 3-GRAM nuclear factor 3
1 3-GRAM factor 3 /
1 3-GRAM 3 / forkhead
1 3-GRAM / forkhead homeotic
1 3-GRAM forkhead homeotic gene
1 3-GRAM homeotic gene family
1 3-GRAM gene family ,
1 3-GRAM family , as
1 3-GRAM , as a
1 3-GRAM as a nuclear
1 3-GRAM a nuclear hormone
1 3-GRAM nuclear hormone receptor
1 3-GRAM hormone receptor (
1 3-GRAM receptor ( NR
1 3-GRAM ( NR )
1 3-GRAM NR ) intermediary
1 3-GRAM ) intermediary protein
1 3-GRAM intermediary protein .
1 3-GRAM protein . STOP
1 3-GRAM * * Unlike
1 3-GRAM * Unlike other
1 3-GRAM Unlike other progenitor
1 3-GRAM other progenitor cells
1 3-GRAM progenitor cells of
1 3-GRAM cells of the
1 3-GRAM of the brain
1 3-GRAM the brain ,
1 3-GRAM brain , SVZa
1 3-GRAM , SVZa progenitor
1 3-GRAM SVZa progenitor cells
1 3-GRAM progenitor cells have
1 3-GRAM cells have the
1 3-GRAM have the capacity
1 3-GRAM the capacity to
1 3-GRAM capacity to divide
1 3-GRAM to divide even
1 3-GRAM divide even though
1 3-GRAM even though they
1 3-GRAM though they express
1 3-GRAM they express a
1 3-GRAM express a neuronal
1 3-GRAM a neuronal phenotype
1 3-GRAM neuronal phenotype .
2 3-GRAM phenotype . STOP
2 3-GRAM * We previously
1 3-GRAM We previously reported
1 3-GRAM previously reported that
1 3-GRAM reported that Tax
1 3-GRAM that Tax induced
1 3-GRAM Tax induced cell
1 3-GRAM induced cell cycle
2 3-GRAM cell cycle progression
1 3-GRAM cycle progression from
1 3-GRAM progression from G0
1 3-GRAM from G0 /
1 3-GRAM G0 / G1
1 3-GRAM / G1 phase
1 3-GRAM G1 phase to
1 3-GRAM phase to S
1 3-GRAM to S and
1 3-GRAM S and G2
1 3-GRAM and G2 /
1 3-GRAM G2 / M
1 3-GRAM / M phases
1 3-GRAM M phases in
1 3-GRAM phases in human
1 3-GRAM in human T
1 3-GRAM human T -
2 3-GRAM T - cell
1 3-GRAM - cell line
1 3-GRAM cell line Kit
1 3-GRAM line Kit 225
1 3-GRAM Kit 225 cells
1 3-GRAM 225 cells .
11 3-GRAM cells . STOP
1 3-GRAM * * Phosphotyrosyl
1 3-GRAM * Phosphotyrosyl peptides
1 3-GRAM Phosphotyrosyl peptides block
1 3-GRAM peptides block Stat3
1 3-GRAM block Stat3 -
1 3-GRAM Stat3 - mediated
1 3-GRAM - mediated DNA
1 3-GRAM mediated DNA binding
1 3-GRAM DNA binding activity
1 3-GRAM binding activity ,
1 3-GRAM activity , gene
1 3-GRAM , gene regulation
1 3-GRAM gene regulation ,
1 3-GRAM regulation , and
1 3-GRAM , and cell
1 3-GRAM and cell transformation
1 3-GRAM cell transformation .
1 3-GRAM transformation . STOP
1 3-GRAM * In Exp
1 3-GRAM In Exp .
1 3-GRAM Exp . STOP
2 3-GRAM * * Human
1 3-GRAM * Human brain
1 3-GRAM Human brain cDNA
1 3-GRAM brain cDNA library
1 3-GRAM cDNA library screening
1 3-GRAM library screening and
1 3-GRAM screening and 5
1 3-GRAM and 5 '
1 3-GRAM 5 ' rapid
1 3-GRAM ' rapid amplification
1 3-GRAM rapid amplification of
1 3-GRAM amplification of cDNA
1 3-GRAM of cDNA ends
1 3-GRAM cDNA ends yielded
1 3-GRAM ends yielded full
1 3-GRAM yielded full -
3 3-GRAM full - length
1 3-GRAM - length DENTT
1 3-GRAM length DENTT cDNA
1 3-GRAM DENTT cDNA containing
1 3-GRAM cDNA containing an
1 3-GRAM containing an 1899
1 3-GRAM an 1899 -
1 3-GRAM 1899 - bp
1 3-GRAM - bp open
1 3-GRAM bp open reading
2 3-GRAM open reading frame
1 3-GRAM reading frame encoding
1 3-GRAM frame encoding a
1 3-GRAM encoding a predicted
1 3-GRAM a predicted 633
1 3-GRAM predicted 633 -
1 3-GRAM 633 - amino
1 3-GRAM - amino -
1 3-GRAM amino - acid
1 3-GRAM - acid protein
1 3-GRAM acid protein with
1 3-GRAM protein with four
1 3-GRAM with four potential
1 3-GRAM four potential nuclear
1 3-GRAM potential nuclear localization
1 3-GRAM nuclear localization signals
1 3-GRAM localization signals (
1 3-GRAM signals ( NLSs
1 3-GRAM ( NLSs )
1 3-GRAM NLSs ) and
1 3-GRAM ) and two
1 3-GRAM and two coiled
1 3-GRAM two coiled -
1 3-GRAM coiled - coil
1 3-GRAM - coil regions
1 3-GRAM coil regions .
2 3-GRAM regions . STOP
1 3-GRAM * * NaeI
1 3-GRAM * NaeI ,
1 3-GRAM NaeI , a
1 3-GRAM , a novel
1 3-GRAM a novel DNA
1 3-GRAM novel DNA endonuclease
1 3-GRAM DNA endonuclease ,
1 3-GRAM endonuclease , shows
1 3-GRAM , shows topoisomerase
1 3-GRAM shows topoisomerase and
1 3-GRAM topoisomerase and recombinase
1 3-GRAM and recombinase activities
1 3-GRAM recombinase activities when
1 3-GRAM activities when a
1 3-GRAM when a Lys
1 3-GRAM a Lys residue
1 3-GRAM Lys residue is
1 3-GRAM residue is substituted
1 3-GRAM is substituted for
1 3-GRAM substituted for Leu
1 3-GRAM for Leu 43
1 3-GRAM Leu 43 .
1 3-GRAM 43 . STOP
1 3-GRAM * We used
1 3-GRAM We used a
1 3-GRAM used a rev
1 3-GRAM a rev -
1 3-GRAM rev - and
1 3-GRAM - and RRE
1 3-GRAM and RRE -
1 3-GRAM RRE - defective
1 3-GRAM - defective HIV
1 3-GRAM defective HIV type
1 3-GRAM HIV type 1
1 3-GRAM type 1 (
1 3-GRAM 1 ( HIV
1 3-GRAM ( HIV -
2 3-GRAM HIV - 1
1 3-GRAM - 1 )
1 3-GRAM 1 ) molecular
1 3-GRAM ) molecular clone
1 3-GRAM molecular clone in
1 3-GRAM clone in complementation
1 3-GRAM in complementation experiments
1 3-GRAM complementation experiments to
1 3-GRAM experiments to establish
1 3-GRAM to establish a
1 3-GRAM establish a method
1 3-GRAM a method for
1 3-GRAM method for the
1 3-GRAM for the rapid
1 3-GRAM the rapid isolation
1 3-GRAM rapid isolation of
1 3-GRAM isolation of posttranscriptional
1 3-GRAM of posttranscriptional regulatory
1 3-GRAM posttranscriptional regulatory elements
1 3-GRAM regulatory elements from
1 3-GRAM elements from the
1 3-GRAM from the mammalian
1 3-GRAM the mammalian genome
1 3-GRAM mammalian genome by
1 3-GRAM genome by selecting
1 3-GRAM by selecting for
1 3-GRAM selecting for rescue
1 3-GRAM for rescue of
1 3-GRAM rescue of virus
1 3-GRAM of virus replication
1 3-GRAM virus replication .
2 3-GRAM replication . STOP
1 3-GRAM * * OBJECTIVES
1 3-GRAM * OBJECTIVES :
1 3-GRAM OBJECTIVES : The
1 3-GRAM : The objective
1 3-GRAM The objective of
1 3-GRAM objective of this
1 3-GRAM of this review
1 3-GRAM this review was
1 3-GRAM review was to
1 3-GRAM was to compare
1 3-GRAM to compare the
1 3-GRAM compare the effectiveness
1 3-GRAM the effectiveness ,
1 3-GRAM effectiveness , safety
1 3-GRAM , safety and
1 3-GRAM safety and acceptability
1 3-GRAM and acceptability of
1 3-GRAM acceptability of the
1 3-GRAM of the diaphragm
1 3-GRAM the diaphragm with
1 3-GRAM diaphragm with and
2 3-GRAM with and without
1 3-GRAM and without spermicide
1 3-GRAM without spermicide .
1 3-GRAM spermicide . STOP
2 3-GRAM * * DESIGN
2 3-GRAM * DESIGN :
1 3-GRAM DESIGN : Retrospective
1 3-GRAM : Retrospective study
1 3-GRAM Retrospective study .
1 3-GRAM study . STOP
1 3-GRAM * * Considering
1 3-GRAM * Considering that
1 3-GRAM Considering that the
1 3-GRAM that the reactor
1 3-GRAM the reactor is
1 3-GRAM reactor is thoroughly
1 3-GRAM is thoroughly mixed
1 3-GRAM thoroughly mixed during
1 3-GRAM mixed during each
1 3-GRAM during each discharge
1 3-GRAM each discharge and
1 3-GRAM discharge and that
1 3-GRAM and that LD50
1 3-GRAM that LD50 =
1 3-GRAM LD50 = 0
19 3-GRAM = 0 .
1 3-GRAM 0 . 9
1 3-GRAM . 9 values
1 3-GRAM 9 values are
1 3-GRAM values are nearly
1 3-GRAM are nearly independent
1 3-GRAM nearly independent of
1 3-GRAM independent of E
1 3-GRAM of E .
3 3-GRAM E . coli
1 3-GRAM . coli concentrations
1 3-GRAM coli concentrations in
2 3-GRAM concentrations in the
2 3-GRAM in the range
2 3-GRAM the range of
1 3-GRAM range of 2
1 3-GRAM of 2 x
1 3-GRAM 2 x 10
2 3-GRAM x 10 (
1 3-GRAM 10 ( 3
2 3-GRAM ( 3 )
1 3-GRAM 3 ) <
3 3-GRAM ) < or
3 3-GRAM < or =
1 3-GRAM or = E
1 3-GRAM = E coli
1 3-GRAM E coli /
1 3-GRAM coli / cfu
1 3-GRAM / cfu mL
1 3-GRAM cfu mL (-
1 3-GRAM mL (- 1
1 3-GRAM (- 1 )
1 3-GRAM 1 ) <
1 3-GRAM or = 3
1 3-GRAM = 3 x
1 3-GRAM 3 x 10
1 3-GRAM 10 ( 6
1 3-GRAM ( 6 ),
1 3-GRAM 6 ), we
1 3-GRAM ), we ascribe
1 3-GRAM we ascribe the
1 3-GRAM ascribe the nonexponential
1 3-GRAM the nonexponential Pn
1 3-GRAM nonexponential Pn decay
1 3-GRAM Pn decay of
1 3-GRAM decay of single
3 3-GRAM of single -
1 3-GRAM single - strain
1 3-GRAM - strain E
1 3-GRAM strain E .
1 3-GRAM . coli colonies
1 3-GRAM coli colonies to
1 3-GRAM colonies to a
1 3-GRAM to a shielding
1 3-GRAM a shielding phenomenon
1 3-GRAM shielding phenomenon where
1 3-GRAM phenomenon where inactive
1 3-GRAM where inactive cells
1 3-GRAM inactive cells protect
1 3-GRAM cells protect the
1 3-GRAM protect the successively
1 3-GRAM the successively smaller
1 3-GRAM successively smaller numbers
1 3-GRAM smaller numbers of
1 3-GRAM numbers of viable
1 3-GRAM of viable cells
1 3-GRAM viable cells in
1 3-GRAM cells in the
1 3-GRAM in the EHD
1 3-GRAM the EHD .
1 3-GRAM EHD . STOP
1 3-GRAM * These genes
1 3-GRAM These genes encode
1 3-GRAM genes encode a
1 3-GRAM encode a tryptophanyl
1 3-GRAM a tryptophanyl tRNA
1 3-GRAM tryptophanyl tRNA ,
1 3-GRAM tRNA , the
2 3-GRAM , the protein
1 3-GRAM the protein translocase
1 3-GRAM protein translocase component
1 3-GRAM translocase component SecE
1 3-GRAM component SecE ,
1 3-GRAM SecE , the
1 3-GRAM , the antiterminator
1 3-GRAM the antiterminator protein
1 3-GRAM antiterminator protein NusG
1 3-GRAM protein NusG ,
1 3-GRAM NusG , and
2 3-GRAM , and the
1 3-GRAM and the ribosomal
1 3-GRAM the ribosomal proteins
1 3-GRAM ribosomal proteins L11
1 3-GRAM proteins L11 and
1 3-GRAM L11 and L1
1 3-GRAM and L1 in
1 3-GRAM L1 in addition
1 3-GRAM in addition to
1 3-GRAM addition to PkwR
1 3-GRAM to PkwR ,
1 3-GRAM PkwR , a
1 3-GRAM , a putative
1 3-GRAM a putative regulatory
1 3-GRAM putative regulatory protein
1 3-GRAM regulatory protein of
1 3-GRAM protein of the
1 3-GRAM of the LacI
1 3-GRAM the LacI -
1 3-GRAM LacI - GalR
1 3-GRAM - GalR family
1 3-GRAM GalR family .
3 3-GRAM family . STOP
1 3-GRAM * * Body
1 3-GRAM * Body fat
1 3-GRAM Body fat distribution
1 3-GRAM fat distribution was
1 3-GRAM distribution was determined
2 3-GRAM was determined by
1 3-GRAM determined by abdominal
1 3-GRAM by abdominal computed
1 3-GRAM abdominal computed tomography
1 3-GRAM computed tomography .
1 3-GRAM tomography . STOP
1 3-GRAM * The telomerase
1 3-GRAM The telomerase RNA
1 3-GRAM telomerase RNA -
1 3-GRAM RNA - protein
1 3-GRAM - protein complex
1 3-GRAM protein complex responsible
1 3-GRAM complex responsible for
1 3-GRAM responsible for maintenance
1 3-GRAM for maintenance of
1 3-GRAM maintenance of telomeric
1 3-GRAM of telomeric DNA
1 3-GRAM telomeric DNA at
1 3-GRAM DNA at chromosome
1 3-GRAM at chromosome ends
1 3-GRAM chromosome ends ,
1 3-GRAM ends , is
1 3-GRAM , is usually
1 3-GRAM is usually inactive
1 3-GRAM usually inactive in
1 3-GRAM inactive in most
1 3-GRAM in most primary
1 3-GRAM most primary somatic
1 3-GRAM primary somatic human
1 3-GRAM somatic human cells
1 3-GRAM human cells ,
1 3-GRAM cells , but
1 3-GRAM , but is
1 3-GRAM but is specifically
1 3-GRAM is specifically activated
1 3-GRAM specifically activated with
1 3-GRAM activated with in
1 3-GRAM with in vitro
1 3-GRAM in vitro immortalization
1 3-GRAM vitro immortalization and
1 3-GRAM immortalization and during
1 3-GRAM and during tumorigenesis
1 3-GRAM during tumorigenesis .
1 3-GRAM tumorigenesis . STOP
1 3-GRAM * This is
1 3-GRAM This is a
1 3-GRAM is a challenging
1 3-GRAM a challenging task
1 3-GRAM challenging task insofar
1 3-GRAM task insofar as
1 3-GRAM insofar as direct
1 3-GRAM as direct measures
1 3-GRAM direct measures of
1 3-GRAM measures of ISF
1 3-GRAM of ISF glucose
1 3-GRAM ISF glucose are
1 3-GRAM glucose are not
1 3-GRAM are not readily
1 3-GRAM not readily available
1 3-GRAM readily available .
1 3-GRAM available . STOP
1 3-GRAM * * SELECTION
1 3-GRAM * SELECTION CRITERIA
1 3-GRAM SELECTION CRITERIA :
1 3-GRAM CRITERIA : All
1 3-GRAM : All randomised
1 3-GRAM All randomised controlled
1 3-GRAM randomised controlled trials
1 3-GRAM controlled trials comparing
1 3-GRAM trials comparing IUSs
1 3-GRAM comparing IUSs with
1 3-GRAM IUSs with other
1 3-GRAM with other forms
1 3-GRAM other forms of
1 3-GRAM forms of reversible
1 3-GRAM of reversible contraceptives
1 3-GRAM reversible contraceptives and
1 3-GRAM contraceptives and reporting
1 3-GRAM and reporting on
1 3-GRAM reporting on pre
1 3-GRAM on pre -
1 3-GRAM pre - determined
1 3-GRAM - determined outcomes
1 3-GRAM determined outcomes in
1 3-GRAM outcomes in women
1 3-GRAM in women of
1 3-GRAM women of reproductive
1 3-GRAM of reproductive years
1 3-GRAM reproductive years .
1 3-GRAM years . STOP
4 3-GRAM * * There
4 3-GRAM * There was
1 3-GRAM There was a
1 3-GRAM was a statistically
2 3-GRAM a statistically significant
1 3-GRAM statistically significant correlation
2 3-GRAM significant correlation between
1 3-GRAM correlation between simultaneous
1 3-GRAM between simultaneous weekly
1 3-GRAM simultaneous weekly average
1 3-GRAM weekly average pollen
1 3-GRAM average pollen levels
1 3-GRAM pollen levels in
1 3-GRAM levels in Philadelphia
1 3-GRAM in Philadelphia and
1 3-GRAM Philadelphia and in
1 3-GRAM and in Cherry
1 3-GRAM in Cherry Hill
1 3-GRAM Cherry Hill (
1 3-GRAM Hill ( Acer
1 3-GRAM ( Acer ,
1 3-GRAM Acer , r
8 3-GRAM , r (
8 3-GRAM r ( p
8 3-GRAM ( p )
8 3-GRAM p ) =
8 3-GRAM ) = 0
1 3-GRAM 0 . 987
1 3-GRAM . 987 ,
1 3-GRAM 987 , Quercus
1 3-GRAM , Quercus ,
1 3-GRAM Quercus , r
1 3-GRAM 0 . 645
1 3-GRAM . 645 ,
1 3-GRAM 645 , Betula
1 3-GRAM , Betula ,
1 3-GRAM Betula , r
1 3-GRAM 0 . 896
1 3-GRAM . 896 ,
1 3-GRAM 896 , Pinus
1 3-GRAM , Pinus ,
1 3-GRAM Pinus , r
1 3-GRAM 0 . 732
1 3-GRAM . 732 ,
1 3-GRAM 732 , Cupressaceae
1 3-GRAM , Cupressaceae ,
1 3-GRAM Cupressaceae , r
1 3-GRAM 0 . 695
1 3-GRAM . 695 ,
1 3-GRAM 695 , Poaceae
1 3-GRAM , Poaceae ,
1 3-GRAM Poaceae , r
1 3-GRAM 0 . 950
1 3-GRAM . 950 ,
1 3-GRAM 950 , Ambrosia
1 3-GRAM , Ambrosia ,
1 3-GRAM Ambrosia , r
1 3-GRAM 0 . 903
1 3-GRAM . 903 ,
1 3-GRAM 903 , and
1 3-GRAM , and Rumex
1 3-GRAM and Rumex ,
1 3-GRAM Rumex , r
1 3-GRAM 0 . 572
1 3-GRAM . 572 ,
1 3-GRAM 572 , P
1 3-GRAM , P <
4 3-GRAM P < 0
4 3-GRAM < 0 .
2 3-GRAM 0 . 001
2 3-GRAM . 001 ).
2 3-GRAM 001 ). STOP
2 3-GRAM * * Through
1 3-GRAM * Through two
1 3-GRAM Through two novel
1 3-GRAM two novel mechanisms
1 3-GRAM novel mechanisms ,
1 3-GRAM mechanisms , Arf
1 3-GRAM , Arf inhibits
1 3-GRAM Arf inhibits the
1 3-GRAM inhibits the oncoprotein
1 3-GRAM the oncoprotein Hdm2
1 3-GRAM oncoprotein Hdm2 ,
1 3-GRAM Hdm2 , a
1 3-GRAM , a negative
1 3-GRAM a negative regulator
1 3-GRAM negative regulator of
1 3-GRAM regulator of p53
2 3-GRAM of p53 .
2 3-GRAM p53 . STOP
2 3-GRAM * * 2
1 3-GRAM * 2 :
1 3-GRAM 2 : The
1 3-GRAM : The dynamic
1 3-GRAM The dynamic moduli
1 3-GRAM dynamic moduli of
1 3-GRAM moduli of microcrystalline
1 3-GRAM of microcrystalline cellulose
1 3-GRAM microcrystalline cellulose .
1 3-GRAM cellulose . STOP
1 3-GRAM * * Such
1 3-GRAM * Such knowledge
1 3-GRAM Such knowledge could
1 3-GRAM knowledge could advance
1 3-GRAM could advance diagnosis
1 3-GRAM advance diagnosis and
1 3-GRAM diagnosis and treatment
1 3-GRAM and treatment of
2 3-GRAM treatment of the
1 3-GRAM of the patient
1 3-GRAM the patient and
1 3-GRAM patient and counseling
1 3-GRAM and counseling of
1 3-GRAM counseling of the
1 3-GRAM of the affected
1 3-GRAM the affected family
1 3-GRAM affected family .
2 3-GRAM Here we show
3 3-GRAM we show that
1 3-GRAM show that independent
1 3-GRAM that independent of
1 3-GRAM independent of uncertainties
1 3-GRAM of uncertainties in
1 3-GRAM uncertainties in the
1 3-GRAM in the models
1 3-GRAM the models ,
1 3-GRAM models , terrestrial
1 3-GRAM , terrestrial planets
1 3-GRAM terrestrial planets with
1 3-GRAM planets with dense
1 3-GRAM with dense atmosphere
1 3-GRAM dense atmosphere like
1 3-GRAM atmosphere like Venus
1 3-GRAM like Venus can
1 3-GRAM Venus can evolve
1 3-GRAM can evolve into
1 3-GRAM evolve into one
1 3-GRAM into one of
1 3-GRAM one of only
1 3-GRAM of only four
1 3-GRAM only four possible
1 3-GRAM four possible rotation
1 3-GRAM possible rotation states
1 3-GRAM rotation states .
1 3-GRAM states . STOP
2 3-GRAM Our results suggest
2 3-GRAM results suggest that
1 3-GRAM suggest that WASP
1 3-GRAM that WASP activates
1 3-GRAM WASP activates transcription
1 3-GRAM activates transcription following
1 3-GRAM transcription following TCR
1 3-GRAM following TCR stimulation
1 3-GRAM TCR stimulation in
1 3-GRAM stimulation in a
2 3-GRAM in a manner
1 3-GRAM a manner that
1 3-GRAM manner that is
1 3-GRAM that is independent
1 3-GRAM is independent of
1 3-GRAM independent of its
1 3-GRAM of its role
1 3-GRAM its role in
1 3-GRAM role in Arp2
1 3-GRAM in Arp2 /
1 3-GRAM Arp2 / 3
1 3-GRAM / 3 -
1 3-GRAM 3 - directed
1 3-GRAM - directed actin
1 3-GRAM directed actin polymerization
1 3-GRAM actin polymerization .
1 3-GRAM polymerization . STOP
5 3-GRAM * In contrast
5 3-GRAM In contrast ,
2 3-GRAM contrast , the
1 3-GRAM , the ubiquitous
1 3-GRAM the ubiquitous expression
1 3-GRAM ubiquitous expression of
1 3-GRAM expression of p19
1 3-GRAM of p19 (
1 3-GRAM p19 ( INK4d
1 3-GRAM ( INK4d )
1 3-GRAM INK4d ) has
1 3-GRAM ) has not
1 3-GRAM has not been
1 3-GRAM been previously described
1 3-GRAM previously described in
1 3-GRAM described in human
1 3-GRAM in human or
1 3-GRAM human or murine
1 3-GRAM or murine B
1 3-GRAM murine B -
1 3-GRAM B - lineage
1 3-GRAM - lineage cells
1 3-GRAM lineage cells .
1 3-GRAM * This animal
1 3-GRAM This animal model
1 3-GRAM animal model of
1 3-GRAM model of dystonia
1 3-GRAM of dystonia appears
1 3-GRAM dystonia appears to
1 3-GRAM appears to be
2 3-GRAM to be a
1 3-GRAM be a model
1 3-GRAM a model of
1 3-GRAM model of NAD
1 3-GRAM of NAD in
1 3-GRAM NAD in man
1 3-GRAM in man from
1 3-GRAM man from the
1 3-GRAM from the viewpoint
1 3-GRAM the viewpoint of
1 3-GRAM viewpoint of treatment
1 3-GRAM of treatment -
1 3-GRAM treatment - response
1 3-GRAM - response .
1 3-GRAM response . STOP
3 3-GRAM * These results
2 3-GRAM These results indicate
3 3-GRAM results indicate that
1 3-GRAM indicate that evaluation
1 3-GRAM that evaluation of
1 3-GRAM evaluation of exposure
1 3-GRAM of exposure to
1 3-GRAM exposure to S
1 3-GRAM to S .
1 3-GRAM S . neurona
1 3-GRAM . neurona by
1 3-GRAM neurona by WB
1 3-GRAM by WB analysis
1 3-GRAM WB analysis of
1 3-GRAM analysis of serum
1 3-GRAM of serum may
1 3-GRAM serum may be
1 3-GRAM may be misleading
1 3-GRAM be misleading in
1 3-GRAM misleading in young
1 3-GRAM in young horses
1 3-GRAM young horses .
1 3-GRAM horses . STOP
1 3-GRAM * The Delta6CCI
1 3-GRAM The Delta6CCI virus
1 3-GRAM Delta6CCI virus was
1 3-GRAM virus was extremely
1 3-GRAM was extremely attenuated
1 3-GRAM extremely attenuated in
1 3-GRAM attenuated in replication
1 3-GRAM in replication capacity
1 3-GRAM replication capacity yet
1 3-GRAM capacity yet retained
1 3-GRAM yet retained infectiousness
1 3-GRAM retained infectiousness for
1 3-GRAM infectiousness for CEMx174
1 3-GRAM for CEMx174 and
1 3-GRAM CEMx174 and MT4
1 3-GRAM and MT4 cells
1 3-GRAM MT4 cells .
2 3-GRAM * * OBJECTIVE
2 3-GRAM * OBJECTIVE :
2 3-GRAM OBJECTIVE : To
1 3-GRAM : To determine
2 3-GRAM To determine the
1 3-GRAM determine the association
1 3-GRAM the association of
1 3-GRAM association of depressive
1 3-GRAM of depressive symptoms
1 3-GRAM depressive symptoms with
1 3-GRAM symptoms with HIV
1 3-GRAM with HIV -
1 3-GRAM HIV - related
1 3-GRAM - related mortality
1 3-GRAM related mortality and
1 3-GRAM mortality and decline
1 3-GRAM and decline in
1 3-GRAM decline in CD4
1 3-GRAM in CD4 lymphocyte
1 3-GRAM CD4 lymphocyte counts
1 3-GRAM lymphocyte counts among
1 3-GRAM counts among women
1 3-GRAM among women with
1 3-GRAM women with HIV
1 3-GRAM with HIV .
2 3-GRAM HIV . STOP
1 3-GRAM * * Phase
1 3-GRAM * Phase II
1 3-GRAM Phase II study
1 3-GRAM II study of
1 3-GRAM study of paclitaxel
1 3-GRAM of paclitaxel and
1 3-GRAM paclitaxel and oral
1 3-GRAM and oral etoposide
1 3-GRAM oral etoposide in
1 3-GRAM etoposide in patients
1 3-GRAM patients with locally
1 3-GRAM with locally advanced
1 3-GRAM locally advanced or
1 3-GRAM advanced or metastatic
1 3-GRAM or metastatic non
1 3-GRAM metastatic non -
1 3-GRAM non - small
1 3-GRAM - small cell
1 3-GRAM small cell lung
1 3-GRAM cell lung cancer
1 3-GRAM lung cancer .
2 3-GRAM cancer . STOP
1 3-GRAM * * Analyses
1 3-GRAM * Analyses revealed
1 3-GRAM Analyses revealed that
1 3-GRAM revealed that scale
1 3-GRAM that scale matters
1 3-GRAM scale matters above
1 3-GRAM matters above and
1 3-GRAM above and beyond
1 3-GRAM and beyond the
1 3-GRAM beyond the effect
2 3-GRAM the effect of
1 3-GRAM effect of quadrat
1 3-GRAM of quadrat area
1 3-GRAM quadrat area .
1 3-GRAM area . STOP
1 3-GRAM * * Rind
1 3-GRAM * Rind et
1 3-GRAM Rind et al
1 3-GRAM et al .'
1 3-GRAM al .' s
1 3-GRAM .' s study
1 3-GRAM s study '
1 3-GRAM study ' s
1 3-GRAM ' s main
1 3-GRAM s main conclusions
1 3-GRAM main conclusions were
1 3-GRAM conclusions were not
1 3-GRAM were not supported
1 3-GRAM not supported by
1 3-GRAM supported by the
1 3-GRAM by the original
1 3-GRAM the original data
1 3-GRAM original data .
1 3-GRAM data . STOP
1 3-GRAM * * Not
1 3-GRAM * Not Available
1 3-GRAM Not Available STOP
1 3-GRAM * * Lactate
1 3-GRAM * Lactate accumulation
1 3-GRAM Lactate accumulation peak
1 3-GRAM accumulation peak was
1 3-GRAM peak was unaffected
1 3-GRAM was unaffected by
1 3-GRAM unaffected by supplementation
1 3-GRAM by supplementation (
1 3-GRAM supplementation ( HMB
1 3-GRAM ( HMB ,
1 3-GRAM HMB , 8
1 3-GRAM , 8 .
2 3-GRAM 8 . 1
1 3-GRAM . 1 +/-
1 3-GRAM 1 +/- 1
2 3-GRAM +/- 1 .
1 3-GRAM 1 . 1
1 3-GRAM . 1 mM
1 3-GRAM 1 mM ;
1 3-GRAM mM ; LEU
1 3-GRAM ; LEU ,
1 3-GRAM LEU , 6
1 3-GRAM , 6 .
1 3-GRAM 6 . 2
1 3-GRAM . 2 +/-
1 3-GRAM 2 +/- 0
3 3-GRAM +/- 0 .
1 3-GRAM 0 . 8
1 3-GRAM . 8 mM
1 3-GRAM 8 mM ;
1 3-GRAM mM ; CON
1 3-GRAM ; CON ,
1 3-GRAM CON , 7
1 3-GRAM , 7 .
1 3-GRAM 7 . 5
1 3-GRAM . 5 +/-
1 3-GRAM 5 +/- 1
3 3-GRAM 1 . 3
1 3-GRAM . 3 mM
1 3-GRAM 3 mM ).
1 3-GRAM mM ). STOP
1 3-GRAM , the abi1
1 3-GRAM the abi1 -
1 3-GRAM abi1 - 1
2 3-GRAM - 1 gene
1 3-GRAM 1 gene product
1 3-GRAM gene product has
1 3-GRAM product has no
1 3-GRAM has no effect
1 3-GRAM no effect on
1 3-GRAM on the ABA
1 3-GRAM the ABA suppression
1 3-GRAM ABA suppression of
1 3-GRAM suppression of a
1 3-GRAM of a GA
1 3-GRAM a GA -
1 3-GRAM GA - responsive
1 3-GRAM - responsive alpha
1 3-GRAM responsive alpha -
2 3-GRAM alpha - amylase
1 3-GRAM - amylase gene
1 3-GRAM amylase gene .
8 3-GRAM gene . STOP
1 3-GRAM * * Polyclonal
1 3-GRAM * Polyclonal antibodies
1 3-GRAM Polyclonal antibodies against
2 3-GRAM antibodies against the
1 3-GRAM against the N
4 3-GRAM the N -
2 3-GRAM - terminal part
2 3-GRAM terminal part (
2 3-GRAM part ( amino
2 3-GRAM ( amino acids
1 3-GRAM amino acids 12
1 3-GRAM acids 12 -
1 3-GRAM 12 - 363
1 3-GRAM - 363 )
1 3-GRAM 363 ) and
1 3-GRAM ) and the
1 3-GRAM and the C
4 3-GRAM the C -
7 3-GRAM C - terminal
1 3-GRAM amino acids 330
1 3-GRAM acids 330 -
1 3-GRAM 330 - 730
1 3-GRAM - 730 )
1 3-GRAM 730 ) of
1 3-GRAM ) of rainbow
1 3-GRAM of rainbow trout
1 3-GRAM rainbow trout HIF
1 3-GRAM trout HIF -
2 3-GRAM HIF - 1alpha
2 3-GRAM - 1alpha protein
1 3-GRAM 1alpha protein recognized
1 3-GRAM protein recognized rainbow
1 3-GRAM recognized rainbow trout
1 3-GRAM rainbow trout and
1 3-GRAM trout and chinook
1 3-GRAM and chinook salmon
1 3-GRAM chinook salmon HIF
1 3-GRAM salmon HIF -
1 3-GRAM 1alpha protein in
1 3-GRAM protein in Western
1 3-GRAM in Western blot
1 3-GRAM Western blot analysis
1 3-GRAM blot analysis .
3 3-GRAM analysis . STOP
1 3-GRAM * * Southern
1 3-GRAM * Southern blot
1 3-GRAM Southern blot analysis
1 3-GRAM blot analysis of
1 3-GRAM analysis of genomic
1 3-GRAM of genomic DNA
1 3-GRAM genomic DNA from
1 3-GRAM DNA from somatic
1 3-GRAM from somatic cell
1 3-GRAM somatic cell hybrids
1 3-GRAM cell hybrids showed
1 3-GRAM hybrids showed that
1 3-GRAM showed that endothelial
1 3-GRAM that endothelial -
1 3-GRAM endothelial - TACC
1 3-GRAM - TACC -
1 3-GRAM TACC - related
1 3-GRAM - related cDNA
1 3-GRAM related cDNA maps
1 3-GRAM cDNA maps to
1 3-GRAM maps to chromosome
1 3-GRAM to chromosome 10
1 3-GRAM chromosome 10 .
1 3-GRAM 10 . STOP
1 3-GRAM * * PABP
1 3-GRAM * PABP is
1 3-GRAM PABP is a
1 3-GRAM is a modular
1 3-GRAM a modular protein
1 3-GRAM modular protein ,
1 3-GRAM protein , with
1 3-GRAM , with four
1 3-GRAM with four N
1 3-GRAM four N -
1 3-GRAM - terminal RNA
1 3-GRAM terminal RNA -
1 3-GRAM RNA - binding
1 3-GRAM - binding domains
1 3-GRAM binding domains and
1 3-GRAM domains and an
1 3-GRAM and an extensive
1 3-GRAM an extensive C
1 3-GRAM extensive C terminus
1 3-GRAM C terminus .
1 3-GRAM terminus . STOP
1 3-GRAM * * 9
1 3-GRAM * 9 .
2 3-GRAM 9 . 7
1 3-GRAM . 7 (
1 3-GRAM 7 ( 95
1 3-GRAM ( 95 %
1 3-GRAM 95 % CI
1 3-GRAM % CI :
1 3-GRAM CI : 9
1 3-GRAM : 9 .
1 3-GRAM 9 . 6
3 3-GRAM . 6 -
1 3-GRAM 6 - 9
1 3-GRAM - 9 .
1 3-GRAM . 7 )
1 3-GRAM 7 ) micromol
1 3-GRAM ) micromol /
1 3-GRAM micromol / L
1 3-GRAM / L among
1 3-GRAM L among women
1 3-GRAM among women (
1 3-GRAM women ( P
3 3-GRAM ( P =
7 3-GRAM P = 0
1 3-GRAM 0 . 003
1 3-GRAM . 003 ).
1 3-GRAM 003 ). STOP
2 3-GRAM * The mean
1 3-GRAM The mean waiting
1 3-GRAM mean waiting time
1 3-GRAM waiting time to
1 3-GRAM time to receive
1 3-GRAM to receive the
1 3-GRAM receive the pancreas
1 3-GRAM the pancreas transplant
1 3-GRAM pancreas transplant was
1 3-GRAM transplant was 244
1 3-GRAM was 244 days
1 3-GRAM 244 days for
1 3-GRAM days for SPK
1 3-GRAM for SPK and
1 3-GRAM SPK and 167
1 3-GRAM and 167 days
1 3-GRAM 167 days for
1 3-GRAM days for PAK
1 3-GRAM for PAK recipients
1 3-GRAM PAK recipients (
1 3-GRAM recipients ( P
1 3-GRAM * * Zarix
1 3-GRAM * Zarix expected
1 3-GRAM Zarix expected patient
1 3-GRAM expected patient enrollment
1 3-GRAM patient enrollment in
1 3-GRAM enrollment in Canadian
1 3-GRAM in Canadian clinical
1 3-GRAM Canadian clinical sites
1 3-GRAM clinical sites to
1 3-GRAM sites to begin
1 3-GRAM to begin in
1 3-GRAM begin in Spring
1 3-GRAM in Spring 2001
1 3-GRAM Spring 2001 [
1 3-GRAM 2001 [ 397955
1 3-GRAM [ 397955 ],
1 3-GRAM 397955 ], [
1 3-GRAM ], [ 405928
1 3-GRAM [ 405928 ].
1 3-GRAM 405928 ]. STOP
1 3-GRAM * The isoform
1 3-GRAM The isoform ,
1 3-GRAM isoform , designated
1 3-GRAM , designated HDAC9a
1 3-GRAM designated HDAC9a ,
1 3-GRAM HDAC9a , is
1 3-GRAM , is 132
1 3-GRAM is 132 aa
1 3-GRAM 132 aa shorter
1 3-GRAM aa shorter at
1 3-GRAM shorter at the
2 3-GRAM at the C
1 3-GRAM the C terminus
1 3-GRAM C terminus than
1 3-GRAM terminus than HDAC9
1 3-GRAM than HDAC9 .
1 3-GRAM HDAC9 . STOP
1 3-GRAM * * Long
1 3-GRAM * Long -
1 3-GRAM Long - range
1 3-GRAM - range comparison
1 3-GRAM range comparison of
1 3-GRAM comparison of human
1 3-GRAM of human and
1 3-GRAM human and mouse
1 3-GRAM and mouse SCL
1 3-GRAM mouse SCL loci
1 3-GRAM SCL loci :
1 3-GRAM loci : localized
1 3-GRAM : localized regions
1 3-GRAM localized regions of
1 3-GRAM regions of sensitivity
1 3-GRAM of sensitivity to
1 3-GRAM sensitivity to restriction
1 3-GRAM to restriction endonucleases
1 3-GRAM restriction endonucleases correspond
1 3-GRAM endonucleases correspond precisely
1 3-GRAM correspond precisely with
1 3-GRAM precisely with peaks
1 3-GRAM with peaks of
1 3-GRAM peaks of conserved
1 3-GRAM of conserved noncoding
1 3-GRAM conserved noncoding sequences
1 3-GRAM noncoding sequences .
1 3-GRAM sequences . STOP
1 3-GRAM * In Saccharomyces
1 3-GRAM In Saccharomyces cerevisiae
1 3-GRAM Saccharomyces cerevisiae ,
1 3-GRAM cerevisiae , eIF6
1 3-GRAM , eIF6 is
1 3-GRAM eIF6 is encoded
1 3-GRAM is encoded by
1 3-GRAM encoded by a
1 3-GRAM by a single
1 3-GRAM a single -
1 3-GRAM single - copy
1 3-GRAM - copy essential
1 3-GRAM copy essential gene
1 3-GRAM essential gene .
2 3-GRAM * * Three
1 3-GRAM * Three patients
1 3-GRAM Three patients received
1 3-GRAM patients received additional
1 3-GRAM received additional cycles
1 3-GRAM additional cycles of
1 3-GRAM cycles of 5
2 3-GRAM of 5 -
2 3-GRAM 5 - fluorouracil
1 3-GRAM - fluorouracil +/-
1 3-GRAM fluorouracil +/- leucovorin
1 3-GRAM +/- leucovorin as
1 3-GRAM leucovorin as maintenance
1 3-GRAM as maintenance chemotherapy
1 3-GRAM maintenance chemotherapy .
1 3-GRAM chemotherapy . RESULTS
1 3-GRAM . RESULTS :
1 3-GRAM RESULTS : Thirty
1 3-GRAM : Thirty males
1 3-GRAM Thirty males and
1 3-GRAM males and 21
1 3-GRAM and 21 females
1 3-GRAM 21 females with
1 3-GRAM females with a
1 3-GRAM with a median
1 3-GRAM a median age
1 3-GRAM median age of
1 3-GRAM age of 55
1 3-GRAM of 55 years
1 3-GRAM 55 years (
1 3-GRAM years ( range
1 3-GRAM ( range 31
1 3-GRAM range 31 --
1 3-GRAM 31 -- 73
1 3-GRAM -- 73 years
1 3-GRAM 73 years )
1 3-GRAM years ) were
1 3-GRAM ) were treated
1 3-GRAM were treated .
1 3-GRAM treated . STOP
7 3-GRAM * * RESULTS
7 3-GRAM * RESULTS :
1 3-GRAM RESULTS : Within
1 3-GRAM : Within 7
1 3-GRAM Within 7 days
1 3-GRAM 7 days ,
1 3-GRAM days , all
1 3-GRAM , all groups
1 3-GRAM all groups re
1 3-GRAM groups re -
1 3-GRAM re - acquired
1 3-GRAM - acquired responding
1 3-GRAM acquired responding for
1 3-GRAM responding for heroin
1 3-GRAM for heroin under
1 3-GRAM heroin under CRF
1 3-GRAM under CRF at
1 3-GRAM CRF at rates
1 3-GRAM at rates similar
1 3-GRAM rates similar to
1 3-GRAM similar to their
1 3-GRAM to their pre
1 3-GRAM their pre -
1 3-GRAM pre - lesion
1 3-GRAM - lesion performance
1 3-GRAM lesion performance .
1 3-GRAM performance . STOP
1 3-GRAM * The application
1 3-GRAM The application of
1 3-GRAM application of the
1 3-GRAM of the biotechnology
1 3-GRAM the biotechnology at
1 3-GRAM biotechnology at the
1 3-GRAM at the plants
1 3-GRAM the plants for
1 3-GRAM plants for treatment
2 3-GRAM for treatment of
1 3-GRAM of the surface
1 3-GRAM the surface storm
1 3-GRAM surface storm waters
1 3-GRAM storm waters from
1 3-GRAM waters from the
1 3-GRAM from the industrial
1 3-GRAM the industrial zone
1 3-GRAM industrial zone Telychka
1 3-GRAM zone Telychka of
1 3-GRAM Telychka of the
1 3-GRAM of the city
1 3-GRAM the city of
1 3-GRAM city of Kyiv
1 3-GRAM of Kyiv has
1 3-GRAM Kyiv has allowed
1 3-GRAM has allowed the
1 3-GRAM allowed the content
1 3-GRAM the content of
1 3-GRAM content of petroleum
1 3-GRAM of petroleum in
1 3-GRAM petroleum in water
1 3-GRAM in water dropped
1 3-GRAM water dropped to
1 3-GRAM dropped to the
1 3-GRAM to the Dnieper
1 3-GRAM the Dnieper to
1 3-GRAM Dnieper to be
1 3-GRAM to be constantly
1 3-GRAM be constantly reduced
1 3-GRAM constantly reduced 50
1 3-GRAM reduced 50 -
1 3-GRAM 50 - 100
1 3-GRAM - 100 times
1 3-GRAM 100 times .
1 3-GRAM times . STOP
2 3-GRAM * * Using
1 3-GRAM * Using immunochemical
1 3-GRAM Using immunochemical co
1 3-GRAM immunochemical co -
1 3-GRAM co - precipitation
1 3-GRAM - precipitation methods
1 3-GRAM precipitation methods ,
1 3-GRAM methods , we
1 3-GRAM , we also
1 3-GRAM we also found
1 3-GRAM also found that
1 3-GRAM found that the
1 3-GRAM that the two
1 3-GRAM the two proteins
1 3-GRAM two proteins are
1 3-GRAM proteins are bound
1 3-GRAM are bound in
1 3-GRAM bound in vivo
3 3-GRAM in vivo .
3 3-GRAM vivo . STOP
1 3-GRAM * * Utility
1 3-GRAM * Utility of
1 3-GRAM Utility of OAE
1 3-GRAM of OAE screener
1 3-GRAM OAE screener (
1 3-GRAM screener ( GSI
1 3-GRAM ( GSI 70
1 3-GRAM GSI 70 )
1 3-GRAM 70 ) for
1 3-GRAM ) for the
1 3-GRAM for the evaluation
1 3-GRAM the evaluation of
1 3-GRAM evaluation of distortion
1 3-GRAM of distortion product
1 3-GRAM distortion product otoacoustic
1 3-GRAM product otoacoustic emissions
1 3-GRAM otoacoustic emissions ]
1 3-GRAM emissions ] The
1 3-GRAM ] The purpose
2 3-GRAM The purpose of
2 3-GRAM purpose of this
1 3-GRAM of this study
1 3-GRAM this study was
1 3-GRAM study was to
1 3-GRAM was to investigate
2 3-GRAM to investigate the
1 3-GRAM investigate the ability
1 3-GRAM the ability of
2 3-GRAM ability of the
1 3-GRAM of the OAE
1 3-GRAM the OAE screener
1 3-GRAM OAE screener GSI
1 3-GRAM screener GSI 70
1 3-GRAM GSI 70 to
1 3-GRAM 70 to evaluate
1 3-GRAM to evaluate of
1 3-GRAM evaluate of cochlea
1 3-GRAM of cochlea function
1 3-GRAM cochlea function in
1 3-GRAM function in neonates
1 3-GRAM in neonates ,
1 3-GRAM neonates , infants
1 3-GRAM , infants and
1 3-GRAM infants and adults
2 3-GRAM and adults .
2 3-GRAM adults . STOP
1 3-GRAM Our results demonstrated
1 3-GRAM results demonstrated that
1 3-GRAM demonstrated that 50
1 3-GRAM that 50 %
2 3-GRAM 50 % of
2 3-GRAM % of the
1 3-GRAM of the hepatic
1 3-GRAM the hepatic artery
1 3-GRAM hepatic artery -
1 3-GRAM artery - alone
1 3-GRAM - alone ALT
1 3-GRAM alone ALT graft
1 3-GRAM ALT graft showed
1 3-GRAM graft showed almost
1 3-GRAM showed almost normal
1 3-GRAM almost normal structure
1 3-GRAM normal structure histologically
1 3-GRAM structure histologically at
1 3-GRAM histologically at 1
1 3-GRAM at 1 month
1 3-GRAM 1 month after
1 3-GRAM month after grafting
1 3-GRAM after grafting ,
1 3-GRAM grafting , with
1 3-GRAM , with bile
1 3-GRAM with bile secretion
1 3-GRAM bile secretion preserved
1 3-GRAM secretion preserved .
1 3-GRAM preserved . STOP
1 3-GRAM * * Mean
1 3-GRAM * Mean Hg
1 3-GRAM Mean Hg concentrations
1 3-GRAM Hg concentrations in
1 3-GRAM in the livers
1 3-GRAM the livers of
1 3-GRAM livers of mice
1 3-GRAM of mice at
1 3-GRAM mice at some
1 3-GRAM at some sites
1 3-GRAM some sites in
1 3-GRAM sites in Isle
1 3-GRAM in Isle Royale
1 3-GRAM Isle Royale are
1 3-GRAM Royale are not
1 3-GRAM are not significantly
1 3-GRAM not significantly lower
1 3-GRAM significantly lower (
1 3-GRAM lower ( P
2 3-GRAM 0 . 62
1 3-GRAM . 62 )
1 3-GRAM 62 ) than
1 3-GRAM ) than Hg
1 3-GRAM than Hg concentrations
1 3-GRAM Hg concentrations considered
1 3-GRAM concentrations considered by
1 3-GRAM considered by some
1 3-GRAM by some government
1 3-GRAM some government agencies
1 3-GRAM government agencies to
1 3-GRAM agencies to be
1 3-GRAM to be unhealthy
1 3-GRAM be unhealthy for
1 3-GRAM unhealthy for human
1 3-GRAM for human consumption
1 3-GRAM human consumption .
1 3-GRAM consumption . STOP
1 3-GRAM * We show
1 3-GRAM We show here
1 3-GRAM show here that
1 3-GRAM here that the
1 3-GRAM that the in
1 3-GRAM the in vitro
1 3-GRAM in vitro transcription
1 3-GRAM vitro transcription extract
1 3-GRAM transcription extract contains
1 3-GRAM extract contains a
1 3-GRAM contains a binding
1 3-GRAM a binding activity
1 3-GRAM binding activity that
1 3-GRAM activity that is
1 3-GRAM that is specific
1 3-GRAM is specific for
1 3-GRAM specific for the
1 3-GRAM for the initiator
1 3-GRAM the initiator element
1 3-GRAM initiator element and
1 3-GRAM element and thus
1 3-GRAM and thus may
1 3-GRAM thus may participate
1 3-GRAM may participate in
1 3-GRAM participate in recruiting
1 3-GRAM in recruiting RNA
1 3-GRAM recruiting RNA polymerase
1 3-GRAM polymerase II to
1 3-GRAM II to the
1 3-GRAM to the SL
1 3-GRAM the SL RNA
1 3-GRAM SL RNA gene
1 3-GRAM RNA gene promoter
2 3-GRAM gene promoter .
10 3-GRAM promoter . STOP
1 3-GRAM * The desirability
1 3-GRAM The desirability function
1 3-GRAM desirability function is
1 3-GRAM function is based
2 3-GRAM is based on
2 3-GRAM based on the
1 3-GRAM on the search
1 3-GRAM the search for
1 3-GRAM search for a
1 3-GRAM for a global
1 3-GRAM a global optimum
1 3-GRAM global optimum [
1 3-GRAM optimum [ D
1 3-GRAM [ D =
1 3-GRAM D = f
1 3-GRAM = f (
1 3-GRAM f ( Y1
1 3-GRAM ( Y1 ,
1 3-GRAM Y1 , Y2
1 3-GRAM , Y2 ,
1 3-GRAM Y2 , ...,
1 3-GRAM , ..., Yn
1 3-GRAM ..., Yn )]
1 3-GRAM Yn )] by
1 3-GRAM )] by the
1 3-GRAM by the transformation
1 3-GRAM the transformation of
1 3-GRAM transformation of the
1 3-GRAM of the measured
1 3-GRAM the measured property
1 3-GRAM measured property to
1 3-GRAM property to a
1 3-GRAM to a dimensionless
1 3-GRAM a dimensionless scale
1 3-GRAM dimensionless scale for
1 3-GRAM scale for each
1 3-GRAM for each criterion
1 3-GRAM each criterion .
1 3-GRAM criterion . STOP
1 3-GRAM * * Naltrexone
1 3-GRAM * Naltrexone hydrochloride
1 3-GRAM Naltrexone hydrochloride is
1 3-GRAM hydrochloride is a
1 3-GRAM is a synthetic
1 3-GRAM a synthetic opioid
1 3-GRAM synthetic opioid receptor
1 3-GRAM opioid receptor antagonist
1 3-GRAM receptor antagonist recently
1 3-GRAM antagonist recently used
1 3-GRAM recently used in
1 3-GRAM used in efforts
1 3-GRAM in efforts to
1 3-GRAM efforts to provide
1 3-GRAM to provide rapid
1 3-GRAM provide rapid opioid
1 3-GRAM rapid opioid detoxification
1 3-GRAM opioid detoxification .
1 3-GRAM detoxification . STOP
1 3-GRAM * We mapped
1 3-GRAM We mapped the
1 3-GRAM mapped the DGCR6
1 3-GRAM the DGCR6 gene
1 3-GRAM DGCR6 gene to
1 3-GRAM gene to chromosome
1 3-GRAM to chromosome 22q11
1 3-GRAM chromosome 22q11 within
1 3-GRAM 22q11 within a
1 3-GRAM within a low
1 3-GRAM a low copy
1 3-GRAM low copy repeat
1 3-GRAM copy repeat ,
1 3-GRAM repeat , termed
2 3-GRAM , termed sc11
2 3-GRAM termed sc11 .
1 3-GRAM sc11 . 1a
1 3-GRAM . 1a ,
1 3-GRAM 1a , and
1 3-GRAM , and identified
1 3-GRAM and identified a
1 3-GRAM identified a second
1 3-GRAM a second copy
1 3-GRAM second copy of
1 3-GRAM copy of the
4 3-GRAM of the gene
1 3-GRAM the gene ,
1 3-GRAM gene , DGCR6L
1 3-GRAM , DGCR6L ,
1 3-GRAM DGCR6L , within
1 3-GRAM , within the
1 3-GRAM within the duplicate
1 3-GRAM the duplicate locus
1 3-GRAM duplicate locus ,
1 3-GRAM locus , termed
1 3-GRAM sc11 . 1b
1 3-GRAM . 1b .
1 3-GRAM 1b . STOP
1 3-GRAM * * Proliferative
1 3-GRAM * Proliferative vasculopathy
1 3-GRAM Proliferative vasculopathy and
1 3-GRAM vasculopathy and cutaneous
1 3-GRAM and cutaneous hemorrhages
1 3-GRAM cutaneous hemorrhages in
1 3-GRAM hemorrhages in porcine
1 3-GRAM in porcine neonates
1 3-GRAM porcine neonates infected
1 3-GRAM neonates infected with
1 3-GRAM infected with the
1 3-GRAM with the porcine
1 3-GRAM the porcine reproductive
1 3-GRAM porcine reproductive and
1 3-GRAM reproductive and respiratory
1 3-GRAM and respiratory syndrome
1 3-GRAM respiratory syndrome virus
1 3-GRAM syndrome virus .
1 3-GRAM virus . STOP
1 3-GRAM * The child
1 3-GRAM The child left
1 3-GRAM child left behind
1 3-GRAM left behind .
1 3-GRAM behind . STOP
1 3-GRAM * Using the
1 3-GRAM Using the two
1 3-GRAM the two -
2 3-GRAM two - hybrid
1 3-GRAM - hybrid system
1 3-GRAM hybrid system ,
1 3-GRAM system , we
1 3-GRAM , we show
1 3-GRAM show that nonprenylated
1 3-GRAM that nonprenylated Rac1
1 3-GRAM nonprenylated Rac1 interacts
1 3-GRAM Rac1 interacts very
1 3-GRAM interacts very weakly
1 3-GRAM very weakly with
1 3-GRAM weakly with Rho
1 3-GRAM with Rho -
1 3-GRAM Rho - GDI
1 3-GRAM - GDI ,
1 3-GRAM GDI , pointing
1 3-GRAM , pointing to
1 3-GRAM pointing to the
1 3-GRAM to the predominant
1 3-GRAM the predominant role
1 3-GRAM predominant role of
1 3-GRAM role of protein
1 3-GRAM of protein -
1 3-GRAM protein - isoprene
1 3-GRAM - isoprene interaction
1 3-GRAM isoprene interaction in
1 3-GRAM interaction in complex
1 3-GRAM in complex formation
1 3-GRAM complex formation .
2 3-GRAM formation . STOP
1 3-GRAM contrast , neither
1 3-GRAM , neither I
1 3-GRAM neither I .
1 3-GRAM I . argentina
1 3-GRAM . argentina nor
1 3-GRAM argentina nor I
1 3-GRAM nor I .
1 3-GRAM I . theezans
1 3-GRAM . theezans exerted
1 3-GRAM theezans exerted any
1 3-GRAM exerted any effect
2 3-GRAM any effect on
1 3-GRAM effect on BF
1 3-GRAM on BF or
1 3-GRAM BF or intestinal
1 3-GRAM or intestinal propulsion
1 3-GRAM intestinal propulsion .
1 3-GRAM propulsion . STOP
1 3-GRAM * The region
1 3-GRAM The region containing
1 3-GRAM region containing both
1 3-GRAM containing both serines
1 3-GRAM both serines is
1 3-GRAM serines is homologous
1 3-GRAM is homologous to
1 3-GRAM homologous to the
1 3-GRAM to the N
1 3-GRAM - terminal destruction
1 3-GRAM terminal destruction box
1 3-GRAM destruction box of
1 3-GRAM box of IkappaBalpha
1 3-GRAM of IkappaBalpha ,
1 3-GRAM IkappaBalpha , -
1 3-GRAM , - beta
1 3-GRAM - beta ,
1 3-GRAM beta , and
1 3-GRAM , and -
1 3-GRAM and - epsilon
1 3-GRAM - epsilon .
1 3-GRAM epsilon . STOP
2 3-GRAM * * No
1 3-GRAM * No dominant
1 3-GRAM No dominant clinical
1 3-GRAM dominant clinical factor
1 3-GRAM clinical factor of
1 3-GRAM factor of risk
1 3-GRAM of risk was
1 3-GRAM risk was found
1 3-GRAM was found ,
1 3-GRAM found , but
1 3-GRAM , but multiple
1 3-GRAM but multiple regression
1 3-GRAM multiple regression analysis
1 3-GRAM regression analysis identified
1 3-GRAM analysis identified age
1 3-GRAM identified age ,
1 3-GRAM age , body
1 3-GRAM , body surface
1 3-GRAM body surface area
1 3-GRAM surface area ,
1 3-GRAM area , valve
1 3-GRAM , valve size
1 3-GRAM valve size ,
1 3-GRAM size , shop
1 3-GRAM , shop order
1 3-GRAM shop order fracture
1 3-GRAM order fracture rate
1 3-GRAM fracture rate ,
1 3-GRAM rate , and
1 3-GRAM , and manufacturing
1 3-GRAM and manufacturing period
1 3-GRAM manufacturing period as
1 3-GRAM period as risk
1 3-GRAM as risk factors
1 3-GRAM risk factors for
1 3-GRAM factors for OSF
1 3-GRAM for OSF .
1 3-GRAM OSF . STOP
2 3-GRAM * A novel
1 3-GRAM A novel growth
1 3-GRAM novel growth -
1 3-GRAM growth - related
1 3-GRAM - related nuclear
1 3-GRAM related nuclear protein
1 3-GRAM nuclear protein binds
1 3-GRAM protein binds and
1 3-GRAM binds and inhibits
1 3-GRAM and inhibits rat
1 3-GRAM inhibits rat aldolase
1 3-GRAM rat aldolase B
1 3-GRAM aldolase B gene
1 3-GRAM B gene promoter
2 3-GRAM * * Northern
1 3-GRAM * Northern blot
1 3-GRAM Northern blot analysis
1 3-GRAM blot analysis revealed
1 3-GRAM analysis revealed that
1 3-GRAM revealed that mlt
1 3-GRAM that mlt 1
3 3-GRAM mlt 1 is
1 3-GRAM 1 is normally
1 3-GRAM is normally expressed
1 3-GRAM normally expressed in
1 3-GRAM expressed in brain
1 3-GRAM in brain ,
1 3-GRAM brain , spleen
1 3-GRAM , spleen ,
1 3-GRAM spleen , stom
1 3-GRAM , stom ach
1 3-GRAM stom ach ,
1 3-GRAM ach , and
1 3-GRAM , and liver
1 3-GRAM and liver .
1 3-GRAM liver . STOP
1 3-GRAM * * NO
1 3-GRAM * NO metabolites
1 3-GRAM NO metabolites were
1 3-GRAM metabolites were determined
1 3-GRAM were determined by
2 3-GRAM determined by the
1 3-GRAM by the measurement
1 3-GRAM the measurement of
1 3-GRAM measurement of nitrate
1 3-GRAM of nitrate /
1 3-GRAM nitrate / nitrite
1 3-GRAM / nitrite (
1 3-GRAM nitrite ( NOx
1 3-GRAM ( NOx ,
1 3-GRAM NOx , micromol
1 3-GRAM , micromol /
1 3-GRAM micromol / mmol
2 3-GRAM / mmol creatinine
2 3-GRAM mmol creatinine )
1 3-GRAM creatinine ) and
1 3-GRAM ) and cyclic
1 3-GRAM and cyclic guanosine
1 3-GRAM cyclic guanosine monophosphate
1 3-GRAM guanosine monophosphate (
1 3-GRAM monophosphate ( cGMP
1 3-GRAM ( cGMP ,
1 3-GRAM cGMP , nmol
1 3-GRAM , nmol /
1 3-GRAM nmol / mmol
1 3-GRAM creatinine ) in
1 3-GRAM ) in plasma
1 3-GRAM in plasma and
1 3-GRAM plasma and urine
1 3-GRAM and urine .
1 3-GRAM urine . STOP
1 3-GRAM * As a
1 3-GRAM As a complement
1 3-GRAM a complement to
1 3-GRAM complement to genome
1 3-GRAM to genome -
1 3-GRAM genome - wide
1 3-GRAM - wide mapping
1 3-GRAM wide mapping and
1 3-GRAM mapping and sequencing
1 3-GRAM and sequencing efforts
1 3-GRAM sequencing efforts ,
1 3-GRAM efforts , it
1 3-GRAM , it is
1 3-GRAM it is often
1 3-GRAM is often important
1 3-GRAM often important to
1 3-GRAM important to generate
1 3-GRAM to generate detailed
1 3-GRAM generate detailed maps
1 3-GRAM detailed maps and
1 3-GRAM maps and sequence
1 3-GRAM and sequence data
1 3-GRAM sequence data for
1 3-GRAM data for specific
1 3-GRAM for specific regions
1 3-GRAM specific regions of
1 3-GRAM regions of interest
1 3-GRAM of interest .
1 3-GRAM interest . STOP
1 3-GRAM * The observed
1 3-GRAM The observed phenotypes
1 3-GRAM observed phenotypes may
1 3-GRAM phenotypes may be
1 3-GRAM may be explained
1 3-GRAM be explained by
1 3-GRAM explained by (
1 3-GRAM by ( i
1 3-GRAM ( i )
1 3-GRAM i ) a
1 3-GRAM ) a selective
1 3-GRAM a selective disruption
1 3-GRAM selective disruption of
1 3-GRAM disruption of very
1 3-GRAM of very -
1 3-GRAM very - low
1 3-GRAM - low -
1 3-GRAM low - density
2 3-GRAM - density lipoprotein
1 3-GRAM density lipoprotein secretion
1 3-GRAM lipoprotein secretion due
1 3-GRAM secretion due to
1 3-GRAM due to decreased
1 3-GRAM to decreased expression
1 3-GRAM decreased expression of
1 3-GRAM expression of genes
1 3-GRAM of genes encoding
1 3-GRAM genes encoding apolipoprotein
1 3-GRAM encoding apolipoprotein B
1 3-GRAM apolipoprotein B and
1 3-GRAM B and microsomal
1 3-GRAM and microsomal triglyceride
1 3-GRAM microsomal triglyceride transfer
1 3-GRAM triglyceride transfer protein
1 3-GRAM transfer protein ,
1 3-GRAM protein , (
1 3-GRAM , ( ii
1 3-GRAM ( ii )
1 3-GRAM ii ) an
1 3-GRAM ) an increase
1 3-GRAM increase in hepatic
1 3-GRAM in hepatic cholesterol
1 3-GRAM hepatic cholesterol uptake
1 3-GRAM cholesterol uptake due
1 3-GRAM uptake due to
1 3-GRAM due to increased
1 3-GRAM to increased expression
1 3-GRAM increased expression of
6 3-GRAM expression of the
3 3-GRAM of the major
1 3-GRAM the major high
1 3-GRAM major high -
1 3-GRAM high - density
1 3-GRAM density lipoprotein receptor
1 3-GRAM lipoprotein receptor ,
1 3-GRAM receptor , scavenger
1 3-GRAM , scavenger receptor
1 3-GRAM scavenger receptor BI
1 3-GRAM receptor BI ,
1 3-GRAM BI , and
1 3-GRAM , and (
1 3-GRAM and ( iii
1 3-GRAM ( iii )
1 3-GRAM iii ) a
1 3-GRAM ) a decrease
1 3-GRAM decrease in bile
1 3-GRAM in bile acid
1 3-GRAM bile acid uptake
1 3-GRAM acid uptake to
1 3-GRAM uptake to the
1 3-GRAM to the liver
1 3-GRAM the liver due
1 3-GRAM liver due to
1 3-GRAM due to down
2 3-GRAM to down -
2 3-GRAM down - regulation
2 3-GRAM - regulation of
3 3-GRAM regulation of the
1 3-GRAM the major basolateral
1 3-GRAM major basolateral bile
1 3-GRAM basolateral bile acid
1 3-GRAM bile acid transporters
1 3-GRAM acid transporters sodium
1 3-GRAM transporters sodium taurocholate
1 3-GRAM sodium taurocholate cotransporter
1 3-GRAM taurocholate cotransporter protein
1 3-GRAM cotransporter protein and
1 3-GRAM protein and organic
1 3-GRAM and organic anion
1 3-GRAM organic anion transporter
1 3-GRAM anion transporter protein
1 3-GRAM transporter protein 1
1 3-GRAM protein 1 .
1 3-GRAM 1 . STOP
2 3-GRAM * * Effects
2 3-GRAM * Effects of
1 3-GRAM Effects of aerosol
1 3-GRAM of aerosol -
1 3-GRAM aerosol - vapor
1 3-GRAM - vapor JP
1 3-GRAM vapor JP -
1 3-GRAM JP - 8
1 3-GRAM - 8 jet
1 3-GRAM 8 jet fuel
1 3-GRAM jet fuel on
1 3-GRAM fuel on the
1 3-GRAM on the functional
1 3-GRAM the functional observational
1 3-GRAM functional observational battery
1 3-GRAM observational battery ,
1 3-GRAM battery , and
1 3-GRAM , and learning
1 3-GRAM and learning and
1 3-GRAM learning and memory
1 3-GRAM and memory in
1 3-GRAM memory in the
2 3-GRAM in the rat
1 3-GRAM the rat .
1 3-GRAM rat . STOP
1 3-GRAM * In mouse
1 3-GRAM In mouse ,
1 3-GRAM mouse , Mmip1
1 3-GRAM , Mmip1 (
1 3-GRAM Mmip1 ( Mad
1 3-GRAM ( Mad member
1 3-GRAM Mad member interacting
1 3-GRAM member interacting protein
1 3-GRAM interacting protein 1
1 3-GRAM protein 1 )
1 3-GRAM 1 ) and
1 3-GRAM ) and Smc3
1 3-GRAM and Smc3 share
1 3-GRAM Smc3 share 99
1 3-GRAM share 99 %
1 3-GRAM 99 % sequence
1 3-GRAM % sequence identity
1 3-GRAM sequence identity and
1 3-GRAM identity and are
1 3-GRAM and are products
1 3-GRAM are products of
1 3-GRAM products of the
1 3-GRAM of the same
1 3-GRAM the same gene
1 3-GRAM same gene .
7 3-GRAM * * To
1 3-GRAM * To identify
1 3-GRAM To identify the
1 3-GRAM identify the important
1 3-GRAM the important cis
1 3-GRAM important cis -
1 3-GRAM cis - DNA
1 3-GRAM - DNA regulatory
1 3-GRAM DNA regulatory element
1 3-GRAM regulatory element (
1 3-GRAM element ( s
1 3-GRAM ( s )
1 3-GRAM s ) involved
1 3-GRAM ) involved in
2 3-GRAM involved in the
1 3-GRAM in the tissue
1 3-GRAM the tissue -,
1 3-GRAM tissue -, region
1 3-GRAM -, region -,
1 3-GRAM region -, and
1 3-GRAM -, and cell
1 3-GRAM and cell -
2 3-GRAM cell - specific
2 3-GRAM - specific expression
1 3-GRAM specific expression of
1 3-GRAM of the mE
1 3-GRAM the mE -
1 3-GRAM mE - RABP
1 3-GRAM - RABP gene
1 3-GRAM RABP gene ,
2 3-GRAM gene , the
2 3-GRAM , the 5
1 3-GRAM the 5 -
2 3-GRAM 5 - kb
1 3-GRAM - kb DNA
1 3-GRAM kb DNA fragment
1 3-GRAM DNA fragment was
1 3-GRAM fragment was sequenced
1 3-GRAM was sequenced .
1 3-GRAM sequenced . STOP
1 3-GRAM * * Regional
1 3-GRAM * Regional blood
1 3-GRAM Regional blood blow
1 3-GRAM blood blow was
1 3-GRAM blow was measured
2 3-GRAM was measured by
1 3-GRAM measured by means
2 3-GRAM by means of
1 3-GRAM means of microspheres
1 3-GRAM of microspheres in
1 3-GRAM microspheres in predefined
1 3-GRAM in predefined regions
1 3-GRAM predefined regions of
1 3-GRAM of the C6
1 3-GRAM the C6 ,
1 3-GRAM C6 , T11
1 3-GRAM , T11 ,
1 3-GRAM T11 , and
1 3-GRAM , and L6
1 3-GRAM and L6 vertebrae
1 3-GRAM L6 vertebrae .
1 3-GRAM vertebrae . STOP
1 3-GRAM * * Breast
1 3-GRAM * Breast cancer
1 3-GRAM Breast cancer risk
1 3-GRAM cancer risk assessment
1 3-GRAM risk assessment :
1 3-GRAM assessment : Who
1 3-GRAM : Who holds
1 3-GRAM Who holds the
1 3-GRAM holds the magic
1 3-GRAM the magic crystal
1 3-GRAM magic crystal ball
1 3-GRAM crystal ball ?
1 3-GRAM ball ? STOP
1 3-GRAM * The frameshift
1 3-GRAM The frameshift initiated
1 3-GRAM frameshift initiated by
1 3-GRAM initiated by ADEx2
1 3-GRAM by ADEx2 is
1 3-GRAM ADEx2 is believed
1 3-GRAM is believed to
1 3-GRAM believed to alter
1 3-GRAM to alter the
1 3-GRAM alter the regular
1 3-GRAM the regular coding
1 3-GRAM regular coding sequence
1 3-GRAM coding sequence ,
1 3-GRAM sequence , acting
1 3-GRAM , acting as
1 3-GRAM acting as a
1 3-GRAM as a loss
1 3-GRAM a loss -
1 3-GRAM loss - of
1 3-GRAM - of -
1 3-GRAM of - function
1 3-GRAM - function ASIP
1 3-GRAM function ASIP mutation
1 3-GRAM ASIP mutation .
1 3-GRAM mutation . STOP
7 3-GRAM * * CONCLUSIONS
7 3-GRAM * CONCLUSIONS :
1 3-GRAM CONCLUSIONS : Adding
1 3-GRAM : Adding MMF
1 3-GRAM Adding MMF ,
1 3-GRAM MMF , a
1 3-GRAM , a potent
1 3-GRAM a potent topical
1 3-GRAM potent topical corticosteroid
1 3-GRAM topical corticosteroid ,
1 3-GRAM corticosteroid , to
1 3-GRAM , to an
1 3-GRAM to an emollient
1 3-GRAM an emollient cream
1 3-GRAM emollient cream is
1 3-GRAM cream is statistically
1 3-GRAM is statistically significantly
1 3-GRAM statistically significantly more
1 3-GRAM significantly more effective
1 3-GRAM more effective than
1 3-GRAM effective than emollient
1 3-GRAM than emollient cream
1 3-GRAM emollient cream alone
1 3-GRAM cream alone in
1 3-GRAM alone in reducing
1 3-GRAM in reducing acute
1 3-GRAM reducing acute radiation
1 3-GRAM acute radiation dermatitis
1 3-GRAM radiation dermatitis .
1 3-GRAM dermatitis . STOP
1 3-GRAM CONCLUSIONS : Although
1 3-GRAM : Although the
1 3-GRAM Although the levels
2 3-GRAM the levels of
1 3-GRAM levels of oxLDL
1 3-GRAM of oxLDL antibodies
1 3-GRAM oxLDL antibodies might
1 3-GRAM antibodies might be
1 3-GRAM might be modified
1 3-GRAM be modified in
1 3-GRAM modified in early
1 3-GRAM in early hypertension
1 3-GRAM early hypertension ,
1 3-GRAM hypertension , once
1 3-GRAM , once advanced
1 3-GRAM once advanced coronary
1 3-GRAM advanced coronary artery
2 3-GRAM coronary artery disease
1 3-GRAM artery disease has
1 3-GRAM disease has developed
1 3-GRAM has developed the
1 3-GRAM developed the presence
1 3-GRAM the presence of
1 3-GRAM presence of hypertension
1 3-GRAM of hypertension does
1 3-GRAM hypertension does not
2 3-GRAM does not affect
1 3-GRAM not affect anti
1 3-GRAM affect anti -
1 3-GRAM anti - oxLDL
1 3-GRAM - oxLDL levels
1 3-GRAM oxLDL levels .
2 3-GRAM levels . STOP
1 3-GRAM As an application
1 3-GRAM an application of
1 3-GRAM application of reverse
1 3-GRAM of reverse genetics
1 3-GRAM reverse genetics ,
1 3-GRAM genetics , we
1 3-GRAM , we introduced
1 3-GRAM we introduced one
1 3-GRAM introduced one nucleotide
1 3-GRAM one nucleotide change
1 3-GRAM nucleotide change (
1 3-GRAM change ( UCU
1 3-GRAM ( UCU to
1 3-GRAM UCU to ACU
1 3-GRAM to ACU )
1 3-GRAM ACU ) to
1 3-GRAM ) to immediate
1 3-GRAM to immediate downstream
1 3-GRAM immediate downstream of
1 3-GRAM downstream of the
1 3-GRAM of the RNA
1 3-GRAM the RNA -
1 3-GRAM RNA - editing
1 3-GRAM - editing site
1 3-GRAM editing site of
1 3-GRAM site of the
1 3-GRAM of the V
1 3-GRAM the V gene
1 3-GRAM V gene in
1 3-GRAM gene in the
1 3-GRAM in the full
1 3-GRAM the full -
1 3-GRAM - length hPIV2
1 3-GRAM length hPIV2 cDNA
1 3-GRAM hPIV2 cDNA and
1 3-GRAM cDNA and were
1 3-GRAM and were able
1 3-GRAM were able to
1 3-GRAM able to obtain
1 3-GRAM to obtain infectious
1 3-GRAM obtain infectious viruses
1 3-GRAM infectious viruses [
1 3-GRAM viruses [ rPIV2V
1 3-GRAM [ rPIV2V (-)]
1 3-GRAM rPIV2V (-)] from
1 3-GRAM (-)] from the
1 3-GRAM from the cDNA
1 3-GRAM the cDNA .
1 3-GRAM cDNA . STOP
1 3-GRAM * At both
1 3-GRAM At both companies
1 3-GRAM both companies sites
1 3-GRAM companies sites Salmonella
1 3-GRAM sites Salmonella enteritidis
1 3-GRAM Salmonella enteritidis and
1 3-GRAM enteritidis and Salmonella
1 3-GRAM and Salmonella typhimurium
1 3-GRAM Salmonella typhimurium Tr104
1 3-GRAM typhimurium Tr104 were
1 3-GRAM Tr104 were also
1 3-GRAM were also isolated
1 3-GRAM also isolated occasionally
1 3-GRAM isolated occasionally from
1 3-GRAM occasionally from various
1 3-GRAM from various locations
1 3-GRAM various locations .
1 3-GRAM locations . STOP
2 3-GRAM * * Most
1 3-GRAM * Most yeast
1 3-GRAM Most yeast peroxisomal
1 3-GRAM yeast peroxisomal matrix
1 3-GRAM peroxisomal matrix proteins
1 3-GRAM matrix proteins contain
1 3-GRAM proteins contain a
1 3-GRAM contain a type
1 3-GRAM a type 1C
1 3-GRAM type 1C -
1 3-GRAM 1C - terminal
1 3-GRAM - terminal peroxisomal
1 3-GRAM terminal peroxisomal targeting
1 3-GRAM peroxisomal targeting signal
1 3-GRAM targeting signal (
1 3-GRAM signal ( PTS1
1 3-GRAM ( PTS1 )
1 3-GRAM PTS1 ) consisting
1 3-GRAM ) consisting of
2 3-GRAM consisting of the
1 3-GRAM of the tripeptide
1 3-GRAM the tripeptide SKL
1 3-GRAM tripeptide SKL or
1 3-GRAM SKL or a
1 3-GRAM or a conservative
1 3-GRAM a conservative variant
1 3-GRAM conservative variant thereof
1 3-GRAM variant thereof .
1 3-GRAM thereof . STOP
2 3-GRAM * * Tumor
1 3-GRAM * Tumor -
1 3-GRAM Tumor - like
1 3-GRAM - like accumulation
1 3-GRAM like accumulation on
1 3-GRAM accumulation on Tl
1 3-GRAM on Tl -
1 3-GRAM Tl - 201
1 3-GRAM - 201 SPECT
1 3-GRAM 201 SPECT in
1 3-GRAM SPECT in subacute
1 3-GRAM in subacute hemorrhagic
1 3-GRAM subacute hemorrhagic cerebral
1 3-GRAM hemorrhagic cerebral infarction
1 3-GRAM cerebral infarction .
1 3-GRAM infarction . STOP
1 3-GRAM * * WRN
1 3-GRAM * WRN helicase
1 3-GRAM WRN helicase resolves
1 3-GRAM helicase resolves alternate
1 3-GRAM resolves alternate DNA
1 3-GRAM alternate DNA structures
1 3-GRAM DNA structures including
1 3-GRAM structures including tetraplex
1 3-GRAM including tetraplex and
1 3-GRAM tetraplex and triplex
1 3-GRAM and triplex DNA
1 3-GRAM triplex DNA ,
1 3-GRAM DNA , and
1 3-GRAM , and Holliday
1 3-GRAM and Holliday junctions
1 3-GRAM Holliday junctions .
1 3-GRAM junctions . STOP
1 3-GRAM * The increase
1 3-GRAM The increase in
1 3-GRAM increase in number
1 3-GRAM in number of
1 3-GRAM number of terminal
1 3-GRAM of terminal hairs
1 3-GRAM terminal hairs ,
1 3-GRAM hairs , which
4 3-GRAM , which are
1 3-GRAM which are defined
1 3-GRAM are defined as
1 3-GRAM defined as hairs
1 3-GRAM as hairs more
1 3-GRAM hairs more than
1 3-GRAM more than 60
1 3-GRAM than 60 microm
1 3-GRAM 60 microm in
1 3-GRAM microm in diameter
1 3-GRAM in diameter ,
1 3-GRAM diameter , in
4 3-GRAM , in the
1 3-GRAM in the designated
1 3-GRAM the designated area
1 3-GRAM designated area (
1 3-GRAM area ( 0
1 3-GRAM 0 . 5
1 3-GRAM . 5 cm
1 3-GRAM 5 cm square
1 3-GRAM cm square =
1 3-GRAM square = 0
3 3-GRAM 0 . 25
3 3-GRAM . 25 cm2
1 3-GRAM 25 cm2 area
1 3-GRAM cm2 area )
1 3-GRAM area ) of
2 3-GRAM ) of the
1 3-GRAM of the procyanidin
1 3-GRAM the procyanidin B
2 3-GRAM procyanidin B -
2 3-GRAM B - 2
1 3-GRAM - 2 group
1 3-GRAM 2 group subjects
1 3-GRAM group subjects after
1 3-GRAM subjects after the
1 3-GRAM after the 6
1 3-GRAM the 6 -
1 3-GRAM 6 - month
1 3-GRAM - month trial
1 3-GRAM month trial was
1 3-GRAM trial was significantly
1 3-GRAM was significantly greater
1 3-GRAM significantly greater than
1 3-GRAM greater than that
1 3-GRAM than that of
1 3-GRAM that of the
1 3-GRAM of the placebo
1 3-GRAM the placebo control
1 3-GRAM placebo control group
1 3-GRAM control group subjects
1 3-GRAM group subjects (
1 3-GRAM subjects ( procyanidin
1 3-GRAM ( procyanidin B
5 3-GRAM - 2 ,
1 3-GRAM 2 , 1
1 3-GRAM , 1 .
1 3-GRAM 1 . 99
1 3-GRAM . 99 +/-
1 3-GRAM 99 +/- 2
1 3-GRAM +/- 2 .
1 3-GRAM 2 . 58
1 3-GRAM . 58 (
1 3-GRAM 58 ( mean
2 3-GRAM ( mean +/-
2 3-GRAM mean +/- SD
2 3-GRAM +/- SD )/
2 3-GRAM SD )/ 0
2 3-GRAM )/ 0 .
2 3-GRAM 25 cm2 ;
1 3-GRAM cm2 ; placebo
1 3-GRAM ; placebo ,
1 3-GRAM placebo , -
1 3-GRAM , - 0
4 3-GRAM - 0 .
1 3-GRAM 0 . 82
1 3-GRAM . 82 +/-
1 3-GRAM 82 +/- 3
1 3-GRAM +/- 3 .
1 3-GRAM 3 . 40
1 3-GRAM . 40 (
1 3-GRAM 40 ( mean
1 3-GRAM cm2 ; P
1 3-GRAM ; P <
1 3-GRAM 0 . 02
1 3-GRAM . 02 ,
1 3-GRAM 02 , two
1 3-GRAM , two -
1 3-GRAM two - sample
1 3-GRAM - sample t
1 3-GRAM sample t test
1 3-GRAM t test ).
1 3-GRAM test ). STOP
1 3-GRAM * * SKP1
1 3-GRAM * SKP1 -
1 3-GRAM SKP1 - SnRK
1 3-GRAM - SnRK protein
1 3-GRAM SnRK protein kinase
1 3-GRAM protein kinase interactions
1 3-GRAM kinase interactions mediate
1 3-GRAM interactions mediate proteasomal
1 3-GRAM mediate proteasomal binding
1 3-GRAM proteasomal binding of
1 3-GRAM binding of a
1 3-GRAM of a plant
1 3-GRAM a plant SCF
1 3-GRAM plant SCF ubiquitin
1 3-GRAM SCF ubiquitin ligase
1 3-GRAM ubiquitin ligase .
1 3-GRAM ligase . STOP
1 3-GRAM * * Based
1 3-GRAM * Based on
1 3-GRAM Based on the
1 3-GRAM on the hypothesis
2 3-GRAM the hypothesis that
1 3-GRAM hypothesis that evolutionarily
1 3-GRAM that evolutionarily conserved
1 3-GRAM evolutionarily conserved regions
1 3-GRAM conserved regions are
1 3-GRAM regions are functionally
1 3-GRAM are functionally important
1 3-GRAM functionally important and
1 3-GRAM important and likely
1 3-GRAM and likely to
1 3-GRAM likely to interact
1 3-GRAM to interact with
1 3-GRAM interact with coactivators
1 3-GRAM with coactivators ,
1 3-GRAM coactivators , we
2 3-GRAM , we compared
2 3-GRAM we compared the
1 3-GRAM compared the amino
1 3-GRAM the amino acid
1 3-GRAM amino acid sequence
1 3-GRAM acid sequence of
1 3-GRAM sequence of C
1 3-GRAM of C /
1 3-GRAM C / EBPalpha
1 3-GRAM / EBPalpha from
1 3-GRAM EBPalpha from different
1 3-GRAM from different species
1 3-GRAM different species (
1 3-GRAM species ( frog
1 3-GRAM ( frog to
1 3-GRAM frog to human
1 3-GRAM to human )
1 3-GRAM human ) and
2 3-GRAM ) and identified
1 3-GRAM and identified four
1 3-GRAM identified four highly
1 3-GRAM four highly conserved
1 3-GRAM highly conserved regions
1 3-GRAM conserved regions (
1 3-GRAM regions ( CR1
1 3-GRAM ( CR1 -
1 3-GRAM CR1 - CR4
1 3-GRAM - CR4 )
1 3-GRAM CR4 ) within
1 3-GRAM ) within the
1 3-GRAM within the transactivation
1 3-GRAM the transactivation domain
1 3-GRAM transactivation domain .
2 3-GRAM domain . STOP
1 3-GRAM * * Colorectal
1 3-GRAM * Colorectal cancer
1 3-GRAM Colorectal cancer was
1 3-GRAM cancer was shown
1 3-GRAM was shown to
1 3-GRAM shown to disproportionately
1 3-GRAM to disproportionately overburden
1 3-GRAM disproportionately overburden Ashkenazi
1 3-GRAM overburden Ashkenazi Jews
1 3-GRAM Ashkenazi Jews ,
1 3-GRAM Jews , who
1 3-GRAM , who may
1 3-GRAM who may also
1 3-GRAM may also be
1 3-GRAM also be at
1 3-GRAM be at increased
1 3-GRAM at increased risk
1 3-GRAM increased risk for
1 3-GRAM risk for ovarian
1 3-GRAM for ovarian ,
1 3-GRAM ovarian , pancreatic
1 3-GRAM , pancreatic and
1 3-GRAM pancreatic and stomach
1 3-GRAM and stomach cancer
1 3-GRAM stomach cancer ,
2 3-GRAM cancer , and
1 3-GRAM , and non
1 3-GRAM and non -
1 3-GRAM non - Hodgkin
1 3-GRAM - Hodgkin '
1 3-GRAM Hodgkin ' s
1 3-GRAM ' s lymphoma
1 3-GRAM s lymphoma .
1 3-GRAM lymphoma . STOP
1 3-GRAM * * Percentages
1 3-GRAM * Percentages of
1 3-GRAM Percentages of recovery
1 3-GRAM of recovery for
1 3-GRAM recovery for overload
1 3-GRAM for overload and
1 3-GRAM overload and dilution
1 3-GRAM and dilution tests
1 3-GRAM dilution tests were
1 3-GRAM tests were between
1 3-GRAM were between 87
1 3-GRAM between 87 and
1 3-GRAM 87 and 120
1 3-GRAM and 120 %.
1 3-GRAM 120 %. STOP
1 3-GRAM * This shows
1 3-GRAM This shows that
1 3-GRAM shows that in
1 3-GRAM that in situations
1 3-GRAM in situations of
1 3-GRAM situations of separated
1 3-GRAM of separated breaks
1 3-GRAM separated breaks ,
1 3-GRAM breaks , NHEJ
1 3-GRAM , NHEJ deficiency
1 3-GRAM NHEJ deficiency leads
1 3-GRAM deficiency leads to
1 3-GRAM leads to genomic
1 3-GRAM to genomic rearrangements
1 3-GRAM genomic rearrangements ,
1 3-GRAM rearrangements , in
1 3-GRAM , in agreement
1 3-GRAM in agreement with
1 3-GRAM agreement with chromosomal
1 3-GRAM with chromosomal studies
1 3-GRAM chromosomal studies .
2 3-GRAM studies . STOP
1 3-GRAM Copyright 2001 S
1 3-GRAM 2001 S .
1 3-GRAM S . STOP
1 3-GRAM * * After
1 3-GRAM * After nerve
1 3-GRAM After nerve injury
1 3-GRAM nerve injury ,
1 3-GRAM injury , the
1 3-GRAM , the nociceptive
1 3-GRAM the nociceptive responses
1 3-GRAM nociceptive responses through
1 3-GRAM responses through type
1 3-GRAM through type I
1 3-GRAM type I neurons
1 3-GRAM I neurons ,
1 3-GRAM neurons , which
2 3-GRAM which are polymodal
2 3-GRAM are polymodal C
2 3-GRAM polymodal C -
2 3-GRAM C - fibers
2 3-GRAM - fibers and
2 3-GRAM fibers and drive
1 3-GRAM and drive NK1
1 3-GRAM drive NK1 -
1 3-GRAM NK1 - receptor
2 3-GRAM - receptor mechanisms
1 3-GRAM receptor mechanisms in
1 3-GRAM mechanisms in spinal
1 3-GRAM in spinal pain
1 3-GRAM spinal pain transmission
1 3-GRAM pain transmission ,
1 3-GRAM transmission , were
1 3-GRAM , were completely
1 3-GRAM were completely lost
1 3-GRAM completely lost ,
1 3-GRAM lost , but
1 3-GRAM , but without
1 3-GRAM but without changes
1 3-GRAM without changes in
1 3-GRAM changes in type
1 3-GRAM in type II
1 3-GRAM type II ones
1 3-GRAM II ones ,
2 3-GRAM ones , which
2 3-GRAM and drive NMDA
1 3-GRAM drive NMDA receptor
1 3-GRAM NMDA receptor -
1 3-GRAM receptor - mechanisms
1 3-GRAM - mechanisms ,
1 3-GRAM mechanisms , while
1 3-GRAM , while type
1 3-GRAM while type III
1 3-GRAM type III ones
1 3-GRAM III ones ,
1 3-GRAM which are capsaicin
1 3-GRAM are capsaicin -
1 3-GRAM capsaicin - insensitive
1 3-GRAM - insensitive (
1 3-GRAM insensitive ( possibly
1 3-GRAM ( possibly A
1 3-GRAM possibly A -
1 3-GRAM A - fibers
1 3-GRAM - fibers )
1 3-GRAM fibers ) and
1 3-GRAM ) and drive
1 3-GRAM drive NMDA -
1 3-GRAM NMDA - receptor
1 3-GRAM receptor mechanisms ,
1 3-GRAM mechanisms , were
1 3-GRAM , were markedly
1 3-GRAM were markedly enhanced
1 3-GRAM markedly enhanced .
1 3-GRAM enhanced . STOP
1 3-GRAM * * SV1
1 3-GRAM * SV1 has
1 3-GRAM SV1 has a
1 3-GRAM has a 33
1 3-GRAM a 33 -
1 3-GRAM 33 - amino
1 3-GRAM - amino acid
1 3-GRAM amino acid insert
1 3-GRAM acid insert in
1 3-GRAM insert in the
1 3-GRAM in the S1
1 3-GRAM the S1 transmembrane
1 3-GRAM S1 transmembrane domain
1 3-GRAM transmembrane domain that
1 3-GRAM domain that does
1 3-GRAM that does not
1 3-GRAM does not alter
1 3-GRAM not alter S1
1 3-GRAM alter S1 overall
1 3-GRAM S1 overall hydrophobicity
1 3-GRAM overall hydrophobicity ,
1 3-GRAM hydrophobicity , but
1 3-GRAM , but makes
1 3-GRAM but makes the
1 3-GRAM makes the S0
1 3-GRAM the S0 -
1 3-GRAM S0 - S1
1 3-GRAM - S1 linker
1 3-GRAM S1 linker longer
1 3-GRAM linker longer .
1 3-GRAM longer . STOP
1 3-GRAM * A variety
1 3-GRAM A variety of
1 3-GRAM variety of receptor
1 3-GRAM of receptor -
2 3-GRAM receptor - mediated
1 3-GRAM - mediated signaling
1 3-GRAM mediated signaling pathways
1 3-GRAM signaling pathways are
1 3-GRAM pathways are controlled
1 3-GRAM are controlled by
1 3-GRAM controlled by both
1 3-GRAM by both positive
1 3-GRAM both positive and
1 3-GRAM positive and negative
1 3-GRAM and negative extracellular
1 3-GRAM negative extracellular regulators
1 3-GRAM extracellular regulators .
1 3-GRAM regulators . STOP
1 3-GRAM * A 20
1 3-GRAM A 20 -
1 3-GRAM 20 - base
2 3-GRAM - base pair
1 3-GRAM base pair oligonucleotide
1 3-GRAM pair oligonucleotide containing
1 3-GRAM oligonucleotide containing this
1 3-GRAM containing this nonamer
1 3-GRAM this nonamer confers
1 3-GRAM nonamer confers up
1 3-GRAM confers up -
1 3-GRAM up - regulation
1 3-GRAM - regulation by
1 3-GRAM regulation by hypoxia
1 3-GRAM by hypoxia and
1 3-GRAM hypoxia and inhibition
1 3-GRAM and inhibition by
1 3-GRAM inhibition by unsaturated
1 3-GRAM by unsaturated fatty
1 3-GRAM unsaturated fatty acids
1 3-GRAM fatty acids when
1 3-GRAM acids when placed
1 3-GRAM when placed upstream
1 3-GRAM placed upstream of
1 3-GRAM upstream of a
1 3-GRAM of a heterologous
2 3-GRAM a heterologous promoter
1 3-GRAM heterologous promoter in
1 3-GRAM promoter in a
1 3-GRAM in a lacZ
1 3-GRAM a lacZ reporter
1 3-GRAM lacZ reporter construct
1 3-GRAM reporter construct .
1 3-GRAM construct . STOP
1 3-GRAM Our results indicate
1 3-GRAM indicate that D
1 3-GRAM that D (
1 3-GRAM D ( 4
1 3-GRAM ( 4 )
1 3-GRAM 4 ) and
1 3-GRAM ) and D
1 3-GRAM and D (
1 3-GRAM D ( 2L
1 3-GRAM ( 2L )
1 3-GRAM 2L ) receptors
1 3-GRAM ) receptors activate
1 3-GRAM receptors activate the
1 3-GRAM activate the ERK
1 3-GRAM the ERK kinase
1 3-GRAM ERK kinase cascade
1 3-GRAM kinase cascade by
1 3-GRAM cascade by first
1 3-GRAM by first mobilizing
1 3-GRAM first mobilizing signaling
1 3-GRAM mobilizing signaling by
1 3-GRAM signaling by the
1 3-GRAM by the PDGF
1 3-GRAM the PDGF receptor
1 3-GRAM PDGF receptor ,
1 3-GRAM receptor , followed
1 3-GRAM , followed by
1 3-GRAM followed by the
1 3-GRAM by the subsequent
1 3-GRAM the subsequent activation
1 3-GRAM subsequent activation of
1 3-GRAM activation of ERK1
1 3-GRAM of ERK1 /
1 3-GRAM ERK1 / 2
1 3-GRAM / 2 by
1 3-GRAM 2 by pathways
1 3-GRAM by pathways associated
1 3-GRAM pathways associated with
1 3-GRAM associated with this
1 3-GRAM with this receptor
1 3-GRAM this receptor tyrosine
2 3-GRAM receptor tyrosine kinase
1 3-GRAM tyrosine kinase .
3 3-GRAM kinase . STOP
1 3-GRAM * * Raes
1 3-GRAM * Raes ,
1 3-GRAM Raes , P
1 3-GRAM , P .
1 3-GRAM P . STOP
1 3-GRAM Finally , we
1 3-GRAM compared the differential
1 3-GRAM the differential screening
1 3-GRAM differential screening techniques
1 3-GRAM screening techniques in
1 3-GRAM techniques in terms
1 3-GRAM in terms of
1 3-GRAM terms of sensitivity
1 3-GRAM of sensitivity ,
1 3-GRAM sensitivity , efficiency
1 3-GRAM , efficiency and
1 3-GRAM efficiency and occurrence
1 3-GRAM and occurrence of
1 3-GRAM occurrence of false
1 3-GRAM of false positives
1 3-GRAM false positives .
1 3-GRAM positives . STOP
1 3-GRAM * * C
1 3-GRAM * C /
1 3-GRAM C / EBPbeta
1 3-GRAM / EBPbeta LIP
1 3-GRAM EBPbeta LIP overexpressing
1 3-GRAM LIP overexpressing HC11
1 3-GRAM overexpressing HC11 cells
1 3-GRAM HC11 cells did
1 3-GRAM cells did not
1 3-GRAM did not express
1 3-GRAM not express beta
1 3-GRAM express beta -
1 3-GRAM beta - casein
1 3-GRAM - casein mRNA
1 3-GRAM casein mRNA (
1 3-GRAM mRNA ( mammary
1 3-GRAM ( mammary epithelial
1 3-GRAM mammary epithelial cell
1 3-GRAM epithelial cell differentiation
1 3-GRAM cell differentiation marker
1 3-GRAM differentiation marker )
1 3-GRAM marker ) in
1 3-GRAM ) in response
6 3-GRAM in response to
1 3-GRAM response to lactogenic
1 3-GRAM to lactogenic hormones
1 3-GRAM lactogenic hormones .
1 3-GRAM hormones . STOP
1 3-GRAM * * NF
1 3-GRAM * NF -
1 3-GRAM - kappaB is
1 3-GRAM kappaB is involved
1 3-GRAM is involved in
2 3-GRAM in the regulation
2 3-GRAM the regulation of
1 3-GRAM regulation of CD154
1 3-GRAM of CD154 (
1 3-GRAM CD154 ( CD40
1 3-GRAM ( CD40 ligand
1 3-GRAM CD40 ligand )
1 3-GRAM ligand ) expression
1 3-GRAM ) expression in
1 3-GRAM expression in primary
1 3-GRAM in primary human
1 3-GRAM primary human T
1 3-GRAM human T cells
1 3-GRAM T cells .
1 3-GRAM * * Subacute
1 3-GRAM * Subacute diencephalic
1 3-GRAM Subacute diencephalic angioencephalopathy
1 3-GRAM diencephalic angioencephalopathy (
1 3-GRAM angioencephalopathy ( SDAE
1 3-GRAM ( SDAE )
1 3-GRAM SDAE ) is
1 3-GRAM ) is a
1 3-GRAM is a rare
1 3-GRAM a rare and
1 3-GRAM rare and fatal
1 3-GRAM and fatal disease
1 3-GRAM fatal disease of
1 3-GRAM disease of unknown
1 3-GRAM of unknown etiology
1 3-GRAM unknown etiology that
1 3-GRAM etiology that involves
1 3-GRAM that involves the
1 3-GRAM involves the thalami
1 3-GRAM the thalami bilaterally
1 3-GRAM thalami bilaterally .
1 3-GRAM bilaterally . STOP
2 3-GRAM * * NGF
1 3-GRAM * NGF elicits
1 3-GRAM NGF elicits a
1 3-GRAM elicits a more
1 3-GRAM a more delayed
1 3-GRAM more delayed and
1 3-GRAM delayed and sustained
1 3-GRAM and sustained ERK
1 3-GRAM sustained ERK phosphorylation
1 3-GRAM ERK phosphorylation than
1 3-GRAM phosphorylation than EGF
1 3-GRAM than EGF ,
1 3-GRAM EGF , consistent
1 3-GRAM consistent with previous
1 3-GRAM with previous reports
1 3-GRAM previous reports .
1 3-GRAM reports . STOP
1 3-GRAM * * TBARS
1 3-GRAM * TBARS levels
1 3-GRAM TBARS levels ,
1 3-GRAM levels , oxygen
1 3-GRAM , oxygen -
1 3-GRAM oxygen - radical
1 3-GRAM - radical absorbing
1 3-GRAM radical absorbing capacity
1 3-GRAM absorbing capacity assay
1 3-GRAM capacity assay and
1 3-GRAM assay and AFR
1 3-GRAM and AFR release
1 3-GRAM AFR release assessed
1 3-GRAM release assessed by
1 3-GRAM assessed by electron
1 3-GRAM by electron paramagnetic
1 3-GRAM electron paramagnetic resonance
1 3-GRAM paramagnetic resonance (
1 3-GRAM resonance ( EPR
1 3-GRAM ( EPR )
1 3-GRAM EPR ) were
1 3-GRAM ) were used
1 3-GRAM were used to
1 3-GRAM used to explore
2 3-GRAM to explore the
1 3-GRAM explore the existence
1 3-GRAM the existence of
1 3-GRAM existence of oxidative
1 3-GRAM of oxidative stress
1 3-GRAM oxidative stress in
1 3-GRAM stress in diabetes
2 3-GRAM in diabetes .
2 3-GRAM diabetes . STOP
1 3-GRAM * * Pulmonary
1 3-GRAM * Pulmonary vein
1 3-GRAM Pulmonary vein varix
1 3-GRAM vein varix in
1 3-GRAM varix in association
1 3-GRAM in association with
1 3-GRAM association with bilateral
1 3-GRAM with bilateral pulmonary
1 3-GRAM bilateral pulmonary vein
1 3-GRAM pulmonary vein stenosis
1 3-GRAM vein stenosis .
1 3-GRAM stenosis . STOP
1 3-GRAM * * Derivation
1 3-GRAM * Derivation and
1 3-GRAM Derivation and initial
1 3-GRAM and initial characterization
1 3-GRAM initial characterization of
1 3-GRAM characterization of a
1 3-GRAM of a mouse
1 3-GRAM a mouse mammary
1 3-GRAM mouse mammary tumor
1 3-GRAM mammary tumor cell
1 3-GRAM tumor cell line
1 3-GRAM cell line carrying
1 3-GRAM line carrying the
1 3-GRAM carrying the polyomavirus
1 3-GRAM the polyomavirus middle
1 3-GRAM polyomavirus middle T
1 3-GRAM middle T antigen
1 3-GRAM T antigen :
1 3-GRAM antigen : utility
1 3-GRAM : utility in
1 3-GRAM utility in the
1 3-GRAM in the development
3 3-GRAM the development of
1 3-GRAM development of novel
1 3-GRAM of novel cancer
1 3-GRAM novel cancer therapeutics
1 3-GRAM cancer therapeutics .
1 3-GRAM therapeutics . STOP
1 3-GRAM * The images
1 3-GRAM The images showed
1 3-GRAM images showed rapid
1 3-GRAM showed rapid ,
1 3-GRAM rapid , predominantly
1 3-GRAM , predominantly urinary
1 3-GRAM predominantly urinary excretion
1 3-GRAM urinary excretion of
1 3-GRAM excretion of 99mTc
1 3-GRAM of 99mTc ciprofloxacin
1 3-GRAM 99mTc ciprofloxacin ,
1 3-GRAM ciprofloxacin , with
2 3-GRAM , with low
1 3-GRAM with low to
1 3-GRAM low to absent
1 3-GRAM to absent brain
1 3-GRAM absent brain ,
1 3-GRAM brain , lung
1 3-GRAM , lung and
1 3-GRAM lung and bone
1 3-GRAM and bone marrow
1 3-GRAM bone marrow uptake
1 3-GRAM marrow uptake and
1 3-GRAM uptake and low
1 3-GRAM and low liver
1 3-GRAM low liver uptake
1 3-GRAM liver uptake and
1 3-GRAM uptake and excretion
1 3-GRAM and excretion .
1 3-GRAM excretion . STOP
2 3-GRAM Thus , the
1 3-GRAM , the anti
1 3-GRAM the anti -
1 3-GRAM anti - interferon
1 3-GRAM - interferon functions
1 3-GRAM interferon functions of
1 3-GRAM functions of vIRF
1 3-GRAM of vIRF -
1 3-GRAM vIRF - 2
1 3-GRAM - 2 may
1 3-GRAM 2 may contribute
1 3-GRAM may contribute to
1 3-GRAM contribute to the
1 3-GRAM to the establishment
1 3-GRAM the establishment of
1 3-GRAM establishment of a
1 3-GRAM of a chronic
1 3-GRAM a chronic or
1 3-GRAM chronic or latent
1 3-GRAM or latent infection
1 3-GRAM latent infection .
2 3-GRAM infection . STOP
1 3-GRAM * * Topological
1 3-GRAM * Topological and
1 3-GRAM Topological and mutational
1 3-GRAM and mutational analysis
1 3-GRAM mutational analysis of
1 3-GRAM analysis of Saccharomyces
1 3-GRAM of Saccharomyces cerevisiae
1 3-GRAM Saccharomyces cerevisiae Ste14p
1 3-GRAM cerevisiae Ste14p ,
1 3-GRAM Ste14p , founding
1 3-GRAM , founding member
1 3-GRAM founding member of
1 3-GRAM of the isoprenylcysteine
1 3-GRAM the isoprenylcysteine carboxyl
1 3-GRAM isoprenylcysteine carboxyl methyltransferase
1 3-GRAM carboxyl methyltransferase family
1 3-GRAM methyltransferase family .
3 3-GRAM * * Two
1 3-GRAM * Two remotely
1 3-GRAM Two remotely situated
1 3-GRAM remotely situated exons
1 3-GRAM situated exons within
1 3-GRAM exons within the
1 3-GRAM within the complement
1 3-GRAM the complement C3
1 3-GRAM complement C3 gene
1 3-GRAM C3 gene locus
1 3-GRAM gene locus encode
1 3-GRAM locus encode an
1 3-GRAM encode an alternate
1 3-GRAM an alternate 5
1 3-GRAM alternate 5 '
1 3-GRAM 5 ' end
1 3-GRAM ' end and
1 3-GRAM end and proximal
1 3-GRAM and proximal ORF
1 3-GRAM proximal ORF under
1 3-GRAM ORF under the
3 3-GRAM under the control
3 3-GRAM the control of
2 3-GRAM control of a
1 3-GRAM of a bidirectional
1 3-GRAM a bidirectional promoter
1 3-GRAM bidirectional promoter .
2 3-GRAM * * Although
1 3-GRAM * Although there
1 3-GRAM Although there was
1 3-GRAM there was a
1 3-GRAM was a high
1 3-GRAM a high correlation
1 3-GRAM high correlation between
1 3-GRAM correlation between sap
1 3-GRAM between sap flux
2 3-GRAM sap flux densities
1 3-GRAM flux densities registered
1 3-GRAM densities registered by
1 3-GRAM registered by the
1 3-GRAM by the old
1 3-GRAM the old and
1 3-GRAM old and new
1 3-GRAM and new sensors
1 3-GRAM new sensors ,
1 3-GRAM sensors , significant
1 3-GRAM , significant differences
3 3-GRAM significant differences in
1 3-GRAM differences in sap
1 3-GRAM in sap flux
1 3-GRAM flux densities between
1 3-GRAM densities between the
1 3-GRAM between the duplicated
1 3-GRAM the duplicated sensors
1 3-GRAM duplicated sensors were
1 3-GRAM sensors were detected
1 3-GRAM were detected .
1 3-GRAM detected . STOP
1 3-GRAM * * Their
1 3-GRAM * Their numbers
1 3-GRAM Their numbers have
1 3-GRAM numbers have regularly
1 3-GRAM have regularly increased
1 3-GRAM regularly increased since
1 3-GRAM increased since the
1 3-GRAM since the mid
1 3-GRAM the mid -
1 3-GRAM mid - 1970s
1 3-GRAM - 1970s .
1 3-GRAM 1970s . STOP
1 3-GRAM * The hcKrox
1 3-GRAM The hcKrox gene
1 3-GRAM hcKrox gene family
1 3-GRAM gene family regulates
1 3-GRAM family regulates multiple
1 3-GRAM regulates multiple extracellular
1 3-GRAM multiple extracellular matrix
1 3-GRAM extracellular matrix genes
1 3-GRAM matrix genes .
4 3-GRAM genes . STOP
1 3-GRAM * * NB
1 3-GRAM * NB -
1 3-GRAM NB - 506
1 3-GRAM - 506 completely
1 3-GRAM 506 completely inhibits
1 3-GRAM completely inhibits the
1 3-GRAM inhibits the capacity
1 3-GRAM the capacity of
1 3-GRAM capacity of topoisomerase
1 3-GRAM of topoisomerase I
1 3-GRAM topoisomerase I to
1 3-GRAM I to phosphorylate
1 3-GRAM to phosphorylate ,
1 3-GRAM phosphorylate , in
1 3-GRAM , in vitro
1 3-GRAM in vitro ,
1 3-GRAM vitro , the
1 3-GRAM , the human
1 3-GRAM the human splicing
1 3-GRAM human splicing factor
1 3-GRAM splicing factor 2
1 3-GRAM factor 2 /
1 3-GRAM 2 / alternative
1 3-GRAM / alternative splicing
1 3-GRAM alternative splicing factor
1 3-GRAM splicing factor (
1 3-GRAM factor ( SF2
1 3-GRAM ( SF2 /
1 3-GRAM SF2 / ASF
1 3-GRAM / ASF ).
1 3-GRAM ASF ). STOP
2 3-GRAM * * Recent
1 3-GRAM * Recent studies
1 3-GRAM Recent studies using
1 3-GRAM studies using isolated
1 3-GRAM using isolated rat
1 3-GRAM isolated rat adipocytes
1 3-GRAM rat adipocytes and
1 3-GRAM adipocytes and chemically
1 3-GRAM and chemically synthesized
1 3-GRAM chemically synthesized PIG
1 3-GRAM synthesized PIG compounds
1 3-GRAM PIG compounds point
1 3-GRAM compounds point to
1 3-GRAM point to IRS1
1 3-GRAM to IRS1 /
1 3-GRAM IRS1 / 3
1 3-GRAM / 3 tyrosine
1 3-GRAM 3 tyrosine phosphorylation
1 3-GRAM tyrosine phosphorylation by
1 3-GRAM phosphorylation by p59Lyn
1 3-GRAM by p59Lyn kinase
1 3-GRAM p59Lyn kinase as
1 3-GRAM kinase as the
1 3-GRAM as the site
1 3-GRAM the site of
1 3-GRAM site of cross
1 3-GRAM of cross -
1 3-GRAM cross - talk
1 3-GRAM - talk ,
1 3-GRAM talk , the
1 3-GRAM , the negative
1 3-GRAM the negative regulation
2 3-GRAM negative regulation of
1 3-GRAM regulation of which
1 3-GRAM of which by
1 3-GRAM which by interaction
1 3-GRAM by interaction with
1 3-GRAM interaction with caveolin
1 3-GRAM with caveolin is
1 3-GRAM caveolin is apparently
1 3-GRAM is apparently abrogated
1 3-GRAM apparently abrogated by
1 3-GRAM abrogated by PIG
1 3-GRAM by PIG .
1 3-GRAM PIG . STOP
1 3-GRAM * To investigate
2 3-GRAM To investigate the
1 3-GRAM investigate the effects
1 3-GRAM the effects of
1 3-GRAM effects of exogenous
1 3-GRAM of exogenous hyaluronic
1 3-GRAM exogenous hyaluronic acid
1 3-GRAM hyaluronic acid ,
1 3-GRAM acid , the
1 3-GRAM , the development
1 3-GRAM development of port
1 3-GRAM of port -
1 3-GRAM port - site
1 3-GRAM - site metastasis
1 3-GRAM site metastasis was
1 3-GRAM metastasis was examined
1 3-GRAM was examined using
1 3-GRAM examined using mouse
1 3-GRAM using mouse adenocarcinoma
1 3-GRAM mouse adenocarcinoma cell
1 3-GRAM adenocarcinoma cell -
1 3-GRAM cell - line
1 3-GRAM - line colon
1 3-GRAM line colon 26
1 3-GRAM colon 26 cells
1 3-GRAM 26 cells .
8 3-GRAM * * METHODS
7 3-GRAM * METHODS :
1 3-GRAM METHODS : Thyroid
1 3-GRAM : Thyroid status
1 3-GRAM Thyroid status was
1 3-GRAM status was measured
1 3-GRAM was measured at
1 3-GRAM measured at baseline
1 3-GRAM at baseline (
1 3-GRAM baseline ( 1990
1 3-GRAM ( 1990 -
1 3-GRAM 1990 - 93
1 3-GRAM - 93 ),
1 3-GRAM 93 ), through
1 3-GRAM ), through assessment
1 3-GRAM through assessment of
1 3-GRAM assessment of serum
1 3-GRAM of serum antibodies
1 3-GRAM serum antibodies to
1 3-GRAM antibodies to thyroid
1 3-GRAM to thyroid peroxidase
1 3-GRAM thyroid peroxidase (
1 3-GRAM peroxidase ( TPO
1 3-GRAM ( TPO -
1 3-GRAM TPO - Abs
1 3-GRAM - Abs ,
1 3-GRAM Abs , positive
1 3-GRAM , positive :
1 3-GRAM positive : >
1 3-GRAM : > 10
1 3-GRAM > 10 IU
1 3-GRAM 10 IU /
1 3-GRAM IU / ml
3 3-GRAM / ml ),
1 3-GRAM ml ), serum
1 3-GRAM ), serum TSH
1 3-GRAM serum TSH levels
1 3-GRAM TSH levels ,
1 3-GRAM , and when
1 3-GRAM and when TSH
1 3-GRAM when TSH was
1 3-GRAM TSH was abnormal
1 3-GRAM was abnormal (<
1 3-GRAM abnormal (< 0
1 3-GRAM (< 0 .
1 3-GRAM . 4 or
1 3-GRAM 4 or >
1 3-GRAM or > 4
1 3-GRAM > 4 .
1 3-GRAM 4 . 0
1 3-GRAM . 0 mU
1 3-GRAM 0 mU /
1 3-GRAM mU / l
1 3-GRAM / l ),
1 3-GRAM l ), serum
1 3-GRAM ), serum thyroxin
1 3-GRAM serum thyroxin levels
1 3-GRAM thyroxin levels (
1 3-GRAM levels ( T4
1 3-GRAM ( T4 ).
1 3-GRAM T4 ). STOP
1 3-GRAM * * Mechanical
1 3-GRAM * Mechanical ventilation
1 3-GRAM Mechanical ventilation in
1 3-GRAM ventilation in control
1 3-GRAM in control lungs
1 3-GRAM control lungs produced
1 3-GRAM lungs produced a
1 3-GRAM produced a 47
1 3-GRAM a 47 %
1 3-GRAM 47 % decrease
1 3-GRAM % decrease in
1 3-GRAM decrease in chord
1 3-GRAM in chord compliance
1 3-GRAM chord compliance ,
1 3-GRAM compliance , an
1 3-GRAM , an increase
1 3-GRAM increase in lung
1 3-GRAM in lung lavage
1 3-GRAM lung lavage levels
1 3-GRAM lavage levels of
1 3-GRAM levels of tumor
1 3-GRAM of tumor necrosis
2 3-GRAM tumor necrosis factor
2 3-GRAM necrosis factor (
2 3-GRAM factor ( TNF
1 3-GRAM ( TNF )-
1 3-GRAM TNF )- alpha
1 3-GRAM )- alpha (
1 3-GRAM alpha ( 722
1 3-GRAM ( 722 +/-
1 3-GRAM 722 +/- 306
1 3-GRAM +/- 306 pg
1 3-GRAM 306 pg /
4 3-GRAM pg / ml
1 3-GRAM ml ), interleukin
1 3-GRAM ), interleukin (
1 3-GRAM interleukin ( IL
1 3-GRAM ( IL )-
1 3-GRAM IL )- 1beta
1 3-GRAM )- 1beta (
1 3-GRAM 1beta ( 902
1 3-GRAM ( 902 +/-
1 3-GRAM 902 +/- 322
1 3-GRAM +/- 322 pg
1 3-GRAM 322 pg /
1 3-GRAM ml ), and
1 3-GRAM ), and macrophage
1 3-GRAM and macrophage inflammatory
2 3-GRAM macrophage inflammatory protein
1 3-GRAM inflammatory protein -
3 3-GRAM protein - 2
1 3-GRAM - 2 (
1 3-GRAM 2 ( MIP
1 3-GRAM ( MIP -
1 3-GRAM MIP - 2
2 3-GRAM - 2 )
1 3-GRAM 2 ) (
1 3-GRAM ) ( 363
1 3-GRAM ( 363 +/-
1 3-GRAM 363 +/- 104
1 3-GRAM +/- 104 pg
1 3-GRAM 104 pg /
1 3-GRAM / ml )
1 3-GRAM ml ) as
2 3-GRAM ) as compared
1 3-GRAM as compared with
1 3-GRAM compared with low
1 3-GRAM with low levels
1 3-GRAM low levels of
1 3-GRAM levels of cytokines
1 3-GRAM of cytokines detected
1 3-GRAM cytokines detected in
1 3-GRAM detected in preventilation
1 3-GRAM in preventilation data
1 3-GRAM preventilation data ,
2 3-GRAM data , and
1 3-GRAM , and no
1 3-GRAM and no change
1 3-GRAM no change in
1 3-GRAM change in percentage
1 3-GRAM in percentage of
1 3-GRAM percentage of surfactant
1 3-GRAM of surfactant large
1 3-GRAM surfactant large aggregates
1 3-GRAM large aggregates (
1 3-GRAM aggregates ( LA
1 3-GRAM ( LA ).
1 3-GRAM LA ). STOP
1 3-GRAM * * Autoregulation
1 3-GRAM * Autoregulation enables
1 3-GRAM Autoregulation enables different
1 3-GRAM enables different pathways
1 3-GRAM different pathways to
1 3-GRAM pathways to control
1 3-GRAM to control CCAAT
1 3-GRAM control CCAAT /
1 3-GRAM CCAAT / enhancer
1 3-GRAM / enhancer binding
1 3-GRAM enhancer binding protein
1 3-GRAM binding protein beta
1 3-GRAM protein beta (
1 3-GRAM beta ( C
1 3-GRAM ( C /
5 3-GRAM C / EBP
2 3-GRAM / EBP beta
1 3-GRAM EBP beta )
1 3-GRAM beta ) transcription
1 3-GRAM ) transcription .
1 3-GRAM transcription . STOP
1 3-GRAM In the past
1 3-GRAM the past decade
1 3-GRAM past decade ,
1 3-GRAM decade , there
1 3-GRAM , there have
1 3-GRAM there have been
1 3-GRAM have been enormous
1 3-GRAM been enormous advances
1 3-GRAM enormous advances in
1 3-GRAM advances in the
1 3-GRAM in the use
1 3-GRAM use of Bayesian
1 3-GRAM of Bayesian methodology
1 3-GRAM Bayesian methodology for
1 3-GRAM methodology for analysis
1 3-GRAM for analysis of
1 3-GRAM analysis of epidemiologic
1 3-GRAM of epidemiologic data
1 3-GRAM epidemiologic data ,
1 3-GRAM , and there
1 3-GRAM and there are
1 3-GRAM there are now
1 3-GRAM are now many
1 3-GRAM now many practical
1 3-GRAM many practical advantages
1 3-GRAM practical advantages to
1 3-GRAM advantages to the
1 3-GRAM to the Bayesian
1 3-GRAM the Bayesian approach
1 3-GRAM Bayesian approach .
1 3-GRAM approach . STOP
1 3-GRAM * In strains
1 3-GRAM In strains lacking
1 3-GRAM strains lacking tup11
1 3-GRAM lacking tup11 and
1 3-GRAM tup11 and tup12
1 3-GRAM and tup12 ,
1 3-GRAM tup12 , the
1 3-GRAM , the atf1
1 3-GRAM the atf1 -
1 3-GRAM atf1 - pcr1
1 3-GRAM - pcr1 transcriptional
1 3-GRAM pcr1 transcriptional activator
1 3-GRAM transcriptional activator continues
1 3-GRAM activator continues to
1 3-GRAM continues to play
1 3-GRAM play a central
1 3-GRAM a central role
1 3-GRAM central role in
1 3-GRAM role in fbp1
1 3-GRAM in fbp1 -
1 3-GRAM fbp1 - lacZ
1 3-GRAM - lacZ expression
1 3-GRAM lacZ expression ;
1 3-GRAM expression ; however
1 3-GRAM ; however ,
1 3-GRAM however , spc1
1 3-GRAM , spc1 MAPK
1 3-GRAM spc1 MAPK phosphorylation
1 3-GRAM MAPK phosphorylation of
1 3-GRAM phosphorylation of atf1
1 3-GRAM of atf1 is
1 3-GRAM atf1 is no
1 3-GRAM is no longer
1 3-GRAM no longer essential
1 3-GRAM longer essential for
1 3-GRAM essential for its
1 3-GRAM for its activation
1 3-GRAM its activation .
1 3-GRAM * * Single
1 3-GRAM * Single amino
1 3-GRAM Single amino acid
1 3-GRAM amino acid substitutions
1 3-GRAM acid substitutions at
1 3-GRAM substitutions at the
1 3-GRAM at the acyl
1 3-GRAM the acyl -
2 3-GRAM acyl - CoA
2 3-GRAM - CoA -
2 3-GRAM CoA - binding
2 3-GRAM - binding domain
1 3-GRAM binding domain interrupt
1 3-GRAM domain interrupt 14
1 3-GRAM interrupt 14 [
1 3-GRAM 14 [ C
1 3-GRAM [ C ]
1 3-GRAM C ] palmitoyl
1 3-GRAM ] palmitoyl -
1 3-GRAM palmitoyl - CoA
1 3-GRAM - CoA binding
1 3-GRAM CoA binding of
1 3-GRAM binding of ACBP2
1 3-GRAM of ACBP2 ,
1 3-GRAM ACBP2 , an
1 3-GRAM , an Arabidopsis
1 3-GRAM an Arabidopsis acyl
1 3-GRAM Arabidopsis acyl -
2 3-GRAM - binding protein
1 3-GRAM binding protein with
1 3-GRAM protein with ankyrin
1 3-GRAM with ankyrin repeats
1 3-GRAM ankyrin repeats .
1 3-GRAM repeats . STOP
1 3-GRAM RESULTS : Sixty
1 3-GRAM : Sixty per
1 3-GRAM Sixty per cent
1 3-GRAM per cent of
1 3-GRAM cent of African
1 3-GRAM of African Americans
1 3-GRAM African Americans exposed
1 3-GRAM Americans exposed in
1 3-GRAM exposed in 26
1 3-GRAM in 26 community
1 3-GRAM 26 community outbreaks
1 3-GRAM community outbreaks were
1 3-GRAM outbreaks were TST
1 3-GRAM were TST positive
1 3-GRAM TST positive compared
1 3-GRAM positive compared to
1 3-GRAM compared to only
1 3-GRAM to only 40
1 3-GRAM only 40 %
1 3-GRAM 40 % of
1 3-GRAM % of whites
1 3-GRAM of whites following
1 3-GRAM whites following comparable
1 3-GRAM following comparable exposures
1 3-GRAM comparable exposures .
1 3-GRAM exposures . STOP
4 3-GRAM * * For
1 3-GRAM * For immunological
1 3-GRAM For immunological methods
1 3-GRAM immunological methods ,
1 3-GRAM methods , identification
1 3-GRAM , identification of
1 3-GRAM identification of such
1 3-GRAM of such antigens
1 3-GRAM such antigens with
1 3-GRAM antigens with intermolecular
1 3-GRAM with intermolecular variability
1 3-GRAM intermolecular variability ,
1 3-GRAM variability , e
1 3-GRAM , e .
1 3-GRAM e . g
1 3-GRAM . g .,
1 3-GRAM g ., the
1 3-GRAM ., the structural
1 3-GRAM the structural aescin
1 3-GRAM structural aescin analogs
1 3-GRAM aescin analogs ,
1 3-GRAM analogs , is
1 3-GRAM , is of
1 3-GRAM is of unknown
1 3-GRAM of unknown validity
1 3-GRAM unknown validity .
1 3-GRAM validity . STOP
3 3-GRAM * * It
1 3-GRAM * It was
1 3-GRAM It was found
2 3-GRAM was found that
1 3-GRAM found that intrathecal
1 3-GRAM that intrathecal administration
1 3-GRAM intrathecal administration (
1 3-GRAM administration ( i
1 3-GRAM ( i .
1 3-GRAM i . t
1 3-GRAM . t .)
1 3-GRAM t .) of
1 3-GRAM .) of D2
1 3-GRAM of D2 receptor
2 3-GRAM D2 receptor agonist
1 3-GRAM receptor agonist LY171555
1 3-GRAM agonist LY171555 or
1 3-GRAM LY171555 or D1
1 3-GRAM or D1 /
1 3-GRAM D1 / D2
1 3-GRAM / D2 receptor
1 3-GRAM receptor agonist apomorphine
1 3-GRAM agonist apomorphine increased
1 3-GRAM apomorphine increased pain
1 3-GRAM increased pain threshold
1 3-GRAM pain threshold and
1 3-GRAM threshold and had
1 3-GRAM and had a
1 3-GRAM had a potentiating
1 3-GRAM a potentiating effect
1 3-GRAM potentiating effect on
1 3-GRAM effect on AA
1 3-GRAM on AA .
1 3-GRAM AA . STOP
1 3-GRAM * * Interactions
1 3-GRAM * Interactions between
1 3-GRAM Interactions between the
1 3-GRAM between the checkpoint
1 3-GRAM the checkpoint abrogator
1 3-GRAM checkpoint abrogator UCN
1 3-GRAM abrogator UCN -
1 3-GRAM UCN - 01
1 3-GRAM - 01 and
1 3-GRAM 01 and several
1 3-GRAM and several pharmacological
1 3-GRAM several pharmacological inhibitors
1 3-GRAM pharmacological inhibitors of
1 3-GRAM inhibitors of the
2 3-GRAM of the mitogen
3 3-GRAM the mitogen -
3 3-GRAM mitogen - activated
3 3-GRAM - activated protein
3 3-GRAM activated protein kinase
1 3-GRAM protein kinase (
1 3-GRAM MAPK ) kinase
1 3-GRAM ) kinase (
2 3-GRAM kinase ( MEK
1 3-GRAM ( MEK )/
1 3-GRAM MEK )/ MAPK
1 3-GRAM )/ MAPK pathway
1 3-GRAM MAPK pathway have
1 3-GRAM pathway have been
1 3-GRAM have been examined
1 3-GRAM been examined in
1 3-GRAM examined in a
1 3-GRAM in a variety
1 3-GRAM a variety of
1 3-GRAM variety of human
1 3-GRAM of human leukemia
1 3-GRAM human leukemia cell
1 3-GRAM leukemia cell lines
3 3-GRAM * * Analysis
3 3-GRAM * Analysis of
1 3-GRAM Analysis of regulatory
1 3-GRAM of regulatory regions
1 3-GRAM regulatory regions in
1 3-GRAM regions in the
1 3-GRAM in the promoter
1 3-GRAM the promoter of
1 3-GRAM promoter of the
1 3-GRAM of the ctr4
1 3-GRAM the ctr4 (+)
1 3-GRAM ctr4 (+) copper
1 3-GRAM (+) copper transporter
1 3-GRAM copper transporter gene
1 3-GRAM transporter gene in
1 3-GRAM gene in fission
1 3-GRAM in fission yeast
1 3-GRAM fission yeast Schizosaccharomyces
1 3-GRAM yeast Schizosaccharomyces pombe
1 3-GRAM Schizosaccharomyces pombe reveals
1 3-GRAM pombe reveals the
1 3-GRAM reveals the identity
1 3-GRAM the identity of
1 3-GRAM identity of a
1 3-GRAM of a conserved
1 3-GRAM a conserved copper
1 3-GRAM conserved copper -
1 3-GRAM copper - signaling
1 3-GRAM - signaling element
1 3-GRAM signaling element (
1 3-GRAM element ( CuSE
1 3-GRAM ( CuSE ),
1 3-GRAM CuSE ), which
1 3-GRAM ), which is
1 3-GRAM which is recognized
1 3-GRAM is recognized by
1 3-GRAM recognized by the
2 3-GRAM by the transcription
2 3-GRAM the transcription factor
1 3-GRAM transcription factor Cuf1
1 3-GRAM factor Cuf1 .
1 3-GRAM Cuf1 . STOP
1 3-GRAM However , during
1 3-GRAM , during our
1 3-GRAM during our work
1 3-GRAM our work with
1 3-GRAM work with a
1 3-GRAM with a replication
1 3-GRAM a replication -
1 3-GRAM replication - deficient
1 3-GRAM - deficient virus
1 3-GRAM deficient virus expressing
1 3-GRAM virus expressing the
1 3-GRAM expressing the ASF
1 3-GRAM the ASF /
2 3-GRAM ASF / SF2
1 3-GRAM / SF2 splicing
1 3-GRAM SF2 splicing factor
1 3-GRAM splicing factor from
1 3-GRAM factor from a
1 3-GRAM from a progesterone
1 3-GRAM a progesterone antagonist
1 3-GRAM progesterone antagonist -
1 3-GRAM antagonist - inducible
1 3-GRAM - inducible gene
1 3-GRAM inducible gene cassette
1 3-GRAM gene cassette ,
1 3-GRAM cassette , we
2 3-GRAM , we discovered
2 3-GRAM we discovered that
1 3-GRAM discovered that ASF
1 3-GRAM that ASF /
1 3-GRAM / SF2 was
1 3-GRAM SF2 was expressed
1 3-GRAM was expressed at
1 3-GRAM expressed at a
1 3-GRAM at a significant
1 3-GRAM a significant level
1 3-GRAM significant level in
1 3-GRAM level in the
1 3-GRAM in the 293
1 3-GRAM the 293 producer
1 3-GRAM 293 producer cell
1 3-GRAM producer cell line
1 3-GRAM cell line ,
1 3-GRAM line , even
1 3-GRAM , even in
2 3-GRAM even in the
4 3-GRAM in the absence
4 3-GRAM the absence of
1 3-GRAM absence of inducer
1 3-GRAM of inducer .
1 3-GRAM inducer . STOP
3 3-GRAM * This study
1 3-GRAM This study suggests
1 3-GRAM study suggests that
1 3-GRAM suggests that PSP
1 3-GRAM that PSP is
1 3-GRAM PSP is more
1 3-GRAM is more common
1 3-GRAM more common than
1 3-GRAM common than previously
1 3-GRAM than previously considered
1 3-GRAM previously considered ,
1 3-GRAM considered , is
1 3-GRAM , is commonly
1 3-GRAM is commonly misdiagnosed
1 3-GRAM commonly misdiagnosed and
1 3-GRAM misdiagnosed and that
1 3-GRAM and that the
1 3-GRAM that the majority
1 3-GRAM the majority of
1 3-GRAM majority of cases
1 3-GRAM of cases are
1 3-GRAM cases are not
1 3-GRAM are not initially
1 3-GRAM not initially referred
1 3-GRAM initially referred to
1 3-GRAM referred to neurologists
1 3-GRAM to neurologists .
1 3-GRAM neurologists . STOP
1 3-GRAM * * Between
1 3-GRAM * Between 1967
1 3-GRAM Between 1967 and
1 3-GRAM 1967 and 1994
1 3-GRAM and 1994 ,
1 3-GRAM 1994 , 495
1 3-GRAM , 495 patients
1 3-GRAM 495 patients underwent
1 3-GRAM patients underwent surgery
2 3-GRAM underwent surgery for
1 3-GRAM surgery for primary
1 3-GRAM for primary PTC
1 3-GRAM primary PTC at
1 3-GRAM PTC at the
1 3-GRAM at the Department
1 3-GRAM Department of Surgery
1 3-GRAM of Surgery ,
1 3-GRAM Surgery , Helsinki
1 3-GRAM , Helsinki University
1 3-GRAM Helsinki University Central
1 3-GRAM University Central Hospital
1 3-GRAM Central Hospital .
1 3-GRAM Hospital . STOP
1 3-GRAM * The described
1 3-GRAM The described results
1 3-GRAM described results show
2 3-GRAM results show that
1 3-GRAM show that DTD
1 3-GRAM that DTD is
1 3-GRAM DTD is fast
1 3-GRAM is fast ,
1 3-GRAM fast , simple
1 3-GRAM , simple ,
1 3-GRAM simple , and
1 3-GRAM , and easy
1 3-GRAM and easy to
1 3-GRAM easy to automate
1 3-GRAM to automate ;
1 3-GRAM automate ; requires
1 3-GRAM ; requires only
1 3-GRAM requires only a
1 3-GRAM only a small
1 3-GRAM a small amount
1 3-GRAM small amount of
1 3-GRAM amount of sample
1 3-GRAM of sample (
1 3-GRAM sample ( approximately
1 3-GRAM ( approximately 50
1 3-GRAM approximately 50 mg
1 3-GRAM 50 mg );
1 3-GRAM mg ); and
1 3-GRAM ); and affords
1 3-GRAM and affords quantitative
1 3-GRAM affords quantitative information
1 3-GRAM quantitative information about
1 3-GRAM information about the
1 3-GRAM about the main
1 3-GRAM the main groups
1 3-GRAM main groups of
1 3-GRAM groups of compounds
1 3-GRAM of compounds present
1 3-GRAM compounds present in
1 3-GRAM present in cheeses
1 3-GRAM in cheeses .
1 3-GRAM * * Srb10
1 3-GRAM * Srb10 is
1 3-GRAM Srb10 is a
1 3-GRAM is a physiological
1 3-GRAM a physiological regulator
1 3-GRAM physiological regulator of
1 3-GRAM regulator of Gcn4
1 3-GRAM of Gcn4 stability
1 3-GRAM Gcn4 stability because
1 3-GRAM stability because both
1 3-GRAM because both phosphorylation
1 3-GRAM both phosphorylation and
1 3-GRAM phosphorylation and turnover
1 3-GRAM and turnover of
1 3-GRAM turnover of Gcn4
1 3-GRAM of Gcn4 are
1 3-GRAM Gcn4 are diminished
1 3-GRAM are diminished in
1 3-GRAM diminished in srb10
1 3-GRAM in srb10 mutants
1 3-GRAM srb10 mutants .
2 3-GRAM mutants . STOP
1 3-GRAM * The promoter
1 3-GRAM The promoter activity
1 3-GRAM promoter activity of
4 3-GRAM activity of the
1 3-GRAM of the proximal
1 3-GRAM the proximal region
1 3-GRAM proximal region was
1 3-GRAM region was found
2 3-GRAM was found to
2 3-GRAM found to be
1 3-GRAM to be restricted
1 3-GRAM be restricted to
1 3-GRAM restricted to a
1 3-GRAM to a subset
1 3-GRAM a subset of
1 3-GRAM subset of prestalk
1 3-GRAM of prestalk cells
1 3-GRAM prestalk cells .
1 3-GRAM * Two nuclear
1 3-GRAM Two nuclear medicine
1 3-GRAM nuclear medicine physicians
1 3-GRAM medicine physicians blinded
1 3-GRAM physicians blinded to
1 3-GRAM blinded to the
1 3-GRAM to the surgical
1 3-GRAM the surgical findings
1 3-GRAM surgical findings interpreted
1 3-GRAM findings interpreted all
1 3-GRAM interpreted all available
1 3-GRAM all available images
1 3-GRAM available images and
1 3-GRAM images and various
1 3-GRAM and various Tc
1 3-GRAM various Tc -
1 3-GRAM Tc - 99m
1 3-GRAM - 99m MIBI
1 3-GRAM 99m MIBI image
1 3-GRAM MIBI image combinations
1 3-GRAM image combinations at
1 3-GRAM combinations at 15
1 3-GRAM at 15 minutes
1 3-GRAM 15 minutes alone
1 3-GRAM minutes alone ;
1 3-GRAM alone ; 15
1 3-GRAM ; 15 minutes
3 3-GRAM 15 minutes and
2 3-GRAM minutes and 2
1 3-GRAM and 2 hours
1 3-GRAM 2 hours ,
1 3-GRAM hours , 15
1 3-GRAM , 15 minutes
1 3-GRAM minutes and 4
2 3-GRAM and 4 hours
1 3-GRAM 4 hours ;
1 3-GRAM hours ; and
1 3-GRAM ; and 15
1 3-GRAM and 15 minutes
1 3-GRAM and 2 and
1 3-GRAM 2 and 4
1 3-GRAM 4 hours each
1 3-GRAM hours each with
1 3-GRAM each with and
1 3-GRAM and without correlative
1 3-GRAM without correlative pertechnetate
1 3-GRAM correlative pertechnetate thyroid
1 3-GRAM pertechnetate thyroid imaging
1 3-GRAM thyroid imaging .
1 3-GRAM imaging . STOP
1 3-GRAM * We demonstrated
1 3-GRAM We demonstrated that
1 3-GRAM demonstrated that ,
1 3-GRAM that , under
1 3-GRAM , under serum
1 3-GRAM under serum -
1 3-GRAM serum - starved
1 3-GRAM - starved conditions
1 3-GRAM starved conditions ,
1 3-GRAM conditions , KMS
1 3-GRAM , KMS -
1 3-GRAM KMS - 11
1 3-GRAM - 11 and
1 3-GRAM 11 and OPM
1 3-GRAM and OPM -
1 3-GRAM OPM - 2
2 3-GRAM - 2 cells
1 3-GRAM 2 cells express
1 3-GRAM cells express appreciable
1 3-GRAM express appreciable levels
1 3-GRAM appreciable levels of
1 3-GRAM levels of phosphorylated
1 3-GRAM of phosphorylated FGFR3
1 3-GRAM phosphorylated FGFR3 mutants
1 3-GRAM FGFR3 mutants indicating
1 3-GRAM mutants indicating a
1 3-GRAM indicating a constitutive
1 3-GRAM a constitutive activation
1 3-GRAM constitutive activation of
1 3-GRAM of the Y373C
1 3-GRAM the Y373C and
1 3-GRAM Y373C and K650E
1 3-GRAM and K650E receptors
1 3-GRAM K650E receptors ;
1 3-GRAM receptors ; the
1 3-GRAM ; the addition
2 3-GRAM the addition of
2 3-GRAM addition of the
1 3-GRAM of the aFGF
1 3-GRAM the aFGF ligand
1 3-GRAM aFGF ligand further
1 3-GRAM ligand further increased
1 3-GRAM further increased the
1 3-GRAM increased the level
1 3-GRAM the level of
1 3-GRAM level of receptor
1 3-GRAM of receptor phosphorylation
1 3-GRAM receptor phosphorylation .
1 3-GRAM * * Identical
1 3-GRAM * Identical effects
1 3-GRAM Identical effects were
1 3-GRAM effects were obtained
1 3-GRAM were obtained when
1 3-GRAM obtained when inhibitors
1 3-GRAM when inhibitors and
1 3-GRAM inhibitors and dominant
1 3-GRAM and dominant negative
1 3-GRAM dominant negative mutants
1 3-GRAM negative mutants were
1 3-GRAM mutants were tested
1 3-GRAM were tested on
1 3-GRAM tested on the
1 3-GRAM on the -
1 3-GRAM the - 29
1 3-GRAM - 29 to
1 3-GRAM 29 to +
1 3-GRAM to + 139
1 3-GRAM + 139 bp
1 3-GRAM 139 bp region
1 3-GRAM bp region of
5 3-GRAM region of the
2 3-GRAM of the cyclin
2 3-GRAM the cyclin D1
1 3-GRAM cyclin D1 promoter
1 3-GRAM D1 promoter .
1 3-GRAM * In this
1 3-GRAM In this paper
1 3-GRAM this paper the
1 3-GRAM paper the tyrosine
1 3-GRAM the tyrosine dephosphorylating
1 3-GRAM tyrosine dephosphorylating enzymes
1 3-GRAM dephosphorylating enzymes ,
1 3-GRAM enzymes , the
1 3-GRAM the protein -
1 3-GRAM protein - tyrosine
1 3-GRAM - tyrosine phosphatases
1 3-GRAM tyrosine phosphatases (
1 3-GRAM phosphatases ( PTPs
1 3-GRAM ( PTPs ),
1 3-GRAM PTPs ), are
1 3-GRAM ), are studied
1 3-GRAM are studied which
1 3-GRAM studied which can
1 3-GRAM which can be
1 3-GRAM can be grouped
1 3-GRAM be grouped into
1 3-GRAM grouped into two
1 3-GRAM into two subfamilies
1 3-GRAM two subfamilies ,
1 3-GRAM subfamilies , the
1 3-GRAM , the soluble
1 3-GRAM the soluble PTPs
1 3-GRAM soluble PTPs and
1 3-GRAM PTPs and the
1 3-GRAM and the receptor
1 3-GRAM the receptor PTPs
1 3-GRAM receptor PTPs (
1 3-GRAM PTPs ( RPTPs
1 3-GRAM ( RPTPs ).
1 3-GRAM RPTPs ). STOP
1 3-GRAM * * Coexposure
1 3-GRAM * Coexposure to
1 3-GRAM Coexposure to FP
1 3-GRAM to FP also
1 3-GRAM FP also resulted
1 3-GRAM also resulted in
1 3-GRAM resulted in a
1 3-GRAM in a more
1 3-GRAM a more pronounced
1 3-GRAM more pronounced and
1 3-GRAM pronounced and sustained
1 3-GRAM and sustained activation
1 3-GRAM sustained activation of
2 3-GRAM protein kinase kinase
1 3-GRAM kinase kinase /
1 3-GRAM kinase / extracellular
2 3-GRAM / extracellular signal
2 3-GRAM extracellular signal -
2 3-GRAM signal - regulated
1 3-GRAM - regulated protein
1 3-GRAM regulated protein kinase
1 3-GRAM protein kinase cascade
1 3-GRAM kinase cascade after
1 3-GRAM cascade after PMA
1 3-GRAM after PMA treatment
1 3-GRAM PMA treatment ,
1 3-GRAM treatment , although
1 3-GRAM , although disruption
1 3-GRAM although disruption of
1 3-GRAM disruption of this
1 3-GRAM of this pathway
1 3-GRAM this pathway by
1 3-GRAM pathway by the
1 3-GRAM by the mitogen
1 3-GRAM kinase kinase 1
1 3-GRAM kinase 1 inhibitor
1 3-GRAM 1 inhibitor U0126
1 3-GRAM inhibitor U0126 did
1 3-GRAM U0126 did not
1 3-GRAM did not prevent
1 3-GRAM not prevent potentiation
1 3-GRAM prevent potentiation of
1 3-GRAM potentiation of apoptosis
1 3-GRAM of apoptosis .
1 3-GRAM apoptosis . STOP
1 3-GRAM * The LA
1 3-GRAM The LA 50s
1 3-GRAM LA 50s derived
1 3-GRAM 50s derived from
1 3-GRAM derived from this
1 3-GRAM from this combined
1 3-GRAM this combined data
1 3-GRAM combined data when
1 3-GRAM data when compared
1 3-GRAM when compared with
1 3-GRAM compared with our
1 3-GRAM with our earlier
1 3-GRAM our earlier series
1 3-GRAM earlier series from
1 3-GRAM series from 1965
1 3-GRAM from 1965 to
1 3-GRAM 1965 to 1970
1 3-GRAM to 1970 also
1 3-GRAM 1970 also did
1 3-GRAM also did not
1 3-GRAM did not show
1 3-GRAM not show a
1 3-GRAM show a significant
1 3-GRAM a significant change
1 3-GRAM significant change in
1 3-GRAM change in mortality
1 3-GRAM in mortality .
1 3-GRAM mortality . STOP
1 3-GRAM * Most patients
1 3-GRAM Most patients harboring
1 3-GRAM patients harboring metronidazole
1 3-GRAM harboring metronidazole -
1 3-GRAM metronidazole - and
1 3-GRAM - and clarithromycin
1 3-GRAM and clarithromycin -
1 3-GRAM clarithromycin - resistant
1 3-GRAM - resistant strains
1 3-GRAM resistant strains were
1 3-GRAM strains were eradicated
1 3-GRAM were eradicated at
1 3-GRAM eradicated at an
1 3-GRAM at an equal
1 3-GRAM an equal rate
1 3-GRAM equal rate by
1 3-GRAM rate by each
1 3-GRAM by each of
1 3-GRAM each of the
1 3-GRAM of the three
1 3-GRAM the three regimens
1 3-GRAM three regimens .
1 3-GRAM regimens . STOP
1 3-GRAM Responses of single
1 3-GRAM single - unit
1 3-GRAM - unit carotid
1 3-GRAM unit carotid body
1 3-GRAM carotid body chemoreceptors
1 3-GRAM body chemoreceptors in
1 3-GRAM chemoreceptors in adult
1 3-GRAM in adult rats
1 3-GRAM adult rats .
1 3-GRAM rats . STOP
1 3-GRAM Thus , MKK7
1 3-GRAM , MKK7 is
1 3-GRAM MKK7 is an
1 3-GRAM is an essential
1 3-GRAM an essential and
1 3-GRAM essential and specific
1 3-GRAM and specific regulator
1 3-GRAM specific regulator of
1 3-GRAM regulator of stress
1 3-GRAM of stress -
1 3-GRAM stress - induced
1 3-GRAM - induced SAPK
1 3-GRAM induced SAPK /
2 3-GRAM SAPK / JNK
2 3-GRAM / JNK activation
1 3-GRAM JNK activation in
1 3-GRAM activation in mast
1 3-GRAM in mast cells
1 3-GRAM mast cells and
1 3-GRAM cells and MKK7
1 3-GRAM and MKK7 negatively
1 3-GRAM MKK7 negatively regulates
1 3-GRAM negatively regulates growth
1 3-GRAM regulates growth factor
1 3-GRAM growth factor and
1 3-GRAM factor and antigen
1 3-GRAM and antigen receptor
1 3-GRAM antigen receptor -
1 3-GRAM receptor - driven
1 3-GRAM - driven proliferation
1 3-GRAM driven proliferation in
1 3-GRAM proliferation in hematopoietic
1 3-GRAM in hematopoietic cells
1 3-GRAM hematopoietic cells .
1 3-GRAM * The N
1 3-GRAM The N -
2 3-GRAM - terminal portion
2 3-GRAM terminal portion of
1 3-GRAM portion of Notch
1 3-GRAM of Notch (
1 3-GRAM Notch ( IC
1 3-GRAM ( IC )
1 3-GRAM IC ) inhibited
1 3-GRAM ) inhibited p50
1 3-GRAM inhibited p50 DNA
1 3-GRAM p50 DNA binding
1 3-GRAM DNA binding and
1 3-GRAM binding and interacted
1 3-GRAM and interacted specifically
1 3-GRAM interacted specifically with
1 3-GRAM specifically with p50
1 3-GRAM with p50 subunit
1 3-GRAM p50 subunit ,
1 3-GRAM subunit , not
1 3-GRAM , not p65
1 3-GRAM not p65 of
1 3-GRAM p65 of NF
1 3-GRAM of NF -
1 3-GRAM - kappaB .
1 3-GRAM kappaB . STOP
1 3-GRAM * To account
1 3-GRAM To account for
1 3-GRAM account for this
1 3-GRAM for this observation
1 3-GRAM this observation ,
1 3-GRAM observation , other
1 3-GRAM , other possible
1 3-GRAM other possible causes
1 3-GRAM possible causes include
1 3-GRAM causes include increased
1 3-GRAM include increased CSF
1 3-GRAM increased CSF pulsation
1 3-GRAM CSF pulsation in
1 3-GRAM pulsation in children
1 3-GRAM in children creating
1 3-GRAM children creating motion
1 3-GRAM creating motion artifact
1 3-GRAM motion artifact ,
1 3-GRAM artifact , changes
1 3-GRAM , changes in
1 3-GRAM changes in arterial
1 3-GRAM in arterial oxygen
1 3-GRAM arterial oxygen concentration
1 3-GRAM oxygen concentration intrinsic
1 3-GRAM concentration intrinsic to
1 3-GRAM intrinsic to propofol
1 3-GRAM to propofol or
1 3-GRAM propofol or related
1 3-GRAM or related to
1 3-GRAM related to the
1 3-GRAM to the supplemental
1 3-GRAM the supplemental oxygen
1 3-GRAM supplemental oxygen normally
1 3-GRAM oxygen normally administered
1 3-GRAM normally administered ,
1 3-GRAM administered , or
1 3-GRAM , or changes
1 3-GRAM or changes in
1 3-GRAM changes in CSF
1 3-GRAM in CSF protein
1 3-GRAM CSF protein levels
1 3-GRAM protein levels related
1 3-GRAM levels related to
1 3-GRAM related to propofol
1 3-GRAM to propofol binding
1 3-GRAM propofol binding to
1 3-GRAM binding to proteins
1 3-GRAM to proteins for
1 3-GRAM proteins for uptake
1 3-GRAM for uptake into
1 3-GRAM uptake into CSF
1 3-GRAM into CSF .
1 3-GRAM CSF . STOP
3 3-GRAM * * Molecular
1 3-GRAM * Molecular cloning
1 3-GRAM Molecular cloning and
1 3-GRAM cloning and characterization
1 3-GRAM characterization of OsPSK
1 3-GRAM of OsPSK ,
1 3-GRAM OsPSK , a
1 3-GRAM , a gene
1 3-GRAM a gene encoding
1 3-GRAM gene encoding a
1 3-GRAM encoding a precursor
1 3-GRAM a precursor for
1 3-GRAM precursor for phytosulfokine
1 3-GRAM for phytosulfokine -
1 3-GRAM phytosulfokine - alpha
1 3-GRAM - alpha ,
1 3-GRAM alpha , required
2 3-GRAM , required for
1 3-GRAM required for rice
1 3-GRAM for rice cell
1 3-GRAM rice cell proliferation
2 3-GRAM cell proliferation .
2 3-GRAM proliferation . STOP
2 3-GRAM * The present
1 3-GRAM The present study
1 3-GRAM present study was
1 3-GRAM study was initiated
1 3-GRAM was initiated to
1 3-GRAM initiated to explore
1 3-GRAM explore the potential
1 3-GRAM the potential of
1 3-GRAM potential of a
1 3-GRAM of a hybrid
1 3-GRAM a hybrid biological
1 3-GRAM hybrid biological reactor
1 3-GRAM biological reactor ,
1 3-GRAM reactor , combining
1 3-GRAM , combining trickling
1 3-GRAM combining trickling filter
1 3-GRAM trickling filter (
1 3-GRAM filter ( TF
1 3-GRAM ( TF )
1 3-GRAM TF ) and
1 3-GRAM ) and activated
1 3-GRAM and activated sludge
1 3-GRAM activated sludge process
1 3-GRAM sludge process (
1 3-GRAM process ( ASP
1 3-GRAM ( ASP ),
1 3-GRAM ASP ), to
1 3-GRAM ), to treat
1 3-GRAM to treat wastewater
1 3-GRAM treat wastewater containing
1 3-GRAM wastewater containing trichloroethylene
1 3-GRAM containing trichloroethylene (
1 3-GRAM trichloroethylene ( TCE
1 3-GRAM ( TCE )
1 3-GRAM TCE ) at
1 3-GRAM ) at ambient
1 3-GRAM at ambient temperature
1 3-GRAM ambient temperature at
1 3-GRAM temperature at different
1 3-GRAM at different hydraulic
1 3-GRAM different hydraulic retention
1 3-GRAM hydraulic retention time
1 3-GRAM retention time (
1 3-GRAM time ( HRT
1 3-GRAM ( HRT ).
1 3-GRAM HRT ). STOP
1 3-GRAM * * If
1 3-GRAM * If you
1 3-GRAM If you think
1 3-GRAM you think education
1 3-GRAM think education is
1 3-GRAM education is expensive
1 3-GRAM is expensive --
1 3-GRAM expensive -- try
1 3-GRAM -- try ignorance
1 3-GRAM try ignorance --
1 3-GRAM ignorance -- Bok
1 3-GRAM -- Bok '
1 3-GRAM Bok ' s
1 3-GRAM ' s Law
1 3-GRAM s Law .
1 3-GRAM Law . STOP
1 3-GRAM * The COD
1 3-GRAM The COD and
1 3-GRAM COD and color
1 3-GRAM and color removals
1 3-GRAM color removals were
1 3-GRAM removals were both
1 3-GRAM were both more
1 3-GRAM both more than
1 3-GRAM more than 90
1 3-GRAM than 90 %
1 3-GRAM 90 % when
1 3-GRAM % when FeCl3
1 3-GRAM when FeCl3 was
1 3-GRAM FeCl3 was used
1 3-GRAM was used as
1 3-GRAM used as the
1 3-GRAM as the coagulation
1 3-GRAM the coagulation (
1 3-GRAM coagulation ( dosages
1 3-GRAM ( dosages of
1 3-GRAM dosages of two
1 3-GRAM of two -
1 3-GRAM two - step
1 3-GRAM - step coagulation
1 3-GRAM step coagulation were
1 3-GRAM coagulation were 0
1 3-GRAM were 0 .
1 3-GRAM 0 . 031
1 3-GRAM . 031 and
1 3-GRAM 031 and 0
2 3-GRAM and 0 .
1 3-GRAM 0 . 012
1 3-GRAM . 012 mol
1 3-GRAM 012 mol /
2 3-GRAM mol / L
1 3-GRAM / L respectively
1 3-GRAM L respectively )
1 3-GRAM respectively ) after
1 3-GRAM ) after a
1 3-GRAM after a ferrous
1 3-GRAM a ferrous hydrogen
1 3-GRAM ferrous hydrogen peroxide
1 3-GRAM hydrogen peroxide oxidation
1 3-GRAM peroxide oxidation pretreatment
1 3-GRAM oxidation pretreatment at
1 3-GRAM pretreatment at a
1 3-GRAM at a H2O2
1 3-GRAM a H2O2 dosage
1 3-GRAM H2O2 dosage of
1 3-GRAM dosage of 0
1 3-GRAM of 0 .
2 3-GRAM 0 . 06
1 3-GRAM . 06 mol
1 3-GRAM 06 mol /
1 3-GRAM / L .
1 3-GRAM L . STOP
1 3-GRAM * An element
1 3-GRAM An element within
1 3-GRAM element within the
1 3-GRAM within the 5
2 3-GRAM the 5 '
1 3-GRAM 5 ' untranslated
1 3-GRAM ' untranslated region
2 3-GRAM untranslated region of
1 3-GRAM region of human
1 3-GRAM of human Hsp70
1 3-GRAM human Hsp70 mRNA
1 3-GRAM Hsp70 mRNA which
1 3-GRAM mRNA which acts
1 3-GRAM which acts as
1 3-GRAM acts as a
1 3-GRAM as a general
1 3-GRAM a general enhancer
1 3-GRAM general enhancer of
1 3-GRAM enhancer of mRNA
1 3-GRAM of mRNA translation
1 3-GRAM mRNA translation .
1 3-GRAM translation . STOP
1 3-GRAM * The selective
1 3-GRAM The selective alteration
1 3-GRAM selective alteration of
1 3-GRAM alteration of the
1 3-GRAM of the genome
1 3-GRAM the genome using
1 3-GRAM genome using Cre
1 3-GRAM using Cre recombinase
1 3-GRAM Cre recombinase to
1 3-GRAM recombinase to target
1 3-GRAM to target the
1 3-GRAM target the rearrangement
1 3-GRAM the rearrangement of
1 3-GRAM rearrangement of genes
1 3-GRAM of genes flanked
1 3-GRAM genes flanked by
2 3-GRAM flanked by LOX
1 3-GRAM by LOX recognition
1 3-GRAM LOX recognition sequences
1 3-GRAM recognition sequences has
1 3-GRAM sequences has required
1 3-GRAM has required the
1 3-GRAM required the use
1 3-GRAM use of two
1 3-GRAM of two separate
1 3-GRAM two separate genetic
1 3-GRAM separate genetic constructs
1 3-GRAM genetic constructs in
1 3-GRAM constructs in trans
1 3-GRAM in trans ,
1 3-GRAM trans , one
1 3-GRAM , one containing
1 3-GRAM one containing cre
1 3-GRAM containing cre and
1 3-GRAM cre and the
1 3-GRAM and the other
1 3-GRAM the other containing
1 3-GRAM other containing the
1 3-GRAM containing the gene
1 3-GRAM the gene of
1 3-GRAM gene of interest
1 3-GRAM of interest flanked
1 3-GRAM interest flanked by
1 3-GRAM by LOX sites
1 3-GRAM LOX sites .
2 3-GRAM sites . STOP
1 3-GRAM * It has
1 3-GRAM It has been
1 3-GRAM has been suggested
1 3-GRAM been suggested that
1 3-GRAM suggested that members
1 3-GRAM that members of
1 3-GRAM members of this
1 3-GRAM of this protein
1 3-GRAM this protein family
1 3-GRAM protein family exhibit
1 3-GRAM family exhibit both
1 3-GRAM exhibit both prolyl
1 3-GRAM both prolyl isomerase
1 3-GRAM prolyl isomerase and
1 3-GRAM isomerase and chaperone
1 3-GRAM and chaperone activity
1 3-GRAM chaperone activity .
1 3-GRAM * * Newcastle
1 3-GRAM * Newcastle disease
1 3-GRAM Newcastle disease antibody
1 3-GRAM disease antibody titre
1 3-GRAM antibody titre is
1 3-GRAM titre is dependent
1 3-GRAM is dependent on
1 3-GRAM dependent on serum
1 3-GRAM on serum calcium
1 3-GRAM serum calcium concentration
1 3-GRAM calcium concentration .
2 3-GRAM concentration . STOP
1 3-GRAM * In three
1 3-GRAM In three cases
1 3-GRAM three cases (
1 3-GRAM cases ( 21
1 3-GRAM ( 21 .
1 3-GRAM 21 . 4
1 3-GRAM . 4 %),
1 3-GRAM 4 %), the
1 3-GRAM %), the MR
1 3-GRAM the MR imaging
1 3-GRAM MR imaging was
1 3-GRAM imaging was interpreted
1 3-GRAM was interpreted as
1 3-GRAM interpreted as negative
1 3-GRAM as negative ,
1 3-GRAM negative , but
1 3-GRAM , but microscopic
1 3-GRAM but microscopic tumor
1 3-GRAM microscopic tumor was
1 3-GRAM tumor was shown
1 3-GRAM was shown around
1 3-GRAM shown around seroma
1 3-GRAM around seroma on
1 3-GRAM seroma on reexcision
1 3-GRAM on reexcision .
1 3-GRAM reexcision . STOP
1 3-GRAM * 2 were
1 3-GRAM 2 were nonviable
1 3-GRAM were nonviable ,
1 3-GRAM nonviable , and
1 3-GRAM and the mutant
1 3-GRAM the mutant Vp1s
1 3-GRAM mutant Vp1s unexpectedly
1 3-GRAM Vp1s unexpectedly failed
1 3-GRAM unexpectedly failed to
1 3-GRAM failed to localize
1 3-GRAM to localize to
1 3-GRAM localize to the
1 3-GRAM to the nucleus
1 3-GRAM the nucleus though
1 3-GRAM nucleus though Vp2
1 3-GRAM though Vp2 and
1 3-GRAM Vp2 and Vp3
1 3-GRAM and Vp3 did
1 3-GRAM Vp3 did ,
1 3-GRAM did , suggesting
1 3-GRAM , suggesting that
1 3-GRAM suggesting that the
1 3-GRAM that the mutated
1 3-GRAM the mutated NLS1
1 3-GRAM mutated NLS1 acted
1 3-GRAM NLS1 acted as
1 3-GRAM acted as a
1 3-GRAM as a dominant
1 3-GRAM a dominant signal
1 3-GRAM dominant signal for
1 3-GRAM signal for the
1 3-GRAM for the cytoplasmic
1 3-GRAM the cytoplasmic localization
1 3-GRAM cytoplasmic localization of
1 3-GRAM localization of Vp1
1 3-GRAM of Vp1 .
1 3-GRAM Vp1 . STOP
1 3-GRAM * * Compared
1 3-GRAM * Compared with
1 3-GRAM Compared with normal
1 3-GRAM with normal control
1 3-GRAM normal control subjects
1 3-GRAM control subjects ,
1 3-GRAM subjects , all
1 3-GRAM , all 74
1 3-GRAM all 74 TOF
1 3-GRAM 74 TOF patients
1 3-GRAM TOF patients had
1 3-GRAM patients had decreased
1 3-GRAM had decreased systolic
1 3-GRAM decreased systolic and
1 3-GRAM systolic and diastolic
1 3-GRAM and diastolic myocardial
1 3-GRAM diastolic myocardial velocities
1 3-GRAM myocardial velocities and
1 3-GRAM velocities and a
1 3-GRAM and a longer
1 3-GRAM a longer isovolumic
1 3-GRAM longer isovolumic relaxation
1 3-GRAM isovolumic relaxation time
1 3-GRAM relaxation time .
1 3-GRAM time . STOP
1 3-GRAM * The corresponding
1 3-GRAM The corresponding orifice
1 3-GRAM corresponding orifice voltages
1 3-GRAM orifice voltages for
1 3-GRAM voltages for the
1 3-GRAM for the three
1 3-GRAM the three instruments
1 3-GRAM three instruments were
1 3-GRAM instruments were 20
1 3-GRAM were 20 /
1 3-GRAM 20 / 50
1 3-GRAM / 50 /
1 3-GRAM 50 / 80
1 3-GRAM / 80 V
1 3-GRAM 80 V (
3 3-GRAM V ( API
1 3-GRAM ( API 365
1 3-GRAM API 365 ),
1 3-GRAM 365 ), 30
1 3-GRAM ), 30 /
1 3-GRAM 30 / 90
1 3-GRAM / 90 /
1 3-GRAM 90 / 130
1 3-GRAM / 130 V
1 3-GRAM 130 V (
1 3-GRAM ( API 2000
1 3-GRAM API 2000 )
1 3-GRAM 2000 ) and
1 3-GRAM ) and 40
1 3-GRAM and 40 /
1 3-GRAM 40 / 80
1 3-GRAM / 80 /
1 3-GRAM 80 / 120
1 3-GRAM / 120 V
1 3-GRAM 120 V (
1 3-GRAM ( API 3000
1 3-GRAM API 3000 ).
1 3-GRAM 3000 ). STOP
1 3-GRAM * We compared
1 3-GRAM We compared previously
1 3-GRAM compared previously the
1 3-GRAM previously the methylation
1 3-GRAM the methylation status
1 3-GRAM methylation status between
1 3-GRAM status between normal
1 3-GRAM between normal liver
1 3-GRAM normal liver and
1 3-GRAM liver and liver
1 3-GRAM and liver tumors
1 3-GRAM liver tumors in
1 3-GRAM tumors in SV40
1 3-GRAM in SV40 T
1 3-GRAM SV40 T /
1 3-GRAM T / t
1 3-GRAM / t antigen
1 3-GRAM t antigen transgenic
1 3-GRAM antigen transgenic mice
1 3-GRAM transgenic mice (
1 3-GRAM mice ( MT
1 3-GRAM ( MT -
1 3-GRAM MT - D2
1 3-GRAM - D2 mice
1 3-GRAM D2 mice )
1 3-GRAM mice ) using
1 3-GRAM ) using Restriction
1 3-GRAM using Restriction Landmark
1 3-GRAM Restriction Landmark Genomic
1 3-GRAM Landmark Genomic Scanning
1 3-GRAM Genomic Scanning for
1 3-GRAM Scanning for Methylation
1 3-GRAM for Methylation (
1 3-GRAM Methylation ( RLGS
1 3-GRAM ( RLGS -
1 3-GRAM RLGS - M
1 3-GRAM - M )
1 3-GRAM M ) and
1 3-GRAM and identified several
1 3-GRAM identified several loci
1 3-GRAM several loci /
1 3-GRAM loci / spots
1 3-GRAM / spots that
1 3-GRAM spots that appeared
1 3-GRAM that appeared to
1 3-GRAM appeared to be
1 3-GRAM to be methylated
1 3-GRAM be methylated frequently
1 3-GRAM methylated frequently in
1 3-GRAM frequently in liver
1 3-GRAM in liver tumors
1 3-GRAM liver tumors .
2 3-GRAM tumors . STOP
1 3-GRAM We have cloned
1 3-GRAM have cloned a
1 3-GRAM cloned a novel
1 3-GRAM a novel mouse
1 3-GRAM novel mouse protein
1 3-GRAM mouse protein ,
1 3-GRAM protein , TAF
1 3-GRAM , TAF (
1 3-GRAM TAF ( II
2 3-GRAM ( II )
1 3-GRAM II ) 140
1 3-GRAM ) 140 ,
1 3-GRAM 140 , containing
1 3-GRAM , containing an
1 3-GRAM containing an HFD
1 3-GRAM an HFD and
1 3-GRAM HFD and a
1 3-GRAM and a plant
1 3-GRAM a plant homeodomain
1 3-GRAM plant homeodomain (
1 3-GRAM homeodomain ( PHD
1 3-GRAM ( PHD )
1 3-GRAM PHD ) finger
1 3-GRAM ) finger ,
1 3-GRAM finger , which
2 3-GRAM , which we
1 3-GRAM which we demonstrated
1 3-GRAM we demonstrated by
1 3-GRAM demonstrated by immunoprecipitation
1 3-GRAM by immunoprecipitation to
1 3-GRAM immunoprecipitation to be
1 3-GRAM be a mammalian
1 3-GRAM a mammalian TFIID
1 3-GRAM mammalian TFIID component
1 3-GRAM TFIID component .
1 3-GRAM component . STOP
1 3-GRAM * * 3D
1 3-GRAM * 3D image
1 3-GRAM 3D image -
1 3-GRAM image - processing
1 3-GRAM - processing permits
1 3-GRAM processing permits to
1 3-GRAM permits to analyse
1 3-GRAM to analyse ultrasound
1 3-GRAM analyse ultrasound data
1 3-GRAM ultrasound data interactively
1 3-GRAM data interactively in
1 3-GRAM interactively in three
1 3-GRAM in three orthogonal
1 3-GRAM three orthogonal planes
1 3-GRAM orthogonal planes (
1 3-GRAM planes ( section
1 3-GRAM ( section mode
1 3-GRAM section mode )
1 3-GRAM mode ) or
1 3-GRAM ) or in
1 3-GRAM or in realistic
1 3-GRAM in realistic 3D
1 3-GRAM realistic 3D views
1 3-GRAM 3D views (
1 3-GRAM views ( rendering
1 3-GRAM ( rendering mode
1 3-GRAM rendering mode ).
1 3-GRAM mode ). STOP
1 3-GRAM * A proposal
1 3-GRAM A proposal of
1 3-GRAM proposal of 50
1 3-GRAM of 50 performance
1 3-GRAM 50 performance indicators
1 3-GRAM performance indicators divided
1 3-GRAM indicators divided into
1 3-GRAM divided into five
1 3-GRAM into five different
1 3-GRAM five different groups
1 3-GRAM different groups is
1 3-GRAM groups is presented
1 3-GRAM is presented here
1 3-GRAM presented here ,
1 3-GRAM here , namely
1 3-GRAM , namely structural
1 3-GRAM namely structural indicators
1 3-GRAM structural indicators ,
1 3-GRAM indicators , operational
1 3-GRAM , operational indicators
1 3-GRAM operational indicators ,
1 3-GRAM indicators , water
1 3-GRAM , water and
1 3-GRAM water and service
1 3-GRAM and service quality
1 3-GRAM service quality indicators
1 3-GRAM quality indicators ,
1 3-GRAM indicators , personnel
1 3-GRAM , personnel indicators
1 3-GRAM personnel indicators and
1 3-GRAM indicators and economic
1 3-GRAM and economic indicators
1 3-GRAM economic indicators .
1 3-GRAM indicators . STOP
1 3-GRAM * These analyses
1 3-GRAM These analyses re
1 3-GRAM analyses re -
1 3-GRAM re - open
1 3-GRAM - open the
1 3-GRAM open the question
1 3-GRAM the question whether
1 3-GRAM question whether all
1 3-GRAM whether all the
1 3-GRAM all the CesA
1 3-GRAM the CesA genes
1 3-GRAM CesA genes encode
1 3-GRAM genes encode cellulose
1 3-GRAM encode cellulose synthases
1 3-GRAM cellulose synthases or
1 3-GRAM synthases or whether
1 3-GRAM or whether some
1 3-GRAM whether some of
1 3-GRAM some of the
1 3-GRAM of the sub
1 3-GRAM the sub -
1 3-GRAM sub - class
1 3-GRAM - class members
1 3-GRAM class members may
1 3-GRAM members may encode
1 3-GRAM may encode other
1 3-GRAM encode other non
1 3-GRAM other non -
1 3-GRAM non - cellulosic
1 3-GRAM - cellulosic (
1 3-GRAM cellulosic ( 1
1 3-GRAM ( 1 -->
1 3-GRAM 1 --> 4
1 3-GRAM --> 4 )
1 3-GRAM 4 ) beta
1 3-GRAM ) beta -
1 3-GRAM beta - glycan
1 3-GRAM - glycan synthases
1 3-GRAM glycan synthases in
1 3-GRAM synthases in plants
1 3-GRAM in plants .
1 3-GRAM plants . STOP
1 3-GRAM * The relationship
1 3-GRAM The relationship of
1 3-GRAM relationship of the
1 3-GRAM of the factor
1 3-GRAM the factor V
1 3-GRAM factor V Leiden
1 3-GRAM V Leiden mutation
1 3-GRAM Leiden mutation or
1 3-GRAM mutation or the
1 3-GRAM or the deletion
1 3-GRAM the deletion -
1 3-GRAM deletion - deletion
1 3-GRAM - deletion polymorphism
1 3-GRAM deletion polymorphism of
1 3-GRAM polymorphism of the
1 3-GRAM of the angiotensin
1 3-GRAM the angiotensin converting
1 3-GRAM angiotensin converting enzyme
1 3-GRAM converting enzyme to
1 3-GRAM enzyme to postoperative
1 3-GRAM to postoperative thromboembolic
1 3-GRAM postoperative thromboembolic events
1 3-GRAM thromboembolic events following
1 3-GRAM events following total
1 3-GRAM following total joint
1 3-GRAM total joint arthroplasty
1 3-GRAM joint arthroplasty .
1 3-GRAM arthroplasty . STOP
1 3-GRAM contrast , exogenous
1 3-GRAM , exogenous PTHrP1
1 3-GRAM exogenous PTHrP1 -
1 3-GRAM PTHrP1 - 34
1 3-GRAM - 34 and
1 3-GRAM 34 and 1
1 3-GRAM and 1 -
1 3-GRAM 1 - 86
1 3-GRAM - 86 peptides
1 3-GRAM 86 peptides did
1 3-GRAM peptides did not
1 3-GRAM did not significantly
1 3-GRAM not significantly affect
1 3-GRAM significantly affect IL
1 3-GRAM affect IL -
2 3-GRAM IL - 8
1 3-GRAM - 8 production
1 3-GRAM 8 production ;
1 3-GRAM production ; moreover
1 3-GRAM ; moreover ,
1 3-GRAM moreover , PTHrP
1 3-GRAM , PTHrP -
1 3-GRAM PTHrP - neutralizing
1 3-GRAM - neutralizing antibodies
1 3-GRAM neutralizing antibodies did
1 3-GRAM antibodies did not
1 3-GRAM did not inhibit
1 3-GRAM not inhibit the
1 3-GRAM inhibit the production
3 3-GRAM the production of
1 3-GRAM production of IL
1 3-GRAM of IL -
1 3-GRAM - 8 by
1 3-GRAM 8 by transfected
1 3-GRAM by transfected PTHrP
1 3-GRAM transfected PTHrP .
1 3-GRAM PTHrP . STOP
3 3-GRAM * * Furthermore
3 3-GRAM * Furthermore ,
1 3-GRAM Furthermore , this
1 3-GRAM , this kinase
1 3-GRAM this kinase -
1 3-GRAM kinase - deficient
1 3-GRAM - deficient mutant
1 3-GRAM deficient mutant inhibited
1 3-GRAM mutant inhibited 2
1 3-GRAM inhibited 2 -
1 3-GRAM 2 - MeSADP
1 3-GRAM - MeSADP -
1 3-GRAM MeSADP - induced
1 3-GRAM - induced caspase
1 3-GRAM induced caspase -
1 3-GRAM caspase - 3
1 3-GRAM - 3 stimulation
1 3-GRAM 3 stimulation and
1 3-GRAM stimulation and the
1 3-GRAM and the associated
1 3-GRAM the associated decrease
1 3-GRAM associated decrease in
1 3-GRAM decrease in cell
1 3-GRAM in cell number
1 3-GRAM cell number .
1 3-GRAM number . STOP
1 3-GRAM * * Against
1 3-GRAM * Against gram
1 3-GRAM Against gram -
1 3-GRAM gram - positive
1 3-GRAM - positive organisms
1 3-GRAM positive organisms ,
1 3-GRAM organisms , E
1 3-GRAM , E -
1 3-GRAM E - 4767
1 3-GRAM - 4767 and
1 3-GRAM 4767 and E
1 3-GRAM and E -
1 3-GRAM E - 5065
1 3-GRAM - 5065 were
1 3-GRAM 5065 were ,
1 3-GRAM were , in
1 3-GRAM , in general
1 3-GRAM in general ,
1 3-GRAM general , eight
1 3-GRAM , eight -
1 3-GRAM eight - and
1 3-GRAM - and fourfold
1 3-GRAM and fourfold more
1 3-GRAM fourfold more active
1 3-GRAM more active than
1 3-GRAM active than tosufloxacin
1 3-GRAM than tosufloxacin ,
1 3-GRAM tosufloxacin , which
4 3-GRAM , which is
1 3-GRAM which is the
1 3-GRAM is the most
1 3-GRAM the most potent
1 3-GRAM most potent of
1 3-GRAM potent of the
1 3-GRAM of the reference
1 3-GRAM the reference compounds
1 3-GRAM reference compounds .
1 3-GRAM compounds . STOP
2 3-GRAM * The results
1 3-GRAM The results presented
1 3-GRAM results presented here
1 3-GRAM presented here show
1 3-GRAM here show that
1 3-GRAM show that AR1
1 3-GRAM that AR1 of
1 3-GRAM AR1 of the
2 3-GRAM of the promoter
1 3-GRAM the promoter -
1 3-GRAM promoter - proximal
1 3-GRAM - proximal CAP
1 3-GRAM proximal CAP subunit
1 3-GRAM CAP subunit was
1 3-GRAM subunit was required
1 3-GRAM was required for
1 3-GRAM required for papBA
1 3-GRAM for papBA transcription
1 3-GRAM papBA transcription even
1 3-GRAM transcription even in
1 3-GRAM absence of the
1 3-GRAM of the histone
1 3-GRAM the histone -
1 3-GRAM histone - like
1 3-GRAM - like protein
1 3-GRAM like protein H
1 3-GRAM protein H -
1 3-GRAM H - NS
1 3-GRAM - NS .
1 3-GRAM NS . STOP
1 3-GRAM CONCLUSIONS : Under
1 3-GRAM : Under current
1 3-GRAM Under current immunization
1 3-GRAM current immunization practices
1 3-GRAM immunization practices ,
1 3-GRAM practices , the
1 3-GRAM , the authors
1 3-GRAM the authors estimate
1 3-GRAM authors estimate that
1 3-GRAM estimate that nearly
1 3-GRAM that nearly 13
1 3-GRAM nearly 13 ,
1 3-GRAM 13 , 000
1 3-GRAM , 000 Asian
1 3-GRAM 000 Asian and
1 3-GRAM Asian and Pacific
1 3-GRAM and Pacific Islander
1 3-GRAM Pacific Islander children
1 3-GRAM Islander children living
1 3-GRAM children living in
1 3-GRAM living in the
2 3-GRAM in the United
2 3-GRAM the United States
1 3-GRAM United States today
1 3-GRAM States today will
1 3-GRAM today will become
1 3-GRAM will become infected
1 3-GRAM become infected with
1 3-GRAM infected with HBV
1 3-GRAM with HBV in
1 3-GRAM HBV in the
1 3-GRAM in the future
1 3-GRAM the future ,
1 3-GRAM future , resulting
1 3-GRAM , resulting in
1 3-GRAM resulting in more
1 3-GRAM in more than
1 3-GRAM more than 600
1 3-GRAM than 600 liver
1 3-GRAM 600 liver carcinoma
1 3-GRAM liver carcinoma deaths
1 3-GRAM carcinoma deaths .
1 3-GRAM deaths . STOP
1 3-GRAM METHODS : A
1 3-GRAM : A structured
1 3-GRAM A structured interview
1 3-GRAM structured interview was
1 3-GRAM interview was undertaken
1 3-GRAM was undertaken at
1 3-GRAM undertaken at the
1 3-GRAM at the time
1 3-GRAM the time of
1 3-GRAM time of initial
1 3-GRAM of initial consultation
1 3-GRAM initial consultation and
1 3-GRAM consultation and at
1 3-GRAM and at subsequent
1 3-GRAM at subsequent 1
1 3-GRAM subsequent 1 -
1 3-GRAM 1 - year
1 3-GRAM - year intervals
1 3-GRAM year intervals regarding
1 3-GRAM intervals regarding type
1 3-GRAM regarding type of
1 3-GRAM type of BHS
1 3-GRAM of BHS ,
1 3-GRAM BHS , frequency
1 3-GRAM , frequency of
1 3-GRAM frequency of spells
1 3-GRAM of spells ,
1 3-GRAM spells , associated
1 3-GRAM , associated phenomenon
1 3-GRAM associated phenomenon ,
1 3-GRAM phenomenon , sequelae
1 3-GRAM , sequelae ,
1 3-GRAM sequelae , family
1 3-GRAM , family history
1 3-GRAM family history ,
1 3-GRAM history , and
1 3-GRAM , and age
1 3-GRAM and age at
1 3-GRAM age at termination
1 3-GRAM at termination of
1 3-GRAM termination of spells
1 3-GRAM of spells .
1 3-GRAM spells . STOP
1 3-GRAM * * Cell
1 3-GRAM * Cell .
1 3-GRAM Cell . STOP
1 3-GRAM * * Rapid
1 3-GRAM * Rapid evolution
1 3-GRAM Rapid evolution of
1 3-GRAM evolution of the
1 3-GRAM of the DNA
1 3-GRAM the DNA -
1 3-GRAM DNA - binding
1 3-GRAM - binding site
1 3-GRAM binding site in
1 3-GRAM site in LAGLIDADG
1 3-GRAM in LAGLIDADG homing
1 3-GRAM LAGLIDADG homing endonucleases
1 3-GRAM homing endonucleases .
1 3-GRAM endonucleases . STOP
1 3-GRAM * These mutations
1 3-GRAM These mutations ,
1 3-GRAM mutations , when
1 3-GRAM , when placed
1 3-GRAM when placed in
1 3-GRAM placed in a
1 3-GRAM in a wild
1 3-GRAM a wild -
1 3-GRAM - type fliF
1 3-GRAM type fliF background
1 3-GRAM fliF background ,
1 3-GRAM background , had
1 3-GRAM , had no
1 3-GRAM had no mutant
1 3-GRAM no mutant phenotype
1 3-GRAM mutant phenotype .
2 3-GRAM * * Inhibition
2 3-GRAM * Inhibition of
1 3-GRAM Inhibition of JNK1
1 3-GRAM of JNK1 and
1 3-GRAM JNK1 and ERK
1 3-GRAM and ERK kinase
1 3-GRAM ERK kinase activities
1 3-GRAM kinase activities either
1 3-GRAM activities either by
1 3-GRAM either by expression
1 3-GRAM by expression of
1 3-GRAM of the dominant
1 3-GRAM the dominant negative
1 3-GRAM dominant negative mutant
1 3-GRAM negative mutant JNK1
1 3-GRAM mutant JNK1 or
1 3-GRAM JNK1 or by
1 3-GRAM or by treatment
1 3-GRAM by treatment with
1 3-GRAM treatment with a
1 3-GRAM with a selective
1 3-GRAM a selective chemical
1 3-GRAM selective chemical inhibitor
1 3-GRAM chemical inhibitor of
1 3-GRAM inhibitor of ERK
1 3-GRAM of ERK (
1 3-GRAM ERK ( PD098059
1 3-GRAM ( PD098059 )
1 3-GRAM PD098059 ) substantially
1 3-GRAM ) substantially abrogates
1 3-GRAM substantially abrogates the
1 3-GRAM abrogates the UV
1 3-GRAM the UV induction
1 3-GRAM UV induction of
1 3-GRAM induction of the
1 3-GRAM of the GADD45
1 3-GRAM the GADD45 promoter
1 3-GRAM GADD45 promoter .
1 3-GRAM * At termination
1 3-GRAM At termination (
1 3-GRAM termination ( gd
1 3-GRAM ( gd 20
1 3-GRAM gd 20 ),
1 3-GRAM 20 ), confirmed
1 3-GRAM ), confirmed -
1 3-GRAM confirmed - pregnant
1 3-GRAM - pregnant females
1 3-GRAM pregnant females (
1 3-GRAM females ( 21
1 3-GRAM ( 21 to
1 3-GRAM 21 to 25
1 3-GRAM to 25 per
1 3-GRAM 25 per group
1 3-GRAM per group )
1 3-GRAM group ) were
1 3-GRAM ) were evaluated
1 3-GRAM were evaluated for
1 3-GRAM evaluated for clinical
1 3-GRAM for clinical status
1 3-GRAM clinical status and
1 3-GRAM status and gestational
1 3-GRAM and gestational outcome
1 3-GRAM gestational outcome ;
1 3-GRAM outcome ; live
1 3-GRAM ; live fetuses
1 3-GRAM live fetuses were
1 3-GRAM fetuses were examined
1 3-GRAM were examined for
1 3-GRAM examined for external
1 3-GRAM for external ,
1 3-GRAM external , visceral
1 3-GRAM , visceral ,
1 3-GRAM visceral , and
1 3-GRAM , and skeletal
1 3-GRAM and skeletal malformations
1 3-GRAM skeletal malformations .
1 3-GRAM malformations . STOP
1 3-GRAM * In mammals
1 3-GRAM In mammals ,
1 3-GRAM mammals , the
1 3-GRAM , the transcriptional
1 3-GRAM the transcriptional repressors
1 3-GRAM transcriptional repressors in
1 3-GRAM repressors in the
1 3-GRAM in the Wnt
1 3-GRAM the Wnt pathway
1 3-GRAM Wnt pathway are
1 3-GRAM pathway are not
1 3-GRAM are not well
1 3-GRAM not well defined
1 3-GRAM well defined .
1 3-GRAM defined . STOP
1 3-GRAM * * Intravenous
1 3-GRAM * Intravenous L
1 3-GRAM Intravenous L -
1 3-GRAM L - carnitine
1 3-GRAM - carnitine treatment
1 3-GRAM carnitine treatment increased
1 3-GRAM treatment increased plasma
1 3-GRAM increased plasma carnitine
1 3-GRAM plasma carnitine concentrations
1 3-GRAM carnitine concentrations ,
1 3-GRAM concentrations , improved
1 3-GRAM , improved patient
1 3-GRAM improved patient -
1 3-GRAM patient - assessed
1 3-GRAM - assessed fatigue
1 3-GRAM assessed fatigue ,
1 3-GRAM fatigue , and
1 3-GRAM , and may
1 3-GRAM and may prevent
1 3-GRAM may prevent the
1 3-GRAM prevent the decline
1 3-GRAM the decline in
1 3-GRAM decline in peak
1 3-GRAM in peak exercise
1 3-GRAM peak exercise capacity
1 3-GRAM exercise capacity in
1 3-GRAM capacity in hemodialysis
1 3-GRAM in hemodialysis patients
1 3-GRAM hemodialysis patients .
2 3-GRAM patients . STOP
1 3-GRAM * The Van
1 3-GRAM The Van der
1 3-GRAM Van der Hoeve
1 3-GRAM der Hoeve '
1 3-GRAM Hoeve ' s
2 3-GRAM ' s syndrome
1 3-GRAM s syndrome lesions
1 3-GRAM syndrome lesions as
1 3-GRAM lesions as poorly
1 3-GRAM as poorly mineralized
1 3-GRAM poorly mineralized ,
1 3-GRAM mineralized , with
1 3-GRAM with low calcium
1 3-GRAM low calcium salt
1 3-GRAM calcium salt and
1 3-GRAM salt and apparent
1 3-GRAM and apparent increase
1 3-GRAM apparent increase of
1 3-GRAM increase of phosphates
1 3-GRAM of phosphates .
1 3-GRAM phosphates . STOP
1 3-GRAM * A computerized
1 3-GRAM A computerized method
1 3-GRAM computerized method of
1 3-GRAM method of determining
1 3-GRAM of determining the
1 3-GRAM determining the focal
1 3-GRAM the focal point
1 3-GRAM focal point of
1 3-GRAM point of electrical
1 3-GRAM of electrical activity
1 3-GRAM electrical activity in
2 3-GRAM activity in the
1 3-GRAM in the pallidum
1 3-GRAM the pallidum of
1 3-GRAM pallidum of parkinsonian
1 3-GRAM of parkinsonian patients
1 3-GRAM parkinsonian patients was
1 3-GRAM patients was developed
1 3-GRAM was developed using
1 3-GRAM developed using on
1 3-GRAM using on -
1 3-GRAM on - line
1 3-GRAM - line quantitative
1 3-GRAM line quantitative physiological
1 3-GRAM quantitative physiological data
1 3-GRAM physiological data analysis
1 3-GRAM data analysis .
2 3-GRAM * The first
1 3-GRAM The first hypothesis
1 3-GRAM first hypothesis was
1 3-GRAM hypothesis was supported
1 3-GRAM was supported in
1 3-GRAM supported in the
1 3-GRAM in the sense
1 3-GRAM the sense that
1 3-GRAM sense that stimulus
1 3-GRAM that stimulus differences
1 3-GRAM stimulus differences might
1 3-GRAM differences might affect
1 3-GRAM might affect behaviour
1 3-GRAM affect behaviour even
1 3-GRAM behaviour even without
1 3-GRAM even without their
1 3-GRAM without their successful
1 3-GRAM their successful attentive
1 3-GRAM successful attentive processing
1 3-GRAM attentive processing in
1 3-GRAM processing in normal
1 3-GRAM in normal participants
1 3-GRAM normal participants .
1 3-GRAM participants . STOP
1 3-GRAM * We interpret
1 3-GRAM We interpret these
1 3-GRAM interpret these data
1 3-GRAM these data as
1 3-GRAM data as further
1 3-GRAM as further evidence
1 3-GRAM further evidence that
1 3-GRAM evidence that interaction
1 3-GRAM that interaction with
1 3-GRAM interaction with a
1 3-GRAM with a small
1 3-GRAM a small GTPase
1 3-GRAM small GTPase is
1 3-GRAM GTPase is the
1 3-GRAM is the main
1 3-GRAM the main regulatory
1 3-GRAM main regulatory function
1 3-GRAM regulatory function of
1 3-GRAM function of the
1 3-GRAM of the C1
1 3-GRAM the C1 domain
1 3-GRAM C1 domain in
1 3-GRAM domain in yeast
1 3-GRAM in yeast .
1 3-GRAM yeast . STOP
1 3-GRAM * This effect
1 3-GRAM This effect was
1 3-GRAM effect was observed
1 3-GRAM was observed in
1 3-GRAM observed in the
1 3-GRAM absence of de
1 3-GRAM of de novo
2 3-GRAM de novo protein
2 3-GRAM novo protein synthesis
1 3-GRAM protein synthesis and
1 3-GRAM synthesis and was
1 3-GRAM and was independent
1 3-GRAM was independent of
1 3-GRAM independent of histone
1 3-GRAM of histone deacetylase
1 3-GRAM histone deacetylase activity
1 3-GRAM deacetylase activity .
1 3-GRAM * Mutation analyses
1 3-GRAM Mutation analyses identified
1 3-GRAM analyses identified the
1 3-GRAM identified the cobalt
1 3-GRAM the cobalt -
1 3-GRAM cobalt - responsive
1 3-GRAM - responsive sequences
1 3-GRAM responsive sequences as
1 3-GRAM sequences as the
1 3-GRAM as the stress
1 3-GRAM the stress -
1 3-GRAM stress - response
1 3-GRAM - response elements
1 3-GRAM response elements (
1 3-GRAM elements ( StREs
1 3-GRAM ( StREs ).
1 3-GRAM StREs ). STOP
1 3-GRAM * In order
1 3-GRAM In order to
1 3-GRAM order to quantify
1 3-GRAM to quantify these
1 3-GRAM quantify these effects
1 3-GRAM these effects ,
1 3-GRAM effects , tests
1 3-GRAM , tests were
1 3-GRAM tests were conducted
1 3-GRAM were conducted in
1 3-GRAM conducted in the
2 3-GRAM in the NASA
1 3-GRAM the NASA MSFC
1 3-GRAM NASA MSFC Neutral
1 3-GRAM MSFC Neutral Buoyancy
1 3-GRAM Neutral Buoyancy Simulator
1 3-GRAM Buoyancy Simulator ,
1 3-GRAM Simulator , in
1 3-GRAM the NASA KC
1 3-GRAM NASA KC -
1 3-GRAM KC - 135
1 3-GRAM - 135 in
1 3-GRAM 135 in parabolic
1 3-GRAM in parabolic flight
1 3-GRAM parabolic flight ,
1 3-GRAM flight , and
1 3-GRAM , and in
1 3-GRAM and in space
1 3-GRAM in space with
1 3-GRAM space with the
1 3-GRAM with the EASE
1 3-GRAM the EASE program
1 3-GRAM EASE program during
1 3-GRAM program during the
1 3-GRAM during the Shuttle
1 3-GRAM the Shuttle Atlantis
1 3-GRAM Shuttle Atlantis mission
1 3-GRAM Atlantis mission 61
1 3-GRAM mission 61 -
1 3-GRAM 61 - B
1 3-GRAM - B .
1 3-GRAM B . STOP
1 3-GRAM : To investigate
1 3-GRAM investigate the association
1 3-GRAM the association between
1 3-GRAM association between complete
1 3-GRAM between complete congenital
1 3-GRAM complete congenital heart
1 3-GRAM congenital heart block
1 3-GRAM heart block (
1 3-GRAM block ( CCHB
1 3-GRAM ( CCHB )
1 3-GRAM CCHB ) in
2 3-GRAM ) in the
1 3-GRAM in the fetus
1 3-GRAM the fetus and
1 3-GRAM fetus and adult
1 3-GRAM and adult disease
1 3-GRAM adult disease .
1 3-GRAM disease . STOP
1 3-GRAM The present chemotherapy
1 3-GRAM present chemotherapy of
1 3-GRAM chemotherapy of AE
1 3-GRAM of AE is
1 3-GRAM AE is based
1 3-GRAM on the administration
1 3-GRAM the administration of
1 3-GRAM administration of benzimidazole
1 3-GRAM of benzimidazole carbamate
1 3-GRAM benzimidazole carbamate derivatives
1 3-GRAM carbamate derivatives ,
1 3-GRAM derivatives , such
1 3-GRAM , such as
1 3-GRAM such as mebendazole
1 3-GRAM as mebendazole and
1 3-GRAM mebendazole and albendazole
1 3-GRAM and albendazole .
1 3-GRAM albendazole . STOP
1 3-GRAM * The uptake
1 3-GRAM The uptake of
1 3-GRAM uptake of fluorine
1 3-GRAM of fluorine -
1 3-GRAM fluorine - 18
1 3-GRAM - 18 fluorodeoxyglucose
1 3-GRAM 18 fluorodeoxyglucose (
1 3-GRAM fluorodeoxyglucose ( F
1 3-GRAM ( F -
1 3-GRAM F - 18
1 3-GRAM - 18 FDG
1 3-GRAM 18 FDG )
1 3-GRAM FDG ) by
1 3-GRAM ) by a
1 3-GRAM by a malignant
1 3-GRAM a malignant tumor
1 3-GRAM malignant tumor depends
1 3-GRAM tumor depends on
1 3-GRAM depends on the
1 3-GRAM on the blood
1 3-GRAM the blood glucose
1 3-GRAM blood glucose level
1 3-GRAM glucose level .
1 3-GRAM level . STOP
1 3-GRAM * * Deterministic
1 3-GRAM * Deterministic effects
1 3-GRAM Deterministic effects .
1 3-GRAM effects . STOP
1 3-GRAM DESIGN : A
1 3-GRAM : A retrospective
1 3-GRAM A retrospective chart
1 3-GRAM retrospective chart review
1 3-GRAM chart review of
1 3-GRAM review of 9
1 3-GRAM of 9 ,
1 3-GRAM 9 , 322
1 3-GRAM , 322 patients
1 3-GRAM 322 patients undergoing
1 3-GRAM patients undergoing surgical
1 3-GRAM undergoing surgical procedures
1 3-GRAM surgical procedures in
1 3-GRAM procedures in the
1 3-GRAM in the period
1 3-GRAM the period January
1 3-GRAM period January 1993
1 3-GRAM January 1993 to
1 3-GRAM 1993 to December
1 3-GRAM to December 1998
1 3-GRAM December 1998 .
1 3-GRAM 1998 . STOP
1 3-GRAM * * Peripheral
1 3-GRAM * Peripheral and
1 3-GRAM Peripheral and preemptive
1 3-GRAM and preemptive opioid
1 3-GRAM preemptive opioid antinociception
1 3-GRAM opioid antinociception in
1 3-GRAM antinociception in a
1 3-GRAM in a mouse
1 3-GRAM a mouse visceral
1 3-GRAM mouse visceral pain
1 3-GRAM visceral pain model
1 3-GRAM pain model .
1 3-GRAM model . STOP
2 3-GRAM METHODS : We
1 3-GRAM : We studied
1 3-GRAM We studied the
1 3-GRAM studied the clinical
1 3-GRAM the clinical benefit
1 3-GRAM clinical benefit of
1 3-GRAM benefit of depth
1 3-GRAM of depth -
1 3-GRAM depth - dependent
1 3-GRAM - dependent RR
1 3-GRAM dependent RR ,
1 3-GRAM RR , nonuniform
1 3-GRAM , nonuniform AC
1 3-GRAM nonuniform AC using
1 3-GRAM AC using a
1 3-GRAM using a scanning
1 3-GRAM a scanning line
1 3-GRAM scanning line source
1 3-GRAM line source ,
1 3-GRAM source , and
1 3-GRAM , and scatter
1 3-GRAM and scatter correction
1 3-GRAM scatter correction (
1 3-GRAM correction ( photon
1 3-GRAM ( photon energy
1 3-GRAM photon energy recovery
1 3-GRAM energy recovery [
1 3-GRAM recovery [ PER
1 3-GRAM [ PER ])
1 3-GRAM PER ]) compared
1 3-GRAM ]) compared with
1 3-GRAM compared with filtered
1 3-GRAM with filtered backprojection
1 3-GRAM filtered backprojection alone
1 3-GRAM backprojection alone .
1 3-GRAM alone . STOP
1 3-GRAM * * Cloning
1 3-GRAM * Cloning and
1 3-GRAM Cloning and characterization
1 3-GRAM of the murine
1 3-GRAM the murine beta
1 3-GRAM murine beta (
1 3-GRAM beta ( 3
1 3-GRAM 3 ) integrin
1 3-GRAM ) integrin gene
1 3-GRAM integrin gene promoter
1 3-GRAM gene promoter :
1 3-GRAM promoter : identification
1 3-GRAM : identification of
1 3-GRAM identification of an
1 3-GRAM of an interleukin
1 3-GRAM an interleukin -
1 3-GRAM interleukin - 4
1 3-GRAM - 4 responsive
1 3-GRAM 4 responsive element
1 3-GRAM responsive element and
1 3-GRAM element and regulation
1 3-GRAM and regulation by
1 3-GRAM regulation by STAT
1 3-GRAM by STAT -
1 3-GRAM STAT - 6
2 3-GRAM - 6 .
1 3-GRAM 6 . STOP
2 3-GRAM * * DNA
1 3-GRAM * DNA binding
1 3-GRAM DNA binding assays
1 3-GRAM binding assays confirmed
1 3-GRAM assays confirmed the
1 3-GRAM confirmed the interference
1 3-GRAM the interference of
1 3-GRAM interference of p30
1 3-GRAM of p30 (
1 3-GRAM p30 ( II
1 3-GRAM II ) with
1 3-GRAM ) with the
1 3-GRAM with the assembly
1 3-GRAM the assembly of
1 3-GRAM assembly of CREB
1 3-GRAM of CREB -
1 3-GRAM CREB - Tax
1 3-GRAM - Tax -
1 3-GRAM Tax - p300
1 3-GRAM - p300 /
1 3-GRAM p300 / CBP
1 3-GRAM / CBP multiprotein
1 3-GRAM CBP multiprotein complexes
1 3-GRAM multiprotein complexes on
1 3-GRAM complexes on 21
1 3-GRAM on 21 -
1 3-GRAM 21 - bp
1 3-GRAM - bp repeat
1 3-GRAM bp repeat oligonucleotides
1 3-GRAM repeat oligonucleotides in
1 3-GRAM oligonucleotides in vitro
1 3-GRAM in vitro .
1 3-GRAM vitro . STOP
1 3-GRAM * * Transient
1 3-GRAM * Transient transfections
1 3-GRAM Transient transfections showed
1 3-GRAM transfections showed that
1 3-GRAM showed that a
1 3-GRAM that a single
1 3-GRAM a single mutation
1 3-GRAM single mutation (
1 3-GRAM mutation ( 556M
1 3-GRAM ( 556M )
1 3-GRAM 556M ) decreased
1 3-GRAM ) decreased TBLV
1 3-GRAM decreased TBLV enhancer
1 3-GRAM TBLV enhancer activity
1 3-GRAM enhancer activity at
1 3-GRAM activity at least
1 3-GRAM at least 20
1 3-GRAM least 20 -
1 3-GRAM 20 - fold
1 3-GRAM - fold in
1 3-GRAM fold in two
2 3-GRAM in two different
1 3-GRAM two different T
1 3-GRAM different T -
1 3-GRAM - cell lines
4 3-GRAM * In conclusion
4 3-GRAM In conclusion ,
1 3-GRAM conclusion , tube
1 3-GRAM , tube size
1 3-GRAM tube size estimated
1 3-GRAM size estimated by
1 3-GRAM estimated by Cole
1 3-GRAM by Cole '
1 3-GRAM Cole ' s
1 3-GRAM ' s formula
1 3-GRAM s formula tends
1 3-GRAM formula tends to
1 3-GRAM tends to be
1 3-GRAM to be smaller
1 3-GRAM be smaller than
1 3-GRAM smaller than practically
1 3-GRAM than practically appropriate
1 3-GRAM practically appropriate tube
1 3-GRAM appropriate tube size
1 3-GRAM tube size for
1 3-GRAM size for pediatric
1 3-GRAM for pediatric cardiac
1 3-GRAM pediatric cardiac anesthesia
1 3-GRAM cardiac anesthesia ,
1 3-GRAM anesthesia , and
1 3-GRAM , and therefore
1 3-GRAM and therefore we
1 3-GRAM therefore we suggest
1 3-GRAM we suggest new
1 3-GRAM suggest new formula
1 3-GRAM new formula to
1 3-GRAM formula to estimate
1 3-GRAM to estimate the
1 3-GRAM estimate the tube
1 3-GRAM the tube size
1 3-GRAM tube size .
1 3-GRAM size . STOP
1 3-GRAM Thus , in
1 3-GRAM , in T47D
1 3-GRAM in T47D breast
1 3-GRAM T47D breast carcinoma
1 3-GRAM breast carcinoma cells
1 3-GRAM carcinoma cells ,
1 3-GRAM cells , IL
1 3-GRAM , IL -
2 3-GRAM IL - 6
1 3-GRAM - 6 acts
1 3-GRAM 6 acts in
1 3-GRAM acts in synergy
1 3-GRAM in synergy with
1 3-GRAM synergy with EGF
1 3-GRAM with EGF receptor
1 3-GRAM EGF receptor autocrine
1 3-GRAM receptor autocrine activity
1 3-GRAM autocrine activity to
1 3-GRAM activity to signal
1 3-GRAM to signal through
1 3-GRAM signal through the
1 3-GRAM through the MAPK
1 3-GRAM the MAPK /
1 3-GRAM MAPK / PI3K
1 3-GRAM / PI3K pathways
1 3-GRAM PI3K pathways .
1 3-GRAM pathways . STOP
1 3-GRAM * * Nerve
1 3-GRAM * Nerve growth
1 3-GRAM Nerve growth factor
2 3-GRAM growth factor (
1 3-GRAM factor ( NGF
1 3-GRAM ( NGF )
1 3-GRAM NGF ) and
1 3-GRAM ) and retinoic
1 3-GRAM and retinoic acid
1 3-GRAM retinoic acid (
1 3-GRAM acid ( RA
1 3-GRAM ( RA )
1 3-GRAM RA ) exert
1 3-GRAM ) exert important
1 3-GRAM exert important actions
1 3-GRAM important actions on
1 3-GRAM actions on PC12
1 3-GRAM on PC12 cells
1 3-GRAM PC12 cells .
1 3-GRAM * * HexA71
1 3-GRAM * HexA71 negatively
1 3-GRAM HexA71 negatively affects
1 3-GRAM negatively affects RpoS
1 3-GRAM affects RpoS ,
1 3-GRAM RpoS , as
1 3-GRAM , as the
1 3-GRAM as the levels
1 3-GRAM levels of this
1 3-GRAM of this alternative
1 3-GRAM this alternative sigma
1 3-GRAM alternative sigma factor
1 3-GRAM sigma factor are
1 3-GRAM factor are higher
1 3-GRAM are higher in
3 3-GRAM higher in the
2 3-GRAM in the HexA
1 3-GRAM the HexA -
1 3-GRAM HexA - mutant
1 3-GRAM - mutant than
1 3-GRAM mutant than in
2 3-GRAM than in the
1 3-GRAM the HexA +
1 3-GRAM HexA + strain
1 3-GRAM + strain .
2 3-GRAM strain . STOP
1 3-GRAM * * Moreover
1 3-GRAM * Moreover ,
1 3-GRAM Moreover , elderly
1 3-GRAM , elderly men
1 3-GRAM elderly men with
2 3-GRAM men with bioavailable
2 3-GRAM with bioavailable estradiol
2 3-GRAM bioavailable estradiol levels
1 3-GRAM estradiol levels below
1 3-GRAM levels below the
1 3-GRAM below the median
1 3-GRAM the median [
1 3-GRAM median [ 40
1 3-GRAM [ 40 pmol
2 3-GRAM 40 pmol /
2 3-GRAM pmol / liter
1 3-GRAM / liter (
1 3-GRAM liter ( 11
1 3-GRAM ( 11 pg
1 3-GRAM 11 pg /
1 3-GRAM / ml )]
1 3-GRAM ml )] had
1 3-GRAM )] had significantly
1 3-GRAM had significantly higher
1 3-GRAM significantly higher rates
1 3-GRAM higher rates of
1 3-GRAM rates of bone
1 3-GRAM of bone loss
1 3-GRAM bone loss and
1 3-GRAM loss and levels
1 3-GRAM and levels of
1 3-GRAM levels of bone
1 3-GRAM of bone resorption
1 3-GRAM bone resorption markers
1 3-GRAM resorption markers than
1 3-GRAM markers than men
1 3-GRAM than men with
1 3-GRAM estradiol levels above
1 3-GRAM levels above 40
1 3-GRAM above 40 pmol
1 3-GRAM / liter .
1 3-GRAM liter . STOP
1 3-GRAM * The histamine
1 3-GRAM The histamine H1
1 3-GRAM histamine H1 receptor
1 3-GRAM H1 receptor antagonists
1 3-GRAM receptor antagonists (
1 3-GRAM antagonists ( antihistamines
1 3-GRAM ( antihistamines )
1 3-GRAM antihistamines ) are
1 3-GRAM ) are an
1 3-GRAM are an important
1 3-GRAM an important class
1 3-GRAM important class of
1 3-GRAM class of medications
1 3-GRAM of medications used
1 3-GRAM medications used for
3 3-GRAM used for the
1 3-GRAM for the relief
1 3-GRAM the relief of
1 3-GRAM relief of common
1 3-GRAM of common symptoms
1 3-GRAM common symptoms associated
1 3-GRAM symptoms associated with
1 3-GRAM associated with hyperhistaminic
1 3-GRAM with hyperhistaminic conditions
1 3-GRAM hyperhistaminic conditions occurring
1 3-GRAM conditions occurring in
1 3-GRAM occurring in children
1 3-GRAM in children and
1 3-GRAM children and adults
1 3-GRAM * The production
1 3-GRAM The production of
1 3-GRAM production of ceramide
1 3-GRAM of ceramide is
1 3-GRAM ceramide is emerging
1 3-GRAM is emerging as
1 3-GRAM emerging as a
1 3-GRAM as a fixture
1 3-GRAM a fixture of
1 3-GRAM fixture of programmed
1 3-GRAM of programmed cell
1 3-GRAM cell death .
1 3-GRAM death . STOP
1 3-GRAM * The flux
1 3-GRAM The flux rates
1 3-GRAM flux rates of
1 3-GRAM rates of p
1 3-GRAM of p -
1 3-GRAM p - toluidine
1 3-GRAM - toluidine decreased
1 3-GRAM toluidine decreased as
1 3-GRAM decreased as the
1 3-GRAM as the pH
1 3-GRAM the pH value
1 3-GRAM pH value in
1 3-GRAM value in the
1 3-GRAM in the donor
1 3-GRAM the donor solution
1 3-GRAM donor solution increased
1 3-GRAM solution increased .
1 3-GRAM increased . STOP
2 3-GRAM * * Managing
1 3-GRAM * Managing HIV
1 3-GRAM Managing HIV .
2 3-GRAM * * BACKGROUND
1 3-GRAM * BACKGROUND :
1 3-GRAM BACKGROUND : There
2 3-GRAM : There is
1 3-GRAM There is increasing
1 3-GRAM is increasing interest
1 3-GRAM increasing interest on
1 3-GRAM interest on the
1 3-GRAM on the part
1 3-GRAM the part of
1 3-GRAM part of investigators
1 3-GRAM of investigators and
1 3-GRAM investigators and the
1 3-GRAM and the public
1 3-GRAM the public at
1 3-GRAM public at large
1 3-GRAM at large in
1 3-GRAM large in finding
1 3-GRAM in finding ways
1 3-GRAM finding ways to
1 3-GRAM ways to study
1 3-GRAM to study and
1 3-GRAM study and improve
1 3-GRAM and improve treatments
1 3-GRAM improve treatments for
1 3-GRAM treatments for the
1 3-GRAM for the seriously
1 3-GRAM the seriously mentally
1 3-GRAM seriously mentally ill
1 3-GRAM mentally ill without
1 3-GRAM ill without exposing
1 3-GRAM without exposing such
1 3-GRAM exposing such individuals
1 3-GRAM such individuals to
1 3-GRAM individuals to unnecessary
1 3-GRAM to unnecessary risks
1 3-GRAM unnecessary risks .
1 3-GRAM risks . STOP
1 3-GRAM * * Multidrug
1 3-GRAM * Multidrug resistance
1 3-GRAM Multidrug resistance in
1 3-GRAM resistance in Saccharomyces
1 3-GRAM in Saccharomyces cerevisiae
1 3-GRAM Saccharomyces cerevisiae mainly
1 3-GRAM cerevisiae mainly results
1 3-GRAM mainly results from
1 3-GRAM results from the
1 3-GRAM from the overexpression
1 3-GRAM the overexpression of
1 3-GRAM overexpression of genes
1 3-GRAM of genes coding
1 3-GRAM genes coding for
1 3-GRAM coding for the
1 3-GRAM for the membrane
1 3-GRAM the membrane efflux
1 3-GRAM membrane efflux pumps
1 3-GRAM efflux pumps ,
1 3-GRAM pumps , the
1 3-GRAM , the major
1 3-GRAM the major facilitators
1 3-GRAM major facilitators and
1 3-GRAM facilitators and the
1 3-GRAM and the ABC
1 3-GRAM the ABC binding
1 3-GRAM ABC binding cassette
1 3-GRAM binding cassette transporters
1 3-GRAM cassette transporters ,
1 3-GRAM transporters , under
1 3-GRAM , under the
1 3-GRAM control of key
1 3-GRAM of key transcription
1 3-GRAM key transcription regulators
1 3-GRAM transcription regulators encoded
1 3-GRAM regulators encoded by
1 3-GRAM encoded by the
1 3-GRAM by the PDR1
1 3-GRAM the PDR1 and
1 3-GRAM PDR1 and PDR3
1 3-GRAM and PDR3 genes
1 3-GRAM PDR3 genes .
1 3-GRAM * * Serum
1 3-GRAM * Serum PTH
1 3-GRAM Serum PTH tended
1 3-GRAM PTH tended to
1 3-GRAM tended to increase
1 3-GRAM to increase in
1 3-GRAM in the WL
1 3-GRAM the WL group
1 3-GRAM WL group but
1 3-GRAM group but not
1 3-GRAM but not in
1 3-GRAM not in the
1 3-GRAM in the WM
1 3-GRAM the WM group
1 3-GRAM WM group (
1 3-GRAM group ( P
2 3-GRAM ( P <
1 3-GRAM . 06 ).
1 3-GRAM 06 ). STOP
1 3-GRAM * * Bandshift
1 3-GRAM * Bandshift experiments
1 3-GRAM Bandshift experiments demonstrate
1 3-GRAM experiments demonstrate that
1 3-GRAM demonstrate that BmHR3A
1 3-GRAM that BmHR3A binds
1 3-GRAM BmHR3A binds specifically
1 3-GRAM binds specifically to
1 3-GRAM specifically to RORE
1 3-GRAM to RORE (
1 3-GRAM RORE ( Retinoic
1 3-GRAM ( Retinoic acid
1 3-GRAM Retinoic acid -
1 3-GRAM acid - related
1 3-GRAM - related Orphan
1 3-GRAM related Orphan receptor
1 3-GRAM Orphan receptor Response
1 3-GRAM receptor Response Element
1 3-GRAM Response Element )-
1 3-GRAM Element )- like
1 3-GRAM )- like sequences
1 3-GRAM like sequences in
1 3-GRAM sequences in the
1 3-GRAM in the promoters
1 3-GRAM the promoters of
1 3-GRAM promoters of both
1 3-GRAM of both genes
1 3-GRAM both genes ,
1 3-GRAM genes , thus
1 3-GRAM , thus suggesting
1 3-GRAM thus suggesting a
1 3-GRAM suggesting a direct
1 3-GRAM a direct role
1 3-GRAM direct role for
1 3-GRAM role for BmHR3A
1 3-GRAM for BmHR3A in
1 3-GRAM BmHR3A in regulating
1 3-GRAM in regulating the
1 3-GRAM regulating the expression
1 3-GRAM the expression of
1 3-GRAM expression of BmGATAbeta
1 3-GRAM of BmGATAbeta and
1 3-GRAM BmGATAbeta and ESP
1 3-GRAM and ESP genes
1 3-GRAM ESP genes during
1 3-GRAM genes during vitellogenesis
1 3-GRAM during vitellogenesis .
1 3-GRAM vitellogenesis . STOP
1 3-GRAM * * Efficacy
1 3-GRAM * Efficacy of
1 3-GRAM Efficacy of first
1 3-GRAM of first -
1 3-GRAM first - generation
1 3-GRAM - generation Cavermap
1 3-GRAM generation Cavermap to
1 3-GRAM Cavermap to verify
1 3-GRAM to verify location
1 3-GRAM verify location and
1 3-GRAM location and function
1 3-GRAM and function of
1 3-GRAM function of cavernous
1 3-GRAM of cavernous nerves
1 3-GRAM cavernous nerves during
1 3-GRAM nerves during radical
1 3-GRAM during radical prostatectomy
1 3-GRAM radical prostatectomy :
1 3-GRAM prostatectomy : a
1 3-GRAM : a multi
1 3-GRAM a multi -
1 3-GRAM multi - institutional
1 3-GRAM - institutional evaluation
1 3-GRAM institutional evaluation by
1 3-GRAM evaluation by experienced
1 3-GRAM by experienced surgeons
1 3-GRAM experienced surgeons .
1 3-GRAM surgeons . STOP
1 3-GRAM * * During
1 3-GRAM * During most
1 3-GRAM During most of
1 3-GRAM most of the
1 3-GRAM of the cell
1 3-GRAM the cell cycle
1 3-GRAM cell cycle ,
1 3-GRAM cycle , separase
1 3-GRAM , separase is
1 3-GRAM separase is kept
1 3-GRAM is kept inactive
1 3-GRAM kept inactive by
1 3-GRAM inactive by binding
1 3-GRAM by binding to
1 3-GRAM binding to an
1 3-GRAM to an inhibitory
1 3-GRAM an inhibitory protein
1 3-GRAM inhibitory protein called
1 3-GRAM protein called securin
1 3-GRAM called securin .
1 3-GRAM securin . STOP
1 3-GRAM conclusion , obesity
1 3-GRAM , obesity ,
1 3-GRAM obesity , alcohol
1 3-GRAM , alcohol intake
1 3-GRAM alcohol intake ,
1 3-GRAM intake , and
1 3-GRAM , and multimetabolic
1 3-GRAM and multimetabolic disorders
1 3-GRAM multimetabolic disorders were
1 3-GRAM disorders were determined
1 3-GRAM were determined to
1 3-GRAM determined to be
1 3-GRAM to be independent
1 3-GRAM be independent predictors
1 3-GRAM independent predictors for
1 3-GRAM predictors for the
1 3-GRAM for the development
1 3-GRAM development of hyperuricemia
1 3-GRAM of hyperuricemia .
1 3-GRAM hyperuricemia . STOP
1 3-GRAM This study examined
1 3-GRAM study examined the
1 3-GRAM examined the role
1 3-GRAM role of cholesteryl
1 3-GRAM of cholesteryl ester
2 3-GRAM cholesteryl ester transfer
1 3-GRAM ester transfer (
1 3-GRAM transfer ( CET
1 3-GRAM ( CET ),
1 3-GRAM CET ), cholesteryl
1 3-GRAM ), cholesteryl ester
1 3-GRAM ester transfer protein
2 3-GRAM transfer protein (
1 3-GRAM protein ( CETP
1 3-GRAM ( CETP )
1 3-GRAM CETP ) activity
1 3-GRAM ) activity ,
1 3-GRAM activity , and
1 3-GRAM , and phospholipid
1 3-GRAM and phospholipid transfer
1 3-GRAM phospholipid transfer protein
1 3-GRAM protein ( PLTP
1 3-GRAM ( PLTP )
1 3-GRAM PLTP ) activity
1 3-GRAM ) activity in
1 3-GRAM in the increased
1 3-GRAM the increased prevalence
1 3-GRAM increased prevalence of
1 3-GRAM prevalence of coronary
1 3-GRAM of coronary artery
1 3-GRAM coronary artery calcification
1 3-GRAM artery calcification (
1 3-GRAM calcification ( CAC
1 3-GRAM ( CAC )
1 3-GRAM CAC ) in
1 3-GRAM ) in diabetic
1 3-GRAM in diabetic subjects
1 3-GRAM diabetic subjects compared
1 3-GRAM subjects compared with
1 3-GRAM compared with nondiabetic
1 3-GRAM with nondiabetic subjects
1 3-GRAM nondiabetic subjects and
1 3-GRAM subjects and in
1 3-GRAM and in the
1 3-GRAM in the loss
1 3-GRAM the loss of
2 3-GRAM loss of the
1 3-GRAM of the sex
1 3-GRAM the sex difference
1 3-GRAM sex difference in
1 3-GRAM difference in CAC
1 3-GRAM in CAC in
1 3-GRAM CAC in diabetes
1 3-GRAM In the mouse
1 3-GRAM the mouse ,
1 3-GRAM mouse , both
1 3-GRAM , both genes
1 3-GRAM both genes reside
1 3-GRAM genes reside in
1 3-GRAM reside in the
1 3-GRAM in the syntenic
1 3-GRAM the syntenic region
1 3-GRAM syntenic region 8E1
1 3-GRAM region 8E1 on
1 3-GRAM 8E1 on chromosome
1 3-GRAM on chromosome 8
1 3-GRAM chromosome 8 .
1 3-GRAM 8 . STOP
1 3-GRAM * We observed
1 3-GRAM We observed NP
1 3-GRAM observed NP /
1 3-GRAM NP / NMP4
1 3-GRAM / NMP4 /
1 3-GRAM NMP4 / CIZ
1 3-GRAM / CIZ expression
1 3-GRAM CIZ expression in
1 3-GRAM expression in osteocytes
1 3-GRAM in osteocytes ,
1 3-GRAM osteocytes , osteoblasts
1 3-GRAM , osteoblasts ,
1 3-GRAM osteoblasts , and
1 3-GRAM , and chondrocytes
1 3-GRAM and chondrocytes in
1 3-GRAM chondrocytes in rat
1 3-GRAM in rat bone
1 3-GRAM rat bone .
1 3-GRAM bone . STOP
1 3-GRAM * * Following
1 3-GRAM * Following baseline
1 3-GRAM Following baseline clinical
1 3-GRAM baseline clinical examination
1 3-GRAM clinical examination and
1 3-GRAM examination and initial
1 3-GRAM and initial periodontal
1 3-GRAM initial periodontal therapy
1 3-GRAM periodontal therapy ,
1 3-GRAM therapy , 32
1 3-GRAM , 32 patients
1 3-GRAM 32 patients received
1 3-GRAM patients received mucogingival
1 3-GRAM received mucogingival surgery
1 3-GRAM mucogingival surgery with
1 3-GRAM surgery with free
1 3-GRAM with free gingival
1 3-GRAM free gingival grafts
1 3-GRAM gingival grafts for
1 3-GRAM grafts for treatment
1 3-GRAM treatment of insufficient
1 3-GRAM of insufficient attached
1 3-GRAM insufficient attached gingiva
1 3-GRAM attached gingiva .
1 3-GRAM gingiva . STOP
1 3-GRAM , the failure
1 3-GRAM the failure of
1 3-GRAM failure of the
1 3-GRAM of the QKTT
1 3-GRAM the QKTT motif
1 3-GRAM QKTT motif and
1 3-GRAM motif and TGN46
1 3-GRAM and TGN46 cytoplasmic
1 3-GRAM TGN46 cytoplasmic tail
1 3-GRAM cytoplasmic tail to
1 3-GRAM tail to induce
1 3-GRAM to induce steady
1 3-GRAM induce steady -
1 3-GRAM steady - state
1 3-GRAM - state ER
1 3-GRAM state ER localization
1 3-GRAM ER localization of
1 3-GRAM localization of vesicular
1 3-GRAM of vesicular stomatitis
1 3-GRAM vesicular stomatitis virus
1 3-GRAM stomatitis virus glycoprotein
1 3-GRAM virus glycoprotein (
1 3-GRAM glycoprotein ( VSVG
1 3-GRAM ( VSVG )
1 3-GRAM VSVG ) chimeras
1 3-GRAM ) chimeras in
1 3-GRAM chimeras in HeLa
1 3-GRAM in HeLa and
1 3-GRAM HeLa and NRK
1 3-GRAM and NRK cells
1 3-GRAM NRK cells indicates
1 3-GRAM cells indicates that
1 3-GRAM indicates that significant
1 3-GRAM that significant differences
1 3-GRAM differences in early
1 3-GRAM in early secretory
1 3-GRAM early secretory trafficking
1 3-GRAM secretory trafficking also
1 3-GRAM trafficking also exist
1 3-GRAM also exist .
1 3-GRAM exist . STOP
1 3-GRAM We previously showed
1 3-GRAM previously showed that
1 3-GRAM showed that this
1 3-GRAM that this proteolysis
1 3-GRAM this proteolysis 1
1 3-GRAM proteolysis 1 )
1 3-GRAM 1 ) can
1 3-GRAM ) can be
1 3-GRAM can be acutely
1 3-GRAM be acutely promoted
1 3-GRAM acutely promoted by
1 3-GRAM promoted by the
1 3-GRAM by the phorbol
1 3-GRAM the phorbol ester
1 3-GRAM phorbol ester phorbol
1 3-GRAM ester phorbol 12
2 3-GRAM phorbol 12 -
2 3-GRAM 12 - myristate
2 3-GRAM - myristate 13
2 3-GRAM myristate 13 -
2 3-GRAM 13 - acetate
2 3-GRAM - acetate (
2 3-GRAM acetate ( PMA
1 3-GRAM ( PMA ),
1 3-GRAM PMA ), 2
1 3-GRAM ), 2 )
1 3-GRAM 2 ) requires
1 3-GRAM ) requires a
1 3-GRAM requires a metalloprotease
1 3-GRAM a metalloprotease activity
1 3-GRAM metalloprotease activity ,
1 3-GRAM activity , 3
1 3-GRAM , 3 )
1 3-GRAM 3 ) generates
1 3-GRAM ) generates both
1 3-GRAM generates both shed
1 3-GRAM both shed GHBP
1 3-GRAM shed GHBP and
1 3-GRAM GHBP and a
1 3-GRAM and a membrane
1 3-GRAM a membrane -
1 3-GRAM membrane - associated
1 3-GRAM - associated GHR
1 3-GRAM associated GHR transmembrane
1 3-GRAM GHR transmembrane /
1 3-GRAM transmembrane / cytoplasmic
1 3-GRAM / cytoplasmic domain
1 3-GRAM cytoplasmic domain remnant
1 3-GRAM domain remnant ,
1 3-GRAM remnant , and
1 3-GRAM , and 4
1 3-GRAM and 4 )
1 3-GRAM 4 ) results
1 3-GRAM ) results in
1 3-GRAM results in down
1 3-GRAM in down -
1 3-GRAM regulation of GHR
1 3-GRAM of GHR abundance
1 3-GRAM GHR abundance and
1 3-GRAM abundance and GH
1 3-GRAM and GH signaling
1 3-GRAM GH signaling .
2 3-GRAM signaling . STOP
1 3-GRAM * Our data
1 3-GRAM Our data indicate
1 3-GRAM data indicate that
1 3-GRAM indicate that SIP1
1 3-GRAM that SIP1 is
1 3-GRAM SIP1 is required
1 3-GRAM is required to
1 3-GRAM required to confine
1 3-GRAM to confine XBra
1 3-GRAM confine XBra gene
1 3-GRAM XBra gene expression
1 3-GRAM gene expression to
1 3-GRAM expression to the
1 3-GRAM to the mesoderm
1 3-GRAM the mesoderm .
1 3-GRAM mesoderm . STOP
1 3-GRAM * * Changes
1 3-GRAM * Changes of
1 3-GRAM Changes of the
1 3-GRAM of the DB
1 3-GRAM the DB sequence
1 3-GRAM DB sequence without
1 3-GRAM sequence without affecting
1 3-GRAM without affecting the
1 3-GRAM affecting the postulated
1 3-GRAM the postulated stem
1 3-GRAM postulated stem structure
1 3-GRAM stem structure led
1 3-GRAM structure led to
1 3-GRAM led to drastic
1 3-GRAM to drastic losses
1 3-GRAM drastic losses of
1 3-GRAM losses of translation
1 3-GRAM of translation efficiency
1 3-GRAM translation efficiency .
2 3-GRAM efficiency . STOP
1 3-GRAM * This subfamily
1 3-GRAM This subfamily of
1 3-GRAM subfamily of genes
1 3-GRAM of genes all
1 3-GRAM genes all have
1 3-GRAM all have a
1 3-GRAM have a single
1 3-GRAM a single ATP
1 3-GRAM single ATP -
1 3-GRAM binding domain at
1 3-GRAM domain at the
1 3-GRAM at the N
1 3-GRAM N - terminus
1 3-GRAM - terminus and
1 3-GRAM terminus and a
1 3-GRAM and a single
1 3-GRAM a single C
1 3-GRAM single C -
1 3-GRAM - terminal set
1 3-GRAM terminal set of
1 3-GRAM set of transmembrane
1 3-GRAM of transmembrane segments
1 3-GRAM transmembrane segments .
1 3-GRAM segments . STOP
1 3-GRAM * * Subsequently
1 3-GRAM * Subsequently ,
1 3-GRAM Subsequently , these
1 3-GRAM , these coordinates
1 3-GRAM these coordinates must
1 3-GRAM coordinates must be
1 3-GRAM must be interpreted
1 3-GRAM be interpreted to
1 3-GRAM interpreted to define
1 3-GRAM to define particular
1 3-GRAM define particular tissues
1 3-GRAM particular tissues and
1 3-GRAM tissues and organs
1 3-GRAM and organs .
1 3-GRAM organs . STOP
1 3-GRAM * The cyclins
1 3-GRAM The cyclins bind
1 3-GRAM cyclins bind to
1 3-GRAM bind to and
1 3-GRAM to and activate
1 3-GRAM and activate the
1 3-GRAM activate the CDK
1 3-GRAM the CDK ,
1 3-GRAM CDK , which
1 3-GRAM , which leads
1 3-GRAM which leads to
1 3-GRAM leads to phosphorylation
1 3-GRAM to phosphorylation (
1 3-GRAM phosphorylation ( and
1 3-GRAM ( and then
1 3-GRAM and then inhibition
1 3-GRAM then inhibition )
1 3-GRAM inhibition ) of
1 3-GRAM of the tumor
1 3-GRAM the tumor suppressor
2 3-GRAM tumor suppressor protein
1 3-GRAM suppressor protein ,
1 3-GRAM protein , pRb
1 3-GRAM , pRb .
1 3-GRAM pRb . pRb
1 3-GRAM . pRb controls
1 3-GRAM pRb controls commitment
1 3-GRAM controls commitment to
1 3-GRAM commitment to progress
1 3-GRAM to progress from
1 3-GRAM progress from the
1 3-GRAM from the G1
1 3-GRAM the G1 to
1 3-GRAM G1 to S
1 3-GRAM to S phase
1 3-GRAM S phase ,
1 3-GRAM phase , at
1 3-GRAM , at least
1 3-GRAM at least in
1 3-GRAM least in part
1 3-GRAM in part by
1 3-GRAM part by repressing
1 3-GRAM by repressing the
1 3-GRAM repressing the activity
1 3-GRAM the activity of
1 3-GRAM of the E2F
1 3-GRAM the E2F transcription
1 3-GRAM E2F transcription factors
1 3-GRAM transcription factors known
1 3-GRAM factors known to
1 3-GRAM known to promote
1 3-GRAM to promote cell
1 3-GRAM promote cell proliferation
1 3-GRAM The mean serum
1 3-GRAM mean serum creatinine
1 3-GRAM serum creatinine level
1 3-GRAM creatinine level did
1 3-GRAM level did not
1 3-GRAM did not change
1 3-GRAM not change during
1 3-GRAM change during the
2 3-GRAM during the first
1 3-GRAM the first 6
1 3-GRAM first 6 months
1 3-GRAM 6 months after
1 3-GRAM months after withdrawal
1 3-GRAM after withdrawal of
1 3-GRAM withdrawal of MMF
1 3-GRAM of MMF .
1 3-GRAM MMF . STOP
2 3-GRAM * The severity
2 3-GRAM The severity of
1 3-GRAM severity of pathologic
1 3-GRAM of pathologic changes
1 3-GRAM pathologic changes increased
1 3-GRAM changes increased with
1 3-GRAM increased with the
1 3-GRAM with the magnitude
1 3-GRAM the magnitude of
1 3-GRAM magnitude of percussion
1 3-GRAM of percussion .
1 3-GRAM percussion . STOP
1 3-GRAM * * Patients
1 3-GRAM * Patients with
1 3-GRAM Patients with antibody
1 3-GRAM with antibody peaks
1 3-GRAM antibody peaks ,
1 3-GRAM peaks , defined
1 3-GRAM , defined as
1 3-GRAM defined as fivefold
1 3-GRAM as fivefold or
1 3-GRAM fivefold or higher
1 3-GRAM or higher increase
1 3-GRAM higher increase in
1 3-GRAM increase in antibody
1 3-GRAM in antibody titer
1 3-GRAM antibody titer compared
1 3-GRAM titer compared to
2 3-GRAM compared to the
1 3-GRAM to the lowest
1 3-GRAM the lowest antibody
1 3-GRAM lowest antibody titer
1 3-GRAM antibody titer over
1 3-GRAM titer over the
1 3-GRAM over the course
1 3-GRAM the course of
1 3-GRAM course of GBS
1 3-GRAM of GBS ,
1 3-GRAM GBS , had
1 3-GRAM , had higher
1 3-GRAM had higher disability
1 3-GRAM higher disability scores
1 3-GRAM disability scores during
1 3-GRAM scores during the
1 3-GRAM the first two
1 3-GRAM first two weeks
1 3-GRAM two weeks of
1 3-GRAM weeks of GBS
1 3-GRAM of GBS and
1 3-GRAM GBS and a
1 3-GRAM and a worse
1 3-GRAM a worse clinical
1 3-GRAM worse clinical outcome
1 3-GRAM clinical outcome (
1 3-GRAM outcome ( anti
2 3-GRAM ( anti -
1 3-GRAM anti - GM1
1 3-GRAM - GM1 IgG
1 3-GRAM GM1 IgG and
1 3-GRAM IgG and anti
1 3-GRAM and anti -
2 3-GRAM anti - GD1a
2 3-GRAM - GD1a IgM
2 3-GRAM GD1a IgM antibody
2 3-GRAM IgM antibody peaks
1 3-GRAM antibody peaks )
1 3-GRAM peaks ) and
1 3-GRAM ) and axonal
1 3-GRAM and axonal damage
1 3-GRAM axonal damage (
1 3-GRAM damage ( anti
1 3-GRAM antibody peaks ),
1 3-GRAM peaks ), compared
1 3-GRAM ), compared to
1 3-GRAM compared to patients
1 3-GRAM to patients without
1 3-GRAM patients without peak
1 3-GRAM without peak antibody
1 3-GRAM peak antibody titers
1 3-GRAM antibody titers .
1 3-GRAM titers . STOP
1 3-GRAM * At 20
1 3-GRAM At 20 days
1 3-GRAM 20 days (
1 3-GRAM days ( D
1 3-GRAM ( D )
1 3-GRAM D ) and
1 3-GRAM ) and at
1 3-GRAM and at 3
1 3-GRAM at 3 months
1 3-GRAM 3 months post
2 3-GRAM months post -
2 3-GRAM post - TBI
1 3-GRAM - TBI ,
1 3-GRAM TBI , irradiated
1 3-GRAM , irradiated rats
1 3-GRAM irradiated rats had
1 3-GRAM rats had a
1 3-GRAM had a significantly
1 3-GRAM a significantly lower
1 3-GRAM significantly lower percentage
1 3-GRAM lower percentage of
1 3-GRAM percentage of avoidance
1 3-GRAM of avoidance than
1 3-GRAM avoidance than controls
1 3-GRAM than controls but
1 3-GRAM controls but no
1 3-GRAM but no statistical
1 3-GRAM no statistical difference
1 3-GRAM statistical difference was
1 3-GRAM difference was found
1 3-GRAM was found at
1 3-GRAM found at 5
1 3-GRAM at 5 months
1 3-GRAM 5 months post
1 3-GRAM - TBI .
1 3-GRAM TBI . b
1 3-GRAM . b /
1 3-GRAM b / Two
1 3-GRAM / Two -
1 3-GRAM Two - way
1 3-GRAM - way avoidance
1 3-GRAM way avoidance test
1 3-GRAM avoidance test :
1 3-GRAM test : this
1 3-GRAM : this test
1 3-GRAM this test was
1 3-GRAM test was performed
1 3-GRAM was performed only
1 3-GRAM performed only after
1 3-GRAM only after TBI
1 3-GRAM after TBI .
1 3-GRAM TBI . STOP
1 3-GRAM * * TE
1 3-GRAM * TE -
1 3-GRAM TE - 671
1 3-GRAM - 671 cells
1 3-GRAM 671 cells that
1 3-GRAM cells that were
1 3-GRAM that were transfected
1 3-GRAM were transfected with
1 3-GRAM transfected with cAMP
1 3-GRAM with cAMP response
1 3-GRAM cAMP response element
1 3-GRAM response element mutant
1 3-GRAM element mutant constructs
1 3-GRAM mutant constructs demonstrated
1 3-GRAM constructs demonstrated a
1 3-GRAM demonstrated a diminished
1 3-GRAM a diminished basal
1 3-GRAM diminished basal activity
1 3-GRAM basal activity of
1 3-GRAM of the GnRH
1 3-GRAM the GnRH -
1 3-GRAM GnRH - II
1 3-GRAM - II promoter
1 3-GRAM II promoter .
1 3-GRAM severity of clinical
1 3-GRAM of clinical course
1 3-GRAM clinical course was
1 3-GRAM course was expressed
1 3-GRAM was expressed by
1 3-GRAM expressed by means
1 3-GRAM means of SOFA
1 3-GRAM of SOFA score
1 3-GRAM SOFA score (
2 3-GRAM score ( group
2 3-GRAM ( group A
1 3-GRAM group A 0
1 3-GRAM A 0 .
1 3-GRAM 0 . 3
4 3-GRAM . 3 -
1 3-GRAM 3 - 1
1 3-GRAM - 1 -
1 3-GRAM 1 - 1
1 3-GRAM - 1 .
2 3-GRAM . 3 point
1 3-GRAM 3 point ,
4 3-GRAM point , group
2 3-GRAM , group B
1 3-GRAM group B 2
1 3-GRAM B 2 .
1 3-GRAM 2 . 2
2 3-GRAM . 2 -
1 3-GRAM 2 - 2
1 3-GRAM 2 . 9
1 3-GRAM . 9 -
1 3-GRAM 9 - 2
1 3-GRAM 2 . 6
1 3-GRAM . 6 point
1 3-GRAM 6 point ,
2 3-GRAM , group C
1 3-GRAM group C 7
1 3-GRAM C 7 .
1 3-GRAM 7 . 4
2 3-GRAM . 4 -
1 3-GRAM 4 - 8
2 3-GRAM - 8 .
1 3-GRAM 8 . 3
1 3-GRAM 3 - 7
2 3-GRAM - 7 .
1 3-GRAM 7 . 7
1 3-GRAM . 7 point
1 3-GRAM 7 point )
1 3-GRAM point ) and
1 3-GRAM ) and APACHE
1 3-GRAM and APACHE II
1 3-GRAM APACHE II score
1 3-GRAM II score (
1 3-GRAM group A 3
1 3-GRAM A 3 .
1 3-GRAM 3 . 7
1 3-GRAM . 7 -
1 3-GRAM 7 - 7
1 3-GRAM 7 . 6
1 3-GRAM 6 - 8
1 3-GRAM . 1 point
1 3-GRAM 1 point ,
1 3-GRAM group B 8
1 3-GRAM B 8 .
2 3-GRAM 8 . 6
1 3-GRAM 6 - 11
1 3-GRAM - 11 .
1 3-GRAM 11 . 1
1 3-GRAM . 1 -
1 3-GRAM 1 - 10
1 3-GRAM - 10 .
1 3-GRAM 10 . 5
1 3-GRAM . 5 point
1 3-GRAM 5 point ,
1 3-GRAM group C 16
1 3-GRAM C 16 .
1 3-GRAM 16 . 3
1 3-GRAM 3 - 15
1 3-GRAM - 15 .
1 3-GRAM 15 . 2
1 3-GRAM 2 - 14
1 3-GRAM - 14 .
1 3-GRAM 14 . 3
1 3-GRAM 3 point ).
1 3-GRAM point ). STOP
1 3-GRAM A novel potential
1 3-GRAM novel potential effector
1 3-GRAM potential effector of
1 3-GRAM effector of M
1 3-GRAM of M -
2 3-GRAM M - Ras
2 3-GRAM - Ras and
2 3-GRAM Ras and p21
2 3-GRAM and p21 Ras
1 3-GRAM p21 Ras negatively
1 3-GRAM Ras negatively regulates
1 3-GRAM negatively regulates p21
1 3-GRAM regulates p21 Ras
1 3-GRAM p21 Ras -
1 3-GRAM Ras - mediated
1 3-GRAM - mediated gene
1 3-GRAM mediated gene induction
1 3-GRAM gene induction and
1 3-GRAM induction and cell
1 3-GRAM and cell growth
1 3-GRAM cell growth .
2 3-GRAM growth . STOP
1 3-GRAM * * Promoter
1 3-GRAM * Promoter transcriptional
1 3-GRAM Promoter transcriptional activity
1 3-GRAM transcriptional activity was
1 3-GRAM activity was determined
1 3-GRAM was determined for
1 3-GRAM determined for a
1 3-GRAM for a wide
1 3-GRAM a wide 5
1 3-GRAM wide 5 '
1 3-GRAM 5 ' portion
1 3-GRAM ' portion of
1 3-GRAM portion of the
2 3-GRAM of the human
1 3-GRAM the human annexin
1 3-GRAM human annexin A5
1 3-GRAM annexin A5 gene
1 3-GRAM A5 gene ,
1 3-GRAM gene , from
1 3-GRAM , from bp
1 3-GRAM from bp -
1 3-GRAM bp - 1275
1 3-GRAM - 1275 to
1 3-GRAM 1275 to +
1 3-GRAM to + 79
1 3-GRAM + 79 relative
1 3-GRAM 79 relative to
1 3-GRAM relative to the
1 3-GRAM to the most
1 3-GRAM the most 5
1 3-GRAM most 5 '
1 3-GRAM 5 ' of
1 3-GRAM ' of several
1 3-GRAM of several discrete
1 3-GRAM several discrete transcription
1 3-GRAM discrete transcription start
1 3-GRAM transcription start points
1 3-GRAM start points .
1 3-GRAM points . STOP
1 3-GRAM * * Structure
1 3-GRAM * Structure of
1 3-GRAM Structure of the
1 3-GRAM of the EMAPII
1 3-GRAM the EMAPII domain
1 3-GRAM EMAPII domain of
1 3-GRAM domain of human
1 3-GRAM of human aminoacyl
1 3-GRAM human aminoacyl -
1 3-GRAM aminoacyl - tRNA
1 3-GRAM - tRNA synthetase
1 3-GRAM tRNA synthetase complex
1 3-GRAM synthetase complex reveals
1 3-GRAM complex reveals evolutionary
1 3-GRAM reveals evolutionary dimer
1 3-GRAM evolutionary dimer mimicry
1 3-GRAM dimer mimicry .
1 3-GRAM mimicry . STOP
1 3-GRAM * * Adding
1 3-GRAM * Adding 10
1 3-GRAM Adding 10 mmol
1 3-GRAM 10 mmol SDS
1 3-GRAM mmol SDS /
1 3-GRAM SDS / l
1 3-GRAM / l led
1 3-GRAM l led to
1 3-GRAM led to transient
1 3-GRAM to transient inhibition
1 3-GRAM transient inhibition of
1 3-GRAM inhibition of acidification
1 3-GRAM of acidification ,
1 3-GRAM acidification , metal
1 3-GRAM , metal solubilization
1 3-GRAM metal solubilization and
1 3-GRAM solubilization and sulfur
1 3-GRAM and sulfur oxidation
1 3-GRAM sulfur oxidation .
1 3-GRAM oxidation . STOP
1 3-GRAM * * Competition
1 3-GRAM * Competition electrophoretic
1 3-GRAM Competition electrophoretic mobility
1 3-GRAM electrophoretic mobility shift
1 3-GRAM mobility shift and
1 3-GRAM shift and immunoshift
1 3-GRAM and immunoshift assays
1 3-GRAM immunoshift assays confirmed
1 3-GRAM assays confirmed that
1 3-GRAM confirmed that NF1
1 3-GRAM that NF1 factors
1 3-GRAM NF1 factors present
1 3-GRAM factors present in
1 3-GRAM present in nuclear
1 3-GRAM in nuclear extracts
1 3-GRAM nuclear extracts of
1 3-GRAM extracts of HeLa
1 3-GRAM of HeLa and
1 3-GRAM HeLa and CV
1 3-GRAM and CV -
1 3-GRAM CV - 1
1 3-GRAM 1 cells bind
1 3-GRAM cells bind to
2 3-GRAM bind to the
1 3-GRAM to the BKV
1 3-GRAM the BKV -
1 3-GRAM BKV - MLP
1 3-GRAM - MLP .
1 3-GRAM MLP . STOP
1 3-GRAM * Northern and
1 3-GRAM Northern and Western
1 3-GRAM and Western blot
1 3-GRAM Western blot analyses
1 3-GRAM blot analyses demonstrated
1 3-GRAM analyses demonstrated that
1 3-GRAM demonstrated that Graf2
1 3-GRAM that Graf2 is
1 3-GRAM Graf2 is expressed
2 3-GRAM is expressed in
1 3-GRAM expressed in several
1 3-GRAM in several tissues
1 3-GRAM several tissues ,
1 3-GRAM tissues , with
1 3-GRAM , with the
1 3-GRAM with the highest
1 3-GRAM the highest expression
1 3-GRAM highest expression in
1 3-GRAM expression in skeletal
1 3-GRAM in skeletal muscle
1 3-GRAM skeletal muscle .
1 3-GRAM muscle . STOP
1 3-GRAM * A minimal
1 3-GRAM A minimal ER3
1 3-GRAM minimal ER3 sequence
1 3-GRAM ER3 sequence of
1 3-GRAM sequence of DNA
1 3-GRAM of DNA was
1 3-GRAM DNA was further
1 3-GRAM was further demonstrated
1 3-GRAM further demonstrated to
1 3-GRAM demonstrated to function
1 3-GRAM to function as
1 3-GRAM function as a
1 3-GRAM as a FXR
1 3-GRAM a FXR HRE
1 3-GRAM FXR HRE and
1 3-GRAM HRE and was
1 3-GRAM and was bound
1 3-GRAM was bound in
1 3-GRAM bound in vitro
3 3-GRAM in vitro by
1 3-GRAM vitro by FXR
1 3-GRAM by FXR -
1 3-GRAM FXR - expressing
1 3-GRAM - expressing yeast
1 3-GRAM expressing yeast extracts
1 3-GRAM yeast extracts .
1 3-GRAM extracts . STOP
1 3-GRAM * In Ka13
1 3-GRAM In Ka13 cells
1 3-GRAM Ka13 cells ,
1 3-GRAM cells , CoCl
1 3-GRAM , CoCl (
1 3-GRAM CoCl ( 2
3 3-GRAM ( 2 )
1 3-GRAM 2 ) stimulated
1 3-GRAM ) stimulated expression
1 3-GRAM stimulated expression of
1 3-GRAM expression of a
1 3-GRAM of a luciferase
1 3-GRAM a luciferase reporter
1 3-GRAM luciferase reporter gene
1 3-GRAM reporter gene under
1 3-GRAM gene under the
1 3-GRAM of a 15
1 3-GRAM a 15 -
1 3-GRAM 15 - kilobase
1 3-GRAM - kilobase pair
1 3-GRAM kilobase pair mouse
1 3-GRAM pair mouse ho
1 3-GRAM mouse ho -
2 3-GRAM ho - 1
1 3-GRAM - 1 promoter
1 3-GRAM 1 promoter (
1 3-GRAM promoter ( pHO15luc
1 3-GRAM ( pHO15luc ).
1 3-GRAM pHO15luc ). STOP
1 3-GRAM * Nine strains
1 3-GRAM Nine strains were
1 3-GRAM strains were subtyped
1 3-GRAM were subtyped as
1 3-GRAM subtyped as Camp
1 3-GRAM as Camp .
1 3-GRAM Camp . jejuni
1 3-GRAM . jejuni subsp
1 3-GRAM jejuni subsp .
1 3-GRAM subsp . jejuni
1 3-GRAM . jejuni biotype
1 3-GRAM jejuni biotype II
1 3-GRAM biotype II and
1 3-GRAM II and the
1 3-GRAM and the remaining
1 3-GRAM the remaining ones
1 3-GRAM remaining ones as
1 3-GRAM ones as biotype
1 3-GRAM as biotype I
1 3-GRAM biotype I .
1 3-GRAM I . STOP
1 3-GRAM * The Ig
1 3-GRAM The Ig -
1 3-GRAM Ig - related
1 3-GRAM - related ,
1 3-GRAM related , typical
1 3-GRAM , typical metazoan
1 3-GRAM typical metazoan ,
1 3-GRAM metazoan , module
1 3-GRAM , module is
1 3-GRAM module is classified
1 3-GRAM is classified to
1 3-GRAM classified to the
1 3-GRAM to the disulphide
1 3-GRAM the disulphide lacking
1 3-GRAM disulphide lacking Ig
1 3-GRAM lacking Ig members
1 3-GRAM Ig members and
1 3-GRAM members and represents
1 3-GRAM and represents the
1 3-GRAM represents the phylogenetic
1 3-GRAM the phylogenetic earliest
1 3-GRAM phylogenetic earliest member
1 3-GRAM earliest member of
1 3-GRAM member of this
1 3-GRAM of this group
1 3-GRAM this group .
2 3-GRAM group . STOP
1 3-GRAM * In budding
1 3-GRAM In budding yeast
1 3-GRAM budding yeast ,
1 3-GRAM yeast , this
1 3-GRAM , this latter
1 3-GRAM this latter checkpoint
1 3-GRAM latter checkpoint response
1 3-GRAM checkpoint response involves
1 3-GRAM response involves the
1 3-GRAM involves the proteins
1 3-GRAM the proteins Mad1
1 3-GRAM proteins Mad1 ,
1 3-GRAM Mad1 , 2
1 3-GRAM , 2 ,
2 3-GRAM 2 , 3
1 3-GRAM 3 , Bub1
1 3-GRAM , Bub1 and
1 3-GRAM Bub1 and Bub3
1 3-GRAM and Bub3 ,
1 3-GRAM Bub3 , whose
1 3-GRAM , whose vertebrate
1 3-GRAM whose vertebrate counterparts
1 3-GRAM vertebrate counterparts localize
1 3-GRAM counterparts localize to
1 3-GRAM localize to unattached
1 3-GRAM to unattached kinetochores
1 3-GRAM unattached kinetochores .
1 3-GRAM kinetochores . STOP
1 3-GRAM * We investigated
1 3-GRAM We investigated the
1 3-GRAM investigated the production
1 3-GRAM production of hyaluronan
1 3-GRAM of hyaluronan (
1 3-GRAM hyaluronan ( HA
2 3-GRAM ( HA )
1 3-GRAM HA ) and
1 3-GRAM ) and its
1 3-GRAM and its effect
1 3-GRAM its effect on
1 3-GRAM effect on cell
1 3-GRAM on cell motility
1 3-GRAM cell motility in
1 3-GRAM motility in cells
1 3-GRAM in cells expressing
1 3-GRAM cells expressing the
1 3-GRAM expressing the v
1 3-GRAM the v -
1 3-GRAM v - src
1 3-GRAM - src mutants
1 3-GRAM src mutants .
1 3-GRAM * * Oral
1 3-GRAM * Oral supplementation
1 3-GRAM Oral supplementation of
1 3-GRAM supplementation of L
1 3-GRAM of L -
1 3-GRAM L - arginine
1 3-GRAM - arginine significantly
1 3-GRAM arginine significantly increased
1 3-GRAM significantly increased plasma
1 3-GRAM increased plasma L
1 3-GRAM plasma L -
1 3-GRAM L - citrulline
1 3-GRAM - citrulline ,
1 3-GRAM citrulline , which
1 3-GRAM , which indicated
1 3-GRAM which indicated enhancement
1 3-GRAM indicated enhancement of
1 3-GRAM enhancement of NO
1 3-GRAM of NO production
1 3-GRAM NO production .
1 3-GRAM production . STOP
1 3-GRAM * We can
1 3-GRAM We can classify
1 3-GRAM can classify antibiotics
1 3-GRAM classify antibiotics into
1 3-GRAM antibiotics into two
1 3-GRAM into two groups
1 3-GRAM two groups based
1 3-GRAM groups based on
1 3-GRAM based on initial
1 3-GRAM on initial bactericidal
1 3-GRAM initial bactericidal activity
1 3-GRAM bactericidal activity against
1 3-GRAM activity against P
1 3-GRAM against P .
1 3-GRAM P . aeruginosa
1 3-GRAM . aeruginosa ;
1 3-GRAM aeruginosa ; one
1 3-GRAM ; one class
1 3-GRAM one class is
1 3-GRAM class is antibiotics
1 3-GRAM is antibiotics having
1 3-GRAM antibiotics having rapid
1 3-GRAM having rapid initial
1 3-GRAM rapid initial killing
1 3-GRAM initial killing such
1 3-GRAM killing such as
1 3-GRAM such as AMK
1 3-GRAM as AMK ,
1 3-GRAM AMK , IPM
1 3-GRAM , IPM and
1 3-GRAM IPM and PAPM
1 3-GRAM and PAPM ,
1 3-GRAM PAPM , the
1 3-GRAM , the other
1 3-GRAM the other is
1 3-GRAM other is CAZ
1 3-GRAM is CAZ ,
1 3-GRAM CAZ , MEPM
1 3-GRAM , MEPM showing
1 3-GRAM MEPM showing slow
1 3-GRAM showing slow initial
1 3-GRAM slow initial killing
1 3-GRAM initial killing .
1 3-GRAM killing . STOP
1 3-GRAM presence of truncated
1 3-GRAM of truncated receptor
1 3-GRAM truncated receptor isoforms
1 3-GRAM receptor isoforms in
1 3-GRAM isoforms in diverse
1 3-GRAM in diverse species
1 3-GRAM diverse species suggests
1 3-GRAM species suggests that
1 3-GRAM suggests that these
1 3-GRAM that these proteins
1 3-GRAM these proteins may
1 3-GRAM proteins may have
1 3-GRAM may have important
1 3-GRAM have important functional
1 3-GRAM important functional roles
1 3-GRAM functional roles in
1 3-GRAM roles in regulating
1 3-GRAM in regulating EGFR
1 3-GRAM regulating EGFR activity
1 3-GRAM EGFR activity .
3 3-GRAM * * Of
1 3-GRAM * Of its
1 3-GRAM Of its gene
1 3-GRAM its gene products
1 3-GRAM gene products ,
1 3-GRAM products , E6
1 3-GRAM , E6 binds
1 3-GRAM E6 binds to
1 3-GRAM binds to and
1 3-GRAM to and inactivates
1 3-GRAM and inactivates p53
1 3-GRAM inactivates p53 tumor
1 3-GRAM p53 tumor suppressor
1 3-GRAM suppressor protein by
1 3-GRAM protein by ubiquitin
1 3-GRAM by ubiquitin /
1 3-GRAM ubiquitin / proteasome
1 3-GRAM / proteasome -
1 3-GRAM proteasome - dependent
1 3-GRAM - dependent degradation
1 3-GRAM dependent degradation .
1 3-GRAM degradation . STOP
2 3-GRAM * * Low
1 3-GRAM * Low affinity
1 3-GRAM Low affinity binding
1 3-GRAM affinity binding of
1 3-GRAM binding of Rab6A
1 3-GRAM of Rab6A -
1 3-GRAM Rab6A - GTP
1 3-GRAM - GTP was
1 3-GRAM GTP was also
1 3-GRAM was also observed
1 3-GRAM also observed (
1 3-GRAM observed ( K
1 3-GRAM ( K (
1 3-GRAM K ( d
1 3-GRAM ( d )
1 3-GRAM d ) =
1 3-GRAM ) = 16
1 3-GRAM = 16 microm
1 3-GRAM 16 microm ),
1 3-GRAM microm ), whereas
1 3-GRAM ), whereas Rab1B
1 3-GRAM whereas Rab1B ,
1 3-GRAM Rab1B , -
1 3-GRAM , - 5
1 3-GRAM - 5 ,
1 3-GRAM 5 , -
1 3-GRAM , - 7
1 3-GRAM - 7 ,
1 3-GRAM 7 , -
1 3-GRAM , - 8
2 3-GRAM - 8 ,
1 3-GRAM 8 , or
1 3-GRAM , or -
1 3-GRAM or - 11A
1 3-GRAM - 11A did
1 3-GRAM 11A did not
1 3-GRAM did not bind
1 3-GRAM not bind .
1 3-GRAM bind . STOP
1 3-GRAM * * (
1 3-GRAM * ( 1997
1 3-GRAM ( 1997 )
1 3-GRAM 1997 ) Nature
1 3-GRAM ) Nature 387
1 3-GRAM Nature 387 ,
1 3-GRAM 387 , 370
1 3-GRAM , 370 -
1 3-GRAM 370 - 376
1 3-GRAM - 376 )],
1 3-GRAM 376 )], we
1 3-GRAM )], we suggest
1 3-GRAM we suggest that
1 3-GRAM that the metal
1 3-GRAM the metal fluoride
1 3-GRAM metal fluoride ions
1 3-GRAM fluoride ions replaced
1 3-GRAM ions replaced phosphate
1 3-GRAM replaced phosphate at
1 3-GRAM phosphate at the
1 3-GRAM at the two
1 3-GRAM the two ATP
1 3-GRAM two ATP -
1 3-GRAM - binding sites
1 3-GRAM binding sites of
1 3-GRAM sites of the
1 3-GRAM of the iron
1 3-GRAM the iron protein
1 3-GRAM iron protein ,
1 3-GRAM protein , Kp2
1 3-GRAM , Kp2 .
1 3-GRAM Kp2 . STOP
1 3-GRAM * A 1
1 3-GRAM A 1 -
1 3-GRAM 1 - base
1 3-GRAM base pair mismatch
1 3-GRAM pair mismatch within
1 3-GRAM mismatch within the
1 3-GRAM within the corresponding
1 3-GRAM the corresponding region
1 3-GRAM corresponding region of
1 3-GRAM of the CYP3A4
1 3-GRAM the CYP3A4 gene
1 3-GRAM CYP3A4 gene was
1 3-GRAM gene was sufficient
1 3-GRAM was sufficient for
1 3-GRAM sufficient for a
1 3-GRAM for a differential
1 3-GRAM a differential enhancer
1 3-GRAM differential enhancer activity
1 3-GRAM enhancer activity .
1 3-GRAM * * AIMS
1 3-GRAM * AIMS :
1 3-GRAM AIMS : To
1 3-GRAM : To establish
1 3-GRAM To establish a
1 3-GRAM establish a baseline
1 3-GRAM a baseline and
1 3-GRAM baseline and intraindividual
2 3-GRAM and intraindividual fluctuations
1 3-GRAM intraindividual fluctuations of
1 3-GRAM fluctuations of the
1 3-GRAM of the tumour
1 3-GRAM the tumour markers
1 3-GRAM tumour markers CEA
1 3-GRAM markers CEA ,
1 3-GRAM CEA , CA
1 3-GRAM , CA 50
1 3-GRAM CA 50 and
1 3-GRAM 50 and CA
1 3-GRAM and CA 242
1 3-GRAM CA 242 in
1 3-GRAM 242 in patients
1 3-GRAM in patients cured
1 3-GRAM patients cured from
1 3-GRAM cured from colorectal
1 3-GRAM from colorectal cancer
1 3-GRAM colorectal cancer ,
2 3-GRAM , and to
1 3-GRAM and to test
1 3-GRAM to test the
1 3-GRAM test the hypothesis
1 3-GRAM hypothesis that serum
1 3-GRAM that serum concentrations
1 3-GRAM serum concentrations and
1 3-GRAM concentrations and intraindividual
1 3-GRAM intraindividual fluctuations do
1 3-GRAM fluctuations do not
1 3-GRAM do not differ
1 3-GRAM not differ from
1 3-GRAM differ from the
1 3-GRAM from the concentrations
1 3-GRAM the concentrations in
1 3-GRAM concentrations in cancer
1 3-GRAM in cancer -
1 3-GRAM cancer - free
1 3-GRAM - free individuals
1 3-GRAM free individuals .
2 3-GRAM individuals . STOP
1 3-GRAM * * Substitution
1 3-GRAM * Substitution of
1 3-GRAM Substitution of serine
1 3-GRAM of serine residues
1 3-GRAM serine residues at
1 3-GRAM residues at the
1 3-GRAM C - terminus
1 3-GRAM - terminus indicated
1 3-GRAM terminus indicated that
1 3-GRAM indicated that loss
1 3-GRAM that loss of
1 3-GRAM loss of phosphorylation
1 3-GRAM of phosphorylation sites
1 3-GRAM phosphorylation sites did
1 3-GRAM sites did not
1 3-GRAM did not appear
1 3-GRAM not appear to
1 3-GRAM appear to have
1 3-GRAM to have any
1 3-GRAM have any effect
1 3-GRAM effect on transcription
1 3-GRAM on transcription and
1 3-GRAM transcription and replication
1 3-GRAM and replication .
1 3-GRAM * Molecular analysis
1 3-GRAM Molecular analysis of
2 3-GRAM analysis of the
1 3-GRAM of the pRA2
1 3-GRAM the pRA2 partitioning
1 3-GRAM pRA2 partitioning region
1 3-GRAM partitioning region :
1 3-GRAM region : ParB
1 3-GRAM : ParB autoregulates
1 3-GRAM ParB autoregulates parAB
1 3-GRAM autoregulates parAB transcription
1 3-GRAM parAB transcription and
1 3-GRAM transcription and forms
1 3-GRAM and forms a
1 3-GRAM forms a nucleoprotein
1 3-GRAM a nucleoprotein complex
1 3-GRAM nucleoprotein complex with
1 3-GRAM complex with the
1 3-GRAM with the plasmid
1 3-GRAM the plasmid partition
1 3-GRAM plasmid partition site
1 3-GRAM partition site ,
1 3-GRAM site , parS
1 3-GRAM , parS .
1 3-GRAM parS . STOP
1 3-GRAM * Tumor cell
1 3-GRAM Tumor cell lines
1 3-GRAM cell lines transduced
1 3-GRAM lines transduced at
1 3-GRAM transduced at an
1 3-GRAM at an MOI
1 3-GRAM an MOI of
1 3-GRAM MOI of 8
1 3-GRAM of 8 for
1 3-GRAM 8 for 3
1 3-GRAM for 3 days
1 3-GRAM 3 days led
1 3-GRAM days led to
1 3-GRAM led to >
1 3-GRAM to > 90
1 3-GRAM > 90 %
1 3-GRAM 90 % gene
1 3-GRAM % gene transfer
1 3-GRAM gene transfer efficiency
1 3-GRAM transfer efficiency .
1 3-GRAM * No ISREs
1 3-GRAM No ISREs could
1 3-GRAM ISREs could be
1 3-GRAM could be identified
1 3-GRAM be identified in
1 3-GRAM identified in the
1 3-GRAM in the mouse
1 3-GRAM the mouse promoter
1 3-GRAM mouse promoter .
1 3-GRAM * * GABA
1 3-GRAM * GABA (
1 3-GRAM GABA ( B
1 3-GRAM ( B )
1 3-GRAM B ) R1g
1 3-GRAM ) R1g was
1 3-GRAM R1g was expressed
1 3-GRAM was expressed in
1 3-GRAM expressed in both
1 3-GRAM in both brain
1 3-GRAM both brain and
1 3-GRAM brain and peripheral
1 3-GRAM and peripheral tissues
1 3-GRAM peripheral tissues .
1 3-GRAM tissues . STOP
1 3-GRAM * * Granulocyte
1 3-GRAM * Granulocyte colony
1 3-GRAM Granulocyte colony -
1 3-GRAM colony - stimulating
1 3-GRAM - stimulating factor
1 3-GRAM stimulating factor (
1 3-GRAM factor ( G
1 3-GRAM ( G -
1 3-GRAM G - CSF
1 3-GRAM - CSF )
1 3-GRAM CSF ) administration
1 3-GRAM ) administration in
1 3-GRAM administration in vivo
1 3-GRAM in vivo has
1 3-GRAM vivo has been
3 3-GRAM has been shown
1 3-GRAM shown to improve
1 3-GRAM to improve the
1 3-GRAM improve the defence
1 3-GRAM the defence mechanisms
1 3-GRAM defence mechanisms against
1 3-GRAM mechanisms against infection
1 3-GRAM against infection by
1 3-GRAM infection by different
1 3-GRAM by different microbes
1 3-GRAM different microbes .
1 3-GRAM microbes . STOP
1 3-GRAM * * Use
1 3-GRAM * Use of
1 3-GRAM Use of a
1 3-GRAM of a dual
1 3-GRAM a dual -
1 3-GRAM dual - pulse
1 3-GRAM - pulse lithotripter
1 3-GRAM pulse lithotripter to
1 3-GRAM lithotripter to generate
1 3-GRAM to generate a
1 3-GRAM generate a localized
1 3-GRAM a localized and
1 3-GRAM localized and intensified
1 3-GRAM and intensified cavitation
1 3-GRAM intensified cavitation field
1 3-GRAM cavitation field .
1 3-GRAM field . STOP
1 3-GRAM * The best
1 3-GRAM The best regression
1 3-GRAM best regression model
1 3-GRAM regression model for
1 3-GRAM model for predicting
1 3-GRAM for predicting changes
1 3-GRAM predicting changes in
1 3-GRAM changes in the
1 3-GRAM in the WCXR
1 3-GRAM the WCXR included
1 3-GRAM WCXR included time
1 3-GRAM included time to
1 3-GRAM time to first
1 3-GRAM to first positive
1 3-GRAM first positive culture
1 3-GRAM positive culture and
1 3-GRAM culture and antibody
1 3-GRAM and antibody titer
1 3-GRAM antibody titer for
1 3-GRAM titer for Pa
1 3-GRAM for Pa elastase
1 3-GRAM Pa elastase .
1 3-GRAM elastase . STOP
2 3-GRAM RESULTS : The
1 3-GRAM : The parameters
1 3-GRAM The parameters SF2
1 3-GRAM parameters SF2 and
1 3-GRAM SF2 and plating
1 3-GRAM and plating efficiency
1 3-GRAM plating efficiency were
1 3-GRAM efficiency were stable
1 3-GRAM were stable throughout
1 3-GRAM stable throughout the
1 3-GRAM throughout the 4
1 3-GRAM the 4 -
1 3-GRAM 4 - year
1 3-GRAM - year test
1 3-GRAM year test period
1 3-GRAM test period .
1 3-GRAM period . STOP
1 3-GRAM * The process
1 3-GRAM The process has
1 3-GRAM process has been
1 3-GRAM has been applied
1 3-GRAM been applied to
1 3-GRAM applied to the
1 3-GRAM to the river
1 3-GRAM the river reclamation
1 3-GRAM river reclamation in
1 3-GRAM reclamation in Yangpu
1 3-GRAM in Yangpu District
1 3-GRAM Yangpu District of
1 3-GRAM District of Shanghai
1 3-GRAM of Shanghai City
1 3-GRAM Shanghai City ,
1 3-GRAM City , China
1 3-GRAM , China .
1 3-GRAM China . STOP
2 3-GRAM * * Multiple
1 3-GRAM * Multiple regression
1 3-GRAM Multiple regression analysis
1 3-GRAM regression analysis performed
1 3-GRAM analysis performed between
1 3-GRAM performed between these
1 3-GRAM between these long
1 3-GRAM these long -
1 3-GRAM long - term
1 3-GRAM - term abiotic
1 3-GRAM term abiotic factors
1 3-GRAM abiotic factors and
1 3-GRAM factors and nymphal
1 3-GRAM and nymphal abundance
1 3-GRAM nymphal abundance in
1 3-GRAM abundance in positive
1 3-GRAM in positive sites
1 3-GRAM positive sites showed
1 3-GRAM sites showed high
1 3-GRAM showed high relationship
1 3-GRAM high relationship (
1 3-GRAM relationship ( R2
1 3-GRAM ( R2 coefficients
1 3-GRAM R2 coefficients )
1 3-GRAM coefficients ) for
1 3-GRAM ) for every
1 3-GRAM for every habitat
1 3-GRAM every habitat category
1 3-GRAM habitat category and
1 3-GRAM category and explained
1 3-GRAM and explained >
1 3-GRAM explained > 50
1 3-GRAM > 50 %
1 3-GRAM of the variation
1 3-GRAM the variation in
1 3-GRAM variation in tick
1 3-GRAM in tick abundance
1 3-GRAM tick abundance .
1 3-GRAM abundance . STOP
1 3-GRAM * The v
1 3-GRAM The v -
1 3-GRAM v - Src
1 3-GRAM - Src SH3
1 3-GRAM Src SH3 domain
1 3-GRAM SH3 domain facilitates
1 3-GRAM domain facilitates a
1 3-GRAM facilitates a cell
1 3-GRAM a cell adhesion
1 3-GRAM cell adhesion -
1 3-GRAM adhesion - independent
1 3-GRAM - independent association
1 3-GRAM independent association with
1 3-GRAM association with focal
1 3-GRAM with focal adhesion
1 3-GRAM focal adhesion kinase
1 3-GRAM adhesion kinase .
1 3-GRAM * Of the
1 3-GRAM Of the six
1 3-GRAM the six cases
1 3-GRAM six cases of
1 3-GRAM cases of malignant
1 3-GRAM of malignant polyposis
1 3-GRAM malignant polyposis ,
1 3-GRAM polyposis , none
1 3-GRAM , none were
1 3-GRAM none were identified
1 3-GRAM were identified using
1 3-GRAM identified using CT
1 3-GRAM using CT ,
1 3-GRAM CT , and
1 3-GRAM , and only
1 3-GRAM and only two
1 3-GRAM only two were
1 3-GRAM two were diagnosed
1 3-GRAM were diagnosed by
1 3-GRAM diagnosed by small
1 3-GRAM by small bowel
1 3-GRAM small bowel follow
1 3-GRAM bowel follow -
1 3-GRAM follow - through
1 3-GRAM - through .
1 3-GRAM through . STOP
1 3-GRAM * * Right
1 3-GRAM * Right LHR
1 3-GRAM Right LHR (
1 3-GRAM LHR ( R
1 3-GRAM R - LHR
1 3-GRAM - LHR )
1 3-GRAM LHR ) provided
1 3-GRAM ) provided the
1 3-GRAM provided the best
1 3-GRAM the best interobserver
1 3-GRAM best interobserver and
1 3-GRAM interobserver and intraobserver
1 3-GRAM and intraobserver reproducibility
1 3-GRAM intraobserver reproducibility .
1 3-GRAM reproducibility . STOP
1 3-GRAM * We also
1 3-GRAM We also reported
1 3-GRAM also reported the
1 3-GRAM reported the identification
2 3-GRAM the identification of
1 3-GRAM identification of three
1 3-GRAM of three corresponding
1 3-GRAM three corresponding alternative
1 3-GRAM corresponding alternative first
1 3-GRAM alternative first exons
1 3-GRAM first exons and
1 3-GRAM exons and an
1 3-GRAM and an intronic
1 3-GRAM an intronic promoter
2 3-GRAM intronic promoter in
2 3-GRAM promoter in the
1 3-GRAM in the human
1 3-GRAM the human PDE5A
1 3-GRAM human PDE5A gene
1 3-GRAM PDE5A gene .
1 3-GRAM * Of major
1 3-GRAM Of major concern
1 3-GRAM major concern to
1 3-GRAM concern to food
1 3-GRAM to food processors
1 3-GRAM food processors is
1 3-GRAM processors is the
1 3-GRAM is the inadvertent
1 3-GRAM the inadvertent cross
1 3-GRAM inadvertent cross -
1 3-GRAM cross - contact
1 3-GRAM - contact of
1 3-GRAM contact of food
1 3-GRAM of food products
1 3-GRAM food products with
1 3-GRAM products with allergenic
1 3-GRAM with allergenic residues
1 3-GRAM allergenic residues ,
1 3-GRAM residues , which
1 3-GRAM , which could
1 3-GRAM which could result
1 3-GRAM could result in
1 3-GRAM result in potentially
1 3-GRAM in potentially life
1 3-GRAM potentially life -
1 3-GRAM life - threatening
1 3-GRAM - threatening reactions
1 3-GRAM threatening reactions in
1 3-GRAM reactions in those
2 3-GRAM in those with
1 3-GRAM those with a
1 3-GRAM with a food
1 3-GRAM a food allergy
1 3-GRAM food allergy .
1 3-GRAM allergy . STOP
1 3-GRAM * * Diffuse
1 3-GRAM * Diffuse myalgias
1 3-GRAM Diffuse myalgias were
1 3-GRAM myalgias were more
1 3-GRAM were more frequent
1 3-GRAM more frequent in
1 3-GRAM frequent in patients
1 3-GRAM patients with than
1 3-GRAM with than without
1 3-GRAM than without an
1 3-GRAM without an MMF
1 3-GRAM an MMF lesion
1 3-GRAM MMF lesion at
1 3-GRAM lesion at deltoid
1 3-GRAM at deltoid muscle
1 3-GRAM deltoid muscle biopsy
1 3-GRAM muscle biopsy (
1 3-GRAM biopsy ( P
1 3-GRAM 0 . 0001
1 3-GRAM . 0001 ).
1 3-GRAM 0001 ). STOP
1 3-GRAM * * Functional
1 3-GRAM * Functional analysis
1 3-GRAM Functional analysis of
1 3-GRAM analysis of various
1 3-GRAM of various PTP
1 3-GRAM various PTP -
1 3-GRAM PTP - deficient
1 3-GRAM - deficient DT40
1 3-GRAM deficient DT40 B
1 3-GRAM DT40 B cell
1 3-GRAM B cell lines
1 3-GRAM cell lines stably
1 3-GRAM lines stably expressing
1 3-GRAM stably expressing wild
1 3-GRAM expressing wild -
1 3-GRAM - type chimeric
1 3-GRAM type chimeric Fc
1 3-GRAM chimeric Fc gamma
1 3-GRAM Fc gamma RIIB1
1 3-GRAM gamma RIIB1 -
1 3-GRAM RIIB1 - PECAM
1 3-GRAM - PECAM -
1 3-GRAM PECAM - 1
1 3-GRAM - 1 receptor
1 3-GRAM 1 receptor indicated
1 3-GRAM receptor indicated that
1 3-GRAM indicated that cytoplasmic
1 3-GRAM that cytoplasmic Src
1 3-GRAM cytoplasmic Src homology
1 3-GRAM Src homology 2
1 3-GRAM homology 2 -
1 3-GRAM 2 - domain
1 3-GRAM - domain -
1 3-GRAM domain - containing
1 3-GRAM - containing phosphatases
1 3-GRAM containing phosphatases ,
1 3-GRAM phosphatases , SHP
1 3-GRAM , SHP -
1 3-GRAM SHP - 1
2 3-GRAM - 1 and
1 3-GRAM 1 and SHP
1 3-GRAM and SHP -
1 3-GRAM SHP - 2
1 3-GRAM 2 , were
1 3-GRAM , were both
1 3-GRAM were both necessary
1 3-GRAM both necessary and
1 3-GRAM necessary and sufficient
1 3-GRAM and sufficient to
1 3-GRAM sufficient to deliver
1 3-GRAM to deliver inhibitory
1 3-GRAM deliver inhibitory negative
1 3-GRAM inhibitory negative regulation
1 3-GRAM negative regulation upon
1 3-GRAM regulation upon coligation
1 3-GRAM upon coligation of
1 3-GRAM coligation of BCR
1 3-GRAM of BCR complex
1 3-GRAM BCR complex with
1 3-GRAM complex with inhibitory
1 3-GRAM with inhibitory receptor
1 3-GRAM inhibitory receptor .
2 3-GRAM receptor . STOP
1 3-GRAM * * Subtraction
1 3-GRAM * Subtraction hybridization
1 3-GRAM Subtraction hybridization identified
1 3-GRAM hybridization identified melanoma
1 3-GRAM identified melanoma differentiation
1 3-GRAM melanoma differentiation associated
1 3-GRAM differentiation associated gene
1 3-GRAM associated gene -
1 3-GRAM gene - 7
1 3-GRAM - 7 (
1 3-GRAM 7 ( mda
1 3-GRAM ( mda -
1 3-GRAM mda - 7
1 3-GRAM - 7 ),
1 3-GRAM 7 ), as
1 3-GRAM ), as a
1 3-GRAM as a gene
1 3-GRAM a gene induced
1 3-GRAM gene induced during
1 3-GRAM induced during these
1 3-GRAM during these physiological
1 3-GRAM these physiological changes
1 3-GRAM physiological changes in
1 3-GRAM changes in human
1 3-GRAM in human melanoma
1 3-GRAM human melanoma cells
1 3-GRAM melanoma cells .
1 3-GRAM * A rare
1 3-GRAM A rare case
1 3-GRAM rare case of
1 3-GRAM case of primary
1 3-GRAM of primary group
1 3-GRAM primary group A
1 3-GRAM group A streptococcal
1 3-GRAM A streptococcal peritonitis
1 3-GRAM streptococcal peritonitis .
1 3-GRAM peritonitis . STOP
1 3-GRAM * * Among
1 3-GRAM * Among individuals
1 3-GRAM Among individuals ,
1 3-GRAM individuals , however
2 3-GRAM , however ,
1 3-GRAM however , changes
1 3-GRAM , changes were
1 3-GRAM changes were strongly
1 3-GRAM were strongly correlated
1 3-GRAM strongly correlated with
1 3-GRAM correlated with ACR
1 3-GRAM with ACR levels
1 3-GRAM ACR levels at
1 3-GRAM levels at baseline
1 3-GRAM at baseline .
1 3-GRAM baseline . STOP
1 3-GRAM : The subjects
1 3-GRAM The subjects in
1 3-GRAM subjects in the
1 3-GRAM in the augmented
1 3-GRAM the augmented feedback
1 3-GRAM augmented feedback group
1 3-GRAM feedback group significantly
1 3-GRAM group significantly reduced
1 3-GRAM significantly reduced their
1 3-GRAM reduced their peak
1 3-GRAM their peak vertical
1 3-GRAM peak vertical ground
1 3-GRAM vertical ground reaction
1 3-GRAM ground reaction force
1 3-GRAM reaction force in
1 3-GRAM force in both
1 3-GRAM in both post
1 3-GRAM both post -
3 3-GRAM post - test
1 3-GRAM - test conditions
1 3-GRAM test conditions (
1 3-GRAM conditions ( 2
3 3-GRAM ( 2 -
1 3-GRAM 2 - minute
1 3-GRAM - minute post
1 3-GRAM minute post -
2 3-GRAM - test reduction
2 3-GRAM test reduction ,
2 3-GRAM reduction , 0
6 3-GRAM , 0 .
1 3-GRAM 0 . 85
1 3-GRAM . 85 +/-
1 3-GRAM 85 +/- 0
1 3-GRAM . 62 ;
1 3-GRAM 62 ; 1
1 3-GRAM ; 1 -
1 3-GRAM 1 - week
1 3-GRAM - week post
1 3-GRAM week post -
1 3-GRAM 0 . 74
1 3-GRAM . 74 +/-
1 3-GRAM 74 +/- 0
1 3-GRAM 0 . 58
1 3-GRAM . 58 )
1 3-GRAM 58 ) as
1 3-GRAM as compared to
1 3-GRAM to the sensory
1 3-GRAM the sensory ,
1 3-GRAM sensory , control
1 3-GRAM , control I
1 3-GRAM control I ,
1 3-GRAM I , and
1 3-GRAM , and control
1 3-GRAM and control II
1 3-GRAM control II feedback
1 3-GRAM II feedback groups
1 3-GRAM feedback groups .
4 3-GRAM groups . STOP
1 3-GRAM * The blood
1 3-GRAM The blood levels
1 3-GRAM blood levels of
1 3-GRAM levels of lactate
1 3-GRAM of lactate ,
1 3-GRAM lactate , pyruvate
1 3-GRAM , pyruvate and
1 3-GRAM pyruvate and amino
1 3-GRAM and amino acids
1 3-GRAM amino acids were
1 3-GRAM acids were not
1 3-GRAM were not elevated
1 3-GRAM not elevated .
1 3-GRAM elevated . STOP
1 3-GRAM * * Histological
1 3-GRAM * Histological examination
1 3-GRAM Histological examination showed
1 3-GRAM examination showed lichenoid
1 3-GRAM showed lichenoid changes
1 3-GRAM lichenoid changes ,
1 3-GRAM changes , acantholytic
1 3-GRAM , acantholytic blister
1 3-GRAM acantholytic blister formation
1 3-GRAM blister formation and
1 3-GRAM formation and apoptotic
1 3-GRAM and apoptotic keratinocytes
1 3-GRAM apoptotic keratinocytes .
1 3-GRAM keratinocytes . STOP
1 3-GRAM * * Enantiomer
1 3-GRAM * Enantiomer separation
1 3-GRAM Enantiomer separation of
1 3-GRAM separation of venlafaxine
1 3-GRAM of venlafaxine and
1 3-GRAM venlafaxine and O
1 3-GRAM and O -
1 3-GRAM O - desmethylvenlafaxine
1 3-GRAM - desmethylvenlafaxine in
1 3-GRAM desmethylvenlafaxine in human
1 3-GRAM in human plasma
1 3-GRAM human plasma .
1 3-GRAM plasma . STOP
1 3-GRAM * * Paul
1 3-GRAM * Paul Monagle
1 3-GRAM Paul Monagle addresses
1 3-GRAM Monagle addresses the
1 3-GRAM addresses the epidemiology
1 3-GRAM the epidemiology of
1 3-GRAM epidemiology of neonatal
1 3-GRAM of neonatal thrombosis
1 3-GRAM neonatal thrombosis outside
1 3-GRAM thrombosis outside of
1 3-GRAM outside of the
1 3-GRAM of the central
1 3-GRAM the central nervous
1 3-GRAM central nervous system
1 3-GRAM nervous system in
1 3-GRAM system in both
1 3-GRAM in both arterial
1 3-GRAM both arterial and
1 3-GRAM arterial and venous
1 3-GRAM and venous locations
1 3-GRAM venous locations ,
1 3-GRAM locations , and
1 3-GRAM , and those
1 3-GRAM and those that
1 3-GRAM those that occur
1 3-GRAM that occur in
1 3-GRAM occur in utero
1 3-GRAM in utero .
1 3-GRAM utero . STOP
1 3-GRAM * The MSL
1 3-GRAM The MSL complex
1 3-GRAM MSL complex is
1 3-GRAM complex is specifically
1 3-GRAM is specifically localized
1 3-GRAM specifically localized on
1 3-GRAM localized on the
1 3-GRAM on the male
1 3-GRAM the male X
1 3-GRAM male X chromosome
1 3-GRAM X chromosome to
1 3-GRAM chromosome to increase
1 3-GRAM to increase its
1 3-GRAM increase its expression
1 3-GRAM its expression approximately
1 3-GRAM expression approximately 2
1 3-GRAM approximately 2 -
1 3-GRAM 2 - fold
1 3-GRAM - fold .
1 3-GRAM fold . STOP
1 3-GRAM Effects of a
1 3-GRAM of a booster
1 3-GRAM a booster dose
1 3-GRAM booster dose of
1 3-GRAM dose of tetanus
1 3-GRAM of tetanus toxoid
1 3-GRAM tetanus toxoid after
1 3-GRAM toxoid after different
1 3-GRAM after different primary
1 3-GRAM different primary courses
1 3-GRAM primary courses of
1 3-GRAM courses of vaccination
1 3-GRAM of vaccination :
1 3-GRAM vaccination : implications
1 3-GRAM : implications on
1 3-GRAM implications on the
1 3-GRAM on the use
1 3-GRAM use of immune
1 3-GRAM of immune globulin
1 3-GRAM immune globulin .
1 3-GRAM globulin . STOP
1 3-GRAM that the C
2 3-GRAM - terminal region
1 3-GRAM terminal region of
1 3-GRAM region of Crk
1 3-GRAM of Crk contains
1 3-GRAM Crk contains negative
1 3-GRAM contains negative regulatory
1 3-GRAM negative regulatory elements
1 3-GRAM regulatory elements important
1 3-GRAM elements important for
1 3-GRAM important for both
1 3-GRAM for both Abl
1 3-GRAM both Abl and
1 3-GRAM Abl and FAK
1 3-GRAM and FAK dependent
1 3-GRAM FAK dependent signal
1 3-GRAM dependent signal pathways
1 3-GRAM signal pathways ,
1 3-GRAM pathways , and
1 3-GRAM , and offers
1 3-GRAM and offers a
1 3-GRAM offers a paradigm
1 3-GRAM a paradigm for
1 3-GRAM paradigm for an
1 3-GRAM for an autoinhibitory
1 3-GRAM an autoinhibitory region
1 3-GRAM autoinhibitory region in
1 3-GRAM region in the
1 3-GRAM in the SH3
1 3-GRAM the SH3 linker
1 3-GRAM SH3 linker /
1 3-GRAM linker / C
1 3-GRAM / C -
1 3-GRAM - terminal SH3
1 3-GRAM terminal SH3 domain
1 3-GRAM SH3 domain .
1 3-GRAM * The distribution
1 3-GRAM The distribution of
1 3-GRAM distribution of red
1 3-GRAM of red rice
1 3-GRAM red rice cultivation
1 3-GRAM rice cultivation in
1 3-GRAM cultivation in Sri
1 3-GRAM in Sri Lanka
1 3-GRAM Sri Lanka is
1 3-GRAM Lanka is coincident
1 3-GRAM is coincident with
1 3-GRAM coincident with the
1 3-GRAM with the HIDD
1 3-GRAM the HIDD villages
1 3-GRAM HIDD villages .
1 3-GRAM villages . STOP
1 3-GRAM * * Prophylactic
1 3-GRAM * Prophylactic lymph
1 3-GRAM Prophylactic lymph node
1 3-GRAM lymph node dissection
1 3-GRAM node dissection or
1 3-GRAM dissection or radiation
1 3-GRAM or radiation therapy
1 3-GRAM radiation therapy to
1 3-GRAM therapy to the
1 3-GRAM to the nodal
1 3-GRAM the nodal chain
1 3-GRAM nodal chain may
1 3-GRAM chain may decrease
1 3-GRAM may decrease local
1 3-GRAM decrease local recurrence
1 3-GRAM local recurrence but
1 3-GRAM recurrence but does
1 3-GRAM but does not
1 3-GRAM does not consistently
1 3-GRAM not consistently affect
1 3-GRAM consistently affect overall
1 3-GRAM affect overall survival
1 3-GRAM overall survival .
1 3-GRAM survival . STOP
1 3-GRAM * * Secretion
1 3-GRAM * Secretion of
1 3-GRAM Secretion of interleukin
1 3-GRAM of interleukin -
1 3-GRAM interleukin - 8
1 3-GRAM 8 , RANTES
1 3-GRAM , RANTES ,
1 3-GRAM RANTES , macrophage
1 3-GRAM , macrophage inflammatory
1 3-GRAM inflammatory protein 1alpha
1 3-GRAM protein 1alpha ,
1 3-GRAM 1alpha , and
1 3-GRAM , and 10
1 3-GRAM and 10 -
1 3-GRAM 10 - kappaDa
1 3-GRAM - kappaDa IFN
1 3-GRAM kappaDa IFN -
1 3-GRAM IFN - gamma
1 3-GRAM - gamma -
1 3-GRAM gamma - inducible
1 3-GRAM - inducible protein
1 3-GRAM inducible protein were
1 3-GRAM protein were increased
1 3-GRAM were increased in
1 3-GRAM increased in differentiating
1 3-GRAM in differentiating keratinocytes
1 3-GRAM differentiating keratinocytes by
1 3-GRAM keratinocytes by E6
1 3-GRAM by E6 .
1 3-GRAM E6 . STOP
1 3-GRAM CONCLUSIONS : ChromaFlo
1 3-GRAM : ChromaFlo -
1 3-GRAM ChromaFlo - enhanced
1 3-GRAM - enhanced IVUS
1 3-GRAM enhanced IVUS demonstrates
1 3-GRAM IVUS demonstrates colorized
1 3-GRAM demonstrates colorized blood
1 3-GRAM colorized blood flow
1 3-GRAM blood flow inside
1 3-GRAM flow inside the
1 3-GRAM inside the vessel
1 3-GRAM the vessel lumen
1 3-GRAM vessel lumen ,
1 3-GRAM lumen , which
1 3-GRAM which is helpful
1 3-GRAM is helpful in
1 3-GRAM helpful in distinguishing
1 3-GRAM in distinguishing echolucent
1 3-GRAM distinguishing echolucent disease
1 3-GRAM echolucent disease from
1 3-GRAM disease from luminal
1 3-GRAM from luminal blood
1 3-GRAM luminal blood flow
1 3-GRAM blood flow and
1 3-GRAM flow and can
1 3-GRAM and can also
1 3-GRAM can also be
1 3-GRAM also be used
1 3-GRAM be used to
1 3-GRAM used to perform
1 3-GRAM to perform peripheral
1 3-GRAM perform peripheral interventions
1 3-GRAM peripheral interventions in
1 3-GRAM interventions in patients
1 3-GRAM patients with renal
1 3-GRAM with renal failure
1 3-GRAM renal failure or
1 3-GRAM failure or allergy
1 3-GRAM or allergy ,
1 3-GRAM allergy , avoiding
1 3-GRAM , avoiding the
1 3-GRAM avoiding the use
1 3-GRAM use of contrast
1 3-GRAM of contrast media
1 3-GRAM contrast media .
1 3-GRAM media . STOP
1 3-GRAM * Additional factors
1 3-GRAM Additional factors such
1 3-GRAM factors such as
1 3-GRAM such as advanced
1 3-GRAM as advanced age
1 3-GRAM advanced age ,
1 3-GRAM age , concomitant
1 3-GRAM , concomitant use
1 3-GRAM concomitant use of
1 3-GRAM use of corticosteroids
1 3-GRAM of corticosteroids or
1 3-GRAM corticosteroids or anticoagulants
1 3-GRAM or anticoagulants ,
1 3-GRAM anticoagulants , prior
1 3-GRAM , prior ulcer
1 3-GRAM prior ulcer complications
1 3-GRAM ulcer complications and
1 3-GRAM complications and co
1 3-GRAM and co -
1 3-GRAM co - morbid
1 3-GRAM - morbid diseases
1 3-GRAM morbid diseases may
1 3-GRAM diseases may further
1 3-GRAM may further increase
1 3-GRAM further increase the
1 3-GRAM increase the risk
1 3-GRAM the risk of
1 3-GRAM risk of bleeding
1 3-GRAM of bleeding .
1 3-GRAM bleeding . STOP
1 3-GRAM CONCLUSIONS : Using
1 3-GRAM : Using icodextrin
1 3-GRAM Using icodextrin -
1 3-GRAM icodextrin - based
1 3-GRAM - based instead
1 3-GRAM based instead of
1 3-GRAM instead of glucose
1 3-GRAM of glucose -
1 3-GRAM glucose - based
1 3-GRAM - based PD
1 3-GRAM based PD fluids
1 3-GRAM PD fluids can
1 3-GRAM fluids can largely
1 3-GRAM can largely reduce
1 3-GRAM largely reduce the
1 3-GRAM reduce the formation
1 3-GRAM the formation of
1 3-GRAM formation of Amadori
1 3-GRAM of Amadori albumin
1 3-GRAM Amadori albumin and
1 3-GRAM albumin and AGEs
1 3-GRAM and AGEs .
1 3-GRAM AGEs . STOP
1 3-GRAM * A central
1 3-GRAM A central finding
1 3-GRAM central finding is
1 3-GRAM finding is the
1 3-GRAM is the identification
1 3-GRAM identification of a
1 3-GRAM of a GC
1 3-GRAM a GC -
1 3-GRAM GC - rich
1 3-GRAM - rich sequence
1 3-GRAM rich sequence in
1 3-GRAM sequence in the
1 3-GRAM in the -
1 3-GRAM the - 99
1 3-GRAM - 99 /-
1 3-GRAM 99 /- 91
1 3-GRAM /- 91 Cp
1 3-GRAM 91 Cp region
1 3-GRAM Cp region that
1 3-GRAM region that is
1 3-GRAM that is essential
2 3-GRAM is essential for
1 3-GRAM essential for oriPI
1 3-GRAM for oriPI -
2 3-GRAM oriPI - EBNA1
2 3-GRAM - EBNA1 -
1 3-GRAM EBNA1 - independent
1 3-GRAM - independent as
1 3-GRAM independent as well
1 3-GRAM well as oriPI
1 3-GRAM as oriPI -
1 3-GRAM EBNA1 - dependent
1 3-GRAM - dependent activity
1 3-GRAM dependent activity of
1 3-GRAM the promoter .
1 3-GRAM Furthermore , SB203580
1 3-GRAM , SB203580 inhibited
1 3-GRAM SB203580 inhibited LPS
1 3-GRAM inhibited LPS -
1 3-GRAM LPS - induced
1 3-GRAM - induced activation
1 3-GRAM induced activation of
1 3-GRAM activation of Sp1
1 3-GRAM of Sp1 ,
1 3-GRAM Sp1 , as
1 3-GRAM , as well
1 3-GRAM well as the
1 3-GRAM as the promoter
1 3-GRAM the promoter activity
1 3-GRAM promoter activity in
1 3-GRAM activity in cells
1 3-GRAM in cells transfected
1 3-GRAM cells transfected with
1 3-GRAM transfected with a
1 3-GRAM with a plasmid
1 3-GRAM a plasmid containing
1 3-GRAM plasmid containing the
1 3-GRAM containing the Sp1
1 3-GRAM the Sp1 consensus
1 3-GRAM Sp1 consensus sequence
1 3-GRAM consensus sequence .
1 3-GRAM sequence . STOP
1 3-GRAM * A new
1 3-GRAM A new echocardiographic
1 3-GRAM new echocardiographic technique
1 3-GRAM echocardiographic technique is
1 3-GRAM technique is described
1 3-GRAM is described with
1 3-GRAM described with a
1 3-GRAM with a conventional
1 3-GRAM a conventional M
1 3-GRAM conventional M mode
1 3-GRAM M mode ,
1 3-GRAM mode , digitalised
1 3-GRAM , digitalised 2D
1 3-GRAM digitalised 2D and
1 3-GRAM 2D and tissular
1 3-GRAM and tissular Doppler
1 3-GRAM tissular Doppler which
1 3-GRAM Doppler which has
1 3-GRAM which has a
1 3-GRAM has a comparable
1 3-GRAM a comparable ability
1 3-GRAM comparable ability to
1 3-GRAM ability to identify
1 3-GRAM to identify the
1 3-GRAM identify the anomalous
1 3-GRAM the anomalous pathways
1 3-GRAM anomalous pathways of
1 3-GRAM pathways of electric
1 3-GRAM of electric conduction
1 3-GRAM electric conduction using
1 3-GRAM conduction using a
1 3-GRAM using a non
1 3-GRAM a non -
1 3-GRAM non - invasive
1 3-GRAM - invasive method
1 3-GRAM invasive method .
2 3-GRAM method . STOP
1 3-GRAM * * Is
1 3-GRAM * Is clopidogrel
1 3-GRAM Is clopidogrel superior
1 3-GRAM clopidogrel superior to
1 3-GRAM superior to aspirin
1 3-GRAM to aspirin in
1 3-GRAM aspirin in secondary
1 3-GRAM in secondary prevention
2 3-GRAM secondary prevention of
2 3-GRAM prevention of vascular
2 3-GRAM of vascular disease
1 3-GRAM vascular disease ?
1 3-GRAM disease ? The
1 3-GRAM ? The cornerstone
1 3-GRAM The cornerstone in
1 3-GRAM cornerstone in clinical
1 3-GRAM in clinical evidence
1 3-GRAM clinical evidence of
1 3-GRAM evidence of the
1 3-GRAM of the relative
1 3-GRAM the relative efficacy
1 3-GRAM relative efficacy of
1 3-GRAM efficacy of thienopyridines
1 3-GRAM of thienopyridines (
1 3-GRAM thienopyridines ( clopidogrel
1 3-GRAM ( clopidogrel ,
1 3-GRAM clopidogrel , ticlopidine
1 3-GRAM , ticlopidine )
1 3-GRAM ticlopidine ) versus
1 3-GRAM ) versus aspirin
1 3-GRAM versus aspirin in
1 3-GRAM aspirin in the
1 3-GRAM in the secondary
1 3-GRAM the secondary prevention
1 3-GRAM vascular disease is
1 3-GRAM disease is the
1 3-GRAM is the Clopidogrel
1 3-GRAM the Clopidogrel versus
1 3-GRAM Clopidogrel versus Aspirin
1 3-GRAM versus Aspirin in
1 3-GRAM Aspirin in Patients
1 3-GRAM in Patients at
1 3-GRAM Patients at Risk
1 3-GRAM at Risk of
1 3-GRAM Risk of Ischaemic
1 3-GRAM of Ischaemic Events
1 3-GRAM Ischaemic Events trial
1 3-GRAM Events trial .
1 3-GRAM trial . STOP
1 3-GRAM * The role
1 3-GRAM The role of
1 3-GRAM role of the
1 3-GRAM of the Vp1
1 3-GRAM the Vp1 DBD
1 3-GRAM Vp1 DBD during
1 3-GRAM DBD during infection
1 3-GRAM during infection was
1 3-GRAM infection was investigated
1 3-GRAM was investigated by
1 3-GRAM investigated by taking
1 3-GRAM by taking advantage
1 3-GRAM taking advantage of
1 3-GRAM advantage of NLS
1 3-GRAM of NLS phenotypic
1 3-GRAM NLS phenotypic complementation
1 3-GRAM phenotypic complementation (
1 3-GRAM complementation ( N
1 3-GRAM ( N .
1 3-GRAM N . STOP
1 3-GRAM * The probability
1 3-GRAM The probability of
1 3-GRAM probability of treatment
1 3-GRAM of treatment with
1 3-GRAM treatment with lamotrigine
1 3-GRAM with lamotrigine being
1 3-GRAM lamotrigine being maintained
1 3-GRAM being maintained for
1 3-GRAM maintained for six
1 3-GRAM for six months
1 3-GRAM six months was
1 3-GRAM months was 86
1 3-GRAM was 86 %,
1 3-GRAM 86 %, for
1 3-GRAM %, for twelve
1 3-GRAM for twelve months
1 3-GRAM twelve months 61
1 3-GRAM months 61 %
1 3-GRAM 61 % and
1 3-GRAM % and for
1 3-GRAM and for three
1 3-GRAM for three years
1 3-GRAM three years 31
1 3-GRAM years 31 %.
1 3-GRAM 31 %. STOP
1 3-GRAM * Recent advances
1 3-GRAM Recent advances have
1 3-GRAM advances have shown
1 3-GRAM have shown that
1 3-GRAM shown that volatile
1 3-GRAM that volatile sulfur
1 3-GRAM volatile sulfur is
1 3-GRAM sulfur is a
1 3-GRAM is a result
1 3-GRAM a result of
1 3-GRAM result of ecological
1 3-GRAM of ecological interactions
1 3-GRAM ecological interactions and
1 3-GRAM interactions and transformation
1 3-GRAM and transformation processes
1 3-GRAM transformation processes through
1 3-GRAM processes through planktonic
1 3-GRAM through planktonic food
1 3-GRAM planktonic food webs
1 3-GRAM food webs .
1 3-GRAM webs . STOP
1 3-GRAM * * OsBBPI
1 3-GRAM * OsBBPI was
1 3-GRAM OsBBPI was found
1 3-GRAM to be rapidly
1 3-GRAM be rapidly induced
1 3-GRAM rapidly induced in
1 3-GRAM induced in rice
1 3-GRAM in rice seedling
1 3-GRAM rice seedling leaf
1 3-GRAM seedling leaf in
1 3-GRAM leaf in response
1 3-GRAM response to cut
1 3-GRAM to cut ,
1 3-GRAM cut , exogenous
1 3-GRAM , exogenous jasmonic
1 3-GRAM exogenous jasmonic acid
1 3-GRAM jasmonic acid (
1 3-GRAM acid ( JA
1 3-GRAM ( JA ),
1 3-GRAM JA ), and
1 3-GRAM ), and two
1 3-GRAM and two potent
1 3-GRAM two potent protein
2 3-GRAM potent protein phosphatase
2 3-GRAM protein phosphatase 2A
2 3-GRAM phosphatase 2A (
2 3-GRAM 2A ( PP2A
2 3-GRAM ( PP2A )
1 3-GRAM PP2A ) inhibitors
1 3-GRAM ) inhibitors ,
1 3-GRAM inhibitors , cantharidin
1 3-GRAM , cantharidin (
1 3-GRAM cantharidin ( CN
1 3-GRAM ( CN )
1 3-GRAM CN ) and
1 3-GRAM ) and endothall
1 3-GRAM and endothall (
1 3-GRAM endothall ( EN
1 3-GRAM ( EN ),
1 3-GRAM EN ), in
1 3-GRAM ), in a
1 3-GRAM in a light
1 3-GRAM a light /
1 3-GRAM light / dark
1 3-GRAM / dark -,
1 3-GRAM dark -, time
1 3-GRAM -, time -
1 3-GRAM time - and
1 3-GRAM - and dose
1 3-GRAM and dose -
1 3-GRAM dose - dependent
1 3-GRAM - dependent manner
1 3-GRAM dependent manner ;
1 3-GRAM manner ; this
1 3-GRAM ; this induction
1 3-GRAM this induction was
1 3-GRAM induction was completely
1 3-GRAM was completely inhibited
1 3-GRAM completely inhibited by
1 3-GRAM inhibited by cycloheximide
1 3-GRAM by cycloheximide (
1 3-GRAM cycloheximide ( CHX
1 3-GRAM ( CHX ),
1 3-GRAM CHX ), indicating
1 3-GRAM ), indicating a
1 3-GRAM indicating a requirement
1 3-GRAM a requirement for
1 3-GRAM requirement for de
1 3-GRAM for de novo
1 3-GRAM protein synthesis in
1 3-GRAM synthesis in its
1 3-GRAM in its induction
1 3-GRAM its induction .
1 3-GRAM induction . STOP
1 3-GRAM Analysis of ace2Delta
1 3-GRAM of ace2Delta cells
1 3-GRAM ace2Delta cells reveals
1 3-GRAM cells reveals that
1 3-GRAM reveals that Ace2p
1 3-GRAM that Ace2p is
1 3-GRAM Ace2p is required
1 3-GRAM required for cell
1 3-GRAM for cell separation
1 3-GRAM cell separation but
1 3-GRAM separation but not
1 3-GRAM but not for
1 3-GRAM not for polarized
1 3-GRAM for polarized growth
1 3-GRAM polarized growth .
1 3-GRAM * The purpose
1 3-GRAM of this investigation
1 3-GRAM this investigation was
1 3-GRAM investigation was to
1 3-GRAM was to study
1 3-GRAM to study the
1 3-GRAM study the morphological
1 3-GRAM the morphological characteristics
1 3-GRAM morphological characteristics of
1 3-GRAM characteristics of the
1 3-GRAM of the fibrous
1 3-GRAM the fibrous tissue
1 3-GRAM fibrous tissue capsule
1 3-GRAM tissue capsule resulting
1 3-GRAM capsule resulting from
2 3-GRAM resulting from the
1 3-GRAM from the implantation
1 3-GRAM the implantation of
1 3-GRAM implantation of aluminum
1 3-GRAM of aluminum calcium
1 3-GRAM aluminum calcium phosphate
1 3-GRAM calcium phosphate (
1 3-GRAM phosphate ( ALCAP
1 3-GRAM ( ALCAP )
1 3-GRAM ALCAP ) and
1 3-GRAM ) and hydroxyapetite
1 3-GRAM and hydroxyapetite (
1 3-GRAM hydroxyapetite ( HA
1 3-GRAM HA ) bioceramics
1 3-GRAM ) bioceramics .
1 3-GRAM bioceramics . STOP
1 3-GRAM * The event
1 3-GRAM The event rate
1 3-GRAM event rate in
1 3-GRAM rate in patients
1 3-GRAM patients with chronic
1 3-GRAM with chronic Irr
1 3-GRAM chronic Irr -
1 3-GRAM Irr - rMFP
2 3-GRAM - rMFP or
1 3-GRAM rMFP or Un
1 3-GRAM or Un -
1 3-GRAM Un - nrMFP
1 3-GRAM - nrMFP was
1 3-GRAM nrMFP was markedly
1 3-GRAM was markedly higher
1 3-GRAM markedly higher than
1 3-GRAM higher than it
1 3-GRAM than it was
1 3-GRAM it was in
1 3-GRAM was in those
1 3-GRAM those with Rev
1 3-GRAM with Rev -
1 3-GRAM Rev - rMFP
1 3-GRAM rMFP or Sta
1 3-GRAM or Sta -
1 3-GRAM Sta - nrMFP
1 3-GRAM - nrMFP .
1 3-GRAM nrMFP . STOP
1 3-GRAM * In summary
1 3-GRAM In summary ,
1 3-GRAM summary , we
1 3-GRAM , we conclude
1 3-GRAM we conclude that
1 3-GRAM conclude that the
1 3-GRAM that the adenoviral
1 3-GRAM the adenoviral oncoprotein
1 3-GRAM adenoviral oncoprotein E1A
1 3-GRAM oncoprotein E1A activates
1 3-GRAM E1A activates transcription
1 3-GRAM activates transcription from
2 3-GRAM transcription from the
1 3-GRAM from the endogenous
1 3-GRAM the endogenous AP
1 3-GRAM endogenous AP -
2 3-GRAM AP - 2alpha
1 3-GRAM - 2alpha gene
1 3-GRAM 2alpha gene ,
1 3-GRAM gene , an
1 3-GRAM , an effect
1 3-GRAM an effect that
1 3-GRAM effect that involves
1 3-GRAM that involves transcriptional
1 3-GRAM involves transcriptional derepression
1 3-GRAM transcriptional derepression of
1 3-GRAM derepression of the
2 3-GRAM of the AP
4 3-GRAM the AP -
1 3-GRAM - 2alpha promoter
1 3-GRAM 2alpha promoter by
1 3-GRAM promoter by interaction
1 3-GRAM by interaction of
1 3-GRAM interaction of E1A
1 3-GRAM of E1A with
1 3-GRAM E1A with the
1 3-GRAM with the AP
1 3-GRAM AP - 2rep
1 3-GRAM - 2rep corepressor
1 3-GRAM 2rep corepressor CtBP1
1 3-GRAM corepressor CtBP1 .
1 3-GRAM CtBP1 . STOP
1 3-GRAM * * Unusual
1 3-GRAM * Unusual two
1 3-GRAM Unusual two -
1 3-GRAM two - domain
1 3-GRAM - domain arginine
1 3-GRAM domain arginine kinases
1 3-GRAM arginine kinases (
1 3-GRAM kinases ( AKs
1 3-GRAM ( AKs )
1 3-GRAM AKs ) arose
1 3-GRAM ) arose independently
1 3-GRAM arose independently at
1 3-GRAM independently at least
1 3-GRAM at least two
1 3-GRAM least two times
1 3-GRAM two times during
1 3-GRAM times during molecular
1 3-GRAM during molecular evolution
1 3-GRAM molecular evolution of
1 3-GRAM evolution of phosphagen
1 3-GRAM of phosphagen kinases
1 3-GRAM phosphagen kinases :
1 3-GRAM kinases : AKs
1 3-GRAM : AKs from
1 3-GRAM AKs from the
1 3-GRAM from the primitive
1 3-GRAM the primitive sea
1 3-GRAM primitive sea anemone
1 3-GRAM sea anemone Anthopleurura
1 3-GRAM anemone Anthopleurura japonicus
1 3-GRAM Anthopleurura japonicus and
1 3-GRAM japonicus and from
1 3-GRAM and from the
1 3-GRAM from the clam
1 3-GRAM the clam Pseudocardium
1 3-GRAM clam Pseudocardium sachalinensis
1 3-GRAM Pseudocardium sachalinensis .
1 3-GRAM sachalinensis . STOP
1 3-GRAM * * Mutagenesis
1 3-GRAM * Mutagenesis of
1 3-GRAM Mutagenesis of SNT1
1 3-GRAM of SNT1 (
1 3-GRAM SNT1 ( IRS
1 3-GRAM ( IRS )
1 3-GRAM IRS ) CX
1 3-GRAM ) CX identified
1 3-GRAM CX identified three
1 3-GRAM identified three classes
1 3-GRAM three classes of
1 3-GRAM classes of effector
1 3-GRAM of effector motifs
1 3-GRAM effector motifs within
1 3-GRAM motifs within SNT
1 3-GRAM within SNT critical
1 3-GRAM SNT critical for
1 3-GRAM critical for both
1 3-GRAM for both sustained
1 3-GRAM both sustained ERK
1 3-GRAM sustained ERK activation
1 3-GRAM ERK activation and
1 3-GRAM activation and neuronal
1 3-GRAM and neuronal differentiation
1 3-GRAM neuronal differentiation :
1 3-GRAM differentiation : 1
2 3-GRAM : 1 )
1 3-GRAM 1 ) four
1 3-GRAM ) four phosphotyrosine
1 3-GRAM four phosphotyrosine motifs
2 3-GRAM phosphotyrosine motifs that
2 3-GRAM motifs that mediate
2 3-GRAM that mediate recruitment
2 3-GRAM mediate recruitment of
1 3-GRAM recruitment of Grb2
1 3-GRAM of Grb2 ,
1 3-GRAM Grb2 , 2
1 3-GRAM , 2 )
1 3-GRAM 2 ) two
1 3-GRAM ) two phosphotyrosine
1 3-GRAM two phosphotyrosine motifs
1 3-GRAM recruitment of Shp2
1 3-GRAM of Shp2 ,
1 3-GRAM Shp2 , and
1 3-GRAM , and 3
1 3-GRAM and 3 )
1 3-GRAM 3 ) a
1 3-GRAM ) a C
1 3-GRAM a C -
1 3-GRAM - terminal motif
1 3-GRAM terminal motif that
1 3-GRAM motif that functions
1 3-GRAM that functions by
1 3-GRAM functions by helping
1 3-GRAM by helping to
1 3-GRAM helping to recruit
1 3-GRAM to recruit Sos
1 3-GRAM recruit Sos .
1 3-GRAM Sos . STOP
1 3-GRAM CONCLUSIONS : Our
1 3-GRAM : Our meta
1 3-GRAM Our meta -
1 3-GRAM meta - analysis
1 3-GRAM - analysis of
1 3-GRAM analysis of randomized
1 3-GRAM of randomized controlled
1 3-GRAM randomized controlled trials
1 3-GRAM controlled trials of
1 3-GRAM trials of HRT
1 3-GRAM of HRT noted
1 3-GRAM HRT noted a
1 3-GRAM noted a statistically
1 3-GRAM statistically significant reduction
1 3-GRAM significant reduction in
1 3-GRAM reduction in nonvertebral
1 3-GRAM in nonvertebral fractures
1 3-GRAM nonvertebral fractures .
1 3-GRAM fractures . STOP
1 3-GRAM However , C4B
1 3-GRAM , C4B proteins
1 3-GRAM C4B proteins encoded
1 3-GRAM proteins encoded by
1 3-GRAM encoded by monomodular
1 3-GRAM by monomodular short
1 3-GRAM monomodular short genes
1 3-GRAM short genes may
1 3-GRAM genes may have
1 3-GRAM may have relatively
1 3-GRAM have relatively higher
1 3-GRAM relatively higher concentrations
1 3-GRAM higher concentrations than
1 3-GRAM concentrations than those
1 3-GRAM than those from
1 3-GRAM those from long
1 3-GRAM from long C4A
1 3-GRAM long C4A genes
1 3-GRAM C4A genes .
1 3-GRAM * * CSR
1 3-GRAM * CSR is
1 3-GRAM CSR is directed
1 3-GRAM is directed to
1 3-GRAM directed to specific
1 3-GRAM to specific heavy
1 3-GRAM specific heavy chain
1 3-GRAM heavy chain isotypes
1 3-GRAM chain isotypes by
1 3-GRAM isotypes by cytokines
1 3-GRAM by cytokines and
1 3-GRAM cytokines and B
1 3-GRAM and B cell
1 3-GRAM B cell activators
1 3-GRAM cell activators that
1 3-GRAM activators that induce
1 3-GRAM that induce transcription
1 3-GRAM induce transcription from
1 3-GRAM from the unrearranged
1 3-GRAM the unrearranged ,
1 3-GRAM unrearranged , or
1 3-GRAM , or germline
1 3-GRAM or germline (
1 3-GRAM germline ( GL
1 3-GRAM ( GL ),
1 3-GRAM GL ), C
1 3-GRAM ), C (
1 3-GRAM C ( H
1 3-GRAM ( H )
1 3-GRAM H ) region
1 3-GRAM ) region genes
1 3-GRAM region genes .
1 3-GRAM * The patterns
1 3-GRAM The patterns of
1 3-GRAM patterns of early
1 3-GRAM of early mRNA
1 3-GRAM early mRNA and
2 3-GRAM mRNA and protein
1 3-GRAM and protein expression
1 3-GRAM protein expression in
1 3-GRAM expression in these
1 3-GRAM in these seven
1 3-GRAM these seven mutants
1 3-GRAM seven mutants were
1 3-GRAM mutants were examined
1 3-GRAM were examined ,
1 3-GRAM examined , and
1 3-GRAM , and it
1 3-GRAM and it was
1 3-GRAM it was found
1 3-GRAM found that mutation
1 3-GRAM that mutation of
1 3-GRAM mutation of the
1 3-GRAM of the T
1 3-GRAM the T '(
1 3-GRAM T '( 135
1 3-GRAM '( 135 )
1 3-GRAM 135 ) acceptor
1 3-GRAM ) acceptor site
1 3-GRAM acceptor site resulted
1 3-GRAM site resulted in
1 3-GRAM resulted in the
1 3-GRAM in the utilization
1 3-GRAM the utilization of
1 3-GRAM utilization of cryptic
1 3-GRAM of cryptic splice
1 3-GRAM cryptic splice sites
1 3-GRAM splice sites and
1 3-GRAM sites and the
1 3-GRAM and the generation
1 3-GRAM the generation of
1 3-GRAM generation of new
1 3-GRAM of new T
1 3-GRAM new T '
1 3-GRAM T ' species
1 3-GRAM ' species .
1 3-GRAM species . STOP
1 3-GRAM * * Mutational
1 3-GRAM * Mutational analysis
1 3-GRAM Mutational analysis showed
1 3-GRAM analysis showed that
1 3-GRAM showed that the
1 3-GRAM that the U
1 3-GRAM the U -
1 3-GRAM U - box
1 3-GRAM - box ,
1 3-GRAM box , like
1 3-GRAM , like the
1 3-GRAM like the RING
1 3-GRAM the RING finger
1 3-GRAM RING finger in
1 3-GRAM finger in other
1 3-GRAM in other proteins
1 3-GRAM other proteins ,
1 3-GRAM proteins , forms
1 3-GRAM , forms the
1 3-GRAM forms the physical
1 3-GRAM the physical basis
1 3-GRAM physical basis for
1 3-GRAM basis for the
2 3-GRAM for the interaction
1 3-GRAM the interaction with
1 3-GRAM interaction with E2
1 3-GRAM with E2 enzymes
1 3-GRAM E2 enzymes .
1 3-GRAM enzymes . STOP
1 3-GRAM * * GafChromic
1 3-GRAM * GafChromic (
1 3-GRAM GafChromic ( MD
1 3-GRAM ( MD -
1 3-GRAM MD - 55
1 3-GRAM - 55 -
1 3-GRAM 55 - 2
1 3-GRAM 2 ) radiochromic
1 3-GRAM ) radiochromic film
1 3-GRAM radiochromic film has
1 3-GRAM film has become
1 3-GRAM has become increasingly
1 3-GRAM become increasingly popular
1 3-GRAM increasingly popular for
1 3-GRAM popular for medical
1 3-GRAM for medical applications
1 3-GRAM medical applications and
1 3-GRAM applications and has
1 3-GRAM and has proven
1 3-GRAM has proven to
1 3-GRAM proven to be
1 3-GRAM to be useful
1 3-GRAM be useful for
1 3-GRAM useful for brachytherapy
1 3-GRAM for brachytherapy dosimetry
1 3-GRAM brachytherapy dosimetry .
2 3-GRAM dosimetry . STOP
1 3-GRAM * The 438
1 3-GRAM The 438 bp
1 3-GRAM 438 bp EcoRI
1 3-GRAM bp EcoRI fragment
1 3-GRAM EcoRI fragment ,
1 3-GRAM fragment , which
1 3-GRAM which was detected
1 3-GRAM was detected by
1 3-GRAM detected by Southern
1 3-GRAM by Southern hybridization
1 3-GRAM Southern hybridization ,
1 3-GRAM hybridization , reveals
1 3-GRAM , reveals an
1 3-GRAM reveals an open
1 3-GRAM an open reading
1 3-GRAM reading frame which
1 3-GRAM frame which encodes
2 3-GRAM which encodes a
1 3-GRAM encodes a protein
1 3-GRAM a protein of
1 3-GRAM protein of 103
1 3-GRAM of 103 amino
1 3-GRAM 103 amino acids
1 3-GRAM amino acids .
2 3-GRAM acids . STOP
1 3-GRAM Furthermore , hormonal
1 3-GRAM , hormonal regulation
1 3-GRAM hormonal regulation of
1 3-GRAM regulation of G
1 3-GRAM of G (
1 3-GRAM G ( 1
1 3-GRAM ( 1 )
1 3-GRAM 1 ) gene
1 3-GRAM ) gene transcription
1 3-GRAM gene transcription can
1 3-GRAM transcription can occur
1 3-GRAM can occur even
1 3-GRAM occur even without
1 3-GRAM even without additional
1 3-GRAM without additional activation
1 3-GRAM additional activation of
1 3-GRAM of the Mek
1 3-GRAM the Mek -
1 3-GRAM Mek - Erk1
1 3-GRAM - Erk1 /
1 3-GRAM Erk1 / 2
1 3-GRAM / 2 pathway
1 3-GRAM 2 pathway by
1 3-GRAM pathway by estrogen
1 3-GRAM by estrogen receptors
1 3-GRAM estrogen receptors .
2 3-GRAM receptors . STOP
1 3-GRAM * In mammalian
1 3-GRAM In mammalian tissue
1 3-GRAM mammalian tissue culture
1 3-GRAM tissue culture cells
1 3-GRAM culture cells ,
1 3-GRAM cells , overexpression
1 3-GRAM , overexpression of
1 3-GRAM overexpression of any
1 3-GRAM of any of
1 3-GRAM any of the
1 3-GRAM of the four
1 3-GRAM the four mouse
1 3-GRAM four mouse deltex
1 3-GRAM mouse deltex homologs
1 3-GRAM deltex homologs suppressed
1 3-GRAM homologs suppressed the
1 3-GRAM suppressed the transcriptional
2 3-GRAM the transcriptional activity
3 3-GRAM transcriptional activity of
1 3-GRAM activity of E47
1 3-GRAM of E47 ,
1 3-GRAM E47 , a
1 3-GRAM , a basic
1 3-GRAM a basic helix
1 3-GRAM basic helix -
1 3-GRAM helix - loop
1 3-GRAM - loop -
1 3-GRAM loop - helix
1 3-GRAM - helix (
1 3-GRAM helix ( bHLH
1 3-GRAM ( bHLH )
1 3-GRAM bHLH ) protein
1 3-GRAM ) protein ,
1 3-GRAM protein , in
1 3-GRAM , in a
1 3-GRAM a manner similar
1 3-GRAM manner similar to
1 3-GRAM similar to suppression
1 3-GRAM to suppression by
1 3-GRAM suppression by an
1 3-GRAM by an activated
1 3-GRAM an activated form
1 3-GRAM activated form of
1 3-GRAM form of human
1 3-GRAM of human Notch1
1 3-GRAM human Notch1 or
1 3-GRAM Notch1 or human
1 3-GRAM or human DTX1
1 3-GRAM human DTX1 .
1 3-GRAM DTX1 . STOP
1 3-GRAM * The authors
1 3-GRAM The authors undertook
1 3-GRAM authors undertook a
1 3-GRAM undertook a retrospective
1 3-GRAM a retrospective analysis
1 3-GRAM retrospective analysis of
1 3-GRAM analysis of pathology
1 3-GRAM of pathology with
1 3-GRAM pathology with quantification
1 3-GRAM with quantification of
1 3-GRAM quantification of the
1 3-GRAM of the percentage
1 3-GRAM the percentage of
1 3-GRAM percentage of papillary
1 3-GRAM of papillary serous
1 3-GRAM papillary serous component
1 3-GRAM serous component (%
1 3-GRAM component (% PSC
1 3-GRAM (% PSC )
1 3-GRAM PSC ) and
1 3-GRAM ) and p53
1 3-GRAM and p53 expression
1 3-GRAM p53 expression .
1 3-GRAM expression . STOP
1 3-GRAM * This function
1 3-GRAM This function requires
1 3-GRAM function requires not
1 3-GRAM requires not only
1 3-GRAM not only the
1 3-GRAM only the kinase
1 3-GRAM the kinase domain
1 3-GRAM kinase domain of
1 3-GRAM domain of Csk
1 3-GRAM of Csk ,
1 3-GRAM Csk , but
1 3-GRAM , but also
1 3-GRAM but also its
1 3-GRAM also its Src
1 3-GRAM its Src homology
1 3-GRAM Src homology 3
2 3-GRAM homology 3 (
2 3-GRAM 3 ( SH3
1 3-GRAM ( SH3 )
1 3-GRAM SH3 ) and
1 3-GRAM ) and SH2
1 3-GRAM and SH2 regions
1 3-GRAM SH2 regions .
1 3-GRAM * * Nucleotide
1 3-GRAM * Nucleotide sequence
1 3-GRAM Nucleotide sequence ,
1 3-GRAM sequence , transcription
1 3-GRAM , transcription map
1 3-GRAM transcription map ,
1 3-GRAM map , and
1 3-GRAM , and mutation
1 3-GRAM and mutation analysis
1 3-GRAM mutation analysis of
1 3-GRAM of the 13q14
1 3-GRAM the 13q14 chromosomal
1 3-GRAM 13q14 chromosomal region
1 3-GRAM chromosomal region deleted
1 3-GRAM region deleted in
1 3-GRAM deleted in B
1 3-GRAM in B -
1 3-GRAM B - cell
1 3-GRAM - cell chronic
1 3-GRAM cell chronic lymphocytic
1 3-GRAM chronic lymphocytic leukemia
1 3-GRAM lymphocytic leukemia .
1 3-GRAM conclusion , primary
1 3-GRAM , primary chemotherapy
1 3-GRAM primary chemotherapy based
1 3-GRAM chemotherapy based on
1 3-GRAM based on high
1 3-GRAM on high dose
1 3-GRAM high dose MTX
1 3-GRAM dose MTX and
1 3-GRAM MTX and ara
1 3-GRAM and ara -
1 3-GRAM ara - C
1 3-GRAM - C is
1 3-GRAM C is highly
1 3-GRAM is highly efficient
1 3-GRAM highly efficient in
1 3-GRAM efficient in PCNSL
1 3-GRAM in PCNSL .
1 3-GRAM PCNSL . STOP
1 3-GRAM * NGF ,
1 3-GRAM NGF , but
2 3-GRAM , but not
1 3-GRAM but not EGF
1 3-GRAM not EGF ,
1 3-GRAM EGF , enhances
1 3-GRAM , enhances the
1 3-GRAM enhances the upper
1 3-GRAM the upper bands
1 3-GRAM upper bands ,
1 3-GRAM bands , corresponding
1 3-GRAM , corresponding to
1 3-GRAM corresponding to phosphorylated
1 3-GRAM to phosphorylated Fra
1 3-GRAM phosphorylated Fra -
2 3-GRAM Fra - 2
2 3-GRAM 2 . STOP
1 3-GRAM * METHODS AND
1 3-GRAM METHODS AND RESULTS
1 3-GRAM AND RESULTS :
1 3-GRAM RESULTS : Palmaz
1 3-GRAM : Palmaz -
1 3-GRAM Palmaz - Schatz
1 3-GRAM - Schatz stents
1 3-GRAM Schatz stents were
1 3-GRAM stents were dip
1 3-GRAM were dip -
1 3-GRAM dip - coated
1 3-GRAM - coated with
1 3-GRAM coated with paclitaxel
1 3-GRAM with paclitaxel (
1 3-GRAM paclitaxel ( 0
1 3-GRAM ( 0 ,
1 3-GRAM 0 , 0
1 3-GRAM 0 . 2
1 3-GRAM . 2 ,
1 3-GRAM 2 , 15
1 3-GRAM , 15 ,
1 3-GRAM 15 , or
1 3-GRAM , or 187
1 3-GRAM or 187 microgram
1 3-GRAM 187 microgram /
1 3-GRAM microgram / stent
1 3-GRAM / stent )
1 3-GRAM stent ) by
1 3-GRAM ) by immersion
1 3-GRAM by immersion in
1 3-GRAM immersion in ethanolic
1 3-GRAM in ethanolic paclitaxel
1 3-GRAM ethanolic paclitaxel and
1 3-GRAM paclitaxel and evaporation
1 3-GRAM and evaporation of
1 3-GRAM evaporation of the
1 3-GRAM of the solvent
1 3-GRAM the solvent .
1 3-GRAM solvent . STOP
1 3-GRAM * * Currently
1 3-GRAM * Currently ,
1 3-GRAM Currently , the
1 3-GRAM , the clinical
1 3-GRAM the clinical use
1 3-GRAM clinical use of
1 3-GRAM use of 5
1 3-GRAM 5 - aminolaevulinic
1 3-GRAM - aminolaevulinic acid
1 3-GRAM aminolaevulinic acid (
1 3-GRAM acid ( ALA
1 3-GRAM ( ALA )
1 3-GRAM ALA ) induced
1 3-GRAM ) induced protoporphyrin
1 3-GRAM induced protoporphyrin IX
1 3-GRAM protoporphyrin IX (
1 3-GRAM IX ( PPIX
1 3-GRAM ( PPIX )
1 3-GRAM PPIX ) for
1 3-GRAM ) for photodynamic
1 3-GRAM for photodynamic therapy
1 3-GRAM photodynamic therapy (
1 3-GRAM therapy ( PDT
1 3-GRAM ( PDT )
1 3-GRAM PDT ) is
1 3-GRAM ) is limited
1 3-GRAM is limited by
1 3-GRAM limited by the
1 3-GRAM by the maximum
1 3-GRAM the maximum tolerated
1 3-GRAM maximum tolerated oral
1 3-GRAM tolerated oral ALA
1 3-GRAM oral ALA dose
1 3-GRAM ALA dose (
1 3-GRAM dose ( 60
1 3-GRAM ( 60 mg
1 3-GRAM 60 mg /
1 3-GRAM mg / kg
1 3-GRAM / kg ).
1 3-GRAM kg ). STOP
1 3-GRAM * A twelfth
1 3-GRAM A twelfth insertion
1 3-GRAM twelfth insertion disrupts
1 3-GRAM insertion disrupts two
1 3-GRAM disrupts two genes
1 3-GRAM two genes ,
1 3-GRAM genes , Nrk
1 3-GRAM , Nrk ,
1 3-GRAM Nrk , a
1 3-GRAM , a "
1 3-GRAM a " neurospecific
1 3-GRAM " neurospecific "
1 3-GRAM neurospecific " receptor
1 3-GRAM " receptor tyrosine
1 3-GRAM tyrosine kinase ,
1 3-GRAM kinase , and
1 3-GRAM , and Tpp
1 3-GRAM and Tpp ,
1 3-GRAM Tpp , which
1 3-GRAM , which encodes
1 3-GRAM encodes a neuropeptidase
1 3-GRAM a neuropeptidase .
1 3-GRAM neuropeptidase . STOP
1 3-GRAM indicate that ATF4
1 3-GRAM that ATF4 regulates
1 3-GRAM ATF4 regulates basal
1 3-GRAM regulates basal and
1 3-GRAM basal and CdCl
1 3-GRAM and CdCl (
1 3-GRAM CdCl ( 2
1 3-GRAM ( 2 )-
1 3-GRAM 2 )- induced
1 3-GRAM )- induced expression
1 3-GRAM induced expression of
1 3-GRAM of the ho
1 3-GRAM the ho -
1 3-GRAM 1 gene in
1 3-GRAM gene in a
1 3-GRAM in a cell
1 3-GRAM a cell -
1 3-GRAM - specific manner
1 3-GRAM specific manner and
1 3-GRAM manner and possibly
1 3-GRAM and possibly in
1 3-GRAM possibly in a
1 3-GRAM in a complex
1 3-GRAM a complex with
1 3-GRAM complex with Nrf2
1 3-GRAM with Nrf2 .
1 3-GRAM Nrf2 . STOP
1 3-GRAM * * Adjuvant
1 3-GRAM * Adjuvant and
1 3-GRAM Adjuvant and neoadjuvant
1 3-GRAM and neoadjuvant treatment
1 3-GRAM neoadjuvant treatment of
1 3-GRAM treatment of breast
1 3-GRAM of breast cancer
1 3-GRAM breast cancer .
1 3-GRAM * The %
1 3-GRAM The % SVend
1 3-GRAM % SVend of
1 3-GRAM SVend of HCM
1 3-GRAM of HCM -
1 3-GRAM HCM - I
1 3-GRAM - I was
1 3-GRAM I was significantly
1 3-GRAM was significantly lower
1 3-GRAM significantly lower than
1 3-GRAM lower than the
1 3-GRAM than the respective
1 3-GRAM the respective values
1 3-GRAM respective values of
1 3-GRAM values of the
1 3-GRAM of the HCM
1 3-GRAM the HCM -
1 3-GRAM HCM - II
1 3-GRAM - II and
1 3-GRAM II and Control
1 3-GRAM and Control groups
1 3-GRAM Control groups .
1 3-GRAM Inhibition of the
1 3-GRAM of the Raf
1 3-GRAM the Raf -
2 3-GRAM Raf - 1
1 3-GRAM - 1 target
1 3-GRAM 1 target ERK
1 3-GRAM target ERK kinase
1 3-GRAM ERK kinase (
1 3-GRAM ( MEK )
1 3-GRAM MEK ) either
1 3-GRAM ) either attenuated
1 3-GRAM either attenuated or
1 3-GRAM attenuated or abolished
1 3-GRAM or abolished Rp
1 3-GRAM abolished Rp -
1 3-GRAM Rp - cAMPS
1 3-GRAM - cAMPS -
1 3-GRAM cAMPS - and
1 3-GRAM - and PKI
1 3-GRAM and PKI -
1 3-GRAM PKI - induced
1 3-GRAM - induced ERK
1 3-GRAM induced ERK activation
1 3-GRAM ERK activation ,
1 3-GRAM activation , caldesmon
1 3-GRAM , caldesmon phosphorylation
1 3-GRAM caldesmon phosphorylation ,
1 3-GRAM phosphorylation , and
1 3-GRAM , and stress
1 3-GRAM and stress fiber
1 3-GRAM stress fiber formation
1 3-GRAM fiber formation .
1 3-GRAM In the TVD
1 3-GRAM the TVD -
1 3-GRAM TVD - patients
1 3-GRAM - patients decreases
1 3-GRAM patients decreases in
1 3-GRAM decreases in skin
1 3-GRAM in skin blood
1 3-GRAM skin blood flow
1 3-GRAM blood flow were
1 3-GRAM flow were similar
1 3-GRAM were similar compared
1 3-GRAM similar compared with
1 3-GRAM compared with the
1 3-GRAM with the healthy
1 3-GRAM the healthy controls
1 3-GRAM healthy controls .
1 3-GRAM controls . STOP
1 3-GRAM Analysis of mCTR
1 3-GRAM of mCTR mRNAs
1 3-GRAM mCTR mRNAs has
1 3-GRAM mRNAs has revealed
1 3-GRAM has revealed that
1 3-GRAM revealed that the
1 3-GRAM that the three
1 3-GRAM the three alternative
1 3-GRAM three alternative promoters
1 3-GRAM alternative promoters give
1 3-GRAM promoters give rise
1 3-GRAM give rise to
1 3-GRAM rise to at
1 3-GRAM to at least
1 3-GRAM at least seven
1 3-GRAM least seven mCTR
1 3-GRAM seven mCTR isoforms
1 3-GRAM mCTR isoforms in
1 3-GRAM isoforms in the
1 3-GRAM in the 5
1 3-GRAM 5 ' region
1 3-GRAM ' region of
1 3-GRAM the gene and
1 3-GRAM gene and generate
1 3-GRAM and generate 5
1 3-GRAM generate 5 '-
2 3-GRAM 5 '- untranslated
1 3-GRAM '- untranslated regions
1 3-GRAM untranslated regions of
1 3-GRAM regions of very
1 3-GRAM of very different
1 3-GRAM very different lengths
1 3-GRAM different lengths .
1 3-GRAM lengths . STOP
1 3-GRAM * The regulation
1 3-GRAM The regulation of
1 3-GRAM regulation of PGHS
1 3-GRAM of PGHS -
1 3-GRAM PGHS - 2
1 3-GRAM - 2 mRNA
1 3-GRAM 2 mRNA and
1 3-GRAM and protein was
1 3-GRAM protein was studied
1 3-GRAM was studied in
1 3-GRAM studied in primary
1 3-GRAM in primary cultures
1 3-GRAM primary cultures of
1 3-GRAM cultures of bovine
1 3-GRAM of bovine uterine
1 3-GRAM bovine uterine stromal
1 3-GRAM uterine stromal cells
1 3-GRAM stromal cells stimulated
1 3-GRAM cells stimulated with
1 3-GRAM stimulated with phorbol
1 3-GRAM with phorbol 12
1 3-GRAM ( PMA ;
1 3-GRAM PMA ; 100
1 3-GRAM ; 100 nM
1 3-GRAM 100 nM ).
1 3-GRAM nM ). STOP
2 3-GRAM There was no
1 3-GRAM was no evidence
1 3-GRAM no evidence of
1 3-GRAM evidence of linkage
1 3-GRAM of linkage disequilibrium
1 3-GRAM linkage disequilibrium between
1 3-GRAM disequilibrium between the
1 3-GRAM between the polymorphic
1 3-GRAM the polymorphic site
1 3-GRAM polymorphic site in
1 3-GRAM in the B
1 3-GRAM the B cell
1 3-GRAM B cell specific
1 3-GRAM cell specific promoter
1 3-GRAM specific promoter and
1 3-GRAM promoter and those
1 3-GRAM and those in
1 3-GRAM those in the
1 3-GRAM in the 3
1 3-GRAM the 3 '
1 3-GRAM 3 ' UTR
1 3-GRAM ' UTR .
1 3-GRAM UTR . STOP
1 3-GRAM * * Several
1 3-GRAM * Several dozen
1 3-GRAM Several dozen HIF
1 3-GRAM dozen HIF -
1 3-GRAM - 1 targets
1 3-GRAM 1 targets are
1 3-GRAM targets are known
1 3-GRAM are known ,
1 3-GRAM known , including
1 3-GRAM , including the
1 3-GRAM including the gene
1 3-GRAM the gene encoding
1 3-GRAM gene encoding vascular
1 3-GRAM encoding vascular endothelial
1 3-GRAM vascular endothelial growth
1 3-GRAM endothelial growth factor
1 3-GRAM factor ( VEGF
1 3-GRAM ( VEGF ).
1 3-GRAM VEGF ). STOP
1 3-GRAM * In Klinefelter
1 3-GRAM In Klinefelter '
1 3-GRAM Klinefelter ' s
1 3-GRAM s syndrome (
1 3-GRAM syndrome ( 47XXY
1 3-GRAM ( 47XXY ),
1 3-GRAM 47XXY ), serum
1 3-GRAM ), serum testosterone
1 3-GRAM serum testosterone levels
1 3-GRAM testosterone levels are
1 3-GRAM levels are at
1 3-GRAM are at the
1 3-GRAM at the lower
1 3-GRAM the lower end
1 3-GRAM lower end of
2 3-GRAM end of the
1 3-GRAM of the normal
1 3-GRAM the normal range
1 3-GRAM normal range and
1 3-GRAM range and dihydrotestosterone
1 3-GRAM and dihydrotestosterone levels
1 3-GRAM dihydrotestosterone levels are
1 3-GRAM levels are low
1 3-GRAM are low .
1 3-GRAM low . STOP
1 3-GRAM * The protein
1 3-GRAM The protein is
1 3-GRAM protein is composed
1 3-GRAM is composed of
1 3-GRAM composed of two
1 3-GRAM of two major
1 3-GRAM two major domains
1 3-GRAM major domains separated
1 3-GRAM domains separated by
1 3-GRAM separated by a
1 3-GRAM by a hydrophobic
1 3-GRAM a hydrophobic linker
1 3-GRAM hydrophobic linker region
1 3-GRAM linker region of
1 3-GRAM region of 20
1 3-GRAM of 20 amino
1 3-GRAM 20 amino acid
1 3-GRAM amino acid residues
1 3-GRAM acid residues .
1 3-GRAM residues . STOP
1 3-GRAM * * When
1 3-GRAM * When mixed
1 3-GRAM When mixed with
1 3-GRAM mixed with aqueous
1 3-GRAM with aqueous solutions
2 3-GRAM aqueous solutions of
1 3-GRAM solutions of TMT
1 3-GRAM of TMT -
1 3-GRAM TMT - 55
1 3-GRAM - 55 ,
1 3-GRAM 55 , aqueous
1 3-GRAM , aqueous solutions
1 3-GRAM solutions of either
1 3-GRAM of either reagent
1 3-GRAM either reagent -
1 3-GRAM reagent - grade
1 3-GRAM - grade zinc
1 3-GRAM grade zinc ,
1 3-GRAM zinc , cadmium
1 3-GRAM , cadmium ,
1 3-GRAM cadmium , or
1 3-GRAM , or lead
1 3-GRAM or lead salts
1 3-GRAM lead salts precipitate
1 3-GRAM salts precipitate crystalline
1 3-GRAM precipitate crystalline "
1 3-GRAM crystalline " Zn
1 3-GRAM " Zn -
1 3-GRAM Zn - TMT
1 3-GRAM - TMT ",
1 3-GRAM TMT ", amorphous
1 3-GRAM ", amorphous or
1 3-GRAM amorphous or crystalline
1 3-GRAM or crystalline "
1 3-GRAM crystalline " Cd
1 3-GRAM " Cd -
1 3-GRAM Cd - TMT
2 3-GRAM - TMT "
1 3-GRAM TMT " or
1 3-GRAM " or amorphous
1 3-GRAM or amorphous "
1 3-GRAM amorphous " Pb
1 3-GRAM " Pb -
1 3-GRAM Pb - TMT
1 3-GRAM TMT " (
1 3-GRAM " ( M3
1 3-GRAM ( M3 [
1 3-GRAM M3 [ S3C3N3
1 3-GRAM [ S3C3N3 ]
1 3-GRAM S3C3N3 ] 2
1 3-GRAM ] 2 .
1 3-GRAM 2 . nH2O
1 3-GRAM . nH2O ,
1 3-GRAM nH2O , where
1 3-GRAM , where M
1 3-GRAM where M =
1 3-GRAM M = Cd2
1 3-GRAM = Cd2 +,
1 3-GRAM Cd2 +, Pb2
1 3-GRAM +, Pb2 +,
1 3-GRAM Pb2 +, and
1 3-GRAM +, and Zn2
1 3-GRAM and Zn2 +
1 3-GRAM Zn2 + and
1 3-GRAM + and n
1 3-GRAM and n >
1 3-GRAM n > or
1 3-GRAM > or =
1 3-GRAM or = 0
1 3-GRAM = 0 )
1 3-GRAM 0 ) that
1 3-GRAM ) that may
1 3-GRAM that may eventually
1 3-GRAM may eventually crystallize
1 3-GRAM eventually crystallize if
1 3-GRAM crystallize if stored
1 3-GRAM if stored in
1 3-GRAM stored in air
1 3-GRAM in air .
1 3-GRAM air . STOP
1 3-GRAM * * Online
1 3-GRAM * Online teaching
1 3-GRAM Online teaching :
1 3-GRAM teaching : design
1 3-GRAM : design and
1 3-GRAM design and techniques
1 3-GRAM and techniques .
1 3-GRAM techniques . STOP
1 3-GRAM * This interaction
1 3-GRAM This interaction is
1 3-GRAM interaction is reciprocal
1 3-GRAM is reciprocal ,
1 3-GRAM reciprocal , since
1 3-GRAM , since C
1 3-GRAM since C /
1 3-GRAM / EBP dimer
1 3-GRAM EBP dimer binding
1 3-GRAM dimer binding to
1 3-GRAM binding to a
1 3-GRAM to a strong
1 3-GRAM a strong C
1 3-GRAM strong C /
1 3-GRAM / EBP site
1 3-GRAM EBP site leads
1 3-GRAM site leads to
1 3-GRAM leads to enhanced
1 3-GRAM to enhanced CREB
1 3-GRAM enhanced CREB -
1 3-GRAM CREB - 1
1 3-GRAM - 1 recruitment
1 3-GRAM 1 recruitment to
1 3-GRAM recruitment to ATF
1 3-GRAM to ATF /
1 3-GRAM ATF / CREB
1 3-GRAM / CREB sites
1 3-GRAM CREB sites that
1 3-GRAM sites that are
1 3-GRAM that are weakly
1 3-GRAM are weakly bound
1 3-GRAM weakly bound by
1 3-GRAM bound by CREB
1 3-GRAM by CREB .
1 3-GRAM CREB . STOP
1 3-GRAM * The absorbed
1 3-GRAM The absorbed dose
1 3-GRAM absorbed dose was
1 3-GRAM dose was measured
1 3-GRAM measured by combination
1 3-GRAM by combination of
1 3-GRAM combination of two
1 3-GRAM of two integrating
1 3-GRAM two integrating detectors
1 3-GRAM integrating detectors :
1 3-GRAM detectors : thermo
1 3-GRAM : thermo -
1 3-GRAM thermo - luminescent
1 3-GRAM - luminescent dosemeter
1 3-GRAM luminescent dosemeter of
1 3-GRAM dosemeter of Mg2SiO4
1 3-GRAM of Mg2SiO4 :
1 3-GRAM : Tb (
1 3-GRAM Tb ( TDMS
1 3-GRAM ( TDMS )
1 3-GRAM TDMS ) and
1 3-GRAM ) and plastic
1 3-GRAM and plastic nuclear
1 3-GRAM plastic nuclear track
1 3-GRAM nuclear track detector
1 3-GRAM track detector (
1 3-GRAM detector ( PNTD
1 3-GRAM ( PNTD ).
1 3-GRAM PNTD ). STOP
1 3-GRAM * To determine
1 3-GRAM determine the genomic
1 3-GRAM the genomic complexity
1 3-GRAM genomic complexity of
1 3-GRAM complexity of the
1 3-GRAM of the deleted
1 3-GRAM the deleted region
1 3-GRAM deleted region shared
1 3-GRAM region shared among
1 3-GRAM shared among tumors
1 3-GRAM among tumors ,
1 3-GRAM tumors , we
1 3-GRAM , we assembled
1 3-GRAM we assembled a
1 3-GRAM assembled a physical
1 3-GRAM a physical map
1 3-GRAM physical map of
1 3-GRAM map of the
1 3-GRAM of the I
1 3-GRAM the I Mbp
1 3-GRAM I Mbp SRO
1 3-GRAM Mbp SRO consisting
1 3-GRAM SRO consisting predominantly
1 3-GRAM consisting predominantly of
1 3-GRAM predominantly of bacteriophage
1 3-GRAM of bacteriophage P1
1 3-GRAM bacteriophage P1 -
1 3-GRAM P1 - derived
1 3-GRAM - derived artificial
1 3-GRAM derived artificial chromosome
1 3-GRAM artificial chromosome (
1 3-GRAM chromosome ( PAC
1 3-GRAM ( PAC )
1 3-GRAM PAC ) clones
1 3-GRAM ) clones .
1 3-GRAM clones . STOP
1 3-GRAM Thus , Xlim
1 3-GRAM , Xlim -
2 3-GRAM Xlim - 1
1 3-GRAM - 1 not
1 3-GRAM 1 not only
1 3-GRAM not only contains
1 3-GRAM only contains a
1 3-GRAM contains a unique
1 3-GRAM a unique tyrosine
1 3-GRAM unique tyrosine -
1 3-GRAM tyrosine - rich
1 3-GRAM - rich activation
1 3-GRAM rich activation domain
1 3-GRAM activation domain but
1 3-GRAM domain but also
1 3-GRAM but also contains
1 3-GRAM also contains a
1 3-GRAM contains a negative
1 3-GRAM a negative regulatory
1 3-GRAM negative regulatory domain
1 3-GRAM regulatory domain in
1 3-GRAM domain in CT239
1 3-GRAM in CT239 -
1 3-GRAM CT239 - 403
1 3-GRAM - 403 ,
1 3-GRAM 403 , suggesting
1 3-GRAM , suggesting a
1 3-GRAM suggesting a complex
1 3-GRAM a complex regulatory
1 3-GRAM complex regulatory mechanism
1 3-GRAM regulatory mechanism underlying
1 3-GRAM mechanism underlying the
1 3-GRAM underlying the transcriptional
1 3-GRAM activity of Xlim
1 3-GRAM of Xlim -
1 3-GRAM - 1 in
1 3-GRAM 1 in the
1 3-GRAM in the organizer
1 3-GRAM the organizer .
1 3-GRAM organizer . STOP
1 3-GRAM * Low -
1 3-GRAM Low - selenium
1 3-GRAM - selenium diet
1 3-GRAM selenium diet has
1 3-GRAM diet has a
1 3-GRAM has a human
1 3-GRAM a human unfavourable
1 3-GRAM human unfavourable impact
1 3-GRAM unfavourable impact .
1 3-GRAM impact . STOP
1 3-GRAM In the next
1 3-GRAM the next week
1 3-GRAM next week ,
1 3-GRAM week , the
1 3-GRAM , the beta
1 3-GRAM beta - adrenergic
1 3-GRAM - adrenergic antagonist
1 3-GRAM adrenergic antagonist atenolol
1 3-GRAM antagonist atenolol was
1 3-GRAM atenolol was added
1 3-GRAM was added at
1 3-GRAM added at an
1 3-GRAM at an initial
1 3-GRAM an initial dose
1 3-GRAM initial dose of
1 3-GRAM dose of 25
1 3-GRAM of 25 mg
1 3-GRAM 25 mg /
2 3-GRAM mg / day
1 3-GRAM / day and
1 3-GRAM day and titrated
1 3-GRAM and titrated to
1 3-GRAM titrated to 50
1 3-GRAM to 50 mg
1 3-GRAM 50 mg /
1 3-GRAM / day within
1 3-GRAM day within 1
1 3-GRAM within 1 week
1 3-GRAM 1 week .
1 3-GRAM week . STOP
1 3-GRAM * To assess
1 3-GRAM To assess more
1 3-GRAM assess more specific
1 3-GRAM more specific PKA
1 3-GRAM specific PKA -
1 3-GRAM PKA - dependent
1 3-GRAM - dependent mediation
1 3-GRAM dependent mediation of
1 3-GRAM mediation of LH
1 3-GRAM of LH '
1 3-GRAM LH ' s
1 3-GRAM ' s contribution
1 3-GRAM s contribution to
1 3-GRAM contribution to combined
1 3-GRAM to combined hormonal
1 3-GRAM combined hormonal drive
1 3-GRAM hormonal drive ,
1 3-GRAM drive , the
1 3-GRAM , the LDL
1 3-GRAM the LDL receptor
1 3-GRAM LDL receptor (-
1 3-GRAM receptor (- 1076
1 3-GRAM (- 1076 to
1 3-GRAM 1076 to +
1 3-GRAM to + 11
1 3-GRAM + 11 bp
1 3-GRAM 11 bp )
1 3-GRAM bp ) reporter
1 3-GRAM ) reporter plasmid
1 3-GRAM reporter plasmid was
1 3-GRAM plasmid was cotransfected
1 3-GRAM was cotransfected with
1 3-GRAM cotransfected with a
1 3-GRAM with a full
1 3-GRAM a full -
1 3-GRAM full - sequence
1 3-GRAM - sequence rabbit
1 3-GRAM sequence rabbit muscle
1 3-GRAM rabbit muscle protein
1 3-GRAM muscle protein kinase
1 3-GRAM protein kinase inhibitor
1 3-GRAM kinase inhibitor (
1 3-GRAM inhibitor ( PKI
1 3-GRAM ( PKI )
1 3-GRAM PKI ) minigene
1 3-GRAM ) minigene driven
1 3-GRAM minigene driven constitutively
1 3-GRAM driven constitutively by
1 3-GRAM constitutively by a
1 3-GRAM by a Rous
1 3-GRAM a Rous sarcoma
1 3-GRAM Rous sarcoma virus
1 3-GRAM sarcoma virus promoter
1 3-GRAM virus promoter .
1 3-GRAM * In SN
1 3-GRAM In SN -
1 3-GRAM SN - 48
1 3-GRAM - 48 neuronal
1 3-GRAM 48 neuronal cells
1 3-GRAM neuronal cells that
1 3-GRAM cells that express
1 3-GRAM that express MR
1 3-GRAM express MR ,
1 3-GRAM MR , GR
1 3-GRAM , GR ,
1 3-GRAM GR , and
1 3-GRAM , and 5
3 3-GRAM and 5 -
2 3-GRAM 5 - HT1A
1 3-GRAM - HT1A receptors
1 3-GRAM HT1A receptors ,
1 3-GRAM receptors , deletion
1 3-GRAM , deletion or
1 3-GRAM deletion or inactivation
1 3-GRAM or inactivation of
1 3-GRAM inactivation of the
1 3-GRAM of the nGRE
1 3-GRAM the nGRE (
1 3-GRAM nGRE ( negative
1 3-GRAM ( negative GRE
1 3-GRAM negative GRE )
1 3-GRAM GRE ) eliminated
1 3-GRAM ) eliminated negative
1 3-GRAM eliminated negative regulation
2 3-GRAM of the rat
1 3-GRAM the rat 5
1 3-GRAM rat 5 -
1 3-GRAM - HT1A or
1 3-GRAM HT1A or heterologous
1 3-GRAM or heterologous promoters
1 3-GRAM heterologous promoters by
1 3-GRAM promoters by corticosteroids
1 3-GRAM by corticosteroids ,
1 3-GRAM corticosteroids , whereas
1 3-GRAM , whereas its
1 3-GRAM whereas its inclusion
1 3-GRAM its inclusion conferred
1 3-GRAM inclusion conferred corticosteroid
1 3-GRAM conferred corticosteroid -
1 3-GRAM corticosteroid - induced
1 3-GRAM - induced inhibition
1 3-GRAM induced inhibition to
1 3-GRAM inhibition to a
1 3-GRAM to a heterologous
1 3-GRAM heterologous promoter .
1 3-GRAM * * Transition
1 3-GRAM * Transition between
1 3-GRAM Transition between P
1 3-GRAM between P -
1 3-GRAM P - and
1 3-GRAM - and H
1 3-GRAM and H -
1 3-GRAM H - BPPV
1 3-GRAM - BPPV was
1 3-GRAM BPPV was found
1 3-GRAM was found in
1 3-GRAM found in 6
1 3-GRAM in 6 cases
1 3-GRAM 6 cases .
2 3-GRAM cases . STOP
1 3-GRAM * These included
1 3-GRAM These included HNF
1 3-GRAM included HNF -
1 3-GRAM HNF - 3
1 3-GRAM - 3 beta
1 3-GRAM 3 beta ,
1 3-GRAM beta , HFH
3 3-GRAM , HFH -
1 3-GRAM HFH - 1
3 3-GRAM - 1 ,
1 3-GRAM 1 , HFH
1 3-GRAM HFH - 2
1 3-GRAM 2 , HFH
1 3-GRAM HFH - 3
1 3-GRAM - 3 ,
1 3-GRAM 3 , C
1 3-GRAM , C /
1 3-GRAM / EBP ,
1 3-GRAM EBP , and
1 3-GRAM , and C
1 3-GRAM and C /
1 3-GRAM EBP beta ,
1 3-GRAM beta , all
1 3-GRAM , all of
1 3-GRAM all of which
2 3-GRAM of which are
1 3-GRAM which are consistent
2 3-GRAM are consistent with
1 3-GRAM consistent with the
1 3-GRAM with the tissue
1 3-GRAM the tissue -
1 3-GRAM tissue - specific
1 3-GRAM specific expression profiles
1 3-GRAM expression profiles of
1 3-GRAM profiles of the
1 3-GRAM the gene .
1 3-GRAM RESULTS : Of
1 3-GRAM : Of the
1 3-GRAM Of the 24
1 3-GRAM the 24 patients
1 3-GRAM 24 patients ,
1 3-GRAM patients , 6
1 3-GRAM , 6 had
1 3-GRAM 6 had Grade
1 3-GRAM had Grade 1
1 3-GRAM Grade 1 pneumonitis
1 3-GRAM 1 pneumonitis ,
1 3-GRAM pneumonitis , and
1 3-GRAM , and 13
1 3-GRAM and 13 had
1 3-GRAM 13 had Grade
1 3-GRAM had Grade 2
1 3-GRAM Grade 2 pneumonitis
1 3-GRAM 2 pneumonitis .
2 3-GRAM pneumonitis . STOP
1 3-GRAM METHODS : The
1 3-GRAM : The passive
1 3-GRAM The passive and
1 3-GRAM passive and active
1 3-GRAM and active transport
1 3-GRAM active transport of
1 3-GRAM transport of fluorescein
1 3-GRAM of fluorescein through
1 3-GRAM fluorescein through the
1 3-GRAM through the BRB
1 3-GRAM the BRB was
1 3-GRAM BRB was quantitated
1 3-GRAM was quantitated by
1 3-GRAM quantitated by vitreous
1 3-GRAM by vitreous fluorometry
1 3-GRAM vitreous fluorometry .
1 3-GRAM fluorometry . STOP
1 3-GRAM * * Sixteen
1 3-GRAM * Sixteen out
1 3-GRAM Sixteen out of
1 3-GRAM out of 52
1 3-GRAM of 52 seropositive
1 3-GRAM 52 seropositive MS
1 3-GRAM seropositive MS patients
1 3-GRAM MS patients (
1 3-GRAM patients ( 30
1 3-GRAM ( 30 .
1 3-GRAM 30 . 8
1 3-GRAM . 8 %)
1 3-GRAM 8 %) showed
1 3-GRAM %) showed intrathecal
1 3-GRAM showed intrathecal synthesis
1 3-GRAM intrathecal synthesis of
1 3-GRAM synthesis of C
1 3-GRAM of C .
1 3-GRAM C . pneumoniae
1 3-GRAM . pneumoniae -
1 3-GRAM pneumoniae - specific
1 3-GRAM - specific IgG
1 3-GRAM specific IgG but
1 3-GRAM IgG but only
1 3-GRAM but only one
1 3-GRAM only one of
1 3-GRAM one of 43
1 3-GRAM of 43 seropositive
1 3-GRAM 43 seropositive controls
1 3-GRAM seropositive controls (
1 3-GRAM controls ( 2
1 3-GRAM ( 2 .
1 3-GRAM 2 . 3
1 3-GRAM . 3 %).
1 3-GRAM 3 %). STOP
1 3-GRAM * * Consistent
1 3-GRAM * Consistent with
1 3-GRAM Consistent with the
1 3-GRAM with the specificity
1 3-GRAM the specificity observed
1 3-GRAM specificity observed for
1 3-GRAM observed for the
1 3-GRAM the interaction of
1 3-GRAM interaction of DmCKIIalpha
1 3-GRAM of DmCKIIalpha with
1 3-GRAM DmCKIIalpha with these
1 3-GRAM with these bHLH
1 3-GRAM these bHLH proteins
1 3-GRAM bHLH proteins ,
1 3-GRAM proteins , sequence
1 3-GRAM , sequence alignment
1 3-GRAM sequence alignment suggests
1 3-GRAM alignment suggests that
1 3-GRAM suggests that only
1 3-GRAM that only m5
1 3-GRAM only m5 ,
1 3-GRAM m5 , m7
1 3-GRAM , m7 ,
1 3-GRAM m7 , and
1 3-GRAM , and m8
1 3-GRAM and m8 contain
1 3-GRAM m8 contain a
1 3-GRAM contain a consensus
1 3-GRAM a consensus site
1 3-GRAM consensus site for
1 3-GRAM site for phosphorylation
1 3-GRAM for phosphorylation by
1 3-GRAM phosphorylation by CKII
1 3-GRAM by CKII within
1 3-GRAM CKII within a
1 3-GRAM within a subdomain
1 3-GRAM a subdomain unique
1 3-GRAM subdomain unique to
1 3-GRAM unique to these
1 3-GRAM to these three
1 3-GRAM these three proteins
1 3-GRAM three proteins .
2 3-GRAM proteins . STOP
1 3-GRAM * * Deletion
1 3-GRAM * Deletion of
1 3-GRAM Deletion of the
1 3-GRAM of the potential
1 3-GRAM the potential initiator
1 3-GRAM potential initiator element
1 3-GRAM initiator element does
1 3-GRAM element does not
1 3-GRAM not affect repression
1 3-GRAM affect repression of
1 3-GRAM repression of the
1 3-GRAM of the p21
1 3-GRAM the p21 promoter
1 3-GRAM p21 promoter by
1 3-GRAM promoter by c
1 3-GRAM by c -
1 3-GRAM c - Myc
1 3-GRAM - Myc .
1 3-GRAM Myc . STOP
1 3-GRAM * * PATIENTS
1 3-GRAM * PATIENTS AND
1 3-GRAM PATIENTS AND METHODS
1 3-GRAM AND METHODS :
1 3-GRAM METHODS : Between
1 3-GRAM : Between June
1 3-GRAM Between June 1991
1 3-GRAM June 1991 and
1 3-GRAM 1991 and December
1 3-GRAM and December 1996
1 3-GRAM December 1996 ,
1 3-GRAM 1996 , we
1 3-GRAM , we administered
1 3-GRAM we administered the
1 3-GRAM administered the nucleoside
1 3-GRAM the nucleoside analog
1 3-GRAM nucleoside analog 2
1 3-GRAM analog 2 -
1 3-GRAM 2 - chlorodeoxyadenosine
1 3-GRAM - chlorodeoxyadenosine (
1 3-GRAM chlorodeoxyadenosine ( 2
1 3-GRAM 2 - CDA
1 3-GRAM - CDA )
1 3-GRAM CDA ) to
1 3-GRAM ) to 73
1 3-GRAM to 73 children
1 3-GRAM 73 children with
1 3-GRAM children with primary
1 3-GRAM with primary AML
1 3-GRAM primary AML and
1 3-GRAM AML and 20
1 3-GRAM and 20 children
1 3-GRAM 20 children with
1 3-GRAM children with secondary
1 3-GRAM with secondary AML
1 3-GRAM secondary AML or
1 3-GRAM AML or myelodysplastic
1 3-GRAM or myelodysplastic syndrome
1 3-GRAM myelodysplastic syndrome (
1 3-GRAM syndrome ( MDS
1 3-GRAM ( MDS ).
1 3-GRAM MDS ). STOP
1 3-GRAM * * Drosophila
1 3-GRAM * Drosophila Menin1
1 3-GRAM Drosophila Menin1 gene
1 3-GRAM Menin1 gene transcripts
1 3-GRAM gene transcripts use
1 3-GRAM transcripts use alternative
1 3-GRAM use alternative polyadenylation
1 3-GRAM alternative polyadenylation sites
1 3-GRAM polyadenylation sites resulting
1 3-GRAM sites resulting in
1 3-GRAM resulting in 4
1 3-GRAM in 4 .
1 3-GRAM 4 . 3
1 3-GRAM . 3 and
1 3-GRAM 3 and 5
1 3-GRAM - kb messages
1 3-GRAM kb messages .
1 3-GRAM messages . STOP
1 3-GRAM * * Mice
1 3-GRAM * Mice homozygous
1 3-GRAM Mice homozygous for
1 3-GRAM homozygous for the
1 3-GRAM for the dlg
1 3-GRAM the dlg mutation
1 3-GRAM dlg mutation exhibit
1 3-GRAM mutation exhibit growth
1 3-GRAM exhibit growth retardation
1 3-GRAM growth retardation in
1 3-GRAM retardation in utero
1 3-GRAM in utero ,
1 3-GRAM utero , have
1 3-GRAM , have hypoplasia
1 3-GRAM have hypoplasia of
1 3-GRAM hypoplasia of the
1 3-GRAM of the premaxilla
1 3-GRAM the premaxilla and
1 3-GRAM premaxilla and mandible
1 3-GRAM and mandible ,
1 3-GRAM mandible , have
1 3-GRAM , have a
1 3-GRAM have a cleft
1 3-GRAM a cleft secondary
1 3-GRAM cleft secondary palate
1 3-GRAM secondary palate ,
1 3-GRAM palate , and
1 3-GRAM , and die
1 3-GRAM and die perinatally
1 3-GRAM die perinatally .
1 3-GRAM perinatally . STOP
1 3-GRAM contrast , we
2 3-GRAM , we did
2 3-GRAM we did not
2 3-GRAM did not detect
1 3-GRAM not detect a
1 3-GRAM detect a significant
1 3-GRAM a significant correlation
1 3-GRAM correlation between plasma
1 3-GRAM between plasma TNFalpha
1 3-GRAM plasma TNFalpha and
1 3-GRAM TNFalpha and radiation
1 3-GRAM and radiation pneumonitis
1 3-GRAM radiation pneumonitis .
1 3-GRAM * * Its
1 3-GRAM * Its transcription
1 3-GRAM Its transcription in
1 3-GRAM transcription in vitro
1 3-GRAM vitro by pol
1 3-GRAM by pol III
1 3-GRAM pol III requires
1 3-GRAM III requires the
1 3-GRAM requires the same
1 3-GRAM the same factors
1 3-GRAM same factors as
1 3-GRAM factors as the
1 3-GRAM as the U6
1 3-GRAM the U6 gene
1 3-GRAM U6 gene with
2 3-GRAM gene with the
1 3-GRAM with the major
1 3-GRAM the major exception
1 3-GRAM major exception that
1 3-GRAM exception that the
1 3-GRAM that the modified
1 3-GRAM the modified TATA
1 3-GRAM modified TATA -
1 3-GRAM TATA - box
1 3-GRAM - box of
1 3-GRAM box of this
1 3-GRAM of this construct
1 3-GRAM this construct only
1 3-GRAM construct only interacts
1 3-GRAM only interacts with
1 3-GRAM interacts with a
1 3-GRAM with a TATA
1 3-GRAM a TATA -
1 3-GRAM TATA - binding
1 3-GRAM binding protein (
1 3-GRAM protein ( TBP
1 3-GRAM ( TBP )
1 3-GRAM TBP ) mutant
1 3-GRAM ) mutant (
1 3-GRAM mutant ( TBP
1 3-GRAM ( TBP -
1 3-GRAM TBP - DR2
1 3-GRAM - DR2 )
1 3-GRAM DR2 ) but
1 3-GRAM ) but not
1 3-GRAM but not with
1 3-GRAM not with TBP
1 3-GRAM with TBP wild
1 3-GRAM TBP wild -
1 3-GRAM - type (
1 3-GRAM type ( TBPwt
1 3-GRAM ( TBPwt ).
1 3-GRAM TBPwt ). STOP
1 3-GRAM * * Expression
1 3-GRAM * Expression of
1 3-GRAM Expression of the
1 3-GRAM of the src
1 3-GRAM the src homology
1 3-GRAM src homology 3
1 3-GRAM ( SH3 )-
1 3-GRAM SH3 )- encoding
1 3-GRAM )- encoding ,
1 3-GRAM encoding , expressed
1 3-GRAM , expressed in
1 3-GRAM expressed in tumorigenic
1 3-GRAM in tumorigenic astrocytes
1 3-GRAM tumorigenic astrocytes (
1 3-GRAM astrocytes ( SETA
1 3-GRAM ( SETA )
1 3-GRAM SETA ) gene
1 3-GRAM ) gene is
1 3-GRAM gene is associated
1 3-GRAM is associated with
1 3-GRAM associated with astrocyte
1 3-GRAM with astrocyte transformation
1 3-GRAM astrocyte transformation in
1 3-GRAM transformation in culture
1 3-GRAM in culture and
1 3-GRAM culture and tumors
1 3-GRAM and tumors in
1 3-GRAM tumors in the
1 3-GRAM in the adult
1 3-GRAM the adult brain
1 3-GRAM adult brain .
1 3-GRAM brain . STOP
1 3-GRAM * In such
1 3-GRAM In such conditions
1 3-GRAM such conditions ,
1 3-GRAM conditions , the
1 3-GRAM , the following
1 3-GRAM the following kinetic
1 3-GRAM following kinetic reactions
1 3-GRAM kinetic reactions have
1 3-GRAM reactions have been
1 3-GRAM have been studied
1 3-GRAM been studied :
1 3-GRAM studied : N2
1 3-GRAM : N2 (
4 3-GRAM N2 ( A
4 3-GRAM ( A )
3 3-GRAM A ) +
3 3-GRAM ) + N2
4 3-GRAM + N2 (
1 3-GRAM A ) -->
2 3-GRAM ) --> N2
3 3-GRAM --> N2 (
1 3-GRAM N2 ( C
1 3-GRAM ( C ,
1 3-GRAM C , B
1 3-GRAM , B ,
3 3-GRAM B , V
3 3-GRAM , V ')
2 3-GRAM V ') +
1 3-GRAM ') + N2
5 3-GRAM N2 ( X
1 3-GRAM ( X ),
1 3-GRAM X ), N2
1 3-GRAM ), N2 (
2 3-GRAM ( X ,
2 3-GRAM X , V
2 3-GRAM , V >
1 3-GRAM V > 5
1 3-GRAM > 5 )
1 3-GRAM 5 ) -->
2 3-GRAM ( X )
2 3-GRAM X ) +
1 3-GRAM N2 ( B
3 3-GRAM ( B ,
1 3-GRAM V ') in
1 3-GRAM ') in pure
1 3-GRAM in pure N2
1 3-GRAM pure N2 post
1 3-GRAM N2 post -
2 3-GRAM post - discharges
1 3-GRAM - discharges and
1 3-GRAM discharges and N2
1 3-GRAM and N2 (
1 3-GRAM ) + CH4
1 3-GRAM + CH4 -->
1 3-GRAM CH4 --> products
1 3-GRAM --> products ,
1 3-GRAM products , C
1 3-GRAM , C +
1 3-GRAM C + N
1 3-GRAM + N +
1 3-GRAM N + M2
1 3-GRAM + M2 -->
1 3-GRAM M2 --> CN
1 3-GRAM --> CN (
2 3-GRAM CN ( B
1 3-GRAM ') + M2
1 3-GRAM + M2 ,
1 3-GRAM M2 , N2
1 3-GRAM , N2 (
1 3-GRAM V > 4
1 3-GRAM > 4 )
1 3-GRAM 4 ) +
2 3-GRAM ) + CN
1 3-GRAM + CN -->
1 3-GRAM CN --> N2
1 3-GRAM + CN (
1 3-GRAM B , A
1 3-GRAM , A ,
1 3-GRAM A , V
1 3-GRAM , V '),
1 3-GRAM V '), in
1 3-GRAM '), in N2
1 3-GRAM in N2 -
1 3-GRAM N2 - 1
1 3-GRAM - 1 %
1 3-GRAM 1 % CH4
1 3-GRAM % CH4 post
1 3-GRAM CH4 post -
1 3-GRAM - discharges .
1 3-GRAM discharges . STOP
1 3-GRAM * BACKGROUND /
1 3-GRAM BACKGROUND / AIMS
1 3-GRAM / AIMS :
1 3-GRAM AIMS : Hepatitis
1 3-GRAM : Hepatitis C
1 3-GRAM Hepatitis C and
1 3-GRAM C and nonalcoholic
1 3-GRAM and nonalcoholic fatty
1 3-GRAM nonalcoholic fatty liver
1 3-GRAM fatty liver disease
1 3-GRAM liver disease (
1 3-GRAM disease ( NAFL
1 3-GRAM ( NAFL )
1 3-GRAM NAFL ) are
1 3-GRAM ) are the
1 3-GRAM are the two
1 3-GRAM the two most
1 3-GRAM two most common
1 3-GRAM most common forms
1 3-GRAM common forms of
1 3-GRAM forms of liver
1 3-GRAM of liver disease
1 3-GRAM liver disease in
1 3-GRAM disease in the
1 3-GRAM United States .
1 3-GRAM States . STOP
1 3-GRAM These results suggested
1 3-GRAM results suggested a
1 3-GRAM suggested a critical
1 3-GRAM a critical role
1 3-GRAM critical role for
1 3-GRAM role for tyrosine
1 3-GRAM for tyrosine residue
1 3-GRAM tyrosine residue 1229
1 3-GRAM residue 1229 in
1 3-GRAM 1229 in the
1 3-GRAM regulation of L1
1 3-GRAM of L1 endocytosis
1 3-GRAM L1 endocytosis .
1 3-GRAM endocytosis . STOP
1 3-GRAM * The androgen
1 3-GRAM The androgen receptor
1 3-GRAM androgen receptor (
1 3-GRAM receptor ( AR
1 3-GRAM ( AR )
1 3-GRAM AR ) amino
1 3-GRAM ) amino -
1 3-GRAM amino - terminus
1 3-GRAM - terminus imposes
1 3-GRAM terminus imposes androgen
1 3-GRAM imposes androgen -
1 3-GRAM androgen - specific
1 3-GRAM - specific regulation
1 3-GRAM specific regulation of
1 3-GRAM regulation of AR
1 3-GRAM of AR gene
1 3-GRAM AR gene expression
1 3-GRAM gene expression via
1 3-GRAM expression via an
1 3-GRAM via an exonic
1 3-GRAM an exonic enhancer
1 3-GRAM exonic enhancer .
1 3-GRAM enhancer . STOP
1 3-GRAM * * Can
1 3-GRAM * Can survival
1 3-GRAM Can survival be
1 3-GRAM survival be prolonged
1 3-GRAM be prolonged for
1 3-GRAM prolonged for patients
1 3-GRAM for patients with
1 3-GRAM patients with hormone
1 3-GRAM with hormone -
1 3-GRAM hormone - resistant
1 3-GRAM - resistant prostate
1 3-GRAM resistant prostate cancer
1 3-GRAM prostate cancer ?
1 3-GRAM cancer ? STOP
1 3-GRAM conclusion , NF
1 3-GRAM , NF -
1 3-GRAM NF - Y
1 3-GRAM - Y and
1 3-GRAM Y and Sp1
1 3-GRAM and Sp1 binding
1 3-GRAM Sp1 binding sites
1 3-GRAM binding sites play
1 3-GRAM sites play a
1 3-GRAM play a decisive
1 3-GRAM a decisive role
1 3-GRAM decisive role in
1 3-GRAM role in the
1 3-GRAM in the basal
1 3-GRAM the basal expression
1 3-GRAM basal expression of
1 3-GRAM the rat mrp2
1 3-GRAM rat mrp2 gene
1 3-GRAM mrp2 gene ,
1 3-GRAM gene , while
1 3-GRAM , while the
1 3-GRAM while the human
1 3-GRAM the human MRP2
1 3-GRAM human MRP2 gene
1 3-GRAM MRP2 gene is
1 3-GRAM gene is regulated
1 3-GRAM is regulated differently
1 3-GRAM regulated differently .
1 3-GRAM differently . STOP
1 3-GRAM * * Intact
1 3-GRAM * Intact Flag
1 3-GRAM Intact Flag -
1 3-GRAM Flag - tagged
1 3-GRAM - tagged protein
1 3-GRAM tagged protein products
1 3-GRAM protein products from
1 3-GRAM products from all
1 3-GRAM from all six
1 3-GRAM all six were
1 3-GRAM six were produced
1 3-GRAM were produced from
1 3-GRAM produced from genomic
1 3-GRAM from genomic expression
1 3-GRAM genomic expression vectors
1 3-GRAM expression vectors ,
1 3-GRAM vectors , although
2 3-GRAM , although the
1 3-GRAM although the ORF40
1 3-GRAM the ORF40 /
1 3-GRAM ORF40 / 41
1 3-GRAM / 41 transcript
1 3-GRAM 41 transcript encoding
1 3-GRAM transcript encoding a
1 3-GRAM encoding a primase
1 3-GRAM a primase -
1 3-GRAM primase - helicase
1 3-GRAM - helicase component
1 3-GRAM helicase component proved
1 3-GRAM component proved to
1 3-GRAM proved to be
1 3-GRAM to be spliced
1 3-GRAM be spliced with
1 3-GRAM spliced with a
1 3-GRAM with a 127
1 3-GRAM a 127 -
1 3-GRAM 127 - bp
1 3-GRAM - bp intron
1 3-GRAM bp intron .
1 3-GRAM intron . STOP
1 3-GRAM * * Hypomorphic
1 3-GRAM * Hypomorphic dSLBP
1 3-GRAM Hypomorphic dSLBP alleles
1 3-GRAM dSLBP alleles support
1 3-GRAM alleles support zygotic
1 3-GRAM support zygotic development
1 3-GRAM zygotic development but
1 3-GRAM development but cause
1 3-GRAM but cause female
1 3-GRAM cause female sterility
1 3-GRAM female sterility .
1 3-GRAM sterility . STOP
1 3-GRAM * In hypertensive
1 3-GRAM In hypertensive nephrosclerosis
1 3-GRAM hypertensive nephrosclerosis ,
1 3-GRAM nephrosclerosis , therapy
1 3-GRAM , therapy containing
1 3-GRAM therapy containing an
1 3-GRAM containing an ACEI
1 3-GRAM an ACEI alone
1 3-GRAM ACEI alone or
1 3-GRAM alone or in
1 3-GRAM or in combination
1 3-GRAM in combination significantly
1 3-GRAM combination significantly reduces
1 3-GRAM significantly reduces the
1 3-GRAM reduces the incidence
1 3-GRAM the incidence of
1 3-GRAM incidence of renal
1 3-GRAM of renal events
1 3-GRAM renal events .
1 3-GRAM events . STOP
1 3-GRAM * We confirmed
1 3-GRAM We confirmed the
1 3-GRAM confirmed the interaction
1 3-GRAM the interaction between
1 3-GRAM interaction between TLS
1 3-GRAM between TLS and
1 3-GRAM TLS and p65
1 3-GRAM and p65 by
1 3-GRAM p65 by the
1 3-GRAM by the pull
1 3-GRAM the pull -
1 3-GRAM pull - down
1 3-GRAM - down assay
1 3-GRAM down assay in
1 3-GRAM assay in vitro
1 3-GRAM in vitro and
1 3-GRAM vitro and by
1 3-GRAM and by a
1 3-GRAM by a coimmunoprecipitation
1 3-GRAM a coimmunoprecipitation experiment
1 3-GRAM coimmunoprecipitation experiment followed
1 3-GRAM experiment followed by
1 3-GRAM followed by Western
1 3-GRAM by Western blot
1 3-GRAM Western blot of
1 3-GRAM blot of the
1 3-GRAM of the cultured
1 3-GRAM the cultured cell
1 3-GRAM cultured cell in
1 3-GRAM cell in vivo
3 3-GRAM * In addition
2 3-GRAM In addition ,
2 3-GRAM addition , we
1 3-GRAM not detect significant
1 3-GRAM detect significant differences
1 3-GRAM differences in CDR3
1 3-GRAM in CDR3 sequences
1 3-GRAM CDR3 sequences of
1 3-GRAM sequences of endogenous
1 3-GRAM of endogenous Ig
1 3-GRAM endogenous Ig lambdaL
1 3-GRAM Ig lambdaL and
1 3-GRAM lambdaL and kappaL
1 3-GRAM and kappaL chain
1 3-GRAM kappaL chain gene
1 3-GRAM chain gene loci
1 3-GRAM gene loci cloned
1 3-GRAM loci cloned from
1 3-GRAM cloned from peripheral
1 3-GRAM from peripheral blood
1 3-GRAM peripheral blood lymphocytes
1 3-GRAM blood lymphocytes of
1 3-GRAM lymphocytes of an
1 3-GRAM of an NBS
1 3-GRAM an NBS patient
1 3-GRAM NBS patient and
1 3-GRAM patient and of
1 3-GRAM and of healthy
1 3-GRAM of healthy individuals
1 3-GRAM healthy individuals .
1 3-GRAM * The diet
1 3-GRAM The diet of
1 3-GRAM diet of migrants
1 3-GRAM of migrants showed
1 3-GRAM migrants showed both
1 3-GRAM showed both positive
1 3-GRAM both positive (
1 3-GRAM positive ( macronutrients
1 3-GRAM ( macronutrients )
1 3-GRAM macronutrients ) and
1 3-GRAM ) and negative
1 3-GRAM and negative (
1 3-GRAM negative ( micronutrients
1 3-GRAM ( micronutrients )
1 3-GRAM micronutrients ) differences
1 3-GRAM ) differences with
1 3-GRAM differences with the
1 3-GRAM with the general
1 3-GRAM the general Dutch
1 3-GRAM general Dutch diet
1 3-GRAM Dutch diet .
1 3-GRAM diet . STOP
1 3-GRAM * * Experimental
1 3-GRAM * Experimental study
1 3-GRAM Experimental study of
1 3-GRAM study of ta
2 3-GRAM of ta chengchi
2 3-GRAM ta chengchi tang
1 3-GRAM chengchi tang decoction
1 3-GRAM tang decoction for
1 3-GRAM decoction for relieving
1 3-GRAM for relieving lung
1 3-GRAM relieving lung injury
1 3-GRAM lung injury during
1 3-GRAM injury during acute
1 3-GRAM during acute necrotizing
2 3-GRAM acute necrotizing pancreatitis
1 3-GRAM necrotizing pancreatitis ]
1 3-GRAM pancreatitis ] The
1 3-GRAM ] The objectives
1 3-GRAM The objectives of
1 3-GRAM objectives of the
1 3-GRAM of the study
1 3-GRAM the study were
1 3-GRAM study were to
1 3-GRAM were to investigate
1 3-GRAM investigate the changes
1 3-GRAM the changes of
1 3-GRAM changes of leukocyte
1 3-GRAM of leukocyte adhesiveness
1 3-GRAM leukocyte adhesiveness and
1 3-GRAM adhesiveness and tumor
1 3-GRAM and tumor necrosis
1 3-GRAM ( TNF )
1 3-GRAM TNF ) in
1 3-GRAM in the early
1 3-GRAM the early stage
1 3-GRAM early stage of
1 3-GRAM stage of acute
1 3-GRAM of acute necrotizing
1 3-GRAM necrotizing pancreatitis (
1 3-GRAM pancreatitis ( ANP
1 3-GRAM ( ANP ),
1 3-GRAM ANP ), to
1 3-GRAM ), to go
1 3-GRAM to go further
1 3-GRAM go further into
1 3-GRAM further into the
1 3-GRAM into the relation
1 3-GRAM the relation of
1 3-GRAM relation of those
1 3-GRAM of those changes
1 3-GRAM those changes to
1 3-GRAM changes to lung
1 3-GRAM to lung injury
1 3-GRAM lung injury of
1 3-GRAM injury of ANP
1 3-GRAM of ANP ,
1 3-GRAM ANP , and
1 3-GRAM and to evaluate
1 3-GRAM to evaluate the
1 3-GRAM evaluate the prohibitive
1 3-GRAM the prohibitive effect
1 3-GRAM prohibitive effect of
1 3-GRAM effect of ta
1 3-GRAM chengchi tang Decoction
1 3-GRAM tang Decoction on
1 3-GRAM Decoction on leukocyte
1 3-GRAM on leukocyte adhesion
1 3-GRAM leukocyte adhesion and
1 3-GRAM adhesion and TNF
1 3-GRAM and TNF secretion
1 3-GRAM TNF secretion .
1 3-GRAM secretion . STOP
1 3-GRAM * We suggest
1 3-GRAM We suggest that
1 3-GRAM suggest that ventriculopleural
1 3-GRAM that ventriculopleural shunting
1 3-GRAM ventriculopleural shunting should
1 3-GRAM shunting should be
2 3-GRAM should be considered
1 3-GRAM be considered as
1 3-GRAM considered as the
1 3-GRAM as the preferred
1 3-GRAM the preferred alternative
1 3-GRAM preferred alternative to
1 3-GRAM alternative to peritoneal
1 3-GRAM to peritoneal drainage
1 3-GRAM peritoneal drainage in
1 3-GRAM drainage in children
1 3-GRAM in children with
1 3-GRAM children with intra
1 3-GRAM with intra -
1 3-GRAM intra - abdominal
1 3-GRAM - abdominal adhesions
1 3-GRAM abdominal adhesions or
1 3-GRAM adhesions or with
1 3-GRAM or with a
1 3-GRAM with a history
1 3-GRAM a history of
1 3-GRAM history of recent
1 3-GRAM of recent peritoneal
1 3-GRAM recent peritoneal infection
1 3-GRAM peritoneal infection .
1 3-GRAM * * Positive
1 3-GRAM * Positive and
1 3-GRAM Positive and significant
1 3-GRAM and significant correlations
1 3-GRAM significant correlations were
1 3-GRAM correlations were found
1 3-GRAM were found between
1 3-GRAM found between the
1 3-GRAM between the weeks
1 3-GRAM the weeks of
1 3-GRAM weeks of pregnancy
1 3-GRAM of pregnancy and
1 3-GRAM pregnancy and Se
1 3-GRAM and Se levels
1 3-GRAM Se levels in
1 3-GRAM levels in kidney
1 3-GRAM in kidney (
1 3-GRAM kidney ( r
2 3-GRAM ( r =
2 3-GRAM r = 0
1 3-GRAM 0 . 433
1 3-GRAM . 433 ,
1 3-GRAM 433 , P
2 3-GRAM , P =
1 3-GRAM 0 . 023
1 3-GRAM . 023 )
1 3-GRAM 023 ) and
1 3-GRAM ) and heart
1 3-GRAM and heart (
1 3-GRAM heart ( r
1 3-GRAM 0 . 313
1 3-GRAM . 313 ,
1 3-GRAM 313 , P
1 3-GRAM 0 . 030
1 3-GRAM . 030 ).
1 3-GRAM 030 ). STOP
1 3-GRAM * * Doxorubicin
1 3-GRAM * Doxorubicin (
1 3-GRAM Doxorubicin ( DOX
1 3-GRAM ( DOX )
1 3-GRAM DOX ) is
1 3-GRAM ) is commonly
1 3-GRAM is commonly used
1 3-GRAM commonly used for
1 3-GRAM treatment of hematological
1 3-GRAM of hematological and
1 3-GRAM hematological and solid
1 3-GRAM and solid tumors
1 3-GRAM solid tumors .
1 3-GRAM was no significant
1 3-GRAM no significant difference
1 3-GRAM significant difference in
1 3-GRAM difference in developmental
1 3-GRAM in developmental scores
1 3-GRAM developmental scores at
1 3-GRAM scores at 9
1 3-GRAM at 9 or
1 3-GRAM 9 or 18
1 3-GRAM or 18 months
1 3-GRAM 18 months ,
1 3-GRAM months , although
1 3-GRAM , although PDF
1 3-GRAM although PDF infants
1 3-GRAM PDF infants had
1 3-GRAM infants had a
1 3-GRAM had a 2
1 3-GRAM a 2 .
1 3-GRAM 2 . 8
1 3-GRAM . 8 (-
1 3-GRAM 8 (- 1
1 3-GRAM (- 1 .
1 3-GRAM 3 - 6
1 3-GRAM 6 . 8
1 3-GRAM . 8 )
1 3-GRAM 8 ) point
1 3-GRAM ) point advantage
1 3-GRAM point advantage in
1 3-GRAM advantage in Bayley
1 3-GRAM in Bayley motor
1 3-GRAM Bayley motor score
1 3-GRAM motor score scales
1 3-GRAM score scales .
1 3-GRAM scales . STOP
1 3-GRAM * * Immunofixation
1 3-GRAM * Immunofixation experiments
1 3-GRAM Immunofixation experiments of
1 3-GRAM experiments of C4A
1 3-GRAM of C4A and
1 3-GRAM C4A and C4B
1 3-GRAM and C4B demonstrate
1 3-GRAM C4B demonstrate >
1 3-GRAM demonstrate > 41
1 3-GRAM > 41 allotypes
1 3-GRAM 41 allotypes in
1 3-GRAM allotypes in the
1 3-GRAM in the two
1 3-GRAM the two classes
1 3-GRAM two classes of
1 3-GRAM classes of proteins
1 3-GRAM of proteins .
1 3-GRAM * These effects
1 3-GRAM These effects were
1 3-GRAM effects were not
1 3-GRAM were not seen
1 3-GRAM not seen with
1 3-GRAM seen with SHIP2
1 3-GRAM with SHIP2 possessing
1 3-GRAM SHIP2 possessing a
1 3-GRAM possessing a mutation
1 3-GRAM a mutation in
1 3-GRAM in the SH2
1 3-GRAM the SH2 domain
1 3-GRAM SH2 domain (
1 3-GRAM domain ( R47G
1 3-GRAM ( R47G ).
1 3-GRAM R47G ). STOP
1 3-GRAM * * Myasthenia
1 3-GRAM * Myasthenia gravis
1 3-GRAM Myasthenia gravis is
1 3-GRAM gravis is an
1 3-GRAM is an autoimmune
1 3-GRAM an autoimmune disease
1 3-GRAM autoimmune disease resulting
1 3-GRAM disease resulting from
1 3-GRAM from the production
1 3-GRAM production of antibodies
1 3-GRAM of antibodies against
1 3-GRAM against the ACh
1 3-GRAM the ACh receptors
1 3-GRAM ACh receptors of
1 3-GRAM receptors of the
1 3-GRAM of the neuromuscular
1 3-GRAM the neuromuscular synapse
1 3-GRAM neuromuscular synapse .
1 3-GRAM synapse . STOP
1 3-GRAM * Human homologue
1 3-GRAM Human homologue of
1 3-GRAM homologue of yeast
1 3-GRAM of yeast Rad23
1 3-GRAM yeast Rad23 protein
1 3-GRAM Rad23 protein A
1 3-GRAM protein A interacts
1 3-GRAM A interacts with
1 3-GRAM interacts with p300
1 3-GRAM with p300 /
1 3-GRAM p300 / cyclic
1 3-GRAM / cyclic AMP
1 3-GRAM cyclic AMP -
1 3-GRAM AMP - responsive
1 3-GRAM - responsive element
1 3-GRAM responsive element binding
1 3-GRAM element binding (
1 3-GRAM binding ( CREB
1 3-GRAM ( CREB )-
1 3-GRAM CREB )- binding
1 3-GRAM )- binding protein
1 3-GRAM binding protein to
1 3-GRAM protein to down
1 3-GRAM down - regulate
1 3-GRAM - regulate transcriptional
1 3-GRAM regulate transcriptional activity
1 3-GRAM activity of p53
1 3-GRAM METHODS : Sixteen
1 3-GRAM : Sixteen pigs
1 3-GRAM Sixteen pigs were
1 3-GRAM pigs were assigned
1 3-GRAM were assigned randomly
1 3-GRAM assigned randomly to
1 3-GRAM randomly to control
1 3-GRAM to control and
1 3-GRAM control and shock
1 3-GRAM and shock groups
1 3-GRAM shock groups .
1 3-GRAM RESULTS : There
1 3-GRAM There is a
1 3-GRAM is a considerable
1 3-GRAM a considerable amount
1 3-GRAM considerable amount of
1 3-GRAM amount of variation
1 3-GRAM of variation between
1 3-GRAM variation between the
2 3-GRAM between the results
3 3-GRAM the results of
1 3-GRAM results of TRA1
1 3-GRAM of TRA1 and
1 3-GRAM TRA1 and TRA2
1 3-GRAM and TRA2 and
1 3-GRAM TRA2 and between
1 3-GRAM and between the
1 3-GRAM results of both
1 3-GRAM of both TRA
1 3-GRAM both TRA '
1 3-GRAM TRA ' s
1 3-GRAM ' s and
1 3-GRAM s and the
1 3-GRAM and the door
1 3-GRAM the door -
1 3-GRAM door - to
1 3-GRAM - to -
1 3-GRAM to - door
1 3-GRAM - door survey
1 3-GRAM door survey .
1 3-GRAM survey . STOP
1 3-GRAM Thus , our
1 3-GRAM , our studies
1 3-GRAM our studies define
1 3-GRAM studies define Rac
1 3-GRAM define Rac /
1 3-GRAM Rac / Cdc42
1 3-GRAM / Cdc42 /
1 3-GRAM Cdc42 / Pak
1 3-GRAM / Pak as
1 3-GRAM Pak as a
1 3-GRAM as a module
1 3-GRAM a module upstream
1 3-GRAM module upstream of
1 3-GRAM upstream of Raf
1 3-GRAM of Raf -
1 3-GRAM - 1 during
1 3-GRAM 1 during its
1 3-GRAM during its activation
1 3-GRAM its activation by
1 3-GRAM activation by microtubule
1 3-GRAM by microtubule disruption
1 3-GRAM microtubule disruption .
1 3-GRAM disruption . STOP
1 3-GRAM * * Zhu
1 3-GRAM * Zhu ,
1 3-GRAM Zhu , V
1 3-GRAM , V .
1 3-GRAM V . STOP
1 3-GRAM However , plasmids
1 3-GRAM , plasmids carrying
1 3-GRAM plasmids carrying the
1 3-GRAM carrying the yeast
1 3-GRAM the yeast TyrRS
1 3-GRAM yeast TyrRS gene
1 3-GRAM TyrRS gene could
1 3-GRAM gene could not
1 3-GRAM could not be
1 3-GRAM not be stably
1 3-GRAM be stably maintained
1 3-GRAM stably maintained in
1 3-GRAM maintained in E
1 3-GRAM in E .
1 3-GRAM . coli .
1 3-GRAM coli . STOP
1 3-GRAM * This supports
1 3-GRAM This supports previous
1 3-GRAM supports previous arguments
1 3-GRAM previous arguments for
1 3-GRAM arguments for the
1 3-GRAM for the improbability
1 3-GRAM the improbability of
1 3-GRAM improbability of biological
1 3-GRAM of biological effects
1 3-GRAM biological effects at
1 3-GRAM effects at UHF
1 3-GRAM at UHF frequencies
1 3-GRAM UHF frequencies unless
1 3-GRAM frequencies unless a
1 3-GRAM unless a mechanism
1 3-GRAM a mechanism can
1 3-GRAM mechanism can be
1 3-GRAM can be found
1 3-GRAM be found for
1 3-GRAM found for accumulating
1 3-GRAM for accumulating energy
1 3-GRAM accumulating energy over
1 3-GRAM energy over time
1 3-GRAM over time and
1 3-GRAM time and space
1 3-GRAM and space and
1 3-GRAM space and focussing
1 3-GRAM and focussing it
1 3-GRAM focussing it .
1 3-GRAM it . STOP
1 3-GRAM * The students
1 3-GRAM The students who
1 3-GRAM students who had
1 3-GRAM who had abnormal
1 3-GRAM had abnormal urine
1 3-GRAM abnormal urine screening
1 3-GRAM urine screening results
1 3-GRAM screening results at
1 3-GRAM results at the
1 3-GRAM at the first
2 3-GRAM the first time
1 3-GRAM first time received
1 3-GRAM time received a
1 3-GRAM received a second
1 3-GRAM a second urine
1 3-GRAM second urine analysis
1 3-GRAM urine analysis 10
1 3-GRAM analysis 10 to
1 3-GRAM 10 to 15
1 3-GRAM to 15 days
1 3-GRAM 15 days later
1 3-GRAM days later to
1 3-GRAM later to confirm
1 3-GRAM to confirm the
1 3-GRAM confirm the abnormal
1 3-GRAM the abnormal urine
1 3-GRAM abnormal urine analysis
1 3-GRAM urine analysis .
1 3-GRAM * * Cells
1 3-GRAM * Cells containing
1 3-GRAM Cells containing alpha
1 3-GRAM containing alpha subunits
1 3-GRAM alpha subunits that
1 3-GRAM subunits that lacked
1 3-GRAM that lacked a
1 3-GRAM lacked a distal
1 3-GRAM a distal domain
1 3-GRAM distal domain (
1 3-GRAM domain ( term
1 3-GRAM ( term -
1 3-GRAM term - 3
1 3-GRAM - 3 )
1 3-GRAM 3 ) or
1 3-GRAM ) or had
1 3-GRAM or had the
1 3-GRAM had the alternatively
1 3-GRAM the alternatively spliced
1 3-GRAM alternatively spliced alpha
1 3-GRAM spliced alpha -
1 3-GRAM alpha - 2
1 3-GRAM - 2 distal
1 3-GRAM 2 distal domain
1 3-GRAM distal domain showed
1 3-GRAM domain showed markedly
1 3-GRAM showed markedly decreased
1 3-GRAM markedly decreased ability
1 3-GRAM decreased ability to
1 3-GRAM ability to support
1 3-GRAM to support tyrosine
1 3-GRAM support tyrosine phosphorylation
1 3-GRAM tyrosine phosphorylation of
1 3-GRAM phosphorylation of Jak
1 3-GRAM of Jak -
1 3-GRAM Jak - 2
1 3-GRAM - 2 and
1 3-GRAM 2 and its
1 3-GRAM and its substrates
1 3-GRAM its substrates or
1 3-GRAM substrates or to
1 3-GRAM or to up
1 3-GRAM to up -
1 3-GRAM up - regulate
1 3-GRAM - regulate CD86
1 3-GRAM regulate CD86 .
1 3-GRAM CD86 . STOP
1 3-GRAM * * Despite
1 3-GRAM * Despite abundant
1 3-GRAM Despite abundant expression
1 3-GRAM abundant expression of
1 3-GRAM expression of NtmybAS
1 3-GRAM of NtmybAS transcripts
1 3-GRAM NtmybAS transcripts in
1 3-GRAM transcripts in mature
1 3-GRAM in mature pollen
1 3-GRAM mature pollen ,
1 3-GRAM pollen , gPAL1
1 3-GRAM , gPAL1 transcripts
1 3-GRAM gPAL1 transcripts were
1 3-GRAM transcripts were not
1 3-GRAM were not detectable
1 3-GRAM not detectable in
1 3-GRAM detectable in pollen
1 3-GRAM in pollen .
1 3-GRAM pollen . STOP
1 3-GRAM Finally , profiling
1 3-GRAM , profiling of
1 3-GRAM profiling of a
1 3-GRAM of a gcn4Delta
1 3-GRAM a gcn4Delta mutant
1 3-GRAM gcn4Delta mutant uncovered
1 3-GRAM mutant uncovered an
1 3-GRAM uncovered an alternative
1 3-GRAM an alternative induction
1 3-GRAM alternative induction pathway
1 3-GRAM induction pathway operating
1 3-GRAM pathway operating at
1 3-GRAM operating at many
1 3-GRAM at many Gcn4p
1 3-GRAM many Gcn4p target
1 3-GRAM Gcn4p target genes
1 3-GRAM target genes in
1 3-GRAM genes in histidine
1 3-GRAM in histidine -
1 3-GRAM histidine - starved
1 3-GRAM - starved cells
1 3-GRAM starved cells .
1 3-GRAM * The R2
1 3-GRAM The R2 between
1 3-GRAM R2 between MFI
1 3-GRAM between MFI of
1 3-GRAM MFI of fresh
1 3-GRAM of fresh and
1 3-GRAM fresh and frozen
1 3-GRAM and frozen muscle
1 3-GRAM frozen muscle was
1 3-GRAM muscle was 0
1 3-GRAM was 0 .
1 3-GRAM 0 . 94
1 3-GRAM . 94 and
1 3-GRAM 94 and 0
1 3-GRAM 0 . 92
1 3-GRAM . 92 for
1 3-GRAM 92 for lamb
1 3-GRAM for lamb and
1 3-GRAM lamb and pork
1 3-GRAM and pork longissimus
1 3-GRAM pork longissimus ,
1 3-GRAM longissimus , respectively
1 3-GRAM , respectively .
1 3-GRAM respectively . STOP
1 3-GRAM * To this
1 3-GRAM To this end
1 3-GRAM this end ,
1 3-GRAM end , an
1 3-GRAM , an expression
1 3-GRAM an expression cassette
1 3-GRAM expression cassette consisting
1 3-GRAM cassette consisting of
1 3-GRAM the gene for
1 3-GRAM gene for a
1 3-GRAM for a green
1 3-GRAM a green fluorescent
1 3-GRAM green fluorescent protein
1 3-GRAM fluorescent protein (
1 3-GRAM protein ( GFP
1 3-GRAM ( GFP )
1 3-GRAM GFP ) flanked
1 3-GRAM ) flanked at
1 3-GRAM flanked at its
1 3-GRAM at its 3
1 3-GRAM its 3 '
1 3-GRAM 3 ' end
1 3-GRAM ' end by
1 3-GRAM end by EAV
1 3-GRAM by EAV -
1 3-GRAM EAV - specific
1 3-GRAM - specific transcription
1 3-GRAM specific transcription -
1 3-GRAM transcription - regulating
1 3-GRAM - regulating sequences
1 3-GRAM regulating sequences was
1 3-GRAM sequences was constructed
1 3-GRAM was constructed .
1 3-GRAM constructed . STOP
1 3-GRAM * * Significantly
1 3-GRAM * Significantly higher
1 3-GRAM Significantly higher lung
1 3-GRAM higher lung function
1 3-GRAM lung function parameters
1 3-GRAM function parameters were
1 3-GRAM parameters were obtained
1 3-GRAM were obtained in
1 3-GRAM obtained in extubated
1 3-GRAM in extubated recipients
1 3-GRAM extubated recipients of
1 3-GRAM recipients of LPD
1 3-GRAM of LPD preserved
1 3-GRAM LPD preserved grafts
1 3-GRAM preserved grafts 2
1 3-GRAM grafts 2 weeks
1 3-GRAM 2 weeks after
1 3-GRAM weeks after TX
1 3-GRAM after TX .
1 3-GRAM TX . STOP
1 3-GRAM * * Lack
1 3-GRAM * Lack of
1 3-GRAM Lack of association
1 3-GRAM of association between
1 3-GRAM association between Kawasaki
1 3-GRAM between Kawasaki syndrome
1 3-GRAM Kawasaki syndrome and
1 3-GRAM syndrome and infection
1 3-GRAM and infection with
1 3-GRAM infection with Rickettsia
1 3-GRAM with Rickettsia conorii
1 3-GRAM Rickettsia conorii ,
1 3-GRAM conorii , Rickettsia
1 3-GRAM , Rickettsia typhi
1 3-GRAM Rickettsia typhi ,
1 3-GRAM typhi , Coxiella
1 3-GRAM , Coxiella burnetii
1 3-GRAM Coxiella burnetii or
1 3-GRAM burnetii or Ehrlichia
1 3-GRAM or Ehrlichia phagocytophila
1 3-GRAM Ehrlichia phagocytophila group
1 3-GRAM phagocytophila group .
1 3-GRAM * These utilisation
1 3-GRAM These utilisation data
1 3-GRAM utilisation data imply
1 3-GRAM data imply annual
1 3-GRAM imply annual drug
1 3-GRAM annual drug costs
1 3-GRAM drug costs in
1 3-GRAM costs in the
1 3-GRAM range of $
1 3-GRAM of $ US
1 3-GRAM $ US 480
1 3-GRAM US 480 ,
1 3-GRAM 480 , 000
1 3-GRAM , 000 to
1 3-GRAM 000 to $
1 3-GRAM to $ US
1 3-GRAM $ US 3
1 3-GRAM US 3 ,
1 3-GRAM 3 , 600
1 3-GRAM , 600 ,
1 3-GRAM 600 , 000
1 3-GRAM , 000 for
1 3-GRAM 000 for TNF
1 3-GRAM for TNF antagonists
1 3-GRAM TNF antagonists for
1 3-GRAM antagonists for RA
1 3-GRAM for RA per
1 3-GRAM RA per 1
1 3-GRAM per 1 million
1 3-GRAM 1 million population
1 3-GRAM million population .
1 3-GRAM population . STOP
1 3-GRAM * * Alignment
1 3-GRAM * Alignment of
1 3-GRAM Alignment of different
1 3-GRAM of different cDNAs
1 3-GRAM different cDNAs of
1 3-GRAM cDNAs of the
1 3-GRAM of the NR5A2
1 3-GRAM the NR5A2 (
1 3-GRAM NR5A2 ( hB1F
1 3-GRAM ( hB1F )
1 3-GRAM hB1F ) gene
1 3-GRAM ) gene with
1 3-GRAM with the genomic
1 3-GRAM the genomic sequence
1 3-GRAM genomic sequence facilitated
1 3-GRAM sequence facilitated the
1 3-GRAM facilitated the delineation
1 3-GRAM the delineation of
1 3-GRAM delineation of its
1 3-GRAM of its structural
1 3-GRAM its structural organization
1 3-GRAM structural organization ,
1 3-GRAM organization , which
1 3-GRAM , which spans
1 3-GRAM which spans over
1 3-GRAM spans over 150
1 3-GRAM over 150 kb
1 3-GRAM 150 kb and
1 3-GRAM kb and consists
1 3-GRAM and consists of
1 3-GRAM consists of eight
1 3-GRAM of eight exons
1 3-GRAM eight exons interrupted
1 3-GRAM exons interrupted by
1 3-GRAM interrupted by seven
1 3-GRAM by seven introns
1 3-GRAM seven introns .
1 3-GRAM introns . STOP
1 3-GRAM CONCLUSIONS : Ketamine
1 3-GRAM : Ketamine -
1 3-GRAM Ketamine - induced
1 3-GRAM - induced dissociative
1 3-GRAM induced dissociative anesthesia
1 3-GRAM dissociative anesthesia produces
1 3-GRAM anesthesia produces persistently
1 3-GRAM produces persistently elevated
1 3-GRAM persistently elevated BIS
1 3-GRAM elevated BIS index
1 3-GRAM BIS index which
1 3-GRAM index which is
1 3-GRAM which is different
1 3-GRAM is different from
1 3-GRAM different from thiamylal
1 3-GRAM from thiamylal and
1 3-GRAM thiamylal and those
1 3-GRAM and those reported
1 3-GRAM those reported with
1 3-GRAM reported with other
1 3-GRAM with other conventional
1 3-GRAM other conventional anesthetic
1 3-GRAM conventional anesthetic agents
1 3-GRAM anesthetic agents .
1 3-GRAM agents . STOP
1 3-GRAM In the remaining
1 3-GRAM the remaining case
1 3-GRAM remaining case ,
1 3-GRAM case , the
1 3-GRAM , the aneurysm
1 3-GRAM the aneurysm originated
1 3-GRAM aneurysm originated from
1 3-GRAM originated from the
1 3-GRAM from the proximal
1 3-GRAM the proximal end
1 3-GRAM proximal end of
1 3-GRAM of the associated
1 3-GRAM the associated A1
1 3-GRAM associated A1 fenestration
1 3-GRAM A1 fenestration .
1 3-GRAM fenestration . STOP
1 3-GRAM * This domain
1 3-GRAM This domain without
1 3-GRAM domain without the
1 3-GRAM without the canonical
1 3-GRAM the canonical anticodon
1 3-GRAM canonical anticodon loop
1 3-GRAM anticodon loop or
1 3-GRAM loop or the
1 3-GRAM or the tyrosine
1 3-GRAM the tyrosine anticodon
1 3-GRAM tyrosine anticodon acts
1 3-GRAM anticodon acts as
1 3-GRAM acts as an
1 3-GRAM as an anchor
1 3-GRAM an anchor for
1 3-GRAM anchor for TyrRS
1 3-GRAM for TyrRS interaction
1 3-GRAM TyrRS interaction leading
1 3-GRAM interaction leading to
1 3-GRAM leading to a
1 3-GRAM to a better
1 3-GRAM a better efficiency
1 3-GRAM better efficiency of
1 3-GRAM efficiency of tyrosylation
1 3-GRAM of tyrosylation .
1 3-GRAM tyrosylation . STOP
1 3-GRAM * * Temperature
1 3-GRAM * Temperature measurement
1 3-GRAM Temperature measurement in
1 3-GRAM measurement in microfluidic
1 3-GRAM in microfluidic systems
1 3-GRAM microfluidic systems using
1 3-GRAM systems using a
1 3-GRAM using a temperature
1 3-GRAM a temperature -
1 3-GRAM temperature - dependent
1 3-GRAM - dependent fluorescent
1 3-GRAM dependent fluorescent dye
1 3-GRAM fluorescent dye .
1 3-GRAM dye . STOP
1 3-GRAM The first exon
1 3-GRAM first exon (
1 3-GRAM exon ( exon
1 3-GRAM ( exon 1A
1 3-GRAM exon 1A )
1 3-GRAM 1A ) that
1 3-GRAM ) that corresponded
1 3-GRAM that corresponded to
1 3-GRAM corresponded to the
1 3-GRAM to the 5
2 3-GRAM the 5 '-
1 3-GRAM '- untranslated region
1 3-GRAM of the GHR
1 3-GRAM the GHR 1A
1 3-GRAM GHR 1A mRNA
1 3-GRAM 1A mRNA was
1 3-GRAM mRNA was 15
1 3-GRAM was 15 ,
1 3-GRAM 15 , 250
1 3-GRAM , 250 bp
1 3-GRAM 250 bp upstream
1 3-GRAM bp upstream from
1 3-GRAM upstream from exon
1 3-GRAM from exon 2
1 3-GRAM exon 2 in
1 3-GRAM 2 in the
1 3-GRAM in the GHR
1 3-GRAM the GHR gene
1 3-GRAM GHR gene .
1 3-GRAM * The NAUSICAA
1 3-GRAM The NAUSICAA system
1 3-GRAM NAUSICAA system gives
1 3-GRAM system gives a
1 3-GRAM gives a good
1 3-GRAM a good knowledge
1 3-GRAM good knowledge of
1 3-GRAM knowledge of LET
1 3-GRAM of LET spectra
1 3-GRAM LET spectra for
1 3-GRAM spectra for the
1 3-GRAM for the first
1 3-GRAM first time in
1 3-GRAM time in space
1 3-GRAM in space dosimetry
1 3-GRAM space dosimetry .
1 3-GRAM * The MABP
1 3-GRAM The MABP and
1 3-GRAM MABP and MCBFV
1 3-GRAM and MCBFV signals
1 3-GRAM MCBFV signals were
1 3-GRAM signals were bandpass
1 3-GRAM were bandpass filtered
1 3-GRAM bandpass filtered in
1 3-GRAM filtered in the
1 3-GRAM in the very
1 3-GRAM the very low
1 3-GRAM very low -
2 3-GRAM low - frequency
3 3-GRAM - frequency range
3 3-GRAM frequency range (
1 3-GRAM range ( VLF
1 3-GRAM ( VLF ,
1 3-GRAM VLF , 0
1 3-GRAM 0 . 015
1 3-GRAM . 015 -
1 3-GRAM 015 - 0
2 3-GRAM 0 . 07
1 3-GRAM . 07 Hz
1 3-GRAM 07 Hz ),
1 3-GRAM Hz ), low
1 3-GRAM ), low -
1 3-GRAM range ( LF
1 3-GRAM ( LF ,
1 3-GRAM LF , 0
1 3-GRAM . 07 -
1 3-GRAM 07 - 0
2 3-GRAM 0 . 15
1 3-GRAM . 15 Hz
1 3-GRAM 15 Hz )
1 3-GRAM Hz ) and
1 3-GRAM ) and high
1 3-GRAM and high -
1 3-GRAM high - frequency
1 3-GRAM range ( HF
1 3-GRAM ( HF ,
1 3-GRAM HF , 0
1 3-GRAM . 15 -
1 3-GRAM 15 - 0
1 3-GRAM 0 . 40
1 3-GRAM . 40 Hz
1 3-GRAM 40 Hz )
1 3-GRAM Hz ) before
1 3-GRAM ) before applying
1 3-GRAM before applying CCF
1 3-GRAM applying CCF for
1 3-GRAM CCF for the
1 3-GRAM for the purpose
1 3-GRAM the purpose of
1 3-GRAM purpose of studying
1 3-GRAM of studying the
1 3-GRAM studying the effect
1 3-GRAM effect of different
1 3-GRAM of different bandwidths
1 3-GRAM different bandwidths on
1 3-GRAM bandwidths on the
1 3-GRAM on the resulting
1 3-GRAM the resulting mean
1 3-GRAM resulting mean CCFs
1 3-GRAM mean CCFs .
1 3-GRAM CCFs . STOP
1 3-GRAM * At cross
1 3-GRAM At cross purposes
1 3-GRAM cross purposes .
1 3-GRAM purposes . STOP
1 3-GRAM * For these
1 3-GRAM For these patients
1 3-GRAM these patients the
1 3-GRAM patients the introduction
1 3-GRAM the introduction of
1 3-GRAM introduction of a
1 3-GRAM of a separate
1 3-GRAM a separate category
1 3-GRAM separate category "
1 3-GRAM category " extended
1 3-GRAM " extended oligoarthritis
1 3-GRAM extended oligoarthritis at
1 3-GRAM oligoarthritis at onset
1 3-GRAM at onset "
1 3-GRAM onset " should
1 3-GRAM " should be
1 3-GRAM be considered to
1 3-GRAM considered to establish
1 3-GRAM to establish comparable
1 3-GRAM establish comparable patient
1 3-GRAM comparable patient groups
1 3-GRAM patient groups .
1 3-GRAM * The susceptibility
1 3-GRAM The susceptibility of
1 3-GRAM susceptibility of Aspergillus
1 3-GRAM of Aspergillus fumigatus
1 3-GRAM Aspergillus fumigatus to
1 3-GRAM fumigatus to mulundocandin
1 3-GRAM to mulundocandin ,
1 3-GRAM mulundocandin , an
1 3-GRAM , an echinocandin
1 3-GRAM an echinocandin -
1 3-GRAM echinocandin - like
1 3-GRAM - like compound
1 3-GRAM like compound ,
1 3-GRAM compound , and
1 3-GRAM , and other
1 3-GRAM and other antifungal
1 3-GRAM other antifungal agents
1 3-GRAM antifungal agents was
1 3-GRAM agents was assessed
1 3-GRAM was assessed by
1 3-GRAM assessed by the
1 3-GRAM by the National
1 3-GRAM the National Committee
1 3-GRAM National Committee for
1 3-GRAM Committee for Clinical
1 3-GRAM for Clinical Laboratory
1 3-GRAM Clinical Laboratory Standards
1 3-GRAM Laboratory Standards (
1 3-GRAM Standards ( NCCLS
1 3-GRAM ( NCCLS )
1 3-GRAM NCCLS ) M38
1 3-GRAM ) M38 -
1 3-GRAM M38 - P
1 3-GRAM - P method
1 3-GRAM P method ,
1 3-GRAM method , a
1 3-GRAM , a 2
1 3-GRAM a 2 ,
1 3-GRAM , 3 -
1 3-GRAM 3 - bis
1 3-GRAM - bis (
1 3-GRAM bis ( 2
1 3-GRAM 2 - methoxy
1 3-GRAM - methoxy -
1 3-GRAM methoxy - 4
1 3-GRAM - 4 -
1 3-GRAM 4 - nitro
1 3-GRAM - nitro -
1 3-GRAM nitro - 5
1 3-GRAM - 5 -
1 3-GRAM 5 - sulfophenyl
1 3-GRAM - sulfophenyl )-
1 3-GRAM sulfophenyl )- 5
1 3-GRAM )- 5 -[(
1 3-GRAM 5 -[( phenyl
1 3-GRAM -[( phenyl -
1 3-GRAM phenyl - amino
1 3-GRAM - amino )
1 3-GRAM amino ) carbonyl
1 3-GRAM ) carbonyl ]-
1 3-GRAM carbonyl ]- 2H
1 3-GRAM ]- 2H -
1 3-GRAM 2H - tetrazolium
1 3-GRAM - tetrazolium hydroxide
1 3-GRAM tetrazolium hydroxide (
1 3-GRAM hydroxide ( XTT
1 3-GRAM ( XTT )-
1 3-GRAM XTT )- based
1 3-GRAM )- based colorimetric
1 3-GRAM based colorimetric assay
1 3-GRAM colorimetric assay ,
1 3-GRAM assay , and
1 3-GRAM , and determination
1 3-GRAM and determination of
1 3-GRAM determination of morphologic
1 3-GRAM of morphologic alterations
1 3-GRAM morphologic alterations by
1 3-GRAM alterations by microscopy
1 3-GRAM by microscopy .
1 3-GRAM microscopy . STOP
1 3-GRAM * The most
1 3-GRAM The most important
1 3-GRAM most important risk
1 3-GRAM important risk factors
1 3-GRAM risk factors are
1 3-GRAM factors are :
1 3-GRAM are : 1
1 3-GRAM 1 ) genetic
1 3-GRAM ) genetic ;
1 3-GRAM genetic ; 2
1 3-GRAM ; 2 )
1 3-GRAM 2 ) Epstein
1 3-GRAM ) Epstein -
1 3-GRAM Epstein - Barr
1 3-GRAM - Barr virus
1 3-GRAM Barr virus (
1 3-GRAM virus ( infectious
1 3-GRAM ( infectious mononucleosis
1 3-GRAM infectious mononucleosis );
1 3-GRAM mononucleosis ); 3
1 3-GRAM ); 3 )
1 3-GRAM 3 ) congenital
1 3-GRAM ) congenital and
1 3-GRAM congenital and acquired
1 3-GRAM and acquired immunodeficiency
1 3-GRAM acquired immunodeficiency ;
1 3-GRAM immunodeficiency ; 4
1 3-GRAM ; 4 )
1 3-GRAM 4 ) occupational
1 3-GRAM ) occupational exposure
1 3-GRAM occupational exposure (
1 3-GRAM exposure ( the
1 3-GRAM ( the wood
1 3-GRAM the wood industry
1 3-GRAM wood industry ).
1 3-GRAM industry ). STOP
1 3-GRAM * * Members
1 3-GRAM * Members of
1 3-GRAM Members of the
2 3-GRAM AP - 1
1 3-GRAM - 1 superfamily
1 3-GRAM 1 superfamily of
1 3-GRAM superfamily of basic
1 3-GRAM of basic -
1 3-GRAM basic - leucine
1 3-GRAM - leucine zipper
1 3-GRAM leucine zipper factors
1 3-GRAM zipper factors bind
1 3-GRAM factors bind to
1 3-GRAM to the StRE
1 3-GRAM the StRE .
1 3-GRAM StRE . STOP
1 3-GRAM * DNA recognition
1 3-GRAM DNA recognition by
1 3-GRAM recognition by F
1 3-GRAM by F factor
1 3-GRAM F factor TraI36
1 3-GRAM factor TraI36 :
1 3-GRAM TraI36 : highly
1 3-GRAM : highly sequence
1 3-GRAM highly sequence -
1 3-GRAM sequence - specific
1 3-GRAM - specific binding
1 3-GRAM specific binding of
1 3-GRAM binding of single
1 3-GRAM single - stranded
1 3-GRAM - stranded DNA
1 3-GRAM stranded DNA .
1 3-GRAM DNA . STOP
1 3-GRAM * * Overexpression
1 3-GRAM * Overexpression of
1 3-GRAM Overexpression of RORgamma
1 3-GRAM of RORgamma has
1 3-GRAM RORgamma has been
1 3-GRAM shown to inhibit
1 3-GRAM to inhibit T
1 3-GRAM inhibit T cell
1 3-GRAM T cell receptor
1 3-GRAM cell receptor -
1 3-GRAM - mediated apoptosis
1 3-GRAM mediated apoptosis in
1 3-GRAM apoptosis in T
1 3-GRAM in T cell
1 3-GRAM T cell hybridomas
1 3-GRAM cell hybridomas and
1 3-GRAM hybridomas and to
1 3-GRAM and to repress
1 3-GRAM to repress the
1 3-GRAM repress the induction
1 3-GRAM the induction of
1 3-GRAM induction of Fas
1 3-GRAM of Fas -
1 3-GRAM Fas - ligand
1 3-GRAM - ligand and
1 3-GRAM ligand and interleukin
1 3-GRAM and interleukin 2
1 3-GRAM interleukin 2 .
1 3-GRAM * Although metabolized
1 3-GRAM Although metabolized by
1 3-GRAM metabolized by the
1 3-GRAM by the cytochrome
1 3-GRAM the cytochrome P
1 3-GRAM cytochrome P -
1 3-GRAM P - 450
1 3-GRAM - 450 (
1 3-GRAM 450 ( CYP
1 3-GRAM ( CYP )
1 3-GRAM CYP ) system
1 3-GRAM ) system ,
1 3-GRAM system , venlafaxine
1 3-GRAM , venlafaxine inhibits
1 3-GRAM venlafaxine inhibits CYP
1 3-GRAM inhibits CYP 2D6
1 3-GRAM CYP 2D6 and
1 3-GRAM 2D6 and 3A4
1 3-GRAM and 3A4 to
1 3-GRAM 3A4 to a
1 3-GRAM to a far
1 3-GRAM a far lesser
1 3-GRAM far lesser extent
1 3-GRAM lesser extent than
1 3-GRAM extent than do
1 3-GRAM than do the
1 3-GRAM do the SSRIs
1 3-GRAM the SSRIs .
1 3-GRAM SSRIs . STOP
1 3-GRAM * * SAPK
1 3-GRAM * SAPK /
1 3-GRAM JNK activation was
1 3-GRAM activation was completely
1 3-GRAM was completely abolished
1 3-GRAM completely abolished in
1 3-GRAM abolished in the
1 3-GRAM absence of MKK7
1 3-GRAM of MKK7 ,
1 3-GRAM MKK7 , even
1 3-GRAM , even though
1 3-GRAM even though expression
1 3-GRAM though expression of
1 3-GRAM expression of MKK4
1 3-GRAM of MKK4 was
1 3-GRAM MKK4 was strongly
1 3-GRAM was strongly upregulated
1 3-GRAM strongly upregulated in
1 3-GRAM upregulated in mkk7
1 3-GRAM in mkk7 (-/-)
1 3-GRAM mkk7 (-/-) mast
1 3-GRAM (-/-) mast cell
1 3-GRAM mast cell lines
1 3-GRAM cell lines ,
1 3-GRAM lines , and
1 3-GRAM , and phosphorylation
1 3-GRAM and phosphorylation of
1 3-GRAM phosphorylation of MKK4
1 3-GRAM of MKK4 occurred
1 3-GRAM MKK4 occurred normally
1 3-GRAM occurred normally in
1 3-GRAM normally in response
1 3-GRAM response to multiple
1 3-GRAM to multiple stress
1 3-GRAM multiple stress stimuli
1 3-GRAM stress stimuli .
1 3-GRAM stimuli . STOP
1 3-GRAM * However these
1 3-GRAM However these search
1 3-GRAM these search engines
1 3-GRAM search engines respond
1 3-GRAM engines respond with
1 3-GRAM respond with such
1 3-GRAM with such cumbersome
1 3-GRAM such cumbersome results
1 3-GRAM cumbersome results that
1 3-GRAM results that domain
1 3-GRAM that domain specific
1 3-GRAM domain specific experts
1 3-GRAM specific experts can
1 3-GRAM experts can not
1 3-GRAM can not tolerate
1 3-GRAM not tolerate .
1 3-GRAM tolerate . STOP
1 3-GRAM * The titer
1 3-GRAM The titer of
1 3-GRAM titer of TSH
1 3-GRAM of TSH binding
1 3-GRAM TSH binding inhibitor
1 3-GRAM binding inhibitor immunoglobulin
1 3-GRAM inhibitor immunoglobulin (
1 3-GRAM immunoglobulin ( TBII
1 3-GRAM ( TBII ),
1 3-GRAM TBII ), which
1 3-GRAM ), which had
1 3-GRAM which had been
1 3-GRAM had been 8
1 3-GRAM been 8 .
1 3-GRAM . 6 %
1 3-GRAM 6 % at
1 3-GRAM % at initial
1 3-GRAM at initial presentation
1 3-GRAM initial presentation ,
1 3-GRAM presentation , rose
1 3-GRAM , rose to
1 3-GRAM rose to 14
1 3-GRAM to 14 .
1 3-GRAM 14 . 9
1 3-GRAM . 9 %
1 3-GRAM 9 % in
1 3-GRAM % in 2
1 3-GRAM in 2 weeks
1 3-GRAM 2 weeks .
1 3-GRAM weeks . STOP
1 3-GRAM * The extraordinary
1 3-GRAM The extraordinary stability
1 3-GRAM extraordinary stability of
1 3-GRAM stability of peptide
1 3-GRAM of peptide --
1 3-GRAM peptide -- gp96
1 3-GRAM -- gp96 complexes
1 3-GRAM gp96 complexes and
1 3-GRAM complexes and the
1 3-GRAM and the plasticity
1 3-GRAM the plasticity of
1 3-GRAM plasticity of the
1 3-GRAM of the peptide
1 3-GRAM the peptide -
1 3-GRAM peptide - binding
1 3-GRAM - binding pocket
1 3-GRAM binding pocket support
1 3-GRAM pocket support the
1 3-GRAM support the proposed
1 3-GRAM the proposed relay
1 3-GRAM proposed relay of
1 3-GRAM relay of diverse
1 3-GRAM of diverse peptides
1 3-GRAM diverse peptides to
1 3-GRAM peptides to MHC
1 3-GRAM to MHC and
1 3-GRAM MHC and /
3 3-GRAM and / or
1 3-GRAM / or other
1 3-GRAM or other molecules
1 3-GRAM other molecules via
1 3-GRAM molecules via molecular
1 3-GRAM via molecular recognition
1 3-GRAM molecular recognition .
1 3-GRAM recognition . STOP
1 3-GRAM * * Elevated
1 3-GRAM * Elevated expression
1 3-GRAM Elevated expression of
1 3-GRAM expression of full
1 3-GRAM of full -
1 3-GRAM - length UhpB
1 3-GRAM length UhpB or
1 3-GRAM UhpB or of
1 3-GRAM or of a
1 3-GRAM of a soluble
1 3-GRAM a soluble hybrid
1 3-GRAM soluble hybrid protein
1 3-GRAM hybrid protein ,
1 3-GRAM protein , GST
1 3-GRAM , GST -
1 3-GRAM GST - Bc
1 3-GRAM - Bc ,
1 3-GRAM Bc , which
1 3-GRAM which is glutathione
1 3-GRAM is glutathione S
1 3-GRAM glutathione S -
1 3-GRAM S - transferase
1 3-GRAM - transferase (
1 3-GRAM transferase ( GST
1 3-GRAM ( GST )
1 3-GRAM GST ) fused
1 3-GRAM ) fused to
1 3-GRAM fused to the
1 3-GRAM to the cytoplasmic
1 3-GRAM the cytoplasmic C
1 3-GRAM cytoplasmic C -
1 3-GRAM portion of UhpB
1 3-GRAM of UhpB ,
1 3-GRAM UhpB , results
1 3-GRAM , results in
1 3-GRAM results in complete
1 3-GRAM in complete blockage
1 3-GRAM complete blockage of
1 3-GRAM blockage of uhpT
1 3-GRAM of uhpT expression
1 3-GRAM uhpT expression in
1 3-GRAM expression in a
1 3-GRAM in a uhp
1 3-GRAM a uhp (+)
1 3-GRAM uhp (+) strain
1 3-GRAM (+) strain .
1 3-GRAM * * Physical
1 3-GRAM * Physical principles
1 3-GRAM Physical principles in
1 3-GRAM principles in therapeutic
1 3-GRAM in therapeutic apheresis
1 3-GRAM therapeutic apheresis .
1 3-GRAM apheresis . STOP
1 3-GRAM * * Evidence
1 3-GRAM * Evidence from
1 3-GRAM Evidence from a
1 3-GRAM from a Northern
1 3-GRAM a Northern hybridization
1 3-GRAM Northern hybridization indicated
1 3-GRAM hybridization indicated that
1 3-GRAM indicated that jadM
1 3-GRAM that jadM expression
1 3-GRAM jadM expression is
1 3-GRAM expression is correlated
1 3-GRAM is correlated with
1 3-GRAM correlated with jadomycin
1 3-GRAM with jadomycin B
1 3-GRAM jadomycin B synthesis
1 3-GRAM B synthesis .
2 3-GRAM synthesis . STOP
1 3-GRAM * Multiple copies
1 3-GRAM Multiple copies of
1 3-GRAM copies of rsmB
1 3-GRAM of rsmB +
1 3-GRAM rsmB + DNA
1 3-GRAM + DNA ,
1 3-GRAM DNA , on
1 3-GRAM , on the
1 3-GRAM on the other
2 3-GRAM the other hand
2 3-GRAM other hand ,
1 3-GRAM hand , stimulate
1 3-GRAM , stimulate exoenzyme
1 3-GRAM stimulate exoenzyme production
1 3-GRAM exoenzyme production by
1 3-GRAM production by relieving
1 3-GRAM by relieving the
1 3-GRAM relieving the negative
1 3-GRAM the negative effects
1 3-GRAM negative effects of
1 3-GRAM effects of a
1 3-GRAM of a chromosomal
1 3-GRAM a chromosomal copy
1 3-GRAM chromosomal copy of
1 3-GRAM copy of hexA
1 3-GRAM of hexA +.
1 3-GRAM hexA +. STOP
1 3-GRAM * * Systematic
1 3-GRAM * Systematic review
1 3-GRAM Systematic review of
1 3-GRAM review of diagnostic
1 3-GRAM of diagnostic tests
1 3-GRAM diagnostic tests for
1 3-GRAM tests for vaginal
1 3-GRAM for vaginal trichomoniasis
1 3-GRAM vaginal trichomoniasis .
1 3-GRAM trichomoniasis . STOP
1 3-GRAM * * Anecdotal
1 3-GRAM * Anecdotal observations
1 3-GRAM Anecdotal observations scattered
1 3-GRAM observations scattered throughout
1 3-GRAM scattered throughout the
1 3-GRAM throughout the literature
1 3-GRAM the literature have
1 3-GRAM literature have often
1 3-GRAM have often provided
1 3-GRAM often provided clues
1 3-GRAM provided clues to
1 3-GRAM clues to underlying
1 3-GRAM to underlying variations
1 3-GRAM underlying variations in
1 3-GRAM variations in humans
1 3-GRAM in humans '
1 3-GRAM humans ' ability
1 3-GRAM ' ability to
1 3-GRAM ability to handle
1 3-GRAM to handle dietary
1 3-GRAM handle dietary chemicals
1 3-GRAM dietary chemicals .
1 3-GRAM chemicals . STOP
1 3-GRAM show that phosphorylation
1 3-GRAM that phosphorylation -
1 3-GRAM phosphorylation - induced
1 3-GRAM - induced loss
1 3-GRAM induced loss of
1 3-GRAM of the protein
1 3-GRAM the protein kinase
1 3-GRAM protein kinase activity
1 3-GRAM kinase activity of
1 3-GRAM activity of DNA
1 3-GRAM of DNA -
1 3-GRAM DNA - PK
1 3-GRAM - PK is
1 3-GRAM PK is restored
1 3-GRAM is restored by
1 3-GRAM restored by the
1 3-GRAM by the addition
1 3-GRAM of the purified
1 3-GRAM the purified catalytic
1 3-GRAM purified catalytic subunit
1 3-GRAM catalytic subunit of
1 3-GRAM subunit of either
1 3-GRAM of either protein
1 3-GRAM either protein phosphatase
1 3-GRAM protein phosphatase 1
1 3-GRAM phosphatase 1 or
1 3-GRAM 1 or protein
1 3-GRAM or protein phosphatase
1 3-GRAM PP2A ) and
1 3-GRAM ) and that
1 3-GRAM and that this
1 3-GRAM that this reactivation
1 3-GRAM this reactivation is
1 3-GRAM reactivation is blocked
1 3-GRAM is blocked by
1 3-GRAM blocked by the
1 3-GRAM by the potent
1 3-GRAM the potent protein
1 3-GRAM protein phosphatase inhibitor
1 3-GRAM phosphatase inhibitor ,
1 3-GRAM inhibitor , microcystin
1 3-GRAM , microcystin .
1 3-GRAM microcystin . STOP
1 3-GRAM * * Herein
1 3-GRAM * Herein PPARgamma
1 3-GRAM Herein PPARgamma ,
1 3-GRAM PPARgamma , liganded
1 3-GRAM , liganded by
1 3-GRAM liganded by either
1 3-GRAM by either natural
1 3-GRAM either natural (
1 3-GRAM natural ( 15d
1 3-GRAM ( 15d -
1 3-GRAM 15d - PGJ
1 3-GRAM - PGJ (
1 3-GRAM PGJ ( 2
1 3-GRAM 2 ) and
1 3-GRAM ) and PGD
1 3-GRAM and PGD (
1 3-GRAM PGD ( 2
2 3-GRAM ( 2 ))
1 3-GRAM 2 )) or
1 3-GRAM )) or synthetic
1 3-GRAM or synthetic ligands
1 3-GRAM synthetic ligands (
1 3-GRAM ligands ( BRL49653
1 3-GRAM ( BRL49653 and
1 3-GRAM BRL49653 and troglitazone
1 3-GRAM and troglitazone ),
1 3-GRAM troglitazone ), selectively
1 3-GRAM ), selectively inhibited
1 3-GRAM selectively inhibited expression
1 3-GRAM inhibited expression of
1 3-GRAM cyclin D1 gene
1 3-GRAM D1 gene .
1 3-GRAM * An integrated
1 3-GRAM An integrated RTC
1 3-GRAM integrated RTC algorithm
1 3-GRAM RTC algorithm for
1 3-GRAM algorithm for the
1 3-GRAM for the urban
1 3-GRAM the urban wastewater
1 3-GRAM urban wastewater system
1 3-GRAM wastewater system is
1 3-GRAM system is formulated
1 3-GRAM is formulated ,
1 3-GRAM formulated , the
1 3-GRAM , the parameters
1 3-GRAM the parameters of
1 3-GRAM parameters of which
1 3-GRAM which are optimized
1 3-GRAM are optimized using
1 3-GRAM optimized using various
1 3-GRAM using various global
1 3-GRAM various global optimization
1 3-GRAM global optimization routines
1 3-GRAM optimization routines .
1 3-GRAM routines . STOP
1 3-GRAM * * Recently
1 3-GRAM * Recently ,
1 3-GRAM Recently , we
1 3-GRAM discovered that alanine
1 3-GRAM that alanine substitutions
1 3-GRAM alanine substitutions of
1 3-GRAM substitutions of the
1 3-GRAM of the active
1 3-GRAM the active center
1 3-GRAM active center cleft
1 3-GRAM center cleft residues
1 3-GRAM cleft residues significantly
1 3-GRAM residues significantly impair
1 3-GRAM significantly impair the
1 3-GRAM impair the depurinating
1 3-GRAM the depurinating and
1 3-GRAM depurinating and ribosome
1 3-GRAM and ribosome inhibitory
1 3-GRAM ribosome inhibitory activity
1 3-GRAM inhibitory activity of
1 3-GRAM activity of PAP
1 3-GRAM of PAP .
1 3-GRAM PAP . STOP
1 3-GRAM * This partial
1 3-GRAM This partial transection
1 3-GRAM partial transection could
1 3-GRAM transection could permit
1 3-GRAM could permit vasopressin
1 3-GRAM permit vasopressin to
1 3-GRAM vasopressin to be
1 3-GRAM to be secreted
1 3-GRAM be secreted in
1 3-GRAM secreted in response
1 3-GRAM response to a
1 3-GRAM to a larger
1 3-GRAM a larger rise
1 3-GRAM larger rise in
1 3-GRAM rise in plasma
1 3-GRAM in plasma sodium
1 3-GRAM plasma sodium concentration
1 3-GRAM sodium concentration .
1 3-GRAM * * Reciprocally
1 3-GRAM * Reciprocally ,
1 3-GRAM Reciprocally , HMGI
1 3-GRAM , HMGI -
1 3-GRAM HMGI - C
1 3-GRAM - C expression
1 3-GRAM C expression also
1 3-GRAM expression also coordinately
1 3-GRAM also coordinately enhances
1 3-GRAM coordinately enhances PIAS3
1 3-GRAM enhances PIAS3 -
1 3-GRAM PIAS3 - mediated
1 3-GRAM - mediated repression
1 3-GRAM mediated repression of
1 3-GRAM repression of STAT3
1 3-GRAM of STAT3 -
1 3-GRAM STAT3 - dependent
1 3-GRAM - dependent transactivation
1 3-GRAM dependent transactivation .
1 3-GRAM transactivation . STOP
1 3-GRAM * The genomic
1 3-GRAM The genomic structure
1 3-GRAM genomic structure of
1 3-GRAM structure of the
1 3-GRAM the human SPEC1
1 3-GRAM human SPEC1 gene
1 3-GRAM SPEC1 gene reveals
1 3-GRAM gene reveals complex
1 3-GRAM reveals complex splicing
1 3-GRAM complex splicing and
1 3-GRAM splicing and close
1 3-GRAM and close promoter
1 3-GRAM close promoter proximity
1 3-GRAM promoter proximity to
1 3-GRAM proximity to the
1 3-GRAM to the AF1q
1 3-GRAM the AF1q translocation
1 3-GRAM AF1q translocation gene
1 3-GRAM translocation gene .
1 3-GRAM * Here ,
1 3-GRAM Here , the
1 3-GRAM , the PEX5
1 3-GRAM the PEX5 -
1 3-GRAM PEX5 - TPR
1 3-GRAM - TPR domains
1 3-GRAM TPR domains from
1 3-GRAM domains from human
1 3-GRAM from human ,
1 3-GRAM human , tobacco
1 3-GRAM , tobacco ,
1 3-GRAM tobacco , and
1 3-GRAM , and nematode
1 3-GRAM and nematode were
1 3-GRAM nematode were inserted
1 3-GRAM were inserted into
1 3-GRAM inserted into a
1 3-GRAM into a TPR
1 3-GRAM a TPR -
1 3-GRAM TPR - less
1 3-GRAM - less yeast
1 3-GRAM less yeast Pex5p
1 3-GRAM yeast Pex5p construct
1 3-GRAM Pex5p construct to
1 3-GRAM construct to generate
1 3-GRAM to generate Pex5p
1 3-GRAM generate Pex5p chimaeras
1 3-GRAM Pex5p chimaeras .
1 3-GRAM chimaeras . STOP
1 3-GRAM This study demonstrates
1 3-GRAM study demonstrates that
1 3-GRAM demonstrates that inducible
1 3-GRAM that inducible expression
1 3-GRAM inducible expression in
1 3-GRAM expression in response
1 3-GRAM response to either
1 3-GRAM to either PMA
1 3-GRAM either PMA or
1 3-GRAM PMA or TPO
1 3-GRAM or TPO is
1 3-GRAM TPO is mediated
1 3-GRAM is mediated through
1 3-GRAM mediated through the
1 3-GRAM through the Ets
1 3-GRAM the Ets site
1 3-GRAM Ets site in
1 3-GRAM in the proximal
1 3-GRAM the proximal promoter
1 3-GRAM proximal promoter of
1 3-GRAM promoter of GPIX
1 3-GRAM of GPIX and
1 3-GRAM GPIX and is
1 3-GRAM and is dependent
1 3-GRAM is dependent upon
1 3-GRAM dependent upon the
1 3-GRAM upon the upstream
1 3-GRAM the upstream activation
1 3-GRAM upstream activation of
1 3-GRAM activation of MAPK
1 3-GRAM of MAPK /
1 3-GRAM MAPK / extracellular
1 3-GRAM - regulated kinase
1 3-GRAM regulated kinase .
1 3-GRAM * Molecular identification
1 3-GRAM Molecular identification of
1 3-GRAM identification of smg
1 3-GRAM of smg -
1 3-GRAM smg - 4
1 3-GRAM - 4 ,
1 3-GRAM 4 , required
1 3-GRAM required for mRNA
1 3-GRAM for mRNA surveillance
1 3-GRAM mRNA surveillance in
1 3-GRAM surveillance in C
1 3-GRAM in C .
1 3-GRAM C . elegans
1 3-GRAM . elegans .
1 3-GRAM elegans . STOP
1 3-GRAM * * Cytosolic
1 3-GRAM * Cytosolic acetyl
1 3-GRAM Cytosolic acetyl -
2 3-GRAM acetyl - CoA
1 3-GRAM - CoA synthetase
1 3-GRAM CoA synthetase (
1 3-GRAM synthetase ( AceCS1
1 3-GRAM ( AceCS1 )
1 3-GRAM AceCS1 ) activates
1 3-GRAM ) activates acetate
1 3-GRAM activates acetate to
1 3-GRAM acetate to supply
1 3-GRAM to supply the
1 3-GRAM supply the cells
1 3-GRAM the cells with
1 3-GRAM cells with acetyl
1 3-GRAM with acetyl -
1 3-GRAM - CoA for
1 3-GRAM CoA for lipid
1 3-GRAM for lipid synthesis
1 3-GRAM lipid synthesis .
1 3-GRAM There was an
1 3-GRAM was an increase
1 3-GRAM increase in protein
1 3-GRAM in protein binding
1 3-GRAM protein binding onto
1 3-GRAM binding onto this
1 3-GRAM onto this element
1 3-GRAM this element only
1 3-GRAM element only after
1 3-GRAM only after peptide
1 3-GRAM after peptide treatment
1 3-GRAM peptide treatment .
1 3-GRAM treatment . STOP
1 3-GRAM * * While
1 3-GRAM * While these
1 3-GRAM While these results
1 3-GRAM these results are
1 3-GRAM results are consistent
1 3-GRAM consistent with previously
1 3-GRAM with previously reported
1 3-GRAM previously reported effects
1 3-GRAM reported effects of
1 3-GRAM effects of the
1 3-GRAM of the C
1 3-GRAM - terminal domain
1 3-GRAM terminal domain on
1 3-GRAM domain on nucleotide
1 3-GRAM on nucleotide binding
1 3-GRAM nucleotide binding ,
1 3-GRAM binding , they
1 3-GRAM , they also
1 3-GRAM they also demonstrate
1 3-GRAM also demonstrate that
1 3-GRAM demonstrate that interactions
1 3-GRAM that interactions with
1 3-GRAM interactions with the
1 3-GRAM with the N
1 3-GRAM - terminal domains
1 3-GRAM terminal domains are
1 3-GRAM domains are necessary
1 3-GRAM are necessary to
1 3-GRAM necessary to inhibit
1 3-GRAM to inhibit proton
1 3-GRAM inhibit proton transport
1 3-GRAM proton transport .
2 3-GRAM transport . STOP
1 3-GRAM suggest that an
1 3-GRAM that an intracellular
1 3-GRAM an intracellular WT
1 3-GRAM intracellular WT -
1 3-GRAM WT - 1
1 3-GRAM - 1 /
1 3-GRAM 1 / HSAL2
1 3-GRAM / HSAL2 pathway
1 3-GRAM HSAL2 pathway may
1 3-GRAM pathway may play
1 3-GRAM may play a
1 3-GRAM play a role
1 3-GRAM a role in
1 3-GRAM role in development
1 3-GRAM in development and
1 3-GRAM development and hematopoiesis
1 3-GRAM and hematopoiesis .
1 3-GRAM hematopoiesis . STOP
1 3-GRAM * The radial
1 3-GRAM The radial forearm
1 3-GRAM radial forearm flap
1 3-GRAM forearm flap is
1 3-GRAM flap is used
1 3-GRAM is used most
1 3-GRAM used most commonly
1 3-GRAM most commonly ,
1 3-GRAM commonly , however
1 3-GRAM , however the
1 3-GRAM however the lateral
1 3-GRAM the lateral arm
1 3-GRAM lateral arm flap
1 3-GRAM arm flap may
1 3-GRAM flap may be
1 3-GRAM may be the
1 3-GRAM be the flap
1 3-GRAM the flap of
1 3-GRAM flap of choice
1 3-GRAM of choice in
1 3-GRAM choice in certain
1 3-GRAM in certain situations
1 3-GRAM certain situations .
1 3-GRAM situations . STOP
1 3-GRAM * The procedure
1 3-GRAM The procedure is
1 3-GRAM procedure is less
1 3-GRAM is less aggressive
1 3-GRAM less aggressive and
1 3-GRAM aggressive and painful
1 3-GRAM and painful than
1 3-GRAM painful than sternotomy
1 3-GRAM than sternotomy .
1 3-GRAM sternotomy . STOP
2 3-GRAM , we have
1 3-GRAM we have isolated
1 3-GRAM have isolated a
1 3-GRAM isolated a genomic
1 3-GRAM a genomic fragment
1 3-GRAM genomic fragment containing
1 3-GRAM fragment containing the
1 3-GRAM containing the most
1 3-GRAM the most distal
1 3-GRAM most distal 5
1 3-GRAM distal 5 '
1 3-GRAM 5 ' sequences
1 3-GRAM ' sequences of
1 3-GRAM sequences of the
1 3-GRAM the major GGT
1 3-GRAM major GGT mRNA
1 3-GRAM GGT mRNA in
1 3-GRAM mRNA in HepG2
1 3-GRAM in HepG2 cells
1 3-GRAM HepG2 cells .
1 3-GRAM * * Further
1 3-GRAM * Further ,
1 3-GRAM Further , the
1 3-GRAM , the osteo
1 3-GRAM the osteo -
1 3-GRAM osteo - retentive
1 3-GRAM - retentive ability
1 3-GRAM retentive ability of
1 3-GRAM of the hydroxyapatite
1 3-GRAM the hydroxyapatite in
1 3-GRAM hydroxyapatite in the
1 3-GRAM in the sockets
1 3-GRAM the sockets was
1 3-GRAM sockets was seen
1 3-GRAM was seen to
1 3-GRAM seen to be
1 3-GRAM to be close
1 3-GRAM be close to
1 3-GRAM close to significance
1 3-GRAM to significance (
1 3-GRAM significance ( after
1 3-GRAM ( after six
1 3-GRAM after six months
1 3-GRAM six months width
1 3-GRAM months width differences
1 3-GRAM width differences ,
1 3-GRAM differences , in
1 3-GRAM in the canine
1 3-GRAM the canine region
1 3-GRAM canine region :
1 3-GRAM region : P
1 3-GRAM : P =
1 3-GRAM 0 . 059
1 3-GRAM . 059 ,
1 3-GRAM 059 , LHS
1 3-GRAM , LHS ,
1 3-GRAM LHS , and
1 3-GRAM , and P
1 3-GRAM and P =
1 3-GRAM 0 . 065
1 3-GRAM . 065 ,
1 3-GRAM 065 , RHS
1 3-GRAM , RHS ).
1 3-GRAM RHS ). STOP
1 3-GRAM findings suggest a
1 3-GRAM suggest a novel
1 3-GRAM a novel ankyrin
1 3-GRAM novel ankyrin -
1 3-GRAM ankyrin - independent
1 3-GRAM - independent role
1 3-GRAM independent role for
1 3-GRAM role for LAD
1 3-GRAM for LAD -
1 3-GRAM LAD - 1
1 3-GRAM - 1 related
1 3-GRAM 1 related to
1 3-GRAM related to FGFR
1 3-GRAM to FGFR signaling
1 3-GRAM FGFR signaling .
1 3-GRAM * Managing vertigo
1 3-GRAM Managing vertigo and
1 3-GRAM vertigo and vertigo
1 3-GRAM and vertigo syndromes
1 3-GRAM vertigo syndromes in
1 3-GRAM syndromes in the
1 3-GRAM in the elderly
1 3-GRAM the elderly STOP
1 3-GRAM * A single
1 3-GRAM A single base
1 3-GRAM single base change
1 3-GRAM base change (
1 3-GRAM change ( A8G
1 3-GRAM ( A8G )
1 3-GRAM A8G ) in
1 3-GRAM ) in either
1 3-GRAM in either sequence
1 3-GRAM either sequence reduces
1 3-GRAM sequence reduces hnRNP
1 3-GRAM reduces hnRNP A2
1 3-GRAM hnRNP A2 binding
1 3-GRAM A2 binding and
1 3-GRAM binding and ,
1 3-GRAM and , in
1 3-GRAM in the case
1 3-GRAM the case of
1 3-GRAM case of A2RE
1 3-GRAM of A2RE -
1 3-GRAM A2RE - 2
1 3-GRAM 2 , inhibits
1 3-GRAM , inhibits RNA
1 3-GRAM inhibits RNA transport
1 3-GRAM RNA transport .
1 3-GRAM * A method
1 3-GRAM A method of
1 3-GRAM method of three
1 3-GRAM of three -
1 3-GRAM three - station
1 3-GRAM - station three
1 3-GRAM station three -
1 3-GRAM three - dimensional
1 3-GRAM - dimensional magnetic
1 3-GRAM dimensional magnetic resonance
2 3-GRAM magnetic resonance (
2 3-GRAM resonance ( MR
1 3-GRAM ( MR )
1 3-GRAM MR ) angiography
1 3-GRAM ) angiography of
1 3-GRAM angiography of the
1 3-GRAM of the lower
1 3-GRAM the lower extremities
1 3-GRAM lower extremities with
1 3-GRAM extremities with segmented
1 3-GRAM with segmented volume
1 3-GRAM segmented volume acquisition
1 3-GRAM volume acquisition is
1 3-GRAM acquisition is presented
1 3-GRAM is presented .
1 3-GRAM presented . STOP
1 3-GRAM * * Treatment
1 3-GRAM * Treatment of
1 3-GRAM Treatment of N18TG
1 3-GRAM of N18TG -
1 3-GRAM N18TG - 2
1 3-GRAM 2 cells with
1 3-GRAM cells with a
1 3-GRAM with a demethylating
1 3-GRAM a demethylating agent
1 3-GRAM demethylating agent ,
1 3-GRAM agent , 5
1 3-GRAM , 5 -
1 3-GRAM 5 - aza
1 3-GRAM - aza -
1 3-GRAM aza - deoxycytidine
1 3-GRAM - deoxycytidine ,
1 3-GRAM deoxycytidine , resulted
1 3-GRAM , resulted in
1 3-GRAM resulted in an
1 3-GRAM in an expression
1 3-GRAM an expression of
1 3-GRAM expression of mlt
2 3-GRAM of mlt 1
1 3-GRAM mlt 1 ,
1 3-GRAM 1 , indicating
1 3-GRAM , indicating that
1 3-GRAM indicating that the
1 3-GRAM that the repression
1 3-GRAM the repression of
1 3-GRAM repression of mlt
1 3-GRAM 1 is attributable
1 3-GRAM is attributable to
1 3-GRAM attributable to methylation
1 3-GRAM to methylation Thus
1 3-GRAM methylation Thus ,
1 3-GRAM Thus , mlt
1 3-GRAM , mlt 1
1 3-GRAM 1 is a
1 3-GRAM is a novel
1 3-GRAM a novel target
1 3-GRAM novel target gene
1 3-GRAM target gene that
1 3-GRAM gene that is
1 3-GRAM that is silenced
1 3-GRAM is silenced by
1 3-GRAM silenced by methylation
1 3-GRAM by methylation during
1 3-GRAM methylation during liver
1 3-GRAM during liver tumorigenesis
1 3-GRAM liver tumorigenesis initiated
1 3-GRAM tumorigenesis initiated by
1 3-GRAM initiated by SV40
1 3-GRAM by SV40 T
1 3-GRAM SV40 T antigen
1 3-GRAM T antigen .
1 3-GRAM antigen . STOP
1 3-GRAM * We found
1 3-GRAM We found in
1 3-GRAM found in the
1 3-GRAM in the control
1 3-GRAM the control subjects
1 3-GRAM control subjects rCBF
1 3-GRAM subjects rCBF increases
1 3-GRAM rCBF increases in
1 3-GRAM increases in regions
1 3-GRAM in regions associated
1 3-GRAM regions associated with
1 3-GRAM associated with the
1 3-GRAM with the meso
1 3-GRAM the meso -
1 3-GRAM meso - striatal
1 3-GRAM - striatal and
1 3-GRAM striatal and meso
1 3-GRAM and meso -
1 3-GRAM meso - corticolimbic
1 3-GRAM - corticolimbic circuits
1 3-GRAM corticolimbic circuits in
1 3-GRAM circuits in response
1 3-GRAM response to both
1 3-GRAM to both monetary
1 3-GRAM both monetary reward
1 3-GRAM monetary reward and
1 3-GRAM reward and nonmonetary
1 3-GRAM and nonmonetary reinforcement
1 3-GRAM nonmonetary reinforcement .
1 3-GRAM reinforcement . STOP
1 3-GRAM * * Reverse
1 3-GRAM * Reverse transcriptase
1 3-GRAM Reverse transcriptase -
1 3-GRAM transcriptase - polymerase
1 3-GRAM - polymerase chain
2 3-GRAM polymerase chain reaction
1 3-GRAM chain reaction assays
1 3-GRAM reaction assays showed
1 3-GRAM assays showed that
1 3-GRAM showed that PKRDeltaE7
1 3-GRAM that PKRDeltaE7 is
1 3-GRAM PKRDeltaE7 is expressed
1 3-GRAM expressed in a
1 3-GRAM in a broad
1 3-GRAM a broad range
1 3-GRAM broad range of
1 3-GRAM range of human
1 3-GRAM of human tissues
1 3-GRAM human tissues at
1 3-GRAM tissues at variable
1 3-GRAM at variable levels
1 3-GRAM variable levels .
1 3-GRAM * For this
1 3-GRAM For this purpose
1 3-GRAM this purpose ,
1 3-GRAM purpose , the
1 3-GRAM , the immediate
1 3-GRAM the immediate and
1 3-GRAM immediate and the
1 3-GRAM and the final
1 3-GRAM the final (
1 3-GRAM final ( after
1 3-GRAM ( after swelling
1 3-GRAM after swelling )
1 3-GRAM swelling ) fixation
1 3-GRAM ) fixation strengths
1 3-GRAM fixation strengths of
1 3-GRAM strengths of two
1 3-GRAM of two variations
1 3-GRAM two variations of
1 3-GRAM variations of the
1 3-GRAM of the swellable
1 3-GRAM the swellable bone
1 3-GRAM swellable bone anchor
1 3-GRAM bone anchor designs
1 3-GRAM anchor designs (
1 3-GRAM designs ( a
1 3-GRAM ( a smooth
1 3-GRAM a smooth anchor
1 3-GRAM smooth anchor and
1 3-GRAM anchor and a
1 3-GRAM and a screw
1 3-GRAM a screw anchor
1 3-GRAM screw anchor )
1 3-GRAM anchor ) were
1 3-GRAM ) were measured
1 3-GRAM were measured in
1 3-GRAM measured in two
1 3-GRAM two different foams
1 3-GRAM different foams (
1 3-GRAM foams ( used
1 3-GRAM ( used to
1 3-GRAM used to simulate
1 3-GRAM to simulate bone
1 3-GRAM simulate bone )
1 3-GRAM bone ) with
1 3-GRAM ) with different
1 3-GRAM with different densities
1 3-GRAM different densities .
1 3-GRAM densities . STOP
1 3-GRAM * * CYP2C19
1 3-GRAM * CYP2C19 genotype
1 3-GRAM CYP2C19 genotype was
1 3-GRAM genotype was determined
1 3-GRAM by the polymerase
1 3-GRAM the polymerase chain
1 3-GRAM chain reaction -
1 3-GRAM reaction - restriction
1 3-GRAM - restriction fragment
1 3-GRAM restriction fragment length
1 3-GRAM fragment length polymorphism
1 3-GRAM length polymorphism method
1 3-GRAM polymorphism method .
1 3-GRAM * It is
1 3-GRAM It is useful
1 3-GRAM is useful as
1 3-GRAM useful as an
1 3-GRAM as an adjunct
1 3-GRAM an adjunct to
1 3-GRAM adjunct to mammography
1 3-GRAM to mammography in
1 3-GRAM mammography in those
1 3-GRAM in those patients
1 3-GRAM those patients with
1 3-GRAM patients with radiographically
1 3-GRAM with radiographically dense
1 3-GRAM radiographically dense breasts
1 3-GRAM dense breasts for
1 3-GRAM breasts for the
1 3-GRAM for the characterization
1 3-GRAM the characterization of
1 3-GRAM characterization of palpable
1 3-GRAM of palpable masses
1 3-GRAM palpable masses .
1 3-GRAM masses . STOP
1 3-GRAM * * Activation
1 3-GRAM * Activation of
1 3-GRAM Activation of transcription
1 3-GRAM of transcription through
1 3-GRAM transcription through the
1 3-GRAM through the AP
1 3-GRAM - 1 site
1 3-GRAM 1 site in
1 3-GRAM site in Jurkat
1 3-GRAM in Jurkat cells
1 3-GRAM Jurkat cells by
1 3-GRAM cells by JunD
1 3-GRAM by JunD and
1 3-GRAM JunD and /
1 3-GRAM / or Fra
1 3-GRAM or Fra -
3 3-GRAM - 2 was
1 3-GRAM 2 was weak
1 3-GRAM was weak .
1 3-GRAM weak . c
1 3-GRAM . c -
1 3-GRAM - Jun ,
1 3-GRAM Jun , JunB
1 3-GRAM , JunB ,
1 3-GRAM JunB , and
1 3-GRAM , and c
1 3-GRAM and c -
1 3-GRAM c - Fos
1 3-GRAM - Fos activation
1 3-GRAM Fos activation was
1 3-GRAM activation was greater
1 3-GRAM was greater ,
1 3-GRAM greater , although
1 3-GRAM although the level
1 3-GRAM the level was
1 3-GRAM level was still
1 3-GRAM was still less
1 3-GRAM still less than
1 3-GRAM less than that
1 3-GRAM than that with
1 3-GRAM that with Tax
1 3-GRAM with Tax .
1 3-GRAM Tax . STOP
1 3-GRAM , the screen
1 3-GRAM the screen for
1 3-GRAM screen for toxic
1 3-GRAM for toxic p53
1 3-GRAM toxic p53 mutants
1 3-GRAM p53 mutants in
1 3-GRAM mutants in yeast
1 3-GRAM in yeast can
1 3-GRAM yeast can identify
1 3-GRAM can identify novel
1 3-GRAM identify novel p53
1 3-GRAM novel p53 variants
1 3-GRAM p53 variants that
1 3-GRAM variants that may
1 3-GRAM that may be
1 3-GRAM may be useful
1 3-GRAM be useful in
1 3-GRAM useful in dissecting
1 3-GRAM in dissecting p53
1 3-GRAM dissecting p53 regulated
1 3-GRAM p53 regulated cellular
1 3-GRAM regulated cellular responses
1 3-GRAM cellular responses and
1 3-GRAM responses and in
1 3-GRAM and in developing
1 3-GRAM in developing p53
1 3-GRAM developing p53 -
1 3-GRAM p53 - based
1 3-GRAM - based cancer
1 3-GRAM based cancer therapies
1 3-GRAM cancer therapies .
1 3-GRAM therapies . STOP
1 3-GRAM * * Local
1 3-GRAM * Local control
1 3-GRAM Local control rates
1 3-GRAM control rates were
1 3-GRAM rates were 91
1 3-GRAM were 91 %
1 3-GRAM 91 % for
1 3-GRAM % for metastatic
1 3-GRAM for metastatic lung
1 3-GRAM metastatic lung cancer
1 3-GRAM lung cancer ,
1 3-GRAM cancer , 89
1 3-GRAM , 89 %
1 3-GRAM 89 % for
1 3-GRAM % for primary
1 3-GRAM for primary lung
1 3-GRAM primary lung cancer
1 3-GRAM lung cancer and
1 3-GRAM cancer and 85
1 3-GRAM and 85 %
1 3-GRAM 85 % for
1 3-GRAM % for T1
1 3-GRAM for T1 ,
1 3-GRAM T1 , 2N0M0
1 3-GRAM , 2N0M0 cases
1 3-GRAM 2N0M0 cases .
1 3-GRAM The results show
1 3-GRAM show that cognitive
1 3-GRAM that cognitive stimulation
1 3-GRAM cognitive stimulation enhanced
1 3-GRAM stimulation enhanced performance
1 3-GRAM enhanced performance on
1 3-GRAM performance on the
1 3-GRAM on the Boston
1 3-GRAM the Boston Naming
1 3-GRAM Boston Naming Test
1 3-GRAM Naming Test and
1 3-GRAM Test and a
1 3-GRAM and a Word
1 3-GRAM a Word List
1 3-GRAM Word List Recognition
1 3-GRAM List Recognition Task
1 3-GRAM Recognition Task ;
1 3-GRAM Task ; physical
1 3-GRAM ; physical intervention
1 3-GRAM physical intervention ,
1 3-GRAM intervention , however
1 3-GRAM however , did
1 3-GRAM , did not
1 3-GRAM did not reach
1 3-GRAM not reach statistical
1 3-GRAM reach statistical significance
1 3-GRAM statistical significance .
1 3-GRAM significance . STOP
1 3-GRAM * * Gimpl
1 3-GRAM * Gimpl ,
1 3-GRAM Gimpl , F
1 3-GRAM , F .
1 3-GRAM F . STOP
1 3-GRAM * The actA
1 3-GRAM The actA gene
1 3-GRAM actA gene is
1 3-GRAM gene is present
1 3-GRAM is present as
1 3-GRAM present as a
1 3-GRAM as a single
1 3-GRAM a single copy
1 3-GRAM single copy in
1 3-GRAM copy in the
1 3-GRAM in the genome
1 3-GRAM the genome of
1 3-GRAM genome of A
1 3-GRAM of A .
1 3-GRAM A . chrysogenum
1 3-GRAM . chrysogenum ;
1 3-GRAM chrysogenum ; and
1 3-GRAM ; and its
1 3-GRAM and its expression
1 3-GRAM its expression level
1 3-GRAM expression level ,
1 3-GRAM level , opposite
1 3-GRAM , opposite to
1 3-GRAM opposite to pcbC
1 3-GRAM to pcbC and
1 3-GRAM pcbC and cefEF
1 3-GRAM and cefEF cephalosporin
1 3-GRAM cefEF cephalosporin biosynthetic
1 3-GRAM cephalosporin biosynthetic genes
1 3-GRAM biosynthetic genes ,
1 3-GRAM genes , was
1 3-GRAM , was steady
1 3-GRAM was steady during
1 3-GRAM steady during cephalosporin
1 3-GRAM during cephalosporin fermentation
1 3-GRAM cephalosporin fermentation ,
1 3-GRAM fermentation , showing
1 3-GRAM , showing a
1 3-GRAM showing a single
1 3-GRAM a single 1
1 3-GRAM single 1 .
1 3-GRAM 1 . 4
1 3-GRAM 4 - kb
1 3-GRAM - kb transcript
1 3-GRAM kb transcript .
1 3-GRAM transcript . STOP
1 3-GRAM * * Maternal
1 3-GRAM * Maternal p
1 3-GRAM Maternal p ,
1 3-GRAM p , p
1 3-GRAM , p '
1 3-GRAM p ' DDE
1 3-GRAM ' DDE and
1 3-GRAM DDE and beta
1 3-GRAM and beta -
1 3-GRAM beta - HCH
1 3-GRAM - HCH levels
1 3-GRAM HCH levels were
1 3-GRAM levels were also
1 3-GRAM were also associated
1 3-GRAM also associated with
1 3-GRAM associated with newborn
1 3-GRAM with newborn levels
1 3-GRAM newborn levels ,
1 3-GRAM levels , but
1 3-GRAM , but levels
1 3-GRAM but levels of
1 3-GRAM levels of PCBs
1 3-GRAM of PCBs were
1 3-GRAM PCBs were not
1 3-GRAM were not .
1 3-GRAM not . STOP
1 3-GRAM * The patients
1 3-GRAM The patients and
1 3-GRAM patients and their
1 3-GRAM and their families
1 3-GRAM their families were
1 3-GRAM families were closely
1 3-GRAM were closely questioned
1 3-GRAM closely questioned ,
1 3-GRAM questioned , and
1 3-GRAM , and full
1 3-GRAM and full clinical
1 3-GRAM full clinical examination
1 3-GRAM clinical examination included
1 3-GRAM examination included a
1 3-GRAM included a test
1 3-GRAM a test for
1 3-GRAM test for orthostasia
1 3-GRAM for orthostasia .
1 3-GRAM orthostasia . STOP
1 3-GRAM * The expression
1 3-GRAM The expression of
1 3-GRAM expression of alpha
1 3-GRAM of alpha -
1 3-GRAM - amylase can
1 3-GRAM amylase can be
1 3-GRAM can be transactivated
1 3-GRAM be transactivated by
1 3-GRAM transactivated by the
1 3-GRAM transcription factor GAMyb
1 3-GRAM factor GAMyb ,
1 3-GRAM GAMyb , which
1 3-GRAM which is itself
1 3-GRAM is itself induced
1 3-GRAM itself induced by
1 3-GRAM induced by GA
1 3-GRAM by GA .
1 3-GRAM GA . STOP
1 3-GRAM * * Cardiac
1 3-GRAM * Cardiac output
1 3-GRAM Cardiac output at
1 3-GRAM output at anaerobic
1 3-GRAM at anaerobic threshold
1 3-GRAM anaerobic threshold (
1 3-GRAM threshold ( COAT
1 3-GRAM ( COAT )
1 3-GRAM COAT ) <
1 3-GRAM or = 7
1 3-GRAM = 7 .
1 3-GRAM 7 . 3
1 3-GRAM . 3 L
1 3-GRAM 3 L /
1 3-GRAM L / min
1 3-GRAM / min was
1 3-GRAM min was the
1 3-GRAM was the best
1 3-GRAM the best cutoff
1 3-GRAM best cutoff value
1 3-GRAM cutoff value for
1 3-GRAM value for identifying
1 3-GRAM for identifying multivessel
1 3-GRAM identifying multivessel coronary
1 3-GRAM multivessel coronary artery
1 3-GRAM artery disease (
1 3-GRAM disease ( relative
1 3-GRAM ( relative risk
1 3-GRAM relative risk ,
1 3-GRAM , 3 .
1 3-GRAM 3 . 1
1 3-GRAM . 1 ).
1 3-GRAM 1 ). STOP
1 3-GRAM * * Tolerance
1 3-GRAM * Tolerance to
1 3-GRAM Tolerance to ADAL
2 3-GRAM to ADAL -
2 3-GRAM ADAL - 2
1 3-GRAM 2 was similar
1 3-GRAM was similar to
1 3-GRAM similar to that
1 3-GRAM to that of
1 3-GRAM that of Vicryl
1 3-GRAM of Vicryl suture
1 3-GRAM Vicryl suture and
1 3-GRAM suture and tolerance
1 3-GRAM and tolerance to
1 3-GRAM tolerance to ADAL
1 3-GRAM 2 was superior
1 3-GRAM was superior to
1 3-GRAM superior to that
1 3-GRAM to that to
1 3-GRAM that to Tisuacryl
1 3-GRAM to Tisuacryl .
1 3-GRAM Tisuacryl . STOP
1 3-GRAM In the base
1 3-GRAM the base -
1 3-GRAM base - case
1 3-GRAM - case analysis
1 3-GRAM case analysis ,
1 3-GRAM analysis , total
1 3-GRAM , total direct
1 3-GRAM total direct costs
1 3-GRAM direct costs per
1 3-GRAM costs per patient
1 3-GRAM per patient were
1 3-GRAM patient were $
1 3-GRAM were $ 728
1 3-GRAM $ 728 for
1 3-GRAM 728 for zoledronic
1 3-GRAM for zoledronic acid
1 3-GRAM zoledronic acid and
1 3-GRAM acid and $
1 3-GRAM and $ 776
1 3-GRAM $ 776 for
1 3-GRAM 776 for pamidronate
1 3-GRAM for pamidronate .
1 3-GRAM pamidronate . STOP
1 3-GRAM : We retrospectively
1 3-GRAM We retrospectively selected
1 3-GRAM retrospectively selected 13
1 3-GRAM selected 13 TFCD
1 3-GRAM 13 TFCD patients
1 3-GRAM TFCD patients who
1 3-GRAM patients who underwent
1 3-GRAM who underwent surgery
1 3-GRAM surgery for intractable
1 3-GRAM for intractable epilepsy
1 3-GRAM intractable epilepsy with
1 3-GRAM epilepsy with the
1 3-GRAM with the aim
1 3-GRAM the aim of
1 3-GRAM aim of removing
1 3-GRAM of removing the
1 3-GRAM removing the magnetic
1 3-GRAM the magnetic resonance
1 3-GRAM ( MR )-
1 3-GRAM MR )- detectable
1 3-GRAM )- detectable lesion
1 3-GRAM detectable lesion and
1 3-GRAM lesion and /
1 3-GRAM / or the
1 3-GRAM or the epileptogenic
1 3-GRAM the epileptogenic zone
1 3-GRAM epileptogenic zone defined
1 3-GRAM zone defined by
1 3-GRAM defined by stereoelectroencephalographic
1 3-GRAM by stereoelectroencephalographic recordings
1 3-GRAM stereoelectroencephalographic recordings .
1 3-GRAM recordings . STOP
1 3-GRAM * To gain
1 3-GRAM To gain an
1 3-GRAM gain an understanding
1 3-GRAM an understanding of
1 3-GRAM understanding of the
1 3-GRAM of the mGSTM2
1 3-GRAM the mGSTM2 regulation
1 3-GRAM mGSTM2 regulation ,
1 3-GRAM regulation , we
1 3-GRAM we have also
1 3-GRAM have also cloned
1 3-GRAM also cloned and
1 3-GRAM cloned and analyzed
1 3-GRAM and analyzed its
1 3-GRAM analyzed its promoter
1 3-GRAM its promoter region
1 3-GRAM promoter region .
1 3-GRAM region . STOP
1 3-GRAM * * Cyclins
1 3-GRAM * Cyclins are
1 3-GRAM Cyclins are one
1 3-GRAM are one of
1 3-GRAM one of the
1 3-GRAM of the pivotal
1 3-GRAM the pivotal determinants
1 3-GRAM pivotal determinants regulating
1 3-GRAM determinants regulating cell
1 3-GRAM regulating cell cycle
1 3-GRAM cycle progression .
1 3-GRAM progression . STOP
1 3-GRAM * * Architecture
1 3-GRAM * Architecture and
1 3-GRAM Architecture and anatomy
1 3-GRAM and anatomy of
1 3-GRAM anatomy of the
1 3-GRAM of the genomic
1 3-GRAM the genomic locus
1 3-GRAM genomic locus encoding
1 3-GRAM locus encoding the
1 3-GRAM encoding the human
1 3-GRAM the human leukemia
1 3-GRAM human leukemia -
1 3-GRAM leukemia - associated
1 3-GRAM - associated transcription
1 3-GRAM associated transcription factor
1 3-GRAM transcription factor RUNX1
1 3-GRAM factor RUNX1 /
1 3-GRAM RUNX1 / AML1
1 3-GRAM / AML1 .
1 3-GRAM AML1 . STOP
1 3-GRAM * Three of
1 3-GRAM Three of the
1 3-GRAM of the proteins
1 3-GRAM the proteins involved
1 3-GRAM proteins involved in
1 3-GRAM involved in checkpoint
1 3-GRAM in checkpoint signaling
1 3-GRAM checkpoint signaling ,
1 3-GRAM signaling , Rad1
1 3-GRAM , Rad1 ,
1 3-GRAM Rad1 , Hus1
1 3-GRAM , Hus1 ,
1 3-GRAM Hus1 , and
1 3-GRAM , and Rad9
1 3-GRAM and Rad9 ,
1 3-GRAM Rad9 , have
1 3-GRAM , have been
1 3-GRAM shown to interact
1 3-GRAM to interact by
1 3-GRAM interact by immunoprecipitation
1 3-GRAM by immunoprecipitation and
1 3-GRAM immunoprecipitation and yeast
1 3-GRAM and yeast two
1 3-GRAM yeast two -
1 3-GRAM - hybrid studies
1 3-GRAM hybrid studies .
1 3-GRAM * * Together
1 3-GRAM * Together these
1 3-GRAM Together these data
1 3-GRAM these data imply
1 3-GRAM data imply that
1 3-GRAM imply that the
1 3-GRAM that the HFV
1 3-GRAM the HFV R
1 3-GRAM HFV R region
1 3-GRAM R region acts
1 3-GRAM region acts in
1 3-GRAM acts in the
1 3-GRAM in the nucleus
1 3-GRAM the nucleus to
1 3-GRAM nucleus to modify
1 3-GRAM to modify the
1 3-GRAM modify the cytoplasmic
1 3-GRAM the cytoplasmic fate
1 3-GRAM cytoplasmic fate of
1 3-GRAM fate of target
1 3-GRAM of target HFV
1 3-GRAM target HFV mRNA
1 3-GRAM HFV mRNA .
1 3-GRAM mRNA . STOP
1 3-GRAM However , patients
1 3-GRAM , patients with
1 3-GRAM patients with isolated
1 3-GRAM with isolated office
1 3-GRAM isolated office hypertension
1 3-GRAM office hypertension had
1 3-GRAM hypertension had fewer
1 3-GRAM had fewer previous
1 3-GRAM fewer previous cardiovascular
1 3-GRAM previous cardiovascular complications
1 3-GRAM cardiovascular complications .
1 3-GRAM complications . STOP
1 3-GRAM * Through deletion
1 3-GRAM Through deletion mutagenesis
1 3-GRAM deletion mutagenesis ,
1 3-GRAM mutagenesis , we
1 3-GRAM , we identify
1 3-GRAM we identify amino
1 3-GRAM identify amino acids
1 3-GRAM amino acids 2003
1 3-GRAM acids 2003 to
1 3-GRAM 2003 to 2212
1 3-GRAM to 2212 of
1 3-GRAM 2212 of CBP
1 3-GRAM of CBP ,
1 3-GRAM CBP , which
1 3-GRAM which we call
1 3-GRAM we call carboxy
1 3-GRAM call carboxy -
1 3-GRAM carboxy - terminal
1 3-GRAM terminal region 2
1 3-GRAM region 2 (
1 3-GRAM 2 ( CR2
1 3-GRAM ( CR2 ),
1 3-GRAM CR2 ), as
1 3-GRAM ), as the
1 3-GRAM as the minimal
1 3-GRAM the minimal region
1 3-GRAM minimal region for
1 3-GRAM region for Tax
1 3-GRAM for Tax interaction
1 3-GRAM Tax interaction .
1 3-GRAM interaction . STOP
1 3-GRAM * * Fetal
1 3-GRAM * Fetal lung
1 3-GRAM Fetal lung volume
1 3-GRAM lung volume :
1 3-GRAM volume : estimation
1 3-GRAM : estimation at
1 3-GRAM estimation at MR
1 3-GRAM at MR imaging
1 3-GRAM MR imaging -
1 3-GRAM imaging - initial
1 3-GRAM - initial results
1 3-GRAM initial results .
1 3-GRAM results . STOP
1 3-GRAM * * Plane
1 3-GRAM * Plane wave
1 3-GRAM Plane wave geometry
1 3-GRAM wave geometry is
1 3-GRAM geometry is impractical
1 3-GRAM is impractical for
1 3-GRAM impractical for clinical
1 3-GRAM for clinical use
1 3-GRAM clinical use but
1 3-GRAM use but the
1 3-GRAM but the results
1 3-GRAM results of this
1 3-GRAM of this work
1 3-GRAM this work encouraged
1 3-GRAM work encouraged us
1 3-GRAM encouraged us to
1 3-GRAM us to further
1 3-GRAM to further develop
1 3-GRAM further develop the
1 3-GRAM develop the P3
1 3-GRAM the P3 approximation
1 3-GRAM P3 approximation for
1 3-GRAM approximation for a
1 3-GRAM for a spherical
1 3-GRAM a spherical geometry
1 3-GRAM spherical geometry ,
1 3-GRAM geometry , described
1 3-GRAM , described in
1 3-GRAM described in this
1 3-GRAM in this paper
1 3-GRAM this paper .
1 3-GRAM paper . STOP
1 3-GRAM * For the
1 3-GRAM For the sample
1 3-GRAM the sample of
1 3-GRAM sample of systematic
1 3-GRAM of systematic reviews
1 3-GRAM systematic reviews drawn
1 3-GRAM reviews drawn from
1 3-GRAM drawn from ACP
1 3-GRAM from ACP Journal
1 3-GRAM ACP Journal Club
1 3-GRAM Journal Club (
1 3-GRAM Club ( n
1 3-GRAM ( n =
1 3-GRAM n = 103
1 3-GRAM = 103 ),
1 3-GRAM 103 ), the
1 3-GRAM ), the PubMed
1 3-GRAM the PubMed strategy
1 3-GRAM PubMed strategy achieved
1 3-GRAM strategy achieved a
1 3-GRAM achieved a sensitivity
1 3-GRAM a sensitivity of
1 3-GRAM sensitivity of 97
1 3-GRAM of 97 %
1 3-GRAM 97 % (
1 3-GRAM % ( CI
1 3-GRAM ( CI ,
1 3-GRAM CI , 91
1 3-GRAM , 91 %
1 3-GRAM 91 % to
1 3-GRAM % to 99
1 3-GRAM to 99 %).
1 3-GRAM 99 %). STOP
1 3-GRAM In addition to
1 3-GRAM addition to that
1 3-GRAM to that ,
1 3-GRAM that , she
1 3-GRAM , she received
1 3-GRAM she received hepatic
1 3-GRAM received hepatic intra
1 3-GRAM hepatic intra -
1 3-GRAM intra - arterial
1 3-GRAM - arterial infusion
1 3-GRAM arterial infusion of
1 3-GRAM infusion of levoforinate
1 3-GRAM of levoforinate (
1 3-GRAM levoforinate ( l
1 3-GRAM ( l -
1 3-GRAM l - LV
1 3-GRAM - LV )
1 3-GRAM LV ) 250
1 3-GRAM ) 250 mg
1 3-GRAM 250 mg and
1 3-GRAM mg and 5
1 3-GRAM - fluorouracil (
1 3-GRAM fluorouracil ( 5
1 3-GRAM ( 5 -
1 3-GRAM 5 - FU
1 3-GRAM - FU )
1 3-GRAM FU ) 500
1 3-GRAM ) 500 mg
1 3-GRAM 500 mg for
1 3-GRAM mg for combined
1 3-GRAM for combined multiple
1 3-GRAM combined multiple hepatic
1 3-GRAM multiple hepatic metastases
1 3-GRAM hepatic metastases starting
1 3-GRAM metastases starting on
1 3-GRAM starting on postoperative
1 3-GRAM on postoperative day
1 3-GRAM postoperative day 14
1 3-GRAM day 14 ,
1 3-GRAM 14 , and
1 3-GRAM , and these
1 3-GRAM and these medications
1 3-GRAM these medications were
1 3-GRAM medications were administered
1 3-GRAM were administered over
1 3-GRAM administered over 48
1 3-GRAM over 48 hours
1 3-GRAM 48 hours once
1 3-GRAM hours once weekly
1 3-GRAM once weekly by
1 3-GRAM weekly by infuser
1 3-GRAM by infuser pump
1 3-GRAM infuser pump .
1 3-GRAM pump . STOP
1 3-GRAM * * Because
1 3-GRAM * Because of
1 3-GRAM Because of differences
1 3-GRAM of differences in
1 3-GRAM differences in patient
1 3-GRAM in patient characteristics
1 3-GRAM patient characteristics ,
1 3-GRAM characteristics , control
1 3-GRAM , control measurements
1 3-GRAM control measurements were
1 3-GRAM measurements were obtained
1 3-GRAM were obtained from
1 3-GRAM obtained from normal
1 3-GRAM from normal muscle
1 3-GRAM normal muscle in
1 3-GRAM muscle in all
1 3-GRAM in all patients
1 3-GRAM all patients .
1 3-GRAM * Two families
1 3-GRAM Two families with
1 3-GRAM families with concordant
1 3-GRAM with concordant inheritance
1 3-GRAM concordant inheritance of
1 3-GRAM inheritance of DNAH9
1 3-GRAM of DNAH9 alleles
1 3-GRAM DNAH9 alleles in
1 3-GRAM alleles in affected
1 3-GRAM in affected individuals
1 3-GRAM affected individuals were
1 3-GRAM individuals were observed
1 3-GRAM were observed .
1 3-GRAM observed . STOP
1 3-GRAM * * NIRS
1 3-GRAM * NIRS was
1 3-GRAM NIRS was used
1 3-GRAM was used for
1 3-GRAM for the quantitative
1 3-GRAM the quantitative measurement
1 3-GRAM quantitative measurement of
1 3-GRAM measurement of muscle
1 3-GRAM of muscle O
1 3-GRAM muscle O (
2 3-GRAM O ( 2
1 3-GRAM 2 ) consumption
1 3-GRAM ) consumption (
1 3-GRAM consumption ( mV
1 3-GRAM ( mV .
1 3-GRAM mV . O
1 3-GRAM . O (
1 3-GRAM 2 )) and
1 3-GRAM )) and forearm
1 3-GRAM and forearm blood
1 3-GRAM forearm blood flow
1 3-GRAM blood flow (
1 3-GRAM flow ( FBF
1 3-GRAM ( FBF )
1 3-GRAM FBF ) in
1 3-GRAM ) in 78
1 3-GRAM in 78 healthy
1 3-GRAM 78 healthy subjects
1 3-GRAM healthy subjects .
1 3-GRAM subjects . STOP
1 3-GRAM * Many factors
1 3-GRAM Many factors do
1 3-GRAM factors do influence
1 3-GRAM do influence the
1 3-GRAM influence the educational
1 3-GRAM the educational outcome
1 3-GRAM educational outcome in
1 3-GRAM outcome in students
1 3-GRAM in students and
1 3-GRAM students and large
1 3-GRAM and large statistical
1 3-GRAM large statistical power
1 3-GRAM statistical power (
1 3-GRAM power ( such
1 3-GRAM ( such as
1 3-GRAM such as meta
1 3-GRAM as meta analysis
1 3-GRAM meta analysis )
1 3-GRAM analysis ) should
1 3-GRAM ) should be
1 3-GRAM should be helpful
1 3-GRAM be helpful to
1 3-GRAM helpful to eliminate
1 3-GRAM to eliminate many
1 3-GRAM eliminate many sources
1 3-GRAM many sources of
1 3-GRAM sources of error
1 3-GRAM of error .
1 3-GRAM error . STOP
1 3-GRAM * * B
1 3-GRAM * B -
1 3-GRAM B - myb
1 3-GRAM - myb is
1 3-GRAM myb is essential
1 3-GRAM essential for G1
1 3-GRAM for G1 /
1 3-GRAM G1 / S
1 3-GRAM / S transition
1 3-GRAM S transition and
1 3-GRAM transition and has
1 3-GRAM and has been
1 3-GRAM shown to be
1 3-GRAM to be phosphorylated
1 3-GRAM be phosphorylated by
1 3-GRAM phosphorylated by the
1 3-GRAM by the cyclin
1 3-GRAM the cyclin A2
1 3-GRAM cyclin A2 /
1 3-GRAM A2 / cdk2
1 3-GRAM / cdk2 complex
1 3-GRAM cdk2 complex .
1 3-GRAM complex . STOP
1 3-GRAM * * Like
1 3-GRAM * Like the
1 3-GRAM Like the consensus
1 3-GRAM the consensus mammalian
1 3-GRAM consensus mammalian LHbeta
1 3-GRAM mammalian LHbeta gene
1 3-GRAM LHbeta gene ,
1 3-GRAM 5 '- flanking
1 3-GRAM '- flanking region
1 3-GRAM flanking region of
1 3-GRAM of the gpLH
1 3-GRAM the gpLH /
1 3-GRAM gpLH / CGbeta
1 3-GRAM / CGbeta gene
1 3-GRAM CGbeta gene contains
1 3-GRAM gene contains a
1 3-GRAM contains a single
1 3-GRAM a single TATA
1 3-GRAM single TATA sequence
1 3-GRAM TATA sequence 37
1 3-GRAM sequence 37 bp
1 3-GRAM 37 bp upstream
1 3-GRAM bp upstream of
1 3-GRAM upstream of the
1 3-GRAM of the translation
1 3-GRAM the translation start
1 3-GRAM translation start codon
1 3-GRAM start codon .
1 3-GRAM codon . STOP
1 3-GRAM * * HTLV
1 3-GRAM * HTLV -
1 3-GRAM HTLV - 1
1 3-GRAM - 1 decreases
1 3-GRAM 1 decreases Th2
1 3-GRAM decreases Th2 type
1 3-GRAM Th2 type of
1 3-GRAM type of immune
1 3-GRAM of immune response
1 3-GRAM immune response in
1 3-GRAM response in patients
1 3-GRAM patients with strongyloidiasis
1 3-GRAM with strongyloidiasis .
1 3-GRAM strongyloidiasis . STOP
1 3-GRAM * * Indeed
1 3-GRAM * Indeed ,
1 3-GRAM Indeed , mutation
1 3-GRAM , mutation of
1 3-GRAM mutation of two
1 3-GRAM of two of
1 3-GRAM two of these
1 3-GRAM of these motifs
1 3-GRAM these motifs ,
1 3-GRAM motifs , known
1 3-GRAM , known to
1 3-GRAM known to be
1 3-GRAM to be important
1 3-GRAM be important to
1 3-GRAM important to regulation
1 3-GRAM to regulation of
1 3-GRAM regulation of sid1
1 3-GRAM of sid1 ,
1 3-GRAM sid1 , altered
1 3-GRAM , altered the
1 3-GRAM altered the differential
1 3-GRAM the differential regulation
1 3-GRAM differential regulation of
1 3-GRAM regulation of sid2
1 3-GRAM of sid2 by
1 3-GRAM sid2 by iron
1 3-GRAM by iron .
1 3-GRAM iron . STOP
1 3-GRAM * * Nutritional
1 3-GRAM * Nutritional status
1 3-GRAM Nutritional status in
1 3-GRAM status in adults
1 3-GRAM in adults on
1 3-GRAM adults on an
1 3-GRAM on an alternative
1 3-GRAM an alternative or
1 3-GRAM alternative or traditional
1 3-GRAM or traditional diet
1 3-GRAM traditional diet ]
1 3-GRAM diet ] BACKGROUND
1 3-GRAM ] BACKGROUND :
1 3-GRAM BACKGROUND : Plant
1 3-GRAM : Plant food
1 3-GRAM Plant food lacks
1 3-GRAM food lacks vitamin
1 3-GRAM lacks vitamin B12
1 3-GRAM vitamin B12 ,
1 3-GRAM B12 , vitamin
1 3-GRAM , vitamin D
1 3-GRAM vitamin D and
1 3-GRAM D and higher
1 3-GRAM and higher n
1 3-GRAM higher n -
1 3-GRAM n - 3
1 3-GRAM - 3 polyunsaturated
1 3-GRAM 3 polyunsaturated fatty
1 3-GRAM polyunsaturated fatty acids
1 3-GRAM fatty acids .
1 3-GRAM * * On
1 3-GRAM * On the
1 3-GRAM On the other
1 3-GRAM hand , forced
1 3-GRAM , forced overexpression
1 3-GRAM forced overexpression of
1 3-GRAM overexpression of the
1 3-GRAM of the wild
1 3-GRAM the wild type
1 3-GRAM wild type ,
1 3-GRAM type , but
1 3-GRAM but not the
1 3-GRAM not the kinase
1 3-GRAM the kinase -
1 3-GRAM kinase - inactivated
1 3-GRAM - inactivated mutant
1 3-GRAM inactivated mutant of
1 3-GRAM mutant of nm23H1
1 3-GRAM of nm23H1 ,
1 3-GRAM nm23H1 , converted
1 3-GRAM , converted the
1 3-GRAM converted the GDP
1 3-GRAM the GDP -
1 3-GRAM GDP - bound
2 3-GRAM - bound forms
1 3-GRAM bound forms of
1 3-GRAM forms of Rac1
1 3-GRAM of Rac1 ,
1 3-GRAM Rac1 , Cdc42
1 3-GRAM , Cdc42 ,
1 3-GRAM Cdc42 , and
1 3-GRAM , and RhoA
1 3-GRAM and RhoA to
1 3-GRAM RhoA to their
1 3-GRAM to their GTP
1 3-GRAM their GTP -
2 3-GRAM GTP - bound
1 3-GRAM bound forms in
1 3-GRAM forms in vitro
1 3-GRAM vitro by its
1 3-GRAM by its nucleoside
1 3-GRAM its nucleoside diphosphate
1 3-GRAM nucleoside diphosphate kinase
1 3-GRAM diphosphate kinase activity
1 3-GRAM kinase activity ,
1 3-GRAM activity , but
1 3-GRAM , but nm23H1
1 3-GRAM but nm23H1 alone
1 3-GRAM nm23H1 alone apparently
1 3-GRAM alone apparently did
1 3-GRAM apparently did not
1 3-GRAM did not produce
1 3-GRAM not produce the
1 3-GRAM produce the GTP
1 3-GRAM the GTP -
1 3-GRAM - bound form
1 3-GRAM bound form of
1 3-GRAM form of these
1 3-GRAM of these GTPases
1 3-GRAM these GTPases in
1 3-GRAM GTPases in vivo
1 3-GRAM * * Novel
1 3-GRAM * Novel intronic
1 3-GRAM Novel intronic promoter
1 3-GRAM the rat ER
1 3-GRAM rat ER alpha
1 3-GRAM ER alpha gene
1 3-GRAM alpha gene responsible
1 3-GRAM gene responsible for
1 3-GRAM responsible for the
1 3-GRAM for the transient
1 3-GRAM the transient transcription
1 3-GRAM transient transcription of
1 3-GRAM transcription of a
1 3-GRAM of a variant
1 3-GRAM a variant receptor
1 3-GRAM variant receptor .
1 3-GRAM RESULTS : Coronary
1 3-GRAM : Coronary mortality
1 3-GRAM Coronary mortality during
1 3-GRAM mortality during the
1 3-GRAM during the median
1 3-GRAM the median follow
1 3-GRAM median follow -
1 3-GRAM follow - up
1 3-GRAM - up time
1 3-GRAM up time of
1 3-GRAM time of 17
1 3-GRAM of 17 months
1 3-GRAM 17 months was
1 3-GRAM months was 6
1 3-GRAM was 6 -
1 3-GRAM 6 - fold
2 3-GRAM - fold higher
2 3-GRAM fold higher in
2 3-GRAM in the highest
2 3-GRAM the highest tertile
2 3-GRAM highest tertile for
1 3-GRAM tertile for CRP
1 3-GRAM for CRP and
1 3-GRAM CRP and IL
1 3-GRAM and IL -
2 3-GRAM - 6 and
1 3-GRAM 6 and 3
1 3-GRAM and 3 .
1 3-GRAM 3 . 5
1 3-GRAM . 5 -
1 3-GRAM 5 - fold
1 3-GRAM tertile for fibrinogen
1 3-GRAM for fibrinogen and
1 3-GRAM fibrinogen and TNF
1 3-GRAM and TNF -
1 3-GRAM - alpha than
1 3-GRAM alpha than in
1 3-GRAM in the respective
1 3-GRAM the respective combined
1 3-GRAM respective combined lower
1 3-GRAM combined lower tertiles
1 3-GRAM lower tertiles .
1 3-GRAM tertiles . STOP
1 3-GRAM * * HIV
1 3-GRAM * HIV -
1 3-GRAM 1 and hepatitis
1 3-GRAM and hepatitis B
1 3-GRAM hepatitis B virus
1 3-GRAM B virus infections
1 3-GRAM virus infections in
1 3-GRAM infections in adolescents
1 3-GRAM in adolescents lodged
1 3-GRAM adolescents lodged in
1 3-GRAM lodged in security
1 3-GRAM in security institutes
1 3-GRAM security institutes of
1 3-GRAM institutes of Buenos
1 3-GRAM of Buenos Aires
1 3-GRAM Buenos Aires .
1 3-GRAM Aires . STOP
1 3-GRAM , the promoter
1 3-GRAM the promoter region
1 3-GRAM promoter region contains
1 3-GRAM region contains several
1 3-GRAM contains several potential
1 3-GRAM several potential cis
1 3-GRAM potential cis -
1 3-GRAM cis - regulatory
1 3-GRAM - regulatory elements
1 3-GRAM regulatory elements such
1 3-GRAM elements such as
1 3-GRAM such as Sp1
1 3-GRAM as Sp1 ,
1 3-GRAM Sp1 , early
1 3-GRAM , early growth
1 3-GRAM early growth response
1 3-GRAM growth response -
1 3-GRAM response - 1
1 3-GRAM 1 , activator
1 3-GRAM , activator protein
1 3-GRAM activator protein -
1 3-GRAM 2 , MyoD
1 3-GRAM , MyoD ,
1 3-GRAM MyoD , p300
1 3-GRAM , p300 ,
1 3-GRAM p300 , nuclear
1 3-GRAM , nuclear factor
1 3-GRAM nuclear factor -
1 3-GRAM factor - kappaB
1 3-GRAM - kappaB ,
1 3-GRAM kappaB , myeloid
1 3-GRAM , myeloid zinc
1 3-GRAM myeloid zinc finger
1 3-GRAM zinc finger protein
1 3-GRAM finger protein -
1 3-GRAM protein - 1
1 3-GRAM 1 , caudal
1 3-GRAM , caudal -
1 3-GRAM caudal - related
1 3-GRAM - related homeobox
1 3-GRAM related homeobox (
1 3-GRAM homeobox ( Cdx
1 3-GRAM ( Cdx )
1 3-GRAM Cdx ) gene
1 3-GRAM ) gene A
1 3-GRAM gene A ,
1 3-GRAM A , and
1 3-GRAM , and Cdx
1 3-GRAM and Cdx protein
1 3-GRAM Cdx protein -
1 3-GRAM - 2 binding
1 3-GRAM 2 binding sites
1 3-GRAM binding sites .
1 3-GRAM * * RPM
1 3-GRAM * RPM /
1 3-GRAM RPM / RGL3
1 3-GRAM / RGL3 resembled
1 3-GRAM RGL3 resembled AF
1 3-GRAM resembled AF -
1 3-GRAM AF - 6
1 3-GRAM 6 and Nore1
1 3-GRAM and Nore1 in
1 3-GRAM Nore1 in interacting
1 3-GRAM in interacting strongly
1 3-GRAM interacting strongly with
1 3-GRAM strongly with constitutively
1 3-GRAM with constitutively active
1 3-GRAM constitutively active M
1 3-GRAM active M -
1 3-GRAM p21 Ras .
1 3-GRAM Ras . STOP
1 3-GRAM METHODS : 93
1 3-GRAM : 93 female
1 3-GRAM 93 female and
1 3-GRAM female and 43
1 3-GRAM and 43 male
1 3-GRAM 43 male patients
1 3-GRAM male patients undergoing
1 3-GRAM patients undergoing thyroid
1 3-GRAM undergoing thyroid surgery
1 3-GRAM thyroid surgery were
1 3-GRAM surgery were stratified
1 3-GRAM were stratified according
1 3-GRAM stratified according to
1 3-GRAM according to gender
1 3-GRAM to gender and
1 3-GRAM gender and then
1 3-GRAM and then randomised
1 3-GRAM then randomised to
1 3-GRAM randomised to receive
1 3-GRAM to receive double
1 3-GRAM receive double -
1 3-GRAM double - blind
1 3-GRAM - blind one
1 3-GRAM blind one of
1 3-GRAM one of four
1 3-GRAM of four antiemetic
1 3-GRAM four antiemetic regimes
1 3-GRAM antiemetic regimes :
1 3-GRAM regimes : 50
1 3-GRAM : 50 mg
1 3-GRAM 50 mg dolasetron
2 3-GRAM mg dolasetron given
1 3-GRAM dolasetron given orally
1 3-GRAM given orally 45
1 3-GRAM orally 45 minutes
1 3-GRAM 45 minutes prior
1 3-GRAM minutes prior to
1 3-GRAM prior to induction
1 3-GRAM to induction of
3 3-GRAM induction of anaesthesia
3 3-GRAM of anaesthesia (
3 3-GRAM anaesthesia ( group
1 3-GRAM ( group I
1 3-GRAM group I ),
1 3-GRAM I ), 12
1 3-GRAM ), 12 .
1 3-GRAM 12 . 5
1 3-GRAM . 5 mg
1 3-GRAM 5 mg dolasetron
1 3-GRAM dolasetron given intravenously
2 3-GRAM given intravenously during
2 3-GRAM intravenously during induction
2 3-GRAM during induction of
1 3-GRAM ( group II
1 3-GRAM group II ),
1 3-GRAM II ), 1
1 3-GRAM ), 1 .
1 3-GRAM 1 . 25
1 3-GRAM . 25 mg
1 3-GRAM 25 mg DHB
1 3-GRAM mg DHB given
1 3-GRAM DHB given intravenously
1 3-GRAM ( group III
1 3-GRAM group III )
1 3-GRAM III ) or
1 3-GRAM ) or placebo
1 3-GRAM or placebo (
1 3-GRAM placebo ( group
1 3-GRAM ( group IV
1 3-GRAM group IV ).
1 3-GRAM IV ). STOP
1 3-GRAM * * Transcriptional
1 3-GRAM * Transcriptional regulation
1 3-GRAM Transcriptional regulation of
1 3-GRAM of the estrogen
1 3-GRAM the estrogen -
1 3-GRAM estrogen - inducible
1 3-GRAM - inducible pS2
1 3-GRAM inducible pS2 breast
1 3-GRAM pS2 breast cancer
1 3-GRAM breast cancer marker
1 3-GRAM cancer marker gene
1 3-GRAM marker gene by
1 3-GRAM gene by the
1 3-GRAM by the ERR
1 3-GRAM the ERR family
1 3-GRAM ERR family of
1 3-GRAM family of orphan
1 3-GRAM of orphan nuclear
1 3-GRAM orphan nuclear receptors
1 3-GRAM nuclear receptors .
